Hoofdstuk 1. Definities en algemene bepalingen

(Te k st ge lde nd o p: 09-09-2013) R e geling va n de Ministe r va n Vo lk sge zo ndhe id, W e lzijn e n Spo rt van 1 se pte m be r 2005, nr. Z/VV-2611957, ho udende rege ls te r za k e van de uitvoe ring va n de Zorgverze k e ringswet (R ege ling zo rgve rzek e ring) De Ministe r va n Vo lk sge zo ndhe id, W e lzijn e n Spo rt, Ha nde le nde in o vere e nste m m ing m e t de Minister va n Fina ncië n e n de Ministe r van So ciale Zak e n en W e rk ge lege nhe id, Ge let o p de a rtik ele n 32, vie rde lid, 35, vierde lid, 38, twe e de lid, 39, vie rde lid, 40, vijfde , tiende en e lfde lid, 43, twee de lid, 45, twe e de e n vie rde lid, 46, e erste lid, 47, 50, vie rde lid, 52, 53, 59, ne ge nde lid, 68, e e rste to t en m e t vie rde lid, 69, twee de en vijfde lid, 70, e lfde lid, 75, derde e n vierde lid, 87, de rde en zesde lid, 88, vie rde lid, 89, ze sde lid, 106, de rde lid, 118, ee rste lid, va n de Zo rgve rze k eringswe t en de artik e le n 2.4, twe e de e n de rde lid, 2.7, ze sde lid, 2.8, e e rste , twe ede , vijfde e n ze sde lid, 2.9, 2.12, twe ede lid, 2.14, twe e de lid, 2.16, 3.1, twe e de lid, 3.3, derde lid, 3.4, twe e de lid, 3.5, de rde lid, 3.6, derde lid, 3.8, vie rde lid, 3.9, e erste , de rde , vie rde en vijfde lid, 3.10, e e rste e n twe e de lid, 3.11, ee rste to t e n m e t de rde lid, 3.12, ee rste to t e n m e t de rde lid, 3.15 de rde lid e n 3.17 va n he t Besluit zorgverze k e ring; Be sluit:

Hoofdstuk 1. Definities en algemene bepalingen A rtikel 1 1.

De ze re geling ve rsta a t onde r: a.

de Minister: de Ministe r va n Volk sge zo ndhe id, W e lzijn en Sport;

b.

spe cia lité : e e n ge ne esm idde l a ls be doe ld in a rtik e l 1, ee rste lid, onde rde e l h, va n de W et o p de Ge nee sm iddele nvo o rzie ning;

c.

pre pa ra a t: e en ge ne e sm idde l a ls bedo e ld in artik e l 1, e e rste lid, o nde rde el i, va n de W e t o p de Ge nee sm iddele nvo o rzie ning;

d.

bra nde d ge ne ric: e en spe cia lité die in de ha nde l wordt ge bra cht o nde r e e n be nam ing wa a rin de sto fnaa m is verm e ld e n wa ara a n ee n m erk a a nduiding is to ege vo e gd;

e.

co m bina tiepre para a t: e e n ge nee sm iddel da t m e e r dan é é n we rk za a m be sta ndde e l be vat;

f.

de el IB van he t registe rdo ssie r: he t re gisterbla d, inhoude nde de ge geve ns, bedo e ld in artik e l 2, e e rste lid, o nde rde el h, va n he t Be sluit re gistratie gene e sm idde len, o f het re giste rbla d, bedo e ld in de e l I, o nde rdee l B, va n de bijla ge va n de richtlijn nr. 75/318/EEG va n de R a ad van de Euro pe se Ge m e enschappe n va n 20 m ei 1975 be treffe nde de o nde rlinge aa npassing va n de we tge vinge n va n de Lid-Sta ten inza k e de a na lytische, to x ico lo gisch-fa rm a co lo gische e n k linische no rm en e n vo o rschrifte n be treffe nde pro e ve n op fa rm aceutische spe cia lite ite n (PbEG L 147/1);

g.

re gistra tie ho ude r: de ge ne op wiens na a m ee n gene e sm idde l in he t registe r, be do e ld in a rtik e l 3, e e rste lid, va n de W et o p de Gene e sm idde lenvoo rzie ning staa t inge schreve n da n we l dege ne die vo o r ee n gene e sm idde l ee n ve rgunning he e ft inge volge de Ve rorde ning (EEG) nr. 2309/93 va n de R a a d va n de Euro pe se Ge m e e nscha ppe n va n 22 juli 1993 to t vastste lling van co m m una utaire procedure s voo r he t ve rlene n va n ve rgunninge n vo o r en he t toe zicht o p gene e sm idde len voo r m e nse lijk e n die rgene e sk undig ge bruik e n tot o prichting va n e en Euro pe es bure a u vo o r de ge ne e sm idde le nbe o orde ling (P bEG L 214);

h.

Ta x e : de Tax e , uitge geve n do o r de Z-inde x B.V.;

i.

De fine d Da ily Dose : de da gdo sis va n e en ge ne e sm idde l, a ls va stge steld o nde r ve ra ntwo o rdelijk he id va n he t W HO C o lla bo rating C entre fo r Drug Sta tistics Metho dolo gy;

j.

Anato m ica l The rape utic C he m ica l C la ssificatio n: de cla ssifica tie van ge ne e sm idde le n, sa m e ngeste ld o nde r vera ntwoo rde lijk he id va n he t W HO C o lla bo rating C entre fo r Drug Sta tistics Metho dolo gy;

k.

standa ardk uur: de to ta le ho eve elhe id van he t we rk za m e be standdee l va n e en ge ne e sm idde l dat, blijk e ns de do sering, verm e ld in dee l IB va n het re giste rdossie r, wordt ge ge ven;

l.

re fe rentie ho e ve e lhe id: de ho e ve e lhe id va n e e n we rk za a m be standdee l, in e e n farm a ce utische vo rm ge bra cht, wa a rm ee , ge ge ven de sta nda a rddo sis e n he t gebruik e lijk e a anta l k e re n pe r da g da t het ge nee sm iddel wo rdt ge geve n o m die standa arddo sis te be reik e n, de gebruik e lijk e dage lijk se do se ring k a n wo rden be reik t, m et die n ve rsta nde da t bij k euze tusse n e e n reta rdvo rm e n e e n nie t-re ta rdvo rm wo rdt uitge ga a n va n de niet-reta rdvo rm ;

m.

dbc: diagno se beha nde ling co m bina tie;

n.

een rekening-courant: e e n rek e ning in de ce ntrale a dm inistra tie van ’s rijk s schatk ist bij he t m inisterie va n Fina ncië n o p na a m va n e e n rek e ning-co ura ntho ude r, wa aro p dage lijk s he t gelde lijk tego e d (po sitie f o f ne ga tie f) wo rdt bijgeho ude n va n de be tro k k e n rek e ning-co ura ntho ude r bij he t R ijk e n de m utatie s in het te go ed;

2.

p.

Euribor: de dage lijk s do o r de Euro pe an Ba nk ing Fe de ra tion vastgeste lde re nte wa arte ge n o p de ge ldm a rk t inte rbanca ir de posito’s in e uro’s va n ve rschillende lo o ptijde n wo rden a a nge bode n in la nde n wa a r de e uro be ta a lm idde l is;

q.

prestatie: e en pre sta tie a ls o m schre ven bij o f k ra chtens artik e l 11 va n de Zo rgve rze k e ringswe t;

r.

prestatiebeschrijving: 1°.

e e n be schrijving va n de pre sta tie zo als die o p gro nd va n de W et m a rk torde ning gezo ndhe idszo rg vo o r ee n zorga a nbie de r is va stge ste ld da n we l

2°.

e e n be schrijving va n de pre sta tie zo als die tussen de ve rze k e rde e n de zorga a nbie de r is o vere e nge k o m e n indie n vo or die zo rga a nbie der nie t ee n presta tie be schrijving o p grond va n de W e t m ark to rdening ge zo ndhe idszorg be ho e ft te wo rde n va stge steld;

s.

declaratieregeling: e en re geling be doe ld in a rtik e l 38, de rde lid, onde r b, va n de W et m a rk torde ning gezo ndhe idszo rg;

t.

formele controle: e e n onde rzo e k wa a rbij de zo rgve rze k era a r naga a t of he t ta rie f da t do o r e en zorga a nbie de r voo r e e n pre sta tie in re k ening is ge bra cht: 1°.

e e n pre sta tie be tre ft, welk e is gele ve rd a an e e n bij die zo rgve rzek e ra ar ve rze k erde perso on;

2°.

e e n pre sta tie be tre ft, welk e be ho ort to t he t ve rze k e rde pa k k e t va n die pe rso o n,

3°.

e e n pre sta tie be tre ft, to t le vering wa a rva n de zo rga a nbie der be vo e gd is, en

4°.

he t tarie f betre ft, da t vo o r die presta tie k ra chtens de W e t m a rk to rde ning ge zo ndhe idszo rg is vastgeste ld o f e en ta rief is da t vo o r die pre sta tie m e t de zo rga a nbie der is ove ree ngek o m en;

u.

materiële controle: ee n o nde rzo e k wa a rbij de zo rgve rze k e raa r na ga a t o f de do or de zo rga anbiede r in re k e ning ge bra chte pre sta tie is gele ve rd e n die ge le ve rde pre sta tie he t m e est was a ange we zen ge zie n de gezo ndhe idstoe stand va n de ve rze k erde ;

v.

fraudeonderzoek: e e n onde rzo e k wa a rbij de zo rgve rze k era a r naga a t of de ve rzek e rde o f de zo rgaa nbie de r va lshe id in ge schrifte , bedro g, be na de ling van re chthebbe nde n of ve rduiste ring ple egt o f tra cht te ple ge n te n na dele va n bij de to tstandk om ing o f uitvo e ring va n e en o ve re e nk o m st van zorgverze k e ring be tro k k e n pe rsone n en o rganisa tie s m e t he t do el e e n pre statie , ve rgo eding, be ta ling of a nder vo orde e l te k rijge n wa a ro p de ve rzek e rde da n we l de zo rga a nbie der ge e n re cht he e ft of re cht k a n he bbe n;

w.

verhaalsrecht: he t re cht va n de ve rze k era a r o p gro nd va n a rtik el 962 va n Bo e k 7 van he t Burge rlijk W e tbo ek de scha de die is ve roo rzaa k t doo r a nde re n da n de ve rze k erde o p de ze de rde n te ve rhale n;

x.

detailcontrole: onde rzo e k do o r de zorgverze k e ra a r na a r bij de zo rgaa nbie de r be ruste nde pe rso o nsge ge vens m e t be trek k ing to t e ige n ve rzek e rden te n be ho eve va n m a te riële co ntrole o f fraude onde rzo e k ;

y.

algemene risicoanalyse: e e n ana lyse die ero p is ge richt te be pa le n o p welk e ge ge ve ns de m a te riële co ntrole o f he t fra udeo nderzo ek zich za l richte n;

z.

specifieke risicoanalyse: e en a nalyse die e ro p is ge richt te be pa le n o p we lk e ge ge vens en o p we lk e zo rga a nbie ders o f cate go rie ë n va n zo rgaa nbie de rs de de ta ilcontro le zich za l richte n;

aa.

bewerker: de ge ne be do eld in a rtik el 1, o nde rdee l e , va n de W e t be scherm ing pe rso o nsge ge vens;

bb.

grensoverschrijdende zorg: zo rg waa ro p de Zo rgve rze k eringswe t recht ge e ft en die ve rze k erde n buite n Ne derla nd he bbe n ge note n.

Vo or de to epa ssing van de ze re ge ling wo rdt o nder m o gendheid m ede ve rstaa n de Ne derla ndse Antille n e n Aruba.

Bepalingen omtrent de prestaties

Hoofdstuk 2.

§ 1. De prestaties en eigen bijdragen § 1.1. Geneeskundige zorg A rtikel 2.1 De zo rg bedo e ld in artik e l 2.4 va n het Be sluit zo rgve rze k e ring o m va t nie t: a.

be ha ndeling va n bo ve no ogle de n die verla m d o f verslapt zijn, a nde rs da n als ge volg va n e en a a nge bore n a fwijk ing o f va n ee n bij de ge bo orte a a nwe zige chronische a a ndo e ning;

b.

lipo suctie van de buik ;

c.

he t ope ra tie f plaa tsen e n he t o pera tie f ve rva ngen van e e n bo rstpro these , ande rs da n na e en ge he le of ge dee lte lijk e bo rsta m puta tie;

d.

he t ope ra tie f verwijde re n va n ee n borstprothe se zonde r m e dische noo dza a k ;

f.

be ha ndelinge n gericht o p ste rilisatie dan we l o p het o ngeda a n m a k en da arva n;

g.

be ha ndelinge n gericht o p circum cisie;

h.

be ha ndeling va n a a npa ssingssto o rnisse n;

i.

hulp bij we rk - e n re la tie pro ble m en;

j.

be ha ndeling va n pla gio ce fa lie e n bra chycefa lie zo nde r cra nio syno sto se m e t ee n re dre ssie he lm .

A rtikel 2.2 De zo rg, bedo e ld in artik e l 2.4 va n het Be sluit zo rgve rze k e ring o m va t teve ns: a.

to t 1 ja nuari 2016 be ha ndeling va n chro nische a spe cifie k e la ge rugk lachte n m et to e passing va n radio freque nte de ne rvatie , indie n de indica tie e n de be ha ndeling va n de ve rzek e rde o vere e nk o m stig de vo orwa a rde n zijn die o pge nom e n zijn in het o nde rzoe k svo orste l da t doo r Zo nMw wo rdt ge financie rd;

b.

to t 1 ja nuari 2017 be ha ndeling va n the ra pie re siste nte hyperte nsie m et to e passing va n pe rcuta ne re na le de ne rvatie indie n de indica tie en de be ha nde ling va n de ve rze k erde o ve re enk o m stig de vo o rwaa rde n zijn die o pgeno m en zijn in he t o nde rzo e k svoo rstel da t do o r ZonMw wo rdt ge fina ncie rd;

c.

to t 1 ja nuari 2017 be ha ndeling va n e e n he rseninfarct m e t to e pa ssing va n intra-a rterië le thro m bo lyse indien de indica tie e n be ha ndeling va n de ve rzek e rden o ve re e nk o m stig de voo rwa arde n zijn die zijn o pgeno m en in de ge rando m isee rde m ultice nte r studie ‘Multice nter R a ndom ize d C linica l tria l o f Endova scula r trea tm e nt fo r Acute ische m ic stro k e in the Ne the rla nds (MR C LEAN)’.

A rtikel 2.3 [Vervallen per 01-01-2013] § 1.2 [Vervallen per 01-01-2013] A rtikel 2.4 [Vervallen per 01-01-2013] § 1.3. Farmaceutische zorg A rtikel 2.5 1.

De a ange we zen ge registre e rde ge nee sm iddele n zijn de gene e sm idde len, ge no e m d in bijla ge 1 bij de ze re ge ling.

2.

Indien e e n ge nee sm iddel, ge no e m d in bijla ge 1 bij de ze re ge ling, be ho o rt to t ee n va n de in bijla ge 2 bij de ze re ge ling ge no e m de ca te gorie ë n va n ge nee sm iddele n, om vat de fa rm a ce utische zo rg sle chts a fle ve ring van da t ge ne esm idde l indie n vo ldaa n is a a n de bij die ca tego rieë n ve rm e lde crite ria .

3.

P o lym ere , o ligo m ere , m o no m e re e n m odulaire die e tprepa ra ten be ho re n sle chts to t de fa rm a ce utische zo rg indie n vo ldaa n is a a n o nde rde el 1 va n bijla ge 2 va n deze rege ling.

§ 1.4. Hulpmiddelenzorg A rtikel 2.6 De a ange we zen hulpm idde len e n ve rbandm idde le n zijn: a.

Uitwendige hulpm idde len te r vo lledige o f ge de e ltelijk e verva nging va n a na tom ische e ige nscha ppen van o nde rde le n va n het m e nse lijk licha a m o f be de k k ing daa rvan, a ls o m schre ve n in a rtik el 2.8;

b.

Uitwendige hulpm idde len voo r he t ade m ha lingsste lse l als om schreve n in a rtik e l 2.9;

c.

uitwe ndige hulpm idde le n gere la tee rd a an stoo rnissen in de ho orfunctie , als om schreve n in a rtik e l 2.10;

d.

uitwe ndige hulpm idde le n te ge bruik e n bij urine lozing e n de fe ca tie a ls o m schre ven in artik e l 2.11;

e.

uitwe ndige hulpm idde le n gere la tee rd a an stoo rnissen in he t be we gingssyste e m , a ls o m schre ven in artik e l 2.12;

f.

uitwe ndige hulpm idde le n gere la tee rd a an stoo rnissen in de visuele functie a ls o m schre ve n in a rtik el 2.13;

g.

[ve rva lle n;]

h.

hulpm idde len voo r pe rso o nlijk e verzo rging en be sche rm ing a ls o m schre ve n in a rtik e l 2.15;

i.

hulpm idde len voo r a nticonce ptione le do e le inde n a ls o m schre ve n in a rtik e l 2.16;

j.

hulpm idde len die sa m e nhange n m e t ve rzorging e n ve rpleging o p bed, a ls o m schre ve n in a rtik el 2.17;

k.

[ve rva lle n;]

l.

inje ctie spuiten a ls o m schre ve n in a rtik el 2.19;

m.

uitwe ndige hulpm idde le n te ge bruik e n bij het la ngdurig com pe nse ren van he t functie ve rlies va n a de re n bij het tra nspo rt va n blo e d e n he t functieve rlie s va n lym fe vate n bij he t transpo rt van lym fe ;

o.

uitwe ndige hulpm idde le n te ge bruik e n bij het contro lere n e n re gule re n va n sto o rnisse n in de blo e dsuik e rspie ge l;

p.

dra agba re, uitwendige infuuspo m pen a ls o m schre ve n in a rtik el 2.22;

q.

schoe nvo o rzie ninge n, nie t zijnde o rthe sen a ls o m schre ve n in a rtik el 2.23;

r.

hulpm idde len voo r he t toe diene n va n vo e ding als om schreve n in a rtik e l 2.24;

s.

uitwe ndige hulpm idde le n gere la tee rd a an e n ter com pe nsa tie van be pe rk inge n in he t spre k e n;

t.

hulpm idde len voo r co m m unica tie, info rm a tie vo o rzie ning en signa le ring a ls o m schre ven in artik e l 2.26;

u.

[ve rva lle n;]

v.

[ve rva lle n;]

w.

[ve rva lle n;]

x.

[ve rva lle n;]

y.

uitwe ndige e le k tro stim ula to rs te gen chro nische pijn m e t to e be ho ren;

z.

[ve rva lle n;]

aa.

[ve rva lle n;]

bb.

[ve rva lle n;]

cc.

[ve rva lle n;]

dd.

[ve rva lle n;]

ee.

[ve rva lle n;]

ff.

[ve rva lle n;]

gg.

[ve rva lle n;]

hh.

thuisdia lyse -a ppa ra tuur a ls o m schre ve n in a rtik el 2.29.

A rtikel 2.7 1.

Indien in de a rtik e le n 2.8 to t en m e t 2.36 e en le eftijd is ve rm e ld, wo rdt be doe ld de le eftijd va n de verze k e rde op he t m o m e nt wa aro p hij zich we ndt to t de aa nbie de r va n he t hulpm idde l.

2.

Indien e e n hulpm idde l in bruik le e n wo rdt ge ge ve n, om vat he t hulpm idde l te vens ve rgoe ding van de k o sten van vervo er va n he t hulpm idde l na a r e n va n de woning va n de ve rzek e rde, va n he t re ge lm atig o nde rhoud e rva n alsm e de va n de voo r ge bruik , o ntsm e tting e n re iniging va n de a ppa ra tuur be no digde che m ica liën.

A rtikel 2.8 Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l a , o m va tte n: a.

b.

hulpm idde len te r vo lledige o f ge de e ltelijk e verva nging va n: 1°.

de onde rste e n bo ve nste e x trem ite ite n, inclusie f o pla a dinrichting e n ba tte rije n indie n he t gaa t o m hulpm iddele n m e t e e n e nergie vo o rzie ning;

2°.

de m a m m a;

3°.

de ste m ba nden;

4°.

he t ha a r indie n sprak e is van ge he le of ge dee lte lijk e k a a lho o fdigheid a ls gevo lg van e e n m e dische aa ndoe ning o f be ha ndeling va n m e dische aa rd;

hulpm idde len te r vo lledige o f ge de e ltelijk e verva nging o f be de k k ing va n: 1°.

de oo gbol;

2°.

he t ge la at.

A rtikel 2.9 1.

2.

Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l b, o m va tte n uitwendige hulpm idde len voo r he t ge he el o f gede e lte lijk o phe ffe n van de ge volge n va n sto ornisse n in de functie va n he t a dem ha lingsstelsel, m e t inbe grip va n sto ffe n die m et be hulp va n deze hulpm idde len wo rde n to ege die nd, te we te n: a.

zuurstof;

b.

stoffe n die ge ce rtifice e rd zijn a ls m e disch hulpm idde l in de zin va n de W et o p de m e dische hulpm iddele n.

De zo rg, bedo e ld in he t e e rste lid, o m va t inge va l va n zuursto fa ppa ra tuur te vens ve rgoe ding van stroo m k oste n.

3.

De zo rg, bedo e ld in he t e e rste lid, o m va t nie t: a.

a ppa ra tuur vo or chro nische a de m halingso nde rste uning;

b.

a ppa ra tuur die uitsluite nd wo rdt ingeze t ter ve rm indering va n snurk e n.

A rtikel 2.10 1.

Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l c, om vatte n: a.

hulpm idde len te r co rre ctie va n sto ornisse n in de ho o rfunctie vo o r zo ver e r spra k e is va n e en re va lide e rbaa r o o r m e t te n m inste ee n ve rlies va n 35 dB o f ernstig o o rsuize n;

b.

hulpm idde len te r co m pe nsa tie va n be pe rk ingen in he t luiste ren o f bepe rk inge n in het ge bruik va n co m m unica tie a ppa ra tuur, indie n de hulpm idde len a ls be do e ld o nder a , hiervo or o nvo ldoe nde ve rbe te ring biede n da n wel indie n de ze hulpm idde le n substitue re n vo or de hulpm idde le n a ls bedo e ld o nde r a .

2.

De zo rg, bedo e ld in he t e e rste lid, o m va t nie t de els im plante e rba re hoo rhulpm idde len.

3.

Een indica tie vo o r de in he t e e rste lid be do e lde hulpm idde len is e vene e ns a anwe zig als spra k e is va n e e n bijzo ndere individuele zorgvraa g.

4.

Vo or signa a lho nde n geldt dat e e n tege m oe tk o m ing k a n worde n ve rlee nd in de rede lijk te achte n gebruik sk oste n.

A rtikel 2.11 1.

Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l d, o m va tte n uitwendige hulpm idde len m e t al da n nie t inwe ndige o nderde len te ge bruik en bij sto ornisse n in de functie s ge rela te erd a a n urinelo zing en de fecatie .

2.

De zo rg, bedo e ld in he t e e rste lid, o m va t inge va l va n a bso rbe re nde inco ntine ntie -a bso rptie m a teria len:

3.

a.

m a teria a l vo or ve rze k erde n va n drie o f vie r ja a r indie n sprak e is van e e n nie t-fysiolo gische vo rm va n inco ntine ntie;

b.

m a teria a l vo or ve rze k erde n va n vijf ja a r e n o uder, te nzij spra k e is va n k o rtdurende inco ntine ntie o f van e nure sis nocturna .

De zo rg, bedo e ld in he t e e rste lid, o m va t nie t: a.

schoo nm aa k m idde le n e n ge urm iddele n;

b.

huidbe sche rm ende m iddele n ande rs da n bij sto m apa tiënte n, vo o r zo ve r de ze nie t valle n o nder de te ve rze k e ren pre sta tie fa rm aceutische zorg;

c.

k leding, m e t uitzo nde ring van ne tbro e k je s;

d.

plaswek k e rs voo r de be ha nde ling va n e nure sis no cturna ;

e.

be sche rm ende onde rle ggers, te nzij sprak e is van e e n

bijzo nde re individue le zo rgvra a g. A rtikel 2.12 1.

Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l e , o m va tte n: a.

hulpm idde len te r co rre ctie va n ge sto o rde functie s van he t be we gingssystee m , a an be we ging verwa nte functie s o f a nato m ische e ige nscha ppe n va n structure n ve rwant a a n be weging, to e te pa sse n bij e en e rnstige a a ndo e ning, waa ro p de verze k e rde pe rm a ne nt e n nie t uitsluite nd bij sporta ctivite ite n is aa ngewe ze n.

b.

hulpm idde len, niet zijnde ee n hulpm idde l vo or ve rzo rging e n ve rple ging o p be d als om schreve n in a rtik e l 2.17, te r co m pensatie va n bepe rk inge n bij he t: 1°.

lo pe n;

2°.

ge bruik en van ha nd e n arm ;

3°.

vera ndere n e n ha ndha ve n licha a m sho uding;

4°.

zich wa sse n e n zo rgdrage n vo o r de to ile tga ng;

5°.

ge bruik va n co m m unicatie a ppa ra tuur.

2.

In he t ge val van ro lsto e le n, drem pe lhulpe n, tra nsfe rhulpm iddele n en hulpm idde len voo r he t zich wasse n e n zo rgdra gen voo r de to ile tga ng ga at he t o m zo rg vo or e e n be pe rk te o f o nze k e re duur.

3.

De zo rg, bedo e ld in he t e e rste lid, o nde rde el b, o m va t nie t a.

hulpm idde len die e e n co m pe nsa tie bie de n vo o r bepe rk inge n bij he t uitvo e ren van huishoude lijk e ta k e n;

b.

e e nvo udige hulpm idde le n te ge bruik en bij be perk inge n bij he t ete n e n drink e n;

4.

c.

a a n functie be pe rk ingen a a nge paste sto e le n, waa rbij de a anpa ssing uitsluite nd e e n sta -o psyste e m be tre ft;

d.

e e nvo udige hulpm idde le n te r co m pensatie va n bepe rk inge n in het lo pen.

Vo or ADL-honde n ge ldt da t e en te gem o e tk o m ing k a n wo rden verle e nd in de re delijk te a chte n ge bruik sk o ste n.

A rtikel 2.13 1.

2.

3.

4.

5.

Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l f, o m va tte n: a.

hulpm idde len te r co rre ctie va n sto ornisse n in de visue le functie va n he t o og e n va n functie s va n a a n he t o o g ve rwa nte structure n;

b.

hulpm idde len te r co m pe nsa tie va n be pe rk ingen; 1°.

in he t le ze n, schrijve n of ge bruik va n te le co m m unica tiea ppara tuur;

2°.

bij he t o m o bsta k e ls hee nlope n of bij de o riënta tie.

De zo rg, bedo e ld in he t e e rste lid, o m va t nie t: a.

brille ngla ze n o f filte rgla zen;

b.

brilm o nture n vo o r brille ngla ze n of filte rgla ze n;

c.

e e nvo udige hulpm idde le n vo or le ze n e n schrijve n.

In he t ge val van le nze n die nt: a.

de sto o rnis he t ge vo lg te zijn va n e en m e dische a a ndo e ning o f ee n tra um a , waa rbij le nze n tot e e n gro te re ve rbete ring in de functies gezichtsscherpte o f k wa lite it va n de visus le ide n dan brille ngla ze n, o f

b.

bij ve rze k erde n jo nger da n achttie n ja a r spra k e te zijn va n patho logische m yo pie m e t e en re fra ctiea fwijk ing va n te n m inste – 6 dio ptrieë n.

In a fwijk ing van he t twe e de lid, onde rde e l a, o m va t de zo rg brillenglaze n e n filte rglaze n vo or ve rze k erde n tot a chttie n ja a r, indien: a.

e r spra k e is va n indica tie voo r le nze n a ls be doe ld in he t de rde lid, m aa r he t dra ge n va n le nze n nie t de vo ork e ur he e ft,

b.

de ve rze k e rde a a n e e n of be ide o gen ge ope re erd is va nwe ge e e n le nsa fwijk ing, o f

c.

de ve rze k e rde lijdt a a n zuive re a ccom m o da tie ve e so tro pie .

Vo or blinde nge le ide honde n ge ldt da t e en te gem o e tk o m ing k a n wo rden verle e nd in de re delijk te a chte n ge bruik sk o ste n.

A rtikel 2.14 [Vervallen per 01-01-2013] A rtikel 2.15 Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l h, o m va tte n: a.

[ve rva lle n;]

b.

[ve rva lle n;]

c.

[ve rva lle n;]

d.

[ve rva lle n;]

e.

[ve rva lle n;]

f.

[ve rva lle n;]

g.

[ve rva lle n;]

h.

k a ppe n ter be sche rm ing van de sche del;

i.

[ve rva lle n;]

j.

verba ndm idde le n to e te pa sse n bij e en e rnstige a a ndo e ning waa rbij e e n la ngdurige m e dische be ha nde ling m et de ze m idde len is a a nge weze n.

A rtikel 2.16 Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l i, o m va tte n, uitsluitend vo o r ve rzek e rden jo nge r dan e e ne ntwintig ja a r: a.

pe ssaria ;

b.

k o pe rho ude nde spira a ltje s.

A rtikel 2.17 1.

2.

Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l j, o m va tte n: a.

be dde n in spe cia le uitvo e ring m e t inbe grip va n daa rvoo r be ste m de m a trasse n;

b.

a nti-de cubitusbedde n, -m a tra sse n e n -o ve rtre k k e n te r be ha nde ling e n pre ve ntie va n de cubitus;

c.

de k e nboge n, be dhek k e n, be drugsteune n e n bedta fe ls;

d.

be dga lge n e n hulpm idde le n vo or he t ze lfsta ndig in en uit be d k om e n;

e.

glij- e n ro lla k ens;

f.

be dve rk o rte rs, -ve rlenge rs e n -ve rho ge rs;

g.

o nde rstek e n;

h.

be dbe sche rm e nde o nde rlegge rs, indie n he t verlie s van bloe d e n e x suda at dusda nige hygiënische pro ble m en o ple vert da t de ze sle chts do o r ge bruik van e e n be dbe scherm e nde o nde rle gge r k unne n wo rden o nde rvange n;

i.

infuussta nda a rden.

De hulpm idde le n, bedo e ld in he t e e rste lid, k unne n oo k worde n aa ngewe nd a ls he t gebruik da a rva n stre k t tot be houd va n de zelfre dza a m he id.

A rtikel 2.18 [Vervallen per 01-01-2010] A rtikel 2.19 1.

Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l l, o m va tte n injectie spuite n m e t to ebe hore n dan we l injectie pe nne n m e t to e be ho ren, indie n spra k e is va n e e n aa ndoe ning die e e n la ngdurig ge bruik van de ze m idde le n noo dza k e lijk m a a k t, m e t uitzo nde ring va n ge bruik bij be ha ndeling va n dia be te s.

2.

Een hulpm idde l als be do eld in he t e erste lid o m va t teve ns e en a a n e e n ha ndicap a a nge paste uitvoe ring, indie n de ve rze k erde ten ge vo lge van e e n e rnstige m o to rische handica p da n we l e en verm inde rd gezichtsverm o gen re delijk e rwijs nie t k a n vo lsta an m e t ee n inje ctie spuit of injectie pe n in e en niet a a nge pa ste uitvo ering.

A rtikel 2.20 [Vervallen per 01-01-2011] A rtikel 2.21 [Vervallen per 01-01-2010] A rtikel 2.22 Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l p, o m va tte n dra a gba re , uitwe ndige infuuspom pe n m e t to ebe hore n, indie n sprak e is van co ntinue pare nte rale to edie ning in de thuissitua tie va n ee n gene e sm idde l da t valt o nde r de farm a ce utische zo rg, be do eld in a rtik el 2.8 va n he t Be sluit zo rgve rze k ering, m e t uitzo nde ring va n insuline . A rtikel 2.23 Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l q, o m va tte n: a.

verba ndscho ene n, indien volda an is a a n ee n va n de zo rginhoude lijk e crite ria , ve rm eld in bijla ge 3, o nderde e l 7, van de ze re ge ling;

b.

a lle rge envrije scho e nen, indie n er sprak e is van e e n a llergie .

A rtikel 2.24 1.

2.

Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l r, o m va tte n, indien he t ge bruik o m m e dische re de ne n a a nge we ze n is: a.

niet-k linisch inge brachte sonde s m e t toe be ho re n;

b.

uitwe ndige vo e dingspo m pe n m et to e beho re n;

c.

uitwe ndige to ebe hore n, beno digd bij de toe diening va n pa re nte ra le vo eding.

Hulpm idde le n a ls be doe ld in he t ee rste lid om vatte n gee n vo e dings-, ge ne es - e n ve rbandm idde le n.

A rtikel 2.25 [Vervallen per 01-01-2009] A rtikel 2.26 Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l t, o m va tte n: a.

[ve rva lle n;]

b.

[ve rva lle n;]

d.

[ve rva lle n;]

e.

[ve rva lle n;]

f.

[ve rva lle n;]

g.

o pna m e- e n vo orle e sa ppa ra tuur, zijnde da isy-spe le rs o f daisy-pro gram m a tuur voo r dyslectici;

h.

[ve rva lle n;]

i.

[ve rva lle n;]

j.

signa le ringsa ppa ra tuur e n ee n a la rm e ringssyste em , zijnde: 1°.

[ve rva lle n;]

2°.

pe rso o nlijk e a larm e ringsappa ratuur vo o r licha m e lijk ge ha ndica pten, indie n de licham e lijk geha ndica pte in e e n ve rho o gde risico situa tie ve rk e e rt.

A rtikel 2.27 [Vervallen per 01-01-2010] A rtikel 2.28 [Vervallen per 01-01-2010] A rtikel 2.29 Hulpm idde le n a ls be doe ld in a rtik e l 2.6, o nderde e l hh, o m va tten: a.

thuisdia lyse-a ppa ra tuur m e t toe be ho re n vo o r he m o dia lyse o f pe rito ne aa ldia lyse ;

b.

de rege lm a tige contro le e n het o nderho ud e rvan e n de che m icalië n e n vlo e isto ffen die no dig zijn vo o r het ve rrichte n va n dia lyse ;

c.

vergo e ding va n de k o ste n vo o r de re delijk e rwijs te ve rrichten a a npa ssinge n in e n aa n de wo ning e n vo or he t herste l in de o o rspro nk e lijk e sta a t, vo o r zo ve r a nde re wette lijk e re ge linge n da a rin nie t vo o rzie n;

d.

vergo e ding va n ove rige re de lijk te a chten k o ste n die re chtstre e k s m et de thuisdia lyse sa m e nhange n, vo or zo ve r a nde re we tte lijk e re gelinge n daa rin nie t vo o rzie n;

e.

o ve rige ge bruik sa rtik ele n die re de lijk e rwijs no dig zijn bij de thuisdia lyse.

§ 1.5. De eigen bijdragen A rtikel 2.30 De e ige n bijdrage vo o r e erste lijnspsycho lo gische zo rg bedra a gt: a.

€ 20 pe r zitting;

b.

€ 50 voo r e e n inte rne tbe ha ndeltra ject.

A rtikel 2.31 1.

De e ige n bijdrage vo o r zo rg a ls bedo e ld in artik e l 2.7, e erste lid, va n het Be sluit zo rgve rze k e ring, vo o r zo ver he t gaa t o m zo rg die niet re chtstree k s in ve rba nd staa t m e t de indica tie vo o r bijzo ndere ta ndhe e lk undige hulp, be dra agt e e n be drag te r groo tte va n het be dra g dat bij de de sbe treffe nde ve rze k erde in re k e ning zo u wo rde n ge bracht indie n a rtik e l 2.7, e e rste lid, van he t Be sluit zorgverze k e ring nie t va n toe pa ssing is.

2.

Indien de zo rg, be do eld in he t e erste lid, e en uitne e m ba re vo lledige pro thetische vo orziening da n we l e en uitne e m ba re vo lledige pro the tische voo rzie ning te pla a tse n o p ta ndhe e lk undige im pla nta te n be tre ft, bedra a gt de e ige n bijdrage € 125.

3.

De e ige n bijdrage bedra a gt vo or e e n uitne em ba re vo lle dige prothe tische vo o rzie ning, bedo e ld in artik e l 2.7, vijfde lid, onde rde e l b, van he t Be sluit zo rgve rzek e ring, vijfe ntwintig pro ce nt va n de k o ste n va n die vo o rzie ning.

A rtikel 2.32 De e ige n bijdrage vo o r e en ge ne e sm idde l dat is inge de e ld in e en gro ep van o nde rling verva ngba re ge nee sm iddele n be dra agt de k o sten van da t ge ne esm idde l, vo or zo ve r de to e passe lijk e ve rgo edingslim ie t, om ge rek e nd na a r de de sbe treffe nde ho e ve e lhe id, la ger is da n de ink o o pprijs die ve rm eld sta a t in de Tax e , ve rho ogd m et de o ve r het ve rschil ve rschuldigde om zetbe lasting. A rtikel 2.33 1.

Indien de aa nscha ffingsk oste n va n hulpm idde le n te r volle dige of ge dee lte lijk e ve rva nging va n ha a r hoge r zijn da n € 393 be dra agt de eige n bijdra ge he t verschil tusse n de a a nscha ffingsk o ste n e n da t bedra g.

2.

De e ige n bijdrage vo o r hulpm idde le n te r co rrectie van stoo rnissen in de ho orfunctie of e rnstig o orsuize n be draa gt vijfe ntwintig pro ce nt va n de a anschafk o ste n.

3.

De e ige n bijdrage vo o r o rtho pe dische scho ene n be dra agt:

4.

a.

€ 137,50 pe r paa r, indie n de verze k e rde ze stie n ja a r o f oude r is;

b.

€ 69 pe r pa a r, indie n de ve rzek e rde jo nge r is da n ze stie n ja a r.

De e ige n bijdrage vo o r lenzen e n brillenglaze n be draa gt: a.

€ 53,50 pe r le ns, indie n sprak e is van le nze n m e t e en ge bruik sduur la nge r da n e e n ja a r;

b.

€ 107 per k a lende rja a r, indie n sprak e is van le nze n m e t e en ge bruik sduur k o rte r da n e en ja ar. Inge va l sle chts é é n oo g die nt te worde n ge co rrigee rd bedra a gt de e ige n bijdrage € 53,50 pe r k ale nde rja ar;

c.

€ 53,50 pe r brille ngla s.

5.

Indien de aa nscha ffingsk oste n va n ve rba ndscho e ne n hoge r zijn da n € 149, be dra agt de eige n bijdra ge he t verschil tusse n de a a nscha ffingsk o ste n e n da t bedra g.

6.

De e ige n bijdrage vo o r a lle rgee nvrije scho e ne n bedra a gt: a.

€ 137,50 pe r paa r, indie n de verze k e rde ze stie n ja a r o f oude r is, ve rm e erde rd m e t he t ve rschil tussen de a a nscha ffingsk o ste n e n € 331,50;

b.

€ 69 pe r pa a r, indie n de ve rzek e rde jo nge r is da n ze stie n ja a r, ve rm e erde rd m e t he t ve rschil tussen de aa nscha ffingsk oste n e n € 263.

A rtikel 2.34 [Vervallen per 01-01-2013] A rtikel 2.35 [Vervallen per 01-01-2013] A rtikel 2.36 1.

De e ige n bijdrage vo o r ve rzorging te n huize va n de ve rzek e rde be draa gt € 4 pe r uur.

2.

De e ige n bijdrage vo o r ve rzorging ve rle e nd in e en inste lling zo nde r da t ve rblijf in de inste lling m e disch noo dza k e lijk is, bedra a gt voo r zowe l de m o ede r a ls het k ind € 16 pe r dag, die wo rdt ve rm ee rde rd m e t het be drag wa arm e e he t ta rief va n de inste lling € 114,50 pe r dag te bove n ga a t.

A rtikel 2.37 1.

He t bedra g, be do eld in a rtik el 2.14, twe e de lid, va n he t Besluit zorgverze k e ring, be draa gt € 0,31 pe r k ilo m e ter.

2.

De e ige n bijdrage vo o r zie k envervo er be draa gt € 95 per k a lende rja a r.

3.

De e ige n bijdrage is niet ve rschuldigd: a.

voo r vervo er va n e e n instelling wa arin de ve rze k erde te n la ste van de zo rgve rze k e ring o f de bijzo nde re zie k te k o stenverze k e ring is opge no m e n na a r ee n a nde re instelling wa arin de ve rze k erde te n la ste van de zo rgve rze k e ring o f de bijzo ndere zie k te k o stenverze k e ring wo rdt opge no m e n vo or he t o nde rgaa n va n e en spe cia listisch o nde rzoe k o f ee n spe cia listische beha nde ling wa arvo or in de e e rstbe doe lde inste lling nie t de m o ge lijk he id be staa t;

b.

voo r vervo er va n e e n instelling a ls be do e ld in o nde rdee l a na a r e en pe rso o n o f inste lling vo o r he t o nde rga an van e e n spe cia listisch o nde rzoe k o f ee n spe cia listische be ha nde ling te n la ste van de zo rgve rze k e ring waa rvoo r in de e e rstbe do e lde inste lling nie t de m o gelijk he id be sta a t, a lsm ede het ve rvo e r terug naa r die inste lling;

c.

voo r vervo er va n e e n instelling wa arin de ve rze k erde te n la ste van de bijzo ndere zie k te k o stenverze k e ring is opge no m e n na ar e e n pe rsoo n o f instelling voo r e e n ta ndhe e lk undige beha nde ling te n la ste va n de bijzonde re ziek te k oste nve rze k ering, wa arvo or in de e e rstbe doe lde inste lling nie t de m o ge lijk he id be staa t, a lsm e de he t ve rvo e r te rug na ar die instelling.

§ 1.6 [Vervallen per 01-01-2013] A rtikel 2.38 [Vervallen per 01-01-2013]

§ 2. De regels voor indeling van geneesmiddelen in groepen van onderling vervangbare geneesmiddelen en voor de berekening van de vergoedingslimieten A rtikel 2.39 Bij de a anwijzing o p gro nd va n artik e l 2.8 va n het Be sluit zo rgve rze k e ring e n bij de to e pa ssing va n de ze pa ragra a f wo rdt uitsluite nd a cht ge sla ge n o p: a.

de el IB van he t registe rdo ssie r,

b.

de publicatie s o nder a uspicië n va n de W orld He alth O rga nizatio n ove r de De fine d Da ily Dose en de Ana to m ica l The ra peutica l C he m ica l C lassifica tion,

c.

de in m e disch-fa rm a ce utische k ringe n ge bruik e lijk e fa rm a co lo gische e n fa rm a co the ra peutische ha ndbo ek e n,

d.

publica ties in tijdschrifte n die in m e disch-fa rm a ce utische k ringe n a ls be tro uwba re bro nne n vo o r gene e sm idde leninform a tie ge lde n,

e.

ge ge vens afk o m stig va n farm a co -e co nom isch o nderzo ek , e n

f.

a nde re gege ve ns e n besche ide n die vo ldoe n a an de rege ls inge volge artik e l 2, zesde lid, va n he t Be sluit re gistra tie ge ne e sm idde le n.

A rtikel 2.40 1.

Ge nee sm iddele n wo rde n a ls o nderling ve rva ngba a r aa ngem e rk t, indien zij: a.

bij e e n ge lijk soo rtig indica tie ge bie d k unnen wo rde n to ege past,

b.

via e e n ge lijk e toe dieningsweg wo rde n to ege die nd, en

c.

in he t a lge m e en voo r de ze lfde le eftijdsca te gorie zijn be stem d.

2.

Bij de to edie ningswe ge n wordt e e n o ndersche id ge m a a k t in to e die ning doo r m idde l va n inje ctie wa a rbij syste m isch he t ge we nste e ffe ct wordt be oo gd, toe diening nie t do o r m idde l va n e e n inje ctie wa a rbij syste m isch he t ge we nste effe ct wo rdt be o o gd, to e die ning do or m idde l va n inje ctie wa a rbij lo k a a l he t ge we nste e ffe ct wordt be oo gd en to e die ning nie t do or m idde l va n e en inje ctie waa rbij lo k a a l he t ge we nste e ffe ct wordt be oo gd.

3.

In a fwijk ing van he t ee rste e n twee de lid worde n ge ne esm idde le n nie t a ls o nde rling verva ngba ar a a nge m e rk t, indie n: a.

tusse n die ge ne esm idde le n ve rschille n in e ige nscha ppe n besta an,

b.

de ze ve rschille n in e ige nscha ppe n zich voo rdo en o f k unne n vo ordo e n bij de ge he le pa tië nte npopulatie , bij we lk e de ge ne e sm idde le n k unne n worde n toe ge pa st, en

c.

uit de ge ge vens en be sche ide n, bedo e ld in artik e l 2.39, blijk t da t deze ve rschillen in eige nscha ppe n, teza m e n geno m en, be pa le nd zijn vo o r de k e uze va n het ge nee sm iddel do or de a rts.

4.

In a fwijk ing van he t ee rste e n twee de lid worde n ge ne esm idde le n die be ho re n tot e e n subgro e p die a lle e n uit prepa ra ten be sta at o f a lle e n uit spe cia lité s o nder de ze lfde m e rk na a m , nie t a ls o nde rling ve rvangbaa r be scho uwd.

5.

In a fwijk ing van he t ee rste, twe e de e n de rde lid wordt e e n com bina tie pre pa raa t a ls o nde rling verva ngba ar a a nge m e rk t m e t e en in e e n gro e p va n o nderling ve rva ngba re ge ne esm idde le n o pge nom e n ge ne esm idde l, nie t zijnde e en co m bina tiepre para a t, dat e e n we rk za am be sta ndde e l be va t da t vo o rk o m t in he t co m bina tie pre pa ra a t, indien:

6.

a.

a lle we rk za m e be sta ndde len van he t co m binatie prepa ra at vo ork o m en in ge ne esm idde le n, nie t zijnde com bina tie pre pa rate n, die zijn o pge no m e n in e e n gro e p va n onde rling ve rva ngba re gene e sm idde len, e n

b.

de in o nde rde el a bedo e lde gene e sm idde len la ngs de zelfde toe dieningsweg wo rde n to ege die nd en in he t a lge m e en voo r de ze lfde le eftijdsca te gorie zijn be stem d a ls het com bina tie pre pa raa t.

He t vijfde lid is nie t van to e pa ssing o p co m bina tie pre pa ra te n va n o e stro ge ne n e n pro gesta ge ne n e n co m bina tie pre pa ra te n va n thiazide - e n k alium spare nde diuretica .

A rtikel 2.41 1.

Vo or de bere k e ning va n ee n ve rgo edingslim ie t wo rdt uitge gaa n va n e en standa arddo sis va n he t werk zam e besta ndde el van he t ge ne e sm idde l.

2.

De sta ndaa rddosis wo rdt be paa ld op ba sis va n de De fine d Daily Do se, te nzij de De fined Da ily Do se lage r is da n de in Ne derla nd ge advise erde m inim ale dose ring o f ho ge r is dan de in Ne de rla nd ge advise erde m ax im ale dose ring.

3.

Indien e e n we rk za a m be sta ndde e l onde r ve rschillende zo ut- o f este rvo rm en in de ha nde l is e n bij de De fine d Da ily Dose ge e n o nde rscheid is ge m a a k t na a r de zo ut- of e stervo rm , wo rdt de standa arddo sis vo or de ve rschille nde zo ut- o f e ste rvo rm e n, vo or zove r m o ge lijk , he rle id to t de zo ut- of e stervo rm die he t m e est vo o rk om t in de in artik e l 2.39 ge no em de bro nnen.

4.

Vo or uitwendig to e gepa ste de rm a to logica geldt a ls sta ndaa rddosis 1 gram , 1 m l o f 100 cm 2, afha nk e lijk van de ge ha nte e rde ho eve elhe idsm a a t.

5.

De sta ndaa rddosis wo rdt zo ve e l m o gelijk va stge ste ld m e t o ve re enk o m stige to e pa ssing va n de m etho die k , geha ntee rd bij de vastste lling va n de De fined Da ily Do se , indie n: a.

voo r e e n ge nee sm iddel ge en De fine d Da ily Dose is va stge steld, o f

b.

de Define d Da ily Do se la ge r is da n de in Ne de rla nd ge a dvise e rde m inim a le do se ring o f ho ge r is da n de in Ne de rla nd ge advise erde m ax im ale dose ring.

6.

In a fwijk ing van he t ee rste to t e n m e t vijfde lid wordt bij ge nee sm iddele n wa a rvo o r geldt dat de duur van de m e dica tie wo rdt be k ort do or de hoe vee lheid per da g ge ge ve n we rk za m e be standdele n te ve rho ge n, uitgega a n va n de sta ndaa rdk uur.

7.

De ve rgo edingslim ie t va n ee n gene e sm idde l wo rdt o pnie uw vastgeste ld, indie n: a.

de Define d Da ily Do se van da t ge ne esm idde l bij ee n herziening va n de De fine d Daily Do ses va n e en ca te gorie va n

De fine d Da ily Dose wa a rva n e erde r bij de be pa ling va n de standa arddo sis wa s uitgega a n,

8.

b.

voo r da t ge ne esm idde l de sta ndaa rddosis wa s be pa a ld o vere e nk o m stig het vijfde lid, a a nhe f e n o nderde e l a , e n vo o r da t ge ne e sm idde l e en De fine d Da ily Dose wo rdt va stge steld, o f

c.

wijziging optre e dt in de in Nede rland gea dvisee rde m inim a le of m a x im a le do se ring va n e e n ge ne esm idde l, be doe ld in he t vijfde lid, a anhe f en o nde rde el b, e n die wijziging zou le ide n tot e e n ande re sta nda a rddo sis da n die wa arva n bij de inde ling van da t ge ne esm idde l in de de sbe tre ffende gro e p va n onde rling ve rva ngba re gene e sm idde len is uitgega a n.

Indien de Define d Da ily Do se van e e n ge nee sm iddel o f va n gene e sm idde len, van de prijs wa a rva n is uitge gaa n vo o r de be rek e ning va n e en vergo e dingslim ie t, bij e e n he rzie ning va n de De fined Da ily Do se va n e en ca te gorie va n gene e sm idde len in de Anato m ica l The rape utic C he m ica l C la ssificatio n op nive a u 4 wo rdt ge wijzigd, wordt de ve rgoe dingslim iet vo or de groe p o nde rling verva ngba re ge nee sm iddele n wa a rto e da t gene e sm idde l be ho ort, o pnie uw va stge ste ld. Bij de be re k e ning van de nie uwe vergo e dingslim ie t worde n sle chts be trok k e n de gene e sm idde len die be tro k k e n zijn bij de e e rde re bere k e ning va n de vergo e dingslim ie t.

A rtikel 2.42 1.

Vo or zo ve r e en gro ep van o nde rling verva ngba re ge nee sm iddele n be staa t uit ge ne esm idde le n die voo r 1 o k to be r 1998 ge registre e rd wa re n en de prijs da a rva n vo o rk wa m in de op da t tijdstip gelde nde Tax e , wordt voo r de be re k ening va n de vergo e dingslim ie t vo o r de to t die gro e p be hore nde ge nee sm iddele n uitge ga a n va n de prijze n, ve rm e ld in de be do elde Ta x e .

2.

Indien e e n gro e p va n o nderling ve rva ngba re ge ne esm idde le n besta at uit gene e sm idde len die na het in het e e rste lid be doe lde tijdstip ge re gistree rd zijn of wa a rva n de prijs vo o r het e e rst vo ork wa m in e en na da t tijdstip ve rsche nen Ta x e , wo rdt vo or de be rek e ning va n de ve rgo e dingslim ie t voo r de tot die gro e p be ho rende ge ne esm idde le n uitge gaa n va n de prijs van he t ge ne e sm idde l, waa rvan de prijs he t e erst in de Tax e is verm e ld.

3.

Bij de bere k e ning va n de vergo e dingslim ie t worde n de prijze n va n pa ra lle l ge ïm po rte e rde ge ne e sm idde le n e n va n co m bina tiepre para te n als be do eld in a rtik el 2.40, vijfde lid, buite n bescho uwing ge late n.

A rtikel 2.43 1.

P e r gro e p va n onde rling ve rva ngba re gene e sm idde len wo rdt e e n ge m idde lde prijs bere k e nd.

2.

Vo or de bere k e ning va n de ge m iddelde prijs wo rdt de gro ep verde e ld in subgro e pen van ge ne e sm idde le n die he tzelfde we rk za m e be sta ndde e l o f de ze lfde co m bina tie va n we rk za m e be sta ndde le n he bbe n.

3.

Binne n ee n subgroe p wordt voo r de spe cialité s m e t ee nze lfde m e rk na a m , m e t uitzo nde ring va n de brande d ge nerics, e en ge m iddelde prijs pe r sta ndaa rddosis be rek e nd.

4.

Binne n ee n subgroe p wordt voo r a nde re gene e sm idde len da n die , be do eld in he t derde lid, e e n ge m idde lde prijs pe r standa arddo sis be re k e nd. Die prijs is he t ge m idde lde van de la a gste prijzen van de ge ne esm idde le n in de ze lfde fa rm a ce utische vorm .

5.

P e r subgro e p wo rde n de inge vo lge he t derde e n vierde lid be rek e nde ge m iddelde prijze n per sta nda a rddo sis opge teld e n wo rdt die uitk o m st ge m idde ld, zoda t e en prijs per subgro e p wo rdt ve rk rege n.

6.

Indien in de Ta x e voo r e e n specia lité m e e r da n é én prijs wordt verm e ld, wo rdt uitge ga a n va n de la agste prijs.

A rtikel 2.44 1.

Indien de gro e p va n onde rling ve rva ngba re gene e sm idde len be sta a t uit sle chts éé n subgroe p, is de in a rtik e l 2.43, vijfde lid, be do e lde prijs per subgro e p de basis voo r de be re k ening va n de ve rgo edingslim ie t va n de to t die gro ep be ho re nde ge ne e sm idde le n.

2.

Indien de gro e p va n onde rling ve rva ngba re gene e sm idde len be sta a t uit m e er da n éé n subgroe p, worde n, indien: a.

de ge ne esm idde le n beho re n to t é é n cate go rie in de Anato m ica l The rape utic C he m ica l C la ssificatio n op nive a u 4, a lle prijze n pe r subgro e p bij e lk a a r opge teld e n wo rdt ve rvo lgens he t ge m iddelde erva n be re k e nd;

b.

de ge ne esm idde le n beho re n to t verschille nde ca te gorie ë n o p nive au 4 va n de Ana tom ica l The ra pe utic C hem ica l C la ssifica tio n, de prijzen voo r de ve rschillende subgro e pen, voo r zove r be ho rend to t de zelfde ca tego rie, ge m idde ld, wo rde n de aldus be rek e nde prijze n vo or de a fzo nde rlijk e ca te go rie ën o pnie uw ge m idde ld e n vo rm t he t a ldus ve rk rege n ge m idde lde de be re k eningsbasis voo r de be pa ling va n de vergo e dingslim ie t.

A rtikel 2.45 1.

Indien e r binne n e e n gro e p va n onde rling ve rva ngba re gene e sm idde len e e n ge nee sm iddel is, wa a rva n de prijs per sta nda a rddo sis ge lijk is a an de in a rtik e l 2.44 be do e lde be rek e ningsba sis, is de ve rgo e dingslim ie t voo r de ge ne esm idde le n uit die gro e p ge lijk a a n de prijs pe r standa arddo sis va n da t gene e sm idde l.

2.

Indien e r binne n e e n gro e p va n onde rling ve rva ngba re gene e sm idde len ge en ge ne e sm idde l is wa arva n de prijs pe r standa arddo sis ge lijk is a an de in a rtik e l 2.44 be do e lde be rek e ningsba sis, is de ve rgo e dingslim ie t voo r de ge ne esm idde le n uit die gro e p ge lijk a a n de prijs pe r standa arddo sis va n he t gene e sm idde l die zo dicht m o ge lijk onde r de be rek e ningsba sis ligt.

A rtikel 2.46 1.

Indien van e e n ge nee sm iddel verschille nde to e die ningsste rk te n besta an, wo rdt de ve rgo edingslim ie t, be re k end o ve re enk o m stig de artik e le n 2.41 to t e n m e t 2.45, voo r he t ge ne esm idde l m e t de k le inste to e die ningsste rk te ge co rrige e rd do o r de o nge co rrigee rde ve rgoe dingslim iet te verm e nigvuldige n m et 2/10 m aa l het quo tië nt va n de re fe re ntie hoe vee lheid e n de k le inste to e die ningsste rk te van da t ge ne esm idde l, ve rm e e rderd m e t 8/10.

2.

Vo or ge nee sm iddele n die vo o r a nde re le e ftijdsca tego rieë n dan volwa ssene n zijn be ste m d, is de re fe re ntie hoe vee lheid de ho eve elhe id die vo ork o m t in he t pre pa raa t van de ho o gste hoe vee lheid va n die a nde re lee ftijdsca te go rie ën.

3.

De dim e nsie va n de re fe rentie ho e ve e lhe id m o e t gelijk zijn a a n de dim e nsie va n de k leinste to e die ningsvo rm .

4.

Bij ge nee sm iddele n als be do eld in de a rtik e len 2.40, vijfde lid, e n 2.41, ze sde lid, blijve n he t e erste tot e n m et he t derde lid buite n to epa ssing.

A rtikel 2.47 1.

De ve rgo edingslim ie t va n ee n co m bina tie pre pa ra a t als be do eld in a rtik el 2.40, vijfde lid, is ge lijk a an de so m va n de vergo e dingslim ie te n vo or de gene e sm idde len, niet zijnde co m binatie prepa ra ten, die de werk zam e besta ndde le n beva tten die in he t co m binatie prepa ra at vo ork o m en e n die langs de ze lfde to e die ningswe g worde n toe ge die nd e n in he t a lge m ee n vo o r deze lfde le eftijdsca te gorie zijn be stem d a ls het com bina tie pre pa raa t.

2.

Indien de in he t ee rste lid be do elde ge ne esm idde le n die ge en co m bina tiepre para te n zijn, e e n in he t co m binatie prepa ra at voo rk o m e nd we rk za a m be standdee l beva tten in ee n a nde re ho e ve e lhe id of in e en a nde re to edie ningsvorm da n die we lk e in het co m bina tiepre para a t vo o rk om t, wo rdt uitgega a n va n de ve rgo edingslim ie ten, die vo or die ge ne esm idde le n zo uden he bbe n ge go lden indie n die gene e sm idde len da t we rk za m e be standdee l zo uden he bbe n be vat in de ho e ve e lhe id e n de to e die ningsvo rm die in het com bina tie pre pa raa t voo rk o m t.

A rtikel 2.48 Vo or zo ve r de to e passing va n de a rtik e le n 2.40 tot e n m et 2.47 na a r het o o rdee l va n de Ministe r to t e en uitk o m st le idt die nie t in o ve re e nste m m ing is m e t de stre k k ing da a rva n, k an de Minister e e n be sluit nem e n in a fwijk ing da arva n. A rtikel 2.49 [Vervallen per 01-01-2013]

§ 3. De aanvraagprocedure voor aanwijzing geregistreerde geneesmiddelen A rtikel 2.50 1.

De re gistratie houde r k a n bij de Minister e e n aa nvra a g indiene n om e e n ge nee sm iddel a a n te wijze n ingevo lge a rtik e l 2.8, e e rste lid, o nderde e l a , van he t Be sluit zo rgve rzek e ring.

2.

De a anvraa g geschiedt m e t ge bruik m a k ing va n ee n doo r de Minister va st te ste llen fo rm ulie r. Daa rbij wo rden de ge ge ve ns e n de be sche ide n ve rschaft die vo o r de be slissing o p de a anvraa g nodig zijn. De da tum van o ntva ngst wordt a a n de a anvrage r m e ege dee ld.

3.

Indien de ove rge le gde gege ve ns e n besche ide n onvoldo ende zijn, ste lt de Ministe r de a a nvra ge r in de ge le ge nhe id binne n e en do or he m te be pale n term ijn de a anvraa g a an te vullen.

4.

De Ministe r ho o rt o ve r de a a nvra a g he t C o lle ge zo rgve rze k eringen.

5.

De Ministe r be slist binnen 90 da ge n na o ntva ngst va n de a a nvra ag. De ze te rm ijn wordt o pge schort m e t inga ng va n de dag wa aro p de Minister de a anvrage r uitno digt de aa nvra a g aa n te vulle n, to t de da g wa a rop de aa nvra a g is a ange vuld o f de da a rvo o r ge ste lde te rm ijn o nge bruik t is verstre k e n.

6.

De inho ud va n he t vo o rgeno m en be sluit, vo or zo ve r betre k k ing hebbe nd o p de a a nvra ag, wo rdt a a n de a a nvra ge r m e ege dee ld. Da a rbij wordt te ve ns he t o orde e l va n he t C o lle ge zo rgve rze k eringen to e ge zonde n e n wordt de m o tive ring ve rm e ld, tenzij re delijk e rwijs k an wo rde n a ange no m e n da t daa ra a n ge e n be hoe fte besta at. Aa n de a a nvra ge r wo rdt m e e ge de eld welk e re chtsm idde le n he m ter be schik k ing sta a n.

7.

He t twee de tot e n m et he t ze sde lid zijn van o ve re e nk o m stige to e passing indien de registra tie ho uder ve rzo e k t o m herziening van e e n be sluit inge vo lge he t ee rste lid en hij da a rtoe nieuw geble k e n fe ite n o f ve ra nde rde o m sta ndighe de n a anvoe rt.

8.

Indien de Minister vo orne m ens is e en ge ne e sm idde l a m btsha lve a a n te wijze n ingevo lge a rtik e l 2.8, e e rste lid, o nde rde el a , va n he t Be sluit zo rgve rzek e ring da n we l zo danige a a nwijzing te wijzigen, de elt hij de re gistratie houde r uite rlijk e en m a and vo o r de be oo gde da tum va n inwerk ingtre ding de za k elijk e inho ud va n he t voo rge no m e n be sluit m e de . Het vierde e n ze sde lid zijn va n o ve re e nk o m stige to e passing.

9.

Indien he t ee n gene e sm idde l be tre ft m et de ze lfde we rk za m e be sta ndde le n, va n de ze lfde ste rk te e n in de ze lfde fa rm aceutische vorm a ls e e n ge nee sm iddel da t ree ds ingevo lge a rtik e l 2.8, e e rste lid, o nde rde el a , va n het Be sluit zo rgve rze k e ring is a a nge weze n, zijn he t twe e de to t e n m e t vie rde lid, het ze sde lid, twee de vo lzin, en he t ze ve nde e n a chtste lid niet va n to e passing.

Hoofdstuk 3. De in het uitvoeringsverslag op te nemen gegevens A rtikel 3.1

1.

2.

De zo rgve rzek e ra ar ne e m t in iede r geva l in zijn uitvoe ringsve rsla g o p: a.

he t pro fie l, de o rga nisa tiestructuur e n het ge vo e rde e n vo o rgeno m en be le id bij de uitvo e ring van de Zo rgve rzek e ringswe t;

b.

de wijze wa aro p hij uitvo e ring gee ft a a n de zo rgplicht;

c.

de wijze wa aro p hij uitvo e ring gee ft a a n de a cce ptatie plicht e n he t verbo d op pre m ie diffe re ntia tie ;

d.

de wijze wa aro p hij de afha nde ling van k lachte n va n de ve rze k erde n he e ft geo rga nisee rd a lsm ede de re sulta te n da a rva n;

e.

de wijze wa aro p hij uitvo e ring gee ft a a n ge dragsco de s wa a ra an hij zich he e ft ve rbo nde n;

f.

o f hij he t Pro to co l inca sso tra je ct wa nbe ta lers Zorgverze k e ringswet is na ge k o m e n, e n zo ne e, we lk e o nde rde le n nie t, wa aro m niet, e n wat hij in de pla a ts van die o nderde len a a n inca sso we rk za a m he de n he e ft ve rricht;

g.

a lge m e ne ge ge vens ove r de ho no re ring van directie e n be stuur van de zo rgve rze k e raa r voo r de uitvoe ring va n de Zo rgve rze k eringswe t

h.

ge ge vens ove r zijn re la tie s m e t a a nbie de r van zorg e n de wijze wa a ro p hij stuurt op de k wa lite it va n doo r he n ge leve rde zorg.

He t uitvo eringsverslag wo rdt, vo or zo ve r het ga a t om de in he t vo rige lid ge noe m de a spe cte n, inge richt ove ree nk om stig e e n do o r de zo rgauto riteit be schik ba a r te ste lle n m ode l.

Hoofdstuk 4. Bepalingen omtrent het Zorgverzekeringsfonds A rtikel 4.1 De re se rve , be do e ld in a rtik e l 39, vie rde lid, va n de Zo rgve rze k e ringswe t wordt vastgeste ld o p nihil. A rtikel 4.2 In de ce ntra le adm inistratie va n ’s rijk s scha tk ist wo rdt e e n rek e ning-co ura nt ge o pe nd op na am van he t C olle ge zorgverze k e ringe n te n be ho e ve van de fina nciële m idde le n va n het Zo rgve rze k e ringsfo nds o p gro nd va n artik e l 40, twee de lid, va n de Zo rgve rze k e ringswe t. A rtikel 4.3 1.

De beta a lrek e ninge n va n he t C o lle ge zo rgve rze k eringen bij in Nede rland geve stigde ba nk e n wo rde n do o r he t Ministe rie va n Fina nciën in ove ree nste m m ing m et de betro k k en ba nk e n opge no m e n in co nce rnve rba nd m e t be taa lre k e ninge n va n ’s rijk s schatk ist bij die bank e n.

2.

Da gelijk s o p na der in o ve rleg m e t de be trok k e n ba nk e n te be pa le n tijdstippe n wo rden de op de be ta a lre k e ningen van he t C olle ge zorgverze k e ringe n vo o rk om e nde po sitieve sa ldi o ve rge bo e k t na a r ’s rijk s scha tk ist, da n we l wo rde n vo ork o m ende ne ga tie ve sa ldi a a nge vuld va nuit ’s rijk s schatk ist. De hierm e e sa m enha nge nde m utatie s o p de be ta alre k eninge n worde n do o r het Ministe rie va n Fina nciën te n gunste da n we l ten la ste va n de re k e ning-co urant, be do e ld in a rtik e l 4.2, ge bo e k t.

3.

He t Ministe rie van Fina nciën sluit m et he t C o lle ge zo rgve rze k eringen e e n o vere e nk o m st te r uitwe rk ing van he t ge bruik van de re k ening-co ura nt.

4.

In de ove ree nk om st, be do eld in he t derde lid, wo rde n a fspra k e n va stge le gd o ve r de we de rzijdse info rm atie vo o rzie ning tussen e nerzijds he t Ministe rie va n Fina ncië n e n a nde rzijds he t C olle ge zorgverze k e ringe n e n k a n bij wijze va n uitzo ndering afge spro k en wo rde n o m e e n be ta a lre k e ning buite n he t co nce rnve rba nd als be do eld in he t e erste lid te ho uden.

A rtikel 4.4 1.

Te n gunste va n de re k e ning-co urant, be do e ld in a rtik e l 4.2, wo rde n doo r he t Ministerie va n Fina ncië n te ve ns ge bo e k t: a.

de bijdrage n va n he t R ijk a a n de re k ening-co ura nthoude r ten be ho e ve van he t Zo rgve rzek e ringsfonds;

b.

de afdra chte n va n de doo r de rijk sbe lastingdienst ge ïnde bijdra gen a a n de re k e ning-coura ntho uder te n beho e ve va n het Zo rgve rze k eringsfo nds;

c.

de cre ditre nte, be doe ld in a rtik e l 4.5, vierde lid.

2.

Te n la ste van de rek e ninge n-co ura nt, bedo e ld in artik e l 4.2, wordt do or he t Ministe rie van Fina nciën te ve ns ge boe k t de de betre nte , be do e ld in a rtik e l 4.5, vie rde lid.

3.

De boe k inge n, be do eld in he t e erste lid, o nde rdee l b, wo rde n do o r he t Ministe rie va n Fina ncië n va n va luta data voo rzie n, zo da nig da t de ze da ta ove ree nk om e n m e t de ge m idde lde da ta wa a rop de bijdrage n do o r de rijk sbe la stingdie nst wo rden ge ïnd.

A rtikel 4.5 1.

O ve r he t da ge lijk se creditsa ldo va n de re k e ning-coura nt wo rdt doo r de Minister va n Fina ncië n e e n rente ve rgo ed die ge lijk is a a n he t 12-m a a nds Euribo r van de de sbe tre ffe nde dag.

2.

O ve r he t da ge lijk se de betsa ldo va n de re k e ning-co urant wo rdt do o r de re k ening-co ura nthoude r ee n re nte be taa ld die gelijk is aa n he t 1-m a a nds Euribor.

4.

De re nte wo rdt ja a rlijk s a chte raf, m e t va lutada tum 31 decem be r va n he t ja ar wa a rop de rente bere k e ning be tre k k ing he e ft, te n gunste respectie velijk te n laste va n de re k ening-co ura nt gebo e k t. Da a rto e ste lt de Ministe r va n Financië n ee n re nte no ta o p.

A rtikel 4.6 De re k e ning-coura ntho uder is be voe gd ee n bedra g va n ten ho ogste € 2,5 m iljo e n buite n de re k e ning-coura nt te ho ude n. A rtikel 4.7 1.

De Ministe r va n Vo lk sge zo ndhe id, W e lzijn e n Spo rt voe rt te n be ho eve va n de be oo rde ling va n de re chtm atigheid va n de verstre k k inge n va n uitk e ringe n als be do eld in a rtik el 118a , e e rste lid, van de Zo rgve rzek e ringswe t e e n sta tistische ste e k pro e f uit.

2.

Bij de a cco unta ntscontro le va n de jaa rre k ening, be doe ld in he t 74, e e rste lid, van de Zo rgve rzek e ringswe t wo rde n de re sulta te n va n de ste e k pro e f, be do eld in he t e erste lid, betro k k en.

Hoofdstuk 5. Bepalingen omtrent de inkomensafhankelijke bijdrage A rtikel 5.1 1.

He t in a rtik el 42, ee rste lid, onde rde e l b, va n de Zorgverze k e ringswet be doe lde tijdstip is de e e rste da g va n de k ale nde rm a and volge nde o p de m aa nd wa a rin de ve rzek e ringsplichtige de pe nsio e nge re chtigde le e ftijd, be do e ld in a rtik e l 7a , e e rste lid, van de Alge m e ne O ude rdo m swe t, hee ft be reik t, m et die n ve rsta nde da t dit tijdstip ge lijk is a a n de datum waa ro p ee n definitie ve vastste lling va n e en bijsta ndsuitk e ring a ls bedo e ld in artik e l 5, a a nhe f, e n o nder a , van de W e t we rk e n bijstand, o f va n ee n uitk e ring a ls be doe ld in de W e t ink o m e nsvo o rzie ning o ude re en ge de e ltelijk a rbe idsonge schik te we rk lo ze we rk ne m e rs o f de W e t ink o m e nsvo o rzie ning o ude re en ge de e ltelijk a rbe idsonge schik te ge weze n ze lfsta ndigen plaa tsvindt, indie n dat tijdstip la te r ligt da n e e rstbe do e ld tijdstip.

2.

De in a rtik el 42, ee rste lid, onde rde e l b, va n de Zorgverze k e ringswet be doe lde be sta ndde le n va n he t loo n zijn: a.

uitk e ringe n inge vo lge e e n pe nsio e nre ge ling of re ge ling vo o r ve rvro e gde uittreding a ls be doe ld in de W e t o p de lo onbe la sting 1964, niet zijnde ee n uitk e ring inge volge ee n re ge ling voo r vervro egde uittre ding die vóó r 1 janua ri 2006 is inge ga a n en o p gro nd wa arva n de uitk e ringsge re chtigde inge vo lge a rtik el 1, o nde rdee l g, va n he t Aa nwijzingsbesluit verze k e rde n Zfw verze k e rd was inge vo lge de Zie k e nfo ndswe t;

b.

uitk e ringe n o f pe nsio e ne n k rachte ns o f vanwe ge e e n pe nsio enre geling a ls be doe ld in a rtik e l 2, ee rste lid, onde r c e n d, van de To e sla gwe t Indo ne sische Pe nsio e ne n 1956, het P e nsio enre gle m e nt Ne derla nds Nie uw Guine a (Gouverne m entsbla d va n Ne de rla nds Nie uw Guinea 1958, 83), de W e t a anpa ssing P ensio e nvo o rzie ning Bijsta ndsk o rps, de Ga ra ntie we t Surinaa m se P e nsioe ne n o f de To e sla grege ling pensio e nen Surina m e e n Nede rlandse Antille n;

c.

uitk e ringe n e n ve rstre k k ingen inge volge ee n a anspra a k op pe rio diek e uitk e ringe n en verstre k k inge n a ls bedo e ld in artik e l 11, ee rste lid, onde rde e l g, va n de W et o p de lo o nbe lasting 1964;

d.

ink o m ste n a ls bedo e ld in artik e l 11, e erste lid, o nde rdele n a, d, f, i, j, k , l, o f v va n he t Uitvo e ringsbe sluit lo o nbe la sting 1965;

e.

uitk e ringe n inge vo lge de Alge m ene O uderdo m swe t;

f.

uitk e ringe n a ls bedo e ld in artik e l 47a va n de W e t we rk e n bijsta nd;

g.

o ve rbruggingsuitk e ringe n inge vo lge e e n a a nspra ak o p he t o ve rbruggingsfo nds va n de Stichting C o ntra ctspele rsfo nds KNVB e n de Stichting Nede rlands W ie lre nnersfo nds, en

h.

uitk e ringe n inge vo lge de derde a fde ling van de Alge m e ne pe nsio e nwe t politiek e a m btsdra ge rs die wo rden o ntva nge n doo r e e n a fge trede n lid va n de Twe ede Kam e r va n wie de arbe idsve rho uding ge dure nde he t lidm a atscha p va n de Twe e de Ka m er inge volge artik e l 4, a a nhe f e n o nderde e l f, va n de W et o p de lo o nbe lasting 1964 voo r de toe pa ssing va n die we t als dienstbe tre k k ing we rd bescho uwd.

A rtikel 5.2 1.

He t loo n, bedo e ld in artik e l 42, twee de lid, va n de Zo rgve rze k e ringswe t, dat vo or de heffing va n de ink o m e nsa fha nk elijk e bijd ra ge, be do e ld in a rtik e l 41 van die we t, te n ho o gste in a a nm e rk ing wordt ge no m e n, wo rdt vo o r he t ja ar 2013 va stge ste ld o p € 50.853,00.

2.

He t bedra g, be do eld in a rtik el 42, de rde lid, va n de Zo rgve rze k e ringswe t, dat vo or de heffing va n de ink o m e nsa fha nk elijk e bijdra ge pe r loo ntijdvak te n ho o gste in a a nm e rk ing wo rdt ge nom e n, wo rdt vo o r het ja a r 2013 va stge ste ld op: Loontijdvak Maximum bijdrage-inkomen Da g

€ 195,58

W e ek

€ 977,94

Vier we k en

€ 3.911,76

Ma a nd

€ 4.237,75

3.

Kwarta a l

€ 12.713,25

Ja a r

€ 50.853,00

In a fwijk ing van he t twe e de lid wo rdt het be drag, be do e ld in a rtik e l 42, de rde lid, va n de Zorgverze k e ringswet, da t vo o r de he ffing van de ink o m e nsa fha nk e lijk e bijdrage per lo o ntijdva k ten ho ogste in a anm e rk ing wo rdt geno m en, voo r we rk ne m ers a ls bedo e ld in a rtik e l 6.2, e e rste lid, o nderde e l a , van de Uitvo eringsre geling lo o nbe lasting 2011 vastgeste ld o p: Loontijdvak Maximum bijdrage-inkomen

4.

Da g

€ 222,06

W e ek

€ 1.110,32

Vier we k en

€ 4.441,31

Ma a nd

€ 4.811,52

Kwarta a l

€ 14.434,56

In a fwijk ing van he t twe e de lid wo rdt het be drag, be do e ld in a rtik e l 42, de rde lid, va n de Zorgverze k e ringswet, da t vo o r de he ffing van de ink o m e nsa fha nk e lijk e bijdrage per lo o ntijdva k ten ho ogste in a anm e rk ing wo rdt geno m en, voo r we rk ne m ers a ls bedo e ld in a rtik e l 6.2, e e rste lid, o nderde e l b, van de Uitvo eringsre geling lo o nbe lasting 2011 vastgeste ld o p: Loontijdvak Maximum bijdrage-inkomen Da g

€ 207,56

W e ek

€ 1.037,81

Vier we k en

€ 4.151,26

Ma a nd

€ 4.497,47

Kwarta a l

€ 13.492,41

A rtikel 5.3 1.

He t bijdra ge -ink om e n, be do eld in a rtik el 43, de rde lid, va n de Zo rgve rze k e ringswe t, dat vo or de heffing va n de ink o m e nsa fha nk elijk e bijdra ge, be doe ld in a rtik e l 41 va n die we t, te n ho o gste in a a nm e rk ing wo rdt ge nom e n, wo rdt vo o r het ja ar 2013 vastgeste ld o p he t be dra g, bedo e ld in artik e l 5.2, e erste lid .

2.

Vo or zo ve r het bijdra ge-ink o m en van e e n ve rze k eringsplichtige be staa t uit lo o n als be do eld in a rtik el 43, twe e de lid, onde rde e l a, van de Zo rgve rzek e ringswe t, is a rtik el 5.2, twe e de to t e n m e t vie rde lid, va n o ve re enk o m stige to e pa ssing.

A rtikel 5.4 1.

He t percenta ge, be doe ld in a rtik e l 45, e e rste lid, va n de Zorgverze k e ringswet, wo rdt va stge ste ld op 7,75.

2.

He t percenta ge, be doe ld in a rtik e l 45, twe e de lid, va n de Zorgverze k e ringswet, wo rdt va stge ste ld op 5,65.

3.

In a fwijk ing van he t ee rste o f twe ede lid, wo rdt he t percenta ge va stge ste ld o p nihil:

4.

a.

o ve r bijdra ge-ink o m e n vo o rtvlo e ie nde uit werk zaa m hede n va n ee n ve rzek e ringsplichtige a a n bo o rd va n e e n ze e schip, m its de ze e we rk geve r of sche epseige na a r het risico a ls be doe ld in ho ofdstuk 3 va n de Zo rgve rze k e ringswe t, zo la ng de ze verze k e ringsplichtige nie t is te rugge k e e rd of he e ft k unnen te rugk e re n na a r he t la nd wa ar hij thuisbe hoo rt, o p gro nd va n ee n verdra gsre chte lijk e be paling o f e e n be paling die da a r o p sto elt in be la ngrijk e m a te vo or zijn re k ening ne e m t;

b.

o ve r be la stba re perio die k e uitk e ringe n o f verstre k k inge n o p gro nd va n e e n rechtstre ek s uit he t fam ilie re cht vo o rtvlo e ie nde verplichting a ls bedo e ld in artik e l 3.101, e e rste lid, o nderde e l b, van de W e t ink o m ste nbela sting 2001, tenzij a rtik e l 11, e e rste lid, o nde rde el g, va n het Uitvoe ringsbesluit lo onbe la sting 1965 to epa ssing vindt, indie n de ze pe rio diek e uitk e ring o f verstre k k ing o o k in 2005 is ge note n.

Indien he t lo o n wa a ro ve r de inhoudingsplichtige ink o m e nsa fha nk elijk e bijdra ge ve rschuldigd is m ee r be dra a gt da n het be drag, ge no e m d in a rtik e l 5.2, e e rste lid, e n is sa m e nge ste ld uit be sta ndde len wa aro ver e e n ve rschillend bijdra ge pe rce nta ge is verschuldigd, wo rden de be standdele n zo danig toe ge rek e nd da t het bijdra ge pe rce nta ge van 7,75 he t e erst in a a nm e rk ing wo rdt ge no m e n, e n daa rna he t pe rce nta ge va n 0.

5.

Indien he t bijdrage -ink o m e n wa a rove r de verze k e ringsplichtige ink om e nsa fhank e lijk e bijdra ge ve rschuldigd is m e er be draa gt dan he t be dra g, be doe ld in a rtik e l 5.3, e e rste lid, e n is sam e nge steld uit be sta ndde le n wa a rove r ee n ve rschille nd bijdra gepe rce ntage is verschuldigd, wo rden de be standdele n zo danig toe ge rek e nd da t het bijdra ge pe rce nta ge van 5,65 he t e erst in a a nm e rk ing wo rdt ge no m e n, e n daa rna he t pe rce nta ge va n 0.

A rtikel 5.5 De ink o m ste n, be do eld in a rtik el 45, vie rde lid, va n de Zorgverze k e ringswet, be tre ffen voo r he t be re k ene n va n de bijdra gepe rce ntage s die m e t inga ng va n 1 ja nua ri 2013 ge lden te lk e ns m e t betre k k ing to t he t de sbe treffe nde k a lende rja a r: a.

he t ge ra a m de to taa lbedra g aa n nom inale re k e nprem ie s, be do e ld in a rtik e l 1, o nderde e l a a , va n het Be sluit zo rgve rze k e ring vo o r a lle zorgverze k e ringe n waa rvoo r pre m ie m oe t wo rde n beta a ld, ve rm e e rderd m e t he t ge raa m de to ta a lbe drag da t de zorgverze k e ra a rs van hun ve rze k erde n zulle n o ntva nge n ten ge vo lge van e e n do o r he n va st te ste lle n opsla g o p de ze no m ina le re k enpre m ie s;

b.

he t ge ra a m de to taa lbedra g aa n e ige n bijdrage n, be do eld in a rtik el 11, de rde lid, va n de Zo rgve rze k e ringswe t;

c.

he t ge ra a m de to taa lbedra g aa n ve rplicht e igen risico da t do o r ve rzek e rden zal wo rde n beta a ld, ve rm inderd m e t he t ge raa m de to ta albe dra g dat he t C AK o p grond va n a rtik e l 118a va n de Zo rgve rze k eringswe t za l uitk e ren;

d.

de aa n het Zo rgve rze k e ringsfo nds to e te vo ege n rijk sbijdra ge , be do eld in a rtik el 54 va n de Zo rgve rze k eringswe t, alsm e de bijdra gen a ls be do e ld in a rtik e l 87a va n de W e t fina ncie ring so cia le ve rze k eringen;

e.

he t ge ra a m de to taa lbedra g aa n ink o m ensafha nk e lijk e bijdra ge n a ls bedo e ld in artik e l 41 va n de Zo rgve rze k e ringswe t dat va n inho udingsplichtige n en verze k e ringsplichtigen ge he ven zal wo rde n, ve rm inde rd m e t he t ge ra a m de bedra g, be do eld in a rtik el 42, a chtste lid, va n die we t.

A rtikel 5.6 Een be dra g dat in a anm e rk ing is geno m en a ls lo on in de zin van a rtik e l 42, e e rste lid, o f a rtik e l 43, twe e de lid, o nderde e l a , van de Zo rgve rze k eringswe t, wo rdt nie t in aa nm erk ing ge nom e n als bijdrage -ink o m e n in de zin va n a rtik el 43, twe e de lid, onde rde e l b, va n die we t. A rtikel 5.7 1.

Vo or de to epa ssing van dit artik e l e n va n a rtik e l 5.8 wo rde n de la nde n va n het Ko nink rijk de r Ne de rla nden a a nge m erk t a ls a fzo nderlijk e m o ge ndhe de n.

2.

To t he t lo on, be do e ld in a rtik e l 42 van de Zo rgve rzek e ringswe t, o f het bijdra ge-ink o m en, be do e ld in a rtik e l 43 van die we t, be ho re n nie t: a.

uitk e ringe n inge vo lge de so cia le-ze k erhe idswetge ving va n ee n a nde re m o ge ndhe id die zijn o nde rwo rpe n a an pre m ie heffing k ra chtens ee n wette lijk e re ge ling inza k e ziek te k oste n va n die ande re m o gendheid;

b.

te n aa nzie n va n de ge ne die ve rze k eringsplichtig is e n die te ve ns we rk za am he de n ve rricht o f he e ft ve rricht buite n he t Euro pe se dee l va n Nede rland:

c.

1°

he t ge de elte va n het lo o n o f he t bijdrage-ink o m e n da t o nde rworpe n is a an he ffing va n ink o m ensafha nk e lijk e prem ie a ls be do e ld in het Be sluit zo rgve rze k e ring BES,

2°

he t ge de elte va n het lo o n o f he t bijdrage-ink o m e n, wa a rop inge volge ee n inte rna tio na le re geling inza k e so cia le zek e rheid die tusse n Ne derla nd e n e en o f m ee r a nde re m oge ndhe den van k ra cht is, de we tgeving van e e n a ndere m o ge ndhe id va n toe pa ssing is,

3°

he t ge de elte va n het lo o n o f he t bijdrage-ink o m e n, da t, bij ge bre k e va n ee n inte rna tio na le re geling, is onde rwo rpe n a a n pre m ie he ffing k rachte ns e e n we tte lijk e rege ling inza k e zie k te k o sten van e e n a ndere m o ge ndhe id;

te n aa nzie n va n de ge ne die nie t is uitge zo nderd van de vo lk sve rzek e ringe n op gro nd van a rtik e l 13, e e rste lid, o nderde e l a , a rtik e l 13, twe e de lid, o nderde e l c, artik e l 13, derde lid, o nde rde el a , a rtik e l 13, vie rde lid, o nde rdee l c, a rtik e l 14, e e rste lid, o nde rde el a , a rtik e l 15, e e rste lid, o nde rde le n a , b e n c, sub 1 0, o f a rtik e l 16, e e rste lid, o nde rde el a , va n het Be sluit uitbre iding e n be perk ing k ring ve rze k erde n vo lk sve rzek e ringe n 1999 in verba nd m e t het ve rrichte n va n de in die a rtik e le n be do e lde a nde re werk zaa m hede n: het be lastbare lo on uit de dienstbe tre k k ing uit ho ofde waa rvan hij zo u zijn uitge zonde rd van de vo lk sve rzek e ringe n indien hij die ande re we rk za a m he den niet zo u he bbe n ve rricht.

A rtikel 5.8 1.

Te n a a nzie n va n de gene die ge dure nde e e n de e l va n he t k ale nde rja ar nie t ve rze k e ringsplichtig is ingevo lge de Zo rgve rze k eringswe t, wo rdt vo o r de bijdra ge he ffing bij we ge va n aa nsla g als bijdrage -ink o m e n ge e n ho ger be drag in aa nm erk ing ge no m e n da n he t bijdra ge-ink o m e n ve rm inde rd m e t he t ge de elte daa rvan wa aro p, inge vo lge e e n inte rnatio nale re ge ling inza k e socia le ze k erhe id die tusse n Nede rland e n e e n of m e e r ande re m o gendhede n va n k ra cht is, de wetge ving va n ee n a nde re m o ge ndhe id va n toe pa ssing is, o f dat, bij ge bre k e van e e n inte rna tio na le rege ling, is o nde rwo rpe n a an pre m ie heffing k ra chte ns e e n we tte lijk e re ge ling inzak e zie k tek o ste n va n e en a nde re m oge ndhe id.

2.

Te n a a nzie n va n de gene die ge dure nde e e n de e l va n he t k ale nde rja ar a nders dan do or o verlijde n nie t verze k e ringsplichtig is

inge volge de Zo rgve rze k eringwe t, wo rdt vo or de bijdra ge he ffing a ls bijdra ge -ink om e n ten ho ogste in a anm e rk ing ge no m e n het be dra g dat na a r tijdse venre dighe id is a fge le id va n he t be dra g, bedo e ld in artik e l 5.3, e erste lid , te nzij to e passing va n de be pa linge n in de Zo rgve rzek e ringswe t o f va n de o verige be pa lingen in de ze re ge ling tot e e n la ge r bijdrage -ink o m e n le idt. A rtikel 5.9 Indien voo r de he ffing va n de ink o m ensafha nk e lijk e bijdra ge bij we ge va n a a nsla g he t bijdra ge -ink om e n wo rdt bepa a ld do or m idde l va n tijdse ve nredige va ststelling, wo rdt da a rbij: a.

e e n k a lende rja a r o p 360 da ge n ge ste ld;

b.

e e n k a lende rm a a nd o p 30 da gen ge ste ld;

c.

de da g waa ro p he t tijdva k a a nva ngt, a ls e e n ge he le da g in a anm e rk ing ge no m e n;

d.

de da g waa ro p he t tijdva k e indigt, nie t in aa nm erk ing ge nom e n.

A rtikel 5.10 [Vervallen per 01-01-2013] A rtikel 5.11 1.

De o ntva ngsten pe r bijdrage jaa r van de co m binee rde he ffing va n de loo nbela sting, de pre m ie s vo or de so cia le ve rze k eringen e n de bijdrage vo o r de Zo rgve rze k e ringswe t a lsm ede o p lo o nink om sten be trek k ing he bbe nde na he ffingsa ansla ge n, be lasting- e n invo rderingsre nte e n boe te o ntva ngsten wo rde n uitge splitst in ee n vo o r de a fdra cht va stge ste ld ve rdee lpercenta ge pe r bijdra ge ja ar.

2.

He t ve rde elpe rce nta ge in he t ee rste lid wo rdt m aa ndelijk s per bijdra ge ja a r o pnie uw be rek e nd o p basis van he t rela tieve aa ndee l van de bijdrage n Zo rgve rzek e ringswe t in alle ontvange n colle ctieve aa ngifte n e n o pgele gde na he ffinge n.

3.

Alle o ntva nge n gelde n o ver he t bijdra ge ja ar wo rden verde e ld o p ba sis va n het ve rde e lpe rce nta ge , be do e ld in het e e rste lid. De m utatie te n o pzichte va n de vo rige perio de vo rm t he t a f te dra gen be dra g.

4.

Een ja ar na a flo o p va n he t bijdra geja a r wo rdt het ve rde e lpe rce nta ge voo r he t be tre ffe nde bijdra ge ja ar de finitie f va stge ste ld. Dit pe rce nta ge wo rdt geha ntee rd vo o r a lle beta linge n die daa rna binnenk o m e n.

A rtikel 5.12 1.

De o ntva ngsten van de ove rige ink o m ensafha nk e lijk e bijdra ge n o ve re enk o m stig a rtik el 49, de rde lid, va n de Zo rgve rze k e ringswe t wo rde n m aa ndelijk s va stge steld.

2.

De o nde r het e e rste lid ge noe m de o ntva ngste n zijn inclusie f de e ve ntuele bela sting- e n invo rde ringsre nte en bo ete o ntva ngste n.

A rtikel 5.13 1.

2.

De inspecteur verle e nt vo oruitlope nd o p e en be schik k ing als be do eld in a rtik el 50, ee rste lid, va n de Zo rgve rze k eringswe t ee n voo rschot indie n: a.

he t be dra g va n de te ve e l be ta alde bijdrage ve rm o ede lijk te n m inste € 100 za l be dra ge n, e n

b.

he t bijdrage -ink o m e n wa a rove r ink o m e nsa fha nk e lijk e bijdrage wordt o f is inge ho ude n afk o m stig is va n ve rschille nde inho udingsplichtige n.

He t e erste lid is niet va n to e passing m e t be trek k ing to t: a.

pe rso nen die o p grond va n a rtik e l 2, twe e de lid, o nderde e l b, van de Zo rgve rzek e ringswe t niet ve rze k eringsplichtig zijn;

b.

pe rso nen die vo or 1 a pril van he t k a le nde rjaa r wa aro p het vo orscho t be tre k k ing he e ft, a ange ve n ge e n vo o rscho t te willen o ntva nge n.

3.

De inspecteur k a n he t vo o rscho t a l da n nie t o p ve rzo e k he rzie n. Ee n ve rzoe k to t he rzie ning van he t vo o rscho t k an wo rde n inge diend to t 1 de ce m be r van he t k a le nde rjaa r wa aro p het vo orscho t be tre k k ing he e ft.

4.

Indien de inspe cte ur e en verzo ek o m ve rlening da n we l herziening va n e e n vo o rscho t gehe e l o f ge de e ltelijk a fwijst, gebe urt dit bij voo r be zwa ar va tba re beschik k ing.

5.

Vo orscho tten wo rde n ve rre k end m et de beschik k ing, be doe ld in a rtik e l 50, e e rste lid, va n de Zorgverze k e ringswet, da n we l – vo o r zove el no dig – bij e en do or de inspecteur te nem e n vo o r be zwa a r va tba re be schik k ing.

Hoofdstuk 6. Het College zorgverzekeringen § 1. Vergoedingen leden Adviescommissie Pakket A rtikel 6.1.1 [Vervallen per 01-07-2011] A rtikel 6.1.2 [Vervallen per 01-07-2011]

§ 2. Subsidies ten laste van het Zorgverzekeringsfonds

§ 2.1. A lgemene subsidiebepalingen § 2.1.1. Begrippen en algemene bepalingen A rtikel 6.2.1 In ho ofdstuk 6.2 wo rdt ve rstaa n o nde r: a.

inste lling: e en priva a trechte lijk e re chtspe rso o n m e t vo lledige re chtsbe voe gdhe id, da n wel e e n re chtspe rsoo n k rachte ns publie k recht inge steld;

b.

pro je ct: ee n a ctivite it m e t e en incide nte el k a rak te r;

c.

inste llingssubsidie : e en subsidie aa n e en inste lling in de k o sten van ha ar structurele a ctivite ite n o f ee n gede e lte da arva n;

d.

pro je ctsubsidie : e e n subsidie in de k oste n va n e e n pro je ct;

e.

o nde rsteuningssubsidie : e e n instellingssubsidie van te n ho o gste € 11 344,51 in e e n ge ring de el van de tota le k o sten van he t a lge m e en functione re n va n e e n instelling.

A rtikel 6.2.2 1.

He t C o lle ge zo rgve rze k eringen verstre k t o p grond va n deze rege ling subsidies vo o r de in dit ho o fdstuk , o nder pa ra gra a f 2.2, a a nge geve n do e le inde n die te n la ste k o m en van he t zo rgve rze k e ringsfo nds.

2.

He t a anvrage n va n de subsidie en de subsidie vastste lling a lsm ede het ne m en van be sluite n m et be tre k k ing to t subsidie s ge schie dt o vere e nk o m stig de in deze rege ling geste lde re ge ls.

A rtikel 6.2.3 1.

2.

Subsidie wordt sle chts ve rstre k t indie n: a.

na ar he t o orde e l va n he t C o lle ge zo rgve rze k eringen m a g wo rden verwa cht dat de m et de subsidiëring be o o gde doe le inde n zulle n wo rden be reik t,

b.

de aa nvra ge r na a r het o o rdee l va n het C o llege zo rgve rzek e ringe n de be ho e fte aa n subsidie he e ft aa ngeto o nd, e n

c.

de aa nvra ge r aa nnem e lijk hee ft ge m a a k t da t de fina nciële m idde le n m et inbegrip va n subsidie voldo ende zulle n zijn om de voo rge no m e n a ctivite ite n uit te vo e ren.

He t e erste lid, o nde rdele n b e n c, zijn nie t van to e pa ssing o p re chtspe rso nen k ra chtens publie k re cht inge ste ld. § 2.1.2.

Berekeningswijze instellingsubsidie A rtikel 6.2.4

Een inste llingssubsidie be staa t uit ee n doo r he t C olle ge zorgverze k e ringe n va st te ste lle n be dra g vo or o vere e nk o m stig e en do or he t C o lle ge zo rgve rze k e ringe n go e dge k eurd a ctivite ite npla n uitge vo e rde a ctivite ite n. A rtikel 6.2.5 1.

He t bedra g, be do eld in a rtik el 6.2.4 wo rdt ve rlaa gd m e t he t be dra g wa a rm e e het m a x im a a l to e gesta ne be dra g va n de in a rtik e l 6.2.23 be do e lde re se rvering wo rdt o ve rschre de n.

2.

He t e erste lid is niet va n to e passing op e e n o nderste uningssubsidie.

A rtikel 6.2.6 Ba ten e n la sten die do o r m iddel van interne doo rbe rek e ninge n wo rden to e ge re k end, worde n be pa ald o p be drijfsecono m ische en m a atscha ppe lijk a anvaa rdbare gro ndsla ge n. Vo o r zo ve r hierin laste n zijn be gre pe n va n m a te rië le va ste a ctiva , wo rde n deze la sten o p ba sis va n a a nscha ffingsprijze n va n die a ctiva be rek e nd. § 2.1.3. Berekeningswijze projectsubsidies A rtikel 6.2.7 Een pro je ctsubsidie besta at uit het ve rschil tusse n de m e t de ge subsidiee rde activiteite n sa m enha nge nde e n m e t in achtne m ing va n de inge volge de ze re ge ling in a a nm e rk ing k om e nde we rk e lijk e laste n, vo or zo ve r o pge nom e n in de do o r het C o llege zo rgve rzek e ringe n go edge k e urde be groting, en de m e t de ge subsidie erde a ctivite ite n sa m e nha nge nde ba te n. De subsidie be dra agt niet m e e r da n het do o r he t C olle ge zorgverze k e ringe n va stge stelde m a x im um . § 2.1.4. Modellen en formulieren A rtikel 6.2.8

He t C o lle ge zo rgve rze k eringen stelt voo r de subsidie s in de ze re ge ling de vo lge nde m o delle n e n fo rm uliere n va st: a.

e e n fo rm ulie r vo o r de a a nvra a g va n subsidie ,

b.

e e n m o del voo r he t pro je ctpla n,

c.

e e n m o del voo r de be gro ting,

d.

e e n m o del voo r he t activiteite npla n,

e.

e e n m o del voo r he t activiteite nve rsla g,

f.

e e n contro lepro to co l,

g.

e e n m o del a cco untantsve rk la ring, e n

h.

e e n fo rm ulie r vo o r de a a nvra a g va n de va stste lling va n de subsidie .

§ 2.1.5. A anvraag van een instellingssubsidie A rtikel 6.2.9 1.

De inste lling die vo o r ha a r a ctivite ite n o f ee n gede e lte da arva n in e en ja ar e e n instellingssubsidie verla ngt, die nt uite rlijk de rtie n we k e n vó ó r de a a nva ng va n he t desbetre ffe nde ja ar e e n subsidie a a nvra ag in. De a a nvra a g wo rdt onde rbo uwd m e t e en a ctivite itenplan e n ee n begro ting e n ga a t, indie n de liquidite itsbe ho e fte nie t re ge lm atig gespreid is o ve r he t ja a r, ve rge ze ld va n e e n liquiditeitspro gnose .

2.

In he t activiteite npla n wo rde n de a ard e n de o m va ng va n de vo o rgeno m en a ctivite iten be schre ve n. Da arbij wo rdt a ange ge ven we lk e doe lste lling de inste lling m et de a ctivite ite n nastre eft, o p welk e wijze zij zulle n wo rden uitge voe rd e n vo or we lk e do e lgro ep zij zijn beste m d.

3.

De begro ting ge eft inzicht in de ba ten e n la sten van de activiteite n va n da t ja ar. De be gro ting is vo o rzie n va n e e n po stge wijze to e lichting. Da a rbij wo rdt uitgega a n va n he t prijspe il en van he t nivea u va n de k o ste n va n de a rbe idsvo o rwa a rden o p he t m o m e nt van indie ning va n de a a nvra a g. In ge va l va n e en priva a trechte lijk e re chtspe rso o n be va t de be gro ting te ve ns zowe l de ba ten e n la ste n va n de inste lling als ge he el a ls de ba te n en la ste n va n elk te onde rsche ide n o nde rdee l va n de inste lling.

4.

De liquidite itspro gno se ge eft ge m otivee rd inzicht in he t ve rloo p va n de liquiditeitsbe ho efte van de activiteite n pe r k a le nderk wa rtaa l.

5.

He t C o lle ge zo rgve rze k eringen k a n o ntheffing ve rlene n va n de in he t e e rste lid ge no e m de a a nvra agte rm ijn.

A rtikel 6.2.10 1.

Bij de a anvraa g va n e en inste llingssubsidie do o r e en priva a trechte lijk e re chtspe rso o n wo rden te ve ns o verge legd: a.

e e n a fschrift va n de o prichtingsa k te o f de sta tute n,

b.

e e n a fschrift wa a ruit de inschrijving va n de inste lling in he t gelde nde o pe nbaa r re giste r blijk t,

c.

e e n vo lle dig o ve rzicht va n de fina ncië le to e sta nd va n de inste lling o p het tijdstip va n de a a nvra ag, e n

d.

indie n de a a nvra ag is o nderte k e nd do or e e n of m e e r ande re pe rso ne n da n de pe rso nen die o p grond va n de sta tute n be vo e gd zijn de inste lling te ve rte ge nwoo rdige n: e e n a fschrift va n de vo lm acht o p grond waa rvan de aa nvra a g do o r die a nde re perso on o f perso ne n is o nde rte k end.

2.

Vo or zo ve r de a a nvra ger vo or de ze lfde be grote uitga ven te ve ns subsidie o f ee n a nde re fina nciële bijdra ge he eft a a nge vraa gd bij a nde re bestuurso rga ne n o f o rganisa tie s, do et hij da a rva n m ede deling in de a a nvra a g, o nder ve rm e lding va n de sta nd van zak e n m e t be tre k k ing tot de beo o rdeling va n die aa nvra a g of a a nvra gen.

3.

O ve rle gging va n de in het e e rste lid be doe lde a fschrifte n k an a chte rwe ge blijve n, indien de aa nvra ge r er re de lijk erwijs van uit k a n ga an da t de ze ge geve ns a an he t C olle ge zorgverze k e ringe n bek e nd zijn.

§ 2.1.6. A anvraag van een projectsubsidie A rtikel 6.2.11 1.

He t C o lle ge zo rgve rze k eringen k a n pro jectsubsidie s ve rlene n die zich uitstre k k e n o ve r m ee r da n e e n k a le nde rjaa r.

2.

De natuurlijk e pe rsoo n o f rechtsperso on die subsidie vo o r e en be pa a ld pro ject ve rlangt, die nt te n m inste dertie n we k e n vó ór de a a nva ng van he t pro je ct e en a a nvra ag in. De a a nvra a g wo rdt onde rbo uwd m e t e en pro je ctpla n e n e en be gro ting e n gaa t verge ze ld van e e n liquiditeitspro gnose .

3.

In he t pro je ctpla n worde n de a a rd e n de o m va ng va n de voo rge no m e n a ctivite ite n be schre ven. Da a rbij wordt a a nge geve n we lk e do elstelling de aa nvra ge r m e t de activiteite n na stree ft e n op we lk e wijze die zulle n worde n uitge vo e rd.

4.

De begro ting ge eft inzicht in de ba ten e n la sten van he t pro je ct. De be gro ting is voo rzie n va n e en po stge wijze to e lichting. Da a rbij wo rdt uitgega a n va n he t prijspe il en van he t nivea u va n de k o ste n va n de a rbe idsvo o rwa a rden o p he t m o m e nt va n indie ning va n de aa nvra a g.

liquidite itspro gno se k a n achte rwe ge blijven a ls de liquidite itsbeho e fte re ge lm a tig ge spre id is ove r de duur va n he t proje ct. 6.

In a fwijk ing van he t twe e de lid k a n het C o llege zo rgve rzek e ringe n be pa le n dat a a nvra gen voo r pro je cte n o p be paa lde te rre ine n vóó r e e n o f m e er do o r he m va stge stelde da ta worde n inge die nd.

7.

He t C o lle ge zo rgve rze k eringen k a n o ntheffing ve rlene n va n de in he t twe ede o f ze sde lid be do e lde a a nvra agte rm ijn.

A rtikel 6.2.12 1.

Bij de a anvraa g va n de subsidie doo r e e n priva a tre chtelijk e re chtspe rso o n wo rde n te vens ove rge le gd: a.

e e n a fschrift va n de o prichtingsa k te o f de sta tute n,

b.

e e n a fschrift wa a ruit de inschrijving va n de inste lling in he t gelde nde o pe nbaa r re giste r blijk t, e n

c.

indie n de a a nvra ag is o nderte k e nd do or e e n of m e e r ande re pe rso ne n da n de pe rso nen die o p grond va n de sta tute n be vo e gd zijn de inste lling te ve rte ge nwoo rdige n: e e n a fschrift va n de vo lm acht o p grond waa rvan de aa nvra a g do o r die a nde re perso on o f perso ne n is o nde rte k end.

2.

Vo or zo ve r de a a nvra ger vo or de ze lfde be grote uitga ven te ve ns subsidie o f ee n a nde re fina nciële bijdra ge he eft a a nge vraa gd bij a nde re bestuurso rga ne n, do e t hij daa rvan m e de de ling in de aa nvra a g, onde r ve rm elding van de sta nd va n za k e n m et be tre k k ing to t de be o orde ling va n die a a nvra ag o f a anvrage n.

3.

O ve rle gging va n in he t e erste lid bedo e lde a fschrifte n k a n achte rwe ge blijven, indie n de a a nvra ge r e r re de lijk e rwijs va n uit k a n ga an da t de ze ge geve ns bij he t C olle ge zorgverze k e ringe n bek e nd zijn.

A rtikel 6.2.13 1.

He t C o lle ge zo rgve rze k eringen k a n e e n aa nvra ge r of e e n ca tego rie a a nvra gers te ve ns verplichten to t het o verle gge n va n e en volle dig o ve rzicht van de fina nciële to esta nd van de instelling o p he t tijdstip va n de a anvraa g.

2.

He t e erste lid is niet va n to e passing indien e e n re chtspe rsoo n, k rachte ns publie k recht ingeste ld, e e n pro jectsubsidie a a nvra agt.

2.1.7. Subsidieverlening en bevoorschotting

§

A rtikel 6.2.14 He t C o lle ge zo rgve rze k eringen ge eft e e n be schik k ing o p ee n a anvraa g binne n de rtien we k e n na o ntva ngst van de aa nvra a g. A rtikel 6.2.15 1.

Na da t e e n subsidie a anvraa g is inge diend, k an he t C olle ge zorgverze k e ringe n vo o rscho tte n ve rlene n. Daa rbij wo rdt rek e ning ge ho uden m e t de liquidite itsbe hoe fte .

2.

He t C o lle ge zo rgve rze k eringen verstre k t, indie n de liquiditeitsbe ho efte re gelm a tig is ge spre id, de vo lgende vo o rscho tte n o p een verle e nde inste llingssubsidie: in ja nua ri 15%, fe brua ri 7%, m a art 7%, a pril 7%, m e i 15%, juni 7%, juli 7%, a ugustus 7%, septe m be r 3%, ok to ber 11%, en no ve m be r 14% va n he t vo o r het de sbe tre ffende ja a r ve rle ende be dra g.

3.

Indien he t C olle ge zorgverze k e ringe n vo o rscho tte n ve rstre k t vo o rdat hij de be schik k ing tot subsidie ve rle ning he e ft gege ve n, wo rde n de pe rce ntage s, be doe ld in he t twe e de lid, tot de datum va n subsidieve rle ning, to e ge pa st o p he t voo r he t vo o rga a nde jaar verle e nde bedra g, in voo rk o m e nde ge va llen bijge ste ld ove ree nk om stig do or he t C o lle ge zo rgve rze k eringen ge ge ven be schik k ingen.

A rtikel 6.2.16 1.

Bij de ve rle ning va n ee n subsidie k a n he t C o lle ge zo rgve rze k e ringe n be pale n da t he t subsidie be dra g doo r he m wo rdt bijgeste ld, re k eningho ude nd m e t de ontwik k e ling va n het prijspe il o f de o ntwik k e ling in de k o sten van de arbe idsvo o rwaa rde n.

2.

Me t he t oo g o p de to epa ssing van he t ee rste lid k a n het C o llege zo rgve rzek e ringe n bij de ve rle ning van de subsidie te ve ns be pa le n we lk de e l va n he t subsidiebe drag in aa nm erk ing za l wo rden ge no m e n vo or e e n bijste lling in ve rba nd m e t de ontwik k e ling van he t prijspe il, o ndersche ide nlijk va n de k o ste n va n de a rbeidsvo orwa a rde n.

3.

Indien e e n subsidie m et to e passing va n he t e e rste lid wo rdt bijge steld, k an de be voo rschotting ove ree nk om stig wo rde n gewijzigd.

2.1.8. Verplichtingen van de subsidieontvanger A rtikel 6.2.17 De subsidieo ntva nger zo rgt e rvoo r da t: a.

de do e leinden, ge ste ld in het a ctivite ite npla n da n we l het pro jectpla n, op do elm a tige wijze wo rden na ge stree fd,

b.

de we rk za a m he de n o p e en zoda nige m anie r wo rde n ge re ge ld da t e e n go e d be leid e n be hee r wo rde n gevo erd, e n

c.

de subsidie o p do e lm a tige wijze wordt ge bruik t vo o r de do ele inde n wa a rvo o r deze wo rdt ve rle end.

A rtikel 6.2.18

§

De subsidieo ntva nger zo rgt e r voo rts vo o r: a.

da t de a dm inistra tie o p o ve rzichte lijk e en do elm a tige wijze wo rdt ge voe rd,

b.

da t de a dm inistra tie e e n juist, vo lle dig e n actue e l be e ld ge e ft va n he t functione re n va n de inste lling, e n

c.

da t va n alle ontvangste n e n uitgave n de ugde lijk e be wijsstuk k en a a nwe zig zijn wa a ruit de a ard e n de o m va ng va n de gele ve rde go ede re n o f van de ve rrichte die nste n duide lijk blijk e n.

A rtikel 6.2.19 Bij inste llinge n die ee n inste llingssubsidie o ntva ngen, is he t boe k jaa r ge lijk aa n het k a lende rja a r. A rtikel 6.2.20 1.

De subsidieo ntva nger do e t zo spo e dig m oge lijk schrifte lijk m ede deling a a n he t C o lle ge zo rgve rze k e ringe n va n o m sta ndighe de n die va n be lang k unne n zijn voo r e e n be slissing to t wijziging, intre k k ing o f vastste lling va n de subsidie .

2.

He t e erste lid is van to e pa ssing in de situa tie da t de feite lijk e liquidite itsbeho e fte la ger is da n de ve rle e nde voo rschotte n.

3.

Bij e e n m e de de ling o ve re e nk o m stig dit a rtik e l worde n de re leva nte stuk k e n o verge legd.

A rtikel 6.2.21 1.

De priva atre chte lijk e rechtsperso on die e e n instellingssubsidie o ntva ngt, ve rze k ert ha a r roe re nde e n onro e rende za k en o p a fdoe nde wijze te ge n het risico va n die fsta l en bra nd a lsm e de te gen he t risico va n we tte lijk e aa nspra k elijk he id te ge no ver de rden.

2.

De o ntva nge r va n e en inste llingssubsidie ve rze k e rt vo o r vrijwillige rs die we rk za a m he de n ve rrichte n in he t k ade r va n de ge subsidie e rde a ctivite ite n, hun we tte lijk e aa nspra k elijk he id.

3.

He t C o lle ge zo rgve rze k eringen k a n o p a anvraa g o nthe ffing verle nen van he t ee rste o f twe ede lid.

4.

He t C o lle ge zo rgve rze k eringen k a n he t e erste of twe e de lid va n o vere e nk o m stige toe pa ssing ve rk lare n o p de o ntva nge r va n e en pro je ctsubsidie .

A rtikel 6.2.22 De subsidieo ntva nger ste lt na a flo o p va n de pe rio de of he t proje ct wa arvo or subsidie is verle e nd e e n ve rsla g va st da t inzicht ge e ft in de a a rd, duur en o m va ng va n de in he t k ade r va n de subsidië ring verrichte a ctivite ite n. He t ve rsla g ve rgelijk t de ve rrichte activiteite n m e t de in he t a ctivite itenplan, o nde rscheide nlijk pro jectpla n, vo o rge no m e n a ctivite ite n. A rtikel 6.2.23 1.

Vo or zo ve r het be drag van de ve rlee nde inste llingssubsidie , zo nder to e passing va n de in artik e l 6.2.5 be do elde ve rm inde ring, na uitvo e ring va n de ge subsidiee rde activiteite n ove ree nk om stig de ge ldende ve rplichtinge n, nie t is be ste e d aa n de do e le inde n wa arvo or he t is verstre k t, wo rdt he t ge rese rve e rd.

2.

Vo or de bere k e ning va n he t in he t e e rste lid be do e lde te re se rve re n be dra g wo rdt he t to ta al van de m e t de ge subsidie erde a ctivite iten sam e nha ngende ba te n, be staa nde uit de ve rle e nde inste llingssubsidie en de ge re a lisee rde ove rige bate n, ve rm inde rd m e t de la ste n va n de ge subsidie e rde a ctivite ite n. De ze uitk om st wo rdt to ege re k e nd na a r ra to va n de ve rle ende instellingssubsidie e n de , in de inge diende be gro ting o pge nom e n, m e t de ge subsidie erde a ctivite ite n sa m e nha nge nde, o verige ba te n. Het te re se rvere n bedra g is het a a n de inste llingssubsidie toe ge rek e nde de el.

3.

To evo eginge n a an voo rzie ninge n als be do eld in a rtik el 374, e e rste lid, va n Bo e k 2 van he t Burge rlijk W e tbo ek , die sa m e nhange n m e t de ge subsidie e rde a ctivite ite n, wo rden ge rek e nd to t de la sten van de ge subsidie erde a ctivite ite n, bedo e ld in he t twe ede lid.

4.

Indien in de inge diende be gro ting o nde r de m e t de ge subsidiee rde activiteite n sa m enha nge nde ba ten e e n vrijge va llen voo rzie ning is o pgeno m en, blijft de ze buite n be schouwing bij de bere k e ning va n he t te re se rve re n be dra g, be doe ld in he t twe e de lid.

5.

De ve rplichting, be do eld in he t e erste lid, geldt nie t voo r de ontvange r va n ee n o nde rste uningssubsidie .

6.

De in he t e erste lid bedo e lde re se rve ring wo rdt uitsluite nd be ste e d a a n do e leinden wa arvo or de subsidie we rd ve rstre k t.

7.

He t to taa l va n de in het e e rste lid be doe lde re serve ring in e nig ja a r be dra agt te n ho o gste 10% van he t be dra g va n de vo o r dat ja a r verle e nde subsidie, zo nde r to epa ssing van de in a rtik e l 6.2.15 bedo e lde ve rm inde ring.

8.

To evo eging a a n de in he t e e rste lid be do e lde re se rvering k a n nie t plaa tsvinde n a ls de in het e e rste lid be doe lde re serve ring re eds 10% o f m e er va n he t vo o r dat ja a r ve rlee nde subsidie betre ft.

A rtikel 6.2.24 O p de ba la ns worde n de voo rzie ninge n, ge splitst na a r hun a ard, e n de re se rvering opge no m e n. In de to elichting o p de ba la ns wo rden de to e vo e gingen e n de o nttrek k inge n aa n de vo orzieninge n e n re serve ring to ege licht. A rtikel 6.2.25 1.

De subsidieo ntva nger dra a gt e r zorg voo r da t, be ho ude ns schrifte lijk e to este m m ing va n he t C o lle ge zo rgve rze k eringen, publica tie

o f het a nderszins o pe nba a r m a k e n o p grond va n deze rege ling gesubsidie e rd o nderzo ek , de le n o f sa m envattingen da arva n, nie t plaa tshe e ft binne n drie m a a nde n nada t deze aa n het C o llege zo rgve rzek e ringe n zijn vo orge legd. 2.

He t C o lle ge zo rgve rze k eringen is be vo e gd o m o nde rzo e k , be do eld in he t e erste lid, desgewe nst te vo o rzie n va n co m m e ntaa r, é é n o f m ee rm a le n te ve rm enigvuldige n o f te publice ren o f a nde rszins o pe nbaa r te m ak e n of te do en o penba ar m a k en, m e t verm e lding va n de bro n, zo nde r dat hie rvo o r enige ve rgo e ding is verschuldigd.

3.

De subsidieo ntva nger dra a gt e r zorg voo r da t de in he t e e rste lid be do e lde o nde rzoe k sge geve ns o p ve rzo e k va n he t C o lle ge zorgverze k e ringe n o nm idde llijk e n k o ste lo os a an he t C olle ge zorgverze k e ringe n o f aa n doo r he t C olle ge zorgverze k e ringe n a a nge weze n na tuurlijk e pe rso nen o f re chtspe rso nen be schik ba a r worde n ge steld.

4.

Indien e e n ge subsidiee rde activiteit le idt to t e en publica tie, k a n he t C o lle ge zo rgve rze k e ringe n be pale n da t de subsidie o ntva nge r e r zo rg vo o r draa gt dat bij de publica tie wo rdt aa ngege ve n wie de uitvoe rde r en subsidië nt va n he t proje ct zijn gewe e st.

5.

Indien e e n subsidie gericht is o f m e de ge richt is op de totsta ndk o m ing va n ee n werk a ls be do e ld in a rtik e l 10, subo nde rde el 1, van de Aute urswe t, dra a gt de subsidie ontvange r er zo rg vo or a ute ursre chthe bbende te zijn te r za k e va n da t we rk .

6.

De subsidieo ntva nger vrijwa a rt de Sta at de r Nede rlande n e n het C o llege zo rgve rzek e ringe n vo o r aa nspra k en van de rde n te r za k e van a lle schade die zij lijde n ten ge vo lge van de do o r o f va nwe ge de subsidie ontvange r ve rrichte publica tie s.

A rtikel 6.2.26 Aa n de subsidie k unne n ve rplichtingen a ls be do e ld in a rtik e l 4:39 van de Alge m e ne we t be stuursre cht worde n ve rbonde n. A rtikel 6.2.27 1.

De subsidieo ntva nger is in de ge valle n, ge noe m d in a rtik e l 4:41, twe e de lid, va n de Alge m ene wet be stuursre cht, e e n ve rgo e ding voo r verm o gensvo rm ing ve rschuldigd.

2.

Bij de bepa ling va n de ho o gte van de ve rgoe ding wo rdt uitgega a n va n de waa rde va n de go ede re n e n a nde re verm o gensbe standdele n op he t tijdstip waa ro p de vergo e ding ve rschuldigd wordt, m e t die n ve rsta nde da t in ge va l va n o ntva ngst van schade ve rgo eding vo or ve rlie s o f be scha diging va n za k e n, wordt uitge ga an van he t be dra g da t a ls scha de ve rgoe ding do or de inste lling wo rdt o ntva nge n. Indie n he t o nroe re nde zak e n be tre ft, geschiedt de wa a rdebe paling do o r éé n o f drie o na fha nk e lijk e de sk undigen.

3.

To epa ssing van he t ee rste lid blijft achte rwe ge indie n de a ctivite iten van de subsidie o ntva nge r, na toe stem m ing van he t C ollege zorgverze k e ringe n, doo r e e n a ndere re chtspe rso o n wo rde n vo ortge ze t e n de a ctiva te gen bo ek wa arde a an die a ndere re chtspe rso o n in e ige ndom zijn o ve rgedra gen.

A rtikel 6.2.28 1.

De ve rgo eding die de inste lling be ta a lt a a n ee n o rga nisa tie die zich de o nderste uning va n é é n of m e e r ge subsidie erde inste llinge n te n do e l ste lt, vo o r do o r die o rganisa tie aa n de inste lling te r be schik k ing ge ste lde go ede re n, is nie t hoge r dan he t be dra g da t o p gro nd van de ve rk rijgingprijs o f ve rva a rdigingprijs verm inde rd m et de o ntva nge n investe ringssubsidie s e n beste m m ingsgifte n be rek e nd wo rdt, rek e ning houde nd m e t de ge lde nde a fschrijvingspe rce nta ge s.

2.

De ve rgo eding die de inste lling be ta a lt a a n ee n o rga nisa tie die zich de o nderste uning va n é é n of m e e r ge subsidie erde inste llinge n te n do e l ste lt, vo o r do o r die o rganisa tie aa n de inste lling gele ve rde die nste n, is indie n he t die nste n betre ft die in het a lgem e e n do or so ortge lijk e instellinge n in e ige n behe e r wo rde n ve rricht, nie t ho ge r da n het be drag da t ge lijk is a a n de k o ste n die de inste lling zo u he bben ge ha d bij he t ve rrichten van de die nste n in e ige n behe e r.

3.

De ve rgo eding die de inste lling be ta a lt a a n ee n o rga nisa tie die zich de o nderste uning va n é é n of m e e r ge subsidie erde inste llinge n te n do e l ste lt, vo o r do o r die o rganisa tie aa n de inste lling gele ve rde die nste n, ande re da n de in he t twe ede lid be do e lde diensten, is nie t ho ge r da n het be drag da t vo o r he t do en verrichte n va n de rge lijk e die nste n do o r ande re o rga nisatie s ge bruik e lijk k a n worde n ge acht.

A rtikel 6.2.29 De subsidieo ntva nger die aa n derde n go e dere n te r be schik k ing stelt o f vo o r derde n die nste n ve rricht, bre ngt da a rvo o r e en vergo e ding in re k ening die ten m inste k o stende k k e nd is, tenzij he t de rde n be tre ft vo o r wie de ge subsidiee rde activiteite n be stem d zijn. A rtikel 6.2.30 1.

De subsidieo ntva nger ve rstre k t aa n de do o r he t C o lle ge zo rgve rze k e ringe n a a nge we ze n am bte na re n of a ndere pe rso nen o p hun verzo ek a lle be sche ide n e n inlichtingen die no o dza k e lijk zijn vo o r e en juiste ve rvulling va n hun ta a k . De be sche ide n worde n o p é é n a dres geto o nd e n de inlichtingen, o p ve rzo e k , schrifte lijk ve rstre k t. Indie n de inste lling sle chts k a n vo ldo e n aa n deze ve rplichting do or inbreuk te m a k e n o p het re cht van e nig pe rso o n o p besche rm ing va n zijn pe rso o nlijk e le ve nssfe er, ve rstre k t de inste lling de verla ngde gege ve ns o p zo da nige wijze da t de ze nie t tot pe rso ne n he rleidbaa r zijn.

2.

O o k a nde rszins wordt zove el m o ge lijk m e de we rk ing ve rlee nd tene inde de do o r he t C o lle ge zo rgve rze k e ringe n a a nge we ze n a m bte na ren o f a nde re pe rsone n in staa t te ste llen hun ta a k op e e n juiste wijze te vervulle n.

3.

De subsidieo ntva nger we rk t m e e a an do or o f na m e ns he t C o lle ge zo rgve rze k eringen inge stelde onde rzo e k ingen die e ro p zijn ge richt inlichtingen te ve rschaffe n te n be hoe ve va n de o ntwik k e ling van he t be le id.

ha nde len. A rtikel 6.2.31 Indien bij he t C o lle ge zo rgve rze k eringen he t ve rm oe de n is ge re ze n dat a rtik el 6.2.28 niet is na ge le e fd, spa nt de subsidieo ntva nger zich de sge vra a gd in de ja arre k e ning va n de de sbe treffe nde o rga nisatie o ve r te le ggen. § 2.1.9. De aanvraag tot subsidievaststelling A rtikel 6.2.32 1.

Binne n ze s m a a nde n na a floo p va n de pe riode o f he t pro je ct wa a rvo o r subsidie is ve rle e nd, die nt de subsidieo ntva nger e e n a a nvra ag in vo o r de subsidie va stste lling.

2.

De a anvraa g vo o r de subsidie va stste lling ga a t ve rge ze ld va n: a.

he t ve rsla g, be do eld in a rtik el 6.2.22,

b.

de subsidie de clara tie , be do eld in a rtik el 6.2.33,

c.

de ja a rre k e ning, e n

d.

indie n de a a nvra ag is o nderte k e nd do or e e n of m e e r ande re pe rso ne n da n de pe rso nen die o p grond va n de sta tute n be vo e gd zijn de inste lling te ve rte ge nwoo rdige n: e e n a fschrift va n de vo lm acht o p grond waa rvan de aa nvra a g do o r die a nde re perso on o f perso ne n is o nde rte k end.

3.

Een subsidie de cla ra tie k a n a chte rwege blijve n indie n de daa rm e e te verstre k k e n info rm atie re eds in de in te ze nden ja arre k e ning is o pgeno m en.

4.

De jaa rre k ening be hoe ft niet te wo rde n inge zo nden, indie n he t ga at o m :

5.

a.

e e n pro jectsubsidie , o f

b.

e e n subsidie a an e e n re chtspe rsoo n k rachte ns publie k recht ingeste ld.

He t C o lle ge zo rgve rze k eringen k a n o ntheffing en vrijstelling verle nen van de in he t ee rste lid ge no em de aa nvra a gterm ijn.

A rtikel 6.2.33 De subsidiede cla ratie gee ft e e n zo da nig inzicht da t ee n ve ra ntwo o rd oo rde el k a n wo rden ge vo rm d o m tre nt de a anwe nding e n de be ste ding va n de subsidie doo r de instelling e n ge e ft de no dige info rm a tie o m de subsidie va st te stelle n. De subsidie de cla ra tie sluit a a n o p de indeling va n de bij de subsidie a a nvra ag inge diende be gro ting. Bela ngrijk e ve rschille n tussen de clara tie en be gro ting wo rden to e ge licht. In de subsidie de cla ra tie van inste llingssubsidie s wo rdt de a ansluiting tusse n de subsidiede cla ratie e n de jaa rre k ening to e ge licht. A rtikel 6.2.34 1.

De a fde linge n 2 to t e n m e t 8 va n Tite l 9 va n Bo e k 2 va n he t Burge rlijk W etbo e k zijn van o ve re e nk o m stige to e passing op de ja arre k e ning, m e t dien versta nde dat de winst- e n ve rlie sre k e ning ve rva ngen wo rdt do o r ee n e x plo ita tie rek e ning. O p deze re k ening zijn de be pa lingen o m trent de winst- en verlie sre k ening zo ve e l m o gelijk va n o vere e nk o m stige toe pa ssing. Bepa linge n o m trent winst e n ve rlie s zijn van o ve re e nk o m stige to e passing op he t ex ploita tiesa ldo .

2.

De grondsla g vo o r de wa arde ring van a ctiva e n pa ssiva is de ve rk rijging- of ve rva a rdigingprijs ve rm inde rd m e t de ontvange n inve ste ringssubsidies e n be ste m m ingsgifte n.

3.

He t C o lle ge zo rgve rze k eringen k a n be pale n da t be pa linge n va n de in he t e e rste lid be do e lde Titel o f o nde rdele n da a rva n nie t van to e pa ssing zijn o p be pa alde instellinge n.

A rtikel 6.2.35 1.

De jaa rre k ening e n de subsidie decla ra tie zijn ie de r a fzo nderlijk vo orzien van e e n ve rk la ring van e e n a ccounta nt a ls be doe ld in a rtik e l 393, e e rste lid, van Bo ek 2 va n het Burgerlijk W e tboe k .

2.

De jaa rre k ening o f de subsidie de clara tie ga a t ve rge ze ld va n e e n rappo rtage o m tre nt de na leving van de subsidie be pa linge n do o r de subsidie o ntva nge r, o pge steld doo r de acco unta nt ove ree nk om stig e e n do o r he t C o lle ge zo rgve rze k e ringe n va st te ste llen pro tocol.

3.

De subsidieo ntva nger dra a gt e r zorg voo r da t de a cco untant m e ewe rk t aa n doo r o f nam e ns he t C olle ge zorgverze k e ringe n in te stelle n o nderzo ek e n na a r de do o r de a cco untant verrichte werk zaa m hede n. Vo o r de a a n dit o nde rzoe k ve rbo nde n k o sten wo rdt ge en subsidie ve rstre k t.

§ 2.1.10. De vaststelling van de subsidie A rtikel 6.2.36.1 Binne n ze s m a a nde n na o ntva ngst va n de a a nvra a g, be doe ld in a rtik e l 6.2.32, gee ft he t C olle ge zorgverze k e ringe n e en be schik k ing tot

vastste lling va n de subsidie . A rtikel 6.2.36.2 Indien he t C olle ge zorgverze k e ringe n bij de va stste lling va n de subsidie re k e ning ho udt m e t de ontwik k e ling va n het prijspe il o f m et de o ntwik k eling in de k o ste n va n de a rbe idsvo o rwa a rden, e n he t be dra g a an subsidie s da t alsda n o p gro nd va n e e n subsidie pa ragra a f vastgeste ld zou wo rde n het in die pa ragra a f ge no em de subsidie plafo nd vo o r he t de sbe treffe nde ja a r zo u ove rschrijde n, wordt da t plafo nd ve rhoo gd m e t he t ve rschil tussen he t tota a l do o r het C o llege zo rgve rzek e ringe n op gro nd van die pa ra gra a f a an subsidie s vast te ste llen be dra g e n da t pla fo nd. § 2.2. Specifieke subsidies § 2.2.1 [Vervallen per 01-01-2009] A rtikel 6.2.37.1 [Vervallen per 01-01-2009] A rtikel 6.2.37.2 [Vervallen per 01-01-2009] A rtikel 6.2.37.3 [Vervallen per 01-01-2009] A rtikel 6.2.37.4 [Vervallen per 01-01-2009] A rtikel 6.2.37.5 [Vervallen per 01-01-2009] § 2.2.2 [Vervallen per 01-03-2007] A rtikel 6.2.38.1 [Vervallen per 01-03-2007] A rtikel 6.2.38.2 [Vervallen per 01-03-2007] A rtikel 6.2.38.3 [Vervallen per 01-03-2007] A rtikel 6.2.38.4 [Vervallen per 01-03-2007] A rtikel 6.2.38.5 [Vervallen per 01-03-2007] A rtikel 6.2.38.6 [Vervallen per 01-03-2007] § 2.2.3 [Vervallen per 01-01-2009] A rtikel 6.2.39.1 [Vervallen per 01-01-2009] A rtikel 6.2.39.2 [Vervallen per 01-01-2009] A rtikel 6.2.39.3 [Vervallen per 01-01-2009] A rtikel 6.2.39.4 [Vervallen per 01-01-2009] A rtikel 6.2.39.5 [Vervallen per 01-01-2009] A rtikel 6.2.39.6 [Vervallen per 01-01-2009] A rtikel 6.2.39.7 [Vervallen per 01-01-2009] A rtikel 6.2.39.8 [Vervallen per 01-01-2009] A rtikel 6.2.39.9 [Vervallen per 01-01-2009] A rtikel 6.2.39.10 [Vervallen per 01-01-2009] A rtikel 6.2.39.11 [Vervallen per 01-01-2009] A rtikel 6.2.39.12 [Vervallen per 01-01-2009] A rtikel 6.2.39.13 [Vervallen per 01-01-2009] A rtikel 6.2.39.14 [Vervallen per 01-01-2009] § 2.2.3a [Vervallen per 01-01-2009] A rtikel 6.2.39a.1 [Vervallen per 01-01-2009]

A rtikel 6.2.39a.2 [Vervallen per 01-01-2009] A rtikel 6.2.39a.3 [Vervallen per 01-01-2009] A rtikel 6.2.39a.4 [Vervallen per 01-01-2009] A rtikel 6.2.39a.5 [Vervallen per 01-01-2009] § 2.2.4 [Vervallen per 01-01-2007] A rtikel 6.2.40.1 [Vervallen per 01-01-2007] A rtikel 6.2.40.2 [Vervallen per 01-01-2007] A rtikel 6.2.40.3 [Vervallen per 01-01-2007] A rtikel 6.2.40.4 [Vervallen per 01-01-2007] A rtikel 6.2.40.5 [Vervallen per 01-01-2007] A rtikel 6.2.40.6 [Vervallen per 01-01-2007] A rtikel 6.2.40.7 [Vervallen per 01-01-2007] § 2.2.4a [Vervallen per 01-01-2009] A rtikel 6.2.40a.1 [Vervallen per 01-01-2009] A rtikel 6.2.40a.2 [Vervallen per 01-01-2009] § 2.2.5 [Vervallen per 01-01-2009] A rtikel 6.2.41.1 [Vervallen per 01-01-2009] A rtikel 6.2.41.2 [Vervallen per 01-01-2009] A rtikel 6.2.41.3 [Vervallen per 01-01-2009] A rtikel 6.2.41.4 [Vervallen per 01-01-2009] A rtikel 6.2.41.5 [Vervallen per 01-01-2009] A rtikel 6.2.41.6 [Vervallen per 01-01-2009] A rtikel 6.2.41.7 [Vervallen per 01-01-2009]

§ 3. Bijdrage van verdragsgerechtigden A rtikel 6.3.1 1.

De doo r e e n pe rso o n, be do eld in a rtik el 69, va n de Zo rgve rze k eringwe t, verschuldigde bijdra ge wo rdt be re k end doo r de gro ndslag van de bijdrage te ve rm enigvuldige n m e t het ge ta l da t wordt be rek e nd uit de ve rho uding tussen de ge m idde lde uitga ven voo r zorg voo r e e n pe rso o n ten la ste va n de so ciale zo rgve rzek e ring in he t wo onla nd van de ze perso on, e n de ge m iddelde uitga ve n vo o r zorg voo r e e n pe rso o n ten la ste va n de so ciale zo rgve rzek e ringe n in Ne de rla nd.

2.

De grondsla g va n de bijdra ge is ge lijk a a n de so m va n: a.

e e n ink om e nsa fhank e lijk e bijdra ge ter ho o gte van de ink o m e nsa fha nk e lijk e bijdrage die de pe rsoo n, bedo e ld in artik e l 69, e e rste lid, van de Zo rgve rzek e ringswe t o p gro nd va n pa ra graa f 5.2 va n die wet ve rschuldigd zo u zijn ge wee st indien hij verze k e ringsplichtig zo u zijn ge wee st,

b.

e e n ink om e nsa fhank e lijk e bijdra ge , be re k end o ve re enk o m stig de o p gro nd va n de W et fina ncie ring so ciale ve rzek e ringe n verschuldigde pre m ie vo o r de Algem e ne W e t Bijzonde re Zie k te k o ste n, en verm inde rd m et he t bedra g wa a ro p de partne r va n de ge ne die de bijdra ge ve rschuldigd is volge ns de a rtik ele n 8.9 e n 8.9a va n de W e t ink o m ste nbe la sting 2001 re cht zou he bbe n indien de ge ne die de bijdra ge ve rschuldigd is verze k e rd zo u zijn inge vo lge de Alge m e ne W e t Bijzo nde re Ziek te k oste n, vo or zo ve r o p gro nd va n de ze be pa linge n ge e n teruggave in de ink o m ste nbe lasting is ve rle e nd, e n,

c.

vana f de e e rste da g va n de k ale nde rm a and vo lgende op de k a le nde rm aa nd wa a rin de ze pe rso o n de lee ftijd va n a chttie n ja ar he e ft be re ik t, e e n bijdrage per m a a nd o ve re e nk o m ende m e t e e ntwa a lfde va n het be drag van de ge ra a m de gem idde lde pre m ie vo o r e en verze k e rde vo o r ee n zo rgve rzek e ring in he t be rek e ningsja a r, be do eld in a rtik el 4 va n de W e t o p de zorgto e sla g (hie rna: no m ina le de e l).

Vo or de to epa ssing van de ze bepa ling wordt o nde r e e n pa rtner ve rsta a n e e n pa rtne r in de zin va n artik e l 1.2 va n de W e t ink o m ste nbela sting 2001. 3.

De peildatum vo o r de va ststelling van he t in he t ee rste lid ge no em de wo o nla nd is te lk e ns de ee rste da g va n de k a le nderm a a nd volge nde o p de k ale nde rm a and waa rin ee n wijziging va n he t woo nland hee ft plaa tsge vonde n.

4.

Vo or de to epa ssing van de W e t o p de zorgto e sla g wo rdt he t in he t twe ede lid be do e lde no m ina le de el, a ls pre m ie vo o r e en zorgverze k e ring be scho uwd.

5.

De bijdra ge die e e n pe nsio e n- of re nte ve rstre k k end o rga a n als be do eld in a rtik el 69, de rde lid, va n de Zo rgve rze k e ringswe t verschuldigd is, is gelijk a a n de ink o m e nsa fha nk elijk e bijdra ge die dit o rgaa n o ve r het lo o n a ls be doe ld in a rtik e l 42 va n die we t verschuldigd zo u zijn ge we e st, indie n dege ne a a n wie hij he t pe nsio e n o f de rente ve rstrek t, in Ne de rla nd zo u he bben ge wo o nd, verm e nigvuldigd m e t he t ge tal, be do e ld in het e e rste lid.

6.

De ink o m ensge ge ve ns, be no digd voo r de be re k ening va n de in he t twee de lid bedo e lde grondsla g en de in he t vijfde lid be doe lde bijdra ge, wo rden o ntle e nd a a n he t to e tsingsink o m en, be do e ld in a rtik e l 8, e e rste e n twe e de lid, va n de Alge m e ne we t ink o m e nsa fha nk elijk e re gelinge n.

7.

Indien he t in a rtik e l 8, twe e de lid, va n de Alge m e ne we t ink o m e nsa fha nk e lijk e rege linge n be doe lde, nie t in Ne de rla nd be la stba a r ink o m e n nie t is va stge steld o p gro nd va n a rtik el 8a va n de Alge m e ne we t ink o m e nsa fha nk e lijk e rege linge n, wo rdt he t do or de rijk sbela stingdie nst vastgeste ld m e t ove ree nk om stige to epa ssing van da t artik e l.

8.

Te r za k e va n de o pga a f va n nie t in Ne derla nd be lastbaa r ink o m e n is de Alge m e ne we t inzak e rijk sbe la stinge n, m et uitzo ndering van Ho o fdstuk VIIIA, va n toe pa ssing a ls ware de ze o pga a f ee n a angifte ink om stenbe la sting.

9.

He t in he t e erste lid geno e m de ve rho udingsgeta l wordt pe r la nd va stge ste ld en m e t ee n to elichting o ve r de wijze van be rek e ning ja arlijk s uite rlijk in no vem be r in de Sta a tscoura nt ge publice e rd.

A rtikel 6.3.1a In de artik e le n 6.3.2 to t e n m e t 6.3.4 wo rdt ve rsta a n o nder: a.

bijdrageplichtige: e e nie de r die k rachte ns a rtik el 69 va n de Zo rgve rze k eringswe t in verbinding m e t a rtik e l 6.3.1 e e n bijdra ge ve rschuldigd is,

b.

hoofdbijdrageplichtige: e e n bijdrage plichtige m e t e en o f m ee r ge zinsle de n die niet bijdra ge plichtig zo ude n zijn ge wee st indien zij niet to t he t ge zin van de ho o fdbijdrage plichtige zo ude n he bben be ho o rd,

c.

gezinslid: ee n to t he t ge zin va n ee n hoo fdbijdra ge plichtige of e e n ve rze k e ringsplichtige beho re nd ge zinslid da t nie t bijdra geplichtig zo u zijn ge we e st indie n hij niet to t he t ge zin van de ho o fdbijdrage plichtige o f e e n ve rze k eringsplichtige zo u he bben be ho o rd.

A rtikel 6.3.1b De vo o r e en ge zinslid va n e e n ve rze k e ringsplichtige ve rschuldigde bijdra ge , be do e ld in a rtik e l 6.3.1, wordt do or he t C o lle ge zorgverze k e ringe n gehe ve n e n ge ïnd bij de ve rzek e ringsplichtige . A rtikel 6.3.2 1.

O rga nen die pe nsio en o f re nte uitk e re n da n wel we rk ge ve rs, ve rrichten de he n doo r he t C olle ge zorgverze k e ringe n o pge drage n we rk za am he de n te r vo o rbe re iding en uitvo e ring va n de he ffings- e n inningsbe schik k inge n, be doe ld in a rtik e l 69, vierde lid, van de Zo rgve rze k eringswe t.

2.

De werk zaa m hede n, be do eld in he t e erste lid, houde n te n m inste in dat, na dat zij da a rtoe do or he t C o lle ge zo rgve rze k eringen van de be no digde ge geve ns zijn vo o rzie n: a.

o rgane n die pensio e n of re nte uitk e ren bijdra gen die bijdra ge plichtige pe rso nen verschuldigd zijn o p he t pe nsioe n o f de re nte van die bijdra ge plichtige n inho ude n,

b.

o rgane n die pensio e n of re nte aa n e en ho ofdbijdra geplichtige uitk e re n de bijdra ge die die ns gezinslede n ve rschuldigd zijn op he t pe nsio e n o f de rente va n die ho ofdbijdra geplichtige inho ude n, e n

c.

we rk ge ve rs va n gre nsa rbe ide rs de bijdra ge n va n gezinslede n va n die grensarbe ide rs op he t lo o n va n de gre nsa rbe ider inho uden.

3.

He t C o lle ge zo rgve rze k eringen k a n e e n orga a n da t pensio e n of re nte uitk e ert o f e e n we rk ge ver va n e e n gre nsa rbe ide r o pdra gen e e n bijdra ge op he t pe nsio e n, de re nte o f o p he t loo n in te ho ude n en a f te dra ge n, zo la ng da t co llege nie t be schik t ove r de ge ge vens, be do eld in he t twee de lid. In dat ge va l bere k e nt he t o rga a n of de werk ge ve r de bijdra ge uitga ande va n de bij he m be k e nde ge geve ns o ve r de sa m e nste lling va n het ge zin va n de bijdra ge plichtige .

4.

Indien e e n bijdra ge plichtige re cht hee ft o p m e e r dan é é n pe nsio en o f re nte , wo rdt he t in a rtik el 6.3.1, twe e de lid, be doe lde no m ina le de el van de bijdrage dat hij en zijn e ve ntue le ge zinsle de n ve rschuldigd zijn ingeho ude n o p he t pensio e n da t o f de re nte die he t e erst is to e ge k e nd. Indien dit pe nsio e n o f de ze re nte da arto e nie t to e reik e nd is, k a n he t C o lle ge zo rgve rze k e ringe n he tze lfde o f e en a nde r o rgaa n o pdra gen he t resta nt o p e en a nde r pe nsioe n o f ee n a nde re rente in te ho ude n.

5.

Vo or de inho uding va n he t do or e e n ge zinslid ve rschuldigde nom inale dee l va n de bijdra ge op he t pe nsio e n o f de rente va n de

ho ofdbijdra geplichtige dan we l o p het lo o n va n de grensarbe ide r, wo rde n wijziginge n in de situa tie van da t ge zinslid die in de lo op van e e n k a lende rm a a nd do ch na de e erste da g va n die m a and pla a tsvinde n, ee rst in a a nm e rk ing geno m en vana f de e e rste da g van de da a ro pvo lge nde k a le nderm a a nd. 6.

Vo or de to epa ssing van he t twe e de lid wo rdt e en to e sla g, wa a ronde r be gre pe n e en to e sla g a ls be doe ld in de To e sla genwe t, ee n to e la ge of e nige a a nvulling, o nder we lk e be na m ing o o k , o p het pe nsio en o f de re nte da n wel o p he t lo on van e e n gre nsa rbeide r die do o r he t o rgaa n o f de we rk ge ve r in he t a lge m e en m e t de zelfde rege lm a a t e n ge lijk tijdig m e t de uitk e ring beta a lba a r wordt ge ste ld, a ls o nderde e l va n he t pensio e n, va n de re nte o f van he t lo o n aa ngem e rk t.

7.

O nde r de in he t e e rste lid be do e lde o rgane n die pensio e n of re nte uitk e ren wo rde n m ede ve rstaa n werk ge ve rs a a n wie o p gro nd van a rtik e l 40 va n de W et fina ncie ring so ciale ve rzek e ringe n toe stem m ing is ve rle e nd he t risico te dra ge n va n de beta linge n, be do e ld in a rtik e l 40, e e rste lid, van die we t.

A rtikel 6.3.3 1.

He t ve rschil tusse n de doo r de bijdrage plichtigen verschuldigde bijdra ge e n de ingeho ude n e n a fge dra ge n o f a nde rszins ge ïnde bijdra gen wo rdt, m e t ina chtne m ing va n he t zesde to t e n m e t he t achtste lid va n a rtik e l 6.3.1 e n he t twee de lid va n dit a rtik el, do or he t C olle ge zorgverze k e ringe n va stge steld e n ve rrek e nd, ge ïnd o f uitge k ee rd. Uitk e ring vindt plaa ts aa n de bijdra ge plichtige da n we l, indie n a rtik e l 6.3.1b va n toe pa ssing is, a a n de ve rzek e ringsplichtige .

2.

De in a rtik el 6.3.1, e e rste lid, be doe lde pe rso o n die a anspra a k m a a k t op é é n o f m e er va n de in ho o fdstuk 8 van de W e t ink o m ste nbela sting 2001 ve rm elde he ffingsk ortingen niet zijnde de a lge m e ne he ffingsk o rting, de jo ngge ha ndica ptenk o rting, de o ude re nk o rting o f de alle enstaa nde o udere nk orting, k a n het C o llege zo rgve rzek e ringe n ve rzo e k en da ar bij de vastste lling va n het verschil, be doe ld in he t ee rste lid, rek e ning m ee te houde n.

3.

Indien sle chts ee n bijdra ge a ls be do e ld in a rtik e l 6.3.1, twee de lid, o nde rdee l c, verschuldigd is, ste lt he t C o lle ge zorgverze k e ringe n het in het e e rste lid be doe lde ve rschil va st vó ór 1 a pril van he t ja a r vo lgend o p he t k ale nde rja ar wa a rop de bijdra ge be tre k k ing he e ft. In ande re ge va llen stelt he t C olle ge he t ve rschil vo o r 30 se pte m ber va n he t jaa r volge nd o p k a le nderja a r wa a ro p de bijdra ge be trek k ing he eft vo orlo pig vast, e n ste lt he t het ve rschil uite rlijk ze s m a a nde n na he t tijdstip wa aro p zo we l de a ansla g ink o m ste nbe la sting a ls de beschik k ing nie t in Ne de rla nd be la stba a r ink o m en o nhe rro e pe lijk zijn ge wo rde n, de finitie f va st.

4.

Bij de va stste lling va n he t in he t e e rste lid be do e lde verschil bre ngt he t C o lle ge zo rgve rze k eringen e nk e lvo udige wette lijk e re nte in re k ening o ver te we inig ge he ve n of ge ïnde bijdra ge da n we l ve rgoe dt het we tte lijk e re nte inge va l va n teve el ge he ven o f geïnde bijdra ge, o ver he t tijdvak da t aa nva ngt op de da g na he t e inde va n he t k a le nderja a r wa a ro p de bijdra ge be trek k ing he eft e n e indigt op de da g va n de da gtek e ning va n de va ststelling do or he t C o lle ge zo rgve rze k eringen.

5 He t C o lle ge zo rgve rze k eringen is be vo e gd he t te restitue re n be dra g, indie n dit m inde r be dra a gt da n € 25, te ve rre k e ne n m e t e en in de to e k o m st ge lege n ve rschuldigde bijdrage . A rtikel 6.3.4 Vo or de to epa ssing van a rtik e l 69, ne gende lid, va n de Zo rgve rze k e ringswe t wordt m e t he t tijdstip va n a a nm e lding bij he t C olle ge zorgverze k e ringe n gelijk ge ste ld de da tum wa aro p de k e nnisge ving a an he t C olle ge zorgverze k e ringe n va n de a a nm e lding va n de re chthebbe nde o p pe nsio en o f re nte bij he t o rga a n va n de wo onplaa ts va n de re chthebbe nde , doo r da t orga a n is onde rtek e nd. A rtikel 6.3.5 [Vervallen per 01-08-2008]

§ 4. Spaarrekening gemoedsbezwaarden A rtikel 6.4.1 1.

Vo or he t bepa len van he t sa ldo van de rek e ning, a ls bedo e ld in artik e l 70, e erste lid, va n de Zo rgve rze k e ringswe t gaa t he t C olle ge zorgverze k e ringe n uit va n de bijdra ge verva nge nde be la sting die de Be la stingdie nst o p gro nd va n de W et ink om stenbe la sting 2001 vastste lt.

2.

Zo la ng de bijdra geve rva nge nde be lasting no g nie t is va stge steld, bepa a lt he t C o lle ge zo rgve rze k eringen he t sa ldo van de re k ening o p grond va n de ge geve ns zo a ls die o p dat m o m ent be schik ba a r zijn in de po lisa dm inistra tie va n he t Uitvo e ringsinstituut we rk ne m ersve rzek e ringe n. Het C o llege zo rgve rzek e ringe n k a n de ge m oe dsbe zwa a rde verzo ek e n om o rigine le lo on- e n sala risstrok e n of a nderszins o ver te le gge n wa a ruit de inho uding va n bijdrage ve rvange nde bela sting tot da t m om e nt blijk t.

3.

Een vastste lling a ls bedo e ld in he t e e rste lid, die a fwijk t van he t do o r het C o llege zo rgve rzek e ringe n be pa alde sa ldo van de re k ening vo or da t jaa r, wo rdt ve rrek e nd m e t het sa ldo va n de re k e ning in he t da a ro pvo lge nde ja ar. Ee n ve rrek e ning hee ft a lle e n ge vo lge n vo o r het sa ldo va n de re k e ning in he t ja a r waa rin die ve rre k ening pla atsvindt.

4.

Uitk eringen te r ve rgo eding va n k o ste n va n zo rg o f ove rige die nste n a ls bedo e ld in artik e l 11 va n de Zo rgve rze k e ringswe t doe t he t C o lle ge zo rgve rze k e ringe n uitsluitend o p ba sis va n origine le no ta ’s. Vo or de hoo gte va n de uitk e ring is he t saldo va n de re k ening, be do e ld in a rtik e l 70, e e rste lid, van de Zo rgve rzek e ringswe t, be pa le nd.

5.

Ve rzo e k e n to t he t do en van uitk e ringe n te r ve rgoe ding van k o ste n va n zo rg of o verige die nste n als be do eld in a rtik el 11 va n de Zo rgve rze k eringwe t m o ete n zijn ge da an uiterlijk binne n twee k a le nderja re n vo lge nd o p het k a lende rja a r waa rin de zorg is a a nge va ngen.

wa arin het ve rzo e k wo rdt inge die nd. A rtikel 6.4.2 Een ge m o e dsbe zwa arde die e e n ge za m e nlijk e huishouding m e t ee n o f m e e r a nde re ge m o edsbe zwa a rden verla a t, k a n het C o llege zorgverze k e ringe n ve rzoe k e n e e n eve nre dig ge dee lte va n he t saldo va n de in artik e l 70, twee de lid, va n de Zo rgve rze k e ringswe t be do e lde re k ening, o ver te m a k e n o p e e n vo o r he m te ope nen re k ening a ls be doe ld in a rtik e l 70, e e rste lid va n de Zo rgve rze k eringswe t.

§ 4a. De bestanden waarmee onverzekerden worden opgespoord A rtikel 6.4a.1 De besta nde n, be do eld in a rtik el 9a , ee rste lid, va n de Zo rgve rze k eringswe t zijn: a.

he t be stand va n perso ne n die verze k e rd zijn op gro nd van de Alge m e ne W e t Bijzo nde re Zie k tek o ste n;

b.

he t be stand m et pe rso ne n a ls be doe ld in a rtik e l 2, twe e de lid, onde rde e l a, va n de Zorgverze k e ringswet;

c.

he t be stand m et pe rso ne n a ls be doe ld in a rtik e l 2, twe e de lid, onde rde e l b, va n de Zorgverze k e ringswet;

d.

he t be stand va n perso ne n die o p gro nd va n ee n zo rgve rzek e ring verze k e rd zijn.

§ 5. De bestuursrechtelijke premie A rtikel 6.5.1 Bij sa m e nloo p o ve r e enzelfde tijdva k va n bestuursre chtelijk e pre m ie heffing m e t é é n o f m e er va n de navo lge nde , inge volge de socia le ze k erhe idswetge ving vo o rge schreve n inhoudinge n of ve rrek e ninge n, ga a t de be stuursre chte lijk e pre m ie he ffing vo o r: a.

do or he t Uitvo e ringsinstituut we rk nem e rsve rze k eringen, ge no e m d in hoo fdstuk 5 va n de W e t structuur uitvoe ringso rga nisa tie we rk e n ink o m e n, de So cia le verze k e ringsbank , geno e m d in ho o fdstuk 6 va n die we t, o f doo r e e n colle ge van burge m e este r en we tho uders ve rrichte inho uding o f verre k e ning va n ee n doo r é é n va n de ze insta ntie s in he t k a de r va n ee n doo r die insta ntie uitge voe rde so cia le zek e rheidswe t o pge legde be stuurlijk e boe te ,

b.

inho udinge n o f verre k e ningen a ls be do e ld in a rtik e l 24, twe ede juncto e e rste lid, van de W e t inburge ring.

A rtikel 6.5.2 [Vervallen per 01-01-2013] A rtikel 6.5.3 Indien na be ë indiging va n de ve rschuldigdhe id va n de be stuursre chte lijk e pre m ie te r za k e va n die prem ie ee n re stschuld besta at, m a a k t he t C olle ge zorgverze k e ringe n vo o r de inning daa rvan ge en ge bruik m e e r va n de instrum e nte n, bedo e ld in artik e l 18f, twee de of ze sde lid, va n de Zorgverze k e ringswet. A rtikel 6.5.3a He t C o lle ge zo rgve rze k eringen stort o ver 2011 0%, o ve r 2012 23% e n ove r 2013 23% va n de in de de sbe tre ffende k a le nde rjare n geïnde be stuursre chte lijk e pre m ie s, be do eld in a rtik el 18d va n de Zorgverze k e ringswet, in 's R ijk s k as. A rtikel 6.5.4 1.

He t C o lle ge zo rgve rze k eringen k e nt de zo rgve rzek e ra ar vo or ie dere zorgverze k e ring te r zak e waa rvan hij a a n de voo rwa arde n, be do e ld in a rtik e l 34a , e erste lid, va n de Zo rgve rze k e ringswe t hee ft volda an, e e n bijdra ge toe .

2.

De bijdra ge wo rdt to e gek e nd o ver de perio de wa a rove r ter za k e van de zo rgve rze k e ring bestuursre chtelijk e pre m ie ve rschuldigd is.

3.

In a a nvulling o p het twe e de lid wo rdt de bijdra ge te vens toe ge k e nd ove r de pe rio de wa a ro ve r te n a a nzie n va n e e n zo rgve rze k e ring de be stuursrechte lijk e prem ie nie t ve rschuldigd wa s o m da t de m e lding, bedo e ld in artik e l 18c, e e rste lid, van de Zo rgve rze k eringswe t ten ge vo lge van de toe pa sselijk he id va n he t twee de lid, o nde rdee l b, c o f d, va n da t a rtik e l no g nie t k o n wo rde n geda a n.

4.

De bijdra ge be dra a gt pe r m a and de to t e e n m a a ndbe dra g herle ide standa ardpre m ie , bedo e ld in de W e t op de zo rgtoe sla g.

5.

He t C o lle ge zo rgve rze k eringen verstre k t de zo rgve rzek e ra ar o ver de perio de, be doe ld in he t twe e de lid, ee n vo o rscho t o p de bijdra ge.

6.

Uite rlijk in a pril van he t twe e de ja a r vo lge nde o p het k a lende rja a r te r za k e wa a rva n de bijdra gen, be do e ld in de vo rige lede n, zijn to e ge k e nd, stelt he t C olle ge zorgverze k e ringe n per zo rgve rze k era a r het to ta a lbe drag a a n o ver da t jaa r te ve rstrek k e n bijdra ge n vast.

7.

He t to taa lbedra g aa n te ve rstre k k en bijdra ge is ge lijk a a n de so m va n de o ver he t k ale nde rja ar be vo o rscho tte bijdra ge n verm e e rde rd m et de so m va n de bijdra ge n die de zorgverze k e ra a r inge vo lge he t de rde lid zijn toe ge k e nd, en verm inde rd m et de som van de bijdrage n die zijn toe ge k e nd vo o r zo rgve rze k e ringe n te r zak e waa rvan na ar he t o orde e l va n de Nede rlandse

Zo rga uto rite it nie t de vo o rwa a rden, be do e ld in a rtik e l 34a , twee de lid, va n de Zo rgve rze k e ringswe t, in a cht zijn geno m en e n m e t inge volge he t de rde lid to e gek e nde bijdra gen voo r zove r na a r het o o rdee l va n die a utorite it de da ar be doe lde ve rtraging in de a a nm e lding in o ve rwe ge nde m a te aa n de zo rgve rze k era a r te wijte n is. 8.

He t C o lle ge zo rgve rze k eringen is be vo e gd ve rschille n tussen he t be dra g a a n va stge ste lde bijdra ge n e n to ege k ende bijdrage n te verre k e ne n m et o ver e e n la te r jaa r te bevo orscho tten bijdra gen a ls be do e ld in dit a rtik el.

A rtikel 6.5.5 Indien te n aa nzie n va n ee n zo rgve rzek e ring, re nte e n incasso k o ste n buite n be scho uwing late nd, op de da tum va n inwe rk ingtreding va n de ze wet re e ds e e n a chte rsta nd in de be ta ling va n de ve rschuldigde pre m ie te r hoo gte va n ze s o f m e er m a a ndpre m ie s is ontstaa n, is de zorgverze k e ra a r be voe gd de ze schuld, zonde r da t dit ge volge n he e ft vo o r zijn bijdra ge n vo or he t o nve rm inderd verze k e rd houde n va n de de sbe treffe nde ve rze k erde , k wijt te sche lde n, m its: a.

hij vo lda a n he e ft aa n a rtik e l 18a va n de Zo rgve rze k e ringswe t in ve rbinding m et a rtik el IX, e e rste e n twe e de lid, va n de wet va n 18 juli 2009 to t wijziging va n de Zorgverze k e ringswet, de W et o p de zo rgto e sla g en e nige a nde re we tte n, ho udende m a a tre ge le n o m o o k wa nbe ta lers vo o r hun zorgverze k e ring te la ten be tale n (structure le m a a trege len wa nbe ta le rs zo rgve rze k e ring), e n

b.

do or tusse nk o m st va n e e n schuldhulpve rle ne r als be do eld in a rtik el 48 va n de W e t op he t co nsum e nte nk re die t e e n schuldre geling to t sta nd is gek o m en wa arin, naa st de verze k e ringne m er, te n m inste de zo rgve rzek e ra ar de e lne e m t, e n

c.

voo r de zo rgve rze k e ring gedure nde te n m inste twee ja ren te re k e ne n va na f de da tum wa a ro p de schuldrege ling is inge ga an, na ast nieuw ve rvalle nde prem ie term ijne n e en bij de re ge ling a fgesprok e n de e l va n de re e ds besta ande schuld is afbe ta ald.

Hoofdstuk 7. Verwerking persoonsgegevens A rtikel 7.1 1.

Als pe rso o nsgege ve ns, wa a ronde r pe rsoo nsge geve ns betre ffe nde de ge zondheid a ls bedo e ld in de W e t be scherm ing pe rso o nsgege ve ns, die vo o r ee n zo rgve rzek e ra ar no o dza k e lijk zijn vo o r de uitvo e ring van de zo rgve rze k e ring o f va n de Zo rgve rze k eringswe t wo rde n a a nge m e rk t de in a rtik el 7.2 be do elde pe rsoo nsge geve ns.

2.

Een zorgverze k e ra a r m a g de in het e e rste lid be doe lde ge geve ns gebruik e n vo o r het ve rrichte n va n fo rm e le co ntro le da n wel m a terië le contro le te n beho e ve va n:

3.

a.

de ge he el o f gede e lte lijk e beta ling a a n e e n zo rgaa nbie de r;

b.

de ge he el o f gede e lte lijk e ve rgo eding a a n ee n ve rzek e rde va n he t in re k e ning ge bra chte ta rie f vo o r aa n e en verze k e rde ge le verde presta tie ;

c.

de va stste lling va n de e ige n bijdrage n va n ee n ve rzek e rde;

d.

de va stste lling va n e e n ve rplicht o f vrijwillig e igen risico van e e n ve rze k erde , e n

e.

he t ve rrichten van fra ude o nde rzoe k .

Een zorgverze k e ra a r m a g de in het e e rste lid be doe lde ge geve ns gebruik e n vo o r het uito efe ne n va n ve rha a lsre cht.

A rtikel 7.2 De zo rgve rzek e ra ar be schik t te n be hoe ve va n de in he t vo o rgaa nde a rtik el a a nge geve n do e le n e n va n de uitvo ering va n artik e l 7.4a , o ve r de vo lge nde ge geve ns va n de ve rze k erde : a.

na am , a dres, postco de e n woo npla a ts;

b.

po lisnum m er, burgerse rvice num m e r of, bij he t o ntbre k e n da a rva n, so cia al-fisca alnum m e r, geslacht e n gebo o rteda tum ;

c.

de pre statie beschrijving van de aa n de ve rze k erde gele ve rde pre statie ;

d.

wa nne e r de pre sta tie is ge le ve rd;

e.

he t vo o r de ge le verde presta tie in rek e ning gebra chte tarie f;

f.

de ge ge ve ns die o p grond va n e en de clara tie rege ling m oe te n wo rde n ve rstre k t;

g.

de ge ge ve ns die no o dza k e lijk zijn o m va st te ste llen o f de pre sta tie be ho ort to t he t ve rze k e rde pa k k e t va n die verze k e rde en

h.

he t ba nk - o f giro re k e ningnum m e r;

i.

o ve rige ge geve ns die no odzak e lijk zijn vo o r he t verrichte n va n m a te riële co ntrole dan we l fra udeo nderzo ek .

A rtikel 7.3 1.

De zo rga anbiede r is verplicht de in artik e l 7.2, o nde rdee l a tot e n m et g , be do e lde ge ge vens te ve rstre k k e n a an: a.

de zo rgve rze k e raa r, o f e en do or die zo rgve rze k e raa r da arto e a ange we zen pe rso o n, indie n die zorga a nbie de r he t tarie f vo o r de ge le ve rde pre sta tie k ra chte ns e e n do o r he m m et de zo rgve rzek e ra ar ge slo te n o vere e nk o m st re chtstree k s bij die zorgverze k e ra a r in re k ening bre ngt;

b.

de ve rze k e rde , indie n de zorga a nbie de r he t tarie f vo o r de ge leve rde pre sta tie bij de verze k e rde in re k ening bre ngt.

2.

De zo rga anbiede r is verplicht de in artik e l 7.2, o nde rdee l i, be do elde ge ge ve ns de sge vra a gd te ve rstrek k e n a a n de zorgverze k e ra a r of a a n ee n doo r die zo rgve rze k era a r daa rto e aa ngewe ze n perso on.

3.

Vo or de doo r de zo rgve rze k e raa r o f de be werk e r a ange we zen pe rso o n ge lde n deze lfde wette lijk e vo o rschrifte n inzak e de ge he im ho uding va n de ve rwe rk te ge ge ve ns a ls voo r de zo rgve rze k e raa r o f de be werk e r die he m he e ft aa ngewe ze n.

A rtikel 7.4 1.

De zo rgve rzek e ra ar ve rricht m a te rië le co ntro le op de wijze zoa ls be paa ld in de artik e le n 7.5 to t e n m e t 7.9.

2.

De zo rga anbiede r is verplicht zijn m e dewe rk ing te ve rlene n aa n de o vere e nk o m stig het e e rste lid uitgevo erde m ate rië le co ntro le .

3.

De zo rgve rzek e ra ar ve rricht fra udeo nderzo ek o p de wijze zo a ls bepa a ld in artik e l 7.10.

4.

De zo rga anbiede r is verplicht zijn m e dewe rk ing te ve rlene n aa n o ve re enk o m stig he t derde lid uitge voe rd fra ude o nde rzo e k .

A rtikel 7.4a De zo rgve rzek e ra ar ve rstre k t aa n het C AK vo o r 1 ok to ber va n he t jaa r wa arin e en uitk e ring a ls be doe ld in a rtik e l 118a va n de we t wordt verstre k t, va n zijn verze k e rde n o f ge we zen verze k e rde n die in da t ja a r de le e ftijd va n a chttie n jaa r he bbe n be re ik t o f no g zulle n be re ik e n e n die in de twee k a le nderja re n, vo ora fga ande aa n dat ja a r vo ldo e n aa n de vo orwa a rde n, bedo e ld in artik e l 8.3, e erste lid, o f in e e n DKG a ls bedo e ld in artik e l 8.3, twee de lid, zijn inge de e ld, de vo lgende pe rsoo nsge geve ns: a.

he t burge rse rvice num m e r o f, bij het o ntbrek e n da a rva n, het so ciaa l-fiscaa lnum m e r,

b.

he t ba nk - o f giro re k e ningnum m e r.

A rtikel 7.5 1.

De zo rgve rzek e ra ar ste lt vo ora fga and a an de uitvoe ring va n m a te rië le co ntro le he t do el e rva n va st do o r te be pa le n wanne er voldo ende ze k erhe id is ve rk rege n da t de do o r de zo rga a nbie der in re k e ning ge bra chte presta tie is ge leve rd o f die ge leve rde pre sta tie he t m ee st wa s aa ngewe ze n gezien de ge zondheidsto e sta nd va n de verze k e rde . Bij de va ststelling ne em t de zorgverze k e ra a r he t bij o f k ra chtens de W e t m a rk to rde ning ge zo ndhe idszo rg doo r de Ne de rla ndse Zorga utorite it be pa alde m e t be trek k ing to t het uitvo e re n va n contro les in a cht.

2.

De va stste lling do o r de zo rgve rze k era a r wanne er vo ldo e nde ze k e rhe id is ve rk re ge n dat de gele ve rde pre statie het m e e st wa s a a nge weze n ge zie n de ge zo ndhe idsto esta nd van de ve rze k e rde , ge schie dt m e t ina chtne m ing va n he t be pa a lde in artik e l 2.1 va n he t Be sluit zo rgve rzek e ring e n zo danig da t voo r verze k e rde n e n zo rga anbiede rs zo ve e l m o gelijk inzichte lijk is we lk e m aa tstave n da arbij ge lden.

3.

De zo rgve rzek e ra ar m a g ve rze k e rde n m et ge bruik m ak ing va n pe rso o nsge ge vens wa a ro ve r hij in ve rband m et de uitvo ering va n de zorgverze k e ring re e ds be schik t enquête fo rm ulie ren zende n o m o nde rzo e k te do e n 1°.

o f de in re k e ning ge bra chte zo rg daa dwerk e lijk is verle e nd, e n

2°.

na ar de doo r die ve rze k erde n erva ren k walite it va n de ve rzek e rde zo rg die ee n zo rga anbiede r ve rle ent o f hee ft verle e nd.

4.

Bij de ve rzending van e nquê te form ulie re n als be do eld in he t derde lid inform e e rt de zorgverze k e ra a r de verze k e rde ero ver da t hij niet ve rplicht is to t bea ntwoo rding van de ge stelde vra gen e n da t o ntho uden van m e de we rk ing op ge en e nk e le wijze to t zijn na de el zal strek k e n.

5.

De zo rgve rzek e ra ar dra a gt e r zorg voo r da t terug o ntva nge n enquête fo rm ulie ren a ls be do e ld in het de rde lid, onde rde e l 2°, nie t he rle idba a r zijn tot pe rso ne n e n dat nie t he rle idba ar is we lk e ve rze k erde n ge e n form ulie r he bbe n teruggestuurd.

A rtikel 7.6 1.

De zo rgve rzek e ra ar vo ert e e n alge m e ne risico ana lyse uit o p ba sis va n ge ge ve ns wa aro ver de ze in ve rband m et de uitvo ering va n de zo rgve rze k e ring beschik t.

2.

De zo rgve rzek e ra ar ste lt o p basis van de in he t ee rste lid uitge vo e rde a lge m e ne risico a nalyse e en a lge m e en co ntro le plan vast, wa arin de o bjecten van m a terië le contro le e n de in te ze tte n contro le-instrum e nten zijn o pge nom e n.

3.

He t naa r a a nle iding va n de a lge m e ne risico a nalyse o pge ste lde a lgem e ne contro lepla n vo orziet nie t in de inzet va n he t co ntrole instrum ent de tailco ntrole .

4.

Indien uit he t uitge voe rde alge m e ne co ntro le pla n blijk t da t het contro ledo e l, be doe ld in a rtik e l 7.5, e e rste lid, is be re ik t, k a n a lle e n de ta ilcontro le wo rden uitge voe rd a ls e r va n ee n a nde r dan de zo rgve rze k e raa r a fk om stige o f uit de uitge vo e rde co ntro le voo rtvlo e iende aa nwijzinge n zijn wa aruit blijk t da t e r spra k e is va n onvoldo ende ze k erhe id.

A rtikel 7.7 De zo rgve rzek e ra ar m a a k t info rm a tie ope nba a r o ve r het ingevo lge a rtik e l 7.5 vastgeste lde co ntrole doe l e n he t inge vo lge a rtik el 7.6 vastgeste lde a lge m ene co ntrole pla n o p e e n zo danige wijze dat die info rm atie vo o r ve rzek e rden e n zo rgaa nbie de rs ge m a k k elijk verk rijgba a r is.

A rtikel 7.8 1.

De zo rgve rzek e ra ar vo ert ge e n de ta ilco ntro le uit, da n nada t is volda an a a n de vo lgende vo o rwa a rden: a.

de zo rgve rze k e raa r he eft e e n spe cifie k e risico ana lyse ve rricht o p de be vindinge n uit het uitgevo erde a lge m ene co ntrole pla n be do e ld in a rtik e l 7.6, twe ede lid;

b.

de zo rgve rze k e raa r he eft na a r aa nleiding van de spe cifie k e risico ana lyse e e n spe cifie k co ntrole pla n e n specifie k co ntro le do e l o pge steld, waa rin de o bje cte n va n m ate rië le co ntro le e n de m e tho de n va n de ta ilco ntro le zijn o pge nom e n;

c.

he t ove ree nk om stig o nde rde el b va stge stelde spe cifie k e do e l va n de m a terië le contro le k a n zo nde r de tailco ntrole nie t wo rde n bere ik t;

d.

uit he t spe cifie k e co ntro le plan blijk t dat de deta ilco ntro le nie t ve rde r ga a t dan ge le t o p he t m e t he t o nde rzoe k sdo e l e n de o m sta ndighede n va n he t te o nde rzo e k en ge va l no o dza k elijk is;

e.

de zo rgve rze k e raa r he eft de zo rga anbiede r vo o ra fga a nd a a n de uitvo e ring va n de de ta ilco ntro le to e reik e nde – en o p verzo ek van de zo rgaa nbie de r schrifte lijk e – inform a tie ve rstre k t wa a rin wo rdt ge m o tive erd ho e is vo lda a n aa n de in dit lid ge no e m de voo rwa arde n.

2.

Indien bij de uitvo ering va n de ta ilcontro le pe rso o nsge ge vens va n ve rze k e rde n worde n ve rwerk t, ge schie dt dit o nde r vera ntwoo rde lijk he id va n ee n m edisch a dviseur in opdra cht va n de zorgverze k e ra a r en is de ze o p vo o rafga a nd verzo ek van de zorga a nbie de r a a nwe zig bij dit de e l va n de co ntro le .

3.

In a fwijk ing van he t ee rste lid k a n de zo rgve rze k era a r m et be tre k k ing to t e e n individue le ve rze k erde deta ilco ntro le uitvoe re n zonde r da t de in da t lid geno e m de vo o rwaa rde n va n to e passing zijn, indie n deze ve rze k e rde te n be ho eve va n de m a terië le co ntro le schrifte lijk to e ste m m ing aa n de zo rga a nbie der he e ft ge ge ve n vo o r ve rstre k k ing va n perso onsge ge ve ns be treffe nde die ns ge zo ndhe id a a n de zorgverze k e ra a r. De zo rgve rze k era a r ve rwe rk t bij de de tailco ntrole nie t m e er ge geve ns dan ge le t o p he t o nde rzoe k sdo e l e n de o m sta ndighe de n va n het ge va l noo dza k e lijk is.

4.

De zo rgve rzek e ra ar info rm e e rt de zo rga a nbie der o ver de za k e lijk e inhoud va n de vo orge nom e n uitk o m ste n va n de deta ilco ntro le e n ste lt de zorga a nbie de r in de ge le ge nhe id da a rop binne n ee n re de lijk e te rm ijn te re a gere n. De zo rgve rze k e raa r be trek t de re a ctie va n de zo rga anbiede r bij de va stste lling va n de definitie ve uitk om sten van de de ta ilcontro le e n bericht de ze uitk o m ste n a a n de zo rga anbiede r.

A rtikel 7.9 1.

De zo rgve rzek e ra ar le gt de spe cifie k e risico a nalyse e n de uitvo ering va n de ta ilcontro les in zijn a dm inistra tie va st o m toe tsing doo r e n ve ra ntwo o rding aa n to ezichtho uders m oge lijk te m a k e n. Da a rbij wo rde n nie t m e er pe rso o nsge ge vens, wa a ro nde r pe rso o nsgege ve ns be tre ffende de ge zo ndhe id, ve rwe rk t dan voo r dit do e l no o dza k elijk is.

2.

De zo rgve rzek e ra ar be waa rt na de ta ilcontro les de da a rbij ve rwe rk te pe rso o nsgege ve ns va n ve rze k erde n nie t lange r da n no odzak e lijk is voo r he t do e l wa a rvo o r zij zijn ve rk rege n.

A rtikel 7.10 1.

Bij fra udeo nderzo ek zijn de vo orwa a rde n bedo e ld in artik e l 7.8, e erste lid, o nde rdele n b e n d, va n ove ree nk om stige to epa ssing, e n is de in o nderde e l e be do e lde voo rwa arde va n o ve re enk o m stige to e pa ssing vo or zo ve r het o nderzo ek sbe la ng o f het be lang va n de be scherm ing va n de perso onlijk e leve nssfe e r va n de be tro k k e n ve rze k e rde zich da a r nie t te ge n ve rzet.

2.

In a fwijk ing van he t ee rste lid k a n de zo rgve rze k era a r m et be tre k k ing to t e e n individue le ve rze k erde deta ilco ntro le uitvoe re n zonde r da t de in da t lid geno e m de vo o rwaa rde n va n to e passing zijn, indie n deze ve rze k e rde te n be ho eve va n he t fra ude o nde rzoe k schrifte lijk to este m m ing he e ft ge ge ve n vo o r ve rstre k k ing va n perso onsge ge ve ns be treffe nde die ns gezo ndhe id a a n de zo rgve rzek e ra ar. De zorgverze k e ra a r ve rwerk t bij de deta ilco ntro le nie t m ee r ge ge vens da n gele t o p he t o nde rzo e k sdo el e n de om standighe den van he t ge val no odzak e lijk is.

A rtikel 7.11 De zo rgve rzek e ra ar ve rwe rk t de pe rso o nsge ge vens, be do eld in a rtik el 87, ee rste e n twee de lid, va n de we t sle chts ve rde r voo r de uitvo e ring va n de zo rgve rze k ering en de aa nvullende zie k te k o ste nve rze k e ring indie n e n vo o r zo ver dit noo dza k e lijk is vo o r de do e le n o m schre ve n in a rtik el 7.1 va n de ze re ge ling.

Hoofdstuk 7a. Gegevens die de zorgaanbieder moet verstrekken aan het college voor zorgverzekeringen indien hij in aanmerking wenst te komen voor een bijdrage in de kosten in verband met het verlenen van medisch noodzakelijke zorg aan bepaalde groepen vreemdelingen A rtikel 7a.1 1.

De gege ve ns a ls be doe ld in a rtik e l 122a , dertie nde lid, va n de Zorgverze k e ringswet, be sta a n uit: a.

de pre statie beschrijving van de aa n de vre em de ling ge le ve rde pre sta tie ;

b.

he t vo o r de ge le verde presta tie in rek e ning gebra chte tarie f;

2.

c.

de in verba nd m e t het vo or die pre statie in re k e ning ge bra chte ta rie f ontvange n be ta lingen o f ve rgo edinge n va n de vree m deling, zijn verze k e ra a r of de rden;

d.

de le e ftijd, de na tio na liteit, de initiale n en he t ge sla cht van de vre e m de ling.

Bij de gege ve ns, be doe ld in he t ee rste lid, wo rdt ve rm e ld wa nne e r de pre sta tie is ge le ve rd.

slotbepalingen

Hoofdstuk 8. Overige en

A rtikel 8.1 Indien de ve rze k e rde o p he t tijdstip va n inwerk ingtre ding van de ze re ge ling in he t be zit is van e e n ho o rtoe stel a ls be do e ld in a rtik e l 2.14, e e rste lid, o nderde e l a , wo rdt dit to este l vo or de to epa ssing van a rtik e l 2.14, de rde to t e n m e t het ze sde lid, bescho uwd a ls te zijn verstre k t o p grond va n deze rege ling. A rtikel 8.2 1.

Te r za k e va n he t ve rle ne n va n zo rg o f die nste n in zie k e nhuize n en m e disch-spe cia listische zo rg ande rs da n in zie k enhuize n, is a rtik e l 118, e e rste lid, van de Zo rgve rzek e ringswe t van to e pa ssing.

2.

He t e erste lid is niet va n to e passing op inste llingen wa arin e en e nk e lvo udige o nde rzo e k - o f be ha nde lfunctie wordt uitge o e fend, k linische re va lida tie-inste llinge n, ce ntra vo or e pile ptici, bra ndwo ndence ntra en a stm a ce ntra.

A rtikel 8.3 1.

Een verze k e rde vo ldo e t a an de vo o rwa a rden, be do e ld o m a rtik e l 3a .1, e erste lid, va n het Be sluit zo rgve rze k e ring, indie n: a.

a a n he m ee n gene e sm idde l, ge no em d in bijla ge 5 vo or de daa rbij ve rm e lde a a ndo e ning te r ha nd is geste ld;

b.

a a n he m va n da t ge ne e sm idde l e en ho eve elhe id van m e er da n 180 k ee r de bij dat m idde l in bijla ge 5 ge noe m de e e nhe id of indie n in de bijlage bij da t ge ne esm idde l e e n receptre gel a ls e e nhe id is ge no em d, e en ho eve elhe id te r hand is ge ste ld, e n

c.

he t ge ne esm idde l vo or re k e ning va n de zorgverze k e ring k o m t.

2.

In dit artik e l wo rdt ve rsta a n onde r bijlage 5: bijla ge 5 zo a ls die ge ldt vo or de te rha ndste lling va n ge ne esm idde le n in de twee k a le nderja re n vo ora fga ande aa n het k a lende rja a r waa ro p de uitk e ring, be doe ld 118a , ee rste lid, va n de we t, be tre k k ing he e ft.

3.

De ve rvange n bijla ge 5 blijft va n to e passing op de uitk e ring, bedo e ld in artik e l 118a, e e rste lid, va n de wet, wa a rvo o r die verva nge n bijlage gold.

4.

Als DKG’s a ls be do e ld in a rtik e l 3a .1, e erste lid, o nde rdee l b, va n he t Be sluit zo rgve rze k ering, vo o r de inde ling in he t ja ar da t drie ja ar vo ora fga at a a n he t k a le nderja a r wa a ro p de uitk e ring, be do e ld in a rtik e l 118a , ee rste lid, va n de we t be tre k k ing he e ft, worde n a a nge weze n de DKG’s die in tabe l 1 va n bijla ge 6 zijn o pge no m e n.

5.

Als DKG’s a ls be do e ld in a rtik e l 3a .1, e erste lid, o nde rdee l b, va n he t Be sluit zo rgve rze k ering, vo o r de inde ling in he t ja ar da t twe e voo ra fgaa t a a n he t k ale nde rja ar wa a rop de uitk e ring, bedo e ld in artik e l 118a, e e rste lid, va n de wet, be tre k k ing he e ft, wo rden a a nge weze n, de DKG’s die in tabe l 2 va n bijla ge 6 zijn o pge no m e n.

6.

De ta be llen 1 e n 2 van de ve rva ngen bijla ge 6 blijven van to e pa ssing o p de uitk ering, be do eld in a rtik el 118a , e e rste lid, van de we t, wa a rvo o r die verva nge n bijlage gold.

A rtikel 8.4 De ze re geling tre e dt in we rk ing m e t inga ng va n 1 ja nua ri 2006, m et uitzo ndering va n de a rtik e le n 2.2 e n 2.3 die in we rk ing tre den m e t inga ng va n 1 ja nua ri 2007. A rtikel 8.5 De ze re geling wo rdt aa ngeha a ld a ls: R e ge ling zo rgve rze k e ring. De ze re geling za l m e t de to e lichting in de Sta a tscoura nt wo rde n ge pla a tst. De Minister va n Vo lk sgezo ndhe id, W e lzijn e n Spo rt, J.F. Ho oge rvo rst Bijlage 1. horende bij artikel 2.5, eerste lid, van de Regeling zorgverzekering A . Lijst van geneesmiddelen waarvoor een vergoedingslimiet is vastgesteld C luste r

R e gistra tie num m e r Artik e lnaa m

Sta nda a rddo sis in e e nhe den

Lim ie t pe r e e nhe id

0A01AAADA V 6269

Elm e x m e dica l carie spro te ctie ge l 12,5m g/g

1,00 gra m

0,05696

0A02BAAO

Za nta c ta blet 300m g

1,00 stuk

1,31884

V 11161

0A02BAAO 0A02BAAO

V 12364 V 13064

Ax id ca psule 150m g Za nta c dra nk 150m g/10m l

2,00 stuk 20,00 m l

0,79130 0,06594

0A02BAAO

V 14330

0A02BAAO

V 15366

Za nta c bruista ble t 150m g

2,00 stuk

0,65942

Za nta c bruista ble t 300m g

1,00 stuk

0A02BAAO 0A02BAAO

1,31884

V 17231 V 17232

C IMETIDINE TEVA TABLET 200MG C IMETIDINE TEVA TABLET 400MG

4,00 stuk 2,00 stuk

0,52753 0,65942

0A02BAAO

V 17233

C IMETIDINE TEVA TABLET 800MG

1,00 stuk

1,31884

0A02BAAO

V 17856

C IMETIDINE AP O TEX TABLET FILMO MHULD 400MG

2,00 STUK

0,65942

0A02BAAO 0A02BAAO

V 17857 V 18080

C im etidinum ta ble t 800m g C IMETIDINE AP O TEX TABLET FILMO MHULD 200MG

1,00 stuk 4,00 STUK

1,31884 0,52753

0A02BAAO

V 19320

Za nta c ta blet 150m g

2,00 stuk

0,65942

0A02BAAO

V 19345

C im etidine m p bruista blet 200m g

4,00 stuk

0,52753

0A02BAAO 0A02BAAO

V 19346 V 19347

C im etidine sando z bruista ble t 400m g C im etidine sando z bruista ble t 800m g

2,00 stuk 1,00 stuk

0,65942 1,31884

0A02BAAO

V 19540=17878

C im etidine bipha rm a ta blet 200m g

4,00 stuk

0,52753

0A02BAAO

V 20946

C im etidine pch bruistable t 400m g

2,00 stuk

0,65942

0A02BAAO 0A02BAAO

V 20947 V 21283

C im etidine pch bruistable t 800m g R a nitidine cf ta blet 150m g

1,00 stuk 2,00 stuk

1,31884 0,65942

0A02BAAO

V 21284

R a nitidine cf ta blet 300m g

1,00 stuk

1,31884

0A02BAAO

V 21969

R a nitidine sando z ta ble t 150m g

2,00 stuk

0,65942

0A02BAAO 0A02BAAO

V 21970 V 22359

R a nitidine sando z ta ble t 300m g R a nitidine m yla n table t 150m g

1,00 stuk 2,00 stuk

1,31884 0,65942

0A02BAAO

V 22360

R ANITIDINE MYLAN TABLET 300MG

1,00 STUK

1,31884

0A02BAAO

V 22508

R a nitidine cf ta blet 150m g

2,00 stuk

0,65942

0A02BAAO 0A02BAAO

V 22509 V 23060

R a nitidine cf ta blet 300m g R a nitidinum ta ble t 150m g

1,00 stuk 2,00 stuk

1,31884 0,65942

0A02BAAO

V 23061

R a nitidinum ta ble t 300m g

1,00 stuk

1,31884

0A02BAAO

V 23422

R a nitidine pch bruistable t 150m g

2,00 stuk

0,65942

0A02BAAO 0A02BAAO

V 23423 V 23701

R a nitidine pch bruistable t 300m g R a nitidine sando z bruista ble t 150m g

1,00 stuk 2,00 stuk

1,31884 0,65942

0A02BAAO

V 23702

R a nitidine sando z bruista ble t 300m g

1,00 stuk

1,31884

0A02BAAO

V 24021

C IMETIDINE AC C O R D TABLET FILMO MHULD 200MG

4,00 stuk

0,52753

0A02BAAO 0A02BAAO

V 24022 V 24023

C IMETIDINE AC C O R D TABLET FILMO MHULD 400MG C IMETIDINE AC C O R D TABLET FILMO MHULD 800MG

2,00 stuk 1,00 stuk

0,65942 1,31884

0A02BAAO

V 24064=17231

C IMETIDINE MYLAN TABLET 200MG

4,00 stuk

0,52753

0A02BAAO

V 24065=17232

C im etidine m yla n table t 400m g

2,00 stuk

0,65942

0A02BAAO 0A02BAAO

V 24066=17233 V 24532

C im etidine m e rck table t 800m g Fam o tidine cf ta ble t 20m g

1,00 stuk 2,00 stuk

1,31884 0,65942

0A02BAAO

V 24533

Fam o tidine cf ta ble t 40m g

1,00 stuk

1,31884

0A02BAAO

V 24769

Fam o tidine rp ta blet 20m g

2,00 stuk

0,65942

0A02BAAO 0A02BAAO

V 24770 V 25004

Fam o tidine rp ta blet 40m g R ANITIDINE AC C O R D TABLET 150MG

1,00 stuk 2,00 stuk

1,31884 0,65942

0A02BAAO

V 25005

R ANITIDINE AC C O R D TABLET 300MG

1,00 stuk

1,31884

0A02BAAO

V 25047

R a nitidine a cta vis bruista blet 150m g

2,00 stuk

0,65942

0A02BAAO 0A02BAAO

V 25048 V 25251

R a nitidine a cta vis bruista blet 300m g Fam o tidine pch ta blet 20m g

1,00 stuk 2,00 stuk

1,31884 0,65942

0A02BAAO

V 25252

Fam o tidine pch ta blet 40m g

1,00 stuk

1,31884

0A02BAAO

V 25358=24532

Fam o tidine actavis ta ble t 20m g

2,00 stuk

0,65942

0A02BAAO 0A02BAAO

V 25359=24533 V 25411

Fam o tidine actavis ta ble t 40m g Fam o tidine sa ndo z table t 20m g

1,00 stuk 2,00 stuk

1,31884 0,65942

0A02BAAO

V 25412

Fam o tidine sa ndo z table t 40m g

1,00 stuk

1,31884

0A02BAAO

V 25580

FAMO TIDINE AP O TEX TABLET 20MG

2,00 stuk

0,65942

0A02BAAO

V 25751

R a nitidine a pote x ta ble t 150m g

2,00 stuk

0,65942

0A02BAAO

V 25752

R a nitidine a pote x ta ble t 300m g

1,00 stuk

1,31884

0A02BAAO

V 26177=17104

C im etidine pch ta ble t 200m g

4,00 stuk

0,52753

0A02BAAO 0A02BAAO

V 26178=17105 V 26179=17106

C im etidine pch ta ble t 400m g C im etidine pch ta ble t 800m g

2,00 stuk 1,00 stuk

0,65942 1,31884

0A02BAAO

V 27788

Fam o tidine m ylan ta ble t 20m g

2,00 stuk

0,65942

0A02BAAO

V 27789

FAMO TIDINE MYLAN TABLET 40MG

0A02BAAO 0A02BAAO

V 29327 V 29328

0A02BAAO 0A02BAAO

1 STUK

1,31884

R ANITIDINE MYLAN BR UISTABLET 150MG R ANITIDINE MYLAN BR UISTABLET 300MG

2,00 STUK 1,00 STUK

0,65942 1,31884

V 31479

R a nitidine pch ta ble t 150m g

2,00 stuk

0,65942

V 31480

R a nitidine pch ta ble t 300m g

1,00 stuk

1,31884

0A02BAAO 0A02BAAO

V 33074 V 33075

R a nitidine a ta ble t 150m g R a nitidine a ta ble t 300m g

2,00 stuk 1,00 stuk

0,65942 1,31884

0A02BAAO

V 56029

C im etidine flx table t 200m g

4,00 stuk

0,52753

0A02BAAO

V 56339

C im etidine cf ta blet 400m g

2,00 stuk

0,65942

0A02BAAO 0A02BAAO

V 56705 V 57066

C im etidine flx table t 400m g C im etidine flx table t 800m g

2,00 stuk 1,00 stuk

0,65942 1,31884

0A02BAAO

V 9265

Za nta c ta blet 150m g

2,00 stuk

0,65942

0A02BAAP

V 11141

Za nta c injvlst 25m g/m l a m pul 2m l

8,00 m l

0,52548

0A02BC AO

V 100105

Lansopra zo l a cta vis capsule m sr 15m g

2,00 stuk

1,00866

0A02BC AO

V 100115

Lansopra zo l a cta vis capsule m sr 30m g

1,00 stuk

1,68111

0A02BC AO 0A02BC AO

V 100345 V 100347

P a nto pra zo l m ylan ta ble t m sr 20m g P a nto pra zo l m ylan ta ble t m sr 40m g

2,00 stuk 1,00 stuk

1,00866 1,68111

0A02BC AO

V 100488//25388

Ne x ium table t m sr 40m g

0,50 stuk

3,36221

0A02BC AO

V 100490//25387

Ne x ium table t m sr 20m g

1,00 stuk

1,68111

0A02BC AO 0A02BC AO

V 100885//23211 V 101600

P a rie t ta ble t m sr 20m g Ne x ium gra nula a t m sr v susp in sa che t 10m g

1,00 stuk 2,00 stuk

1,68111 1,00866

0A02BC AO

V 101640//25388

Ne x ium table t m sr 40m g

0,50 stuk

3,36221

0A02BC AO

V 101642//25387

Ne x ium table t m sr 20m g

1,00 stuk

1,68111

0A02BC AO 0A02BC AO

V 102763//23211 V 104081//25387

P a rie t ta ble t m sr 20m g Ne x ium table t m sr 20m g

1,00 stuk 1,00 stuk

1,68111 1,68111

0A02BC AO

V 12438

Lose c ca psule m ga 20m g

1,00 stuk

1,68111

0A02BC AO

V 14905

Lose c ca psule m ga 40m g

0,50 stuk

3,36221

0A02BC AO 0A02BC AO

V 15420 V 16745

P re za l ca psule m sr 30m g Lose c ca psule m ga 10m g

1,00 stuk 2,00 stuk

1,68111 1,00866

0A02BC AO

V 18300

P a nto zol ta ble t m sr 40m g

1,00 stuk

1,68111

0A02BC AO

V 18696

P re za l ca psule m sr 15m g

2,00 stuk

1,00866

0A02BC AO 0A02BC AO

V 21683 V 21684

Lose c m ups table t m sr 10m g Lose c m ups table t m sr 20m g

2,00 stuk 1,00 stuk

1,00866 1,68111

0A02BC AO

V 21685

Lose c m ups table t m sr 40m g

0,50 stuk

3,36221

0A02BC AO

V 22106

P a nto pra zo l nyco m ed ta ble t m sr 40m g

1,00 stuk

1,68111

0A02BC AO

V 22106

P ANTO P R AZO L NYC O MED TABLET MSR 40MG

1,68111

0A02BC AO

V 23210

P a rie t ta ble t m sr 10m g

1 STUK stuk 2,00 stuk

0A02BC AO

V 23211

P a rie t ta ble t m sr 20m g

1,00 stuk

1,68111

0A02BC AO

V 23513

P a nto zol ta ble t m sr 20m g

2,00 stuk

1,00866

0A02BC AO 0A02BC AO

V 24777 V 24876

O m e prazo l rp ca psule m sr 20m g O m e prazo l rp ca psule m sr 40m g

1,00 stuk 0,50 stuk

1,68111 3,36221

0A02BC AO

V 25342

O m e prazo l rp ca psule m sr 10m g

2,00 stuk

1,00866

0A02BC AO

V 25387

Ne x ium table t m sr 20m g

1,00 stuk

1,68111

1,00866

0A02BC AO

V 25482

O MEP R AZO L MYLAN C AP SULE MSR 20MG

1,00 stuk

1,68111

0A02BC AO

V 25660

O m e prazo l cf ca psule m sr 20m g

1,00 stuk

1,68111

0A02BC AO

V 25661

O m e prazo l cf ca psule m sr 40m g

0,50 stuk

3,36221

0A02BC AO 0A02BC AO

V 25729 V 25730

O m e prazo l sa ndo z capsule m sr 10m g O m e prazo l sa ndo z capsule m sr 20m g

2,00 stuk 1,00 stuk

1,00866 1,68111

0A02BC AO

V 25731

O m e prazo l sa ndo z capsule m sr 40m g

0,50 stuk

3,36221

0A02BC AO

V 26015

O MEP R AZO L MYLAN C AP SULE MSR 10MG

2,00 stuk

1,00866

0A02BC AO 0A02BC AO

V 26016 V 26724

O MEP R AZO L MYLAN C AP SULE MSR 40MG O MEP R AZO L AP O TEX C APSULE MSR 10MG

0,50 stuk 2,00 stuk

3,36221 1,00866

0A02BC AO

V 26725

O m e prazo l a po tex ca psule m sr 20m g

1,00 stuk

1,68111

0A02BC AO

V 26726

O MEP R AZO L AP O TEX C APSULE MSR 40MG

0,50 stuk

3,36221

0A02BC AO 0A02BC AO

V 27872//25388 V 28084

Ne x ium table t m sr 40m g O m e prazo l a ca psule m sr 40m g

0,50 stuk 0,50 stuk

3,36221 3,36221

0A02BC AO

V 29762//25388

Eso pral ta ble t m sr 40m g

0,50 stuk

3,36221

0A02BC AO

V 29932

O m e prazo l cf ca psule m sr 10m g

2,00 stuk

1,00866

0A02BC AO 0A02BC AO

V 29936//25388 V 30448//23211

Ne x ium table t m sr 40m g P a rie t ta ble t m sr 20m g

0,50 stuk 1,00 stuk

3,36221 1,68111

0A02BC AO

V 30453//25387

Eso pral ta ble t m sr 20m g

1,00 stuk

1,68111

0A02BC AO

V 30454//25388

Ne x ium table t m sr 40m g

0,50 stuk

3,36221

0A02BC AO 0A02BC AO

V 30802 V 30803

O m e prazo l pch ca psule m sr 10m g O m e prazo l pch ca psule m sr 20m g

2,00 stuk 1,00 stuk

1,00866 1,68111

0A02BC AO

V 30804

O m e prazo l pch ca psule m sr 40m g

0,50 stuk

3,36221

0A02BC AO

V 31527

O m e prazo l a cta vis ca psule m sr 10m g

2,00 stuk

1,00866

0A02BC AO

V 31528

1,00 stuk

1,68111

0A02BC AO

V 31537

FENISTIL DIMETINDEENW ATER STO FMALEAAT DR UP 1MG/ML Lansopra zo l fo cus ca psule m sr 15m g

2,00 stuk

1,00866

0A02BC AO

V 31538

Lansopra zo l fo cus ca psule m sr 30m g

1,00 stuk

1,68111

0A02BC AO

V 31740

O m e prazo l a cta vis ca psule m sr 40m g

0,50 stuk

3,36221

0A02BC AO 0A02BC AO

V 32328//23211 V 32791

P a rie t ta ble t m sr 20m g LANSO P R AZO L MYLAN C AP SULE MSR 15MG

1,00 stuk 2,00 stuk

1,68111 1,00866

0A02BC AO

V 32792

LANSO P R AZO L MYLAN C AP SULE MSR 30MG

1,00 stuk

1,68111

0A02BC AO

V 33512

Lansopra zo l rp ca psule m sr 15m g

2,00 stuk

1,00866

0A02BC AO 0A02BC AO

V 33513 V 33657

Lansopra zo l rp ca psule m sr 30m g P a nto pra zo l sa ndo z table t m sr 20m g

1,00 stuk 2,00 stuk

1,68111 1,00866

0A02BC AO

V 33658

P a nto pra zo l sa ndo z table t m sr 40m g

1,00 stuk

1,68111

0A02BC AO

V 33989

Lansopra zo l pch ca psule m sr 15m g

2,00 stuk

1,00866

0A02BC AO 0A02BC AO

V 33990 V 34317

Lansopra zo l pch ca psule m sr 30m g P a nto pra zo l pch ta blet m sr 20m g

1,00 stuk 2,00 stuk

1,68111 1,00866

0A02BC AO

V 34318

P a nto pra zo l pch ta blet m sr 40m g

1,00 stuk

1,68111

0A02BC AO

V 34385//23211

P a rie t ta ble t m sr 20m g

1,00 stuk

1,68111

0A02BC AO 0A02BC AO

V 34394//25387 V 34600//23211

Ne x ium table t m sr 20m g P a rie t ta ble t m sr 20m g

1,00 stuk 1,00 stuk

1,68111 1,68111

0A02BC AO

V 34880

P a nto pra zo l apo te x ta blet m sr 20m g

2,00 stuk

1,00866

0A02BC AO

V 34881

P a nto pra zo l apo te x ta blet m sr 40m g

1,00 stuk

1,68111

0A02BC AO 0A02BC AO

V 34882 V 34883

P a nto pra zo l rp ta blet m sr 20m g P a nto pra zo l rp ta blet m sr 40m g

2,00 stuk 1,00 stuk

1,00866 1,68111

0A02BC AO

V 34884

P a nto pra zo l cf ta ble t m sr 20m g

2,00 stuk

1,00866

0A02BC AO

V 34885

P a nto pra zo l cf ta ble t m sr 40m g

1,00 stuk

1,68111

0A02BC AO 0A02BC AO

V 34937 V 34938

P a nto pra zo l ranba x y ta ble t m sr 20m g P a nto pra zo l ranba x y ta ble t m sr 40m g

2,00 stuk 1,00 stuk

1,00866 1,68111

0A02BC AO

V 35033

P a nto pra zo l actavis ta ble t m sr 20m g

2,00 stuk

1,00866

0A02BC AO

V 35034

P a nto pra zo l actavis ta ble t m sr 40m g

1,00 stuk

1,68111

0A02BC AO 0A02BC AO

V 35044 V 35045

P a nto pra zo l a ta blet m sr 20m g P a nto pra zo l a ta blet m sr 40m g

2,00 stuk 1,00 stuk

1,00866 1,68111

0A02BC AO

V 35337

Lansopra zo l cf ca psule m sr 15m g

2,00 stuk

1,00866

0A02BC AO

V 35338

Lansopra zo l cf ca psule m sr 30m g

1,00 stuk

1,68111

0A02BC AP

V 12439

Lose c inje ctie po e der fla co n 40m g + so lve ns 10m l

1,00 stuk

9,48400

0A02BC AP

V 14439

Lose c infusie po ede r flacon 40m g

1,00 stuk

9,48400

0A02BC AP

V 22084

P a nto zol inje ctie poe de r fla co n 40m g

1,00 stuk

9,48400

0A02BXAO

V 102319//11079

Ulco gant suspensie 200m g/m l in zak je 5m l

4,00 stuk

0,26546

0A02BXAO

V 11079

Ulco gant suspensie 200m g/m l in zak je 5m l

4,00 stuk

0,26546

0A02BXAO

V 11079

Ulco gant suspensie 200m g/m l

20,00 m l

0,05309

0A02BXAO 0A02BXAO

V 11079 V 11079

Ulco gant suspensie 200m g/m l Ulco gant suspensie 200m g/m l in zak je 5m l

20,00 m l 4,00 stuk

0,05309 0,26546

0A02BXAO

V 12882

Sucra lfa a t sa ndoz ta ble t 1000m g

4,00 stuk

0,26546

0A02BXAO

V 16859

Sucra lfa a t sa ndoz suspe nsie 200m g/m l in za k je 5m l

4,00 stuk

0,26546

0A02BXAO 0A02BXAO

V 17346 V 21870=17346

Sucra lfa a t pch gra nula a t 1g in sa che t SUC R ALFAAT APO TEX GR ANULAAT 1G IN SAC HET

4,00 stuk 4,00 stuk

0,26546 0,26546

0A02BXAO

V 9131

Ulco gant ta ble t 1000m g

4,00 stuk

0,26546

0A02BXAO

V 9132

Ulco gant gra nula at 1000m g in sa chet

4,00 stuk

0,26546

0A02BXBO

V 10721

De nol ta ble t 120m g

4,00 stuk

0,45537

0A03AAAO

V 11657

Duspa ta l re ta rd ca psule m ga 200m g

2,00 stuk

0,35055

0A03AAAO

V 31404//11657

Duspa ta lin ca psule m ga 200m g

2,00 stuk

0,35055

0A03FAAR

B 19534=7681

Do m pe ridon pch ze tpil 10m g

12,00 stuk

0,40462

0A03FAAR

B 20547=7681

DO MPER IDO N JJC ZETPIL 10MG

12,00 STUK

0,40462

0A03FAAR

B 7681

Mo tilium ze tpil 10m g vo or zuige linge n

12,00 stuk

0,40462

0A03FAAR

K 19536=7682

Do m pe ridon pch ze tpil 30m g

4,00 stuk

0,62395

0A03FAAR

K 20546=7682

DO MPER IDO N JJC ZETPIL 30MG

4,00 STUK

0,62395

0A03FAAR 0A03FAAR

K 21173=7682 K 7682

Do m pe ridon san zetpil 30m g Mo tilium ze tpil 30m g vo or k inde re n

4,00 stuk 4,00 stuk

0,62395 0,62395

0A03FAAR

V 19538=7683

Do m pe ridon pch ze tpil 60m g

2,00 stuk

1,00588

0A03FAAR 0A03FAAR

V 20545=7683 V 21174=7683

DO MPER IDO N JJC ZETPIL 60MG Do m pe ridon san zetpil 60m g

2,00 STUK 2,00 stuk

1,00588 1,00588

0A03FAAR

V 7683

Mo tilium ze tpil 60m g vo or vo lwa sse ne n

2,00 stuk

1,00588

0A03FABO 0A03FABO

V 20544=7678 V 22830

DO MPER IDO N JJC TABLET 10MG Do m pe ridon m yla n table t 10m g

3,00 STUK 3,00 stuk

0,22689 0,22689

0A03FABO

V 23565

Do m pe ridonum table t 10m g

3,00 stuk

0,22689

0A03FABO

V 23949

Do m pe ridon pch ta ble t 10m g

3,00 stuk

0,22689

0A03FABO 0A03FABO

V 24213 V 24277

DO MPER IDO N AC C O R D TABLET 10MG Ma a gk la chte n/m isse lijk heid dom pe rido n table t 10m g

3,00 stuk 3,00 stuk

0,22689 0,22689

0A03FABO

V 24514

DO MPER IDO N AP O TEX TABLET 10MG

3,00 stuk

0,22689

0A03FABO

V 24583

Do m pe ridon sudco ta ble t 10m g

3,00 stuk

0,22689

0A03FABO 0A03FABO

V 24859=24514 V 26065

Do m pe ridonum table t 10m g Do m pe ridon a cta vis table t 10m g

3,00 stuk 3,00 stuk

0,22689 0,22689

0A03FABO

V 26086=24277

Do m pe ridon cf ta blet 10m g

3,00 stuk

0,22689

0A03FABO

V 30008

Do m pe ridon sando z ta ble t 10m g

3,00 stuk

0,22689

0A03FAC O

K 5252

P rim pe ra n dra nk 1m g/m l

30,00 m l

0A03FAC O 0A03FAC O

V 10401 V 27570=55926

Litica n ta ble t 50m g Me to clo pra m ide hcl a cta vis ta blet 10m g

3,00 stuk 3,00 stuk

0,10422 0,10422

0A03FAC O

V 5250

P rim pe ra n ta blet 10m g

3,00 stuk

0,10422

0A03FAC O

V 55926

Me to clo pra m ide hcl cf ta ble t 10m g

3,00 stuk

0,10422

0A03FAC O

V 9715

Me to clo pra m ide hcl pch table t 10m g

3,00 stuk

0,10422

0A04AAAO

V 100182

O nda nse tron a urobindo ta ble t film o m huld 4m g

4,00 stuk

5,81918

0A04AAAO

V 100185

O nda nse tron a urobindo ta ble t film o m huld 8m g

2,00 stuk

9,69864

0A04AAAO 0A04AAAO

V 102757 V 103030

O nda nse tron a ta ble t film o m huld 8m g Gra nise tron a cta vis table t film o m huld 1m g

2,00 stuk 2,00 stuk

9,69864 9,69864

0A04AAAO

V 103031

Gra nise tron a cta vis table t film o m huld 2m g

1,00 stuk

19,39728

0A04AAAO

V 15202

No va ban ca psule 5m g

1,00 stuk

19,39728

0A04AAAO 0A04AAAO

V 16285 V 19203

Kytril ta ble t 1m g Kytril ta ble t 2m g

2,00 stuk 1,00 stuk

9,69864 19,39728

0A04AAAO

V 19922

Zo fran stroo p 0,8m g/m l

0A04AAAO

V 21471

Zo fran zydis sm e ltta ble t 4m g

4,00 stuk

5,81918

0A04AAAO 0A04AAAO

V 21472 V 30185

Zo fran zydis sm e ltta ble t 8m g O nda nse tron cf ta blet film om huld 4m g

2,00 stuk 4,00 stuk

9,69864 5,81918

0A04AAAO

V 30186

O nda nse tron cf ta blet film om huld 8m g

2,00 stuk

9,69864

0A04AAAO

V 30522

O nda nse tron rp ta ble t 4m g

4,00 stuk

5,81918

0A04AAAO 0A04AAAO

V 30753 V 30754

Gra nise tron m yla n table t film o m huld 1m g GR ANISETR O N MYLAN TABLET FILMO MHULD 2MG

2,00 stuk 1 STUK

0A04AAAO

V 31839

O nda nse tron pch ta ble t film o m huld 4m g

4,00 stuk

5,81918

0A04AAAO

V 31840

O nda nse tron pch ta ble t film o m huld 8m g

2,00 stuk

9,69864

0A04AAAO 0A04AAAO

V 32452 V 32453

O nda nse tron sando z ta ble t 4m g O nda nse tron sando z ta ble t 8m g

4,00 stuk 2,00 stuk

5,81918 9,69864

0A04AAAO

V 33333

Gra nise tron sando z ta ble t o m huld 1m g

2,00 stuk

9,69864

0A04AAAO

V 33334

Gra nise tron sando z ta ble t o m huld 2m g

1,00 stuk

19,39728

0A04AAAO 0A04AAAO

V 33335 V 33336

Gra nise tron pch ta ble t o m huld 1m g Gra nise tron pch ta ble t o m huld 2m g

2,00 stuk 1,00 stuk

9,69864 19,39728

0A04AAAO

V 33340

Gra nise tron cf ta blet o m huld 1m g

2,00 stuk

9,69864

0A04AAAO

V 33341

Gra nise tron cf ta blet o m huld 2m g

1,00 stuk

19,39728

0A04AAAO 0A04AAAO

V 33558 V 33559

O NDANSETR O N MYLAN TABLET FILMO MHULD 4MG O NDANSETR O N MYLAN TABLET FILMO MHULD 8MG

0A04AAAO

V 33604

O nda nse tron rp ta ble t 8m g

2,00 stuk

9,69864

0A04AAAO

V 34620//21472

Zo fran zydis sm e ltta ble t 8m g

2,00 stuk

9,69864

0A04AAAP

V 103103

Gra nise tron hik m a infvlst co nc 1m g/m l a m pul 3m l

3,00 m l

9,51577

0A04AAAP

V 14292

Zo fran injvlst 2m g/m l

4,00 m l

7,13683

0A04AAAP

V 14293

Zo fran injvlst 2m g/m l a m pul 4m l

4,00 m l

7,13683

0A04AAAP 0A04AAAP

V 15203 V 19891

No va ban injvlst 1m g/m l a m pul 5m l No va ban injvlst 1m g/m l a m pul 2m l

5,00 m l 5,00 m l

5,70946 5,70946

0A04AAAP

V 20958

Kytril iv injvlst 1m g/m l

3,00 m l

9,51577

0A04AAAP

V 30187

O nda nse tron cf injvlst 2m g/m l

4,00 m l

7,13683

0A04AAAP 0A04AAAP

V 32441 V 33506

O nda nse tron pch injvlst 2m g/m l a m pul O nda nse tron k a bi injvlst 2m g/m l a m pul

4,00 m l 4,00 m l

7,13683 7,13683

0A04AAAP

V 33557

O NDANSETR O N MYLAN INJVLST 2MG/ML

4,00 ML

7,13683

0A04AAAP

V 33570

O nda nse tron hik m a injvlst 2m g/m l a m pul 2m l

4,00 m l

7,13683

0A04AAAP

V 33571

O nda nse tron hik m a injvlst 2m g/m l a m pul 4m l

4,00 m l

7,13683

20,00 m l

4 STUK 2 STUK

0,01636

0,96986

9,69864 19,39728

5,81918 9,69864

0A04AAAP

V 34595

Gra nise tron pch infvlst co nc 1m g/m l

3,00 m l

9,51577

0A04AAAP

V 34915

Gra nise tron hik m a injvlst 1m g/m l a m pul 1m l

3,00 m l

9,51577

0A05AAAO 0A05AAAO

V 22117=9307 V 24592//9307

Ursode o x ycho lzuur im pho s table t 300m g Ursocho l ta ble t 300m g

2,00 stuk 2,00 stuk

0,92453 0,92453

0A05AAAO

V 25351//9307

Ursocho l ta ble t 300m g

2,00 stuk

0,92453

0A05AAAO

V 28468//9307

Ursocho l ta ble t 300m g

2,00 stuk

0,92453

0A05AAAO 0A05AAAO

V 29828 V 7151

Ursocho l ta ble t 450m g C he no fa lk capsule 250m g

1,33 stuk 4,00 stuk

1,38680 0,46227

0A05AAAO

V 8384

Ursofa lk ca psule 250m g

2,40 stuk

0,77044

0A05AAAO

V 9307

Ursocho l ta ble t 300m g

2,00 stuk

0,92453

0A06ABAO

V 20650=50685

Lax e e rtable t bisacodyl ta blet m sr 5m g

2,00 stuk

0,03276

0A06ABAO

V 21904=52273

Lax e e rdra ge e ta blet m sr 5m g

2,00 stuk

0,03276

0A06ABAO

V 24970=55063

Bisa co dyl k ring ta ble t m sr 5m g

2,00 stuk

0,03276

0A06ABAO 0A06ABAO

V 26860=50685 V 3843

Lax e e rtable t bisacodyl ta blet m sr 5m g Dulco la x ta ble t m sr 5m g

2,00 stuk 2,00 stuk

0,03276 0,03276

0A06ABAO

V 50685

Bisa co dyl cf ta ble t m sr 5m g

2,00 stuk

0,03276

0A06ABAO

V 52273

BISAC O DYL AP O TEX TABLET MSR 5MG

2,00 STUK

0,03276

0A06ABAO

V 55063

Bisa co dyl pch table t m sr 5m g

2,00 stuk

0,03276

0A06ABAR

K 55061

Bisa co dyl pch ze tpil 5m g

2,00 stuk

0,06580

0A06ADAO 0A06ADAO

V 12036 V 13144

LAC TULO SESTR O O P SAN 670MG/ML Im po rtal po ede r

10,00 m l 10,00 gra m

0,01566 0,01566

0A06ADAO

V 14299

Lactulo se stroo p pch 15m l in sache t

0,67 stuk

0,23366

0A06ADAO

V 14299

Lactulo se stroo p pch 50% m /m

10,00 m l

0,01566

0A06ADAO 0A06ADAO

V 14299 V 14299

Lactulo se stroo p pch 15m l in sache t Lactulo se stroo p pch 50% m /m

0,67 stuk 10,00 m l

0,23366 0,01566

0A06ADAO

V 1467

Dupha la c stro o p

10,00 m l

0,01566

0A06ADAO

V 1467

Dupha la c stro o p 15m l in sache t

0,67 stuk

0,23366

0A06ADAO 0A06ADAO

V 1467 V 1467

Dupha la c stro o p Dupha la c stro o p 15m l in sache t

10,00 m l 0,67 stuk

0,01566 0,23366

0A06ADAO

V 15520

Lege nda l granulaa t 12g in sa che t

0,56 stuk

0,28040

0A06ADAO

V 16058

Lactulo se cf po e de r 6g in sache t

1,12 stuk

0,14020

0A06ADAO 0A06ADAO

V 17021 V 17374

Im po rtal m ultido se drank 667m g/m l Sirupus la ctulosi 500m g/g

0A06ADAO

V 17837

Lactulo se cf po e de r 12g in sa che t

0,56 stuk

0,28040

0A06ADAO

V 18209=16058

Lactulo se rp poe de r 6g in sa che t

1,12 stuk

0,14020

0A06ADAO 0A06ADAO

V 19065 V 19196

Im po rtal po ede r 10g in sa che t LAC TULO SESTR O O P APO TEX 500MG/G

1,00 stuk 10,00 m l

0,15656 0,01566

0A06ADAO

V 19268

Lax e e rdra nk la ctulo se stro o p 500m g/g

10,00 m l

0,01566

0A06ADAO

V 20869

Dupha la c lactulo se stroo p 667m g/m l

10,00 m l

0,01566

0A06ADAO 0A06ADAO

V 22827 V 24061

Sirupus la ctulosi 500m g/g Lactulo se stroo p flx 667m g/m l

10,00 m l 10,00 m l

0,01566 0,01566

0A06ADAO

V 26499=55298

Lactulo se stroo p k ring 667m g/m l

10,00 m l

0,01566

0A06ADAO

V 28966=17374

Lactulo se stroo p a 667m g/m l o tc

10,00 m l

0,01566

0A06ADAO 0A06ADAO

V 30239 V 32710

Lactulo se stroo p sa ndoz 667m g/m l LAXEER DR ANK AP O TEX STR O O P 667MG/ML

10,00 m l 10,00 m l

0,01566 0,01566

0A06ADAO

V 34633

LAC TULO SESTR O O P MYLAN 500MG/G O TC

10,00 ML

0,01566

0A06ADAO

V 55075

Lactulo se stroo p cf 50% m /m

10,00 m l

0,01566

0A06ADAO 0A06ADAO

V 55298 V 56674

Lactulo se stroo p pch 50% m /m Lactulo se stroo p rp 50% m /m otc

10,00 m l 10,00 m l

0,01566 0,01566

14,93 m l 10,00 m l

0,01049 0,01566

0A06ADAO

V 56888

Lactulo se stroo p rp 500m g/g

0A06ADAO

V 9070

Lege nda l granulaa t 6g in sache t

10,00 m l 1,12 stuk

0,01566 0,14020

0A06ADBO

V 101983//34072

Mo vipre p po e der vo or dra nk in sa che t a +b

4,00 stuk

4,43003

0A06ADBO

V 103073//34072

Mo vipre p po e der vo or dra nk in sa che t a +b

4,00 stuk

4,43003

0A06ADBO

V 103097//15354

Klea n prep po ede r vo o r drank

4,00 stuk

4,43003

0A06ADBO 0A06ADBO

V 103761//34072 V 15354

Mo vipre p po e der vo or dra nk in sa che t a +b Klea n prep po ede r vo o r drank

4,00 stuk 4,00 stuk

4,43003 4,43003

0A06ADBO

V 22626

C o lofo rt po ede r vo o r drank in sa chet

4,00 stuk

4,43003

0A06ADBO

V 29621//15354

Klea n prep po ede r vo o r drank

4,00 stuk

4,43003

0A06ADBO 0A06ADBO

V 29843 V 31800//15354

Endo fa lk po ede r vo o r drank in sa chet Klea n prep po ede r vo o r drank

8,00 stuk 4,00 stuk

2,21501 4,43003

0A06ADBO

V 33182//15354

Klea n prep po ede r vo o r drank

4,00 stuk

4,43003

0A06ADBO

V 34072

Mo vipre p po e der vo or dra nk in sa che t a +b

4,00 stuk

4,43003

0A06ADBO 0A06ADBO

V 34429//22626 V 34479//15354

C o lofo rt po ede r vo o r drank in sa chet Klea n prep po ede r vo o r drank

4,00 stuk 4,00 stuk

4,43003 4,43003

0A06AGAR C V 5128

Klyx clysm a fla co n 120m l

0A06AGBR C V 100027//5069 0A06AGBR C V 104237//5069 0A06AGBR C V 14141

No rga la x k lysm a 12m g/g fla co n 10g

0A06AGBR C V 5069

Micro la x k lysm a fla co n 5m l

0A07DAAO

K 8423

Im o dium drank

0A07DAAO 0A07DAAO

V 10864 V 14220

Dia cure ta blet 2m g Lope ra m ide hcl pch ca psule 2m g

5,00 stuk 5,00 stuk

0,23143 0,23143

0A07DAAO

V 15140

Lope ra m ide hcl cf ca psule 2m g

5,00 stuk

0,23143

0A07DAAO

V 16470

Lope ra m ide hcl flx ca psule 2m g

5,00 stuk

0,23143

0A07DAAO 0A07DAAO

V 17037 V 17112

Lope ra m ide hcl sa ndo z capsule 2m g Are sta l table t 1m g

5,00 stuk 5,00 stuk

0,23143 0,23143

0A07DAAO

V 20642=15140

Dia rree re m m e r lo pe ra m ide ca psule 2m g

5,00 stuk

0,23143

0A07DAAO

V 21760=57788

Dia rree re m m e r ca psule 2m g

5,00 stuk

0,23143

0A07DAAO 0A07DAAO

V 24069=57117 V 24716=14220

LO P ER AMIDE HC L MYLAN C AP SULE 2MG Lope ra m ide hcl sa n capsule 2m g te gen diarre e

5 STUK 5,00 stuk

0,23143 0,23143

0A07DAAO

V 24977=14220

Lope ra m ide hcl k ring capsule 2m g

5,00 stuk

0,23143

0A07DAAO

V 26866=15140

Dia rree re m m e r lo pe ra m ide ca psule 2m g

5,00 stuk

0,23143

0A07DAAO 0A07DAAO

V 31576//17112 V 31833//17112

Are sta l table t 1m g Are sta l table t 1m g

5,00 stuk 5,00 stuk

0,23143 0,23143

0A07DAAO

V 33724

Im o dium sm e lttable t oro disp ta ble t 2m g

5,00 stuk

0,23143

0A07DAAO

V 35307

DIAR R EER EMMER LO P ER AMIDE HC L SAM C AP SULE 2MG

5,00 stuk

0,23143

0A07DAAO 0A07DAAO

V 57117 V 57788

Lope ra m ide hcl rp ca psule 2m g LO P ER AMIDE HC L AP O TEX C AP SULE 2MG

5,00 stuk 5 STUK

0,23143 0,23143

0A07DAAO

V 6945

Im o dium ca psule 2m g

5,00 stuk

0,23143

0A07EABR C V 15660 0A07EABR C V 25708//15660

Ento co rt ta ble t voo r k lysm a + solvens 115m l Ento co rt ta ble t voo r k lysm a + solvens 115m l

1,00 stuk 1,00 stuk

7,42126 7,42126

0A07EABR C V 26118//15660

Ento co rt ta ble t voo r k lysm a + solvens 115m l

1,00 stuk

7,42126

0A07EC BO 0A07EC BO

SULFASALAZINE MER C K TABLET MSR 500MG Sulfa sala zine sa ndo z table t m sr 500m g

6 STUK 6,00 stuk

0,12434 0,12434

V 15007 V 15836=9645

120,00 m l

0,00590

Micro la x k lysm a fla co n 5m l

5,00 m l

0,16518

Micro la x k lysm a fla co n 5m l

5,00 m l

0,16518

10,00 gra m

0,08259

5,00 m l

0,16518

50,00 m l

0,03989

0A07EC BO

V 27887=9645

Sulfa sala zine k a twijk ta ble t m sr 500m g

6,00 stuk

0,12434

0A07EC BO

V 5705

SALAZO P YR INE EC TABLET MSR 500MG

6,00 stuk

0,12434

0A07EC BO 0A07EC BO

V 57373=9645 V 9645

Sulfa sala zine cf ta ble t m sr 500m g Sulfa sala zine pch ta blet m sr 500m g

6,00 stuk 6,00 stuk

0,12434 0,12434

0A07EC C O

V 100059

Sa lo fa lk gra nu-stix gra nula a t m ga 1,5g in sa che t

1,00 stuk

1,87674

0A07EC C O 0A07EC C O

V 101882//28131 V 103120//31379

Sa lo fa lk gra nu-stix gra nula a t m ga 1000m g in sache t P e nta sa gra nula a t m ga 2g in sa che t

1,50 stuk 0,75 stuk

1,25116 2,50233

0A07EC C O

V 103783//31379

P e nta sa gra nula a t m ga 2g in sa che t

0,75 stuk

2,50233

0A07EC C O

V 104106//14797

P e nta sa ta blet m va 500m g

3,00 stuk

0,62558

0A07EC C O 0A07EC C O

V 104446//18706 V 11086

P e nta sa gra nula a t m ga 1g in sa che t Sa lo fa lk ta blet m sr 250m g

1,50 stuk 6,00 stuk

1,25116 0,37535

0A07EC C O

V 11737

Asa co l ta ble t m sr 400m g

3,75 stuk

0,50047

0A07EC C O

V 11790

Dipentum ca psule 250m g

6,00 stuk

0,37535

0A07EC C O 0A07EC C O

V 12144 V 14363

Sa lo fa lk ta blet m sr 500m g Dipentum table t 500m g

3,00 stuk 3,00 stuk

0,62558 0,62558

0A07EC C O

V 14797

P e nta sa ta blet m va 500m g

3,00 stuk

0,62558

0A07EC C O

V 18636

Asa co l ta ble t m sr 800m g

1,88 stuk

1,00093

0A07EC C O 0A07EC C O

V 18706 V 25544

P ENTASA C O MPAC T GR ANULAAT MVA 1G IN SAC HET Me sala zine pch e c ta blet m sr 250m g

1,50 stuk 6,00 stuk

1,25116 0,37535

0A07EC C O

V 25545

Me sala zine pch e c ta blet m sr 500m g

3,00 stuk

0,62558

0A07EC C O

V 27071

Me sala zine alpharm a e c ta ble t m sr 250m g

6,00 stuk

0,37535

0A07EC C O 0A07EC C O

V 27072 V 27550//18706

Me sala zine actavis e c ta ble t m sr 500m g P e nta sa gra nula a t m ga 1g in sa che t

3,00 stuk 1,50 stuk

0,62558 1,25116

0A07EC C O

V 28130

Sa lo fa lk gra nu-stix gra nula a t m ga 500m g in sa chet

3,00 stuk

0,62558

0A07EC C O

V 28131

Sa lo fa lk gra nu-stix gra nula a t m ga 1000m g in sache t

1,50 stuk

1,25116

0A07EC C O 0A07EC C O

V 29366//18706 V 31379

P e nta sa gra nula a t m ga 1g in sa che t P ENTASA C O MPAC T GR ANULAAT MVA 2G IN SAC HET

1,50 stuk 0,75 stuk

1,25116 2,50233

0A07EC C O

V 33527//14797

P e nta sa ta blet m va 500m g

3,00 stuk

0,62558

0A07EC C O

V 33600

Me zava nt ta blet m va 1200m g

1,25 stuk

1,50140

0A07EC C O 0A07EC C O

V 34430//31379 V 35037//14797

P e nta sa gra nula a t m ga 2g in sa che t P e nta sa ta blet m va 500m g

0,75 stuk 3,00 stuk

2,50233 0,62558

0A07EC C R

V 10115

Sa lo fa lk ze tpil 250m g

6,00 stuk

0,60616

0A07EC C R 0A07EC C R

V 11836 V 15064

Sa lo fa lk ze tpil 500m g P e nta sa ze tpil 1g

3,00 stuk 1,50 stuk

1,01027 2,02053

0A07EC C R

V 24111

Me sala zine alpharm a ze tpil 250m g

6,00 stuk

0,60616

0A07EC C R

V 24112

Me sala zine actavis zetpil 500m g

3,00 stuk

1,01027

0A07EC C R 0A07EC C R

V 26917 V 26918

Me sala zine pch ze tpil 250m g Me sala zine pch ze tpil 500m g

6,00 stuk 3,00 stuk

0,60616 1,01027

0A07EC C R C V 11469

Sa lo fa lk k lysm a 4g/60g fla co n 60g

1,00 stuk

10,24246

0A07EC C R C V 11782 0A07EC C R C V 15393

P e nta sa k lysm a 10m g/m l fla co n 100m l Sa lo fa lk k lysm a 2g/30g fla co n 30g

1,00 stuk 2,00 stuk

10,24246 5,12123

0A07EC C R C V 15845

Sa lo fa lk k lysm a 2g/60g fla co n 60g

2,00 stuk

5,12123

0A07EC C R C V 15849

Asa co l k lysm a 2g/50g flacon 50g

2,00 stuk

5,12123

0A07EC C R C V 28179 0A07EC C R C V 31147//11469

Sa lo fa lk schuim 1g/do fla co n 14do Sa lo fa lk k lysm a 4g/60g fla co n 60g

4,00 do 1,00 stuk

2,56061 10,24246

0A09AAAO

V 101794//16055

C R EO N FO R TE C AP SULE MSR (P ANC R EATINE 300MG)

2,40 stuk

1,00796

0A09AAAO 0A09AAAO

V 103696//16055 V 10656

C R EO N FO R TE C AP SULE MSR (P ANC R EATINE 300MG) C R EO N C AP SULE MSR (P ANC R EATINE 150MG)

2,40 stuk 6,00 stuk

1,00796 0,40319

0A09AAAO

V 13760

P ANZYTR AT 25000 C APSULE MSR

2,40 stuk

1,00796

0A09AAAO

V 16055

C R EO N FO R TE C AP SULE MSR (P ANC R EATINE 300MG)

2,40 stuk

1,00796

0A09AAAO 0A09AAAO

V 16134 V 18311

P ANC R EASE HL C AP SULE MSR P ANZYTR AT 10000 C APSULE MSR

2,40 stuk 6,00 stuk

1,00796 0,40319

0A09AAAO

V 24321//13760

P ANZYTR AT 25000 C APSULE MSR

2,40 stuk

1,00796

0A09AAAO

V 25374//13760

P ANZYTR AT 25000 C APSULE

2,40 stuk

1,00796

0A09AAAO 0A09AAAO

V 26230//13760 V 28058//10656

P ANZYTR AT 25000 C APSULE MSR C R EO N C AP SULE MSR (P ANC R EATINE 150MG)

2,40 stuk 6,00 stuk

1,00796 0,40319

0A09AAAO

V 28287//13760

P ANZYTR AT C AP SULE MSR

2,40 stuk

1,00796

0A09AAAO

V 29660//16055

C R EO N FO R TE C AP SULE MSR (P ANC R EATINE 300MG)

2,40 stuk

1,00796

0A09AAAO 0A09AAAO

V 30807//10656 V 34976//16055

C R EO N C AP SULE MSR (P ANC R EATINE 150MG) C R EO N FO R TE C AP SULE MSR (P ANC R EATINE 300MG)

6,00 stuk 2,40 stuk

0,40319 1,00796

0A09AAAO

V 35021//16134

P ANC R EASE HL C AP SULE MSR

2,40 stuk

1,00796

0A10ABAP 0A10ABAP

V EU/1/02/230/003 V EU/1/97/030/028

Actra pid inj 100ie /m l flacon 10m l Insum a n rapid inj 100ie /m l fla co n 5m l

0,40 m l 0,40 m l

1,88228 1,88228

0A10ABAP D V EU/1/02/230/008

Actra pid no vo let inj 100ie/m l wwsp 3m l

0,40 m l

2,48974

0A10ABAP D V EU/1/97/030/067

Insum a n rapid optis inj 100ie/m l wwsp 3m l

0,40 m l

2,48974

0A10ABAP I

V 13040

Hum uline re gula r inj 100ie /m l patro o n 3m l

0,40 m l

2,09465

0A10ABAP I

V EU/1/02/230/006

Actra pid pe nfill inj 100ie /m l pa tr 3m l

0,40 m l

2,09465

0A10ABAP I

V EU/1/97/030/030

Insum a n rapid inj 100ie /m l pa tro on 3m l

0,40 m l

2,09465

0A10ABBP

V EU/1/97/030/053

Insuline insum a n infusa t inj 100ie /m l fla co n 10m l

0,40 m l

2,96528

0A10ABBP

V EU/1/97/030/054

Insum a n infusa t inj 100ie /m l patr 3,15m l

0,40 m l

2,96528

0A10ABBP D V EU/1/04/285/016

Apidra o ptiset inj 100e /m l wwsp 3m l

0,40 m l

2,48974

0A10ABBP D V EU/1/04/285/032

Apidra so lo sta r inj 100e /m l wwsp 3m l

0,40 m l

2,48974

0A10ABBP D V EU/1/96/007/015

Hum alo g pe n injvlst 100e /m l wwsp 3m l

0,40 m l

2,48974

0A10ABBP D V EU/1/96/007/031 0A10ABBP D V EU/1/97/036/001

Hum alo g k wik pe n injvlst 100e /m l wwsp 3m l Hum alo g hum a je ct injvlst 100e/m l wwsp 3m l

0,40 m l 0,40 m l

2,48974 2,48974

0A10ABBP D V EU/1/99/119/005

No vo ra pid novo le t injvlst 100e /m l wwsp 3m l

0,40 m l

2,48974

0A10ABBP D V EU/1/99/119/009

No vo ra pid flex pe n injvlst 100e/m l wwsp 3m l

0,40 m l

2,48974

0A10ABBP I

V EU/1/04/285/008

Apidra inj 100e /m l patro o n 3m l

0,40 m l

2,26345

0A10ABBP I

V EU/1/04/285/024

Apidra o pticlik inj 100e /m l pa tro o n 3m l

0,40 m l

2,26345

0A10ABBP I

V EU/1/96/007/003

Hum alo g injvlst 100e /m l pa tro on 1,5m l

0,40 m l

2,26345

0A10ABBP I 0A10ABBP I

V EU/1/96/007/004 V EU/1/99/119/003

Hum alo g injvlst 100e /m l pa tro on 3m l No vo ra pid penfill injvlst 100e/m l pa troo n 3m l

0,40 m l 0,40 m l

2,26345 2,26345

0A10ABC P

V EU/1/04/285/001 Apidra inj 100e /m l flacon 10m l

0,40 m l

1,88228

0A10ABC P 0A10ABC P

V EU/1/96/007/002 Hum alo g injvlst 100e /m l fla co n 10m l V EU/1/99/119/001 No vo ra pid injvlst 100e /m l fla co n 10m l

0,40 m l 0,40 m l

1,88228 1,88228

0A10AC AP

V EU/1/02/233/003 Insula ta rd inj 100ie/m l fla co n 10m l

0,40 m l

1,88228

0A10AC AP 0A10AC AP

V EU/1/02/235/003 Mo no tard inj 100ie /m l flacon 10m l V EU/1/97/030/033 Insum a n ba sal inj 100ie /m l flacon 5m l

0,40 m l 0,40 m l

1,88228 1,88228

0A10AC APD V 22242

HUMULINE NP H KW IKP EN INJVLST 100IE/ML W W SP 3ML

0A10AC APD V EU/1/02/233/008 Insula ta rd no vo le t inj 100ie /m l wwsp 3m l 0A10AC APD V EU/1/02/233/014 Insula ta rd fle x pe n inj 100ie /m l wwsp 3m l

0,40 m l

2,48974

0,40 m l 0,40 m l

2,48974 2,48974

0A10AC APD V EU/1/97/030/071 Insum a n ba sal o ptis inj 100ie /m l wwsp 3m l

0,40 m l

2,48974

0A10AC API V 14896 Hum uline nph inj 100ie /m l pa tro on 3m l 0A10AC API V EU/1/02/233/006 Insula ta rd pe nfill inj 100ie /m l pa tr 3m l

0,40 m l 0,40 m l

2,09223 2,09223

0A10AC API V EU/1/97/030/035 Insum a n ba sal inj 100ie /m l patro o n 3m l

0,40 m l

2,09223

0A10AEAP D V EU/1/00/134/010 Lantus o ptise t inj 100e /m l wwsp 3m l

0,40 m l

3,92133

0A10AEAP D V EU/1/00/134/033 Lantus so lo star inj 100e /m l wwsp 3m l

0,40 m l

3,92133

0A10AEAP D V EU/1/04/278/005 Leve m ir fle x pe n inj 100e /m l wwsp 3m l

0,40 m l

3,92133

0A10AEAP D V EU/1/04/278/008 Leve m ir inno le t inj 100e /m l wwsp 3m l

0,40 m l

3,92133

0A10AEAP I

V EU/1/00/134/006 Lantus inj 100e /m l pa tro on 3m l

0,40 m l

3,73467

0A10AEAP I

V EU/1/00/134/025 Lantus o pticlik inj 100e/m l pa troo n 3m l

0,40 m l

3,73467

0A10AEAP I

V EU/1/04/278/002 Leve m ir pe nfill inj 100e /m l pa tro o n 3m l

0,40 m l

3,73467

0A10BAAO

V 103319

Me tfo rm ine hcl a ta blet 500m g

4,00 stuk

0,05521

0A10BAAO

V 103320

Me tfo rm ine hcl a ta blet 850m g

2,35 stuk

0,09386

0A10BAAO 0A10BAAO

V 10500 V 18870

Me tfo rm ine hcl pch ta blet 500m g Me tfo rm ine hcl actavis ta ble t 500m g

4,00 stuk 4,00 stuk

0,05521 0,05521

0A10BAAO

V 18871

Me tfo rm ine hcl actavis ta ble t 850m g

2,35 stuk

0,09386

0A10BAAO

V 21698

METFO R MINE HC L SANDO Z TABLET FILMO MHULD 850MG

2,35 stuk

0,09386

0A10BAAO 0A10BAAO

V 22048=447 V 22049=5934

Me tfo rm ine hcl rp ta blet 500m g Me tfo rm ine hcl rp ta blet 850m g

4,00 stuk 2,35 stuk

0,05521 0,09386

0A10BAAO

V 25368

METFO R MINE HC L SANDO Z TABLET FILMO MHULD 500MG

4,00 stuk

0,05521

0A10BAAO

V 25611

METFO R MINE HC L AP O TEX TABLET 500MG

4,00 stuk

0,05521

0A10BAAO 0A10BAAO

V 25612 V 26048

METFO R MINE HC L AP O TEX TABLET 850MG Me tfo rm ine hcl pch ta blet 850m g

2,35 STUK 2,35 stuk

0,09386 0,09386

0A10BAAO

V 30228

Me tfo rm ine hcl cf ta ble t 500m g

4,00 stuk

0,05521

0A10BAAO

V 30229

Me tfo rm ine hcl cf ta ble t 850m g

2,35 stuk

0,09386

0A10BAAO 0A10BAAO

V 30293 V 30403

METFO R MINE HC L SANDO Z TABLET FILMO MHULD 1000MG Me tfo rm ine hcl a ta blet 1000m g

2,00 stuk 2,00 stuk

0,11042 0,11042

0A10BAAO

V 30404

Me tfo rm ine hcl cf ta ble t 1000m g

2,00 stuk

0,11042

0A10BAAO

V 30827

Me tfo rm ine hcl pch ta blet 1000m g

2,00 stuk

0,11042

0A10BAAO 0A10BAAO

V 31685 V 31686

Me tfo rm ine hcl auro bindo table t 500m g Me tfo rm ine hcl auro bindo table t 850m g

4,00 stuk 2,35 stuk

0,05521 0,09386

0A10BAAO

V 31687

Me tfo rm ine hcl auro bindo table t 1000m g

2,00 stuk

0,11042

0A10BAAO

V 31999

Me tfo rm ine hcl cf ta ble t 1000m g

2,00 stuk

0,11042

0A10BAAO 0A10BAAO

V 34123 V 34124

Me tfo rm ine hcl blue fish table t 500m g Me tfo rm ine hcl blue fish table t 850m g

4,00 stuk 2,35 stuk

0,05521 0,09386

0A10BAAO

V 34125

Me tfo rm ine hcl blue fish table t 1000m g

2,00 stuk

0,11042

0A10BAAO

V 34719

Me tfo rm ine hcl actavis ta ble t 1000m g

2,00 stuk

0,11042

0A10BAAO 0A10BAAO

V 34957 V 34958

Me tfo rm ine hcl rp ta blet 500m g Me tfo rm ine hcl rp ta blet 850m g

4,00 stuk 2,35 stuk

0,05521 0,09386

0A10BAAO

V 34959

Me tfo rm ine hcl rp ta blet 1000m g

2,00 stuk

0,11042

0A10BBAO 0A10BBAO

V 102007 V 102016

Glim e piride a cco rd table t 1m g Glim e piride a cco rd table t 2m g

2,00 stuk 1,00 stuk

0,16626 0,27711

0A10BBAO

V 102017

Glim e piride a cco rd table t 3m g

0,67 stuk

0,41566

0A10BBAO

V 102018

Glim e piride a cco rd table t 4m g

0,50 stuk

0,55421

0A10BBAO 0A10BBAO

V 11579 V 15211=56115

Glibe ncla m ide la ga p ta blet 5m g Glibe ncla m ide sa ndo z table t 5m g

2,00 stuk 2,00 stuk

0,13855 0,13855

0A10BBAO

V 15739=56872

Gliclazide pch ta ble t m ga 80m g

2,00 stuk

0,13855

0A10BBAO

V 16011=56872

Gliclazide a cta vis table t m ga 80m g

2,00 stuk

0,13855

0A10BBAO 0A10BBAO

V 16221=56872 V 17843

Gliclazide sando z re ta rd ta blet m ga 80m g Am aryl table t 1m g

2,00 stuk 2,00 stuk

0,13855 0,16626

0A10BBAO

V 17844

Am aryl table t 2m g

1,00 stuk

0,27711

0A10BBAO

V 17845

Am aryl table t 3m g

0,67 stuk

0,41566

0A10BBAO 0A10BBAO

V 17846 V 20719=6702

Am aryl table t 4m g GLIC LAZIDE AP O TEX TABLET MGA 80MG

0,50 stuk 2,00 stuk

0,55421 0,13855

0A10BBAO

V 25617

Dia m icro n m r table t m ga 30m g

2,00 stuk

0,13855

0A10BBAO

V 25649=51887

Glibe ncla m ide a ta blet 5m g

2,00 stuk

0,13855

0A10BBAO 0A10BBAO

V 26307 V 27013=56115

Gliclazide m yla n reta rd ta ble t m ga 80m g GLIBENC LAMIDE MYLAN TABLET 5MG

2,00 stuk 2 STUK

0,13855 0,13855

0A10BBAO

V 32745

Glim e piride sa ndoz ta ble t 1m g

2,00 stuk

0,16626

0A10BBAO

V 32746

Glim e piride sa ndoz ta ble t 2m g

1,00 stuk

0,27711

0A10BBAO 0A10BBAO

V 32747 V 32748

Glim e piride sa ndoz ta ble t 3m g Glim e piride sa ndoz ta ble t 4m g

0,67 stuk 0,50 stuk

0,41566 0,55421

0A10BBAO

V 32769

Glim e piridum table t 1m g

2,00 stuk

0,16626

0A10BBAO

V 32770

Glim e piridum table t 2m g

1,00 stuk

0,27711

0A10BBAO 0A10BBAO

V 32771 V 32772

Glim e piridum table t 3m g Glim e piridum table t 4m g

0,67 stuk 0,50 stuk

0,41566 0,55421

0A10BBAO

V 32773

Glim e piride sa ndoz ta ble t 6m g

0,33 stuk

0,83132

0A10BBAO

V 32852

Glim e piride cf ta ble t 1m g

2,00 stuk

0,16626

0A10BBAO 0A10BBAO

V 32853 V 32854

Glim e piride cf ta ble t 2m g Glim e piride cf ta ble t 3m g

1,00 stuk 0,67 stuk

0,27711 0,41566

0A10BBAO

V 32855

Glim e piride cf ta ble t 4m g

0,50 stuk

0,55421

0A10BBAO

V 33016

Glim e piride pch table t 1m g

2,00 stuk

0,16626

0A10BBAO 0A10BBAO

V 33017 V 33018

Glim e piride pch table t 2m g Glim e piride pch table t 3m g

1,00 stuk 0,67 stuk

0,27711 0,41566

0A10BBAO

V 33019

Glim e piride pch table t 4m g

0,50 stuk

0,55421

0A10BBAO

V 33104

Glim e piride a table t 1m g

2,00 stuk

0,16626

0A10BBAO 0A10BBAO

V 33105 V 33106

Glim e piride a table t 2m g Glim e piride a table t 3m g

1,00 stuk 0,67 stuk

0,27711 0,41566

0A10BBAO

V 33107

Glim e piride a table t 4m g

0,50 stuk

0,55421

0A10BBAO

V 34590

Gliclazide m yla n reta rd ta ble t m ga 30m g

2,00 stuk

0,13855

0A10BBAO 0A10BBAO

V 34591 V 51887

Gliclazide pch ta ble t m ga 30m g Glibe ncla m ide table t 5m g

2,00 stuk 2,00 stuk

0,13855 0,13855

0A10BBAO

V 52645

GLIBENC LAMIDE AP O TEX TABLET 5MG

2,00 STUK

0,13855

0A10BBAO

V 55397

Glibe ncla m ide flx ta ble t 5m g

2,00 stuk

0,13855

0A10BBAO 0A10BBAO

V 56114 V 56115

Glibe ncla m ide cf ta ble t 2,5m g Glibe ncla m idum cf table t 5m g

4,00 stuk 2,00 stuk

0,08313 0,13855

0A10BBAO

V 56581

Glibe ncla m ide pch ta blet 5m g

2,00 stuk

0,13855

0A10BBAO

V 56872

Gliclazide cf re ta rd table t m ga 80m g

2,00 stuk

0,13855

0A10BBAO 0A10BBAO

V 57240 V 6702

Glibe ncla m idum ta blet 5m g Dia m icro n ta ble t m ga 80m g

2,00 stuk 2,00 stuk

0,13855 0,13855

0A10BBAO

V EU/1/98/076/004 No vo norm ta ble t 0,5m g

8,00 stuk

0,05542

0A10BBAO

V EU/1/98/076/005 No vo norm ta ble t 0,5m g

8,00 stuk

0,05542

0A10BBAO 0A10BBAO

V EU/1/98/076/011 No vo norm ta ble t 1m g V EU/1/98/076/012 No vo norm ta ble t 1m g

4,00 stuk 4,00 stuk

0,06928 0,06928

0A10BBAO

V EU/1/98/076/018 No vo norm ta ble t 2m g

2,00 stuk

0,13855

0A10BBAO

V EU/1/98/076/019 No vo norm ta ble t 2m g

2,00 stuk

0,13855

0A10BBBO

V 12375

To lbuta m ide sa ndo z table t 500m g

2,00 stuk

0,06249

0A10BBBO

V 12376

To lbuta m ide sa ndo z table t 1000m g

1,00 stuk

0,10414

0A10BBBO 0A10BBBO

V 15524 V 25254=51891

To lbuta m ide actavis ta ble t 1000m g To lbuta m ide apo te x ta blet 1000m g

1,00 stuk 1,00 stuk

0A10BBBO

V 28057=55003

TO LBUTAMIDE MYLAN TABLET 500MG

0A10BBBO

V 29011=51890

To lbuta m ide a ta blet 500m g

2,00 stuk

0,06249

0A10BBBO 0A10BBBO

V 29012=51891 V 29059=56652

To lbuta m ide a ta blet 1000m g TO LBUTAMIDE MYLAN TABLET 1000MG

1,00 stuk 1,00 STUK

0,10414 0,10414

0A10BBBO

V 51890

To lbuta m idum ta blet 500m g

2,00 stuk

0,06249

0A10BBBO

V 51891

To lbuta m idum ta blet 1000m g

1,00 stuk

0,10414

0A10BBBO 0A10BBBO

V 55003 V 55354

TO LBUTAMIDE APO TEX TABLET 500MG To lbuta m ide cf ta ble t 500m g

2,00 STUK 2,00 stuk

0,06249 0,06249

0A10BBBO

V 55355

To lbuta m ide cf ta ble t 1000m g

1,00 stuk

0,10414

0A10BBBO

V 55384

TO LBUTAMIDE AC C O R D TABLET 500MG

2,00 stuk

0,06249

0A10BBBO 0A10BBBO

V 55385 V 55891

TO LBUTAMIDE AC C O R D TABLET 1000MG To lbuta m ide rp ta blet 500m g

1,00 stuk 2,00 stuk

0,10414 0,06249

0A10BBBO

V 56249

To lbuta m ide pch ta blet 500m g

2,00 stuk

0,06249

0A10BBBO

V 56250

To lbuta m ide pch ta blet 1000m g

1,00 stuk

0,10414

0A10BBBO 0A10BBBO

V 56652 V 57267

To lbuta m ide rp ta blet 1000m g To lbuta m idum ta blet 500m g

1,00 stuk 2,00 stuk

0,10414 0,06249

0A10BBBO

V 57268

To lbuta m idum ta blet 1000m g

1,00 stuk

0,10414

0A10BFAO 0A10BFAO

V 12604 V 12605

Gluco ba y 50 ta ble t 50m g Gluco ba y 100 ta ble t 100m g

6,00 stuk 3,00 stuk

0,14825 0,24708

0A10BFAO

V 24522//12605

Gluco ba y 100 ta ble t 100m g

3,00 stuk

0,24708

0A10BGAO 0A10BGAO

V EU/1/00/150/004 Acto s ta blet 30m g V EU/1/00/150/006 Acto s ta blet 30m g

1,00 stuk 1,00 stuk

1,61756 1,61756

0A10BGAO

V EU/1/00/150/012 Acto s ta blet 45m g

0,67 stuk

2,42634

0A10BHAO 0A10BHAO

V EU/1/07/383/002 Ja nuvia table t film o m huld 25m g V EU/1/07/383/008 Ja nuvia table t film o m huld 50m g

4,00 stuk 2,00 stuk

1,28800 1,61000

0A10BHAO

V EU/1/07/383/014 Ja nuvia table t film o m huld 100m g

1,00 stuk

3,22000

0A10BHAO

V EU/1/07/414/003 Ga lvus ta blet 50m g

2,00 stuk

1,61000

0A10BHAO

V EU/1/07/414/005 Ga lvus ta blet 50m g

2,00 stuk

1,61000

0A11C C AO

V 10890

Alfacalcido l pch ca psule 0,25m cg

4,00 stuk

0,22078

0A11C C AO

V 10891

ALFAC ALC IDO L P C H C AP SULE 1MC G

1,00 stuk

0,55195

0A11C C AO 0A11C C AO

V 22263 V 7603

Etalpha le o ca psule 0,5m cg Etalpha le o ca psule 1m cg

2,00 stuk 1,00 stuk

0,27597 0,55195

0A11C C AO

V 8318

Etalpha le o ca psule 0,25m cg

4,00 stuk

0,22078

0A11C C AO

V 9284

Etalpha le o druppels 2m cg/m l

0,50 m l

1,10389

0A11C C AP

V 14698

Etalpha injvlst 2m cg/m l am pul 0,5m l

0,50 m l

9,77080

0A12AAAO

V 52036

C a lcium glucona a t pch k a uwta blet 500m g pe pe rm unt

22,22 stuk

0,01448

0A12AABO

V 10017

C a lcium sando z fo rtissim um bruista blet 1000m g

1,00 stuk

0,43684

0A12AABO

V 100773//14032

C a lci chew k a uwta ble t 500m g

2,00 stuk

0,26210

0A12AABO

V 103767//10017

C a lcium e ureco -ph fo rtissim um bruista blet 1000m g

1,00 stuk

0,43684

0A12AABO 0A12AABO

V 13134 V 13261

C a lcium sando z fo rte po e der 500m g sache t C a cit bruistable t 500m g

2,00 stuk 2,00 stuk

0,26210 0,26210

0A12AABO

V 14032

C a lci chew k a uwta ble t 500m g

2,00 stuk

0,26210

0A12AABO

V 16366

C a cit bruistable t 1000m g

1,00 stuk

0,43684

2 STUK

0,10414 0,10414 0,06249

0A12AABO 0A12AABO

V 19871//5002 V 22719

C a lcium sando z fo rte bruista blet 500m g C a lcium bruis 500 pch bruistable t 500m g

2,00 stuk 2,00 stuk

0,26210 0,26210

0A12AABO 0A12AABO

V 22720

C a lcium bruis 1000 pch bruista blet 1000m g

1,00 stuk

0,43684

V 23185//13261

C a cit bruistable t 500m g

2,00 stuk

0,26210

0A12AABO 0A12AABO

V 23468 V 24887//5002

C a lci chew k a uwta ble t 1000m g C a lcium sando z fo rte bruista blet 500m g

1,00 stuk 2,00 stuk

0,43684 0,26210

0A12AABO

V 26463//13261

C a cit bruistable t 500m g

2,00 stuk

0,26210

0A12AABO

V 26672//5002

C ALC IUM EUR EC O -P H FO R TE BR UISTABLET 500MG

2,00 stuk

0,26210

0A12AABO 0A12AABO

V 27646 V 27870//14032

C a lcium bruis sa ndoz bruistable t 500m g C a lci chew k a uwta ble t 500m g

2,00 stuk 2,00 stuk

0,26210 0,26210

0A12AABO

V 27882//14032

C a lci chew k a uwta ble t 500m g

2,00 stuk

0,26210

0A12AABO

V 27901//23468

C a lci chew k a uwta ble t 1000m g

1,00 stuk

0,43684

0A12AABO 0A12AABO

V 28347//23468 V 29464//14032

C a lci chew k a uwta ble t 1000m g C a lci chew k a uwta ble t 500m g

1,00 stuk 2,00 stuk

0,43684 0,26210

0A12AABO

V 29524//23468

C a lci chew k a uwta ble t 1000m g

1,00 stuk

0,43684

0A12AABO

V 32185//14032

C a lci chew k a uwta ble t 500m g

2,00 stuk

0,26210

0A12AABO 0A12AABO

V 33065//14032 V 5002

C a lci chew k a uwta ble t 500m g C a lcium sando z fo rte bruista blet 500m g

2,00 stuk 2,00 stuk

0,26210 0,26210

0A12AAC O

V 15863

P hose x 250 table t 1,1g

1,82 stuk

0,25071

0A12AAC O

V 33448

P hoslo ge lca psule 667m g

3,00 stuk

0,15202

0A12BAAO

V 6050

Slow k ta ble t m ga 600m g

5,00 stuk

0,03548

0B01AAAO 0B01AAAO

V 18669=4464 V 21068

AC ENO C O UMAR O L TEVA TABLET 1MG Fenpro co um o n sa ndo z table t 3m g

5,00 stuk 1,00 stuk

0,01688 0,08441

0B01AAAO

V 21245=50674

Ace nocoum a rol pch ta ble t 1m g

5,00 stuk

0,01688

0B01AAAO

V 21483=50674

Ace nocoum a rol a cta vis table t 1m g

5,00 stuk

0,01688

0B01AAAO 0B01AAAO

V 22045=4464 V 23189=21068

Ace nocoum a rol rp ta ble t 1m g FENP R O C O UMO N MYLAN TABLET 3MG

5,00 stuk 1,00 stuk

0,01688 0,08441

0B01AAAO

V 23964=21068

Fenpro co um o n rp ta blet 3m g

1,00 stuk

0B01AAAO

V 29037=4464

AC ENO C O UMAR O L MYLAN TABLET 1MG

0B01AAAO 0B01AAAO

V 3819 V 4464

Ma rco um ar ta blet 3m g Ace nocoum a rol sando z ta ble t 1m g

1,00 stuk 5,00 stuk

0,08441 0,01688

0B01AAAO

V 50674

Ace nocoum a rol cf ta blet 1m g

5,00 stuk

0,01688

0B01ABAP 0B01ABAP

V 100064//23794 V 100077//23795

Frax o di injvlst 19000 ie /m l wwsp 0,6m l Frax o di injvlst 19000 ie /m l wwsp 0,8m l

0,15 m l 0,15 m l

11,85880 11,85880

0B01ABAP

V 11876

Frax iparine injvlst 9500ie /m l wwsp 0,3m l

0,30 m l

5,92940

0B01ABAP

V 11877

Frax iparine injvlst 9500ie /m l wwsp 0,6m l

0,30 m l

5,92940

0B01ABAP 0B01ABAP

V 12786 V 12787

Fragm in 10000 injvlst 10.000ie/m l a m pul 1m l Fragm in 2500 injvlst 12.500ie /m l wwsp 0,2m l

0,25 m l 0,20 m l

7,11528 8,89410

0B01ABAP

V 12788

Fragm in 5000 injvlst 25.000ie /m l wwsp 0,2m l

0,10 m l

17,78820

0B01ABAP

V 13068

C le x a ne injvlst 100m g/m l

0,20 m l

8,89410

0B01ABAP 0B01ABAP

V 14781 V 14781

Inno he p injvlst 11700 ie /m l wwsp 0,3m l Inno he p injvlst 10000 ie /m l wwsp 0,35m l

0,30 m l 0,35 m l

5,94634 5,08234

0B01ABAP

V 14781

Inno he p injvlst 10000 ie /m l wwsp 0,35m l

0,35 m l

5,08234

0B01ABAP

V 14781

Inno he p injvlst 11700 ie /m l wwsp 0,3m l

0,30 m l

5,94634

0B01ABAP 0B01ABAP

V 14782 V 15963

Inno he p injvlst 10000 ie /m l flacon 2m l Frax iparine injvlst 9500ie /m l wwsp 0,4m l

0,35 m l 0,30 m l

5,08234 5,92940

0B01ABAP

V 15965

Frax iparine injvlst 9500ie /m l wwsp 0,8m l

0,30 m l

5,92940

0B01ABAP

V 20607

Fragm in 7500 injvlst 25.000ie /m l wwsp 0,3m l

0,10 m l

17,78820

5 STUK

0,08441 0,01688

0B01ABAP

V 20818

Inno he p injvlst 20000 ie /m l wwsp 0,7m l

0,18 m l

0B01ABAP

V 20819

Inno he p injvlst 20000 ie /m l wwsp 0,9m l

0,18 m l

10,16469 10,16469

0B01ABAP

V 21896

Fragm in 10000 injvlst 25.000ie/m l wwsp 0,4m l

0,10 m l

17,78820

0B01ABAP 0B01ABAP

V 21897 V 21898

Fragm in 12500 injvlst 25.000ie/m l wwsp 0,5m l Fragm in 15000 injvlst 25.000ie/m l wwsp 0,6m l

0,10 m l 0,10 m l

17,78820 17,78820

0B01ABAP

V 21899

Fragm in 18000 injvlst 25.000ie/m l wwsp 0,72m l

0,10 m l

17,78820

0B01ABAP

V 22478

Inno he p injvlst 10000 ie /m l wwsp 0,45m l

0,35 m l

5,08234

0B01ABAP 0B01ABAP

V 23794 V 23795

Frax o di injvlst 19000 ie /m l wwsp 0,6m l Frax o di injvlst 19000 ie /m l wwsp 0,8m l

0,15 m l 0,15 m l

11,85880 11,85880

0B01ABAP

V 24584

C le x a ne injvlst 150m g/m l

0,13 m l

13,34115

0B01ABAP

V 34597//23794

Frax o di injvlst 19000 ie /m l wwsp 0,6m l

0,15 m l

11,85880

0B01ABAP

V 34598//23795

Frax o di injvlst 19000 ie /m l wwsp 0,8m l

0,15 m l

11,85880

0B01AC AO

V 102607

Ace tylsalicylzuur cardio actavis disp ta ble t 80m g

1,00 stuk

0,05249

0B01AC AO 0B01AC AO

V 16466 V 16831

Ace tylsalicylzuur cardio pch disp ta ble t 80m g Ascal ca rdio sa chet 100m g

1,00 stuk 1,00 stuk

0,05249 0,05249

0B01AC AO

V 20952

Aspirine pro tect ec table t m sr 100m g

1,00 stuk

0,05249

0B01AC AO

V 22214=16831

C a rbasa la a tca lcium ca rdio pch sache t 100m g

1,00 stuk

0,05249

0B01AC AO 0B01AC AO

V 22277=16831 V 22290=16831

C a rbasa la a tca lcium ca rdio sa ndo z sa chet 100m g C a rbasa la a tca lcium ca rdio rp sache t 100m g

1,00 stuk 1,00 stuk

0,05249 0,05249

0B01AC AO

V 22311=16831

C AR BASALAATC ALC IUM C F SAC HET 100MG

1,00 stuk

0,05249

0B01AC AO

V 22349=16831

C AR BASALAATC ALC IUM C AR DIO MYLAN SAC HET 100MG

1,00 stuk

0,05249

0B01AC AO 0B01AC AO

V 22716 V 23470

C a rbasa la a tca lcium ca rdio sa chet 100m g Ascal ca rdio brispe r bruistable t 100m g

1,00 stuk 1,00 stuk

0,05249 0,05249

0B01AC AO

V 26194

Ace tylsalicylzuur cardio disp ta blet 80m g

1,00 stuk

0,05249

0B01AC AO

V 26196

Ace tylsalicylzuur cardio rp disp ta ble t 80m g

1,00 stuk

0,05249

0B01AC AO 0B01AC AO

V 26865 V 27600=26194

Ace tylsalicylzuur cardio apo te x ta blet 80m g Ace tylsalicylzuur cardio sa ndo z disp ta blet 80m g

1,00 stuk 1,00 stuk

0,05249 0,05249

0B01AC AO

V 27602=26194

AC ETYLSALIC YLZUUR C AR DIO MYLAN DISP TABLET 80MG

1,00 stuk

0,05249

0B01AC AO

V 27704=26194

Ace tylsalicylzuur cardio cf disp table t 80m g

1,00 stuk

0,05249

0B01AC AO 0B01AC AO

V 27984=22716 V 28256

C AR BASALAATC ALC IUM C AR DIO AP O TEX SAC HET 100MG Ascal brispe r ca rdio -ne uro bruista ble t 100m g

1,00 stuk 1,00 stuk

0,05249 0,05249

0B01AC AO

V 28499=26865

Ace tylsalicylzuur m yla n ta ble t 80m g

1,00 stuk

0,05249

0B01AC AO

V 30828//20952

Aspirine e c ta ble t m sr 100m g

1,00 stuk

0,05249

0B01AC AP

V 14469

FLO LAN INFUSIEP O EDER FLAC O N 0,5MG + SO LV 100ML

8,60 stuk

145,83590

0B01AC AP

V 23523

FLO LAN INFUSIEP O EDER FLAC O N 0,5MG

8,60 stuk

145,83590

0B01AC AP

V 23524

FLO LAN INFUSIEP O EDER FLAC O N 1,5MG

2,87 stuk

437,50770

0B01AC AP 0B01AC AP

V 23525 V 32550

FLO LAN INFUSIEP O EDER FLAC O N 1,5MG + SO LV 100ML R e m odulin infvlst 1m g/m l fla co n 20m l

2,87 stuk 4,30 m l

437,50770 291,67180

0B01AC AP

V 32551

R e m odulin infvlst 2,5m g/m l fla co n 20m l

1,72 m l

729,17950

0B01AC AP

V 32552

R e m odulin infvlst 5m g/m l fla co n 20m l

0,86 m l

1.458,35900

0B01AC AP

V 32553

R e m odulin infvlst 10m g/m l fla co n 20m l

0,43 m l

2.916,71800

0B01AC BO

V 15199

Ascal sache t 38m g

1,00 stuk

0,06353

0B01AC BO

V 18116

Ace tylsalicylzuur ne uro pch disp ta ble t 30m g

1,00 stuk

0,06353

0B01AC BO 0B01AC BO

V 21021 V 21701

Ascal bruista ble t 38m g C a rbasa la a tca lcium po ede r in sa chet 38m g

1,00 stuk 1,00 stuk

0,06353 0,06353

0B01AC BO

V 21994

Ascal brispe r bruista blet 38m g

1,00 stuk

0,06353

0B01AC BO

V 26195

Ace tylsalicylzuur ne uro disp ta ble t 30m g

1,00 stuk

0,06353

0B01AC BO

V 26197

Ace tylsalicylzuur ne uro rp disp ta ble t 30m g

1,00 stuk

0,06353

0B01AC BO

V 27599=26195

Ace tylsalicylzuur ne uro sa ndo z disp ta ble t 30m g

1,00 stuk

0,06353

0B01AC BO

V 27601=26195

AC ETYLSALIC YLZUUR NEUR O MYLAN DISP TABLET 30MG

1,00 stuk

0,06353

0B01AC BO

V 27703=26195

Ace tylsalicylzuur ne uro cf disp ta blet 30m g

1,00 stuk

0,06353

0B01AC BO 0B01AC BO

V 27983=21701 V 28359

C a rbasa la a tca lcium ne uro k a twijk sa che t 38m g AC ETYLSALIC YLZUUR NEUR O AP O TEX TABLET 30MG

1,00 stuk 1,00 STUK

0,06353 0,06353

0B01AC C O

V 10186

P e rsa ntin re ta rd capsule m ga 150m g

0B01AC C O 0B01AC C O

V 13690=9538 V 13691=9539

Dipyridam o l sa ndo z dra ge e 25m g Dipyridam o l sa ndo z dra ge e 75m g

0B01AC C O

V 14870

P e rsa ntin re ta rd capsule m ga 200m g

0B01AC C O

V 15542=9538

Dipyridam o l dum e x dra gee 25m g

0B01AC C O 0B01AC C O

V 15543=9539 V 17517=9539

Dipyridam o l actavis dra ge e 75m g DIP YR IDAMO L APO TEX TABLET O MHULD 75MG

5,33 stuk 5,33 STUK

0,08528 0,08528

0B01AC C O

V 24524//10186

P e rsa ntine re tard ca psule m ga 150m g

2,67 stuk

0,17057

0B01AC C O

V 57393=9539

Dipyridam o l cf drage e 75m g

5,33 stuk

0,08528

0B01AC C O 0B01AC C O

V 9538 V 9539

Dipyridam o l pch dra gee 25m g Dipyridam o l pch dra gee 75m g

16,00 stuk 5,33 stuk

0,03980 0,08528

0B01AC DO

V EU/1/98/069/001 P lavix ta blet film om huld 75m g

1,00 stuk

1,88043

0B01AC DO 0B01AC DO

V EU/1/98/069/004 P lavix ta blet film om huld 75m g V EU/1/98/069/005 P lavix ta blet film om huld 75m g

1,00 stuk 1,00 stuk

1,88043 1,88043

0B01AC DO

V EU/1/98/069/009 P lavix ta blet film om huld 300m g

0,25 stuk

7,52173

0B01AC DO

V EU/1/98/070/001 Isco ve r ta ble t film o m huld 75m g

1,00 stuk

1,88043

0B01ADAP

V 8044

Stre pta se injectie po ede r

1,50 m e -e

152,43387

0B01ADAP

V 8044

Stre pta se infusie po e der

1,50 m e -e

152,43387

0B01ADAP

V 8044

Stre pta se infusie po e der

1,50 m e -e

152,43387

0B01ADAP

V 8044

Stre pta se injectie po ede r

1,50 m e -e

152,43387

0B03AAAO

K 51411

Ferro fum ara a t pch suspe nsie 20m g/m l

0B03AAAO 0B03AAAO

V 14546 V 16406//5752

Losfe rron bruista ble t 695m g Ferro gra d ta blet m ga 105m g fe

2,45 stuk 1,90 stuk

0,06406 0,08266

0B03AAAO

V 24135=50719

Ferro fum ara a t sa ndoz ta ble t 200m g

3,00 stuk

0,05223

0B03AAAO

V 28892=52216

Ferro fum ara a t a cta vis ta blet 200m g

3,00 stuk

0,05223

0B03AAAO 0B03AAAO

V 28895=52216 V 33291

Ferro fum ara a t m yla n ta blet 200m g Ferro fum ara a t pch table t om huld 100m g

3,00 stuk 6,00 stuk

0,05223 0,03134

0B03AAAO

V 50165

Ferro fum ara a t pch table t 200m g

3,00 stuk

0,05223

0B03AAAO

V 50719

Ferro fum ara a t cf ta ble t 200m g

3,00 stuk

0,05223

0B03AAAO 0B03AAAO

V 52216 V 5752

FER R O FUMAR AAT AP O TEX TABLET 200MG Fero gra dum e t table t m ga 105m g fe

3,00 stuk 1,90 stuk

0,05223 0,08266

0B03BAAP

V 2471

Hydro co ba m ine injvlst 500m cg/m l a m pul 2m l

0,04 m l

0,32808

0B03BAAP

V 50830

Hydro x o co ba la m ine hcl cf injvlst 500m cg/m l a m p 2m l

0,04 m l

0,32808

0B03BABP

V 50822

C yano co bala m ine cf injvlst 1000m cg/m l am pul 1m l

0,02 m l

0,97200

0B03XAAP 0B03XAAP

V 18479 V 18480

Epre x 1000 injvlst 2000ie/m l wwsp 0,5m l Epre x 2000 injvlst 4000ie/m l wwsp 0,5m l

1,00 m l 0,50 m l

24,57202 49,14403

0B03XAAP

V 18481

Epre x 3000 injvlst 10000ie /m l wwsp 0,3m l

0,20 m l

122,86008

0B03XAAP

V 18482

Epre x 4000 injvlst 10000ie /m l wwsp 0,4m l

0,20 m l

122,86008

0B03XAAP

V 18483

Epre x 10000 injvlst 10000ie /m l wwsp 1,0m l

0,20 m l

122,86008

2,67 stuk

0,17057

16,00 stuk 5,33 stuk

0,03980 0,08528

2,00 stuk

0,22742

16,00 stuk

0,03980

30,00 m l

0,01554

0B03XAAP

V 25884

Epre x 8000 injvlst 10000ie /m l wwsp 0,8m l

0,20 m l

0B03XAAP

V 33268

Epre x 40000 injvlst 40000ie /m l wwsp 1m l

0,05 m l

122,86008 491,44032

0B03XAAP 0B03XAAP

V 33780 V 35142

Epre x 20000 injvlst 40000ie /m l wwsp 0,5m l Epre x 30000 injvlst 40000ie /m l wwsp 0,75m l

0,05 m l 0,05 m l

491,44032 491,44032

0B03XAAP

V EU/1/01/185/001 Ara ne sp 10 injvlst 25m cg/m l wwsp 0,4m l

0,40 m l

61,43004

0B03XAAP

V EU/1/01/185/002 Ara ne sp 10 injvlst 25m cg/m l wwsp 0,4m l

0,40 m l

61,43004

0B03XAAP 0B03XAAP

V EU/1/01/185/004 Ara ne sp 15 injvlst 40m cg/m l wwsp 0,375m l V EU/1/01/185/005 Ara ne sp 20 injvlst 40m cg/m l wwsp 0,5m l

0,25 m l 0,25 m l

98,28806 98,28806

0B03XAAP

V EU/1/01/185/006 Ara ne sp 20 injvlst 40m cg/m l wwsp 0,5m l

0,25 m l

98,28806

0B03XAAP

V EU/1/01/185/007 Ara ne sp 30 injvlst 100m cg/m l wwsp 0,3m l

0,10 m l

245,72016

0B03XAAP 0B03XAAP

V EU/1/01/185/008 Ara ne sp 30 injvlst 100m cg/m l wwsp 0,3m l V EU/1/01/185/009 Ara ne sp 40 injvlst 100m cg/m l wwsp 0,4m l

0,10 m l 0,10 m l

245,72016 245,72016

0B03XAAP

V EU/1/01/185/010 Ara ne sp 40 injvlst 100m cg/m l wwsp 0,4m l

0,10 m l

245,72016

0B03XAAP

V EU/1/01/185/011 Ara ne sp 50 injvlst 100m cg/m l wwsp 0,5m l

0,10 m l

245,72016

0B03XAAP 0B03XAAP

V EU/1/01/185/012 Ara ne sp 50 injvlst 100m cg/m l wwsp 0,5m l V EU/1/01/185/013 Ara ne sp 60 injvlst 200m cg/m l wwsp 0,3m l

0,10 m l 0,05 m l

245,72016 491,44032

0B03XAAP

V EU/1/01/185/014 Ara ne sp 60 injvlst 200m cg/m l wwsp 0,3m l

0,05 m l

491,44032

0B03XAAP

V EU/1/01/185/015 Ara ne sp 80 injvlst 200m cg/m l wwsp 0,4m l

0,05 m l

491,44032

0B03XAAP 0B03XAAP

V EU/1/01/185/016 Ara ne sp 80 injvlst 200m cg/m l wwsp 0,4m l V EU/1/01/185/017 Ara ne sp 100 injvlst 200m cg/m l wwsp 0,5m l

0,05 m l 0,05 m l

491,44032 491,44032

0B03XAAP

V EU/1/01/185/018 Ara ne sp 100 injvlst 200m cg/m l wwsp 0,5m l

0,05 m l

491,44032

0B03XAAP

V EU/1/01/185/019 Ara ne sp 150 injvlst 500m cg/m l wwsp 0,3m l

0,02 m l

1.228,60080

0B03XAAP 0B03XAAP

V EU/1/01/185/020 Ara ne sp 150 injvlst 500m cg/m l wwsp 0,3m l V EU/1/01/185/021 Ara ne sp 300 injvlst 500m cg/m l wwsp 0,6m l

0,02 m l 0,02 m l

1.228,60080 1.228,60080

0B03XAAP

V EU/1/01/185/031 Ara ne sp 500 injvlst 500m cg/m l wwsp 1m l

0,02 m l

1.228,60080

0B03XAAP

V EU/1/01/185/047 Ara ne sp sureclick 20 injvlst 40m cg/m l wwsp 0,5m l

0,25 m l

98,28806

0B03XAAP 0B03XAAP

V EU/1/01/185/049 Ara ne sp sureclick 40 injvlst 100m cg/m l wwsp 0,4m l V EU/1/01/185/051 Ara ne sp sureclick 60 injvlst 200m cg/m l wwsp 0,3m l

0,10 m l 0,05 m l

245,72016 491,44032

0B03XAAP

V EU/1/01/185/052 Ara ne sp sureclick 80 injvlst 200m cg/m l wwsp 0,4m l

0,05 m l

491,44032

0B03XAAP

V EU/1/01/185/053 Ara ne sp sureclick 100 injvlst 200m cg/m l wwsp 0,5m l

0,05 m l

491,44032

0B03XAAP 0B03XAAP

V EU/1/01/185/054 Ara ne sp sureclick 150 injvlst 500m cg/m l wwsp 0,3m l V EU/1/01/185/055 Ara ne sp sureclick 300 injvlst 500m cg/m l wwsp 0,6m l

0,02 m l 0,02 m l

1.228,60080 1.228,60080

0B03XAAP

V EU/1/01/185/056 Ara ne sp sureclick 500 injvlst 500m cg/m l wwsp 1m l

0,02 m l

1.228,60080

0B03XAAP

V EU/1/01/185/070 Ara ne sp 130 injvlst 200m cg/m l wwsp 0,65m l

0,05 m l

491,44032

0B03XAAP 0B03XAAP

V EU/1/01/185/072 Ara ne sp sureclick 130 injvlst 200m cg/m l wws 0,65m l V EU/1/07/400/008 Mirce ra 50 injvlst 167m cg/m l wwsp 0,3m l

0,05 m l 0,02 m l

491,44032 1.025,88167

0B03XAAP

V EU/1/07/400/009 Mirce ra 75 injvlst 250m cg/m l wwsp 0,3m l

0,02 m l

1.535,75100

0B03XAAP

V EU/1/07/400/010 Mirce ra 100 injvlst 333m cg/m l wwsp 0,3m l

0,01 m l

2.045,62033

0B03XAAP 0B03XAAP

V EU/1/07/400/011 Mirce ra 150 injvlst 500m cg/m l wwsp 0,3m l V EU/1/07/400/012 Mirce ra 200 injvlst 667m cg/m l wwsp 0,3m l

0,01 m l 0,01 m l

3.071,50200 4.097,38367

0B03XAAP

V EU/1/07/400/013 Mirce ra 250 injvlst 833m cg/m l wwsp 0,3m l

0,00 m l

5.117,12233

0B03XAAP

V EU/1/07/400/017 Mirce ra 30 injvlst 100m cg/m l wwsp 0,3m l

0,04 m l

614,30040

0B03XAAP 0B03XAAP

V EU/1/07/400/020 Mirce ra 120 injvlst 400m cg/m l wwsp 0,3m l V EU/1/07/400/021 Mirce ra 360 injvlst 600m cg/m l wwsp 0,6m l

0,01 m l 0,01 m l

2.457,20160 3.685,80240

0B03XAAP

V EU/1/07/410/002 Bino crit 1000 injvlst 2000ie /m l wwsp 0,5m l

1,00 m l

24,57202

0B03XAAP

V EU/1/07/410/004 Bino crit 2000 injvlst 2000ie /m l wwsp 1m l

1,00 m l

24,57202

0B03XAAP 0B03XAAP

V EU/1/07/410/006 Bino crit 3000 injvlst 10000ie/m l wwsp 0,3m l V EU/1/07/410/008 Bino crit 4000 injvlst 10000ie/m l wwsp 0,4m l

0,20 m l 0,20 m l

122,86008 122,86008

0B03XAAP

V EU/1/07/410/010 Bino crit 5000 injvlst 10000ie/m l wwsp 0,5m l

0,20 m l

122,86008

0B03XAAP

V EU/1/07/410/012 Bino crit 6000 injvlst 10000ie/m l wwsp 0,6m l

0,20 m l

122,86008

0B03XAAP 0B03XAAP

V EU/1/07/410/014 Bino crit 8000 injvlst 10000ie/m l wwsp 0,8m l V EU/1/07/410/016 Bino crit 10000 injvlst 10000ie /m l wwsp 1m l

0,20 m l 0,20 m l

122,86008 122,86008

0B03XAAP

V EU/1/07/412/002 Abse a m e d 1000 injvlst 2000ie/m l wwsp 0,5m l

1,00 m l

24,57202

0B03XAAP

V EU/1/07/412/004 Abse a m e d 2000 injvlst 2000ie/m l wwsp 1m l

1,00 m l

24,57202

0B03XAAP 0B03XAAP

V EU/1/07/412/006 Abse a m e d 3000 injvlst 10000ie /m l wwsp 0,3m l V EU/1/07/412/008 Abse a m e d 4000 injvlst 10000ie /m l wwsp 0,4m l

0,20 m l 0,20 m l

122,86008 122,86008

0B03XAAP

V EU/1/07/412/010 Abse a m e d 5000 injvlst 10000ie /m l wwsp 0,5m l

0,20 m l

122,86008

0B03XAAP

V EU/1/07/412/012 Abse a m e d 6000 injvlst 10000ie /m l wwsp 0,6m l

0,20 m l

122,86008

0B03XAAP 0B03XAAP

V EU/1/07/412/014 Abse a m e d 8000 injvlst 10000ie /m l wwsp 0,8m l V EU/1/07/412/016 Abse a m e d 10000 injvlst 10000ie /m l wwsp 1m l

0,20 m l 0,20 m l

122,86008 122,86008

0B03XAAP

V EU/1/07/431/002 R e ta crit 1000 injvlst 3333ie /m l wwsp 0,3m l

0,60 m l

40,95332

0B03XAAP

V EU/1/07/431/004 R e ta crit 2000 injvlst 3333ie /m l wwsp 0,6m l

0,60 m l

40,95332

0B03XAAP 0B03XAAP

V EU/1/07/431/006 R e ta crit 3000 injvlst 3333ie /m l wwsp 0,9m l V EU/1/07/431/008 R e ta crit 4000 injvlst 10000ie /m l wwsp 0,4m l

0,60 m l 0,20 m l

40,95332 122,86008

0B03XAAP

V EU/1/07/431/010 R e ta crit 5000 injvlst 10000ie /m l wwsp 0,5m l

0,20 m l

122,86008

0B03XAAP

V EU/1/07/431/012 R e ta crit 6000 injvlst 10000ie /m l wwsp 0,6m l

0,20 m l

122,86008

0B03XAAP 0B03XAAP

V EU/1/07/431/014 R e ta crit 8000 injvlst 10000ie /m l wwsp 0,8m l V EU/1/07/431/016 R e ta crit 10000 injvlst 10000ie /m l wwsp 1m l

0,20 m l 0,20 m l

122,86008 122,86008

0B03XAAP

V EU/1/07/431/017 R e ta crit 20000 injvlst 40000ie /m l wwsp 0,5m l

0,05 m l

491,44032

0B03XAAP

V EU/1/07/431/018 R e ta crit 30000 injvlst 40000ie /m l wwsp 0,75m l

0,05 m l

491,44032

0B03XAAP 0B03XAAP

V EU/1/07/431/019 R e ta crit 40000 injvlst 40000ie /m l wwsp 1m l V EU/1/97/031/019 Ne ore co rm o n m ultido se injpdr fl 50000ie +so lv 10m l

0,05 m l 0,40 m l

491,44032 61,43004

0B03XAAP

V EU/1/97/031/020 Ne ore co rm o n m ultido se injpdr fl100000ie +so lv 5m l

0,10 m l

245,72016

0B03XAAP

V EU/1/97/031/022 Ne ore co rm o n injpdr pa troo n 10000ie + solv 1m l

0,20 m l

122,86008

0B03XAAP 0B03XAAP

V EU/1/97/031/024 Ne ore co rm o n injpdr pa troo n 20000ie + solv 1m l V EU/1/97/031/026 Ne ore co rm o n 500 injvlst 1667ie /m l wwsp 0,3m l

0,10 m l 1,20 m l

245,72016 20,48078

0B03XAAP

V EU/1/97/031/028 Ne ore co rm o n 1000 injvlst 3333ie /m l wwsp 0,3m l

0,60 m l

40,95332

0B03XAAP

V EU/1/97/031/029 Ne ore co rm o n 2000 injvlst 6667ie /m l wwsp 0,3m l

0,30 m l

81,90676

0B03XAAP 0B03XAAP

V EU/1/97/031/030 Ne ore co rm o n 2000 injvlst 6667ie /m l wwsp 0,3m l V EU/1/97/031/032 Ne ore co rm o n 3000 injvlst 10000ie /m l wwsp 0,3m l

0,30 m l 0,20 m l

81,90676 122,86008

0B03XAAP

V EU/1/97/031/034 Ne ore co rm o n 5000 injvlst 16667ie /m l wwsp 0,3m l

0,12 m l

204,76684

0B03XAAP

V EU/1/97/031/035 Ne ore co rm o n 10000 injvlst 16667ie/m l wwsp 0,6m l

0,12 m l

204,76684

0B03XAAP 0B03XAAP

V EU/1/97/031/036 Ne ore co rm o n 10000 injvlst 16667ie/m l wwsp 0,6m l V EU/1/97/031/037 Ne ore co rm o n 20000 injvlst 33333ie/m l wwsp 0,6m l

0,12 m l 0,06 m l

204,76684 409,52950

0B03XAAP

V EU/1/97/031/038 Ne ore co rm o n 20000 injvlst 33333ie/m l wwsp 0,6m l

0,06 m l

409,52950

0B03XAAP

V EU/1/97/031/039 Ne ore co rm o n injpdr pa troo n 60000ie + solv 1m l

0,03 m l

737,16048

0B03XAAP 0B03XAAP

V EU/1/97/031/041 Ne ore co rm o n 4000 injvlst 13333ie /m l wwsp 0,3m l V EU/1/97/031/042 Ne ore co rm o n 4000 injvlst 13333ie /m l wwsp 0,3m l

0,15 m l 0,15 m l

163,81340 163,81340

0B03XAAP

V EU/1/97/031/043 Ne ore co rm o n 6000 injvlst 20000ie /m l wwsp 0,3m l

0,10 m l

245,72016

0B03XAAP

V EU/1/97/031/044 Ne ore co rm o n 6000 injvlst 20000ie /m l wwsp 0,3m l

0,10 m l

245,72016

0B03XAAP 0B03XAAP

V EU/1/97/031/045 Ne ore co rm o n 30000 injvlst 50000ie/m l wwsp 0,6m l V EU/1/97/031/046 Ne ore co rm o n 30000 injvlst 50000ie/m l wwsp 0,6m l

0,04 m l 0,04 m l

614,30040 614,30040

0C 01AAAO

G 8963

Lano x in ta ble t 0,125m g

2,00 stuk

0,03020

0C 01AAAO

K 7548

Lano x in pg table t 0,0625m g

4,00 stuk

0,02420

0C 01AAAO

V 1363

Lano x in ta ble t 0,25m g

1,00 stuk

0,01709

0C 01BABO

V 50909

Kinidine sulfa a t pch dra gee 200m g

6,00 stuk

0,14140

0C 01BAC O

V 10244

Diso pyra m ide pch ca psule 100m g

4,00 stuk

0,12207

0C 01BAC O

V 8613

R itm ofo rine re ta rd table t m ga 250m g

1,60 stuk

0,30517

0C 01BC AO

V 12449

R ytm o no rm ta blet o m huld 300m g

2,00 stuk

0,41131

0C 01BC AO 0C 01BC AO

V 24487=12448 V 24489=12449

P ro pa fe non hcl pch table t om huld 150m g P ro pa fe non hcl pch table t om huld 300m g

4,00 stuk 2,00 stuk

0,20565 0,41131

0C 01BC BO

V 10098

Ta m bo co r ta ble t 100m g

2,00 stuk

0,51852

0C 01BC BO 0C 01BC BO

V 15854 V 25927

Ta m bo co r ta ble t 50m g Fle ca inide a ce taa t a cta vis table t 50m g

4,00 stuk 4,00 stuk

0,31111 0,31111

0C 01BC BO

V 25928

Fle ca inide a ce taa t a cta vis table t 100m g

2,00 stuk

0,51852

0C 01BC BO

V 26666=15854

Fle ca inide a ce taa t a ta ble t 50m g

4,00 stuk

0,31111

0C 01BC BO 0C 01BC BO

V 26667=10098 V 26849

Fle ca inide a ce taa t a ta ble t 100m g Fle ca inide a ce taa t sando z ta ble t 50m g

2,00 stuk 4,00 stuk

0,51852 0,31111

0C 01BC BO

V 26850

Fle ca inide a ce taa t sando z ta ble t 100m g

2,00 stuk

0,51852

0C 01BC BO

V 26963

Fle ca inide a ce taa t pch ta ble t 50m g

4,00 stuk

0,31111

0C 01BC BO 0C 01BC BO

V 26964 V 27131

Fle ca inide a ce taa t pch ta ble t 100m g Ta m bo co r cr ca psule m ga 50m g

2,00 stuk 4,00 stuk

0,51852 0,31111

0C 01BC BO

V 27132

Ta m bo co r cr ca psule m ga 100m g

2,00 stuk

0,51852

0C 01BC BO

V 27133

Ta m bo co r cr ca psule m ga 150m g

1,33 stuk

0,77778

0C 01BC BO 0C 01BC BO

V 27134 V 27199

Ta m bo co r cr ca psule m ga 200m g Fle ca inide a ce taa t m yla n table t 50m g

1,00 stuk 4,00 stuk

1,03704 0,31111

0C 01BC BO

V 27200

FLEC AINIDEAC ETAAT MYLAN TABLET 100MG

0C 01BC BO

V 29671

FLEC AINIDEAC ETAAT AP O TEX TABLET 50MG

4,00 stuk

0,31111

0C 01BC BO 0C 01BC BO

V 29672 V 30058

FLEC AINIDEAC ETAAT AP O TEX TABLET 100MG Fle ca inide a ce taa t rp ta ble t 100m g

2,00 stuk 2,00 stuk

0,51852 0,51852

0C 01BC BO

V 31783

Fle ca inide a ce taa t cf ta blet 50m g

4,00 stuk

0,31111

0C 01BC BO

V 31784

Fle ca inide a ce taa t cf ta blet 100m g

2,00 stuk

0,51852

0C 01BC BO 0C 01BC BO

V 34515 V 34516

Fle ca inide a ce taa t rp ta ble t 50m g Fle ca inide a ce taa t rp ta ble t 100m g

4,00 stuk 2,00 stuk

0,31111 0,51852

0C 01BDAO

V 21966

Am io da ron hcl sa ndoz ta ble t 200m g

1,00 stuk

0,26210

0C 01BDAO 0C 01BDAO

V 23940=57505 V 24082=57505

AMIO DAR O N HC L APO TEX TABLET 200MG Am io da ron hcl cf ta ble t 200m g

1,00 stuk 1,00 stuk

0,26210 0,26210

0C 01BDAO

V 24101=57505

Am io da ron hcl m yla n ta blet 200m g

1,00 stuk

0,26210

0C 01BDAO

V 25530=5443

Am io da ron hcl pch table t 200m g

1,00 stuk

0,26210

0C 01BDAO 0C 01BDAO

V 27609=57505 V 5443

Am io da ron hcl a cta vis ta blet 200m g C o rdaro ne table t 200m g

1,00 stuk 1,00 stuk

0,26210 0,26210

0C 01BDAO

V 55349=5443

Am io da ron ta ble t 200m g

1,00 stuk

0,26210

0C 01BDAO

V 57505

AMIO DAR O N HC L TEVA TABLET 200MG

1,00 stuk

0,26210

0C 01C AAP

K 31436

ANAP EN 150 JUNIO R INJVLST 0,5MG/ML W W SP 0,3ML

1,00 m l

148,23500

0C 01C AAP

K 32726

Epipe n junio r injvlst 0,5m g/m l wwsp 0,3m l

1,00 m l

148,23500

0C 01C AAP 0C 01C AAP

V 31435 V 32727

ANAP EN 300 INJVLST 1MG/ML W W SP 0,3ML Epipe n injvlst 1m g/m l wwsp 0,3m l

1,00 m l 1,00 m l

148,23500 148,23500

0C 01DABO

V 17730

Nitrolingua l oro m uco sa le spray 0,4m g/do fla c 250do

2,00 do

0,02367

0C 01DABO 0C 01DABO

V 21493 V 24723

Glytrin o rom uco sa a l spra y 0,4m g/do flac 200do Nitroglycerine sdz o ro m uc spra y 0,4m g/do flacon

2,00 do 2,00 do

0,02367 0,02367

0C 01DABO

V 24948=53026

Iso so rbide dinitra at pch ta bl 5m g

1,00 stuk

0,04734

0C 01DABO

V 53026

Iso so rbide dinitra at cf table t 5m g

1,00 stuk

0,04734

0C 01DABO

V 8807

Iso rdil ta ble t 5m g

1,00 stuk

0,04734

0C 02ABAO

V 10647

Me thyldo pa (l) pch ta ble t 125m g

8,00 stuk

0,06730

2 STUK

0,51852

0C 02ABAO

V 10648

Me thyldo pa (l) pch ta ble t 250m g

4,00 stuk

0,08413

0C 02ABAO 0C 02ABAO

V 10649 V 16576=10647

Me thyldo pa (l) pch ta ble t 500m g Me thyldo pa m p table t 125m g

2,00 stuk 8,00 stuk

0,16826 0,06730

0C 02ABAO

V 16577=10648

Me thyldo pa sando z ta ble t 250m g

4,00 stuk

0,08413

0C 02ABAO

V 16578=10649

Me thyldo pa m p table t 500m g

2,00 stuk

0,16826

0C 02ABAO 0C 02ABAO

V 57522 V 57523

Me thyldo pa cf ta blet 250m g Me thyldo pa cf ta blet 500m g

4,00 stuk 2,00 stuk

0,08413 0,16826

0C 02AC AO

V 16337=56919

C lo nidine hcl sa ndoz ta ble t 0,150m g

3,00 stuk

0,09876

0C 02AC AO 0C 02AC AO

V 19846=56919 V 28802=56919

C LO NIDINE HC L TEVA TABLET 0,150MG C lo nidine hcl a cta vis ta blet 0,150m g

3,00 stuk 3,00 stuk

0,09876 0,09876

0C 02AC AO

V 29258

Mo x o nidine cf ta blet 0,2m g

1,50 stuk

0,19752

0C 02AC AO

V 29259

Mo x o nidine cf ta blet 0,3m g

1,00 stuk

0,29628

0C 02AC AO 0C 02AC AO

V 29260 V 29264

Mo x o nidine cf ta blet 0,4m g Mo x o nidine sando z ta ble t 0,2m g

0,75 stuk 1,50 stuk

0,39504 0,19752

0C 02AC AO

V 29265

Mo x o nidine sando z ta ble t 0,3m g

1,00 stuk

0,29628

0C 02AC AO

V 29266

Mo x o nidine sando z ta ble t 0,4m g

0,75 stuk

0,39504

0C 02AC AO 0C 02AC AO

V 29270 V 29271

Mo x o nidine pch ta ble t 0,2m g Mo x o nidine pch ta ble t 0,3m g

1,50 stuk 1,00 stuk

0,19752 0,29628

0C 02AC AO

V 29272

Mo x o nidine pch ta ble t 0,4m g

0,75 stuk

0,39504

0C 02AC AO

V 56919

C lo nidine hcl cf ta ble t 0,150m g

3,00 stuk

0,09876

0C 02C AAO

V 13207

Ebra ntil m itis ca psule m ga 30m g

4,00 stuk

0,29513

0C 02C AAO

V 13208

Ebra ntil 60 ca psule m ga 60m g

2,00 stuk

0,42161

0C 02C AAO

V 13209

Ebra ntil fo rte ca psule m ga 90m g

1,33 stuk

0,63242

0C 02C AAO 0C 02C AAO

V 14559 V 14560

Hytrin ta ble t 2m g Hytrin ta ble t 5m g

2,50 stuk 1,00 stuk

0,33729 0,84322

0C 02C AAO

V 14561

Hytrin ta ble t 10m g

0,50 stuk

1,68644

0C 02C AAO

V 16646

Hytrin startve rpa k k ing (3ta bl 1m g+11ta bl 2m g)

0,18 verp

4,62085

0C 02C AAO 0C 02C AAO

V 22558 V 22559

Do x azo sine pch ta ble t 1m g Do x azo sine pch ta ble t 2m g

4,00 stuk 2,00 stuk

0,33729 0,42161

0C 02C AAO

V 22560

Do x azo sine pch ta ble t 4m g

1,00 stuk

0,84322

0C 02C AAO

V 22688

C a rdura x l table t m ga 4m g

1,00 stuk

0,84322

0C 02C AAO 0C 02C AAO

V 22689 V 26357

C a rdura x l table t m ga 8m g Te razo sine pch ta ble t 2m g

0,50 stuk 2,50 stuk

1,68644 0,33729

0C 02C AAO

V 26358

Te razo sine pch ta ble t 5m g

1,00 stuk

0,84322

0C 02C AAO

V 31396

Te razo sine sa ndo z ta blet 2m g

2,50 stuk

0,33729

0C 02C AAO 0C 02C AAO

V 31397 V 33102

Te razo sine sa ndo z ta blet 5m g Do x azo sine cf reta rd ta ble t m va 4m g

1,00 stuk 1,00 stuk

0,84322 0,84322

0C 02C AAO

V 33210

Do x azo sine m yla n re tard ta ble t m va 4m g

1,00 stuk

0,84322

0C 02C AAO

V 33594

Do x azo sine sa ndo z re ta rd table t m va 4m g

1,00 stuk

0,84322

0C 02DBAO

V 50724

Hydra la zine hcl cf ta blet 10m g

7,50 stuk

0,02501

0C 02DBAO

V 50725

Hydra la zine hcl cf dra gee 50m g

1,50 stuk

0,09620

0C 02KXAO 0C 02KXAO

V EU/1/02/220/002 Tra clee r ta ble t film o m huld 62,5m g V EU/1/02/220/004 Tra clee r ta ble t film o m huld 125m g

4,00 stuk 2,00 stuk

32,98929 54,98214

0C 02KXAO

V EU/1/08/451/002 Vo libris ta ble t film o m huld 5m g

1,50 stuk

73,30952

0C 02KXAO

V EU/1/08/451/004 Vo libris ta ble t film o m huld 10m g

0,75 stuk

146,61905

0C 03C AAO

V 10129

Lasix re ta rd ca psule m ga 60m g

0,67 stuk

0,11307

0C 03C AAO

V 10185

Furo sem ide pch ta ble t 20m g

2,00 stuk

0,04523

0C 03C AAO 0C 03C AAO

V 19996=55844 V 20519

Furo sem ide a ta ble t 40m g Furo sem ide sa ndo z ta blet 40m g

1,00 stuk 1,00 stuk

0,07538 0,07538

0C 03C AAO

V 2057

Lasix ta blet 40m g

1,00 stuk

0,07538

0C 03C AAO

V 23048

Bum e ta nide sa ndoz ta ble t 1m g

1,00 stuk

0,07538

0C 03C AAO 0C 03C AAO

V 23049 V 23140

Bum e ta nide sa ndoz ta ble t 5m g Bum e ta nide cf ta ble t 1m g

0,20 stuk 1,00 stuk

0,37690 0,07538

0C 03C AAO

V 23141

Bum e ta nide cf ta ble t 5m g

0,20 stuk

0,37690

0C 03C AAO

V 23385

BUMETANIDE MYLAN TABLET 1 MG

1,00 stuk

0,07538

0C 03C AAO 0C 03C AAO

V 23386 V 23886=57488

BUMETANIDE MYLAN TABLET 5 MG Bum e ta nide pch table t 1m g

0,20 stuk 1,00 stuk

0,37690 0,07538

0C 03C AAO

V 23887=57489

Bum e ta nide pch table t 5m g

0,20 stuk

0,37690

0C 03C AAO

V 24020=20148

Bum e ta nide pch table t 2m g

0,50 stuk

0,15076

0C 03C AAO 0C 03C AAO

V 24275=23385 V 24276=23386

BUMETANIDE AP O TEX TABLET 1MG BUMETANIDE AP O TEX TABLET 5MG

1,00 stuk 0,20 stuk

0,07538 0,37690

0C 03C AAO

V 24312

Bum e ta nide sa ndoz ta ble t 2m g

0,50 stuk

0,15076

0C 03C AAO

V 24313

Bum e ta nide cf ta ble t 2m g

0,50 stuk

0,15076

0C 03C AAO 0C 03C AAO

V 24314 V 24366=23048

BUMETANIDE MYLAN TABLET 2 MG Bum e ta nide a cta vis ta blet 1m g

0,50 stuk 1,00 stuk

0,15076 0,07538

0C 03C AAO

V 24367=23049

Bum e ta nide a cta vis ta blet 5m g

0,20 stuk

0,37690

0C 03C AAO

V 24808=24312

Bum e ta nide a cta vis ta blet 2m g

0,50 stuk

0,15076

0C 03C AAO

V 24809=24314

BUMETANIDE AP O TEX TABLET 2MG

0,50 stuk

0,15076

0C 03C AAO V 27917=53385

Furo sem ide m yla n ta ble t 40m g

1,00 stuk

0,07538

0C 03C AAO V 28303=10185

Furo sem ide a cta vis ta ble t 20m g

2,00 stuk

0,04523

0C 03C AAO V 30465

Bum e ta nide rp table t 1m g

1,00 stuk

0,07538

0C 03C AAO V 30466 0C 03C AAO V 30467

Bum e ta nide rp table t 2m g Bum e ta nide rp table t 5m g

0,50 stuk 0,20 stuk

0,15076 0,37690

0C 03C AAO V 51855

Furo sem idum ta ble t 40m g

1,00 stuk

0,07538

0C 03C AAO V 53385

FUR O SEMIDE AP O TEX TABLET 40MG

1,00 stuk

0,07538

0C 03C AAO V 55150 0C 03C AAO V 55322

Furo sem idum ta ble t 40m g Furo sem ide cf table t 40m g

1,00 stuk 1,00 stuk

0,07538 0,07538

0C 03C AAO V 55535

Furo sem ide flx ta ble t 40m g

1,00 stuk

0,07538

0C 03C AAO V 55844

Furo sem ide rp ta ble t 40m g

1,00 stuk

0,07538

0C 03C AAO V 56582 0C 03C AAO V 57091

Furo sem idum ta ble t 40m g Furo sem ide cf table t 20m g

1,00 stuk 2,00 stuk

0,07538 0,04523

0C 03C AAO V 57488

Bum e ta nidum table t 1m g

1,00 stuk

0,07538

0C 03C AAO V 57489

Bum e ta nidum table t 5m g

0,20 stuk

0,37690

0C 03C AAO V 6733 0C 03C AAO V 6785

Lasile tte n table t 20m g Burine x table t 1m g

2,00 stuk 1,00 stuk

0,04523 0,07538

0C 03C AAO V 8705

Furo sem ide a cta vis ta ble t 40m g

1,00 stuk

0,07538

0C 03C AAO V 8812

Burine x table t 5m g

0,20 stuk

0,37690

0C 03C AAO V 9511

Furo sem ide pch ta ble t 40m g

1,00 stuk

0,07538

0C 03DAAO V 18637

Spiro no la cto num ta blet 25m g

4,00 stuk

0,11723

0C 03DAAO V 18638

Spiro no la cto num ta blet 50m g

2,00 stuk

0,23445

0C 03DAAO V 18639 0C 03DAAO V 19479

Spiro no la cto num ta blet 100m g Spiro no la cto n rp table t 25m g

1,00 stuk 4,00 stuk

0,46891 0,11723

0C 03DAAO V 19480

Spiro no la cto n rp table t 50m g

2,00 stuk

0,23445

0C 03DAAO V 19481

Spiro no la cto n rp table t 100m g

1,00 stuk

0,46891

0C 03DAAO V 23149 0C 03DAAO V 23150

Spiro no la cto n sa ndoz ta ble t 25m g Spiro no la cto n sa ndoz ta ble t 50m g

4,00 stuk 2,00 stuk

0,11723 0,23445

0C 03DAAO V 23151

Spiro no la cto n sa ndoz ta ble t 100m g

1,00 stuk

0,46891

0C 03DAAO V 23429

Spiro no la cto n a cta vis ta blet 25m g

4,00 stuk

0,11723

0C 03DAAO V 23430 0C 03DAAO V 23431

Spiro no la cto n a cta vis ta blet 50m g Spiro no la cto n a cta vis ta blet 100m g

2,00 stuk 1,00 stuk

0,23445 0,46891

0C 03DAAO V 24025

Spiro no la cto n a cco rd table t om huld 25m g

4,00 stuk

0,11723

0C 03DAAO V 24026

Spiro no la cto n a cco rd table t om huld 50m g

2,00 stuk

0,23445

0C 03DAAO V 24027 0C 03DAAO V 24686

Spiro no la cto n a cco rd table t om huld 100m g SP IR O NO LAC TO N AP O TEX TABLET 25MG

1,00 stuk 0,46891 4 STUK 0,11723

0C 03DAAO V 24687

SP IR O NO LAC TO N AP O TEX TABLET 50MG

2,00 stuk

0,23445

0C 03DAAO V 24688

SP IR O NO LAC TO N AP O TEX TABLET 100MG

1,00 stuk

0,46891

0C 03DAAO V 24779 0C 03DAAO V 24780

Spiro no la cto n cf ta ble t 25m g Spiro no la cto n cf ta ble t 50m g

4,00 stuk 2,00 stuk

0,11723 0,23445

0C 03DAAO V 24781

Spiro no la cto n cf ta ble t 100m g

1,00 stuk

0,46891

0C 03DAAO V 25271

Spiro no la cto num ta blet 25m g

4,00 stuk

0,11723

0C 03DAAO V 25272 0C 03DAAO V 25273

Spiro no la cto num ta blet 50m g Spiro no la cto num ta blet 100m g

2,00 stuk 1,00 stuk

0,23445 0,46891

0C 03DAAO V 25518=23149

Spiro no la cto n a table t 25m g

4,00 stuk

0,11723

0C 03DAAO V 25519=23150

Spiro no la cto n a table t 50m g

2,00 stuk

0,23445

0C 03DAAO V 25520=23151 0C 03DAAO V 25923

Spiro no la cto n a table t 100m g SP IR O NO LAC TO N MYLAN TABLET 25MG

1,00 stuk 0,46891 4 STUK 0,11723

0C 03DAAO V 25924

Spiro no la cto n m yla n ta blet 50m g

2,00 stuk

0C 03DAAO V 25925

SP IR O NO LAC TO N MYLAN TABLET 100MG

0C 03DAAO V 55837 0C 03DAAO V 55838

SP IR O NO LAC TO N TEVA TABLET 25MG SP IR O NO LAC TO N TEVA TABLET 100MG

4,00 stuk 1,00 stuk

0,11723 0,46891

0C 03DAAO V 55973

SP IR O NO LAC TO N TEVA TABLET 50MG

2,00 stuk

0,23445

0C 03DBAO V 15844 0C 03DBAO V 19097

Triam te re en sando z ta ble t 50m g Triam te re en a cta vis table t 50m g

2,00 stuk 2,00 stuk

0,08576 0,08576

0C 03DBAO V 27904=56731

Triam te re en a ta ble t 50m g

2,00 stuk

0,08576

0C 03DBAO V 28904=55974

TR IAMTER EEN AP O TEX TABLET 50MG

2,00 stuk

0,08576

0C 03DBAO V 29038=56731 0C 03DBAO V 55951

Triam te re en m yla n table t 50m g Triam te re en flx table t 50m g

2,00 stuk 2,00 stuk

0,08576 0,08576

0C 03DBAO V 55974

Triam te re en pch ta ble t 50m g

2,00 stuk

0,08576

0C 03DBAO V 56731

Triam te re en cf ta blet 50m g

2,00 stuk

0,08576

0C 07AABO V 16723

So talo l hcl a cta vis ta ble t 80m g

2,00 stuk

0,12781

0C 07AABO V 16724

So talo l hcl a cta vis ta ble t 160m g

1,00 stuk

0,25563

0C 07AABO V 17705

So talo l hcl sa ndo z ta blet 80m g

2,00 stuk

0,12781

0C 07AABO V 17706 0C 07AABO V 19579

So talo l hcl sa ndo z ta blet 160m g So talo l hcl m yla n ta ble t 80m g

1,00 stuk 2,00 stuk

0,25563 0,12781

0C 07AABO V 19580

So talo l hcl m yla n ta ble t 160m g

1,00 stuk

0,25563

0C 07AABO V 20329

So talo l hcl flx ta ble t 80m g

2,00 stuk

0,12781

0C 07AABO V 20330 0C 07AABO V 22333

So talo l hcl flx ta ble t 160m g SO TALO L HC L AP O TEX TABLET 80MG

1,00 stuk 2,00 stuk

0,25563 0,12781

0C 07AABO V 22334

SO TALO L HC L AP O TEX TABLET 160MG

1,00 stuk

0,25563

0C 07AABO V 28268

So talo l hcl pch ta ble t 80m g

2,00 stuk

0,12781

0C 07AABO V 28269 0C 07AABO V 33884

So talo l hcl pch ta ble t 160m g So talo l hcl pch ta ble t 40m g

1,00 stuk 4,00 stuk

0,25563 0,07669

0C 07AABO V 57480

So talo l hcl cf table t 80m g

2,00 stuk

0,12781

0C 07AABO V 57481

So talo l hcl cf table t 160m g

1,00 stuk

0,25563

0C 07ABAO V 101897

METO P R O LO LSUC C INAAT R P R ETAR D 25 TABL MGA 23,75MG

6,00 stuk

0,10830

0C 07ABAO V 101898

METO P R O LO LSUC C INAAT R P R ETAR D 50 TABL MGA 47,5MG

3,00 stuk

0,13538

0,23445

1 STUK 0,46891

0C 07ABAO V 101900 0C 07ABAO V 102063

METO P R O LO LSUC C INAAT R P R ETAR D 200 TABLET MGA 190MG METO P R O LO LSUC C INAAT A R ETAR D 100 TABLET MGA 95MG

0,75 stuk 1,50 stuk

0,54151 0,27075

0C 07ABAO V 12072

Me to prolo ltartra a t rp table t 50m g

3,00 stuk

0,16245

0C 07ABAO V 12073

Me to prolo ltartra a t rp table t 100m g

1,50 stuk

0,27075

0C 07ABAO V 12149 0C 07ABAO V 12150

Se lo k e en zoc 100 ta ble t m ga 95m g Se lo k e en zoc 200 ta ble t m ga 190m g

1,50 stuk 0,75 stuk

0,27075 0,54151

0C 07ABAO V 12408

Em cor 5 ta ble t 5m g

2,00 stuk

0,20307

0C 07ABAO V 12409

BISO P R O LO LFUMAR AAT MYLAN TABLET 10MG

1,00 stuk

0,40613

0C 07ABAO V 13074 0C 07ABAO V 13197

Dilano rm table t 200m g Se lo k e en zoc 50 ta ble t m ga 47,5m g

1,00 stuk 3,00 stuk

0,40613 0,13538

0C 07ABAO V 14225

Ace buto lo l pch ta ble t 200m g

2,00 stuk

0,24368

0C 07ABAO V 14226

Ace buto lo l pch ta ble t 400m g

1,00 stuk

0,40613

0C 07ABAO V 14705 0C 07ABAO V 14706

Ate no lo l sa ndo z ta blet 50m g Ate no lo l sa ndo z ta blet 100m g

1,50 stuk 0,75 stuk

0,27075 0,54151

0C 07ABAO V 16049

Ate no lo l cf table t 25m g

3,00 stuk

0,16245

0C 07ABAO V 16272

Ate no lo l pch ta ble t 25m g

3,00 stuk

0,16245

0C 07ABAO V 16551 0C 07ABAO V 16552

Me to prolo ltartra a t cf ta ble t 50m g Me to prolo ltartra a t cf ta ble t 100m g

3,00 stuk 1,50 stuk

0,16245 0,27075

0C 07ABAO V 16553

Me to prolo ltartra a t cf re ta rd ta blet m ga 200m g

0,75 stuk

0,54151

0C 07ABAO V 16944

METO P R O LO LTAR TR AAT AP O TEX TABLET 50MG

3,00 stuk

0,16245

0C 07ABAO V 16945 0C 07ABAO V 17286

METO P R O LO LTAR TR AAT AP O TEX TABLET 100MG ATENO LO L AP O TEX TABLET 50MG

1,50 stuk 1,50 stuk

0,27075 0,27075

0C 07ABAO V 17287

ATENO LO L AP O TEX TABLET 100MG

0,75 stuk

0,54151

0C 07ABAO V 17742

Ate no lo lum ta ble t 50m g

1,50 stuk

0,27075

0C 07ABAO V 17743 0C 07ABAO V 17744

Ate no lo lum ta ble t 100m g Dilano rm table t 400m g

0,75 stuk 0,50 stuk

0,54151 0,81226

0C 07ABAO V 17887

ATENO LO L AP O TEX TABLET 25MG

3,00 stuk

0,16245

0C 07ABAO V 18442

Me to prolo ltartra a t a cta vis ta blet 50m g

3,00 stuk

0,16245

0C 07ABAO V 18443 0C 07ABAO V 18794

Me to prolo ltartra a t a cta vis ta blet 100m g Ate no lo l a cta vis ta ble t 25m g

1,50 stuk 3,00 stuk

0,27075 0,16245

0C 07ABAO V 18795

Ate no lo l a cta vis ta ble t 50m g

1,50 stuk

0,27075

0C 07ABAO V 18796

Ate no lo l a cta vis ta ble t 100m g

0,75 stuk

0,54151

0C 07ABAO V 18849 0C 07ABAO V 18899=14225

Ne bile t table t 5m g Ace buto lo l a cta vis ta ble t 200m g

1,00 stuk 2,00 stuk

0,40613 0,24368

0C 07ABAO V 18900=14226

Ace buto lo l a cta vis ta ble t 400m g

1,00 stuk

0,40613

0C 07ABAO V 19095

Ate no lo l rp ta ble t 50m g

1,50 stuk

0,27075

0C 07ABAO V 19096 0C 07ABAO V 19517

Ate no lo l rp ta ble t 100m g Ate no lo lum ta ble t 50m g

0,75 stuk 1,50 stuk

0,54151 0,27075

0C 07ABAO V 19518

Ate no lo lum ta ble t 100m g

0,75 stuk

0,54151

0C 07ABAO V 20205

Ate no lo l sa ndo z ta blet 25m g

3,00 stuk

0,16245

0C 07ABAO V 20829 0C 07ABAO V 20830

Ate no lo l ta blet 50m g Ate no lo lum ta ble t 100m g

1,50 stuk 0,75 stuk

0,27075 0,54151

0C 07ABAO V 21338

Ate no lo l rp ta ble t 25m g

3,00 stuk

0,16245

0C 07ABAO V 21345

Ate no lo lum ta ble t 50m g

1,50 stuk

0,27075

0C 07ABAO V 21346 0C 07ABAO V 22366=14225

Ate no lo lum ta ble t 100m g Ace buto lo l cf table t 200m g

0,75 stuk 2,00 stuk

0,54151 0,24368

0C 07ABAO V 22367=14226

Ace buto lo l cf table t 400m g

1,00 stuk

0,40613

0C 07ABAO V 23281

ATENO LO L AC C O R D TABLET 25MG

3,00 stuk

0,16245

0C 07ABAO V 24008 0C 07ABAO V 24009

Biso prolo lfum a ra at pch ta ble t 5m g Biso prolo lfum a ra at pch ta ble t 10m g

2,00 stuk 1,00 stuk

0,20307 0,40613

0C 07ABAO V 24096=14225

Ace buto lo l sa ndo z ta blet 200m g

2,00 stuk

0,24368

0C 07ABAO V 24097=14226

Ace buto lo l sa ndo z ta blet 400m g

1,00 stuk

0,40613

0C 07ABAO V 24382 0C 07ABAO V 24383

Biso prolo lfum a ra at rp ta ble t 5m g Biso prolo lfum a ra at rp ta ble t 10m g

2,00 stuk 1,00 stuk

0,20307 0,40613

0C 07ABAO V 24399

Ate no lo l sa ndo z ta blet 25m g

3,00 stuk

0,16245

0C 07ABAO V 24503

EMC O R DEC O TABLET 2,5MG

4,00 stuk

0,10153

0C 07ABAO V 24506 0C 07ABAO V 24509

Em cor de co ta ble t 7,5m g BISO P R O LO LFUMAR AAT DEC O MYLAN TABLET 2,5MG

1,33 stuk 0,30460 4,00 STUK 0,10153

0C 07ABAO V 25204

Biso prolo lfum a ra at pch ta ble t 5m g

2,00 stuk

0,20307

0C 07ABAO V 25205

Biso prolo lfum a ra at pch ta ble t 10m g

1,00 stuk

0,40613

0C 07ABAO V 25209 0C 07ABAO V 25210

Se lo k e en zoc 25 ta ble t m ga 23,75m g Biso prolo lfum a ra at sa ndo z ta blet 5m g

6,00 stuk 2,00 stuk

0,10830 0,20307

0C 07ABAO V 25211

Biso prolo lfum a ra at sa ndo z ta blet 10m g

1,00 stuk

0,40613

0C 07ABAO V 25233=12408

Biso prolo lfum a ra at m yla n ta ble t 5m g

2,00 stuk

0,20307

0C 07ABAO V 25249 0C 07ABAO V 25267=12072

ATENO LO L MYLAN TABLET 25MG Me to prolo ltartra a t m yla n ta blet 50m g

3 STUK 0,16245 3,00 stuk 0,16245

0C 07ABAO V 25268=12073

METO P R O LO LTAR TR AAT MYLAN TABLET 100MG

1,50 stuk

0C 07ABAO V 25366

ATENO LO L AC C O R D TABLET 50MG

1,50 stuk

0,27075

0C 07ABAO V 25367 0C 07ABAO V 25647=19517

ATENO LO L AC C O R D TABLET 100MG Ate no lo l a ta ble t 50m g

0,75 stuk 1,50 stuk

0,54151 0,27075

0C 07ABAO V 25648=19518

Ate no lo l a ta ble t 100m g

0,75 stuk

0,54151

0C 07ABAO V 25686=24386

BISO P R O LO LFUMAR AAT AP O TEX TABLET 5MG

2,00 stuk

0,20307

0C 07ABAO V 25687=24387 0C 07ABAO V 25806

BISO P R O LO LFUMAR AAT AP O TEX TABLET 10MG Biso prolo lfum a ra at a cta vis ta ble t 5m g

1,00 stuk 2,00 stuk

0,40613 0,20307

0C 07ABAO V 25807

Biso prolo lfum a ra at a cta vis ta ble t 10m g

1,00 stuk

0,40613

0C 07ABAO V 25832

Biso prolo li fum a ras ta ble t 5m g

2,00 stuk

0,20307

0C 07ABAO V 25833 0C 07ABAO V 27376

Biso prolo li fum a ras ta ble t 10m g C e lipro lol hcl pch table t 200m g

1,00 stuk 1,00 stuk

0,40613 0,40613

0C 07ABAO V 27377

C e lipro lol hcl pch table t 400m g

0,50 stuk

0,81226

0C 07ABAO V 27390

BISO P R O LO LI FUMAR AS TABLET 2,5MG

4,00 stuk

0,10153

0C 07ABAO V 28416=16553 0C 07ABAO V 28990=16553

Me to prolo ltartra a t a reta rd ta ble t m ga 200m g Me to prolo ltartra a t pch reta rd ta ble t m ga 200m g

0,75 stuk 0,75 stuk

0,54151 0,54151

0C 07ABAO V 29013=25243

Ate no lo l a ta ble t 25m g

3,00 stuk

0,16245

0C 07ABAO V 30129

METO P R O LO LSUC C INAAT P C H R ET 25 TABL MGA 23,75MG

6,00 stuk

0,10830

0C 07ABAO V 30130 0C 07ABAO V 30131

METO P R O LO LSUC C INAAT P C H R ET 50 TABLET MGA 47,5MG METO P R O LO LSUC C INAAT P C H R ETAR D 100 TABL MGA 95MG

3,00 stuk 1,50 stuk

0,13538 0,27075

0C 07ABAO V 30133

METO P R O LO LSUC C INAAT P C H R ETAR D 200 TABL MGA 190MG

0,75 stuk

0,54151

0C 07ABAO V 30149

Me to prolo ltartra a t a cta vis re ta rd tabl m ga 200m g

0,75 stuk

0,54151

0C 07ABAO V 30770 0C 07ABAO V 30771

ATENO LO L MYLAN TABLET 50MG ATENO LO L MYLAN TABLET 100MG

1,5 STUK 0,27075 0,75 STUK 0,54151

0C 07ABAO V 32376

METO P R O LO LSUC C INAAT SANDO Z R ET 25 TAB MGA 23,75MG

6,00 stuk

0,10830

0C 07ABAO V 32377

METO P R O LO LSUC C INAAT SANDO Z R ET 50 TAB MGA 47,5MG

3,00 stuk

0,13538

0C 07ABAO V 32378 0C 07ABAO V 32380

METO P R O LO LSUC C INAAT SANDO Z R ET 100 TABL MGA 95MG METO P R O LO LSUC C INAAT SANDO Z R ET 200 TABL MGA 190MG

1,50 stuk 0,75 stuk

0,27075 0,54151

0C 07ABAO V 33097

BISO P R O LO LFUMAR AAT SANDO Z TABLET 2,5MG

4,00 stuk

0,10153

0C 07ABAO V 33099

Biso prolo lfum a ra at sa ndo z ta blet 5m g

2,00 stuk

0,20307

0C 07ABAO V 33101 0C 07ABAO V 34267

Biso prolo lfum a ra at sa ndo z ta blet 10m g Ne bivolo l pch ta blet 5m g

1,00 stuk 1,00 stuk

0,40613 0,40613

0C 07ABAO V 34438

Me to prolo ltartra a t rp reta rd ta ble t m ga 50m g

3,00 stuk

0,16245

0C 07ABAO V 34439

Me to prolo ltartra a t rp reta rd ta ble t m ga 100m g

1,50 stuk

0,27075

0C 07ABAO V 34440 0C 07ABAO V 56331

Me to prolo ltartra a t rp reta rd ta ble t m ga 200m g Ate no lo l pch ta ble t 50m g

0,75 stuk 1,50 stuk

0,54151 0,27075

0C 07ABAO V 56332

Ate no lo l pch ta ble t 100m g

0,75 stuk

0,54151

0C 07ABAO V 56499

Me to prolo ltartra a t pch table t 50m g

3,00 stuk

0,16245

0,27075

0C 07ABAO V 57022

Ate no lo lum ta ble t 50m g

1,50 stuk

0,27075

0C 07ABAO V 57023

Ate no lo lum ta ble t 100m g

0,75 stuk

0,54151

0C 07ABAO V 57170

Me to prolo ltartra a t a cco rd table t 50m g

3,00 stuk

0,16245

0C 07ABAO V 57171 0C 07ABAO V 57552

Me to prolo ltartra a t a cco rd table t 100m g Ate no lo l sa ndo z ta blet 50m g

1,50 stuk 1,50 stuk

0,27075 0,27075

0C 07ABAO V 57553

Ate no lo l sa ndo z ta blet 100m g

0,75 stuk

0,54151

0C 07ABAO V 57720

Me to prolo ltartra a t sa ndoz ta ble t 50m g

3,00 stuk

0,16245

0C 07ABAO V 57721 0C 07ABAO V 7318

Me to prolo ltartra a t sa ndoz ta ble t 100m g Se ctra l ta blet 200m g

1,50 stuk 2,00 stuk

0,27075 0,24368

0C 07ABAO V 7650

Se ctra l ta blet 400m g

1,00 stuk

0,40613

0C 07ABAO V 9984

Ke rlo n ta ble t 20m g

1,00 stuk

0,40613

0C 07AGAO V 11106

Labe ta lo l hcl rp ta blet 100m g

6,00 stuk

0,16155

0C 07AGAO V 11107

Labe ta lo l hcl rp ta blet 200m g

3,00 stuk

0,20193

0C 07AGAO V 11108

Labe ta lo l hcl rp ta blet 400m g

1,50 stuk

0,40386

0C 07AGAO V 13949 0C 07AGAO V 13950

Labe ta lo l hcl pch ta blet 100m g Labe ta lo l hcl pch ta blet 200m g

6,00 stuk 3,00 stuk

0,16155 0,20193

0C 07AGAO V 13951

Labe ta lo l hcl pch ta blet 400m g

1,50 stuk

0,40386

0C 07AGAO V 17011=11106

LABETALO L HC L APO TEX TABLET 100MG

6,00 stuk

0,16155

0C 07AGAO V 17012=11107 0C 07AGAO V 17013=11108

LABETALO L HC L APO TEX TABLET 200MG LABETALO L HC L APO TEX TABLET 400MG

3,00 stuk 1,50 stuk

0,20193 0,40386

0C 07AGAO V 24103=11106

LABETALO L HC L MYLAN TABLET 100MG

0C 07AGAO V 24104=11107

LABETALO L HC L MYLAN TABLET 200MG

0C 07AGAO V 24105=11108 0C 07AGAO V 25595=11108

LABETALO L HC L MYLAN TABLET 400MG Labe ta lo l hcl actavis ta ble t 400m g

1,50 stuk 1,50 stuk

0,40386 0,40386

0C 07AGAO V 28444=13949

Labe ta lo l hcl sa ndo z table t 100m g

6,00 stuk

0,16155

0C 07AGAO V 28445=13950

Labe ta lo l hcl sa ndo z table t 200m g

3,00 stuk

0,20193

0C 07AGAO V 28446=13951 0C 07AGAO V 28617=13949

Labe ta lo l hcl sa ndo z table t 400m g Labe ta lo l hcl actavis ta ble t 100m g

1,50 stuk 6,00 stuk

0,40386 0,16155

0C 07AGAO V 28618=13950

Labe ta lo l hcl actavis ta ble t 200m g

3,00 stuk

0,20193

0C 07AGAO V 57573=11106

Labe ta lo l hcl cf ta ble t 100m g

6,00 stuk

0,16155

0C 07AGAO V 57574=11107 0C 07AGAO V 57575=11108

Labe ta lo l hcl cf ta ble t 200m g Labe ta lo l hcl cf ta ble t 400m g

3,00 stuk 1,50 stuk

0,20193 0,40386

0C 08C AAO V 100102

Nifedipine pch reta rd ta ble t m ga 30m g

1,00 stuk

0,65450

0C 08C AAO V 100104 0C 08C AAO V 101061//20554

Nifedipine pch reta rd ta ble t m ga 60m g Ba rnidipine hcl capsule m ga 10m g

0,50 stuk 1,00 stuk

1,30901 0,65450

0C 08C AAO V 101062//20555

Ba rnidipine hcl capsule m ga 20m g

0,50 stuk

1,30901

0C 08C AAO V 10572

Adala t ca psule 5m g

6,00 stuk

0,17453

0C 08C AAO V 11391 0C 08C AAO V 11392

Ba ypre ss table t 10m g Ba ypre ss table t 20m g

2,00 stuk 1,00 stuk

0,39270 0,65450

0C 08C AAO V 13348

No rva sc table t 5m g

1,00 stuk

0,65450

0C 08C AAO V 13349

No rva sc table t 10m g

0,50 stuk

1,30901

0C 08C AAO V 13385 0C 08C AAO V 13693

Lom ir ta ble t 2,5m g P lendil ta blet m va 5m g

2,00 stuk 1,00 stuk

0,39270 0,65450

0C 08C AAO V 13694

P lendil ta blet m va 10m g

0,50 stuk

1,30901

0C 08C AAO V 14772

Mo te ns ta ble t 2m g

2,00 stuk

0,39270

0C 08C AAO V 14773 0C 08C AAO V 14794

Mo te ns ta ble t 4m g Adala t o ros ta ble t m ga 30m g

1,00 stuk 1,00 stuk

0,65450 0,65450

0C 08C AAO V 14795

Adala t o ros ta ble t m ga 60m g

0,50 stuk

1,30901

0C 08C AAO V 14833

C a rdene sr capsule m ga 45m g

2,00 stuk

0,32725

0C 08C AAO V 15099

Lom ir sro ca psule m ga 5m g

1,00 stuk

0,65450

6 STUK 0,16155 3 STUK 0,20193

0C 08C AAO V 15580

P lendil ta blet m va 2,5m g

2,00 stuk

0,39270

0C 08C AAO V 15869

Nifedipine cf ca psule 5m g

6,00 stuk

0,17453

0C 08C AAO V 15870

Nifedipine cf ca psule 10m g

3,00 stuk

0,21817

0C 08C AAO V 15976 0C 08C AAO V 16385

Nifedipine cf re ta rd ta blet 20m g Nifedipine cf re ta rd ta blet 10m g

1,50 stuk 3,00 stuk

0,43634 0,21817

0C 08C AAO V 17073

Nifedipine a reta rd ta ble t m ga 60m g

0,50 stuk

1,30901

0C 08C AAO V 19426=16385

NIFEDIP INE TEVA R ETAR D TABLET 10MG

3,00 stuk

0,21817

0C 08C AAO V 19879=16385 0C 08C AAO V 20138=16385

Nifedipine sa ndoz re tard ta ble t 10m g Nifedipine a cta vis re ta rd table t 10m g

3,00 stuk 3,00 stuk

0,21817 0,21817

0C 08C AAO V 20139=15976

Nifedipine a cta vis re ta rd table t 20m g

1,50 stuk

0,43634

0C 08C AAO V 20554

C yress capsule m ga 10m g

1,00 stuk

0,65450

0C 08C AAO V 20555 0C 08C AAO V 20813

C yress capsule m ga 20m g Lerdip table t om huld 10m g

0,50 stuk 1,00 stuk

1,30901 0,65450

0C 08C AAO V 22964=15976

Nifedipine sa ndoz re tard ta ble t 20m g

1,50 stuk

0,43634

0C 08C AAO V 23645//15099

Lom ir sro ca psule m ga 5m g

1,00 stuk

0,65450

0C 08C AAO V 24673//15099 0C 08C AAO V 25409

Lom ir sro ca psule m ga 5m g Nifedipine k atwijk re ta rd table t 10m g

1,00 stuk 3,00 stuk

0,65450 0,21817

0C 08C AAO V 25410

NIFEDIP INE AP O TEX R ETAR D TABLET 20MG

1,50 stuk

0,43634

0C 08C AAO V 26557=15976

NIFEDIP INE TEVA R ETAR D TABLET 20MG

1,50 stuk

0,43634

0C 08C AAO V 27318 0C 08C AAO V 27319

Am lo dipine m ylan ta ble t 5m g AMLO DIP INE MYLAN TABLET 10MG (ALS MALEAAT)

1,00 stuk 0,50 stuk

0,65450 1,30901

0C 08C AAO V 27322

Am lo dipine cf ta ble t 5m g (a ls m a lea a t)

1,00 stuk

0,65450

0C 08C AAO V 27323

Am lo dipine cf ta ble t 10m g (a ls m a le a a t)

0,50 stuk

1,30901

0C 08C AAO V 28644 0C 08C AAO V 28944

Lerdip table t om huld 20m g Nifedipine sa ndoz re tard ta ble t m ga 30m g

0,50 stuk 1,00 stuk

1,30901 0,65450

0C 08C AAO V 28945

Nifedipine sa ndoz re tard ta ble t m ga 60m g

0,50 stuk

1,30901

0C 08C AAO V 28956

Nifedipine rp reta rd ta ble t m ga 30m g

1,00 stuk

0,65450

0C 08C AAO V 28957 0C 08C AAO V 29036=25410

Nifedipine rp reta rd ta ble t m ga 60m g Nifedipine m yla n re ta rd table t 20m g

0,50 stuk 1,50 stuk

1,30901 0,43634

0C 08C AAO V 29399

Felo dipine pch re ta rd ta blet m ga 5m g

1,00 stuk

0,65450

0C 08C AAO V 29400

Felo dipine pch re ta rd ta blet m ga 10m g

0,50 stuk

1,30901

0C 08C AAO V 29746 0C 08C AAO V 29747

Felo dipine cf reta rd ta ble t m ga 5m g Felo dipine cf reta rd ta ble t m ga 10m g

1,00 stuk 0,50 stuk

0,65450 1,30901

0C 08C AAO V 29933

Felo dipine rp ta ble t m ga 5m g

1,00 stuk

0,65450

0C 08C AAO V 29934

Felo dipine rp ta ble t m ga 10m g

0,50 stuk

1,30901

0C 08C AAO V 30075 0C 08C AAO V 30076

Am lo dipine actavis ta ble t 5m g Am lo dipine actavis ta ble t 10m g

1,00 stuk 0,50 stuk

0,65450 1,30901

0C 08C AAO V 30220

Am lo dipine a ta blet 5m g

1,00 stuk

0,65450

0C 08C AAO V 30221

Am lo dipine a ta blet 10m g

0,50 stuk

1,30901

0C 08C AAO V 30223 0C 08C AAO V 30224

Am lo dipine cf ta ble t 5m g (a ls m e sila at) Am lo dipine cf ta ble t 10m g (a ls m e silaa t)

1,00 stuk 0,50 stuk

0,65450 1,30901

0C 08C AAO V 30520

Felo dipine a cta vis re tard ta ble t m ga 5m g

1,00 stuk

0,65450

0C 08C AAO V 30521

Felo dipine a cta vis re tard ta ble t m ga 10m g

0,50 stuk

1,30901

0C 08C AAO V 31805 0C 08C AAO V 31806

Am lo dipine rp ta blet 5m g (a ls besila a t) Am lo dipine rp ta blet 10m g (als be sila a t)

1,00 stuk 0,50 stuk

0,65450 1,30901

0C 08C AAO V 31847

Felo dipine sa ndo z ta blet m ga 5m g

1,00 stuk

0,65450

0C 08C AAO V 31848

Felo dipine sa ndo z ta blet m ga 10m g

0,50 stuk

1,30901

0C 08C AAO V 32119 0C 08C AAO V 32120

Am lo dipine pch ta blet 5m g Am lo dipine pch ta blet 10m g

1,00 stuk 0,50 stuk

0,65450 1,30901

0C 08C AAO V 32819//20554

Ba rnidipine hcl capsule m ga 10m g

1,00 stuk

0,65450

0C 08C AAO V 32820//20555

Ba rnidipine hcl capsule m ga 20m g

0,50 stuk

1,30901

0C 08C AAO V 34063 0C 08C AAO V 34065

Am lo dipine sa ndo z table t 5m g (a ls be silaa t) Am lo dipine sa ndo z table t 10m g (a ls besila a t)

1,00 stuk 0,50 stuk

0,65450 1,30901

0C 08C AAO V 34592

AMLO DIP INE AP O TEX TABLET 5MG

1,00 stuk

0C 08C AAO V 34593

AMLO DIP INE AP O TEX TABLET 10MG

0,50 STUK 1,30901

0,65450

0C 08C AAO V 35289//28644 0C 08C AAO V 56477

Lerdip table t om huld 20m g NIFEDIP INE AC C O R D C AP SULE 10MG

0,50 stuk 3,00 stuk

0C 08C AAO V 57107

Nifedipine pch ca psule 5m g

6,00 stuk

0,17453

0C 08C AAO V 57108

Nifedipine pch ca psule 10m g

3,00 stuk

0,21817

0C 08C AAO V 57524 0C 08C AAO V 57525

Nifedipine sa ndoz ca psule 5m g Nifedipine sa ndoz ca psule 10m g

6,00 stuk 3,00 stuk

0,17453 0,21817

0C 08DAAO V 12102

Iso ptin sr ta blet m ga 240m g

1,67 stuk

0,31283

0C 08DAAO V 13536 0C 08DAAO V 13537

Ve rapa m il hcl sa ndoz drage e 40m g Ve rapa m il hcl sa ndoz drage e 80m g

10,00 stuk 5,00 stuk

0,07299 0,10428

0C 08DAAO V 14495

Ve rapa m il hcl pch dra ge e 120m g

3,33 stuk

0,15642

0C 08DAAO V 15481

Iso ptin sr ta blet m ga 120m g

3,33 stuk

0,15642

0C 08DAAO V 15853 0C 08DAAO V 18013

Iso ptin sr ta blet m ga 180m g Ve rapa m il hcl sa ndoz ta ble t 40m g

2,22 stuk 10,00 stuk

0,23463 0,07299

0C 08DAAO V 18014

Ve rapa m il hcl sa ndoz ta ble t 80m g

5,00 stuk

0,10428

0C 08DAAO V 18015

Ve rapa m il hcl sa ndoz ta ble t 120m g

3,33 stuk

0,15642

0C 08DAAO V 18016 0C 08DAAO V 18499

Ve rapa m il hcl sa ndoz re tard ta ble t m ga 120m g Ve rapa m il hcl cf re ta rd ta blet m ga 240m g

3,33 stuk 1,67 stuk

0,15642 0,31283

0C 08DAAO V 19074

Ve rapa m il hcl rp dra ge e 40m g

10,00 stuk

0,07299

0C 08DAAO V 19075

Ve rapa m il hcl rp dra ge e 80m g

5,00 stuk

0,10428

0C 08DAAO V 19076 0C 08DAAO V 19936

Ve rapa m il hcl rp dra ge e 120m g Ve rapa m il hcl sa ndoz re tard ta ble t m ga 240m g

3,33 stuk 1,67 stuk

0,15642 0,31283

0C 08DAAO V 21611=18016

VER AP AMIL HC L MYLAN R ETAR D TABLET MGA 120MG

3,33 stuk

0,15642

0C 08DAAO V 21612=19936

VER AP AMIL HC L MYLAN R ETAR D TABLET MGA 240MG

1,67 stuk

0,31283

0C 08DAAO V 21976=18016 0C 08DAAO V 21977=19936

Ve rapa m il hcl pch reta rd ta ble t m ga 120m g Ve rapa m il hcl pch reta rd ta ble t m ga 240m g

3,33 stuk 1,67 stuk

0,15642 0,31283

0C 08DAAO V 21997

Ve rapa m il hcl cf ta ble t 40m g

10,00 stuk

0,07299

0C 08DAAO V 21998

Ve rapa m il hcl cf ta ble t 80m g

5,00 stuk

0,10428

0C 08DAAO V 21999 0C 08DAAO V 25284=15481

Ve rapa m il hcl cf ta ble t 120m g Ve rapa m il hcl cf re ta rd ta blet m ga 120m g

3,33 stuk 3,33 stuk

0,15642 0,15642

0C 08DAAO V 25917=15481

VER AP AMIL HC L AP O TEX R ETAR D TABLET MGA 120MG

3,33 STUK 0,15642

0C 08DAAO V 25919=12102

VER AP AMIL HC L AP O TEX R ETAR D TABLET MGA 240MG

1,67 stuk

0,31283

0C 08DAAO V 26239=24174 0C 08DAAO V 26544=18016

Ve rapa m il hcl a cta vis re ta rd table t m ga 240m g Ve rapa m il hcl rp reta rd ta ble t m ga 120m g

1,67 stuk 3,33 stuk

0,31283 0,15642

0C 08DAAO V 26545=19936

Ve rapa m il hcl rp reta rd ta ble t m ga 240m g

1,67 stuk

0,31283

0C 08DAAO V 56552

Ve rapa m il hcl pch dra ge e 40m g

10,00 stuk

0,07299

0C 08DAAO V 56553 0C 08DAAO V 57530

Ve rapa m il hcl pch dra ge e 80m g VER AP AMIL HC L AP O TEX TABLET 40MG

5,00 stuk 10,00 stuk

0,10428 0,07299

0C 08DAAO V 57531

VER AP AMIL HC L AP O TEX TABLET 80MG

5,00 stuk

0,10428

0C 08DAAO V 57532

VER AP AMIL HC L AP O TEX TABLET 120MG

3,33 stuk

0,15642

0C 09AAAO V 100346//23722

Zo fil ta ble t o m huld 30m g

1,00 stuk

0,58408

0C 09AAAO V 100449

P e rindo pril te rt-butylam ine pch ta ble t 2m g

2,00 stuk

0,35045

0C 09AAAO V 100451

P e rindo pril te rt-butylam ine pch ta ble t 4m g

1,00 stuk

0,58408

0C 09AAAO V 100452 0C 09AAAO V 101126

P e rindo pril te rt-butylam ine pch ta ble t 8m g P e rindo pril te rt-butylam ine rp ta ble t 8m g

0,50 stuk 0,50 stuk

1,16816 1,16816

0C 09AAAO V 101736

P e rindo pril te rt-butylam ine a cta vis ta ble t 2m g

2,00 stuk

0,35045

0C 09AAAO V 101741

P e rindo pril te rt-butylam ine a cta vis ta ble t 4m g

1,00 stuk

0,58408

0C 09AAAO V 101744 0C 09AAAO V 102177//31958

P e rindo pril te rt-butylam ine a cta vis ta ble t 8m g C o ve rsyl a rg ta blet film om huld 5m g

0,50 stuk 0,80 stuk

1,16816 0,73010

1,30901 0,21817

0C 09AAAO V 102179//31959

C o ve rsyl a rg ta blet film om huld 10m g

0,40 stuk

1,46020

0C 09AAAO V 102218

Lisino pril a ccord ta ble t 5m g

2,00 stuk

0,35045

0C 09AAAO V 102219 0C 09AAAO V 102220

P e rindo pril te rt-butylam ine sa ndo z ta blet 8m g Lisino pril a ccord ta ble t 10m g

0,50 stuk 1,00 stuk

1,16816 0,58408

0C 09AAAO V 102221

Lisino pril a ccord ta ble t 20m g

0,50 stuk

1,16816

0C 09AAAO V 103777//31958

C o ve rsyl a rg ta blet film om huld 5m g

0,80 stuk

0,73010

0C 09AAAO V 103778//31959 0C 09AAAO V 104882//31958

C o ve rsyl a rg ta blet film om huld 10m g C o ve rsyl a rg ta blet film om huld 5m g

0,40 stuk 0,80 stuk

1,46020 0,73010

0C 09AAAO V 10575

R e nite c ta blet 5m g

2,00 stuk

0,35045

0C 09AAAO V 10576

R e nite c ta blet 20m g

0,50 stuk

1,16816

0C 09AAAO V 10852 0C 09AAAO V 12560

R e nite c ta blet 10m g Ze stril table t 5m g

1,00 stuk 2,00 stuk

0,58408 0,35045

0C 09AAAO V 12561

Ze stril table t 10m g

1,00 stuk

0,58408

0C 09AAAO V 12562

Ze stril table t 20m g

0,50 stuk

1,16816

0C 09AAAO V 13294 0C 09AAAO V 13295

Tritace capsule 1,25m g Tritace capsule 2,5m g

2,00 stuk 1,00 stuk

0,35045 0,58408

0C 09AAAO V 13296

Tritace capsule 5m g

0,50 stuk

1,16816

0C 09AAAO V 13297

Tritace capsule 10m g

0,25 stuk

2,33631

0C 09AAAO V 13601 0C 09AAAO V 13602

Acupril ta ble t 5m g Acupril ta ble t 10m g

3,00 stuk 1,50 stuk

0,23363 0,38939

0C 09AAAO V 13603

Acupril ta ble t 20m g

0,75 stuk

0,77877

0C 09AAAO V 13635

C o ve rsyl ta ble t 2m g

2,00 stuk

0,35045

0C 09AAAO V 13636 0C 09AAAO V 14079

C o ve rsyl ta ble t 4m g C ibacen ta ble t 5m g

1,00 stuk 1,50 stuk

0,58408 0,38939

0C 09AAAO V 14080

C ibacen ta ble t 10m g

0,75 stuk

0,77877

0C 09AAAO V 14081

C ibacen ta ble t 20m g

0,38 stuk

1,55754

0C 09AAAO V 15132 0C 09AAAO V 15134

Va sca se ta blet 0,5m g Va sca se ta blet 2,5m g

5,00 stuk 1,00 stuk

0,21027 0,58408

0C 09AAAO V 15135

Va sca se ta blet 5m g

0,50 stuk

1,16816

0C 09AAAO V 15860

Go pten ca psule 0,5m g

4,00 stuk

0,23363

0C 09AAAO V 15861 0C 09AAAO V 16252

Go pten ca psule 2m g Tritace ta blet 2,5m g

1,00 stuk 1,00 stuk

0,58408 0,58408

0C 09AAAO V 16253

Tritace ta blet 5m g

0,50 stuk

1,16816

0C 09AAAO V 19839

Acupril ta ble t 40m g

0,38 stuk

1,55754

0C 09AAAO V 19987 0C 09AAAO V 19988

C a ptopril apo te x ta blet 12,5m g C a ptopril apo te x ta blet 25m g

4,00 stuk 2,00 stuk

0,23363 0,29204

0C 09AAAO V 19989

C a ptopril apo te x ta blet 50m g

1,00 stuk

0,58408

0C 09AAAO V 20972

Tritace ta blet 10m g

0,25 stuk

2,33631

0C 09AAAO V 21771 0C 09AAAO V 21772

C a ptopril sa ndo z table t 12,5m g C a ptopril sa ndo z table t 25m g

4,00 stuk 2,00 stuk

0,23363 0,29204

0C 09AAAO V 21773

C a ptopril sa ndo z table t 50m g

1,00 stuk

0,58408

0C 09AAAO V 22028

C a ptoprilum ta ble t 25m g

2,00 stuk

0,29204

0C 09AAAO V 22029 0C 09AAAO V 22833

C a ptoprilum ta ble t 50m g Tritace ta blet 1,25m g

1,00 stuk 2,00 stuk

0,58408 0,35045

0C 09AAAO V 23055

C a ptopril acco rd ta blet 12,5m g

4,00 stuk

0,23363

0C 09AAAO V 23056

C a ptopril acco rd ta blet 25m g

2,00 stuk

0,29204

0C 09AAAO V 23057 0C 09AAAO V 23069

C a ptopril acco rd ta blet 50m g C a ptopril pch ta blet 12,5m g

1,00 stuk 4,00 stuk

0,58408 0,23363

0C 09AAAO V 23070

C a ptopril pch ta blet 25m g

2,00 stuk

0,29204

0C 09AAAO V 23071

C a ptopril pch ta blet 50m g

1,00 stuk

0,58408

0C 09AAAO V 23287 0C 09AAAO V 23288

C a ptopril cf ta ble t 12,5m g C a ptopril cf ta ble t 25m g

4,00 stuk 2,00 stuk

0,23363 0,29204

0C 09AAAO V 23289

C a ptopril cf ta ble t 50m g

1,00 stuk

0,58408

0C 09AAAO V 23648

Ena la pril m ale a at sa ndo z ta blet 5m g

2,00 stuk

0,35045

0C 09AAAO V 23649 0C 09AAAO V 23650

Ena la pril m ale a at sa ndo z ta blet 10m g Ena la pril m ale a at sa ndo z ta blet 20m g

1,00 stuk 0,50 stuk

0,58408 1,16816

0C 09AAAO V 23682

C a ptopril m ylan ta ble t 12,5m g

4,00 stuk

0,23363

0C 09AAAO V 23683

C a ptopril m ylan ta ble t 25m g

2,00 stuk

0,29204

0C 09AAAO V 23684 0C 09AAAO V 23717

C a ptopril m ylan ta ble t 50m g Ena la pril m ale a at a po tex ta ble t 5m g

1,00 stuk 2,00 stuk

0,58408 0,35045

0C 09AAAO V 23718

Ena la pril m ale a at a po tex ta ble t 10m g

1,00 stuk

0,58408

0C 09AAAO V 23719

Ena la pril m ale a at a po tex ta ble t 20m g

0,50 stuk

1,16816

0C 09AAAO V 23720 0C 09AAAO V 23722

Zo fil ta ble t o m huld 7,5m g Zo fil ta ble t o m huld 30m g

4,00 stuk 1,00 stuk

0,23363 0,58408

0C 09AAAO V 24015

Ze stril table t 30m g

0,33 stuk

1,75224

0C 09AAAO V 24297

C a ptoprilum ta ble t 12,5m g

4,00 stuk

0,23363

0C 09AAAO V 24298 0C 09AAAO V 24299

C a ptoprilum ta ble t 25m g C a ptoprilum ta ble t 50m g

2,00 stuk 1,00 stuk

0,29204 0,58408

0C 09AAAO V 24376

Ena la pril m ale a at pch ta ble t 5m g

2,00 stuk

0,35045

0C 09AAAO V 24377

Ena la pril m ale a at pch ta ble t 10m g

1,00 stuk

0,58408

0C 09AAAO V 24378 0C 09AAAO V 24499

Ena la pril m ale a at pch ta ble t 20m g Ena la pril m ale a at cf table t 5m g

0,50 stuk 2,00 stuk

1,16816 0,35045

0C 09AAAO V 24500

Ena la pril m ale a at cf table t 10m g

1,00 stuk

0,58408

0C 09AAAO V 24501

Ena la pril m ale a at cf table t 20m g

0,50 stuk

1,16816

0C 09AAAO V 24515 0C 09AAAO V 24516

Ena la pril m ale a at sa ndo z ta blet 5m g Ena la pril m ale a at sa ndo z ta blet 10m g

2,00 stuk 1,00 stuk

0,35045 0,58408

0C 09AAAO V 24517

Ena la pril m ale a at sa ndo z ta blet 20m g

0,50 stuk

1,16816

0C 09AAAO V 24648//10575

R e nite c ta blet 5m g

2,00 stuk

0,35045

0C 09AAAO V 24866 0C 09AAAO V 24867

Ena la pril m ale a at m yla n ta ble t 5m g Ena la pril m ale a at m yla n ta ble t 10m g

2,00 stuk 1,00 stuk

0,35045 0,58408

0C 09AAAO V 24868

Ena la pril m ale a at m yla n ta ble t 20m g

0,50 stuk

1,16816

0C 09AAAO V 25289

Ena la pril m ale a at rp ta ble t 5m g

2,00 stuk

0,35045

0C 09AAAO V 25290 0C 09AAAO V 25291

Ena la pril m ale a at rp ta ble t 10m g Ena la pril m ale a at rp ta ble t 20m g

1,00 stuk 0,50 stuk

0,58408 1,16816

0C 09AAAO V 26331

Lisino pril pch ta ble t 5m g

2,00 stuk

0,35045

0C 09AAAO V 26332

Lisino pril pch ta ble t 10m g

1,00 stuk

0,58408

0C 09AAAO V 26333 0C 09AAAO V 26361

Lisino pril pch ta ble t 20m g Lisino pril cf table t 5m g

0,50 stuk 2,00 stuk

1,16816 0,35045

0C 09AAAO V 26362

Lisino pril cf table t 10m g

1,00 stuk

0,58408

0C 09AAAO V 26363

Lisino pril cf table t 20m g

0,50 stuk

1,16816

0C 09AAAO V 27121 0C 09AAAO V 27122

Lisino pril a po tex ta ble t 5m g Lisino pril a po tex ta ble t 10m g

2,00 stuk 1,00 stuk

0,35045 0,58408

0C 09AAAO V 27123

Lisino pril a po tex ta ble t 20m g

0,50 stuk

1,16816

0C 09AAAO V 27197

Ena la pril m ale a at sa ndo z ta blet 40m g

0,25 stuk

2,33631

0C 09AAAO V 27273 0C 09AAAO V 27274

Lisino pril rp ta ble t 5m g Lisino pril rp ta ble t 10m g

2,00 stuk 1,00 stuk

0,35045 0,58408

0C 09AAAO V 27275

Lisino pril rp ta ble t 20m g

0,50 stuk

1,16816

0C 09AAAO V 27708

Lisino pril a cta vis ta ble t 5m g

2,00 stuk

0,35045

0C 09AAAO V 27709 0C 09AAAO V 27710

Lisino pril a cta vis ta ble t 10m g Lisino pril a cta vis ta ble t 20m g

1,00 stuk 0,50 stuk

0,58408 1,16816

0C 09AAAO V 27786

C o ve rsyl ta ble t 8m g

0,50 stuk

1,16816

0C 09AAAO V 27913

LISINO P R IL MYLAN TABLET 10MG

1 STUK 0,58408

0C 09AAAO V 27914 0C 09AAAO V 27967//13636

LISINO P R IL MYLAN TABLET 20MG C o ve rsyl ta ble t 4m g

0,50 STUK 1,16816 1,00 stuk 0,58408

0C 09AAAO V 28001

R a m ipril sa ndo z table t 1,25m g

2,00 stuk

0,35045

0C 09AAAO V 28003 0C 09AAAO V 28004

R a m ipril sa ndo z table t 5m g R a m ipril sa ndo z table t 10m g

0,50 stuk 0,25 stuk

1,16816 2,33631

0C 09AAAO V 28133

Lisino pril a ta ble t 5m g

2,00 stuk

0,35045

0C 09AAAO V 28134

Lisino pril a ta ble t 10m g

1,00 stuk

0,58408

0C 09AAAO V 28135 0C 09AAAO V 28424

Lisino pril a ta ble t 20m g Lisino pril sa ndo z ta blet 5m g

0,50 stuk 2,00 stuk

1,16816 0,35045

0C 09AAAO V 28425

Lisino pril sa ndo z ta blet 10m g

1,00 stuk

0,58408

0C 09AAAO V 28426

Lisino pril sa ndo z ta blet 20m g

0,50 stuk

1,16816

0C 09AAAO V 28502 0C 09AAAO V 28503

R a m ipril rp ta blet 1,25m g R a m ipril rp ta blet 2,5m g

2,00 stuk 1,00 stuk

0,35045 0,58408

0C 09AAAO V 28504

R a m ipril rp ta blet 5m g

0,50 stuk

1,16816

0C 09AAAO V 28505

R a m ipril rp ta blet 10m g

0,25 stuk

2,33631

0C 09AAAO V 28529 0C 09AAAO V 28530

Q uinapril a ta blet 5m g Q uinapril a ta blet 10m g

3,00 stuk 1,50 stuk

0,23363 0,38939

0C 09AAAO V 28531

Q uinapril a ta blet 20m g

0,75 stuk

0,77877

0C 09AAAO V 29153

R a m ipril pch capsule 1,25m g

2,00 stuk

0,35045

0C 09AAAO V 29154 0C 09AAAO V 29155

R a m ipril pch capsule 2,5m g R a m ipril pch capsule 5m g

1,00 stuk 0,50 stuk

0,58408 1,16816

0C 09AAAO V 29156

R a m ipril pch capsule 10m g

0,25 stuk

2,33631

0C 09AAAO V 29354

Fosino prilna trium pch ta ble t 10m g

1,50 stuk

0,38939

0C 09AAAO V 29355 0C 09AAAO V 29477

Fosino prilna trium pch ta ble t 20m g Q uinapril pch ta blet 5m g

0,75 stuk 3,00 stuk

0,77877 0,23363

0C 09AAAO V 29478

Q uinapril pch ta blet 10m g

1,50 stuk

0,38939

0C 09AAAO V 29479

Q uinapril pch ta blet 20m g

0,75 stuk

0,77877

0C 09AAAO V 29480 0C 09AAAO V 29589

Q uinapril pch ta blet 40m g Q uinapril sa ndo z table t 5m g

0,38 stuk 3,00 stuk

1,55754 0,23363

0C 09AAAO V 29590

Q uinapril sa ndo z table t 10m g

1,50 stuk

0,38939

0C 09AAAO V 29591

Q uinapril sa ndo z table t 20m g

0,75 stuk

0,77877

0C 09AAAO V 29592 0C 09AAAO V 29859

Q uinapril sa ndo z table t 40m g Q UINAP R IL AP O TEX TABLET 5MG

0,38 stuk 3 STUK

1,55754 0,23363

0C 09AAAO V 29860

Q UINAP R IL AP O TEX TABLET 10MG

1,50 stuk

0,38939

0C 09AAAO V 29861

Q UINAP R IL AP O TEX TABLET 20MG

0,75 stuk

0,77877

0C 09AAAO V 29862 0C 09AAAO V 29965

Q UINAP R IL AP O TEX TABLET 40MG Q uinapril ranba x y ta ble t 5m g

0,38 stuk 3,00 stuk

1,55754 0,23363

0C 09AAAO V 29966

Q uinapril ranba x y ta ble t 10m g

1,50 stuk

0,38939

0C 09AAAO V 29967

Q uinapril ranba x y ta ble t 20m g

0,75 stuk

0,77877

0C 09AAAO V 29968 0C 09AAAO V 30213//27786

Q uinapril ranba x y ta ble t 40m g C o ve rsyl ta ble t 8m g

0,38 stuk 0,50 stuk

1,55754 1,16816

0C 09AAAO V 30306

Q uinapril rp ta blet 5m g

3,00 stuk

0,23363

0C 09AAAO V 30307

Q uinapril rp ta blet 10m g

1,50 stuk

0,38939

0C 09AAAO V 30308 0C 09AAAO V 30310

Q uinapril rp ta blet 20m g Q uinapril cf ta ble t 5m g

0,75 stuk 3,00 stuk

0,77877 0,23363

0C 09AAAO V 30311

Q uinapril cf ta ble t 10m g

1,50 stuk

0,38939

0C 09AAAO V 30312

Q uinapril cf ta ble t 20m g

0,75 stuk

0,77877

0C 09AAAO V 30968 0C 09AAAO V 30969

R a m ipril a ta blet 1,25m g R AMIP R IL MYLAN TABLET 2,5MG

2,00 stuk 1,00 stuk

0,35045 0,58408

0C 09AAAO V 30970

R AMIP R IL MYLAN TABLET 5MG

0,50 stuk

1,16816

0C 09AAAO V 30971

R AMIP R IL MYLAN TABLET 10MG

0,25 stuk

2,33631

0C 09AAAO V 30976 0C 09AAAO V 30977

R a m ipril actavis ta ble t 1,25m g R a m ipril actavis ta ble t 2,5m g

2,00 stuk 1,00 stuk

0,35045 0,58408

0C 09AAAO V 30978

R a m ipril actavis ta ble t 5m g

0,50 stuk

1,16816

0C 09AAAO V 30979

R a m ipril actavis ta ble t 10m g

0,25 stuk

2,33631

0C 09AAAO V 30981 0C 09AAAO V 30982

R a m ipril cf ta ble t 2,5m g R a m ipril cf ta ble t 5m g

1,00 stuk 0,50 stuk

0,58408 1,16816

0C 09AAAO V 30983

R a m ipril cf ta ble t 10m g

0,25 stuk

2,33631

0C 09AAAO V 31094

Q UINAP R IL MYLAN TABLET 5MG

3,00 stuk

0,23363

0C 09AAAO V 31095 0C 09AAAO V 31096

Q UINAP R IL MYLAN TABLET 10MG Q UINAP R IL MYLAN TABLET 20MG

1,50 STUK 0,75 STUK

0,38939 0,77877

0C 09AAAO V 31097

Q UINAP R IL MYLAN TABLET 40MG

0,38 STUK

1,55754

0C 09AAAO V 31957

C o ve rsyl a rg ta blet film om huld 2,5m g

1,60 stuk

0,36505

0C 09AAAO V 31958 0C 09AAAO V 31959

C o ve rsyl a rg ta blet film om huld 5m g C o ve rsyl a rg ta blet film om huld 10m g

0,80 stuk 0,40 stuk

0,73010 1,46020

0C 09AAAO V 32022

Q uinapril actavis ta ble t 5m g

3,00 stuk

0,23363

0C 09AAAO V 32023

Q uinapril actavis ta ble t 10m g

1,50 stuk

0,38939

0C 09AAAO V 32024 0C 09AAAO V 32025

Q uinapril actavis ta ble t 20m g Q uinapril actavis ta ble t 40m g

0,75 stuk 0,38 stuk

0,77877 1,55754

0C 09AAAO V 32258

Fosino prilna trium sando z ta ble t 10m g

1,50 stuk

0,38939

0C 09AAAO V 32259

Fosino prilna trium sando z ta ble t 20m g

0,75 stuk

0,77877

0C 09AAAO V 32261 0C 09AAAO V 32262

FO SINO P R ILNATR IUM MYLAN TABLET 10MG Fosino prilna trium m yla n table t 20m g

1,5 STUK 0,75 stuk

0,38939 0,77877

0C 09AAAO V 32264

Fosino prilna trium a cta vis table t 10m g

1,50 stuk

0,38939

0C 09AAAO V 32265

Fosino prilna trium a cta vis table t 20m g

0,75 stuk

0,77877

0C 09AAAO V 32270 0C 09AAAO V 32271

Fosino prilna trium cf ta blet 10m g Fosino prilna trium cf ta blet 20m g

1,50 stuk 0,75 stuk

0,38939 0,77877

0C 09AAAO V 32683

Lisino pril a uro bindo ta blet 10m g

1,00 stuk

0,58408

0C 09AAAO V 32684

Lisino pril a uro bindo ta blet 20m g

0,50 stuk

1,16816

0C 09AAAO V 32945 0C 09AAAO V 33327

Lisino pril m yla n ta ble t 5m g P e rindo pril te rt-butylam ine a ta ble t 2m g

2,00 stuk 2,00 stuk

0,35045 0,35045

0C 09AAAO V 33328

P e rindo pril te rt-butylam ine a ta ble t 4m g

1,00 stuk

0,58408

0C 09AAAO V 33331

P e rindo pril te rt-butylam ine rp ta ble t 2m g

2,00 stuk

0,35045

0C 09AAAO V 33332 0C 09AAAO V 33406//27786

P e rindo pril te rt-butylam ine rp ta ble t 4m g C o ve rsyl ta ble t 8m g

1,00 stuk 0,50 stuk

0,58408 1,16816

0C 09AAAO V 33797

Lisino pril pch ta ble t 30m g

0,33 stuk

0C 09AAAO V 34038

P ER INDO PR IL TER T-BUTYLAMINE MYLAN TABLET 2MG

0C 09AAAO V 34039 0C 09AAAO V 34040

P ER INDO PR IL TER T-BUTYLAMINE MYLAN TABLET 4MG P ER INDO PR IL TER T-BUTYLAMINE MYLAN TABLET 8MG

1,00 stuk 0,50 stuk

0,58408 1,16816

0C 09AAAO V 34512

P e rindo pril te rt-butylam ine sa ndo z ta blet 2m g

2,00 stuk

0,35045

0C 09AAAO V 34513

P e rindo pril te rt-butylam ine sa ndo z ta blet 4m g

1,00 stuk

0,58408

0C 09AAAO V 35199 0C 09AAAO V 35200

P ER INDO PR IL TER T-BUTYLAMINE AP O TEX TABLET 2MG P ER INDO PR IL TER T-BUTYLAMINE AP O TEX TABLET 4MG

2,00 stuk 1,00 stuk

0,35045 0,58408

0C 09AAAO V 35201

P ER INDO PR IL TER T-BUTYLAMINE AP O TEX TABLET 8MG

0,50 STUK

1,16816

0C 09AAAO V 35208

P e rindo pril te rt-butylam ine ra nbax y table t 2m g

2,00 stuk

0,35045

0C 09AAAO V 35209 0C 09AAAO V 35210

P e rindo pril te rt-butylam ine ra nbax y table t 4m g P e rindo pril te rt-butylam ine ra nbax y table t 8m g

1,00 stuk 0,50 stuk

0,58408 1,16816

0C 09C AAO V 101787//21706

C a nde sarta n cilex e til fishe r ta ble t 16m g

0,50 stuk

1,48840

0C 09C AAO V 101789//21705

C a nde sarta n cilex e til fishe r ta ble t 8m g

1,00 stuk

0,74420

0C 09C AAO V 102183//34472 0C 09C AAO V 104809//21705

Dio va n table t om huld 320m g Ata ca nd ta ble t 8m g

0,25 stuk 1,00 stuk

2,97680 0,74420

0C 09C AAO V 104810//21706

Ata ca nd ta ble t 16m g

0,50 stuk

1,48840

0C 09C AAO V 17617

C o za a r ta ble t film o m huld 50m g

1,00 stuk

0,74420

0C 09C AAO V 21704 0C 09C AAO V 21705

Ata ca nd ta ble t 4m g Ata ca nd ta ble t 8m g

2,00 stuk 1,00 stuk

0,44652 0,74420

0C 09C AAO V 21706

Ata ca nd ta ble t 16m g

0,50 stuk

1,48840

0C 09C AAO V 22260

Te ve te n ta blet o m huld 400m g

1,50 stuk

0,49613

2 STUK

1,75224 0,35045

0C 09C AAO V 26791

C o za a r ta ble t film o m huld 100m g

0,50 stuk

1,48840

0C 09C AAO V 26939

Dio va n table t om huld 80m g

1,00 stuk

0,74420

0C 09C AAO V 26940

Dio va n table t om huld 160m g

0,50 stuk

1,48840

0C 09C AAO V 28782 0C 09C AAO V 28783

O lm e tec table t film o m huld 10m g O lm e tec table t film o m huld 20m g

2,00 stuk 1,00 stuk

0,44652 0,74420

0C 09C AAO V 28784

O lm e tec table t film o m huld 40m g

0,50 stuk

1,48840

0C 09C AAO V 30755

Ata ca nd ta ble t 32m g

0,25 stuk

2,97680

0C 09C AAO V 30889//23983 0C 09C AAO V 30890//23983

Te ve te n ta blet o m huld 600m g Te ve te n ta blet o m huld 600m g

1,00 stuk 1,00 stuk

0,74420 0,74420

0C 09C AAO V 31422//21705

Blopre ss ta ble t 8m g

1,00 stuk

0,74420

0C 09C AAO V 31912//23983

Te ve te n ta blet o m huld 600m g

1,00 stuk

0,74420

0C 09C AAO V 32569//23983 0C 09C AAO V 32626//21706

Te ve te n ta blet o m huld 600m g C a nde sarta n cilex e til ta blet 16m g

1,00 stuk 0,50 stuk

0,74420 1,48840

0C 09C AAO V 32629//21705

C a nde sarta n cilex e til ta blet 8m g

1,00 stuk

0,74420

0C 09C AAO V 32645//30755

C a nde sarta n cilex e til ta blet 32m g

0,25 stuk

2,97680

0C 09C AAO V 32736//30755 0C 09C AAO V 32845//21705

C a nde sarta n ta ble t 32m g C a nde sarta n ta ble t 8m g

0,25 stuk 1,00 stuk

2,97680 0,74420

0C 09C AAO V 32846//21706

C a nde sarta n ta ble t 16m g

0,50 stuk

1,48840

0C 09C AAO V 34472

Dio va n table t om huld 320m g

0,25 stuk

2,97680

0C 09C AAO V EU/1/07/405/003 R a sile z ta ble t film o m huld 150m g 0C 09C AAO V EU/1/07/405/013 R a sile z ta ble t film o m huld 300m g

1,00 stuk 0,50 stuk

0,74420 1,48840

0C 09C AAO V EU/1/97/046/004 Aprove l ta blet 150m g

1,00 stuk

0,74420

0C 09C AAO V EU/1/97/046/007 Aprove l ta blet 300m g

0,50 stuk

1,48840

0C 09C AAO V EU/1/97/046/015 Aprove l ta blet 300m g 0C 09C AAO V EU/1/97/046/022 Aprove l ta blet film om huld 150m g

0,50 stuk 1,00 stuk

1,48840 0,74420

0C 09C AAO V EU/1/97/046/024 Aprove l ta blet film om huld 150m g

1,00 stuk

0,74420

0C 09C AAO V EU/1/97/046/027 Aprove l ta blet film om huld 300m g

0,50 stuk

1,48840

0C 09C AAO V EU/1/97/046/029 Aprove l ta blet film om huld 300m g 0C 09C AAO V EU/1/97/046/035 Aprove l ta blet film om huld 150m g

0,50 stuk 1,00 stuk

1,48840 0,74420

0C 09C AAO V EU/1/97/046/036 Aprove l ta blet film om huld 300m g

0,50 stuk

1,48840

0C 09C AAO V EU/1/97/046/038 Aprove l ta blet film om huld 150m g

1,00 stuk

0,74420

0C 09C AAO V EU/1/97/046/039 Aprove l ta blet film om huld 300m g 0C 09C AAO V EU/1/98/090/001 Mica rdis ta ble t 40m g

0,50 stuk 1,00 stuk

1,48840 0,74420

0C 09C AAO V EU/1/98/090/002 Mica rdis ta ble t 40m g

1,00 stuk

0,74420

0C 09C AAO V EU/1/98/090/005 Mica rdis ta ble t 80m g

0,50 stuk

1,48840

0C 09C AAO V EU/1/98/090/006 Mica rdis ta ble t 80m g 0C 09C AAO V EU/1/98/090/010 Mica rdis ta ble t 20m g

0,50 stuk 2,00 stuk

1,48840 0,44652

0C 09C AAO V EU/1/98/091/001 Kinza lm o no ta blet 40m g

1,00 stuk

0,74420

0C 09C AAO V EU/1/98/091/002 Kinza lm o no ta blet 40m g

1,00 stuk

0,74420

0C 09C AAO V EU/1/98/091/005 Kinza lm o no ta blet 80m g 0C 09C AAO V EU/1/98/091/006 Kinza lm o no ta blet 80m g

0,50 stuk 0,50 stuk

1,48840 1,48840

0C 09C AAO V EU/1/98/091/010 Kinza lm o no ta blet 20m g

2,00 stuk

0,44652

0C 09C AAO V EU/1/98/091/013 Kinza lm o no ta blet 40m g

1,00 stuk

0,74420

0C 09C AAO V EU/1/98/091/014 Kinza lm o no ta blet 80m g

0,50 stuk

1,48840

0C 10AAAO V 100355//18719

Fluvasta tine ca psule 20m g

3,00 stuk

0,55361

0C 10AAAO V 100356//18720

Fluvasta tine ca psule 40m g

1,50 stuk

0,92269

0C 10AAAO V 100361 0C 10AAAO V 100363

Sim va sta tine a cco rd ta ble t film o m huld 5m g Sim va sta tine a cco rd ta ble t film o m huld 10m g

6,00 stuk 3,00 stuk

0,36907 0,46134

0C 10AAAO V 100364

Sim va sta tine a cco rd ta ble t film o m huld 20m g

1,50 stuk

0,92269

0C 10AAAO V 100365

Sim va sta tine a cco rd ta ble t film o m huld 40m g

0,75 stuk

1,84537

0C 10AAAO V 100366

Sim va sta tine a cco rd ta ble t film o m huld 80m g

0,38 stuk

3,69075

0C 10AAAO V 100624//21082

Lipito r table t om huld 20m g

1,00 stuk

1,38403

0C 10AAAO V 100625//21083

Lipito r table t om huld 40m g

0,50 stuk

2,76806

0C 10AAAO V 101296

P ra va sta tinena trium a ta ble t 10m g

3,00 stuk

0,55361

0C 10AAAO V 101297 0C 10AAAO V 101298

P ra va sta tinena trium a ta ble t 20m g P ra va sta tinena trium a ta ble t 40m g

1,50 stuk 0,75 stuk

0,92269 1,84537

0C 10AAAO V 102180//26872

C re sto r ta ble t film o m huld 10m g

1,00 stuk

1,38403

0C 10AAAO V 102181//26873

C re sto r ta ble t film o m huld 20m g

0,50 stuk

2,76806

0C 10AAAO V 102463//21082 0C 10AAAO V 102575//26874

Lipito r table t om huld 20m g C re sto r ta ble t film o m huld 40m g

1,00 stuk 0,25 stuk

1,38403 5,53612

0C 10AAAO V 102576//26874

C re sto r ta ble t film o m huld 40m g

0,25 stuk

5,53612

0C 10AAAO V 103072//21081

So rtis ta ble t film o m huld 10m g

2,00 stuk

0,83042

0C 10AAAO V 103077//21082 0C 10AAAO V 103532//26874

So rtis ta ble t film o m huld 20m g C re sto r ta ble t film o m huld 40m g

1,00 stuk 0,25 stuk

1,38403 5,53612

0C 10AAAO V 104202//21081

Lipito r table t om huld 10m g

2,00 stuk

0,83042

0C 10AAAO V 104203//21083

Lipito r table t om huld 40m g

0,50 stuk

2,76806

0C 10AAAO V 104592//21083 0C 10AAAO V 104608//21081

So rtis ta ble t film o m huld 40m g Ato rva sta tine e rc ta blet film om huld 10m g

0,50 stuk 2,00 stuk

2,76806 0,83042

0C 10AAAO V 13193

Zo co r table t 10m g

3,00 stuk

0,46134

0C 10AAAO V 13194

Zo co r table t 20m g

1,50 stuk

0,92269

0C 10AAAO V 13195 0C 10AAAO V 13755

Zo co r table t 40m g Se le k tine ta ble t 10m g

0,75 stuk 3,00 stuk

1,84537 0,55361

0C 10AAAO V 13756

Se le k tine ta ble t 20m g

1,50 stuk

0,92269

0C 10AAAO V 18719

Lesco l ca psule 20m g

3,00 stuk

0,55361

0C 10AAAO V 18720 0C 10AAAO V 20665

Lesco l ca psule 40m g Se le k tine ta ble t 40m g

1,50 stuk 0,75 stuk

0,92269 1,84537

0C 10AAAO V 21081

Lipito r table t om huld 10m g

2,00 stuk

0,83042

0C 10AAAO V 21082

Lipito r table t om huld 20m g

1,00 stuk

1,38403

0C 10AAAO V 21083 0C 10AAAO V 21629//18719

Lipito r table t om huld 40m g Lesco l ca psule 20m g

0,50 stuk 3,00 stuk

2,76806 0,55361

0C 10AAAO V 23376//21083

Ato rva sta tine ta blet o m huld 40m g

0,50 stuk

2,76806

0C 10AAAO V 24302//18720

Lesco l ca psule 40m g

1,50 stuk

0,92269

0C 10AAAO V 25187 0C 10AAAO V 25537

Lesco l x l ta ble t m va 80m g Sim va sta tinum ta ble t film o m huld 10m g

0,75 stuk 3,00 stuk

1,84537 0,46134

0C 10AAAO V 25538

Sim va sta tinum ta ble t film o m huld 20m g

1,50 stuk

0,92269

0C 10AAAO V 25539

Sim va sta tinum ta ble t film o m huld 40m g

0,75 stuk

1,84537

0C 10AAAO V 25596//21083 0C 10AAAO V 26872

Ato rva sta tine ta blet o m huld 40m g C re sto r ta ble t film o m huld 10m g

0,50 stuk 1,00 stuk

2,76806 1,38403

0C 10AAAO V 26873

C re sto r ta ble t film o m huld 20m g

0,50 stuk

2,76806

0C 10AAAO V 26874

C re sto r ta ble t film o m huld 40m g

0,25 stuk

5,53612

0C 10AAAO V 27556 0C 10AAAO V 27557

Sim va sta tine a pote x ta ble t film o m huld 10m g Sim va sta tine a pote x ta ble t film o m huld 20m g

3,00 stuk 1,50 stuk

0,46134 0,92269

0C 10AAAO V 27558

Sim va sta tine a pote x ta ble t film o m huld 40m g

0,75 stuk

1,84537

0C 10AAAO V 27684//21081

P re ve nco r table t om huld 10m g

2,00 stuk

0,83042

0C 10AAAO V 27685//21082 0C 10AAAO V 27974//25187

P re ve nco r table t om huld 20m g Lesco l x l ta ble t m va 80m g

1,00 stuk 0,75 stuk

1,38403 1,84537

0C 10AAAO V 28011

P R AVASTATINENATR IUM MYLAN TABLET 10MG

3,00 stuk

0,55361

0C 10AAAO V 28012

P ra va sta tinena trium m yla n table t 20m g

1,50 stuk

0,92269

0C 10AAAO V 28013 0C 10AAAO V 28014

P R AVASTATINENATR IUM MYLAN TABLET 40MG P ra va sta tinena trium cf ta blet 10m g

0,75 STUK 1,84537 3,00 stuk 0,55361

0C 10AAAO V 28015

P ra va sta tinena trium cf ta blet 20m g

1,50 stuk

0,92269

0C 10AAAO V 28016

P ra va sta tinena trium cf ta blet 40m g

0,75 stuk

1,84537

0C 10AAAO V 28376//18719

Va dito n ca psule 20m g

3,00 stuk

0,55361

0C 10AAAO V 28508

Sim va sta tine cf ta blet film om huld 20m g

1,50 stuk

0,92269

0C 10AAAO V 28509

Sim va sta tine cf ta blet film om huld 40m g

0,75 stuk

1,84537

0C 10AAAO V 28928 0C 10AAAO V 28929

P ra va sta tinena trium pch ta ble t 10m g P ra va sta tinena trium pch ta ble t 20m g

3,00 stuk 1,50 stuk

0,55361 0,92269

0C 10AAAO V 28930

P ra va sta tinena trium pch ta ble t 40m g

0,75 stuk

1,84537

0C 10AAAO V 28935

Sim va sta tine pch ta ble t film o m huld 80m g

0,38 stuk

3,69075

0C 10AAAO V 29104 0C 10AAAO V 29105

Sim va sta tine a ta ble t film o m huld 10m g Sim va sta tine a ta ble t film o m huld 20m g

3,00 stuk 1,50 stuk

0,46134 0,92269

0C 10AAAO V 29106

Sim va sta tine a ta ble t film o m huld 40m g

0,75 stuk

1,84537

0C 10AAAO

V 29282

Sim va sta tine pch ta ble t film o m huld 10m g

3,00 stuk

0,46134

0C 10AAAO 0C 10AAAO

V 29283 V 29284

Sim va sta tine pch ta ble t film o m huld 20m g Sim va sta tine pch ta ble t film o m huld 40m g

1,50 stuk 0,75 stuk

0,92269 1,84537

0C 10AAAO

V 29697//21081

Ato rva sta tine ta blet o m huld 10m g

2,00 stuk

0,83042

0C 10AAAO

V 29698//26874

C re sto r ta ble t film o m huld 40m g

0,25 stuk

5,53612

0C 10AAAO 0C 10AAAO

V 29723//21083 V 30104

Lipito r table t om huld 40m g Sim va sta tine m yla n table t film o m huld 10m g

0,50 stuk 3,00 stuk

2,76806 0,46134

0C 10AAAO

V 30105

Sim va sta tine m yla n table t film o m huld 20m g

1,50 stuk

0,92269

0C 10AAAO

V 30106

Sim va sta tine m yla n table t film o m huld 40m g

0,75 stuk

1,84537

0C 10AAAO 0C 10AAAO

V 30107 V 30138

Sim va sta tine m yla n table t film o m huld 80m g P ra va sta tinena trium sando z ta ble t 10m g

0,38 stuk 3,00 stuk

3,69075 0,55361

0C 10AAAO

V 30139

P ra va sta tinena trium sando z ta ble t 20m g

1,50 stuk

0,92269

0C 10AAAO

V 30141

P ra va sta tinena trium sando z ta ble t 40m g

0,75 stuk

1,84537

0C 10AAAO 0C 10AAAO

V 30292//26874 V 30317//21083

C re sto r ta ble t film o m huld 40m g Ato rva sta tine ta blet o m huld 40m g

0,25 stuk 0,50 stuk

5,53612 2,76806

0C 10AAAO

V 30318//21083

Ato rva sta tine ta blet o m huld 40m g

0,50 stuk

2,76806

0C 10AAAO

V 30384

P ra va sta tinena trium ra nba x y ta blet 40m g

0,75 stuk

1,84537

0C 10AAAO 0C 10AAAO

V 30451//26872 V 30479

C re sto r ta ble t film o m huld 10m g P ra va sta tinena trium sando z ta ble t 10m g

1,00 stuk 3,00 stuk

1,38403 0,55361

0C 10AAAO

V 30503

P ra va sta tinena trium sando z ta ble t 20m g

1,50 stuk

0,92269

0C 10AAAO

V 30504

P ra va sta tinena trium sando z ta ble t 40m g

0,75 stuk

1,84537

0C 10AAAO 0C 10AAAO

V 30805//26872 V 30806//26873

C re sto r ta ble t film o m huld 10m g C re sto r ta ble t film o m huld 20m g

1,00 stuk 0,50 stuk

1,38403 2,76806

0C 10AAAO

V 30823

C re sto r ta ble t film o m huld 5m g

2,00 stuk

0,83042

0C 10AAAO

V 30877//21082

Ato rva sta tine ta blet o m huld 20m g

1,00 stuk

1,38403

0C 10AAAO 0C 10AAAO

V 30878//21083 V 30880//21082

Ato rva sta tine ta blet o m huld 40m g Ato rva sta tine ta blet o m huld 20m g

0,50 stuk 1,00 stuk

2,76806 1,38403

0C 10AAAO

V 30881//21083

Ato rva sta tine ta blet o m huld 40m g

0,50 stuk

2,76806

0C 10AAAO

V 31034//26872

C re sto r ta ble t film o m huld 10m g

1,00 stuk

1,38403

0C 10AAAO 0C 10AAAO

V 31035//26873 V 31036//26874

C re sto r ta ble t film o m huld 20m g C re sto r ta ble t film o m huld 40m g

0,50 stuk 0,25 stuk

2,76806 5,53612

0C 10AAAO

V 31144

Sim va sta tine sando z ta ble t film o m huld 80m g

0,38 stuk

3,69075

0C 10AAAO

V 31547

P ra va sta tinena trium a lpha rm a ta blet 10m g

3,00 stuk

0,55361

0C 10AAAO 0C 10AAAO

V 31548 V 31549

P ra va sta tinena trium a lpha rm a ta blet 20m g P ra va sta tinena trium a lpha rm a ta blet 40m g

1,50 stuk 0,75 stuk

0,92269 1,84537

0C 10AAAO

V 31602

P ra va sta tinena trium cf ta blet 10m g

3,00 stuk

0,55361

0C 10AAAO

V 31603

P ra va sta tinena trium cf ta blet 20m g

1,50 stuk

0,92269

0C 10AAAO 0C 10AAAO

V 31604 V 31834//26873

P ra va sta tinena trium cf ta blet 40m g R o suvasta tine ta ble t film o m huld 20m g

0,75 stuk 0,50 stuk

1,84537 2,76806

0C 10AAAO

V 31872

P R AVASTATINENATR IUM AP O TEX TABLET 10MG

3,00 stuk

0,55361

0C 10AAAO

V 31873

P R AVASTATINENATR IUM AP O TEX TABLET 20MG

1,50 stuk

0,92269

0C 10AAAO

V 31874

P R AVASTATINENATR IUM AP O TEX TABLET 40MG

0,75 stuk

1,84537

0C 10AAAO

V 32196

Sim va sta tine sando z ta ble t film o m huld 60m g

0,50 stuk

2,76806

0C 10AAAO

V 32197

P ra va sta tinena trium a cta vis table t 10m g

3,00 stuk

0,55361

0C 10AAAO

V 32198

P ra va sta tinena trium a cta vis table t 20m g

1,50 stuk

0,92269

0C 10AAAO 0C 10AAAO

V 32199 V 32292//21083

P ra va sta tinena trium a cta vis table t 40m g Lipito r table t om huld 40m g

0,75 stuk 0,50 stuk

1,84537 2,76806

0C 10AAAO

V 32327//26874

R o suvasta tine ta ble t film o m huld 40m g

0,25 stuk

5,53612

0C 10AAAO

V 32352//25187

Fluvasta tine ta ble t m va 80m g

0,75 stuk

1,84537

0C 10AAAO 0C 10AAAO

V 32396 V 32397

Sim va sta tine ra nba x y ta blet film om huld 20m g Sim va sta tine ra nba x y ta blet film om huld 40m g

1,50 stuk 0,75 stuk

0,92269 1,84537

0C 10AAAO

V 32457//26874

C re sto r ta ble t film o m huld 40m g

0,25 stuk

5,53612

0C 10AAAO

V 32471//21081

Ato rva sta tine ta blet o m huld 10m g

2,00 stuk

0,83042

0C 10AAAO 0C 10AAAO

V 32472//21082 V 32863//21082

Ato rva sta tine ta blet o m huld 20m g ATO R VASTATINE FISHER TABLET FILMO MHULD 20MG

1,00 stuk 1,00 stuk

1,38403 1,38403

0C 10AAAO

V 32864//21083

ATO R VASTATINE FISHER TABLET FILMO MHULD 40MG

0,50 stuk

2,76806

0C 10AAAO

V 32904

Sim va sta tine a urobindo ta ble t film o m huld 5m g

6,00 stuk

0,36907

0C 10AAAO 0C 10AAAO

V 32905 V 32906

Sim va sta tine a urobindo ta ble t film o m huld 10m g Sim va sta tine a urobindo ta ble t film o m huld 20m g

3,00 stuk 1,50 stuk

0,46134 0,92269

0C 10AAAO

V 32907

Sim va sta tine a urobindo ta ble t film o m huld 40m g

0,75 stuk

1,84537

0C 10AAAO

V 32908

Sim va sta tine a urobindo ta ble t film o m huld 80m g

0,38 stuk

3,69075

0C 10AAAO 0C 10AAAO

V 33009 V 33010

Sim va sta tine sando z ta ble t film o m huld 10m g Sim va sta tine sando z ta ble t film o m huld 20m g

3,00 stuk 1,50 stuk

0,46134 0,92269

0C 10AAAO

V 33011

Sim va sta tine sando z ta ble t film o m huld 40m g

0,75 stuk

1,84537

0C 10AAAO

V 33507//26873

C re sto r ta ble t film o m huld 20m g

0,50 stuk

2,76806

0C 10AAAO 0C 10AAAO

V 33645//26872 V 33646//26873

C re sto r ta ble t film o m huld 10m g C re sto r ta ble t film o m huld 20m g

1,00 stuk 0,50 stuk

1,38403 2,76806

0C 10AAAO

V 34142//21083

Lipito r table t om huld 40m g

0,50 stuk

2,76806

0C 10AAAO

V 34405

Fluvasta tine sa ndoz ca psule 20m g

3,00 stuk

0,55361

0C 10AAAO 0C 10AAAO

V 34406 V 34640

Fluvasta tine sa ndoz ca psule 40m g Sim va sta tine a cta vis table t film o m huld 80m g

1,50 stuk 0,38 stuk

0,92269 3,69075

0C 10AAAO

V 34762

Sim va sta tine cf ta blet film om huld 80m g

0,38 stuk

3,69075

0C 10AAAO

V 34892

Fluvasta tine pch ca psule 20m g

3,00 stuk

0,55361

0C 10AAAO 0C 10AAAO

V 34893 V 34933

Fluvasta tine pch ca psule 40m g Sim va sta tine a cta vis table t film o m huld 10m g

1,50 stuk 3,00 stuk

0,92269 0,46134

0C 10AAAO

V 34934

Sim va sta tine a cta vis table t film o m huld 20m g

1,50 stuk

0,92269

0C 10AAAO

V 34935

Sim va sta tine a cta vis table t film o m huld 40m g

0,75 stuk

1,84537

0C 10AAAO 0C 10AAAO

V 35074//30823 V 35098//21082

C re sto r ta ble t film o m huld 5m g Ato rva sta tine ta blet o m huld 20m g

2,00 stuk 1,00 stuk

0,83042 1,38403

0C 10AAAO

V 35237

Sim va sta tine blue fish ta ble t film o m huld 10m g

3,00 stuk

0,46134

0C 10AAAO

V 35238

Sim va sta tine blue fish ta ble t film o m huld 20m g

1,50 stuk

0,92269

0C 10AAAO 0C 10AAAO

V 35239 V 35240

Sim va sta tine blue fish ta ble t film o m huld 40m g Sim va sta tine blue fish ta ble t film o m huld 80m g

0,75 stuk 0,38 stuk

1,84537 3,69075

0C 10AAAO

V 35264

Fluvasta tine sa ndoz re tard ta ble t m va 80m g

0,75 stuk

1,84537

0C 10AAAO

V 35265

Fluvasta tine m yla n re ta rd table t m va 80m g

0,75 stuk

1,84537

0C 10AAAO 0C 10AAAO

V 35266 V 35297

Fluvasta tine cf re ta rd ta blet m va 80m g P ra va sta tinena trium a cco rd ta ble t 10m g

0,75 stuk 3,00 stuk

1,84537 0,55361

0C 10AAAO

V 35298

P ra va sta tinena trium a cco rd ta ble t 20m g

1,50 stuk

0,92269

0C 10AAAO

V 35299

P ra va sta tinena trium a cco rd ta ble t 40m g

0,75 stuk

1,84537

0C 10AAAO

V 35306

Fluvasta tine a cta vis sr ta ble t m va 80m g

0,75 stuk

1,84537

0C 10ABBO

V 13827

Lopid table t 600m g

2,00 stuk

0,38685

0C 10ABBO

V 15982

Be za lip ta ble t 200m g

3,00 stuk

0,28134

0C 10ABBO

V 16455

Lopid table t 900m g

1,33 stuk

0,52752

0C 10ABBO

V 17863

Mo da lim ta ble t 100m g

1,00 stuk

0,70336

0C 10ABBO

V 18388

Be za lip re ta rd ta blet m ga 400m g

1,50 stuk

0,46891

0C 10ABBO 0C 10ABBO

V 21426 V 24878

Ge m fibro zil sa ndoz ta ble t 600m g GEMFIBR O ZIL AP O TEX TABLET 600MG

2,00 stuk 2,00 stuk

0,38685 0,38685

0C 10ABBO

V 24879

GEMFIBR O ZIL AP O TEX TABLET 900MG

1,33 stuk

0,52752

0C 10ABBO

V 25031

Ge m fibro zil pch table t 600m g

2,00 stuk

0,38685

0C 10ABBO 0C 10ABBO

V 25032 V 25182

Ge m fibro zil pch table t 900m g Ge m fibro zil sa ndoz ta ble t 600m g

1,33 stuk 2,00 stuk

0,52752 0,38685

0C 10ABBO

V 25183

Ge m fibro zil sa ndoz ta ble t 900m g

1,33 stuk

0,52752

0C 10ABBO

V 25184

Ge m fibro zil cf ta ble t 600m g

2,00 stuk

0,38685

0C 10ABBO 0C 10ABBO

V 25185 V 26283

Ge m fibro zil cf ta ble t 900m g Ge m fibro zil a cta vis ta blet 600m g

1,33 stuk 2,00 stuk

0,52752 0,38685

0C 10ABBO

V 26284

Ge m fibro zil a cta vis ta blet 900m g

1,33 stuk

0,52752

0C 10ABBO

V 28346//18388

Be za lip re ta rd ta blet m ga 400m g

1,50 stuk

0,46891

0C 10ABBO 0C 10ABBO

V 29616 V 29617

GEMFIBR O ZIL MYLAN TABLET 600MG Ge m fibro zil m yla n ta blet 900m g

2,00 stuk 1,33 stuk

0,38685 0,52752

0C 10AC AO

V 101958//28626

Eze tro l ta blet 10m g

1,00 stuk

1,72101

0C 10AC AO 0C 10AC AO

V 102662//28626 V 104204//28626

Eze tro l ta blet 10m g Eze tro l ta blet 10m g

1,00 stuk 1,00 stuk

1,72101 1,72101

0C 10AC AO

V 14276

Q ue stra n a po e der 4g in sa chet

3,50 stuk

0,49172

0C 10AC AO

V 28626

Eze tro l ta blet 10m g

1,00 stuk

1,72101

0C 10AC AO 0C 10AC AO

V 30541//28626 V 33875//28626

Eze tro l ta blet 10m g Eze tro l ta blet 10m g

1,00 stuk 1,00 stuk

1,72101 1,72101

0C 10AC AO

V 34876//28626

Eze tro l ta blet 10m g

1,00 stuk

1,72101

0C 10AC AO

V 6761

Q ue stra n poe de r 4g in sa che t

3,50 stuk

0,49172

0C 10AC AO

V EU/1/03/268/003 C ho le stage l table t film o m huld 625m g

6,00 stuk

0,28683

0C 10ADAO

V 15314=13159

Ne dio s capsule 250m g

2,00 stuk

0,49523

0C 10ADAO

V 26454//13159

O lbe tam ca psule 250m g

2,00 stuk

0,49523

0C 10ADAO 0C 10ADAO

V 30053 V 30054

Niaspan ta ble t m ga 375m g Niaspan ta ble t m ga 500m g

5,33 stuk 4,00 stuk

0,24761 0,24761

0C 10ADAO

V 30055

Niaspan ta ble t m ga 750m g

2,67 stuk

0,37142

0C 10ADAO

V 30056

Niaspan ta ble t m ga 1000m g

2,00 stuk

0,49523

0D01AC ADL V 18384

Myk 1 lo tion 10m g/m l

1,00 m l

0,19150

0D01AC BDL V 102668//12586 0D01AC BDL V 12586

Nizo ra l sham po o 20m g/g Nizo ra l sham po o 20m g/g

1,00 gra m 1,00 gra m

0,18189 0,18189

0D01AC BDL V 23836

KETO C O NAZO L AP O TEX SHAMP O O 20MG/G

1,00 gra m

0,18189

0D01AC BDL V 25203

Ke tocona zo l cf sha m poo 20m g/g

1,00 gra m

0,18189

0D01AC BDL V 25724 0D01AC BDL V 30871

Ke tocona zo l a cta vis sham po o 20m g/g Ke tocona zo l pch sha m po o 20m g/g

1,00 gra m 1,00 gra m

0,18189 0,18189

0D01AC BDL V 32510

Ke tocona zo l m yla n sham po o 20m g/g

1,00 gra m

0,18189

0D01AC BDL V 32534

Ke tocona zo l sa ndoz sha m po o 20m g/g

1,00 gra m

0,18189

0D01BABO

V 28796

TER BINAFINE MYLAN TABLET 250MG

1,00 stuk

2,33152

0D01BABO

V 29426

Te rbina fine rp table t 250m g

1,00 stuk

2,33152

0D01BABO

V 29654

Te rbina fine pch table t 250m g

1,00 stuk

2,33152

0D01BABO 0D01BABO

V 29749 V 31655

Te rbina fine cf ta ble t 250m g Te rbina fine a table t 250m g

1,00 stuk 1,00 stuk

2,33152 2,33152

0D01BABO

V 31711

Te rbina fine sa ndoz ta ble t 250m g

1,00 stuk

2,33152

0D01BABO

V 32777

Te rbina fine a cta vis ta blet 250m g

1,00 stuk

2,33152

0D05AXADZ V 15334

Da ivo nex wa ter-em ulge re nde zalf 50m cg/g

1,00 gra m

0,37745

0D05AXADZ V 16330

Silk is za lf 3m cg/g

1,00 gra m

0,37745

0D05AXADZ V 21759//15334 0D05AXADZ V 32295//16330

Da ivo nex wa ter-em ulge re nde zalf 50m cg/g Silk is za lf 3m cg/g

1,00 gra m 1,00 gra m

0,37745 0,37745

0D05AXADZ V 33410

C a lcipo trio l sa ndo z za lf 50m cg/g

1,00 gra m

0,37745

0D05BAAO

Ge ro x a le n capsule 10m g

1,00 stuk

0,15646

V 7889

0D06AXBDZ V 11651

BAC TR O BAN HYDR O FIELE ZALF 20MG/G

1 GR AM

0,22477

0D06AXBDZ V 32026

MUP IR O C INE P C H HYDR O FIELE ZALF 20MG/G

1 GR AM

0,22477

0D06AXBDZ V 32184//11651

BAC TR O BAN HYDR O FIELE ZALF 20MG/G

1 GR AM

0,22477

0D06BAADC V 23292=55054

Zilve rsulfadia zine sa ndo z crem e 10m g/g

1,00 gra m

0,06262

0D06BAADC V 23869=55054

Zilve rsulfadia zine pch cre m e 10m g/g

1,00 gra m

0,06262

0D06BAADC V 25427=55054 0D06BAADC V 55054

Zilve rsulfadia zine a cta vis cre m e 10m g/g Zilve rsulfadia zine cf cre m e 10m g/g

1,00 gra m 1,00 gra m

0,06262 0,06262

0D06BAADC V 6705

Fla m m azine cre m e 10m g/g

1,00 gra m

0,06262

0D06BBBDL V 101507//19676 0D06BBBDL V 101943//19676

W a rtec cre m e 1,5m g/g W a rtec cre m e 1,5m g/g

1,00 gra m 1,00 gra m

6,08974 6,08974

0D06BBBDL V 102494//19676

W a rtec cre m e 1,5m g/g

1,00 gra m

6,08974

0D06BBBDL V 12093

C o ndyline a pplica tie vlo e isto f 5m g/m l

1,00 m l

6,08974

0D06BBBDL V 19676

W a rtec cre m e 1,5m g/g

1,00 gra m

6,08974

0D06BXADC V 13752

Me tro nida zo l a cta vis crem e 10m g/g

1,00 gra m

0,32733

0D06BXADC V 14416

R O ZEX GEL 7,5MG/G

1,00 gra m

0,32733

0D06BXADC V 25973//14416 0D06BXADC V 30115

R o ze x gel 7,5m g/g R o sice d cre m e 7,5m g/g

1,00 gra m 1,00 gra m

0,32733 0,32733

0D07AAADC V 20729

Hydro co rtiso n fa gro n fna crem e 10m g/g

1,00 gra m

0,03086

0D07AAADC V 51010

Hydro co rtiso n pch cre m e 10m g/g

1,00 gra m

0,03086

0D07ABADL V 16163

Locoid cre lo huide m ulsie 1m g/g

1,00 gra m

0,14143

0D07ABADL V 28061//5910

Locoid scalp lotio n 1m g/m l

1,00 m l

0,14143

0D07ABADL V 5910

Locoid scalp lotio n 1m g/m l

1,00 m l

0,14143

0D07AC ADC V 16004

Be tam e thaso n pch cre m e 1m g/g

1,00 gra m

0,17682

0D07AC ADC V 16647

C utiva te hydrofie le crem e 0,5m g/g

1,00 gra m

0,17682

0D07AC ADC V 17806 0D07AC ADC V 17955//6650

Be tne la n huide m ulsie 1m g/g Diproso ne cre m e 0,5m g/g

1,00 gra m 1,00 gra m

0,17682 0,17682

0D07AC ADC V 24178=16004

Be tam e thaso n rp cre m e 1m g/g

1,00 gra m

0,17682

0D07AC ADC V 28540//16647

C utiva te hydrofie le crem e 0,5m g/g

1,00 gra m

0,17682

0D07AC ADC V 28847=4519 0D07AC ADC V 28902=16004

Be tam e thaso n sa ndo z crem e 1m g/g C re m or be ta m e tha so ni 1m g/g

1,00 gra m 1,00 gra m

0,17682 0,17682

0D07AC ADC V 29743//6650

Diproso ne cre m e 0,5m g/g

1,00 gra m

0,17682

0D07AC ADC V 30641//16647

C utiva te hydrofie le crem e 0,5m g/g

1,00 gra m

0,17682

0D07AC ADC V 4519 0D07AC ADC V 5829

Be tne la n hydro fie le cre m e 1m g/g To pico rte o /w em ulsie 2,5m g/g

1,00 gra m 1,00 gra m

0,17682 0,17682

0D07AC ADC V 8164

Iba ril crem e 2,5m g/g

1,00 gra m

0,17682

0D07AC ADC V 8206

Ne riso na cre m e 1m g/g (0,1%)

1,00 gra m

0,17682

0D07AC ADL V 13546//8211

Diproso ne lo tio n 0,5m g/g

1,00 gra m

0,15333

0D07AC ADL V 14332

Elo co n lotio n 1m g/g

1,00 m l

0,15333

0D07AC ADL V 16002 0D07AC ADL V 24484=16002

Be tam e thaso n pch lo tio n 1m g/g Be tam e thaso n rp lo tio n 1m g/g

1,00 gra m 1,00 gra m

0,15333 0,15333

0D07AC ADL V 28849=5650

Be tam e thaso n sa ndo z lo tion 1m g/g

1,00 gra m

0,15333

0D07AC ADL V 5650

BETNELAN VLO EISTO F VO O R C UTAAN GEBR UIK 1MG/G

1,00 gra m

0,15333

0D07AC ADL V 8211

Diproso ne lo tio n 0,5m g/g (0,05%)

1,00 gra m

0,15333

0D07AC ADZ V 101369//16648

C utiva te hydrofo be za lf 0,05m g/g

1,00 gra m

0,14526

0D07AC ADZ V 14173

Elo co n ve t wa tere m ulge re nde za lf 1m g/g

1,00 gra m

0,14526

0D07AC ADZ V 14174 0D07AC ADZ V 16003

Elo co n wate re m ulge rende za lf 1m g/g Be tam e thaso n pch zalf 1m g/g

1,00 gra m 1,00 gra m

0,14526 0,14526

0D07AC ADZ V 16648

C utiva te hydrofo be za lf 0,05m g/g

1,00 gra m

0,14526

0D07AC ADZ V 24179=16003

Be tam e thaso n rp zalf 1m g/g

1,00 gra m

0,14526

0D07AC ADZ V 28848=4520 0D07AC ADZ V 28901=16003

Be tam e thaso n sa ndo z za lf 1m g/g Ungue ntum be ta m e tha so ni 1m g/g

1,00 gra m 1,00 gra m

0,14526

0D07AC ADZ V 4520

Be tne la n hydro fo be za lf 1m g/g

1,00 gra m

0,14526

0D07AC ADZ V 6864

Diproso ne zalf 0,5m g/g (0,05%)

1,00 gra m

0,14526

0D07ADADL V 29618//7579

De rm ova te lo tion 0,05%

1,00 gra m

0,18635

0D07ADADL V 30096

C la relux schuim vo or cuta a n ge bruik 0,5m g/g

1,00 gra m

0,18635

0D07ADADL V 30965//7579

De rm ova te lo tion 0,05%

1,00 gra m

0,18635

0D07ADADL V 33440 0D07ADADL V 7579

C lo be x sha m po o 0,5m g/g De rm ova te lo tion 0,05%

1,00 gra m 1,00 gra m

0,18635 0,18635

0D10ADADC V 101190//32496

Diffe rin ge l 1m g/g

1,00 gra m

0,23211

0D10ADADC V 32496 0D10ADADC V 8155

Diffe rin ge l 1m g/g Acid a vit cre m e 0,5m g/g

1,00 gra m 1,00 gra m

0,23211 0,23211

0D10AFADL V 10399

Eryde rm lo tion 20m g/m l

1,00 m l

0,16450

0D10AFADL V 14095 0D10AFADL V 19000

Inde rm a pplica tie vlo eistof 1% Erya cne ge l 20m g/g

1,00 gra m 1,00 gra m

0,16450 0,16450

0D10AFADL V 9897

Zine ryt po e der + so lve ns v a pplica tie vlst 40m g/m l

1,00 m l

0,16450

0D10AFBDL V 31531 0D10AFBDL V 32509

Dua c a cne ge l C linda m ycine lo tio n fna 10m g/m l

1,00 gra m 1,00 m l

0,19528 0,19528

0D10AFBDL V 32930//9728

Da lacin t lo tio n 10m g/m l

1,00 m l

0,19528

0D10AFBDL V 33632//9728

Da lacin t lo tio n 10m g/m l

1,00 m l

0,19528

0D10AFBDL V 34135//9728 0D10AFBDL V 9728

Da lacin t lo tio n 10m g/m l Da lacin t lo tio n 10m g/m l

1,00 m l 1,00 m l

0,19528 0,19528

0D10BAAO

V 10305

R O AC C UTANE C APSULE 10MG

3,00 stuk

0,89658

0D10BAAO 0D10BAAO

V 10306 V 26547

R o a ccuta ne ca psule 20m g ISO TR ETINO INE SANDO Z C AP SULE 10MG

1,50 stuk 3,00 stuk

1,49430 0,89658

0D10BAAO

V 26548

Iso tretino ine sa ndoz ca psule 20m g

1,50 stuk

1,49430

0D10BAAO

V 27573

ISO TR ETINO INE MYLAN C AP SULE 10MG

3,00 STUK

0,89658

0D10BAAO 0D10BAAO

V 27574 V 27575

ISO TR ETINO INE MYLAN C AP SULE 20MG ISO TR ETINO INE P C H C APSULE 10MG

1,5 STUK 3,00 stuk

1,49430 0,89658

0D10BAAO

V 27576

Iso tretino ine pch ca psule 20m g

1,50 stuk

1,49430

0D10BAAO

V 27577

ISO TR ETINO INE AC TAVIS C AP SULE 10MG

3,00 stuk

0,89658

Iso tretino ine a cta vis capsule 20m g Elide l crem e 10m g/g

1,50 stuk 1,00 gra m

1,49430 1,03200

0D11AXADC V EU/1/02/201/001 P ro topic zalf 0,3m g/g

1,00 gra m

1,03200

0D11AXADC V EU/1/02/201/002 P ro topic zalf 0,3m g/g

1,00 gra m

1,03200

0D11AXADC V EU/1/02/201/003 P ro topic zalf 1m g/g 0D11AXADC V EU/1/02/201/004 P ro topic zalf 1m g/g

1,00 gra m 1,00 gra m

1,03200 1,03200

0D10BAAO V 27578 0D11AXADC V 28742

0G01AFAV

V 238

Fla gyl o vule 500m g

10,00 stuk

0,54454

0G02C BAO

V 100021//15375

0G02C BAO

V 15375

Do stine x ta blet 0,5m g

0,10 stuk

7,96341

Do stine x ta blet 0,5m g

0,10 stuk

0G02C BAO

7,96341

V 16289

No rpro la c ta ble t 25 + 50m cg (3+3ta bl)

0,29 verp

2,57760

0G02C BAO 0G02C BAO

V 16290 V 26677//15375

No rpro la c ta ble t 75m cg Do stine x ta blet 0,5m g

1,00 stuk 0,10 stuk

0,75812 7,96341

0G02C BAO

V 34176

C a bergo line pch table t 0,5m g

0,10 stuk

7,96341

0G02C BAO

V 34180

C a bergo line sa ndoz ta ble t 0,5m g

0,10 stuk

7,96341

0G02C BAO

V 8202

P a rlo de l ta blet 2,5m g

2,00 stuk

0,37906

0G03AAAO

V 8205

MIC R O GYNO N 50 TABLET O MHULD

0,75 stuk

0,09241

0G03AABO 0G03AABO

V 100223 V 100225

Ethinyle stra diol/ge sto de en m yl tb o m h 0,02/0,075m g Ethinyle stra diol/ge sto de en m yl tb o m h 0,03/0,075m g

0,75 stuk 0,75 stuk

0,13253 0,13253

0G03AABO

V 100493//12846

C ilest ta ble t

0,75 stuk

0,13253

0G03AABO

V 103531//12846

C ilest ta ble t

0,75 stuk

0,13253

0G03AABO 0G03AABO

V 104108//8204 V 104746

MIC R O GYNO N 30 TABLET O MHULD Ethinyle stra diol/ge sto de en sdz tb om h 0,02/0,075m g

0,75 stuk 0,75 stuk

0,13253 0,13253

0G03AABO

V 104747

Ethinyle stra diol/ge sto de en sdz tb om h 0,03/0,075m g

0,75 stuk

0,13253

0G03AABO

V 104806//25073

Nuva ring ring va gina al

0,04 stuk

2,78318

0G03AABO 0G03AABO

V 11508 V 12575

Me rcilo n ta blet Minule t dra ge e

0,75 stuk 0,75 stuk

0,13253 0,13253

0G03AABO

V 12582

Fem o dee n drage e

0,75 stuk

0,13253

0G03AABO

V 12846

C ilest ta ble t

0,75 stuk

0,13253

0G03AABO 0G03AABO

V 16622//8204 V 17774=8204

Micro gyno n 30 dra ge e Levo no rge stre lum /e thinylestr ta b o m 0,15m g/0,030m g

0,75 stuk 0,75 stuk

0,13253 0,13253

0G03AABO

V 21187

Love tte ta blet o m huld

0,75 stuk

0,13253

0G03AABO

V 23827

Ya sm in ta blet o m huld

0,75 stuk

0,13253

0G03AABO 0G03AABO

V 25073 V 25979//8859

Nuva ring ring va gina al Ma rvelo n table t

0,04 stuk 0,75 stuk

2,78318 0,13253

0G03AABO

V 29572//11508

Me rcilo n ta blet

0,75 stuk

0,13253

0G03AABO

V 29722//8859

Ma rvelo n table t

0,75 stuk

0,13253

0G03AABO 0G03AABO

V 30126//8204 V 30375//8204

MIC R O GYNO N 30 TABLET O MHULD MIC R O GYNO N 30 TABLET O MHULD

0,75 stuk 0,75 stuk

0,13253 0,13253

0G03AABO

V 30735

Ethinyle stra diol/le vo no rge s a ta b o m h 0,03/0,15m g

0,75 stuk

0,13253

0G03AABO

V 30735

Ethinyle stra diol/le vo no rge s a ta b o m h 0,03/0,15m g

0,75 stuk

0,13253

0G03AABO 0G03AABO

V 30863 V 31453//8191

Micro gyno n 20 ta ble t o m huld Ste diril 30 dra ge e

0,75 stuk 0,75 stuk

0,13253 0,13253

0G03AABO

V 33720

Ethinyle stra diol/ge sto de en a ta b o m h 0,02/0,075m g

0,75 stuk

0,13253

0G03AABO

V 33721

Ethinyle stra diol/ge sto de en a ta b o m h 0,03/0,075m g

0,75 stuk

0,13253

0G03AABO 0G03AABO

V 33842 V 33928

Ya z 24+4 ta blet film om huld Ge sto de en/e thinylestra dio l pch tb o m h 0,075/0,03m g

0,86 stuk 0,75 stuk

0,11597 0,13253

0G03AABO

V 33931

Ge sto de en/e thinylestra dio l pch tb o m h 0,075/0,02m g

0,75 stuk

0,13253

0G03AABO 0G03AABO

V 7054 V 7284

Minista t ta ble t Ne ocon ta ble t

0,79 stuk 0,75 stuk

0,12651 0,13253

0G03AABO

V 7434

Mo dico n ta blet

0,75 stuk

0,13253

0G03AABO

V 8191

Ste diril 30 dra ge e

0,75 stuk

0,13253

0G03AABO 0G03AABO

V 8204 V 8859

MIC R O GYNO N 30 TABLET O MHULD Ma rvelo n table t

0,75 stuk 0,75 stuk

0,13253 0,13253

0G03AABO

V EU/1/02/223/001 Evra ple iste r tra nsde rm a a l

0,11 stuk

0,92773

0G03AABO

V EU/1/02/223/002 Evra ple iste r tra nsde rm a a l

0,11 stuk

0,92773

0G03ABBO 0G03ABBO

V 100339//8514 V 10111

Trino rdiol dra ge e Trino vum ta ble t

0,75 stuk 0,75 stuk

0,12515 0,12515

0G03ABBO

V 101491

Q la ira ta blet film om huld

0,93 stuk

0,10108

0G03ABBO

V 13591//10111

Trino vum ta ble t

0,75 stuk

0,12515

0G03ABBO 0G03ABBO

V 28198//8514 V 8514

Trino rdiol dra ge e Trino rdiol dra ge e

0,75 stuk 0,75 stuk

0,12515 0,12515

0G03ABBO

V 8663

Trigynon dra ge e

0,75 stuk

0,12515

0G03AC AO 0G03AC AO

V 103955//22743 V 22743

C e ra ze tte table t om huld 0,075m g C e ra ze tte table t om huld 0,075m g

1,00 stuk 1,00 stuk

0,08071 0,08071

0G03AC AO

V 6443

Ex luto n ta blet 0,5m g

1,00 stuk

0,08071

0G03BABO 0G03BABO

V 103526//27741 V 23347//7531

Andro ge l ge l 50m g in sache t Andrio l ca psule 40m g

1,00 stuk 3,00 stuk

1,81512 0,60504

0G03BABO

V 25497//7531

Andrio l ca psule 40m g

3,00 stuk

0,60504

0G03BABO

V 26477//7531

Andrio l ca psule 40m g

3,00 stuk

0,60504

0G03BABO 0G03BABO

V 27740 V 27741

Andro ge l ge l 25m g in sache t Andro ge l ge l 50m g in sache t

2,00 stuk 1,00 stuk

0,90756 1,81512

0G03BABO

V 30653

Te stim ge l 10m g/g tube 5g

1,00 stuk

1,81512

0G03BABO

V 33424

To stra n ge l 20m g/g

2,50 gra m

0,72605

0G03BABO 0G03BABO

V 34266//27741 V 7531

Andro ge l ge l 50m g in sache t Andrio l testo ca ps ca psule 40m g

1,00 stuk 3,00 stuk

1,81512 0,60504

0G03C AAO

V 15462

Zum e no n ta blet 2m g

1,00 stuk

0,18710

0G03C AAO 0G03C AAO

V 16080 V 19258

Syste n 50 ple iste r m ga 50m cg/24uur Syste n 75 ple iste r m ga 75m cg/24uur

0,29 stuk 0,19 stuk

0,65486 0,98229

0G03C AAO

V 19259

Syste n 100 ple iste r m ga 100m cg/24uur

0,14 stuk

1,30973

0G03C AAO

V 19581

Estra dio l sa ndoz 50 ple iste r transde rm a al 4m g

0,29 stuk

0,65486

0G03C AAO 0G03C AAO

V 19582 V 21840=19581

Estra dio l sa ndoz 100 pleister tra nsde rm aa l 8m g ESTR ADIO L MYLAN 50 P LEISTER TR ANSDER MAAL 4MG

0,14 stuk 0,29 stuk

1,30973 0,65486

0G03C AAO

V 21841=19582

ESTR ADIO L MYLAN 100 P LEISTER TR ANSDER MAAL 8MG

0,14 stuk

1,30973

0G03C AAO

V 21842=19581

Estra dio l k atwijk 50 ple iste r tra nsde rm a a l 4m g

0,29 stuk

0,65486

0G03C AAO 0G03C AAO

V 21843=19582 V 23187=19581

Estra dio l k atwijk 100 ple iste r tra nsderm a a l 8m g Estra dio l pch 50 pleister tra nsde rm aa l 4m g

0,14 stuk 0,29 stuk

1,30973 0,65486

0G03C AAO

V 23188=19582

Estra dio l pch 100 ple iste r tra nsde rm a a l 8m g

0,14 stuk

1,30973

0G03C AAO

V 24638

Estra dot 50 ple iste r tra nsde rm a a l

0,29 stuk

0,65486

0G03C AAO 0G03C AAO

V 24640 V 25706

Estra dot 100 ple iste r tra nsderm a a l Ae rodio l ne usspra y 150m cg/do fla co n 60do

0,14 stuk 1,67 do

1,30973 0,11226

0G03C AAO

V 26359

Estra dio l sa ndoz ta ble t 2m g

1,00 stuk

0,18710

0G03C AAO

V 30418//9969

Estrio l ta blet 1m g

2,00 stuk

0,09355

0G03C AAO 0G03C AAO

V 32717//9969 V 5311

Syna pause e 3 ta ble t 1m g P ro gynova dra ge e 2m g

2,00 stuk 1,00 stuk

0,09355 0,18710

0G03C AAO

V 5861

P ro gynova dra ge e 1m g

2,00 stuk

0,11226

0G03C AAO

V 6868

Da gynil ta blet 1,25m g

0,50 stuk

0,37421

0G03C AAO 0G03C AAO

V 6869 V 9126

Da gynil ta blet 0,625m g Da gynil ta blet 0,3m g

1,00 stuk 2,08 stuk

0,18710 0,10927

0G03C AAO

V 9810

0G03C AAO

V 9969

Estro fe m ta blet 2m g

1,00 stuk

0,18710

Syna pause e 3 ta ble t 1m g

2,00 stuk

0G03C AAO

0,09355

V 9970

Syna pause e 3 ta ble t 2m g

1,00 stuk

0,18710

0G03DAAO

V 601

P ro ve ra table t 5m g

1,00 stuk

0,11571

0G03DAAO

V 9986

P ro ve ra table t 10m g

0,50 stuk

0,23143

0G03DC AO

V 2179

P rim o lut n ta blet 5m g

1,50 stuk

0,07855

0G03DC AO

V 278

O rga m etril ta ble t 5m g

1,00 stuk

0,11783

0G03FAAO 0G03FAAO

V 103105//22819 V 103529//27505

Active lle ta blet o m huld Ange liq ta blet film om huld

1,00 stuk 1,00 stuk

0,38944 0,38944

0G03FAAO

V 14942

Klio ge st ta ble t

1,00 stuk

0,38944

0G03FAAO

V 22819

Active lle ta blet o m huld

1,00 stuk

0,38944

0G03FAAO 0G03FAAO

V 24632//14942 V 24830

Klio ge st ta ble t C lim o dien ta ble t o m huld 2/2m g

1,00 stuk 1,00 stuk

0,38944 0,38944

0G03FAAO

V 25549

Fem o sto n co ntinu ta ble t o m huld 1/5m g

1,00 stuk

0,38944

0G03FAAO

V 27505

Ange liq ta blet film om huld

1,00 stuk

0,38944

0G03FAAO 0G03FAAO

V 27680//25549 V 28349//25549

C lim a ston co ntinu ta ble t o m huld 1/5m g Fem o sto n co ntinu ta ble t o m huld 1/5m g

1,00 stuk 1,00 stuk

0,38944 0,38944

0G03GAAP

V 33178

Fostim o n injpdr fl 75ie + so lv 1m l

1,00 stuk

23,00000

0G03GABIM V 103

P re gnyl injectie po ede r a m pul 1500ie + solvens 1m l

0,17 stuk

1,39220

0G03GABIM V 104

P re gnyl injectie po ede r a m pul 5000ie + solvens 1m l

0,05 stuk

4,64067

0G03GABIM V 32191//104

P re gnyl injectie po ede r a m pul 5000ie + solvens 1m l

0,05 stuk

4,64067

0G03GABIM V 35116//103 P re gnyl injectie po ede r a m pul 1500ie + solvens 1m l 0G03GABIM V EU/1/00/165/004 O vitrelle inje ctiepo e de r fla co n 250m cg + so lv 1m l

0,17 stuk 0,05 stuk

1,39220 4,64067

0G03GABIM V EU/1/00/165/007 O vitrelle 250 injvlst 500m cg/m l wwsp 0,5m l

0,05 stuk

4,64067

0G03GABP 0G03GABP

V 102378//24536 V 102479//24536

1,00 stuk 1,00 stuk

33,54345 33,54345

0G03GABP

V 24536

Me no pur injpdr flacon 75ie + solv 1m l

1,00 stuk

33,54345

0G03GABP

V 27813//24536

Me no pur injpdr flacon 75ie + solv 1m l

1,00 stuk

33,54345

0G03GABP 0G03GABP

V 31471//24536 Me no pur injpdr flacon 75ie + solv 1m l + to ebe h V EU/1/95/001/001 Go nal f injpdr a m pul 75ie + so lv 1m l

1,00 stuk 1,00 stuk

33,54345 33,54345

0G03GABP

V EU/1/95/001/002 Go nal f injpdr a m pul 75ie + so lv 1m l

1,00 stuk

33,54345

0G03GABP

V EU/1/95/001/004 Go nal f injpdr a m pul 75ie + so lv 1m l

1,00 stuk

33,54345

0G03GABP 0G03GABP

V EU/1/95/001/009 Go nal f injpdr a m pul 150ie + so lv 1m l V EU/1/95/001/010 Go nal f injpdr a m pul 150ie + so lv 1m l

0,50 stuk 0,50 stuk

67,08690 67,08690

0G03GABP

V EU/1/95/001/012 Go nal f injpdr a m pul 150ie + so lv 1m l

0,50 stuk

67,08690

0G03GABP

V EU/1/95/001/018 Go nal f injpdr a m pul 37,5ie + so lv 1m l

2,00 stuk

20,12607

0G03GABP 0G03GABP

V EU/1/95/001/021 Go nal f injpdr fl 1050ie + solv 1,75m l V EU/1/95/001/021 Go nal f injpdr fl 1050ie + solv 1,75m l

0,07 stuk 0,07 stuk

469,60830 469,60830

0G03GABP

V EU/1/95/001/021 Go nal f 600ie /m l injpdr fla co n 1200ie + solv 2m l

0,06 stuk

536,69520

0G03GABP

V EU/1/95/001/021 Go nal f 600ie /m l injpdr fla co n 1200ie + solv 2m l

0,06 stuk

536,69520

0G03GABP 0G03GABP

V EU/1/95/001/025 Go nal f injpdr fl 75ie + so lv 1m l V EU/1/95/001/026 Go nal f injpdr fl 75ie + so lv 1m l

1,00 stuk 1,00 stuk

33,54345 33,54345

0G03GABP

V EU/1/95/001/031 Go nal f injpdr fl 450ie + so lv 0,75m l

0,17 stuk

201,26070

0G03GABP

V EU/1/95/001/033 Go nal f 300 injvlst 600ie /m l wwsp 0,5m l

0,25 stuk

134,17380

Me no pur injpdr flacon 75ie + solv 1m l Me no pur injpdr flacon 75ie + solv 1m l

0G03GABP

V EU/1/95/001/035 Go nal f 900 injvlst 600ie /m l wwsp 1,5m l

0,08 stuk

402,52140

0G03GABP

V EU/1/96/008/001 P urego n inje ctiepo e de r a m pul 50ie + so lve ns 1m l

1,50 stuk

22,36230

0G03GABP

V EU/1/96/008/003 P urego n inje ctiepo e de r a m pul 50ie + so lve ns 1m l

1,50 stuk

22,36230

0G03GABP 0G03GABP

V EU/1/96/008/004 P urego n inje ctiepo e de r a m pul 50ie +so lv 1m l+toe be h V EU/1/96/008/009 P urego n inje ctiepo e de r a m pul 100ie + so lve ns 1m l

1,50 stuk 0,75 stuk

22,36230 44,72460

0G03GABP

V EU/1/96/008/011 P urego n inje ctiepo e de r a m pul 100ie + so lve ns 1m l

0,75 stuk

44,72460

0G03GABP

V EU/1/96/008/012 P urego n inje ctiepo e de r a m pul 100ie +so lv 1m l+to e beh

0,75 stuk

44,72460

0G03GABP 0G03GABP

V EU/1/96/008/017 P urego n 50 injvlst 100ie /m l fl 0,5m l V EU/1/96/008/023 P urego n 100 injvlst 200ie /m l fl 0,5m l

0,75 m l 0,38 m l

44,72460 89,44920

0G03GABP

V EU/1/96/008/026 P urego n 150 injvlst 300ie /m l fl 0,5m l

0,25 m l

134,17380

0G03GABP

V EU/1/96/008/029 P urego n 200 injvlst 400ie /m l fl 0,5m l

0,19 m l

178,89840

0G03GABP 0G03GABP

V EU/1/96/008/038 P urego n 300 injvlst 833ie /m l pa tro on 0,36m l V EU/1/96/008/039 P urego n 600 injvlst 833ie /m l pa tro on 0,72m l

0,09 m l 0,09 m l

372,55592 372,55592

0G03GABP

V EU/1/96/008/041 P urego n 900 injvlst 833ie /m l pa tro on 1,08m l

0,09 m l

372,55592

0G03GBAO 0G03GBAO

V 53363 V 6492

C lo m ife e ncitra a t cf ta ble t 50m g C lo m id ta ble t 50m g

1,00 stuk 1,00 stuk

0,49598 0,49598

0G03HAAO

V 15742

C ypro te ro na ce ta a t pch ta blet 50m g

2,00 stuk

0,83604

0G03HAAO 0G03HAAO

V 18330 V 6540

C YP R O TER O NAC ETAAT MYLAN TABLET 50MG Andro cur ta ble t 50m g

2 STUK 2,00 stuk

0,83604 0,83604

0G03HBAO

V 11903

Dia ne -35 ta ble t o m huld

0,75 stuk

0,26363

0G03HBAO 0G03HBAO

V 17771=11903 V 24154

Mine rva ta ble t o m huld C ypro te ro n/ethinyle stra dio l m yla n t o m h 2m g/35m cg

0,75 stuk 0,75 stuk

0,26363 0,26363

0G03HBAO

V 28545

C ypro te ro n/ethinyle stra dio l rp t om h 2m g/35m cg

0,75 stuk

0,26363

0G03HBAO

V 28750

C YP R O TER O N/ETHINYLESTR ADIO L AP O TEX T O MH 2MG/35MC G

0,75 stuk

0,26363

0G03HBAO 0G03HBAO

V 29729 V 31382

C YP R O TER O N/ETHINYLESTR ADIO L MYLAN T O MH 2MG/35MC G C ypro te ro n/ethinyle stra dio l sa ndoz t o m h 2m g/35m cg

0,75 stuk 0,75 stuk

0,26363 0,26363

0G03HBAO

V 33581

C ypro te ro n/ethinyle stra dio l pch t om h 2m g/35m cg

0,75 stuk

0,26363

0G03HBAO

V 33596

C ypro te ro n/ethinyle stra dio l cf t o m h 2m g/35m cg

0,75 stuk

0,26363

0G03HBAO

V 33599

C ypro te ro n/ethinyle stra dio l a cta v t o m h 2m g/35m cg

0,75 stuk

0,26363

0G04ABAO

V 10991

P ipra m ta ble t 400m g

2,00 stuk

0,68975

0G04AC BO

V 13066

Mo nuril gra nula at 3000m g/8g in sache t

0,25 stuk

2,28706

0G04AC BO

V 14926=52232

Nitrofura ntoine m c sa ndo z ca psule 100m g

2,00 stuk

0,28588

0G04AC BO

V 15290

Fura bid capsule m ga 100m g

2,00 stuk

0,28588

0G04AC BO 0G04AC BO

V 17971=55722 V 17972=55723

Trim e tho prim rp table t 100m g Trim e tho prim rp table t 300m g

4,00 stuk 1,33 stuk

0,20012 0,42882

0G04AC BO

V 18152

NITR O FUR ANTO INUM MC AP O TEX C AP SULE 50MG

0G04AC BO

V 19700=18152

Nitrofura ntoine m c sa ndo z ca psule 50m g

4,00 stuk

0,14294

0G04AC BO 0G04AC BO

V 19736=18152 V 28451=55722

NITR O FUR ANTO INE MC TEVA C AP SULE 50MG TR IMETHO P R IM MYLAN TABLET 100MG

4,00 stuk 4,00 stuk

0,14294 0,20012

0G04AC BO

V 28452=55723

TR IMETHO P R IM MYLAN TABLET 300MG

1,33 stuk

0,42882

0G04AC BO

V 28842=55722

Trim e tho prim a cta vis ta blet 100m g

4,00 stuk

0,20012

0G04AC BO 0G04AC BO

V 28843=55723 V 29060=18152

Trim e tho prim a cta vis ta blet 300m g Nitrofura ntoine m c m ylan ca psule 50m g

1,33 stuk 4,00 stuk

0,42882 0,14294

0G04AC BO

V 29061=52232

NITR O FUR ANTO INE MC MYLAN C APSULE 100MG

0G04AC BO

V 51105

Nitrofura ntoine m c cf ca psule 100m g

2,00 stuk

0,28588

0G04AC BO

V 52232

NITR O FUR ANTO INE MC APO TEX C AP SULE 100MG

2,00 STUK

0,28588

4 STUK

2 STUK

0,14294

0,28588

0G04AC BO

V 55722

Trim e tho prim cf ta ble t 100m g

4,00 stuk

0,20012

0G04AC BO

V 55723

Trim e tho prim cf ta ble t 300m g

1,33 stuk

0,42882

0G04AC BO

V 56203=5748

Nitrofura ntoinum m c capsule 50m g

4,00 stuk

0,14294

0G04AC BO 0G04AC BO

V 57386=52232 V 5748

NITR O FUR ANTO INE MC TEVA C AP SULE 100MG Fura da ntine m c ca psule 50m g

2,00 stuk 4,00 stuk

0,28588 0,14294

0G04AC BO

V 5749

Fura da ntine m c ca psule 100m g

2,00 stuk

0,28588

0G04AC BO

V 57604=52232

Nitrofura ntoine m c rp capsule 100m g

2,00 stuk

0,28588

0G04AC BO 0G04AC BO

V 9596 V 9597

Trim e tho prim pch table t 100m g Trim e tho prim pch table t 300m g

4,00 stuk 1,33 stuk

0,20012 0,42882

0G04BDBO

V 100228//26669

De trusito l sr ca psule m va 2m g

2,00 stuk

0,41491

0G04BDBO 0G04BDBO

V 103079//22149 V 104641//29151

De trusito l ta blet o m huld 2m g Ve sica re table t film o m huld 5m g

2,00 stuk 1,00 stuk

0,41491 0,82981

0G04BDBO

V 10527

Dridase table t 5m g

3,00 stuk

0,27660

0G04BDBO

V 17499

Dridase table t 2,5m g

6,00 stuk

0,16596

0G04BDBO 0G04BDBO

V 18780 V 19628

O x ybutynine hcl sa ndo z ta blet 5m g O x ybutynini hydrochlo ridum ta ble t 5m g

3,00 stuk 3,00 stuk

0,27660 0,27660

0G04BDBO

V 21209=19628

O x ybutynine hcl ta blet 5m g

3,00 stuk

0,27660

0G04BDBO

V 21285

O x ybutynine hcl a cta vis ta ble t 5m g

3,00 stuk

0,27660

0G04BDBO 0G04BDBO

V 22148 V 22149

De trusito l ta blet o m huld 1m g De trusito l ta blet o m huld 2m g

4,00 stuk 2,00 stuk

0,24894 0,41491

0G04BDBO

V 22158

O x ybutynine hcl nx ta ble t 2,5m g

6,00 stuk

0,16596

0G04BDBO

V 22159

O x ybutynine hcl nx ta ble t 5m g

3,00 stuk

0,27660

0G04BDBO 0G04BDBO

V 22160 V 22822

O x ybutynine hcl cf table t 2,5m g O XYBUTYNINE HC L MYLAN TABLET 2,5MG

6,00 stuk 6 STUK

0,16596 0,16596

0G04BDBO

V 22823

O x ybutynine hcl m e rck ta ble t 5m g

3,00 stuk

0,27660

0G04BDBO

V 23879

O XYBUTYNINE HC L AC C O R D TABLET 5MG

3,00 stuk

0,27660

0G04BDBO 0G04BDBO

V 23885=22455 V 23893=22455

O x ybutynini hydrochlo ridum ta ble t 2,5m g O x ybutynine hcl a cta vis ta ble t 2,5m g

6,00 stuk 6,00 stuk

0,16596 0,16596

0G04BDBO

V 23950

O x ybutynine hcl rp ta ble t 5m g

3,00 stuk

0,27660

0G04BDBO

V 24060

O x ybutynine hcl rp ta ble t 2,5m g

6,00 stuk

0,16596

0G04BDBO 0G04BDBO

V 24081 V 25099

O XYBUTYNINE HC L AC C O R D TABLET 2,5MG O x ybutynine hcl cf table t 5m g

6,00 stuk 3,00 stuk

0,16596 0,27660

0G04BDBO

V 25156

O XYBUTYNINE HC L APO TEX TABLET 2,5MG

6,00 STUK

0,16596

0G04BDBO

V 25157

O XYBUTYNINE HC L APO TEX TABLET 5MG

3,00 stuk

0,27660

0G04BDBO 0G04BDBO

V 26669 V 26670

De trusito l sr ca psule m va 2m g De trusito l sr ca psule m va 4m g

2,00 stuk 1,00 stuk

0,41491 0,82981

0G04BDBO

V 29151

Ve sica re table t film o m huld 5m g

1,00 stuk

0,82981

0G04BDBO

V 29152

Ve sica re table t film o m huld 10m g

0,50 stuk

1,65963

0G04BDBO 0G04BDBO

V 31979 V 34503//26670

O x ybutynine hcl sa ndo z ta blet 2,5m g De trusito l sr ca psule m va 4m g

6,00 stuk 1,00 stuk

0,16596 0,82981

0G04BDBO

V 8322

Urispa s dra gee 200m g

4,00 stuk

0,20745

0G04BDBO

V EU/1/03/270/001 Ke nte ra ple iste r tra nsde rm a a l 36m g

0,29 stuk

2,90435

0G04BDBO 0G04BDBO

V EU/1/03/270/002 Ke nte ra ple iste r tra nsde rm a a l 36m g V EU/1/04/294/003 Em se le x ta ble t m va 7,5m g

0,29 stuk 1,00 stuk

2,90435 0,82981

0G04BDBO

V EU/1/04/294/009 Em se le x ta ble t m va 15m g

0,50 stuk

1,65963

0G04BDBO

V EU/1/04/294/017 Em se le x ta ble t m va 7,5m g

1,00 stuk

0,82981

0G04BDBO 0G04BDBO

V EU/1/04/294/023 Em se le x ta ble t m va 15m g V EU/1/07/386/003 To via z ta ble t m va 4m g

0,50 stuk 1,00 stuk

1,65963 0,82981

0G04BDBO

V EU/1/07/386/008 To via z ta ble t m va 8m g

0,50 stuk

1,65963

0G04C AAO 0G04C AAO

V 13689 V 17931

3,00 stuk 1,00 stuk

0,32067 0,96201

Xa tral ta ble t 2,5m g O m nic ca psule m ga 0,4m g

0G04C AAO

V 23923

Xa tral x r ta ble t m va 10m g

0,75 stuk

1,28268

0G04C AAO

V 28237=23923

Alfuzo sine hcl ta ble t m va 10m g

0,75 stuk

1,28268

0G04C AAO 0G04C AAO

V 30565 V 31128

O m nic o ca s ta ble t m va 0,4m g Alfuzo sine hcl cf ta blet m va 10m g

1,00 stuk 0,75 stuk

0,96201 1,28268

0G04C AAO

V 31635

Alfuzo sine hcl pch ta ble t 2,5m g

3,00 stuk

0,32067

0G04C AAO

V 32577

Ta m sulo sine hcl m ylan re ta rd capsule m ga 0,4m g

1,00 stuk

0,96201

0G04C AAO 0G04C AAO

V 32578 V 32582

Ta m sulo sine hcl a re ta rd ca psule m ga 0,4m g Ta m sulo sine hcl cf ca psule m ga 0,4m g

1,00 stuk 1,00 stuk

0,96201 0,96201

0G04C AAO

V 32584

Ta m sulo sine hcl pch re ta rd ca psule m ga 0,4m g

1,00 stuk

0,96201

0G04C AAO

V 32585

Ta m sulo sine hcl actavis re ta rd capsule m ga 0,4m g

1,00 stuk

0,96201

0G04C AAO 0G04C AAO

V 32690 V 32990

Ta m sulo sine hcl rp capsule m ga 0,4m g Alfuzo sine hcl ra nba x y re ta rd table t m va 10m g

1,00 stuk 0,75 stuk

0,96201 1,28268

0G04C AAO

V 32991

Alfuzo sine hcl a re tard ta ble t m va 10m g

0,75 stuk

1,28268

0G04C AAO

V 33134

Alfuzo sine hcl sando z re ta rd ta blet m va 10m g

0,75 stuk

1,28268

0G04C AAO 0G04C AAO

V 33407 V 33413

ALFUZO SINE HC L MYLAN R ETAR D TABLET MVA 10MG Alfuzo sine hcl rp ta ble t m va 10m g

0,75 STUK 0,75 stuk

1,28268 1,28268

0G04C AAO

V 33595

TAMSULO SINE HC L AP O TEX R ETAR D C APSULE MGA 0,4MG

1,00 stuk

0,96201

0G04C AAO

V 34075

Ta m sulo sine hcl ranba x y ca psule m ga 0,4m g

1,00 stuk

0,96201

0G04C AAO

V 34555

Alfuzo sine hcl a cta vis reta rd ta ble t m va 10m g

0,75 stuk

1,28268

0G04C BAO

V 100233//28317

Avo da rt ca psule 0,5m g

1,00 stuk

1,12371

0G04C BAO

V 100349//28317

Avo da rt ca psule 0,5m g

1,00 stuk

1,12371

0G04C BAO 0G04C BAO

V 100801//28317 V 102438//28317

Avo da rt ca psule 0,5m g Avo da rt ca psule 0,5m g

1,00 stuk 1,00 stuk

1,12371 1,12371

0G04C BAO

V 15482

P ro sca r ta ble t 5m g

1,00 stuk

1,12371

0G04C BAO

V 21662//15482

P ro sca r ta ble t 5m g

1,00 stuk

1,12371

0G04C BAO 0G04C BAO

V 28317 V 31577//28317

Avo da rt ca psule 0,5m g Avo da rt ca psule 0,5m g

1,00 stuk 1,00 stuk

1,12371 1,12371

0G04C BAO

V 31778

Fina ste ride sa ndo z ta blet film om huld 5m g

1,00 stuk

1,12371

0G04C BAO

V 32039//28317

Avo da rt ca psule 0,5m g

1,00 stuk

1,12371

0G04C BAO 0G04C BAO

V 32468 V 32868//28317

Fina ste ride m yla n ta ble t film o m huld 5m g Avo da rt ca psule 0,5m g

1,00 stuk 1,00 stuk

1,12371 1,12371

0G04C BAO

V 33578

Fina ste ride k a twijk ta ble t film o m huld 5m g

1,00 stuk

1,12371

0G04C BAO

V 33590

Fina ste ride a cta vis ta ble t film o m huld 5m g

1,00 stuk

1,12371

0G04C BAO 0G04C BAO

V 34596 V 34605

Fina ste ride a ta ble t film o m huld 5m g Fina ste ride rp ta ble t film o m huld 5m g

1,00 stuk 1,00 stuk

1,12371 1,12371

0G04C BAO

V 35032

Fina ste ride a uro bindo ta blet film om huld 5m g

1,00 stuk

1,12371

0G04C BAO

V 35128

Fina ste ride pch ta ble t film o m huld 5m g

1,00 stuk

1,12371

0H01BAAN

V 13958

Minrin ne usspra y 0,1m g/m l spuitbus 5m l

2,50 do

0,71389

0H01BAAN

V 24110

De sm o pressine sa ndo z ne usspr 10m cg/do fla co n 50do

2,50 do

0,71389

0H01BAAN

V 24278

De sm o pressine actavis ne usspr 10m cg/do fla c 50do

2,50 do

0,71389

0H01BAAN 0H01BAAN

V 27799=24278 V 6684

De sm o pressine pch ne usspr 10m cg/do fla co n 50do Minrin ne usdruppe ls 0,1m g/m l

2,50 do 0,25 m l

0,71389 7,13888

0H01BAAO

V 101728

De sm o pressine aceta a t m yla n ta blet 0,1m g

4,00 stuk

0,94769

0H01BAAO 0H01BAAO

V 101729 V 12624

De sm o pressine aceta a t m yla n ta blet 0,2m g Minrin ta blet 0,1m g

2,00 stuk 4,00 stuk

1,57948 0,94769

0H01BAAO

V 12625

Minrin ta blet 0,2m g

2,00 stuk

1,57948

0H01BAAO

V 30781

De sm o pressine aceta a t pch table t 0,1m g

4,00 stuk

0,94769

0H01BAAO 0H01BAAO

V 30782 V 30783

De sm o pressine aceta a t pch table t 0,2m g De sm o pressine aceta a t a cta vis ta blet 0,1m g

2,00 stuk 4,00 stuk

1,57948 0,94769

0H01BAAO

V 30784

De sm o pressine aceta a t a cta vis ta blet 0,2m g

2,00 stuk

1,57948

0H01BAAO

V 30855

Minrin m e lt lyo philisa at 60m cg

3,00 stuk

1,26358

0H01BAAO 0H01BAAO

V 30856 V 30857

Minrin m e lt lyo philisa at 120m cg Minrin m e lt lyo philisa at 240m cg

1,50 stuk 0,75 stuk

2,10597 4,21194

0H01BAAO

V 32841

De sm o pressine aceta a t sa ndoz ta ble t 0,1m g

4,00 stuk

0,94769

0H01BAAO

V 32842

De sm o pressine aceta a t sa ndoz ta ble t 0,2m g

2,00 stuk

1,57948

0H01C AAP

V 11672

R e lefa ct lh-rh inje ctie vlo eistof 0,1m g/m l a m p 1m l

1,00 m l

0H01C ABP

V 10918

Lutre le f inje ctiepo e de r fl 0,8m g+so lv 10m l injpa tr

0,20 stuk

116,04975

0H01C ABP

V 10919

LUTR ELEF INJPDR FLAC O N 3,2MG + SO LV 10ML + TO EBEH

0,05 stuk

464,19900

0H01C BAP

V 18235

Sa ndo sta tine la r injpdr fl 10m g + so lv 2m l

0,07 stuk

653,44350

0H01C BAP

V 18236

Sa ndo sta tine la r injpdr fl 20m g + so lv 2m l

0,04 stuk

1.089,07250

0H01C BAP 0H01C BAP

V 18237 V 21386

Sa ndo sta tine la r injpdr fl 30m g + so lv 2m l So m a tuline pr injpdr fla co n 30m g+so lv 2m l+to e beh

0,02 stuk 0,07 stuk

1.633,60875 541,99169

0H01C BAP

V 26301

So m a tuline a uto solution 60 inj 300m g/m l wws 0,2m l

0,04 stuk

1.083,98338

0H01C BAP

V 26302

So m a tuline a uto solution 90 inj 300m g/m l wws 0,3m l

0,02 stuk

1.625,97507

0H01C BAP 0H01C BAP

V 26303 V 31749//18235

So m a tuline a uto solution 120 inj 300m g/m l wws 0,4m l Sa ndo sta tine la r injpdr fl 10m g + so lv 2m l

0,02 stuk 0,07 stuk

2.167,96676 653,44350

0H01C BAP

V 31750//18236

Sa ndo sta tine la r injpdr fl 20m g + so lv 2m l

0,04 stuk

1.089,07250

0H01C BAP

V 31751//18237

Sa ndo sta tine la r injpdr fl 30m g + so lv 2m l

0,02 stuk

1.633,60875

0H01C BAP 0H01C BAP

V 33114//26303 V 33509//26302

So m a tuline a uto solution 120 inj 300m g/m l wws 0,4m l So m a tuline a uto solution 90 inj 300m g/m l wws 0,3m l

0,02 stuk 0,02 stuk

2.167,96676 1.625,97507

0H01C BAP

V 33510//26303

So m a tuline a uto solution 120 inj 300m g/m l wws 0,4m l

0,02 stuk

2.167,96676

0H01C BAP

V 34140//26303

So m a tuline a uto solution 120 inj 300m g/m l wws 0,4m l

0,02 stuk

2.167,96676

0H01C BAP 0H01C BAP

V 34634//26301 V 34635//26302

So m a tuline a uto solution 60 inj 300m g/m l wws 0,2m l So m a tuline a uto solution 90 inj 300m g/m l wws 0,3m l

0,04 stuk 0,02 stuk

1.083,98338 1.625,97507

0H01C BAP

V 34636//26303

So m a tuline a uto solution 120 inj 300m g/m l wws 0,4m l

0,02 stuk

2.167,96676

0H01C BBP 0H01C BBP

V 12612 V 12613

Sa ndo sta tine injvlst 0,05m g/m l a m pul 1m l Sa ndo sta tine injvlst 0,1m g/m l a m pul 1m l

0H01C BBP

V 12614

0H01C BBP

V 14997

0H01C BBP 0H01C BBP

17,08480

14,00 m l 7,00 m l

8,68027 10,85034

Sa ndo sta tine injvlst 0,2m g/m l fla co n 5m l

3,50 m l

21,70068

Sa ndo sta tine injvlst 0,5m g/m l a m pul 1m l

1,40 m l

54,25170

V 20391//12613 V 21128//12612

Sa ndo sta tin injvlst 0,1m g/m l a m pul 1m l Sa ndo sta tin injvlst 0,05m g/m l a m pul 1m l

7,00 m l 14,00 m l

10,85034 8,68027

0H01C BBP

V 21230//14997

Sa ndo sta tin injvlst 0,5m g/m l a m pul 1m l

1,40 m l

54,25170

0H01C BBP

V 35046

O C TR EO TIDE HO SP IR A INJVLST 0,05MG/ML FLAC O N 1ML

0H01C BBP 0H01C BBP

V 35047 V 35048

0H01C BBP

V 35049

0H01C C AP 0H01C C AP

14,00 m l

8,68027

O C TR EO TIDE HO SP IR A INJVLST 0,1MG/ML FLAC O N 1ML O C TR EO TIDE HO SP IR A INJVLST 0,5MG/ML FLAC O N 1ML

7,00 m l 1,40 m l

10,85034 54,25170

O C TR EO TIDE HO SP IR A INJVLST 0,2MG/ML FLAC O N 5ML

3,50 m l

21,70068

V EU/1/00/130/001 O rga lutra n injvlst 0,5m g/m l wwsp 0,5m l V EU/1/99/100/001 C e tro tide injpdr fla co n 0,25m g + so lv 1m l + to e beh

1,00 stuk 1,00 stuk

39,29089 39,29089

0H01C C AP

V EU/1/99/100/002 C e tro tide injpdr fla co n 0,25m g + so lv 1m l + to e beh

1,00 stuk

39,29089

0H01C C AP

V EU/1/99/100/003 C e tro tide injpdr fla co n 3m g + solv 3m l + to ebe h

0,08 stuk

471,49063

0H02AAAO

V 21788=50721

Fludro co rtiso n a ce ta a t pch ta blet 62,5m cg

1,60 stuk

0,02612

0H02AAAO

V 50721

Fludro co rtiso n a ce ta a t cf ta ble t 62,5m cg

1,60 stuk

0,02612

0H02AAAO

V 7897

Flo rinef ta blet 0,1m g

1,00 stuk

0,04179

0H02ABAO

V 101367//18765

Ento co rt ca psule m ga 3m g

3,00 stuk

1,02100

0H02ABAO

V 18765

Ento co rt ca psule m ga 3m g

3,00 stuk

1,02100

0H02ABAO

V 22557

Bude no falk ca psule m ga 3m g

3,00 stuk

1,02100

0H02ABAP V 14871

So lu co rte f injpdr 100m g + 2m l so lv in act o vial

0,30 stuk

4,47430

0H02ABAP V 55486

Hydro co rtiso n pch injpdr fla co n 100m g +so lv 2m l

0,30 stuk

4,47430

0H02ABAP V 608

So lu co rte f inje ctie po e der fla co n 100m g

0,30 stuk

4,47430

0H02ABAP V 8375//608

So lu co rte f inje ctie po e der fla co n 100m g

0,30 stuk

4,47430

0H02ABBO V 114

O ra de x o n ta ble t 1,5m g

1,00 stuk

0,09983

0H02ABBO V 14256=50970

P re dniso n sa ndoz ta ble t 5m g

2,00 stuk

0,04992

0H02ABBO V 14257=50969 0H02ABBO V 17518=50969

P re dniso lo n sa ndo z ta blet 5m g P R EDNISO LO N APO TEX TABLET 5MG

2,00 stuk 2,00 stuk

0,04992 0,04992

0H02ABBO V 18233=50969

P re dniso lo n a cta vis ta ble t 5m g

2,00 stuk

0,04992

0H02ABBO V 18234=50970

P re dniso n a cta vis ta blet 5m g

2,00 stuk

0,04992

0H02ABBO V 1834 0H02ABBO V 20281=52542

C e lesto ne ta ble t 0,5m g P R EDNISO LO N A TABLET 5MG

3,00 stuk 2 STUK

0,03328 0,04992

0H02ABBO V 20282=52543

P re dniso n a table t 5m g

2,00 stuk

0,04992

0H02ABBO V 21768=56079

De x am e thaso n rp ta ble t 0,5m g

3,00 stuk

0,03328

0H02ABBO V 21769=56080 0H02ABBO V 22248=53166

De x am e thaso n rp ta ble t 1,5m g Triam cino lo n pch table t 4m g

1,00 stuk 2,00 stuk

0,09983 0,04992

0H02ABBO V 25029

P re dniso lo n pch ta ble t 20m g

0,50 stuk

0,19967

0H02ABBO V 25347

P re dniso lo n ta blet 30m g

0,33 stuk

0,29950

0H02ABBO V 27448=25029 0H02ABBO V 29042=52543

P re dniso lo n a cta vis ta ble t 20m g P re dniso n m erck ta blet 5m g

0,50 stuk 2,00 stuk

0,19967 0,04992

0H02ABBO V 29043=52542

P R EDNISO LO N MYLAN TABLET 5MG

0H02ABBO V 30200

P re dniso lo n pch ta ble t 30m g

0,33 stuk

0,29950

0H02ABBO V 50766 0H02ABBO V 50969

P re dniso lo n cf table t 5m g P re dniso lo n pch ta ble t 5m g

2,00 stuk 2,00 stuk

0,04992 0,04992

0H02ABBO V 50970

P re dniso n pch table t 5m g

2,00 stuk

0,04992

0H02ABBO V 52249

P re dniso n a po te x table t 5m g

2,00 stuk

0,04992

0H02ABBO V 52542 0H02ABBO V 52543

P re dniso lo n rp ta ble t 5m g P re dniso n rp table t 5m g

2,00 stuk 2,00 stuk

0,04992 0,04992

0H02ABBO V 52990

De x am e thaso n cf table t 0,5m g

3,00 stuk

0,03328

0H02ABBO V 53073

P re dniso n cf ta ble t 5m g

2,00 stuk

0,04992

0H02ABBO V 53166 0H02ABBO V 56079

Triam cino lo n cf ta ble t 4m g De x am e thaso n pch ta ble t 0,5m g

2,00 stuk 3,00 stuk

0,04992 0,03328

0H02ABBO V 56080

De x am e thaso n pch ta ble t 1,5m g

1,00 stuk

0,09983

0H02ABBP V 1836 0H02ABBP V 33744//6664

C e lesto ne injvlst 4m g/m l a m pul 1m l So lu m e dro l infusie po ede r flacon 1000m g

0,38 stuk 0,02 stuk

1,70767 32,01880

0H02ABBP V 5302

So lu m e dro l injpdr fla c 40m g+1m l so lv in m ix o via l

0,50 stuk

1,28075

0H02ABBP V 55091

De x am e thaso n cf injvlst 20m g/m l a m pul 1m l

0,08 stuk

8,53835

0H02ABBP V 55091 0H02ABBP V 55091

Injvlst de x a m e tha so num 20m g/m l a m pul 5m l De x am e thaso n cf injvlst 20m g/m l a m pul 1m l

0,02 stuk 0,08 stuk

42,69173 8,53835

0H02ABBP V 55091

Injvlst de x a m e tha so num 20m g/m l a m pul 5m l

0,02 stuk

42,69173

0H02ABBP V 6664

So lu m e dro l infusie po ede r flacon 1000m g

0,02 stuk

32,01880

0H02ABBP V 6664 0H02ABBP V 6664

So lu m e dro l infusie po ede r flacon 500m g So lu m e dro l infusie po ede r flacon 1000m g

0,04 stuk 0,02 stuk

16,00940 32,01880

0H02ABBP V 6664

So lu m e dro l infusie po ede r flacon 500m g

0,04 stuk

16,00940

0H02ABBP V 7041

So lu m e dro l infusie po ede r flacon 125m g +so lv 2m l

0,16 stuk

4,00235

0H02ABBP V 7041 0H02ABBP V 7041

So lu m e dro l infusie po ede r flacon 250m g +so lv 4m l So lu m e dro l infusie po ede r flacon 250m g +so lv 4m l

0,08 stuk 0,08 stuk

8,00470 8,00470

2 STUK

0,04992

0H02ABBP V 7041

So lu m e dro l infusie po ede r flacon 125m g +so lv 2m l

0,16 stuk

4,00235

0H02ABC O V 22520=50730 0H02ABC O V 50730

Hydro co rtiso n pch table t 20m g Hydro co rtiso n cf ta ble t 20m g

1,50 stuk 1,50 stuk

0,10927 0,10927

0H02ABC O V 52054

C o rtiso naceta a t pch table t 5m g

7,50 stuk

0,03934

0H02ABC O V 52055

C o rtiso naceta a t pch table t 25m g

1,50 stuk

0,10927

0H02ABC O V 52495

Hydro co rtiso n rp table t 20m g

1,50 stuk

0,10927

0H02ABEP

V 12916//605

DEPO MEDR O L INJVLST 40MG/ML

0,50 m l

2,06924

0H02ABEP

V 16239//5341

Ke na co rt re ta rd 40 injsusp 40m g/m l a m pul 1m l

0,19 m l

5,51796

0H02ABEP 0H02ABEP

V 23115//5341 V 23847//5341

Ke na co rt a 40 injectie suspensie 40m g/m l a m pul 1m l Ke na co rt a 40 injectie suspensie 40m g/m l a m pul 1m l

0,19 m l 0,19 m l

5,51796 5,51796

0H02ABEP

V 34023//5341

Ke na co rt a 40 injectie suspensie 40m g/m l a m pul 1m l

0,19 m l

5,51796

0H02ABEP

V 50859

P re dniso lo nna trium succina a t cf injpdr flacon 25m g

0,40 stuk

2,58654

0H02ABEP 0H02ABEP

V 5341 V 5399

Ke na co rt a 40 injectie suspensie 40m g/m l C e lesto ne chro nodo se injsusp

0,19 m l 0,07 m l

5,51796 14,74330

0H02ABEP

V 56517

O R ADEXO N INJVLST 5MG/ML

0,30 m l

3,44873

0H02ABEP

V 605

De po m e drol injvlst 40m g/m l

0,50 m l

2,06924

0H03AAAO K 11718

Euthyrox ta ble t 25m cg

6,00 stuk

0,02329

0H03AAAO K 9334

Thyra x duo ta b ta blet 0,025m g

6,00 stuk

0,02329

0H03AAAO V 11344 0H03AAAO V 11345

Euthyrox ta ble t 50m cg Euthyrox ta ble t 150m cg

3,00 stuk 1,00 stuk

0,02563 0,06408

0H03AAAO V 13683

Thyra x duo ta b ta blet 0,150m g

1,00 stuk

0,06408

0H03AAAO V 15468

Euthyrox ta ble t 125m cg

1,20 stuk

0,05340

0H03AAAO V 21494 0H03AAAO V 26173

Euthyrox ta ble t 75m cg Euthyrox ta ble t 175m cg

2,00 stuk 0,86 stuk

0,03204 0,07476

0H03AAAO V 26174

Euthyrox ta ble t 200m cg

0,75 stuk

0,08544

0H03AAAO V 56059

LEVO THYR O XINE NYC O MED TABLET 100MC G

1,50 stuk

0,04272

0H03AAAO V 57234 0H03AAAO V 8389

LEVO THYR O XINE NYC O MED TABLET 50MC G Thyra x duo ta b ta blet 0,100m g

3,00 stuk 1,50 stuk

0,02563 0,04272

0H03AAAO V 8451

Eltro x in 50 ta ble t 50m cg

3,00 stuk

0,02563

0H03AAAO V 8452

Eltro x in 100 table t 100m cg

1,50 stuk

0,04272

0H03AAAO V 9009

Euthyrox ta ble t 100m cg

1,50 stuk

0,04272

0H05AAAP V EU/1/03/247/001

Forste o injvlst 250m cg/m l wwsp 3m l

0,11 m l

145,33333

0H05AAAP V EU/1/06/339/001

P re ota ct injpdr 100m cg/do patro o n + so lv 1,13m l

1,00 do

15,57115

0J01AABO

V 11576

Unido x so lutab ta ble t 100m g

1,00 stuk

0,59289

0J01AABO

V 12871

Do x ycycline a cta vis dispe r ta ble t 100m g

1,00 stuk

0,59289

0J01AABO

V 15344

Do x y disp pch table t 100m g

1,00 stuk

0,59289

0J01AABO 0J01AABO

V 16491 V 19009

Do x ycycline rp disperge e rba a r ta ble t 100m g Do x ycyclinum disperge e rba a r ta ble t 100m g

1,00 stuk 1,00 stuk

0,59289 0,59289

0J01AABO

V 19484

Do x ycyclinum disperge e rba a r ta ble t 100m g

1,00 stuk

0,59289

0J01AABO

V 20361

Do x ycycline sando z dispe r table t 100m g

1,00 stuk

0,59289

0J01AABO 0J01AABO

V 22098 V 22099

Mino cycline actavis ta ble t 50m g Mino cycline actavis ta ble t 100m g

2,00 stuk 1,00 stuk

0,35574 0,59289

0J01AABO

V 22153

MINO C YC LINE MYLAN TABLET 50MG

0J01AABO

V 22154

Mino cycline m ylan ta ble t 100m g

1,00 stuk

0,59289

0J01AABO 0J01AABO

V 22155 V 22156

Mino cycline sa ndo z table t 50m g Mino cycline sa ndo z table t 100m g

2,00 stuk 1,00 stuk

0,35574 0,59289

0J01AABO

V 22423

Do x ycyclinum disperge e rba a r ta ble t 100m g

1,00 stuk

0,59289

2 STUK

0,35574

0J01AABO

V 23881

Do x ycycline a cco rd disper ta blet 100m g

1,00 stuk

0,59289

0J01AABO 0J01AABO

V 25319 V 25320

Mino cycline pch ta blet 50m g Mino cycline pch ta blet 100m g

2,00 stuk 1,00 stuk

0,35574 0,59289

0J01AABO

V 25835

DO XYC YC LINE MYLAN DISPER TABLET 100MG

0J01AABO

V 51845

Do x ycycline rp ta ble t 100m g

1,00 stuk

0,59289

0J01AABO 0J01AABO

V 56596 V 56838

Do x ycyclinum disperge e rba a r ta ble t 100m g Do x ycycline cf dispe r ta ble t 100m g

1,00 stuk 1,00 stuk

0,59289 0,59289

0J01AABO

V 56951

DO XYC YC LINE AP O TEX DISP ER TABLET 100MG

1,00 STUK

0,59289

0J01AABO

V 56952

Do x ycyclinum ta ble t 100m g

1,00 stuk

0,59289

0J01AABO

V 9519

Do x ycycline pch ta ble t 100m g

1,00 stuk

0,59289

1 STUK

0,59289

0J01C AAO B 14819

Am ox icilline pch pdr v susp 100m g/m l

11,25 m l

0,13210

0J01C AAO B 57301

Am ox icilline k a rib suik e rvrij pdr v susp 100m g/m l

11,25 m l

0,13210

0J01C AAO B 7467

Fle m o x in poe de r vo o r suspe nsie 100m g/m l

11,25 m l

0,13210

0J01C AAO K 11162

Am ox icilline pch fo rte pdr v susp 250m g/5m l

22,50 m l

0,04833

0J01C AAO K 12518

Am ox icilline rp capsule 250m g

4,50 stuk

0,24164

0J01C AAO K 12546 0J01C AAO K 12547

Fle m o x in so lutab ta ble t 125m g Fle m o x in so lutab ta ble t 250m g

9,00 stuk 4,50 stuk

0,14498 0,24164

0J01C AAO K 14812=12518

Am ox icilline pch capsule 250m g

0J01C AAO K 14820

Am ox icilline pch po e de r voo r suspensie 125m g/5m l

0J01C AAO K 15434=14778 0J01C AAO K 20691

Am ox icilline sa ndo z ca psule 250m g Am ox icilline dispe r m yla n table t 250m g

0J01C AAO K 24118=12547

AMO XIC ILLINE DISP TEVA TABLET 250MG

0J01C AAO K 29702

Am ox icilline sa ndo z po e der v suspe nsie 125m g/5m l

45,00 m l

0,02900

0J01C AAO K 29703 0J01C AAO K 55351

Am ox icilline sa ndo z po e der v suspe nsie 250m g/5m l Am ox icilline cf ca psule 250m g

22,50 m l 4,50 stuk

0,04833 0,24164

0J01C AAO K 56932

Am ox icillinum capsule 250m g

0J01C AAO K 57302

Am ox icilline k a rib suik e rvrij pdr v susp 125m g/5m l

45,00 m l

0,02900

0J01C AAO K 57303 0J01C AAO K 57443

Am ox icilline k a rib suik e rvrij pdr v susp 250m g/5m l AMO XIC ILLINE AP O TEX SKVR P DR V SUSP 125MG/5ML

22,50 m l 45 ML

0,04833 0,02900

0J01C AAO K 57444

Am ox icilline apo te x sk vr pdr v susp 250m g/5m l

22,50 m l

0,04833

0J01C AAO K 7465

Fle m o x in poe de r vo o r suspe nsie 125m g/5m l

45,00 m l

0,02900

0J01C AAO K 7466

Fle m o x in poe de r vo o r suspe nsie 250m g/5m l

22,50 m l

0,04833

0J01C AAO V 11217

AMO XIC ILLINE MYLAN C AP SULE 500MG

2,25 STUK

0,41542

0J01C AAO V 12519

Am ox icilline rp capsule 375m g

3,00 stuk

0,31157

0J01C AAO V 12520 0J01C AAO V 12548

Am ox icilline rp capsule 500m g Fle m o x in so lutab ta ble t 375m g

2,25 stuk 3,00 stuk

0,41542 0,31157

0J01C AAO V 12549

Fle m o x in so lutab ta ble t 500m g

2,25 stuk

0,41542

0J01C AAO V 12550

Fle m o x in so lutab ta ble t 750m g

1,50 stuk

0,62313

0J01C AAO V 14813=12519 0J01C AAO V 14814=12520

Am ox icilline pch capsule 375m g Am ox icilline pch capsule 500m g

3,00 stuk 2,25 stuk

0,31157 0,41542

0J01C AAO V 15435=14779

Am ox icilline sa ndo z ca psule 375m g

3,00 stuk

0,31157

0J01C AAO V 15436=14780

Am ox icilline m p ca psule 500m g

2,25 stuk

0,41542

0J01C AAO V 16913 0J01C AAO V 17422

AMO XIC ILLINE AP O TEX C APSULE 500MG Am ox icilline dispe r a cta vis table t 375m g

2,25 STUK 3,00 stuk

0,41542 0,31157

0J01C AAO V 17423

Am ox icilline dispe r a cta vis table t 500m g

2,25 stuk

0,41542

0J01C AAO V 17424

Am ox icilline dispe r a cta vis table t 750m g

1,50 stuk

0,62313

0J01C AAO V 20456 0J01C AAO V 20457

Am ox icilline dispe r cf ta blet 375m g Am ox icilline dispe r cf ta blet 500m g

3,00 stuk 2,25 stuk

0,31157 0,41542

0J01C AAO V 20458

Am ox icilline dispe r cf ta blet 750m g

1,50 stuk

0,62313

4,50 stuk 45,00 m l 4,50 stuk 4,50 stuk 4,50 stuk

4,50 stuk

0,24164 0,02900 0,24164 0,24164 0,24164

0,24164

0J01C AAO V 20693 0J01C AAO V 20694

Am ox icilline dispe r m yla n table t 500m g AMO XIC ILLINE DISP ER MYLAN TABLET 750MG

2,25 stuk 1,50 STUK

0,41542 0,62313

0J01C AAO V 24119=12548

AMO XIC ILLINE DISP TEVA TABLET 375MG

3,00 stuk

0,31157

0J01C AAO V 24120=12549

AMO XIC ILLINE DISP TEVA TABLET 500MG

2,25 stuk

0,41542

0J01C AAO V 24121=12550 0J01C AAO V 24239=12548

AMO XIC ILLINE DISP TEVA TABLET 750MG AMO XIC ILLINE DISP ER AP O TEX TABLET 375MG

1,50 stuk 3,00 stuk

0,62313 0,31157

0J01C AAO V 24240=12549

AMO XIC ILLINE DISP ER AP O TEX TABLET 500MG

2,25 stuk

0,41542

0J01C AAO V 24241=12550

AMO XIC ILLINE DISP ER AP O TEX TABLET 750MG

1,50 stuk

0,62313

0J01C AAO V 24256=12548 0J01C AAO V 24257=12549

Am ox icilline dispe r sando z ta ble t 375m g Am ox icilline dispe r sando z ta ble t 500m g

3,00 stuk 2,25 stuk

0,31157 0,41542

0J01C AAO V 24258=12550

Am ox icilline dispe r m p table t 750m g

1,50 stuk

0,62313

0J01C AAO V 24271=12548

Am ox icilline dispe r rp ta ble t 375m g

3,00 stuk

0,31157

0J01C AAO V 24272=12549 0J01C AAO V 24273=12550

Am ox icilline dispe r rp ta ble t 500m g Am ox icilline dispe r rp ta ble t 750m g

2,25 stuk 1,50 stuk

0,41542 0,62313

0J01C AAO V 25942

Am ox icilline sa ndo z ca psule 500m g

2,25 stuk

0,41542

0J01C AAO V 26684

Am ox icilline dispe r sando z ta ble t 500m g

2,25 stuk

0,41542

0J01C AAO V 26685 0J01C AAO V 26686

Am ox icilline dispe r sando z ta ble t 750m g Am ox icilline dispe r sando z ta ble t 1000m g

1,50 stuk 1,12 stuk

0,62313 0,83084

0J01C AAO V 55047

Am ox icillinum capsule 375m g

3,00 stuk

0,31157

0J01C AAO V 55060

Am ox icilline cf ca psule 375m g

3,00 stuk

0,31157

0J01C AAO V 55123 0J01C AAO V 55287

Am ox icilline k a rib ca psule 500m g Am ox icilline cf ca psule 500m g

2,25 stuk 2,25 stuk

0,41542 0,41542

0J01C AAO V 56827

Am ox icilline dispe r k a rib ta ble t 500m g

2,25 stuk

0,41542

0J01C AAO V 56828

Am ox icilline dispe r k a rib ta ble t 750m g

1,50 stuk

0,62313

0J01C AAO V 56933 0J01C AAO V 56934

Am ox icillinum capsule 375m g Am ox icilline ca psule 500m g

3,00 stuk 2,25 stuk

0,31157 0,41542

0J01C ADP

V 57326

Am ox icilline cf inje ctie po e der fla co n 250m g

4,50 stuk

0,91392

0J01C ADP 0J01C ADP

V 57326 V 57326

Am ox icilline cf inje ctie po e der fla co n 500m g Am ox icilline cf inje ctie po e der fla co n 500m g

2,25 stuk 2,25 stuk

1,82783 1,82783

0J01C ADP

V 57326

Am ox icilline cf inje ctie po e der fla co n 1000m g

1,12 stuk

3,65566

0J01C ADP

V 57326

Am ox icilline cf inje ctie po e der fla co n 500m g

2,25 stuk

1,82783

0J01C ADP 0J01C ADP

V 57326 V 57326

Am ox icilline cf inje ctie po e der fla co n 250m g Am ox icilline cf inje ctie po e der fla co n 250m g

4,50 stuk 4,50 stuk

0,91392 0,91392

0J01C ADP

V 57326

Am ox icilline cf inje ctie po e der fla co n 1000m g

1,12 stuk

3,65566

0J01C ADP

V 57326

Am ox icilline cf inje ctie po e der fla co n 1000m g

1,12 stuk

3,65566

0J01C EAO

K 2672

BR O XIL PO EDER VO O R SUSP ENSIE 125MG/5ML

0J01C EAO

V 22314=18645

Feno x ym e thylpe nicilline pch ta ble t disp 500m g

1,50 stuk

0,29950

0J01C EAO 0J01C EAO

V 24589=50288 V 4959

Feno x ym e thylpe nicilline pch ca psule 250m g Bro x il ca psule 250m g

3,00 stuk 3,00 stuk

0,14975 0,14975

0J01C EAO

V 50288

Feno x ym e thylpe nicilline cf ca psule 250m g

3,00 stuk

0,14975

0J01C EAO

V 9101

Bro x il ca psule 500m g

1,50 stuk

0,29950

0J01C FAO

K 10927

Fluclo x acilline gf ca psule 250m g

0J01C FAO

K 14314

Flo x a pe n poe de r vo o r suspe nsie 125m g/5m l

0J01C FAO

K 16939

Fluclo x acilline a cta vis ca psule 250m g

8,00 stuk

0,41748

0J01C FAO 0J01C FAO

K 18806=16939 K 32164

Fluclo x acilline cf capsule 250m g Fluclo x acilline sando z ca psule 250m g

8,00 stuk 8,00 stuk

0,41748 0,41748

0J01C FAO

K 9827

Fluclo x acilline pch ca psule 250m g

8,00 stuk

0,41748

30,00 m l

8,00 stuk 80,00 m l

0,03358

0,41748 0,04175

0J01C FAO 0J01C FAO

V 10928 V 16940

Fluclo x acilline rp ca psule 500m g Fluclo x acilline a cta vis ca psule 500m g

4,00 stuk 4,00 stuk

0,64891 0,64891

0J01C FAO 0J01C FAO

V 18564

FLUC LO XAC ILLINE AP O TEX C APSULE 500MG

4,00 STUK

0,64890

V 18807=16940

Fluclo x acilline cf capsule 500m g

4,00 stuk

0,64891

0J01C FAO 0J01C FAO

V 19237=9829 V 24102=10928

Fluclo x acilline e b 500 ca psule 500m g FLUC LO XAC ILLINE MYLAN C AP SULE 500MG

4,00 stuk 4,00 STUK

0,64891 0,64890

0J01C FAO

V 32165

Fluclo x acilline sando z ca psule 500m g

4,00 stuk

0,64891

0J01C FAO

V 9828

Fluclo x acilline pch ca psule 500m g

4,00 stuk

0,64891

0J01C R AO K 11018

Augm e ntin suik e rvrij pdr v susp 250/62,50m g/5m l

30,00 m l

0,09298

0J01C R AO K 21691

Am ox i/cla v sa ndo z pdr v susp 125/31,25m g/5m l

60,00 m l

0,05579

0J01C R AO K 21692

Am ox i/cla v sa ndo z pdr v susp 250/62,5m g/5m l

30,00 m l

0,09298

0J01C R AO K 24114 0J01C R AO K 24337=21691

Forcid soluta b ta blet 250m g/62,5m g Am ox i/cla v pch pdr v susp 125/31,25m g/5m l

6,00 stuk 60,00 m l

0,46490 0,05579

0J01C R AO K 24338=21692

Am ox i/cla v pch fo rte pdr v susp 250/62,5m g/5m l

30,00 m l

0,09298

0J01C R AO K 24430=9842

Am ox i/cla v a pdr v susp 125/31,25m g/5m l

60,00 m l

0,05579

0J01C R AO K 24431=11018 0J01C R AO K 24805=21691

Am ox i/cla v a pdr v susp 250/62,5m g/5m l Am ox i/cla v a cta vis pdr v susp 125/31,25m g/5m l

30,00 m l 60,00 m l

0,09298 0,05579

0J01C R AO K 24806=21692

Am ox i/cla v a cta vis pdr v susp 250/62,5m g/5m l

30,00 m l

0,09298

0J01C R AO K 24814

AMO XI/C LAV MYLAN PDR V SUSP 125/31,25MG/5ML

60 ML

0,05579

0J01C R AO K 24815 0J01C R AO K 25437

AMO XI/C LAV MYLAN PDR V SUSP 250/62,5MG/5ML Am ox i/cla v cf pdr v susp 125/31,25m g/5m l

30 ML 60,00 m l

0,09298 0,05579

0J01C R AO K 25438

Am ox i/cla v cf pdr v susp 250/62,5m g/5m l

30,00 m l

0,09298

0J01C R AO K 26935=25588

Am ox i/cla v sa ndo z dispe r ta ble t 250/62,5m g

0J01C R AO K 33637 0J01C R AO K 33638

Am ox i/cla v a uro bindo pdr v susp 125/31,25m g/5m l Am ox i/cla v a uro bindo pdr v susp 250/62,5m g/5m l

60,00 m l 30,00 m l

0,05579 0,09298

0J01C R AO K 9842

Augm e ntin suik e rvrij pdr v susp 125/31,25m g/5m l

60,00 m l

0,05579

0J01C R AO V 102419 0J01C R AO V 102433

Am ox i/cla v rp ta ble t o m huld 500/125m g AMO XI/C LAV R P TABLET O MHULD 875/125MG

3,00 stuk 1,71 STUK

0,77778 1,36112

0J01C R AO V 18553

Augm e ntin bd table t om huld 875/125m g

1,71 stuk

1,36112

0J01C R AO V 21693

Am ox i/cla v sa ndo z ta blet 500/125m g

3,00 stuk

0,77778

0J01C R AO V 24116 0J01C R AO V 24339=21693

Forcid soluta b ta blet 500m g/125m g Am ox i/cla v pch ta ble t 500/125m g

3,00 stuk 3,00 stuk

0,77778 0,77778

0J01C R AO V 24432=9840

Am ox i/cla v a ta ble t 500/125m g

3,00 stuk

0,77778

0J01C R AO V 24807=21693

Am ox i/cla v a cta vis ta ble t 500/125m g

3,00 stuk

0,77778

0J01C R AO V 24816 0J01C R AO V 25439

Am ox i/cla v m yla n ta ble t 500/125m g Am ox i/cla v cf table t 500/125m g

3,00 stuk 3,00 stuk

0,77778 0,77778

0J01C R AO V 26932=25590

Am ox i/cla v pch dispe r table t 500/125m g

3,00 stuk

0,77778

0J01C R AO V 26937=25590

Am ox i/cla v sa ndo z dispe r ta ble t 500/125m g

3,00 stuk

0,77778

0J01C R AO V 27141 0J01C R AO V 28581=25590

Am ox i/cla v sa ndo z ta blet o m huld 875/125m g Am ox i/cla v a cta vis disper ta blet 500/125m g

1,71 stuk 3,00 stuk

1,36112 0,77778

0J01C R AO V 29415

Am ox i/cla v cf table t 875/125m g

1,71 stuk

1,36112

0J01C R AO V 29475

Am ox i/cla v pch dispe r table t 875/125m g

1,71 stuk

1,36112

0J01C R AO V 30176 0J01C R AO V 33635

AMO XI/C LAV AP O TEX TABLET O MHULD 500/125MG Am ox i/cla v a uro bindo ta blet o m huld 500/125m g

3,00 stuk 3,00 stuk

0,77778 0,77778

0J01C R AO V 33636

Am ox i/cla v a uro bindo ta blet o m huld 875/125m g

1,71 stuk

1,36112

0J01C R AO V 9840

Augm e ntin ta ble t 500/125m g

3,00 stuk

0,77778

0J01C R AP

K 10662

Augm e ntin inje ctie poe de r fla co n 1000/100m g (iv)

3,00 stuk

3,96600

0J01C R AP

K 11438

Augm e ntin inje ctie poe de r fla co n 500/ 50m g (iv)

6,00 stuk

1,98300

0J01C R AP

K 29420

Am ox i/cla v pch injpdr flacon 500/ 50m g

6,00 stuk

1,98300

6,00 stuk

0,46490

0J01C R AP

K 29725

Am ox i/cla v sa ndo z injpdr fla co n 500/ 50m g

6,00 stuk

1,98300

0J01C R AP

V 10661

Augm e ntin inje ctie poe de r fla co n 1000/200m g (iv)

3,00 stuk

3,49185

0J01C R AP 0J01C R AP

V 11437 V 11439

Augm e ntin inje ctie poe de r fla co n 500/100m g (iv) Augm e ntin infusiepo e de r fla co n 2000/200m g (iv)

6,00 stuk 1,50 stuk

2,09511 6,98370

0J01C R AP

V 27998

Am ox i/cla v pch injpdr flacon 1000/200m g

3,00 stuk

3,49185

0J01C R AP

V 27999

Am ox i/cla v pch infpdr fla co n 2000/200m g

1,50 stuk

6,98370

0J01C R AP 0J01C R AP

V 28025 V 28026

Am ox i/cla v sa ndo z injpdr fla co n 1000/200m g Am ox i/cla v sa ndo z infpdr fla co n 2000/200m g

3,00 stuk 1,50 stuk

3,49185 6,98370

0J01C R AP

V 29421

Am ox i/cla v pch injpdr flacon 500/100m g

6,00 stuk

2,09511

0J01C R AP

V 29678

Am ox i/cla v sa ndo z injpdr fla co n 500/100m g

6,00 stuk

2,09511

0J01DAAO V 6325

Ke fora l ta ble t 500m g

4,00 stuk

0,51227

0J01DAAP

V 16532

C e fa zo line m yla n injectie po ede r flac 1000m g

3,00 stuk

4,53780

0J01DAAP 0J01DAAP

V 4990 V 57366

Ke flin inje ctie po e der fla co n 1000m g C e fa zo line cf inje ctie poe de r fla co n 1000m g

4,00 stuk 3,00 stuk

3,40335 4,53780

0J01DAAP

V 6836

Ke fzo l inje ctiepo e de r fla co n 1000m g

3,00 stuk

4,53780

0J01DABO K 13225 0J01DABO K 14376

Zinna t 125 ta ble t 125m g Zinna t granulaa t voo r suspensie 25m g/m l

4,00 stuk 20,00 m l

0,78549 0,15710

0J01DABO K 15747

C e dax po ede r vo o r suspe nsie 180m g/5m l

11,11 m l

0,28278

0J01DABO K 8152

C e clo r gra nula a t vo o r suspe nsie 125m g/5m l

40,00 m l

0,09426

0J01DABO K 8153

C e clo r gra nula a t vo o r suspe nsie 250m g/5m l

20,00 m l

0,15710

0J01DABO V 101978//15745

C e dax ca psule 400m g

1,00 stuk

0J01DABO V 103108//15745

C e dax ca psule 400m g

1,00 stuk

4,18022

0J01DABO V 13226 0J01DABO V 13227

Zinna t 250 ta ble t 250m g Zinna t 500 ta ble t 500m g

2,00 stuk 1,00 stuk

2,09011 4,18022

0J01DABO V 15745

C e dax ca psule 400m g

1,00 stuk

4,18022

0J01DABO V 20440

C e fa clor sa ndo z ta blet 500m g

2,00 stuk

2,09011

0J01DABO V 8150 0J01DABO V 8151

C e clo r ca psule 250m g C e clo r ca psule 500m g

4,00 stuk 2,00 stuk

1,04506 2,09011

0J01DABP

V 100046

C e ftriax o n frese nius k a bi infpdr fla co n 2000m g

1,00 stuk

41,56640

0J01DABP 0J01DABP

V 100048 V 12824

C e ftriax o n frese nius k a bi injpdr fla co n 1000m g Zina ce f inje ctie poe de r fla co n 250m g

2,00 stuk 12,00 stuk

20,78320 4,84941

0J01DABP

V 12825

Zina ce f infusiepo e de r fla co n 1500m g

2,00 stuk

20,78320

0J01DABP

V 12826

Zina ce f inje ctie poe de r fla co n 1500m g

2,00 stuk

20,78320

0J01DABP 0J01DABP

V 15264 V 15264

C e furox im pch injectie po ede r flacon 1500m g C e furox im pch injectie po ede r flacon 750m g

2,00 stuk 4,00 stuk

20,78320 10,39160

0J01DABP

V 15264

C e furox im pch injectie po ede r flacon 250m g

12,00 stuk

4,84941

0J01DABP

V 15264

C e furox im pch injectie po ede r flacon 750m g

4,00 stuk

10,39160

0J01DABP 0J01DABP

V 15264 V 15264

C e furox im pch injectie po ede r flacon 250m g C e furox im pch injectie po ede r flacon 1500m g

12,00 stuk 2,00 stuk

4,84941 20,78320

0J01DABP

V 15264

C e furox im pch injectie po ede r flacon 750m g

4,00 stuk

10,39160

0J01DABP

V 15264

C e furox im pch injectie po ede r flacon 1500m g

2,00 stuk

20,78320

0J01DABP 0J01DABP

V 15264 V 20588

C e furox im pch injectie po ede r flacon 250m g C e furox im hik m a injpdr iv/im fla co n 750m g

12,00 stuk 4,00 stuk

4,84941 10,39160

0J01DABP

V 20590

C e furox im hik m a injpdr iv fla co n 1500m g

2,00 stuk

20,78320

0J01DABP

V 25608

C EFO TAXIME HO SPIR A INJPDR FLAC 1000 MG + SO LV 4 ML

4,00 stuk

10,39160

0J01DABP

V 25609

C EFO TAXIME HO SPIR A INJPDR FLAC 2000 MG + SO LV 10 ML

2,00 stuk

20,78320

4,18022

0J01DABP

V 26050

C e ftriax o n sa ndo z injpdr fla co n 1000m g

2,00 stuk

20,78320

0J01DABP

V 26051

C e ftriax o n sa ndo z injpdr fla co n 2000m g

1,00 stuk

41,56640

0J01DABP

V 27750

C e fo tax im pch injectie po ede r flacon 500m g

8,00 stuk

5,19580

0J01DABP 0J01DABP

V 27751 V 27755

C e fo tax im pch injectie po ede r flacon 1000m g C e fo tax im sa ndo z inje ctiepo e de r fla co n 1000m g

4,00 stuk 4,00 stuk

10,39160 10,39160

0J01DABP

V 27756

C e fo tax im sa ndo z inje ctiepo e de r fla co n 500m g

8,00 stuk

5,19580

0J01DABP

V 27773

C e ftriax o n pch injpdr fla co n 500m g

4,00 stuk

10,39160

0J01DABP 0J01DABP

V 27774 V 27775

C e ftriax o n pch injpdr fla co n 1000m g C e ftriax o n pch infusie po e der fla co n 2000m g

2,00 stuk 1,00 stuk

20,78320 41,56640

0J01DABP

V 28713

C e furox im sa ndo z inje ctiepo e de r fla co n 750m g

4,00 stuk

10,39160

0J01DABP

V 28714

C e furox im sa ndo z inje ctiepo e de r fla co n 1500m g

2,00 stuk

20,78320

0J01DABP 0J01DABP

V 29315 V 29316

C EFTR IAXO N AC TAVIS INJP DR FLAC O N 500MG C EFTR IAXO N AC TAVIS INJP DR FLAC O N 1000MG

4,00 stuk 2,00 stuk

10,39160 20,78320

0J01DABP

V 29317

C EFTR IAXO N AC TAVIS INFUSIEPO EDER FLAC O N 2000MG

1,00 stuk

41,56640

0J01DABP

V 29324

C e ftriax o n bipharm a injpdr fla co n 500m g

4,00 stuk

10,39160

0J01DABP 0J01DABP

V 29325 V 29326

C EFTR IAXO N FO C US INJP DR FLAC O N 1000MG C EFTR IAXO N FO C US INFUSIEP O EDER FLAC O N 2000MG

2,00 stuk 1,00 stuk

20,78320 41,56640

0J01DABP

V 29391

C e ftriax o n hik m a injpdr fla co n 1000m g

2,00 stuk

20,78320

0J01DABP

V 29392

C e ftriax o n hik m a infpdr fla co n 2000m g

1,00 stuk

41,56640

0J01DABP 0J01DABP

V 32695//9917 V 7586

R o ce phin infusie po ede r flacon 2000m g Ma ndol inje ctie poe de r fla co n 1000m g

1,00 stuk 6,00 stuk

41,56640 6,92773

0J01DABP

V 7587

Ma ndol inje ctie poe de r fla co n 2000m g

3,00 stuk

13,85547

0J01DABP

V 7623

Zina ce f inje ctie poe de r fla co n 750m g

4,00 stuk

10,39160

0J01DABP 0J01DABP

V 8647 V 8649

C la fora n injpdr fl 250m g C la fora n injpdr fl 1000m g

16,00 stuk 4,00 stuk

4,15664 10,39160

0J01DABP

V 9911

R o ce phin injpdr fla c 250m g + solv lido c 2m l (im )

8,00 stuk

5,19580

0J01DABP

V 9913

R o ce phin injpdr fla c 1000m g + so lv lidoc 3,5m l(im )

2,00 stuk

20,78320

0J01DABP 0J01DABP

V 9915 V 9916

R o ce phin injpdr fla c 500m g + solvens 5m l (iv) R o ce phin injpdr fla c 1000m g + so lve ns 10m l (iv)

4,00 stuk 2,00 stuk

10,39160 20,78320

0J01DABP

V 9917

R o ce phin infusie po ede r flacon 2000m g

1,00 stuk

41,56640

0J01DAC P 0J01DAC P

V 100278 V 100281

C e fta zidim m yla n inje ctiepo e de r fla co n 500m g C e fta zidim m yla n inje ctiepo e de r fla co n 1000m g

8,00 stuk 4,00 stuk

10,99283 21,98565

0J01DAC P

V 100282

C e fta zidim m yla n inje ctiepo e de r fla co n 2000m g

2,00 stuk

43,97130

0J01DAC P

V 10540

Fortum inje ctie po e der fla co n 1000m g (im /iv)

4,00 stuk

21,98565

0J01DAC P 0J01DAC P

V 12847 V 12848

Fortum inje ctie po e der fla co n 500m g (im /iv) Fortum inje ctie po e der fla co n 2000m g (iv)

8,00 stuk 2,00 stuk

10,99283 43,97130

0J01DAC P

V 28176

C e fta zidim pch inje ctie po e der fla co n 500m g

8,00 stuk

10,99283

0J01DAC P

V 28177

C e fta zidim pch inje ctie po e der fla co n 1000m g

4,00 stuk

21,98565

0J01DAC P 0J01DAC P

V 28178 V 31649

C e fta zidim pch inje ctie po e der fla co n 2000m g C e fta zidim sando z inje ctie poe de r fla co n 500m g

2,00 stuk 8,00 stuk

43,97130 10,99283

0J01DAC P

V 31650

C e fta zidim sando z inje ctie poe de r fla co n 1000m g

4,00 stuk

21,98565

0J01DAC P

V 31651

C e fta zidim sando z inje ctie poe de r fla co n 2000m g

2,00 stuk

43,97130

0J01DHAP

V 11089

Tiena m infusie poe de r fla co n 250m g (iv)

8,00 stuk

9,15956

0J01DHAP

V 11089

Tiena m infusie poe de r fla co n 250m g (iv)

8,00 stuk

9,15956

0J01DHAP

V 11089

Tiena m infusie poe de r fla co n 500m g

4,00 stuk

18,31911

0J01DHAP 0J01DHAP

V 11089 V 17864

Tiena m infusie poe de r fla co n 500m g Me ro nem inje ctie poe de r fla co n 250m g

4,00 stuk 8,00 stuk

18,31911 9,15956

0J01DHAP

V 17864

Me ro nem inje ctie poe de r fla co n 500m g

4,00 stuk

18,31911

0J01DHAP

V 17864

Me ro nem inje ctie poe de r fla co n 250m g

8,00 stuk

9,15956

0J01DHAP

V 17864

Me ro nem inje ctie poe de r fla co n 500m g

4,00 stuk

18,31911

0J01DHAP

V 17864

Me ro nem inje ctie poe de r fla co n 1000m g

2,00 stuk

36,63822

0J01DHAP

V 17864

Me ro nem inje ctie poe de r fla co n 1000m g

2,00 stuk

36,63822

0J01DHAP 0J01DHAP

V 17864 V 17864

Me ro nem inje ctie poe de r fla co n 1000m g Me ro nem inje ctie poe de r fla co n 250m g

2,00 stuk 8,00 stuk

36,63822 9,15956

0J01EEAO

K 10550

C o trim o x a zo l pch suspe nsie 240m g/5m l

40,00 m l

0,02659

0J01EEAO 0J01EEAO

K 6214 K 9714

Ba ctrim e l suspe nsie 48m g/m l C o trim o x a zo l pch ta blet 120m g

40,00 m l 16,00 stuk

0,02659 0,06648

0J01EEAO

V 10243

C o trim o x a zo l pch ta blet 960m g

2,00 stuk

0,24078

0J01EEAO 0J01EEAO

V 13358 V 13359

C o trim o x a zo l actavis ta ble t 480m g C o trim o x a zo l forte a cta vis table t 960m g

4,00 stuk 2,00 stuk

0,14447 0,24078

0J01EEAO

V 19370

C o trim o x a zo l sa ndo z table t 960m g

2,00 stuk

0,24078

0J01EEAO

V 19370

C o trim o x a zo l sa ndo z table t 960m g

2,00 stuk

0,24078

0J01EEAO 0J01EEAO

V 19460=55510 V 19461=55511

C O TR IMO XAZO L APO TEX TABLET 480MG C O TR IMO XAZO L FO R TE APO TEX TABLET 960MG

4,00 STUK 2,00 STUK

0,14447 0,24078

0J01EEAO

V 20710=20517

C o trim o x a zo l a ta blet 480m g

4,00 stuk

0,14447

0J01EEAO

V 20711=20518

C o trim o x a zo l a ta blet 960m g

2,00 stuk

0,24078

0J01EEAO 0J01EEAO

V 55505 V 55506

C o trim o x a zo l cf ta ble t 480m g C o trim o x a zo l forte cf ta blet 960m g

4,00 stuk 2,00 stuk

0,14447 0,24078

0J01EEAO

V 55510

C o trim o x a zo l table t

4,00 stuk

0,14447

0J01EEAO

V 55511

C o trim o x a zo lum fo rte table t

2,00 stuk

0,24078

0J01EEAO 0J01EEAO

V 56823 V 56823

C o trim o x a zo l flx ta ble t 480m g C o trim o x a zo l flx ta ble t 480m g

4,00 stuk 4,00 stuk

0,14447 0,14447

0J01EEAO

V 56824

C o trim o x a zo l forte flx table t 960m g

2,00 stuk

0,24078

0J01EEAO

V 56824

C o trim o x a zo l forte flx table t 960m g

2,00 stuk

0,24078

0J01EEAO 0J01EEAO

V 9647 V 9647

C o trim o x a zo l pch ta blet 480m g C o trim o x a zo l pch ta blet 480m g

4,00 stuk 4,00 stuk

0,14447 0,14447

0J01FAAO

K 10246

Erythro cine -e s k e rsen gra n v susp 500m g/5m l

15,00 m l

0,20547

0J01FAAO 0J01FAAO

K 10247 K 10248

Erythro cine -e s k e rsen gra n v susp 250m g/5m l Erythro cine -e s k e rsen gra n v susp 125m g/5m l

30,00 m l 60,00 m l

0,10274 0,08219

0J01FAAO

K 14999

Zithro m a x po e de r voo r suspensie 200m g/5m l

7,50 m l

0,41094

0J01FAAO

K 15868

Klacid gra nula at vo or suspe nsie 125m g/5m l

20,00 m l

0,15410

0J01FAAO 0J01FAAO

K 16752 K 30439

Klacid gra nula at vo or suspe nsie 250m g/5m l Azitro m ycine pch po e de r voo r suspensie 200m g/5m l

10,00 m l 7,50 m l

0,30821 0,41094

0J01FAAO

K 30849

C la ritro m ycine sa ndoz gran v suspe nsie 125m g/5m l

20,00 m l

0,15410

0J01FAAO

K 30850

C la ritro m ycine sa ndoz gran v suspe nsie 250m g/5m l

10,00 m l

0,30821

0J01FAAO 0J01FAAO

K 32017 K 34300

Azitro m ycine sa ndo z po e der v suspe nsie 200m g/5m l Azitro m ycine m ylan po ede r vo o r suspe nsie 200m g/5m l

7,50 m l 7,50 m l

0,41094 0,41094

0J01FAAO

V 12459

R ulide ta ble t film o m huld 150m g

2,00 stuk

1,21516

0J01FAAO 0J01FAAO

V 16029 V 1799

R ulide ta ble t film o m huld 300m g Erythro cine ta ble t 250m g

1,00 stuk 6,00 stuk

2,43031 0,48606

0J01FAAO

V 19432

Zithro m a x ta blet 250m g

1,20 stuk

2,02526

0J01FAAO

V 19433

Zithro m a x ta blet 500m g

0,60 stuk

4,05052

0J01FAAO 0J01FAAO

V 21555 V 25664

Klacid sr table t m ga 500m g R o x itro m ycine sa ndoz ta ble t film o m huld 150m g

1,00 stuk 2,00 stuk

2,43031 1,21516

0J01FAAO

V 25665

R o x itro m ycine sa ndoz ta ble t film o m huld 300m g

1,00 stuk

2,43031

0J01FAAO

V 26688

R o x itro m ycine cf ta ble t film o m huld 150m g

2,00 stuk

1,21516

0J01FAAO 0J01FAAO

V 26689 V 28931

R o x itro m ycine cf ta ble t film o m huld 300m g Azitro m ycine pch ta blet o m huld 250m g

1,00 stuk 1,20 stuk

2,43031 2,02526

0J01FAAO

V 28932

Azitro m ycine pch ta blet o m huld 500m g

0,60 stuk

4,05052

0J01FAAO

V 29081

C la ritro m ycine pch table t 250m g

2,00 stuk

1,21516

0J01FAAO 0J01FAAO

V 29082 V 29677

C la ritro m ycine pch table t 500m g AZITR O MYC INE MYLAN TABLET O MHULD 500MG

1,00 stuk 0,6 STUK

2,43031 4,05052

0J01FAAO

V 29847

C la ritro m ycine cf ta ble t 250m g

2,00 stuk

1,21516

0J01FAAO

V 29848

C la ritro m ycine cf ta ble t 500m g

1,00 stuk

2,43031

0J01FAAO 0J01FAAO

V 29849 V 29850

C la ritro m ycine ra nba x y ta ble t 250m g C la ritro m ycine ra nba x y ta ble t 500m g

2,00 stuk 1,00 stuk

1,21516 2,43031

0J01FAAO

V 30079

C la ritro m ycine rp table t 250m g

2,00 stuk

1,21516

0J01FAAO

V 30080

C la ritro m ycine rp table t 500m g

1,00 stuk

2,43031

0J01FAAO 0J01FAAO

V 30789 V 30790

C la ritro m ycine sa ndoz ta ble t 250m g C la ritro m ycine sa ndoz ta ble t 500m g

2,00 stuk 1,00 stuk

1,21516 2,43031

0J01FAAO

V 32491

Azitro m ycine sa ndo z table t om huld 250m g

1,20 stuk

2,02526

0J01FAAO

V 32492

Azitro m ycine sa ndo z table t om huld 500m g

0,60 stuk

4,05052

0J01FAAO 0J01FAAO

V 32493 V 32494

Azitro m ycine cf ta ble t o m huld 250m g Azitro m ycine cf ta ble t o m huld 500m g

1,20 stuk 0,60 stuk

2,02526 4,05052

0J01FAAO

V 32618

C la ritro m ycine m yla n ta blet 250m g

2,00 stuk

1,21516

0J01FAAO

V 32619

C la ritro m ycine m yla n ta blet 500m g

1,00 stuk

2,43031

0J01FAAO 0J01FAAO

V 32708 V 32709

C la ritro m ycine a cta vis ta blet 250m g C la ritro m ycine a cta vis ta blet 500m g

2,00 stuk 1,00 stuk

1,21516 2,43031

0J01FAAO

V 57672

Erytro m ycine sa ndo z gra nula a t 500m g in sache t

3,00 stuk

0,81010

0J01FAAO

V 57672

Erytro m ycine sa ndo z gra nula a t 500m g in sache t

3,00 stuk

0,81010

0J01FAAO 0J01FAAO

V 57673 V 57673

Erytro m ycine sa ndo z gra nula a t 1000m g in sa che t Erytro m ycine sa ndo z gra nula a t 1000m g in sa che t

1,50 stuk 1,50 stuk

1,62021 1,62021

0J01FAAO

V 6737

R o va m ycine ta ble t 500m g

4,00 stuk

0,60758

0J01FAAO

V 8335

Erythro cine -e s gra nula a t 1000m g in sa che t

1,50 stuk

1,62021

0J01FAAO 0J01FAAO

V 9314 V 9658

Erythro cine -e s table t 500m g suik e rvrij Erythro m ycinum ta ble t m sr 250m g

3,00 stuk 6,00 stuk

0,81010 0,48606

0J01FAAO

V 9659

Erythro m ycinum ta ble t m sr 500m g

3,00 stuk

0,81010

0J01FAAP

V 1800

ER YTHR O C INE IV INFUSIEP O EDER FLAC O N 1000MG

1,00 stuk

13,61340

0J01FFAO

V 14457

Da lacin c capsule 300m g

4,00 stuk

0,91648

0J01FFAO

V 21828

C linda m ycine sa ndo z ca psule 150m g

8,00 stuk

0,54989

0J01FFAO 0J01FFAO

V 21829 V 23168=21828

C linda m ycine sa ndo z ca psule 300m g C LINDAMYC INE MYLAN C APSULE 150MG

4,00 stuk 8,00 stuk

0,91648 0,54989

0J01FFAO

V 23169=21829

C LINDAMYC INE MYLAN C APSULE 300MG

4,00 stuk

0,91648

0J01FFAO

V 23339=21828

C linda m ycine pch capsule 150m g

8,00 stuk

0,54989

0J01FFAO 0J01FFAO

V 23340=21829 V 32374

C linda m ycine pch capsule 300m g C linda m ycine rp capsule 300m g

4,00 stuk 4,00 stuk

0,91648 0,91648

0J01FFAO

V 5871

Da lacin c capsule 150m g

8,00 stuk

0,54989

0J01GBAII V 25484 0J01GBAII V 29664

To bi inhvlst 60m g/m l a m pul 5m l C o listin pdr v ve rne velo pl fl 1 m ilj ie + so lv 3m l

5,00 m l 3,00 stuk

9,01888 15,03147

0J01GBAII V 33841

Bra m ito b ve rneve lo plossing 75m g/m l a m pul 4m l

4,00 m l

11,27360

0J01GBAP 0J01GBAP

K 57429 K 57571

To bra m ycine cf injvlst 10m g/m l a m pul 2m l Ge ntam icine cf injvlst 10m g/m l a m pul 2m l

24,00 m l 24,00 m l

1,42941 1,42941

0J01GBAP

K 8886

O bra cin injvlst 10m g/m l fla co n 2m l

24,00 m l

1,42941

0J01GBAP 0J01GBAP

V 22424 V 57430

AMIKAC INE HO SP IR A INJVLST 250MG/ML To bra m ycine cf injvlst 40m g/m l a m pul

4,00 m l 6,00 m l

5,24117 3,49411

0J01GBAP

V 6890

O bra cin injvlst 40m g/m l fla co n

6,00 m l

3,49411

0J01MAAO V 100043//21812

Ta va nic table t om huld 500m g

0,50 stuk

6,11332

0J01MAAO V 102382//21811

Ta va nic table t om huld 250m g

1,00 stuk

3,05666

0J01MAAO V 102691//28118

Ave lo x ta blet film om huld 400m g

1,00 stuk

3,05666

0J01MAAO V 11939 0J01MAAO V 15359

Ta rivid ta blet 200m g Ta rivid ta blet 400m g

2,00 stuk 1,00 stuk

1,52833 3,05666

0J01MAAO V 19341

C iprox in suspe nsie 50m g/m l

20,00 m l

0,18340

0J01MAAO V 19342

C iprox in suspe nsie 100m g/m l

10,00 m l

0,30567

0J01MAAO V 21811 0J01MAAO V 21812

Ta va nic table t om huld 250m g Ta va nic table t om huld 500m g

1,00 stuk 0,50 stuk

3,05666 6,11332

0J01MAAO V 25153

C iproflo x acine rp table t 250m g

4,00 stuk

0,91700

0J01MAAO V 25154

C iproflo x acine rp table t 500m g

2,00 stuk

1,52833

0J01MAAO V 25155 0J01MAAO V 25206

C iproflo x acine rp table t 750m g C iproflo x acine sa ndoz ta ble t 250m g

1,33 stuk 4,00 stuk

2,29250 0,91700

0J01MAAO V 25207

C iproflo x acine sa ndoz ta ble t 500m g

2,00 stuk

1,52833

0J01MAAO V 25208

C iproflo x acine sa ndoz ta ble t 750m g

1,33 stuk

2,29250

0J01MAAO V 25738 0J01MAAO V 25739

C IP R O FLO XAC INE AP O TEX TABLET 250MG C IP R O FLO XAC INE AP O TEX TABLET 500MG

4,00 stuk 2,00 stuk

0,91700 1,52833

0J01MAAO V 25740

C IP R O FLO XAC INE AP O TEX TABLET 750MG

1,33 stuk

2,29250

0J01MAAO V 26276

C IP R O FLO XAC INE MYLAN TABLET 250MG

4,00 STUK

0,91700

0J01MAAO V 26277 0J01MAAO V 26813

C IP R O FLO XAC INE MYLAN TABLET 500MG C iproflo x acine a cta vis ta blet 250m g

2,00 stuk 4,00 stuk

1,52833 0,91700

0J01MAAO V 26814

C iproflo x acine a cta vis ta blet 500m g

2,00 stuk

1,52833

0J01MAAO V 26815

C iproflo x acine a cta vis ta blet 750m g

1,33 stuk

2,29250

0J01MAAO V 27232 0J01MAAO V 27233

C iproflo x acine pch table t 250m g C iproflo x acine pch table t 500m g

4,00 stuk 2,00 stuk

0,91700 1,52833

0J01MAAO V 27234

C iproflo x acine pch table t 750m g

1,33 stuk

2,29250

0J01MAAO V 27307

C iproflo x acine rp table t 250m g

4,00 stuk

0,91700

0J01MAAO V 27308 0J01MAAO V 27309

C iproflo x acine rp table t 500m g C iproflo x acine rp table t 750m g

2,00 stuk 1,33 stuk

1,52833 2,29250

0J01MAAO V 27311

C iproflo x acine cf ta ble t 250m g

4,00 stuk

0,91700

0J01MAAO V 27312

C iproflo x acine cf ta ble t 500m g

2,00 stuk

1,52833

0J01MAAO V 27571 0J01MAAO V 27572

O flo x acine pch table t film o m huld 200m g O flo x acine pch table t film o m huld 400m g

2,00 stuk 1,00 stuk

1,52833 3,05666

0J01MAAO V 27753

O FLO XAC INE MYLAN TABLET FILMO MHULD 200MG

0J01MAAO V 27754

O flo x acine m yla n ta blet film om huld 400m g

1,00 stuk

3,05666

0J01MAAO V 28118 0J01MAAO V 28728

Ave lo x ta blet film om huld 400m g O flo x acine cf ta ble t film o m huld 200m g

1,00 stuk 2,00 stuk

3,05666 1,52833

0J01MAAO V 28729

O flo x acine cf ta ble t film o m huld 400m g

1,00 stuk

3,05666

0J01MAAO V 28729

O flo x acine cf ta ble t film o m huld 400m g

1,00 stuk

3,05666

0J01MAAO V 28950 0J01MAAO V 28951

O flo x acine sa ndoz ta ble t film o m huld 200m g O flo x acine sa ndoz ta ble t film o m huld 400m g

2,00 stuk 1,00 stuk

1,52833 3,05666

0J01MAAO V 34523//21811

Ta va nic table t om huld 250m g

1,00 stuk

3,05666

0J01MAAO V 34631//21812

Ta va nic table t om huld 500m g

0,50 stuk

6,11332

0J01MAAP 0J01MAAP

V 29032 V 30476

C iproflo x acine hik m a infvlst 2m g/m l C iproflo x acine k abi infvlst 2m g/m l zak 50m l

250,00 m l 250,00 m l

0,24779 0,24779

0J01MAAP

V 30477

C iproflo x acine k abi infvlst 2m g/m l zak 100m l

250,00 m l

0,24779

0J01MAAP

V 30478

C iproflo x acine k abi infvlst 2m g/m l zak 200m l

250,00 m l

0,24779

0J01MAAP 0J01MAAP

V 32200 V 32680

C iproflo x acine cla ris infvlst 2m g/m l fla co n C iproflo x acine pch infvlst 2m g/m l

250,00 m l 250,00 m l

0,24779 0,24779

0J01MAAP

V 34085

C iproflo x acine m ayne infvlst 2m g/m l

250,00 m l

0,24779

2 STUK

1,52833

0J01MAAP

V 35022

C iproflo x acine a cta vis infvlst 2m g/m l fla co n

250,00 m l

0,24779

0J01MABO V 22824

No rflo x a cine pch ta ble t 400m g

2,00 stuk

0,83722

0J01MABO V 23358

No rflo x a cine rp ta ble t 400m g

2,00 stuk

0,83722

0J01MABO V 24265

No rflo x a cine cf ta blet 400m g

2,00 stuk

0,83722

0J01MABO V 25424=22824 0J01MABO V 26800

No rflo x a cine a cta vis table t 400m g No rflo x a cine sando z ta ble t 400m g

2,00 stuk 2,00 stuk

0,83722 0,83722

0J01MABO V 29846

NO R FLO XAC INE MYLAN TABLET 400MG

0J01XAAP 0J01XAAP

V 10657 V 13473

Va ncocin cp infusiepo e de r fla co n Ta rgo cid injpdr fla co n 200m g + so lve ns 3m l

0J01XAAP

V 15374

Ta rgo cid injpdr fla co n 400m g + so lve ns 3m l

0J01XAAP

V 19201

Va ncom ycine infusiepo e de r fla co n

0J01XAAP 0J01XAAP

V 19497 V 22837

Va ncom ycine ho spira infusie po e der fla co n Va ncom ycine pch infusie po ede r flacon 1000m g

2000,00 m g 2000,00 m g

0,02389 0,02389

0J01XAAP

V 57603

Va ncom ycine pch infusie po ede r flacon 500m g

2000,00 m g

0,02389

2 STUK

0,83722

2000,00 m g 200,00 m g

0,02389 0,23895

200,00 m g

0,23895

2000,00 m g

0,02389

0J02AC AO V 102997 0J02AC AO V 102999

FLUC O NAZO L MYLAN C AP SULE 50MG FLUC O NAZO L MYLAN C AP SULE 150MG

4,00 stuk 1,33 stuk

3,10703 9,32110

0J02AC AO V 103000

FLUC O NAZO L MYLAN C AP SULE 200MG

1,00 stuk

12,42813

0J02AC AO V 13038

Diflucan ca psule 50m g

4,00 stuk

3,10703

0J02AC AO V 13039 0J02AC AO V 13224

Diflucan ca psule 150m g Trispo ral ca psule 100m g

1,33 stuk 2,00 stuk

9,32110 6,21407

0J02AC AO V 14768

Diflucan ca psule 200m g

1,00 stuk

12,42813

0J02AC AO V 15757

Diflucan po ede r vo o r suspe nsie 10m g/m l

20,00 m l

0,62141

0J02AC AO V 15758 0J02AC AO V 21024

Diflucan po ede r vo o r suspe nsie 40m g/m l Trispo ral o s dra nk 10m g/m l

5,00 m l 20,00 m l

2,48563 0,62141

0J02AC AO V 25517=13224

Itra co na zo l jc ca psule 100m g

2,00 stuk

6,21407

0J02AC AO V 26692

Fluco na zo l sa ndo z ca psule 50m g

4,00 stuk

3,10703

0J02AC AO V 26694 0J02AC AO V 26695

Fluco na zo l sa ndo z ca psule 150m g Fluco na zo l sa ndo z ca psule 200m g

1,33 stuk 1,00 stuk

9,32110 12,42813

0J02AC AO V 27715

Fluco na zo le no vo pharm ca psule 50m g

4,00 stuk

3,10703

0J02AC AO V 27717

Fluco na zo le no vo pharm ca psule 150m g

1,33 stuk

9,32110

0J02AC AO V 27718 0J02AC AO V 28342

Fluco na zo le no vo pharm ca psule 200m g Fluco na zo l pch capsule 50m g

1,00 stuk 4,00 stuk

12,42813 3,10703

0J02AC AO V 28344

Fluco na zo l pch capsule 150m g

1,33 stuk

9,32110

0J02AC AO V 28345

Fluco na zo l pch capsule 200m g

1,00 stuk

12,42813

0J02AC AO V 28430 0J02AC AO V 28431

Itra co na zo l cf ca psule 100m g ITR AC O NAZO L MYLAN C AP SULE 100MG

2,00 stuk 2 STUK

6,21407 6,21407

0J02AC AO V 28433

Itra co na zo l pch capsule 100m g

2,00 stuk

6,21407

0J02AC AO V 29393

Fluco na zo l cf ca psule 50m g

4,00 stuk

3,10703

0J02AC AO V 29395 0J02AC AO V 29396

Fluco na zo l cf ca psule 150m g Fluco na zo l cf ca psule 200m g

1,33 stuk 1,00 stuk

9,32110 12,42813

0J02AC AO V 29877

Itra co na zo lum ca psule 100m g

2,00 stuk

6,21407

0J02AC AO V 30219

Itra co na zo l rp capsule 100m g

2,00 stuk

6,21407

0J02AC AO V 31568 0J02AC AO V 31569

Itra co na zo l a capsule 100m g Itra co na zo l actavis ca psule 100m g

2,00 stuk 2,00 stuk

6,21407 6,21407

0J02AC AO V 32412

Itra co na zo l sa ndo z ca psule 100m g

2,00 stuk

6,21407

0J02AC AP 0J02AC AP

V 14769 V 25993

Diflucan infusievloe isto f 2m g/m l Fluco na zo l sa ndo z infvlst 2m g/m l flacon

100,00 m l 100,00 m l

0,41657 0,41657

0J02AC AP

V 25995

Fluco na zo l sa ndo z infvlst 2m g/m l flacon

100,00 m l

0,41657

0J02AC AP 0J02AC AP

V 31562 V 31951

Fluco na zo l pch infvlst 2m g/m l fla co n Fluco na zo l claris infvlst 2m g/m l flacon

100,00 m l 100,00 m l

0,41657 0,41657

0J02AC AP

V 34106

Fluco na zo l hik m a infvlst 2m g/m l

100,00 m l

0,41657

0J02AC BO V EU/1/02/212/006 0J02AC BO V EU/1/02/212/007

Vfe nd ta ble t film o m huld 50m g Vfe nd ta ble t film o m huld 50m g

8,00 stuk 8,00 stuk

13,64800 13,64800

0J02AC BO V EU/1/02/212/018

Vfe nd ta ble t film o m huld 200m g

2,00 stuk

34,12000

0J02AC BO V EU/1/02/212/019

Vfe nd ta ble t film o m huld 200m g

2,00 stuk

34,12000

0J02AC BO V EU/1/02/212/026 0J02AC BO V EU/1/05/320/001

Vfe nd po ede r vo o r suspe nsie 40m g/m l No x a fil suspe nsie 40m g/m l

0J04ABAO

V 5761

R ifa m picine sa ndo z capsule 150m g

4,00 stuk

0,69962

0J04ABAO 0J04ABAO

V 5764 V 5765

R ifa din ca psule 150m g R ifa din ca psule 300m g

4,00 stuk 2,00 stuk

0,69962 0,87453

0J04ABAO

V 6090

R ifa m picine sa ndo z capsule 300m g

2,00 stuk

0,87453

0J04ABAO

V 7190

R im actan dra ge e 450m g

1,33 stuk

1,31179

0J04ABAO 0J04ABAO

V 7191 V 7191

R ifa m picine sa ndo z ta blet o m huld 600m g R ifa m picine sa ndo z ta blet o m huld 600m g

1,00 stuk 1,00 stuk

1,74905 1,74905

0J04ABAO

V 8702

R ifa din drage e 600m g

1,00 stuk

1,74905

0J05ABAO 0J05ABAO

V 17155 V 17156

Zo vira x dispe rs ta blet 200m g Zo vira x dispe rs ta blet 400m g

20,00 stuk 10,00 stuk

1,19798 1,49747

0J05ABAO

V 18065

Ze litre x table t 500m g

6,00 stuk

2,49579

0J05ABAO

V 18843

Aciclo vir cf ta ble t 200m g

20,00 stuk

1,19798

0J05ABAO 0J05ABAO

V 18844 V 18845

Aciclo vir cf ta ble t 400m g Aciclo vir cf ta ble t 800m g

10,00 stuk 5,00 stuk

1,49747 2,99495

0J05ABAO

V 19741

Aciclo vir rp table t 800m g

5,00 stuk

2,99495

0J05ABAO

V 19803

Aciclo vir sa ndoz ta ble t 200m g

20,00 stuk

1,19798

0J05ABAO 0J05ABAO

V 19804 V 19805

Aciclo vir sa ndoz ta ble t 400m g Aciclo vir sa ndoz ta ble t 800m g

10,00 stuk 5,00 stuk

1,49747 2,99495

0J05ABAO

V 19833

Aciclo vir pch table t 200m g

20,00 stuk

1,19798

0J05ABAO

V 19834

Aciclo vir pch table t 400m g

10,00 stuk

1,49747

0J05ABAO 0J05ABAO

V 19835 V 19841

Aciclo vir pch table t 800m g Aciclo vir rp table t 200m g

5,00 stuk 20,00 stuk

2,99495 1,19798

0J05ABAO

V 19889

Aciclo vir rp table t 400m g

10,00 stuk

1,49747

0J05ABAO

V 19934

Aciclo virum ta blet 200m g

20,00 stuk

1,19798

0J05ABAO 0J05ABAO

V 19935 V 20656

Aciclo virum ta blet 400m g Aciclo vir a cta vis dispe r ta ble t 200m g

10,00 stuk 20,00 stuk

1,49747 1,19798

0J05ABAO

V 20657

Aciclo vir a cta vis dispe r ta ble t 400m g

10,00 stuk

1,49747

0J05ABAO

V 20658

Aciclo vir a cta vis dispe r ta ble t 800m g

5,00 stuk

2,99495

0J05ABAO 0J05ABAO

V 21719 V 28291//18065

Ze litre x table t 250m g Va la ciclo vir ta ble t 500m g

12,00 stuk 6,00 stuk

1,49747 2,49579

0J05ABAO

V 34066

Fam ciclo vir pch ta ble t film o m huld 125m g

6,00 stuk

2,49579

0J05ABAO

V 34068

Fam ciclo vir pch ta ble t film o m huld 500m g

1,50 stuk

9,98316

0J05ABAP

V 19324

Infpdr aciclo vir fla co n 250m g

4,20 stuk

16,33608

0J05ABAP

V 23412

AC IC LO VIR HO SP IR A INFVLST C O NC 25MG/ML

0J05ABAP

V 9696

Zo vira x i.v. infusie poe de r

4,20 stuk

0J05ABC O V 26746

C o pegus ta blet film om huld 200m g

5,00 stuk

6,67057

0J05ABC O V 32314

C o pegus ta blet film om huld 400m g

2,50 stuk

11,11761

0J05ABC O V 34751//26746

C o pegus ta blet film om huld 200m g

5,00 stuk

6,67057

10,00 m l 2,50 m l

42,00 m l

6,82400 27,29600

1,63361 16,33608

0J05ABC O V EU/1/99/107/001 0J05ABC O V EU/1/99/107/002

R e beto l ca psule 200m g R e beto l ca psule 200m g

5,00 stuk 5,00 stuk

6,67057 6,67057

0J05ABC O V EU/1/99/107/003

R e beto l ca psule 200m g

5,00 stuk

6,67057

0J05ABDO V 101883//25992 0J05ABDO V 25992

Va lcyte ta ble t film o m huld 450m g Va lcyte ta ble t film o m huld 450m g

2,00 stuk 2,00 stuk

24,63379 24,63379

0J05AFAO

V EU/1/03/251/001

He pse ra table t 10m g

1,00 stuk

17,68900

0J05AFAO 0J05AFAO

V EU/1/06/343/003 V EU/1/06/343/004

Ba raclude table t film o m huld 0,5m g Ba raclude table t film o m huld 1m g

1,00 stuk 0,50 stuk

17,68900 35,37800

0J05AFAO

V EU/1/07/388/001

Se bivo ta blet film om huld 600m g

1,00 stuk

17,68900

0J07AGAP

K 17508

Act hib injectie po ede r flac 10m cg +so lv 0,5m l wwsp

1,00 stuk

24,73100

0J07ALAP

V 20617

P neum o 23 injvlst wwsp 0,5m l

1,00 m l

24,32260

0J07BC AP 0J07BC AP

K 24290 K EU/1/01/183/001

Enge rix -b junio r vaccin 20m cg/m l wwsp 0,5m l Hbva x pro 5 injsusp 10m cg/m l flacon 0,5m l

0,50 m l 0,50 m l

44,28000 44,28000

0J07BC AP

V 17316

Enge rix -b va ccin 20m cg/m l

1,00 m l

29,51840

0J07BC AP 0J07BC AP

V 30095//17316 V 33260//17316

Enge rix -b va ccin 20m cg/m l wwsp 1m l Enge rix -b va ccin 20m cg/m l wwsp 1m l

1,00 m l 1,00 m l

29,51840 29,51840

0J07BC AP

V 35216//17316

Enge rix -b va ccin 20m cg/m l wwsp 1m l

1,00 m l

29,51840

0J07BC AP

V EU/1/01/183/007

Hbva x pro 10 injsusp 10m cg/m l fla co n 1m l

1,00 m l

29,51840

0J07BC AP

V EU/1/01/183/028

Hbva x pro 10 injsusp 10m cg/m l wwsp 1m l

1,00 m l

29,51840

0J07BC BP

V EU/1/01/183/015

Hbva x pro 40 injsusp 40m cg/m l fla co n 1m l

1,00 do

66,03860

0J07BC BP

V EU/1/04/0299/001 Fendrix injsusp 40m cg/m l wwsp 0,5m l

1,00 do

66,03860

0L01AABO V 1155

Endo x an dra ge e 50m g

3,00 stuk

0,16046

0L01BAAO V 28636

Me tho trex a a t sa ndo z table t 2,5m g

2,00 stuk

0,21176

0L01BAAO V 28638 0L01BAAO V 8785

Me tho trex a a t sa ndo z table t 10m g Me tho trex a a t pch ta blet 10m g

0,50 stuk 0,50 stuk

0,84705 0,84705

0L01BAAO V 9957

Me tho trex a a t pch ta blet 2,5m g

2,00 stuk

0,21176

0L01BAAP 0L01BAAP

V 10632 V 10632

Em the x ate pf injvlst 100m g/m l fla co n 50m l Em the x ate pf injvlst 100m g/m l fla co n 10m l

0,00 stuk 0,00 stuk

1.066,72500 213,34500

0L01BAAP

V 10632

Em the x ate pf injvlst 100m g/m l fla co n 50m l

0,00 stuk

1.066,72500

0L01BAAP

V 10632

Em the x ate pf injvlst 100m g/m l fla co n 10m l

0,00 stuk

213,34500

0L01BAAP 0L01BAAP

V 8434 V 8435

Em the x ate pf injvlst 2,5m g/m l fla co n 2m l Em the x ate pf injvlst 25m g/m l fla co n 40m l

0,20 stuk 0,00 stuk

1,06673 213,34500

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 10m l

0,00 stuk

53,33625

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l am pul 2m l

0,02 stuk

10,66725

0L01BAAP 0L01BAAP

V 8435 V 8435

Em the x ate pf injvlst 25m g/m l fla co n 10m l Em the x ate pf injvlst 25m g/m l fla co n 20m l

0,00 stuk 0,00 stuk

53,33625 106,67250

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 2m l

0,02 stuk

10,66725

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 200m l

0,00 stuk

1.066,72500

0L01BAAP 0L01BAAP

V 8435 V 8435

Em the x ate pf injvlst 25m g/m l fla co n 2m l Em the x ate pf injvlst 25m g/m l fla co n 2m l

0,02 stuk 0,02 stuk

10,66725 10,66725

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 40m l

0,00 stuk

213,34500

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 2m l

0,02 stuk

10,66725

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 10m l

0,00 stuk

53,33625

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 20m l

0,00 stuk

106,67250

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l am pul 2m l

0,02 stuk

10,66725

0L01BAAP 0L01BAAP

V 8435 V 8435

Em the x ate pf injvlst 25m g/m l fla co n 2m l Em the x ate pf injvlst 25m g/m l fla co n 200m l

0,02 stuk 0,00 stuk

10,66725 1.066,72500

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 40m l

0,00 stuk

213,34500

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l am pul 2m l

0,02 stuk

10,66725

0L01BAAP 0L01BAAP

V 8435 V 8435

Em the x ate pf injvlst 25m g/m l fla co n 20m l Em the x ate pf injvlst 25m g/m l am pul 2m l

0,00 stuk 0,02 stuk

106,67250 10,66725

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 10m l

0,00 stuk

53,33625

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 200m l

0,00 stuk

1.066,72500

0L01BAAP 0L01BAAP

V 8435 V 8435

Em the x ate pf injvlst 25m g/m l fla co n 10m l Em the x ate pf injvlst 25m g/m l fla co n 200m l

0,00 stuk 0,00 stuk

53,33625 1.066,72500

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 20m l

0,00 stuk

106,67250

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l am pul 2m l

0,02 stuk

10,66725

0L01BAAP 0L01BAAP

V 8435 V 8435

Em the x ate pf injvlst 25m g/m l fla co n 40m l Em the x ate pf injvlst 25m g/m l fla co n 40m l

0,00 stuk 0,00 stuk

213,34500 213,34500

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 200m l

0,00 stuk

1.066,72500

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 20m l

0,00 stuk

106,67250

0L01BAAP 0L01BAAP

V 8435 V 8435

Em the x ate pf injvlst 25m g/m l am pul 2m l Em the x ate pf injvlst 25m g/m l fla co n 40m l

0,02 stuk 0,00 stuk

10,66725 213,34500

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 2m l

0,02 stuk

10,66725

0L01BAAP

V 8435

Em the x ate pf injvlst 25m g/m l fla co n 200m l

0,00 stuk

1.066,72500

0L01BAAP 0L01BAAP

V 8435 V 9385

Em the x ate pf injvlst 25m g/m l fla co n 10m l Me tho trex a te teva injvlst 100m g/m l fla co n 10m l

0,00 stuk 0,00 stuk

53,33625 213,34500

0L01BAAP

V 9385

Me tho trex a te teva injvlst 100m g/m l fla co n 50m l

0,00 stuk

1.066,72500

0L01BAAP

V 9385

Me tho trex a te teva injvlst 100m g/m l fla co n 10m l

0,00 stuk

213,34500

0L01BAAP 0L01BAAP

V 9385 V 9386

Me tho trex a te teva injvlst 100m g/m l fla co n 50m l Me tho trex a te teva injvlst 25m g/m l fla co n 2m l

0,00 stuk 0,02 stuk

1.066,72500 10,66725

0L01BAAP

V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 4m l

0,01 stuk

21,33450

0L01BAAP

V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 4m l

0,01 stuk

21,33450

0L01BAAP 0L01BAAP

V 9386 V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 20m l Me tho trex a te teva injvlst 25m g/m l fla co n 4m l

0,00 stuk 0,01 stuk

106,67250 21,33450

0L01BAAP

V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 8m l

0,00 stuk

42,66900

0L01BAAP

V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 20m l

0,00 stuk

106,67250

0L01BAAP 0L01BAAP

V 9386 V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 4m l Me tho trex a te teva injvlst 25m g/m l fla co n 8m l

0,01 stuk 0,00 stuk

21,33450 42,66900

0L01BAAP

V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 8m l

0,00 stuk

42,66900

0L01BAAP

V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 2m l

0,02 stuk

10,66725

0L01BAAP 0L01BAAP

V 9386 V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 20m l Me tho trex a te teva injvlst 25m g/m l fla co n 8m l

0,00 stuk 0,00 stuk

106,67250 42,66900

0L01BAAP

V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 2m l

0,02 stuk

10,66725

0L01BAAP

V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 2m l

0,02 stuk

10,66725

0L01BAAP

V 9386

Me tho trex a te teva injvlst 25m g/m l fla co n 20m l

0,00 stuk

106,67250

0L01BC AP

V 11900

FLUO R O UR AC IL P C H INJVLST 50MG/ML FLAC O N

0,50 m l

0,34487

0L01BC AP

V 14632

Flura ce dyl injvlst 50m g/m l fla co n

0,50 m l

0,34487

0L01BC AP

V 22303

FLUO R O UR AC IL SANDO Z INFVLST C O NC 50MG/ML

0,50 m l

0,34487

0L01C AAP

V 11754

Vinbla stinesulfa a t te va injpdr fl 10m g + so lv 10m l

0,15 stuk

24,95790

Ve pe sid ca psule 50m g

8,00 stuk

8,38722

0L01C BAO V 10375

0L01C BAO V 8543

Ve pe sid ca psule 100m g

4,00 stuk

16,77444

0L01C BAP

V 16010

To po sin infvlst conc 20m g/m l fla co n

10,00 m l

4,41437

0L01C BAP 0L01C BAP

V 16307 V 30530

Epo sin infusievloe isto f co nc 20m g/m l flacon 5m l ETO PO SIDE SANDO Z INFVLST C 20MG/ML

10,00 m l 10,00 m l

4,41437 4,41437

0L01DBC P V 101743

Epirubicine hcl hik m a injvlst 2m g/m l

3,50 m l

0L01DBC P V 10814 0L01DBC P V 10815

Farm o rubicine 10 infusiepo e de r fla co n 10m g Farm o rubicine 50 infusiepo e de r fla co n 50m g

0,70 stuk 0,14 stuk

5,81928

0L01DBC P V 14943

Farm o rubicine rtu infvlst 2m g/m l

3,50 m l

5,81928

0L01DBC P V 21822

Farm o rubicine rtu cyto sa fe infvlst 2m g/m l

3,50 m l

5,81928

0L01DBC P V 28422 0L01DBC P V 29410

Epirubicine hcl cf injvlst 2m g/m l Epirubicine hcl pch infvlst 2m g/m l

3,50 m l 3,50 m l

5,81928 5,81928

0L01DBC P V 32316

EPIR UBIC INE HC L SANDO Z INFVLST 2MG/ML

3,50 m l

5,81928

0L01DBC P V 33726

EPIR UBIC IN HC L HO SP IR A INJVLST 2MG/ML

3,50 m l

5,81928

0L01DC AP V 20171

Bleo m ycine pch injpdr fla co n 15u

0,43 stuk

0L01DC BP V 18029

Mito m ycin-c k yowa inje ctie po e der fla co n 15m g

0,29 stuk

64,75895

0L01DC BP V 18987 0L01DC BP V 9337

Mito m ycin-c k yowa inje ctie po e der fla co n 40m g Mito m ycin-c k yowa inje ctie po e der fla co n 2m g

0,11 stuk 2,14 stuk

172,69053 8,63453

0L01XAAP

V 101430

C ISP LATINE P C H INFVLST C O NC 1MG/ML FLAC O N

175,00 m l

1,53396

0L01XAAP 0L01XAAP

V 10619 V 11918

C ispla tine te va injvlst 0,5m g/m l C ispla tine te va infvlst co nc 1m g/m l fla co n 10m l

350,00 m l 175,00 m l

0,92037 1,53396

0L01XAAP

V 11919

C ispla tine te va infvlst co nc 1m g/m l fla co n 50m l

175,00 m l

1,53396

0L01XAAP

V 15255

P lato sin injvlst 1m g/m l

175,00 m l

1,53396

0L01XAAP 0L01XAAP

V 15603 V 20744

C ispla tine e uro c infvlst co nc 0,5m g/m l C ispla tine m ayne infvlst co nc 1m g/m l

350,00 m l 175,00 m l

0,92037 1,53396

0L01XAAP

V 20745

C ispla tine m ayne infvlst co nc 1m g/m l

175,00 m l

1,53396

0L01XAAP

V 24575

C ISP LATINE SANDO Z INFVLST C O NC 1MG/ML

175,00 m l

1,53396

29,09640 145,48200

46,96625

0L02ABAO V 10597

P ro ve ra table t 200m g

1,00 stuk

1,07346

0L02ABAO V 10598

P ro ve ra table t 250m g

0,80 stuk

1,34183

0L02ABAO V 12120

P ro ve ra table t 500m g

0,40 stuk

2,68366

0L02ABAO V 15248 0L02ABAO V 15250

Me dro x yproge ste ro n aceta a t pch 100 ta ble t 100m g Me dro x yproge ste ro n aceta a t pch 500 ta ble t 500m g

2,00 stuk 0,40 stuk

0,64408 2,68366

0L02ABAO V 15579

Me ge stro laceta a t pch table t 160m g

0,38 stuk

2,86257

0L02ABAO V 6166

P ro ve ra table t 100m g

2,00 stuk

0,64408

0L02AEADI V 100696

Lucrin pds de po t injpdr wwsp 30m g + so lve ns 1m l

0,12 stuk

1.472,60720

0L02AEADI V 101759//18562

Zo la de x im pla nta tie stift 10,8m g in wwsp

0,33 stuk

552,22770

0L02AEADI V 101760//12277

Zo la de x im pla nta tie stift 3,6m g in wwsp

1,00 stuk

184,07590

0L02AEADI V 101982//18562 0L02AEADI V 104113//18562

Zo la de x im pla nta tie stift 10,8m g in wwsp Zo la de x im pla nta tie stift 10,8m g in wwsp

0,33 stuk 0,33 stuk

552,22770 552,22770

0L02AEADI V 12277

Zo la de x im pla nta tie stift 3,6m g in wwsp

1,00 stuk

184,07590

0L02AEADI V 12450

De ca peptyl cr injpdr 3,75m g in wwsp +so lv

1,00 stuk

184,07590

0L02AEADI V 14351 0L02AEADI V 15927

Lucrin de po t injpdr flacon 3,75m g + so lve ns 2m l Supre fa ct de po t im pla ntatie stift 6,3m g in wwsp

1,00 stuk 0,50 stuk

184,07590 368,15180

0L02AEADI V 18562

Zo la de x im pla nta tie stift 10,8m g in wwsp

0,33 stuk

552,22770

0L02AEADI V 21165

Lucrin de po t injpdr flacon 11,25m g + so lve ns 2m l

0,33 stuk

552,22770

0L02AEADI

V 24326//15927

Supre fa ct de po t im pla ntatie stift 6,3m g in wwsp

0,50 stuk

368,15180

0L02AEADI

V 26013//21170

Supre fa ct de po t 3 m nd im pla ntatie st 9,45m g in wwsp

0,33 stuk

552,22770

0L02AEADI

V 27471//21170

Supre fa ct de po t 3 m nd im pla ntatie st 9,45m g in wwsp

0,33 stuk

552,22770

0L02AEADI 0L02AEADI

V 28357//12277 V 28358//18562

Zo la de x im pla nta tie stift 3,6m g in wwsp Zo la de x im pla nta tie stift 10,8m g in wwsp

1,00 stuk 0,33 stuk

184,07590 552,22770

0L02AEADI

V 31138

P a m o re lin injpdr flacon 11,25m g + so lve ns 2m l

0,33 stuk

552,22770

0L02AEADI

V 31668

Eliga rd de pot 1m nd injpdr wwsp 7,5m g + so lve ns

0,50 stuk

368,15180

0L02AEADI 0L02AEADI

V 31669 V 32207//12277

Eliga rd de pot 3m nd injpdr wwsp 22,5m g + so lve ns Zo la de x im pla nta tie stift 3,6m g in wwsp

0,17 stuk 1,00 stuk

1.104,45540 184,07590

0L02AEADI

V 33008//12450

Tripto re line -a c de po t injpdr 3,75m g wwsp + sv 1m l

1,00 stuk

184,07590

0L02AEADI

V 33849

P a m o re lin injpdr flacon 3,75m g + so lve ns 2m l

1,00 stuk

184,07590

0L02AEADI 0L02AEADI

V 33853//12450 V 33871//21170

Tripto re line -a c de po t injpdr 3,75m g wwsp + sv 1m l Supre fa ct de po t 3 m nd im pla ntatie st 9,45m g in wwsp

1,00 stuk 0,33 stuk

184,07590 552,22770

0L02AEADI

V 35313

Eliga rd de pot 6m nd injpdr wwsp 45m g + so lve ns

0,08 stuk

2.208,91080

0L02AEAP 0L02AEAP

V 11645 V 11778

Lucrin injvlst 5m g/m l fl 2,8m l + 14wwsp + do ek je s De ca peptyl injectie vlo e isto f 0,1m g/m l wwsp 1m l

0,20 m l 1,00 m l

50,30314 10,06063

0L02AEAP

V 11779

De ca peptyl injectie vlo e isto f 0,5m g/m l wwsp 0,2m l

0,20 m l

50,30314

0L02AEAP

V 27491//11645

Leupro reline -aceta a t injvlst 5m g/m l fl 2,8m l

0,20 m l

50,30314

0L02AEBN

V 15086

Syna re l ne usspra y 200m cg/dosis

0,03 stuk

127,09930

0L02BAAO

V 10635

Ta m o x ifen pch ta ble t 20m g

1,00 stuk

0,57791

0L02BAAO 0L02BAAO

V 11197 V 11198

Ta m o x ifen rp ta ble t 10m g Ta m o x ifen rp ta ble t 20m g

2,00 stuk 1,00 stuk

0,34675 0,57791

0L02BAAO

V 12189

Ta m o x ifen pch ta ble t 30m g

0,67 stuk

0,86687

0L02BAAO

V 12190

Ta m o x ifen pch ta ble t 40m g

0,50 stuk

1,15583

0L02BAAO 0L02BAAO

V 16102 V 16766

Ta m o x ifen rp ta ble t 40m g Ta m o x ifen sando z ta ble t 10m g

0,50 stuk 2,00 stuk

1,15583 0,34675

0L02BAAO

V 16767

Ta m o x ifen sando z ta ble t 20m g

1,00 stuk

0,57791

0L02BAAO

V 16768

Ta m o x ifen sando z ta ble t 30m g

0,67 stuk

0,86687

0L02BAAO 0L02BAAO

V 16769 V 17115=9322

Ta m o x ifen sando z ta ble t 40m g Ta m o x ifen a cta vis table t 10m g

0,50 stuk 2,00 stuk

1,15583 0,34675

0L02BAAO

V 17116=10635

Ta m o x ifen a cta vis table t 20m g

1,00 stuk

0,57791

0L02BAAO

V 17117=12189

Ta m o x ifen a cta vis table t 30m g

0,67 stuk

0,86687

0L02BAAO 0L02BAAO

V 17118=12190 V 19597

Ta m o x ifen a cta vis table t 40m g Ta m o x ifen rp ta ble t 10m g

0,50 stuk 2,00 stuk

1,15583 0,34675

0L02BAAO

V 19598

Ta m o x ifen rp ta ble t 20m g

1,00 stuk

0,57791

0L02BAAO

V 24005=11197

Ta m o x ifen k a twijk table t 10m g

2,00 stuk

0,34675

0L02BAAO 0L02BAAO

V 24006=11198 V 24007=16102

TAMO XIFEN APO TEX TABLET 20MG Ta m o x ifen k a twijk table t 40m g

1,00 STUK 0,50 stuk

0,57791 1,15583

0L02BAAO

V 24076=11197

TAMO XIFEN MYLAN TABLET 10MG

2,00 STUK

0,34675

0L02BAAO

V 24077=11198

TAMO XIFEN MYLAN TABLET 20MG

1 STUK

0,57791

0L02BAAO 0L02BAAO

V 24078=16102 V 56634

TAMO XIFEN MYLAN TABLET 40MG Ta m o x ifen cf ta blet 20m g

0,50 STUK 1,00 stuk

1,15583 0,57791

0L02BAAO

V 9322

Ta m o x ifen pch ta ble t 10m g

2,00 stuk

0,34675

0L02BBAO 0L02BBAO

V 100033//18356 V 100334

C a so de x ta blet 50m g Bica luta m ide a cco rd table t film o m huld 50m g

1,00 stuk 1,00 stuk

5,44536 5,44536

0L02BBAO

V 100698

Bica luta m ide hik m a table t film o m huld 50m g

1,00 stuk

5,44536

0L02BBAO

V 101344

Bica luta m ide cf ta ble t film o m huld 50m g

1,00 stuk

5,44536

0L02BBAO

V 18282

Fluta m ide pch table t 250m g

3,00 stuk

1,81512

0L02BBAO

V 18356

C a so de x ta blet 50m g

1,00 stuk

5,44536

0L02BBAO

V 18805

Anandro n ta blet 150m g

1,00 stuk

5,44536

0L02BBAO

V 21826

Fluta m ide cf ta ble t 250m g

3,00 stuk

1,81512

0L02BBAO 0L02BBAO

V 23526 V 23617//18356

FLUTAMIDE MYLAN TABLET 250MG C a so de x ta blet 50m g

3,00 STUK 1,00 stuk

1,81512 5,44536

0L02BBAO

V 33519

Bica luta m ide sa ndoz ta ble t film o m huld 50m g

1,00 stuk

5,44536

0L02BBAO

V 33863

Bica luta m ide m yla n ta blet film om huld 50m g

1,00 stuk

5,44536

0L02BBAO 0L02BBAO

V 34467 V 34468

Bica luta m ide pch table t film o m huld 50m g Bica luta m ide pch table t film o m huld 150m g

1,00 stuk 0,33 stuk

5,44536 16,33609

0L02BBAO

V 34705

Bica m e dica table t film o m huld 50m g

1,00 stuk

5,44536

0L02BBAO

V 34711

Bica luta m ide rp table t film o m huld 50m g

1,00 stuk

5,44536

0L02BBAO 0L02BBAO

V 34712 V 34713

Bica luta m ide a cta vis ta blet film om huld 50m g BIC ALUTAMIDE MYLAN TABLET FILMO MHULD 50MG

1,00 stuk 1,00 stuk

5,44536 5,44536

0L02BBAO

V 35020

BIC ALUTAMIDE APO TEX TABLET 50MG

1,00 stuk

5,44536

0L02BGAO 0L02BGAO

V 100629//20755 V 19123

Fem a ra table t om huld 2,5m g Arim ide x ta blet film om huld 1m g

1,00 stuk 1,00 stuk

4,71931 4,71931

0L02BGAO

V 20755

Fem a ra table t om huld 2,5m g

1,00 stuk

4,71931

0L02BGAO

V 24443

Aro m a sin ta ble t o m huld 25m g

1,00 stuk

4,71931

0L02BGAO 0L02BGAO

V 30038//24443 V 31804//19123

Aro m a sin ta ble t o m huld 25m g Arim ide x ta blet film om huld 1m g

1,00 stuk 1,00 stuk

4,71931 4,71931

0L02BGAO

V 32404//24443

Aro m a sin ta ble t o m huld 25m g

1,00 stuk

4,71931

0L02BGAO

V 33067//20755

Fem a ra table t om huld 2,5m g

1,00 stuk

4,71931

0L02BGAO

V 35073//24443

Aro m a sin ta ble t o m huld 25m g

1,00 stuk

4,71931

0L03AABP

V 24155

R o fe ron-a e a syj 3 injvlst 6m ilj ie/m l wws 0,5m l

0,24 m l

58,31080

0L03AABP

V 24156

R o fe ron-a e a syj 4,5 injvlst 9m ilj ie /m l wws 0,5m l

0,16 stuk

87,46620

0L03AABP 0L03AABP

V 24157 V 24158

R o fe ron-a e a syj 6 injvlst 12m ilj ie /m l wws 0,5m l R o fe ron-a e a syj 9 injvlst 18m ilj ie /m l wws 0,5m l

0,12 stuk 0,08 stuk

116,62160 174,93240

0L03AABP

V 25052

R o fe ron-a injvlst 30m ilj ie /m l patro o n 0,6m l

0,05 m l

291,55400

0L03AABP

V EU/1/98/087/002 Infe rgen injvlst 30m cg/m l fla co n 0,3m l+to e beho re n

0,13 m l

107,93541

0L03AABP 0L03AABP

V EU/1/98/087/003 Infe rgen injvlst 30m cg/m l fla co n 0,3m l+to e beho re n V EU/1/99/127/002 Intro na injpdr fl 3.000.000ie + so lv 1m l + to e beh

0,13 m l 0,48 stuk

107,93541 29,15540

0L03AABP

V EU/1/99/127/004 Intro na injpdr fl 5.000.000ie + so lv 1m l + to e beh

0,29 stuk

48,62636

0L03AABP

V EU/1/99/127/006 Intro na injpdr fl 10.000.000ie + so lv 1m l + to e be h

0,14 stuk

97,18467

0L03AABP 0L03AABP

V EU/1/99/127/010 Intro na injpdr fl 30.000.000ie + so lv 1m l + to e be h V EU/1/99/127/029 Intro na injvlst 10.000.000ie /m l fla c 2,5m l

0,05 stuk 0,14 m l

291,55400 97,18467

0L03AABP

V EU/1/99/127/031 Intro na injvlst 15.000.000ie /m l pe n 1,2m l +to ebe h

0,10 m l

145,77700

0L03AABP

V EU/1/99/127/034 Intro na injvlst 25.000.000ie /m l pe n 1,2m l +to ebe h

0,06 m l

242,96167

0L03AABP

V EU/1/99/127/037 Intro na injvlst 50.000.000ie /m l pe n 1,2m l +to ebe h

0,03 m l

485,92333

0L03AAC P

V 14662

Ne upo gen 30 injvlst 30m ilj e /m l fla co n 1m l

1,17 m l

112,31063

0L03AAC P

V 14663

Ne upo gen 48 injvlst 30m ilj e /m l fla co n 1,6m l

1,17 m l

112,31063

0L03AAC P 0L03AAC P

V 16056 V 18232

Gra nocyte 34 injpdr fla co n 263m cg + so lv 1m l Gra nocyte 13 injpdr fla co n 105m cg + so lv 1m l

1,33 stuk 3,33 stuk

0L03AAC P

V 26386

Ne upo gen singlej 30 injvlst 60m ilj e /m l wwsp 0,5m l

0,58 m l

0L03AAC P

V 26387

Ne upo gen singlej 48 injvlst 96m ilj e /m l wwsp 0,5m l

0,36 m l

0L03AAC P 0L03AAC P

V 34137//26386 Ne upo gen singlej 30 injvlst 60m ilj e /m l wwsp 0,5m l V EU/1/02/227/001 Ne ula sta injvlst 10m g/m l wwsp 0,6m l

0L03AAC P 0L03AAC P 0L03AAC P

98,45898 51,13877 224,62125 359,39400

0,58 m l 0,09 stuk

224,62125 1.442,52179

V EU/1/02/227/003 Ne ula sta sure click injvlst 10m g/m l wwsp 0,6m l

0,09 stuk

1.442,52179

V EU/1/08/444/002 R a tiogra stim 30 injvlst 60m ilj e /m l wwsp 0,5m l

0,58 m l

224,62125

V EU/1/08/444/006 R a tiogra stim 48 injvlst 60m ilj e /m l wwsp 0,8m l

0,58 m l

224,62125

0L03AADP

V EU/1/00/131/002 P e gintro n injpdr fl 50m cg + solv 0,5m l + toe be h

0,30 stuk

92,58480

0L03AADP

V EU/1/00/131/007 P e gintro n injpdr fl 80m cg + solv 0,5m l + toe be h

0,19 stuk

148,13568

0L03AADP 0L03AADP

V EU/1/00/131/012 P e gintro n injpdr fl 100m cg + so lv 0,5m l + to e beh V EU/1/00/131/017 P e gintro n injpdr fl 120m cg + so lv 0,5m l + to e beh

0,15 stuk 0,12 stuk

185,16960 222,20352

0L03AADP

V EU/1/00/131/022 P e gintro n injpdr fl 150m cg + so lv 0,5m l + to e beh

0,10 stuk

277,75440

0L03AADP

V EU/1/00/131/031 P e gintro n injpdr pe n 50m cg + so lv 0,5m l

0,30 stuk

92,58480

0L03AADP 0L03AADP

V EU/1/00/131/032 P e gintro n injpdr pe n 50m cg + so lv 0,5m l V EU/1/00/131/035 P e gintro n injpdr pe n 80m cg + so lv 0,5m l

0,30 stuk 0,19 stuk

92,58480 148,13568

0L03AADP

V EU/1/00/131/036 P e gintro n injpdr pe n 80m cg + so lv 0,5m l

0,19 stuk

148,13568

0L03AADP

V EU/1/00/131/039 P e gintro n injpdr pe n 100m cg + so lv 0,5m l

0,15 stuk

185,16960

0L03AADP 0L03AADP

V EU/1/00/131/040 P e gintro n injpdr pe n 100m cg + so lv 0,5m l V EU/1/00/131/043 P e gintro n injpdr pe n 120m cg + so lv 0,5m l

0,15 stuk 0,12 stuk

185,16960 222,20352

0L03AADP

V EU/1/00/131/044 P e gintro n injpdr pe n 120m cg + so lv 0,5m l

0,12 stuk

222,20352

0L03AADP

V EU/1/00/131/047 P e gintro n injpdr pe n 150m cg + so lv 0,5m l

0,10 stuk

277,75440

0L03AADP 0L03AADP

V EU/1/00/131/048 P e gintro n injpdr pe n 150m cg + so lv 0,5m l V EU/1/02/221/005 P e ga sys 135 injvlst 270m cg/m l wwsp 0,5m l

0,10 stuk 0,10 m l

277,75440 288,43726

0L03AADP

V EU/1/02/221/007 P e ga sys 180 injvlst 360m cg/m l wwsp 0,5m l

0,07 m l

384,58302

0L03AADP

V EU/1/02/221/008 P e ga sys 180 injvlst 360m cg/m l wwsp 0,5m l

0,07 m l

384,58302

0L04AAAO

V 101552//17495

Ne ora l ca psule 25m g

12,00 stuk

1,57244

0L04AAAO

V 17495

Ne ora l ca psule 25m g

12,00 stuk

1,57244

0L04AAAO

V 17496

Ne ora l ca psule 100m g

3,00 stuk

3,93110

0L04AAAO 0L04AAAO

V 17497 V 21229//17496

Ne ora l drank 100m g/m l Ne ora l ca psule 100m g

3,00 m l 3,00 stuk

3,93110 3,93110

0L04AAAO

V 21412//17495

Ne ora l ca psule 25m g

12,00 stuk

1,57244

0L04AAAO

V 21413//17496

Ne ora l ca psule 100m g

3,00 stuk

3,93110

0L04AAAO 0L04AAAO

V 21524//17495 V 22788//17497

Ne ora l ca psule 25m g Ne ora l drank 100m g/m l

12,00 stuk 3,00 m l

1,57244 3,93110

0L04AAAO

V 23263

C iclo spo rinum dra nk 100m g/m l

3,00 m l

3,93110

0L04AAAO

V 24645//17496

Ne ora l ca psule 100m g

3,00 stuk

3,93110

0L04AAAO 0L04AAAO

V 24838//17495 V 24839//17496

Ne ora l ca psule 25m g Ne ora l ca psule 100m g

12,00 stuk 3,00 stuk

1,57244 3,93110

0L04AAAO

V 27834//17496

Ne ora l ca psule 100m g

3,00 stuk

3,93110

0L04AAAO

V 32211//17495

Ne ora l ca psule 25m g

12,00 stuk

1,57244

0L04AAAO 0L04AAAO

V 32212//17496 V 34484//17495

Ne ora l ca psule 100m g Ne ora l ca psule 25m g

3,00 stuk 12,00 stuk

3,93110 1,57244

0L04AAAO

V 34542//17495

Ne ora l ca psule 25m g

12,00 stuk

1,57244

0L04AAAO

V 34543//17496

Ne ora l ca psule 100m g

3,00 stuk

3,93110

0L04AAAP

V EU/1/03/256/003 Hum ira 40 injvlst 50m g/m l wwsp 0,8m l

0,07 stuk

543,28418

0L04AAAP

V EU/1/03/256/008 Hum ira 40 injvlst 50m g/m l pe n 0,8m l

0,07 stuk

543,28418

0L04AAAP

V EU/1/99/116/001 R e m icade infusie po ede r flacon 100m g

0,04 stuk

1.034,77526

0L04AAAP 0L04AAAP

V EU/1/99/126/001 Enbre l injpdr fla co n 25m g + so lve ns 1m l V EU/1/99/126/003 Enbre l injpdr fla co n 25m g+so lve ns 1m l+to e beho re n

0,29 stuk 0,29 stuk

135,86860 135,86860

0L04AAAP

V EU/1/99/126/010 Enbre l injpdr fla co n 50m g+so lve ns 1m l+to e beho re n

0,14 stuk

271,73720

0L04AAAP

V EU/1/99/126/012 Enbre l k ind injpdr fla co n 25m g+so lve ns 1m l+to e beh

0,29 stuk

135,86860

0L04AAAP 0L04AAAP

V EU/1/99/126/013 Enbre l injvlst 50m g/m l wwsp 0,5m l V EU/1/99/126/017 ENBR EL INJVLST 50MG/ML W W SP 1ML

0,29 stuk 0,14 STUK

135,86860 271,73720

0L04AABO

V 100344//30203

Myfo rtic table t film o m huld m sr 360m g

4,00 stuk

2,95562

0L04AABO 0L04AABO

V 30202 V 30203

MYFO R TIC TABLET MSR 180MG MYFO R TIC TABLET MSR 360MG

8,00 STUK 4,00 STUK

1,77337 2,95562

0L04AABO

V 34464//30203

4,00 stuk

2,95562

0L04AABO

V EU/1/96/005/001 C e llcept ca psule 250m g

Myfo rtic table t film o m huld m sr 360m g

8,00 stuk

1,77337

0L04AABO 0L04AABO

V EU/1/96/005/002 C e llcept ta ble t 500m g V EU/1/96/005/003 C e llcept ca psule 250m g

4,00 stuk 8,00 stuk

2,95562 1,77337

0L04AABO

V EU/1/96/005/004 C e llcept ta ble t 500m g

0L04AABO

V EU/1/96/005/006 C e llcept po ede r vo o r suspe nsie 200m g/m l

0L04AAC O

V 103695//30043

C e rtica n ta blet 0,75m g

2,00 stuk

14,23305

0L04AAC O

V 103766//30043

C e rtica n ta blet 0,75m g

2,00 stuk

14,23305

0L04AAC O

V 30041

C e rtica n ta blet 0,25m g

6,00 stuk

6,64209

0L04AAC O 0L04AAC O

V 30043 V 30046

C e rtica n ta blet 0,75m g C e rtica n dispe r ta ble t 0,25m g

2,00 stuk 6,00 stuk

14,23305 6,64209

0L04AAC O

V EU/1/01/171/001 R a pam une dra nk 1m g/m l

6,00 m l

4,74435

0L04AAC O

V EU/1/01/171/007 R a pam une ta blet film om huld 1m g

6,00 stuk

5,69322

0L04AAC O 0L04AAC O

V EU/1/01/171/008 R a pam une ta blet film om huld 1m g V EU/1/01/171/009 R a pam une ta blet film om huld 2m g

6,00 stuk 3,00 stuk

5,69322 9,48870

0L04AAC O

V EU/1/01/171/010 R a pam une ta blet film om huld 2m g

3,00 stuk

9,48870

0L04AADO 0L04AADO

V 18107 V 18108

5,00 stuk 1,00 stuk

2,84925 14,24625

0L04AADO

V 22236

P ro gra ft ca psule 0,5m g

10,00 stuk

1,70955

0L04AADO

V 24844//18107

P ro gra f ca psule 1m g

5,00 stuk

2,84925

0L04AADO 0L04AADO

V 25637//18108 V 27856//18107

P ro gra f ca psule 5m g P ro gra f ca psule 1m g

1,00 stuk 5,00 stuk

14,24625 2,84925

0L04AADO

V 27857//18107

P ro gra f ca psule 1m g

5,00 stuk

2,84925

0L04AADO

V 27858//18108

P ro gra f ca psule 5m g

1,00 stuk

14,24625

0L04AADO 0L04AADO

V 28994//18108 V 30859//18107

P ro gra f ca psule 5m g P ro gra f ca psule 1m g

1,00 stuk 5,00 stuk

14,24625 2,84925

0L04AADO

V 31056//22236

P ro gra f ca psule 0,5m g

10,00 stuk

1,70955

0L04AADO

V 32536//18108

P ro gra f ca psule 5m g

1,00 stuk

14,24625

0L04AADO 0L04AADO

V 33232//18108 V 33537//18107

P ro gra f ca psule 5m g P ro gra f ca psule 1m g

1,00 stuk 5,00 stuk

14,24625 2,84925

0L04AADO

V 34285//22236

P ro gra f ca psule 0,5m g

10,00 stuk

1,70955

0L04AADO

V 35214//22236

P ro gra f ca psule 0,5m g

10,00 stuk

1,70955

0L04AADO 0L04AADO

V EU/1/07/387/001 Adva graf capsule m va 0,5m g V EU/1/07/387/002 Adva graf capsule m va 0,5m g

10,00 stuk 10,00 stuk

3,98895 3,98895

0L04AADO

V EU/1/07/387/003 Adva graf capsule m va 1m g

5,00 stuk

2,84925

0L04AADO

V EU/1/07/387/004 Adva graf capsule m va 1m g

5,00 stuk

2,84925

0L04AADO 0L04AADO

V EU/1/07/387/005 Adva graf capsule m va 1m g V EU/1/07/387/007 Adva graf capsule m va 5m g

5,00 stuk 1,00 stuk

2,84925 14,24625

0L04AADO

V EU/1/07/387/008 Adva graf capsule m va 5m g

1,00 stuk

14,24625

0L04AXAO 0L04AXAO

V 10467 V 12476

Aza thioprine pch ta ble t 50m g Im ura n ta blet 25m g

3,00 stuk 6,00 stuk

0,56087 0,33652

0L04AXAO

V 21767=10467

Aza thioprine a cta vis ta ble t 50m g

3,00 stuk

0,56087

0L04AXAO

V 23957=11159

AZATHIO PR INE APO TEX TABLET 50MG

3,00 stuk

0,56087

0L04AXAO 0L04AXAO

V 24581 V 24582

Aza thioprinum ta ble t 25m g Aza thioprinum ta ble t 50m g

6,00 stuk 3,00 stuk

0,33652 0,56087

0L04AXAO

V 24721

AZATHIO PR INE MYLAN TABLET 25MG

0L04AXAO

V 24722

Aza thioprine m yla n ta ble t 50m g

3,00 stuk

0,56087

0L04AXAO 0L04AXAO

V 27562 V 27563

Aza thioprine sa ndo z ta blet 25m g Aza thioprine sa ndo z ta blet 50m g

6,00 stuk 3,00 stuk

0,33652 0,56087

0L04AXAO

V 32566

Aza thioprine a ta ble t 50m g

3,00 stuk

0,56087

P ro gra ft ca psule 1m g P ro gra ft ca psule 5m g

4,00 stuk 10,00 m l

6 STUK

2,95562 1,18225

0,33652

0L04AXAO

V 32650//5565

Im ura n ta blet 50m g

3,00 stuk

0,56087

0L04AXAO

V 5565

Im ura n ta blet 50m g

3,00 stuk

0,56087

0M01ABAIM V 17256

Diclo fena c na trium cf injvlst 25m g/m l a m pul 3m l

4,00 m l

0,31344

0M01ABAIM V 25586

Diclo fena c na trium sdz injvlst 25m g/m l a m pul 3m l

4,00 m l

0,31344

0M01ABAIM V 7460

Vo lta re n injvlst 25m g/m l a m pul 3m l

4,00 m l

0,31344

0M01ABAR

K 13768

Diclo fena c na trium pch ze tpil 25m g

4,00 stuk

0,12933

0M01ABAR

K 16276

Diclo fena c na trium a cta vis ze tpil 25m g

4,00 stuk

0,12933

0M01ABAR 0M01ABAR

K 18341 K 22928=20741

Diclo fena c na trium ze tpil 25m g Diclo fena c na trium sa ndoz ze tpil 25m g

4,00 stuk 4,00 stuk

0,12933 0,12933

0M01ABAR

K 57148

Diclo fena c na trium rp ze tpil 25m g

4,00 stuk

0,12933

0M01ABAR

K 57384

DIC LO FENAC NATR IUM AP O TEX ZETP IL 25MG

4,00 stuk

0,12933

0M01AHBO

V 101645//27707

Arco x ia ta ble t film o m huld 120m g

0,50 stuk

2,26376

0M01AHBO

V 102244//25053

C e lebre x ca psule 100m g

2,00 stuk

0,67913

0M01AHBO

V 102245//25054

C e lebre x ca psule 200m g

1,00 stuk

1,13188

0M01AHBO 0M01AHBO

V 102285//27707 V 102286//27705

Arco x ia ta ble t film o m huld 120m g Arco x ia ta ble t film o m huld 60m g

0,50 stuk 1,00 stuk

2,26376 1,13188

0M01AHBO

V 102287//27706

Arco x ia ta ble t film o m huld 90m g

0,67 stuk

1,69782

0M01AHBO

V 102474//27705

Arco x ia ta ble t film o m huld 60m g

1,00 stuk

1,13188

0M01AHBO 0M01AHBO

V 102475//27706 V 102477//27707

Arco x ia ta ble t film o m huld 90m g Arco x ia ta ble t film o m huld 120m g

0,67 stuk 0,50 stuk

1,69782 2,26376

0M01AHBO

V 102783//27705

Arco x ia ta ble t film o m huld 60m g

1,00 stuk

1,13188

0M01AHBO

V 102784//27706

Arco x ia ta ble t film o m huld 90m g

0,67 stuk

1,69782

0M01AHBO 0M01AHBO

V 103107//27707 V 25053

Arco x ia ta ble t film o m huld 120m g C e lebre x ca psule 100m g

0,50 stuk 2,00 stuk

2,26376 0,67913

0M01AHBO

V 25054

C e lebre x ca psule 200m g

1,00 stuk

1,13188

0M01AHBO

V 27705

Arco x ia ta ble t film o m huld 60m g

1,00 stuk

1,13188

0M01AHBO 0M01AHBO

V 27706 V 27707

Arco x ia ta ble t film o m huld 90m g Arco x ia ta ble t film o m huld 120m g

0,67 stuk 0,50 stuk

1,69782 2,26376

0M01AHBO

V 27711

Aux ib ta ble t film o m huld 60m g

1,00 stuk

1,13188

0M01AHBO

V 29194//25054

C e lebre x ca psule 200m g

1,00 stuk

1,13188

0M01AHBO 0M01AHBO

V 30498//25054 V 30575//25053

C e lebre x ca psule 200m g C e lebre x ca psule 100m g

1,00 stuk 2,00 stuk

1,13188 0,67913

0M01AHBO

V 31059//27705

Arco x ia ta ble t film o m huld 60m g

1,00 stuk

1,13188

0M01AHBO

V 31060//27706

Arco x ia ta ble t film o m huld 90m g

0,67 stuk

1,69782

0M01AHBO 0M01AHBO

V 31745//25053 V 31817//27705

C e lebre x ca psule 100m g Arco x ia ta ble t film o m huld 60m g

2,00 stuk 1,00 stuk

0,67913 1,13188

0M01AHBO

V 32299//25054

C e lebre x ca psule 200m g

1,00 stuk

1,13188

0M01AHBO

V 33830//27705

Etorico x ib e rc ta blet film om huld 60m g

1,00 stuk

1,13188

0M01AHBO 0M01AHBO

V 33831//27706 V 34272//25054

Etorico x ib e rc ta blet film om huld 90m g C e lebre x ca psule 200m g

0,67 stuk 1,00 stuk

1,69782 1,13188

0M01AHBO

V 34279

Arco x ia ta ble t film o m huld 30m g

2,00 stuk

0,67913

0M01AHBO

V 34965//27705

Arco x ia ta ble t film o m huld 60m g

1,00 stuk

1,13188

0M01AHBO 0M01AHBO

V 34966//27706 Arco x ia ta ble t film o m huld 90m g V EU/1/02/239/004 Be x tra ta ble t film o m huld 10m g

0,67 stuk 1,00 stuk

1,69782 1,13188

0M01AHBO

V EU/1/02/239/014 Be x tra ta ble t film o m huld 20m g

0,50 stuk

2,26376

0M01AHBO

V EU/1/02/239/022 Be x tra ta ble t film o m huld 40m g

0,25 stuk

4,52752

0M01AHBO

V EU/1/02/239/023 Be x tra ta ble t film o m huld 40m g

0,25 stuk

4,52752

3,33 stuk

0,17501

0M01C C AO V 9202

Ge ro dyl ca psule 150m g

0M03AXAP 0M03AXAP

V 17379 V 17505

Bo tox inje ctie poe de r fla co n 100e Dyspo rt inje ctiepo e de r fla co n 500e

0,02 stuk 0,02 stuk

272,26810 272,26810

0M03BXAO

V 10036

Sirda lud ta blet 2m g

6,00 stuk

0,14657

0M03BXAO 0M03BXAO

V 10037 V 10952//6347

Sirda lud ta blet 4m g Lio re sa l ta ble t 10m g

3,00 stuk 5,00 stuk

0,24428 0,14657

0M03BXAO

V 10966//6348

Lio re sa l ta ble t 25m g

2,00 stuk

0,36643

0M03BXAO

V 12153

BAC LO FEN TEVA TABLET 10MG

5,00 stuk

0,14657

0M03BXAO 0M03BXAO

V 12154 V 12983

BAC LO FEN TEVA TABLET 25MG Sirda lud m r ca psule m ga 6m g

2,00 stuk 2,00 stuk

0,36643 0,36643

0M03BXAO

V 21618

Ba clofe n a cta vis ta blet 10m g

5,00 stuk

0,14657

0M03BXAO

V 23864=12153

Ba clofe n sa ndoz ta ble t 10m g

5,00 stuk

0,14657

0M03BXAO 0M03BXAO

V 23865=12154 V 24100=12153

Ba clofe n sa ndoz ta ble t 25m g Ba clofe n m yla n ta blet 10m g

2,00 stuk 5,00 stuk

0,36643 0,14657

0M03BXAO

V 25864=12154

BAC LO FEN MYLAN TABLET 25MG

0M03BXAO

V 31642

Tiza nidine hcl pch ta ble t 2m g

6,00 stuk

0,14657

0M03BXAO 0M03BXAO

V 31643 V 6347

Tiza nidine hcl pch ta ble t 4m g Lio re sa l ta ble t 10m g

3,00 stuk 5,00 stuk

0,24428 0,14657

0M03BXAO

V 6348

Lio re sa l ta ble t 25m g

0M03BXAO

V 9086

Lio re sa l ta ble t 5m g

0M04AAAO

V 10376

0M04AAAO

V 10377

0M04AAAO

2 STUK

0,36643

2,00 stuk

0,36643

10,00 stuk

0,08794

Allo purino l nyco ta ble t 100m g

4,00 stuk

0,06025

Allo purino l nyco ta ble t 300m g

1,33 stuk

0,18076

V 11800

Zylo ric ta ble t 200m g

2,00 stuk

0,12050

0M04AAAO 0M04AAAO

V 20406 V 20407

Allo purino l actavis ta ble t 100m g Allo purino l actavis ta ble t 300m g

4,00 stuk 1,33 stuk

0,06025 0,18076

0M04AAAO

V 21011=7210

Allo purino l cf ta ble t 300m g

1,33 stuk

0,18076

0M04AAAO

V 21495=6846

Allo purino l cf ta ble t 100m g

4,00 stuk

0,06025

0M04AAAO 0M04AAAO

V 28893=52185 V 28894=57732

ALLO P UR INO L MYLAN TABLET 100MG ALLO P UR INO L MYLAN TABLET 300MG

4 STUK 1,33 STUK

0,06025 0,18076

0M04AAAO

V 52185

ALLO P UR INO L AP O TEX TABLET 100MG

4,00 STUK

0,06025

0M04AAAO

V 5431

Zylo ric ta ble t 100m g

4,00 stuk

0,06025

0M04AAAO 0M04AAAO

V 57732 V 6846

ALLO P UR INO L AP O TEX TABLET 300MG Allo purino l sa ndo z table t 100m g

1,33 STUK 4,00 stuk

0,18076 0,06025

0M04AAAO

V 7210

Allo purino l sa ndo z table t 300m g

1,33 stuk

0,18076

0M04AAAO

V 7238

Zylo ric ta ble t 300m g

1,33 stuk

0,18076

0M05BAAO

V 13881

Bo ne fo s capsule 400m g

4,00 stuk

2,17191

0M05BAAO

V 18051

O sta c ta ble t 520m g

3,08 stuk

2,66366

0M05BAAO

V 20245

Bo ne fo s ta blet 800m g

0M05BAAO 0M05BAAO

V 24990 Acto nel ta ble t film o m huld 30m g V EU/1/96/012/009 Bo ndro nat ta blet film om huld 50m g

0M05BAAP

V 13882

Bo ne fo s infvlst co nc 60m g/m l a m pul 5m l

0M05BABO

V 100473

Alendro nine zuur acco rd ta blet 10m g

1,00 stuk

0M05BABO

V 100474

Alendro nine zuur acco rd ta blet 70m g

0,14 stuk

8,57645

0M05BABO

V 100522//28338

Acto nel we k e lijk s table t film o m huld 35m g

0,14 stuk

8,57645

0M05BABO 0M05BABO

V 103513//28338 V 104605//34632

Acto nel we k e lijk s table t film o m huld 35m g Acto nel ta ble t film o m huld 75m g

0,14 stuk 0,07 stuk

8,57645 18,37810

0M05BABO

V 18021

Fosa m a x ta ble t 10m g

1,00 stuk

1,22521

0M05BABO

V 25801

Acto nel ta ble t film o m huld 5m g

1,00 stuk

1,22521

2,00 stuk

4,09794

1,00 stuk 1,00 stuk

8,19588 8,19588

25,00 m l

4,30910 1,22521

0M05BABO 0M05BABO

V 26202 V 28338

Fosa m a x ta ble t 70m g Acto nel we k e lijk s table t film o m huld 35m g

0,14 stuk 0,14 stuk

8,57645 8,57645

0M05BABO

V 29116//25801

Acto nel ta ble t film o m huld 5m g

1,00 stuk

1,22521

0M05BABO

V 30222

Alendro nine zuur sa ndo z table t 10m g

1,00 stuk

1,22521

0M05BABO 0M05BABO

V 30269 V 30270

Alendro nine zuur m ylan ta ble t 10m g Alendro nine zuur m ylan ta ble t 70m g

1,00 stuk 0,14 stuk

1,22521 8,57645

0M05BABO

V 31768

Alendro nine zuur pch ta blet 10m g

1,00 stuk

1,22521

0M05BABO

V 31896

Alendro nine zuur actavis ta ble t 70m g

0,14 stuk

8,57645

0M05BABO 0M05BABO

V 32291 V 32307

Alendro nine zuur rp ta blet 70m g Alendro nine zuur cf ta ble t 70m g

0,14 stuk 0,14 stuk

8,57645 8,57645

0M05BABO

V 32960

Alendro nine zuur pch ta blet 70m g

0,14 stuk

8,57645

0M05BABO

V 33160

Alendro nine zuur cf ta ble t 10m g

1,00 stuk

1,22521

0M05BABO 0M05BABO

V 33920 V 34032

Alendro nine zuur ranba x y ta ble t 70m g Alendro nine zuur a ta blet 70m g

0,14 stuk 0,14 stuk

8,57645 8,57645

0M05BABO

V 34632

Acto nel ta ble t film o m huld 75m g

0,07 stuk

18,37810

0M05BABO

V EU/1/03/265/003 Bo nviva ta ble t film o m huld 150m g

0,03 stuk

36,75620

0M05BABO 0M05BABO

V EU/1/03/265/004 Bo nviva ta ble t film o m huld 150m g V EU/1/05/310/002 Fosa va nce table t 70m g/2800ie

0,03 stuk 0,14 stuk

36,75620 8,57645

0M05BABO

V EU/1/05/310/004 Fosa va nce table t 70m g/2800ie

0,14 stuk

8,57645

0M05BABO

V EU/1/05/310/007 Fosa va nce table t 70m g/5600ie

0,14 stuk

8,57645

0M05BABO

V EU/1/06/364/002 Adrova nce ta blet 70m g/2800ie

0,14 stuk

8,57645

0M05BABP

V EU/1/01/176/001 Zo m e ta infpdr flacon 4m g +so lv 5m l

1,00 stuk

297,27600

0M05BABP

V EU/1/01/176/004 Zo m e ta infvlst co nc 0,8m g/m l flacon 5m l

1,00 stuk

297,27600

0M05BABP 0M05BABP

V EU/1/03/265/005 Bo nviva injvlst 1m g/m l wwsp 3m l V EU/1/05/308/001 Acla sta infusie vlo e isto f 0,05m g/m l fla co n 100m l

0M05BABP

4,00 m l 80,00 m l

74,31900 3,71595

V EU/1/96/012/011 Bo ndro nat infvlst co nc 1m g/m l fla co n 6m l

4,00 m l

74,31900

0N02AAAO 0N02AAAO

V 100644 V 100649

O x yco do n hcl sa ndo z table t m va 5m g O x yco do n hcl sa ndo z table t m va 10m g

6,00 stuk 3,00 stuk

0,41607 0,69344

0N02AAAO

V 101359

O x yco do n hcl rp ta blet m va 10m g

3,00 stuk

0,69344

0N02AAAO

V 104440//27509

O x yno rm ca psule 5m g

6,00 stuk

0,41607

0N02AAAO 0N02AAAO

V 104441//27510 V 104442//27511

O x yno rm ca psule 10m g O x yno rm ca psule 20m g

3,00 stuk 1,50 stuk

0,69344 1,38689

0N02AAAO

V 11205

Ms co ntin ta ble t m ga 10m g

10,00 stuk

0,29125

0N02AAAO

V 11206

Ms co ntin ta ble t m ga 30m g

3,33 stuk

0,62410

0N02AAAO 0N02AAAO

V 11207 V 11208

Ms co ntin ta ble t m ga 60m g Ms co ntin ta ble t m ga 100m g

1,67 stuk 1,00 stuk

1,24820 2,08033

0N02AAAO

V 15376

Ms co ntin ta ble t m ga 200m g

0,50 stuk

4,16067

0N02AAAO

V 16674

Ms co ntin ta ble t m ga 15m g

6,67 stuk

0,31205

0N02AAAO 0N02AAAO

V 17210 V 17211

Ka pa no l capsule m ga 20m g Ka pa no l capsule m ga 50m g

5,00 stuk 2,00 stuk

0,41607 1,04017

0N02AAAO

V 17212

Ka pa no l capsule m ga 100m g

1,00 stuk

2,08033

0N02AAAO

V 17881

Mo rfinesulfa a t pch reta rd ta ble t m ga 10m g

10,00 stuk

0,29125

0N02AAAO 0N02AAAO

V 17882 V 17883

Mo rfinesulfa a t pch reta rd ta ble t m ga 30m g Mo rfinesulfa a t pch reta rd ta ble t m ga 60m g

3,33 stuk 1,67 stuk

0,62410 1,24820

0N02AAAO

V 18758

O ra m o rph dra nk 2m g/m l

0N02AAAO

V 18759

O ra m o rph dra nk 20m g/m l

0N02AAAO 0N02AAAO

V 18760 V 18761

O ra m o rph unit do se dra nk 2m g/m l fla co n 5m l O ra m o rph unit do se dra nk 6m g/m l fla co n 5m l

0N02AAAO

V 22107

O XYC O NTIN TABLET MVA 10MG

3,00 stuk

0,69344

0N02AAAO

V 22108

O XYC O NTIN TABLET MVA 20MG

1,50 stuk

1,38689

50,00 m l

0,05825

5,00 m l

0,41607

50,00 m l 16,67 m l

0,05825 0,12482

0N02AAAO

V 22110

O XYC O NTIN TABLET MVA 80MG

0,38 stuk

5,54756

0N02AAAO

V 22162

P a lla don sr ca psule m ga 4m g

2,00 stuk

1,04017

0N02AAAO

V 22163

P a lla don sr ca psule m ga 8m g

1,00 stuk

2,08033

0N02AAAO 0N02AAAO

V 22164 V 22165

P a lla don sr ca psule m ga 16m g P a lla don sr ca psule m ga 24m g

0,50 stuk 0,33 stuk

4,16067 6,24100

0N02AAAO

V 22941

MO R FINE HC L C F R ETAR D TABLET MVA 10MG

10,00 stuk

0,29125

0N02AAAO

V 22942

MO R FINE HC L C F R ETAR D TABLET MVA 30MG

3,33 stuk

0,62410

0N02AAAO 0N02AAAO

V 22943 V 22944

MO R FINE HC L C F R ETAR D TABLET MVA 60MG MO R FINE HC L C F R ETAR D TABLET MVA 100MG

1,67 stuk 1,00 stuk

1,24820 2,08033

0N02AAAO

V 22945

MO R FINE HC L C F R ETAR D TABLET MVA 200MG

0,50 stuk

4,16067

0N02AAAO

V 24997

Mo rfinesulfa a t pch reta rd ta ble t m ga 100m g

1,00 stuk

2,08033

0N02AAAO 0N02AAAO

V 26233=17881 V 26234=17882

Mo rfinesulfa a t a cta vis re ta rd table t m ga 10m g Mo rfinesulfa a t a cta vis re ta rd table t m ga 30m g

10,00 stuk 3,33 stuk

0,29125 0,62410

0N02AAAO

V 26235=17883

Mo rfinesulfa a t a cta vis re ta rd table t m ga 60m g

1,67 stuk

1,24820

0N02AAAO

V 26236=24997

Mo rfinesulfa a t a cta vis re ta rd table t m ga 100m g

1,00 stuk

2,08033

0N02AAAO 0N02AAAO

V 26549 V 26550

P a lla don ir ca psule 1,3m g P a lla don ir ca psule 2,6m g

6,15 stuk 3,08 stuk

0,33805 0,67611

0N02AAAO

V 27349

MO R FINE HC L MYLAN R ETAR D TABLET MGA 10MG

10,00 stuk

0,29125

0N02AAAO

V 27350

MO R FINE HC L MYLAN R ETAR D TABLET MGA 30MG

3,33 stuk

0,62410

0N02AAAO 0N02AAAO

V 27351 V 27352

MO R FINE HC L MYLAN R ETAR D TABLET MGA 60MG MO R FINE HC L MYLAN R ETAR D TABLET MGA100MG

1,67 stuk 1,00 stuk

1,24820 2,08033

0N02AAAO

V 27353

MO R FINE HC L MYLAN R ETAR D TABLET MGA 200MG

0,50 stuk

4,16067

0N02AAAO

V 27509

O x yno rm ca psule 5m g

6,00 stuk

0,41607

0N02AAAO 0N02AAAO

V 27510 V 27511

O x yno rm ca psule 10m g O x yno rm ca psule 20m g

3,00 stuk 1,50 stuk

0,69344 1,38689

0N02AAAO

V 27536

O XYC O NTIN TABLET MVA 5MG

6,00 stuk

0,41607

0N02AAAO

V 27940

O x yno rm drank 10m g/m l

3,00 m l

0,69344

0N02AAAO 0N02AAAO

V 34224 V 34225

O x yco do n hcl rp ta blet m va 20m g O x yco do n hcl rp ta blet m va 40m g

1,50 stuk 0,75 stuk

1,38689 2,77378

0N02AAAO

V 34226

O x yco do n hcl rp ta blet m va 80m g

0,38 stuk

5,54756

0N02AAAO

V 34242

O x yco do n hcl sa ndo z table t m va 20m g

1,50 stuk

1,38689

0N02AAAO 0N02AAAO

V 34243 V 34244

O x yco do n hcl sa ndo z table t m va 40m g O x yco do n hcl sa ndo z table t m va 80m g

0,75 stuk 0,38 stuk

2,77378 5,54756

0N02AAC P

V 21390

Mo rfine hcl cf injvlst 20m g/m l a m pul 1m l

1,50 m l

2,61000

0N02AAC P 0N02AAC P

V 29031 V 50836

O x yno rm injvlst 10m g/m l Mo rfine hcl cf injvlst 10m g/m l

3,00 m l 3,00 m l

1,30500 1,30500

0N02AAC P

V 51950

Mo rfine hcl pch injvlst 10m g/m l am pul 1m l

3,00 m l

1,30500

0N02AAC P

V 51952

Mo rfine hcl pch injvlst 20m g/m l

1,50 m l

2,61000

0N02ABADP K 100900

Fenta nyl m atrix rp ple iste r 12m cg/uur

1,33 stuk

5,69800

0N02ABADP K 31418

Duro ge sic m a trix ple iste r 12m cg/uur

1,33 stuk

5,69800

0N02ABADP K 32749

Fenta nyl m atrix jc ple iste r 12m cg/uur

1,33 stuk

5,69800

0N02ABADP K 32754 0N02ABADP K 34442

Fenta nyl m atrix pch ple iste r 12m cg/uur Fenta nyl m atrix sa ndoz ple iste r 12m cg/uur

1,33 stuk 1,33 stuk

5,69800 5,69800

0N02ABADP V 101901

Fenta nyl m atrix a cta vis ple iste r 25m cg/uur

0,67 stuk

5,39635

0N02ABADP V 101902 0N02ABADP V 101903

Fenta nyl m atrix a cta vis ple iste r 50m cg/uur Fenta nyl m atrix a cta vis ple iste r 75m cg/uur

0,33 stuk 0,22 stuk

10,79271 16,18906

0N02ABADP V 101904

Fenta nyl m atrix a cta vis ple iste r 100m cg/uur

0,17 stuk

21,58541

0N02ABADP V 16845

Duro ge sic 25 pleister 2,5m g

0,67 stuk

5,39635

0N02ABADP V 16846

Duro ge sic 50 pleister 5m g

0,33 stuk

10,79271

0N02ABADP V 16847

Duro ge sic 75 pleister 7,5m g

0,22 stuk

16,18906

0N02ABADP V 16848

Duro ge sic 100 ple iste r 10m g

0,17 stuk

21,58541

0N02ABADP V 32750

Fenta nyl m atrix jc ple iste r 25m cg/uur

0,67 stuk

5,39635

0N02ABADP V 32751 0N02ABADP V 32752

Fenta nyl m atrix jc ple iste r 50m cg/uur Fenta nyl m atrix jc ple iste r 75m cg/uur

0,33 stuk 0,22 stuk

10,79271 16,18906

0N02ABADP V 32753

Fenta nyl m atrix jc ple iste r 100m cg/uur

0,17 stuk

21,58541

0N02ABADP V 32755

Fenta nyl m atrix pch ple iste r 25m cg/uur

0,67 stuk

5,39635

0N02ABADP V 32756 0N02ABADP V 32757

Fenta nyl m atrix pch ple iste r 50m cg/uur Fenta nyl m atrix pch ple iste r 75m cg/uur

0,33 stuk 0,22 stuk

10,79271 16,18906

0N02ABADP V 32758

Fenta nyl m atrix pch ple iste r 100m cg/uur

0,17 stuk

21,58541

0N02ABADP V 34114

Fenta nyl m atrix rp ple iste r 25m cg/uur

0,67 stuk

5,39635

0N02ABADP V 34115 0N02ABADP V 34116

Fenta nyl m atrix rp ple iste r 50m cg/uur Fenta nyl m atrix rp ple iste r 75m cg/uur

0,33 stuk 0,22 stuk

10,79271 16,18906

0N02ABADP V 34117

Fenta nyl m atrix rp ple iste r 100m cg/uur

0,17 stuk

21,58541

0N02ABADP V 34443

Fenta nyl m atrix sa ndoz ple iste r 25m cg/uur

0,67 stuk

5,39635

0N02ABADP V 34444 0N02ABADP V 34445

Fenta nyl m atrix sa ndoz ple iste r 50m cg/uur Fenta nyl m atrix sa ndoz ple iste r 75m cg/uur

0,33 stuk 0,22 stuk

10,79271 16,18906

0N02ABADP V 34446

Fenta nyl m atrix sa ndoz ple iste r 100m cg/uur

0,17 stuk

21,58541

0N02ADAO

Fortra l ca psule 50m g

4,00 stuk

0,21691

0N02AEADP V 11872

Te m ge sic sl table t oro m uco sa a l 0,2m g

6,00 stuk

0,33335

0N02AEADP V 32909

Tra nste c 35m cg/uur m atrix ple iste r

0,36 stuk

5,60021

0N02AEADP V 32910 0N02AEADP V 32911

Tra nste c 52,5m cg/uur m a trix ple iste r Tra nste c 70m cg/uur m atrix ple iste r

0,24 stuk 0,18 stuk

8,40032 11,20043

0N02AXAO

V 15511

Tra m a l ca psule 50m g

6,00 stuk

0,20647

0N02AXAO 0N02AXAO

V 15513 V 18941

Tra m a l druppe lvloe isto f 100m g/m l Tra m a do li hydro chloridum capsule 50m g

3,00 m l 6,00 stuk

0,41294 0,20647

0N02AXAO

V 19990

Tra m a ge tic druppels 100m g/m l

3,00 m l

0,41294

0N02AXAO

V 20977

Tra m a ge tic bruista blet 50m g

6,00 stuk

0,20647

0N02AXAO 0N02AXAO

V 21626 V 21682

TR AMADO L HC L APO TEX C AP SULE 50MG Tra m a do l hcl rp ca psule 50m g

6,00 stuk 6,00 stuk

0,20647 0,20647

0N02AXAO

V 21690

Tra m a do l hcl sando z ca psule 50m g

6,00 stuk

0,20647

0N02AXAO

V 22031

Tra m a do l hcl pch ca psule 50m g

6,00 stuk

0,20647

0N02AXAO 0N02AXAO

V 22233 V 22234

Tra m a ge tic once da ily table t m ga 200m g Tra m a ge tic once da ily table t m ga 300m g

1,50 stuk 1,00 stuk

0,82588 1,23882

0N02AXAO

V 22361

TR AMAL R ETAR D TABLET MVA 100MG

3,00 stuk

0,41294

0N02AXAO

V 22362

TR AMAL R ETAR D TABLET MVA 150MG

2,00 stuk

0,61941

0N02AXAO 0N02AXAO

V 22363 V 22452

TR AMAL R ETAR D TABLET MVA 200MG Tra m a ge tic reta rd ta ble t m ga 100m g

1,50 stuk 3,00 stuk

0,82588 0,41294

0N02AXAO

V 22453

Tra m a ge tic reta rd ta ble t m ga 150m g

2,00 stuk

0,61941

0N02AXAO

V 22454

Tra m a ge tic reta rd ta ble t m ga 200m g

1,50 stuk

0,82588

0N02AXAO 0N02AXAO

V 23006=22325 V 23007=22326

Tra m a do li hydro chloridum re ta rd ca psule m ga 50m g Tra m a do li hydro chloridum re ta rd ca psule m ga 100m g

6,00 stuk 3,00 stuk

0,20647 0,41294

0N02AXAO

V 23008=22327

Tra m a do li hydro chloridum re ta rd ca psule m ga 150m g

2,00 stuk

0,61941

0N02AXAO

V 23009=22328

Tra m a do li hydro chloridum re ta rd ca psule m ga 200m g

1,50 stuk

0,82588

0N02AXAO 0N02AXAO

V 23527 V 25343

Tra m a do l hcl sando z bruista ble t 50m g Tra m a do l hcl pch bruistable t 50m g

6,00 stuk 6,00 stuk

0,20647 0,20647

0N02AXAO

V 25693

Tra m a do l hcl sando z re ta rd ta blet m ga 100m g

3,00 stuk

0,41294

0N02AXAO

V 25694

Tra m a do l hcl sando z re ta rd ta blet m ga 150m g

2,00 stuk

0,61941

0N02AXAO

V 25695

Tra m a do l hcl sando z re ta rd ta blet m ga 200m g

1,50 stuk

0,82588

V 8980

0N02AXAO

V 25697

Tra m a do l hcl rp re tard ta ble t m ga 150m g

2,00 stuk

0N02AXAO

V 25698

Tra m a do l hcl rp re tard ta ble t m ga 200m g

1,50 stuk

0,61941 0,82588

0N02AXAO 0N02AXAO

V 25699 V 25700

Tra m a do l hcl m yla n reta rd ta ble t m ga 100m g TR AMADO L HC L MYLAN R ETAR D TABLET MGA 150MG

3,00 stuk 2 STUK

0,41294 0,61941

0N02AXAO

V 25701

TR AMADO L HC L MYLAN R ETAR D TABLET MGA 200MG

1,5 STUK

0,82588

0N02AXAO

V 26280

Tra m a do l hcl m yla n ca psule 50m g

6,00 stuk

0,20647

0N02AXAO 0N02AXAO

V 26959 V 27163

Tra m a do l hcl a cta vis bruista blet 50m g Tra m a do l hcl cf capsule 50m g

6,00 stuk 6,00 stuk

0,20647 0,20647

0N02AXAO

V 27165

Tra m a do l hcl cf druppe ls 100m g/m l

3,00 m l

0,41294

0N02AXAO

V 27177

Tra m a do l hcl pch druppe ls 100m g/m l

3,00 m l

0,41294

0N02AXAO 0N02AXAO

V 28078 V 28079

Tra m a do l hcl cf disp ta ble t 50m g Tra m a do l hcl cf disp ta ble t 100m g

6,00 stuk 3,00 stuk

0,20647 0,41294

0N02AXAO

V 30752

Tra do na l sm eltta ble t 50m g

6,00 stuk

0,20647

0N02AXAO

V 33751

TR AMADO L HC L TEVA R ETAR D TABLET MGA 100MG

3,00 stuk

0,41294

0N02AXAO 0N02AXAO

V 33752 V 33753

TR AMADO L HC L TEVA R ETAR D TABLET MGA 150MG TR AMADO L HC L TEVA R ETAR D TABLET MGA 200MG

2,00 stuk 1,50 stuk

0,61941 0,82588

0N02AXAP

V 15510

Tra m a l injvlst 50m g/m l am pul 2m l

6,00 m l

0,61782

0N02AXAP

V 19270

Tra m a ge tic injvlst 50m g/m l a m pul 2m l

6,00 m l

0,61782

0N02AXAR

V 15512

Tra m a l-z ze tpil 100m g

3,00 stuk

0,38935

0N02AXAR

V 27166

Tra m a do l hcl cf ze tpil 100m g

3,00 stuk

0,38935

0N02C ADR 0N02C C AO

V 566 V 100169//26579

C a fe rgo t zetpil 2m g R e lpa x ta ble t film o m huld 40m g

2,00 stuk 1,00 stuk

0,32427 6,21227

0N02C C AO

V 103688//21815

Ma x a lt ta blet 5m g

2,00 stuk

3,72736

0N02C C AO

V 103692//21816

Ma x a lt ta blet 10m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 21079 V 21444

Zo m ig ta ble t o m huld 2,5m g Na ram ig table t om huld 2,5m g

1,00 stuk 1,00 stuk

6,21227 6,21227

0N02C C AO

V 21815

Ma x a lt ta blet 5m g

2,00 stuk

3,72736

0N02C C AO

V 21816

Ma x a lt ta blet 10m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 21817 V 21818

Ma x a lt sm eltta ble t 5m g Ma x a lt sm eltta ble t 10m g

2,00 stuk 1,00 stuk

3,72736 6,21227

0N02C C AO

V 23781//21444

Na ram ig table t om huld 2,5m g

1,00 stuk

6,21227

0N02C C AO

V 23815//21079

Zo m ig ta ble t o m huld 2,5m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 24079//21079 V 24079//31917

Zo m ig ta ble t o m huld 2,5m g Zo m ig ta ble t o m huld 2,5m g

1,00 stuk 1,00 stuk

6,21227 6,21227

0N02C C AO

V 24993//21079

Zo m ig ta ble t o m huld 2,5m g

1,00 stuk

6,21227

0N02C C AO

V 25415

Alm o gra n ta blet o m huld 12,5m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 26255//24057 V 26255//31919

Zo m ig o ro sm eltta ble t 2,5m g Zo m ig zip sm e lttable t 2,5m g

1,00 stuk 1,00 stuk

6,21227 6,21227

0N02C C AO

V 26578

R e lpa x ta ble t film o m huld 20m g

2,00 stuk

3,72736

0N02C C AO

V 26579

R e lpa x ta ble t film o m huld 40m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 26607//21444 V 27212

Na ram ig table t om huld 2,5m g From ire x ta blet o m huld 2,5m g

1,00 stuk 1,00 stuk

6,21227 6,21227

0N02C C AO

V 27907//21444

Na ram ig table t om huld 2,5m g

1,00 stuk

6,21227

0N02C C AO

V 28186//24057

Zo m ig o ro sm eltta ble t 2,5m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 28701//24057 V 29125//26579

Zo m ig o ro sm eltta ble t 2,5m g R e lpa x ta ble t film o m huld 40m g

1,00 stuk 1,00 stuk

6,21227 6,21227

0N02C C AO

V 29413

Im igran fta b dispe rge erba re table t 50m g

1,00 stuk

6,21227

0N02C C AO

V 29414

Im igran fta b dispe rge erba re table t 100m g

0,50 stuk

12,42453

0N02C C AO 0N02C C AO

V 29573//26579 V 29836//21818

R e lpa x ta ble t film o m huld 40m g Ma x a lt sm eltta ble t 10m g

1,00 stuk 1,00 stuk

6,21227 6,21227

0N02C C AO

V 29872//25415

Alm o gra n ta blet o m huld 12,5m g

1,00 stuk

6,21227

0N02C C AO

V 30622

SUMATR IP TAN MYLAN TABLET O MHULD 50MG

1,00 STUK

6,21227

0N02C C AO 0N02C C AO

V 30623 V 31076

SUMATR IP TAN MYLAN TABLET O MHULD 100MG Sum a triptan sando z ta ble t o m huld 50m g

0,50 STUK 1,00 stuk

12,42453 6,21227

0N02C C AO

V 31077

Sum a triptan sando z ta ble t o m huld 100m g

0,50 stuk

12,42453

0N02C C AO

V 31743//24057

Zo m ig zip sm e lttable t 2,5m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 31861//21818 V 31899

Ma x a lt sm eltta ble t 10m g Sum a triptan pch ta ble t o m huld 50m g

1,00 stuk 1,00 stuk

6,21227 6,21227

0N02C C AO

V 31900

Sum a triptan pch ta ble t o m huld 100m g

0,50 stuk

12,42453

0N02C C AO

V 31917

Zo m ig ta ble t o m huld 2,5m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 31919 V 32210//26579

Zo m ig zip o rodisp ta ble t 2,5m g R e lpa x ta ble t film o m huld 40m g

1,00 stuk 1,00 stuk

6,21227 6,21227

0N02C C AO

V 32301//25415

Alm o gra n ta blet o m huld 12,5m g

1,00 stuk

6,21227

0N02C C AO

V 32934//21816

R iza triptan ta ble t 10m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 32935//21818 V 33582

R iza triptan sm e ltta ble t 10m g SUMATR IP TAN APO TEX TABLET 50MG

1,00 stuk 1,00 stuk

6,21227 6,21227

0N02C C AO

V 33583

SUMATR IP TAN APO TEX TABLET 100MG

0,50 stuk

12,42453

0N02C C AO

V 33694

Sum a triptan fo cus ta blet 50m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 33695 V 33718

Sum a triptan fo cus ta blet 100m g Sum a triptan cf ta blet 50m g

0,50 stuk 1,00 stuk

12,42453 6,21227

0N02C C AO

V 33719

Sum a triptan cf ta blet 100m g

0,50 stuk

12,42453

0N02C C AO

V 34979

Sum a triptan a urobindo ta ble t 50m g

1,00 stuk

6,21227

0N02C C AO 0N02C C AO

V 34980 V 35090

Sum a triptan a urobindo ta ble t 100m g Sum a triptan a cta vis table t om huld 100m g

0,50 stuk 0,50 stuk

12,42453 12,42453

0N02C C BO

V 19469

Im igran ne usspra y 10m g

2,00 stuk

6,26081

0N02C C BO 0N02C C BO

V 19470 V 19853

Im igran ne usspra y 20m g Im igran zetpil 25m g

1,00 stuk 1,00 stuk

10,43468 10,43468

0N02C C BO

V 24917//19470

Im igran ne usspra y 20m g

1,00 stuk

10,43468

0N02C C BO

V 30649//19853

Im igran zetpil 25m g

1,00 stuk

10,43468

0N02C XBO

V 16336=56917

C lo nidine hcl sa ndoz ta ble t 0,025m g

4,00 stuk

0,08017

0N02C XBO

V 19845=56917

C LO NIDINE HC L TEVA TABLET 0,025MG

4,00 stuk

0,08017

0N02C XBO

V 28800=56917

C lo nidine hcl a cta vis ta blet 0,025m g

4,00 stuk

0,08017

0N02C XBO 0N02C XBO

V 56917 V 6757

C lo nidine hcl cf ta ble t 0,025m g Dix arit dra ge e 0,025m g

4,00 stuk 4,00 stuk

0,08017 0,08017

0N03ABAO

K 2975

Dipha nto ine -z 25 ta ble t 23m g

12,00 stuk

0,01543

0N03ABAO

V 2976

Dipha nto ine -z 100 ta ble t 92m g

3,00 stuk

0,02532

0N03ABAO

V 8050

Dipha nto ine -z 50 ta ble t 46m g

6,00 stuk

0,01519

0N03ABAO

V 8051

Dipha nto ine -z 75 ta ble t 69m g

4,00 stuk

0,01899

0N03ADAO

K 2984

Ethym al siro o p 62,5m g/m l

0N03ADAO

V 2982

Ethym al ca psule 250m g

0N03ADAO 0N03ADAO

V 2982 V 5634

Ethym al ca psule 250m g Ethym al e nteric capsule m sr 125m g

0N03AFAO

V 11874

0N03AFAO 0N03AFAO

V 11875 V 16869

20,00 m l

0,02587

5,00 stuk

0,11050

5,00 stuk 10,00 stuk

0,11050 0,06630

Te gre to l cr ta ble t m ga 200m g

5,00 stuk

0,13904

Te gre to l cr ta ble t m ga 400m g C a rbam a ze pine a pote x re tard ta ble t m ga 400m g

2,50 stuk 2,50 stuk

0,23173 0,23173

0N03AFAO

V 24401

C a rbam a ze pine sando z re ta rd ta blet m ga 200m g

5,00 stuk

0,13904

0N03AFAO 0N03AFAO

V 24402 V 25818=24401

C a rbam a ze pine sando z re ta rd ta blet m ga 400m g C AR BAMAZEPINE TEVA R ETAR D TABLET MGA 200MG

2,50 stuk 5,00 stuk

0,23173 0,13904

0N03AFAO

V 25819=24402

C AR BAMAZEPINE TEVA R ETAR D TABLET MGA 400MG

2,50 stuk

0,23173

0N03AFAO

V 26020=24401

C a rbam a ze pine a re tard ta ble t m ga 200m g

5,00 stuk

0,13904

0N03AFAO 0N03AFAO

V 26021=24402 V 26820=24401

C a rbam a ze pine a re tard ta ble t m ga 400m g C a rbam a ze pine cf re ta rd table t m ga 200m g

2,50 stuk 5,00 stuk

0,23173 0,13904

0N03AFAO

V 26821=24402

C a rbam a ze pine cf re ta rd table t m ga 400m g

2,50 stuk

0,23173

0N03AFAO

V 28995=21169

C a rbam a ze pine a cta vis reta rd ta ble t m ga 200m g

5,00 stuk

0,13904

0N03AFAO 0N03AFAO

V 28996=16869 V 29021=24401

C a rbam a ze pine a cta vis reta rd ta ble t m ga 400m g C a rbam a ze pine m yla n reta rd ta ble t m ga 200m g

2,50 stuk 5,00 stuk

0,23173 0,13904

0N03AFAO

V 29022=24402

C a rbam a ze pine m yla n reta rd ta ble t m ga 400m g

2,50 stuk

0,23173

0N03AFBO 0N03AFBO

V 24751 V 24752

Trile pta l ta blet film om huld 300m g Trile pta l ta blet film om huld 600m g

3,33 stuk 1,67 stuk

0,29201 0,58402

0N03AFBO

V 33445

O x ca rba ze pine m yla n ta blet film om huld 300m g

3,33 stuk

0,29201

0N03AFBO

V 33446

O x ca rba ze pine m yla n ta blet film om huld 600m g

1,67 stuk

0,58402

0N03AFC O

K 34618//6346

Te gre to l stro o p 20m g/m l

50,00 m l

0N03AFC O

K 6346

TEGR ETO L SUSP ENSIE 20MG/ML

50,00 m l

0,02367

0N03AFC O

K 9196

C AR BAMAZEPINE APO TEX SUSP ENSIE 20MG/ML

50,00 ML

0,02367

0N03AFC O

V 10780

C AR BAMAZEPINE APO TEX TABLET 100MG

10,00 stuk

0,08592

0N03AFC O

V 10781

C a rbym a l ta blet 400m g

2,50 stuk

0,21479

0N03AFC O

V 11401

Te gre to l table t 100m g

10,00 stuk

0,08592

0N03AFC O 0N03AFC O

V 11735 V 24266

C a rbam a ze pine rp ta ble t 200m g C a rbam a ze pine sando z ta ble t 100m g

5,00 stuk 10,00 stuk

0,10740 0,08592

0N03AFC O

V 24267

C a rbam a ze pine sando z ta ble t 200m g

5,00 stuk

0,10740

0N03AFC O

V 24301=11735

C a rbam a ze pine m yla n table t 200m g

5,00 stuk

0,10740

0N03AFC O 0N03AFC O

V 25069 V 25255=24266

C a rbam a ze pine pch ta ble t 200m g C a rbam a ze pine rp ta ble t 100m g

5,00 stuk 10,00 stuk

0,10740 0,08592

0N03AFC O

V 3899

Te gre to l table t 200m g

5,00 stuk

0,10740

0N03AFC O

V 55157

C a rbam a ze pine cf ta blet 200m g

5,00 stuk

0,10740

0N03AFC O 0N03AFC O

V 57244 V 9884

C a rbam a ze pinum ta ble t 200m g C AR BAMAZEPINE APO TEX TABLET 200MG

5,00 stuk 5,00 STUK

0,10740 0,10740

0N03AGAO

K 18153

De pak ine suik e rvrije stro o p dra nk 40m g/m l

37,50 m l

0,03146

0N03AGAO 0N03AGAO

K 22731=55567 K 55567

P ro pym al dra nk 300m g/5m l NATR IUMVALP R O AAT AP O TEX DR ANK 60MG/ML

25,00 m l 25,00 m l

0,04719 0,04719

0N03AGAO

V 11775

De pak ine chro no table t m ga 500m g

3,00 stuk

0,26546

0N03AGAO 0N03AGAO

V 13157 V 14911=7476

De pak ine chro no table t m ga 300m g Na trium va lproa a t pch table t m sr 500m g

5,00 stuk 3,00 stuk

0,15928 0,26546

0N03AGAO

V 17172//11775

De pak ine chro no table t m ga 500m g

3,00 stuk

0,26546

0N03AGAO

V 17569

De pak ine vloe isto f voo r k inde re n 300m g/m l

5,00 m l

0,15928

0N03AGAO 0N03AGAO

V 22771//11775 V 23293=55564

De pak ine chro no table t m ga 500m g Na trii valpro as pch table t m sr 150m g

3,00 stuk 10,00 stuk

0,26546 0,07964

0N03AGAO

V 24461

O rfiril cr ca psule m ga 150m g

10,00 stuk

0,07964

0N03AGAO

V 24462

O rfiril cr ca psule m ga 300m g

5,00 stuk

0,15928

0N03AGAO 0N03AGAO

V 24463 V 24464

O rfiril cr granulaa t m ga 500m g in sa che t O rfiril cr granulaa t m ga 1000m g in sa chet

3,00 stuk 1,50 stuk

0,26546 0,53092

0N03AGAO

V 25658=7055

Na trium va lproa a t pch table t m sr 300m g

5,00 stuk

0,15928

0,02367

0N03AGAO

V 27215//11775

De pak ine chro no table t m ga 500m g

3,00 stuk

0,26546

0N03AGAO 0N03AGAO

V 30759 V 30760

De pak ine chro no sphere gra nula at m ga 100m g in sa ch De pak ine chro no sphere gra nula at m ga 250m g in sa ch

15,00 stuk 6,00 stuk

0,12211 0,13273

0N03AGAO

V 30761

De pak ine chro no sphere gra nula at m ga 500m g in sa ch

3,00 stuk

0,26546

0N03AGAO

V 30762

De pak ine chro no sphere gra nula at m ga 750m g in sa ch

2,00 stuk

0,39819

0N03AGAO 0N03AGAO

V 30763 V 33299

De pak ine chro no sphere gra nula at m ga 1000m g in sa ch Na trium va lproa a t sa ndoz chro no ta ble t m va 300m g

1,50 stuk 5,00 stuk

0,53092 0,15928

0N03AGAO

V 33300

Na trium va lproa a t sa ndoz chro no ta ble t m va 500m g

3,00 stuk

0,26546

0N03AGAO

V 33979

Na trium va lproa a t rp chrono ta bl m va 300m g(zuur+na )

5,00 stuk

0,15928

0N03AGAO 0N03AGAO

V 33980 V 35065

Na trium va lproa a t rp chrono ta bl m va 500m g(zuur+na ) Na trium va lproa a t cf chro no ta blet m va 300m g

3,00 stuk 5,00 stuk

0,26546 0,15928

0N03AGAO

V 35066

Na trium va lproa a t cf chro no ta blet m va 500m g

3,00 stuk

0,26546

0N03AGAO

V 55290

Na trii valpro as ta ble t m sr 300m g

5,00 stuk

0,15928

0N03AGAO 0N03AGAO

V 55489=7476 V 55564

Na trii valpro as ta ble t m sr 500m g NATR IUMVALP R O AAT AP O TEX TABLET MSR 150MG

3,00 stuk 10,00 STUK

0,26546 0,07964

0N03AGAO

V 55565

NATR IUMVALP R O AAT AP O TEX TABLET MSR 300MG

5,00 STUK

0,15928

0N03AGAO

V 55566

NATR IUMVALP R O AAT AP O TEX TABLET MSR 600MG

2,50 STUK

0,31855

0N03AGAO 0N03AGAO

V 57606=7405 V 7055

Na trii valpro as ta ble t m sr 150m g De pak ine e nte ric table t 300m g

10,00 stuk 5,00 stuk

0,07964 0,15928

0N03AGAO

V 7405

De pak ine e nte ric table t 150m g

10,00 stuk

0,07964

0N03AGAO

V 7476

De pak ine e nte ric table t 500m g

3,00 stuk

0,26546

0N03AGAO 0N03AGAO

V 8484 V 8659

P ro pym al e nteric capsule m sr 300m g De pak ine -zuur ca psule m sr 125m g

5,00 stuk 12,00 stuk

0,15928 0,06637

0N03AGAO

V 8660

De pak ine -zuur ca psule m sr 250m g

6,00 stuk

0,13273

0N03AGAO

V 8661

De pak ine -zuur ca psule m sr 500m g

3,00 stuk

0,26546

0N03AGAO 0N03AGAO

V 8803 V 8804

P ro pym al e nteric capsule m sr 150m g P ro pym al e nteric capsule m sr 450m g

10,00 stuk 3,33 stuk

0,07964 0,23892

0N03AGAO

V 8805

P ro pym al e nteric capsule m sr 600m g

2,50 stuk

0,31855

0N03AGAP 0N03AGAP

V 14996 V 24465

De pak ine injectie po ede r flac 400m g + so lv 4m l O rfiril injvlst 100m g/m l a m pul 3m l

0N03AXAO

K 19115

Lam icta l dispe rs table t 5m g

60,00 stuk

0,38133

0N03AXAO 0N03AXAO

K 25344 K 29665

Lam icta l dispe rs table t 2m g Lam o trigine cf dispers ta ble t 5m g

150,00 stuk 60,00 stuk

0,19829 0,38133

0N03AXAO

K 29707

Lam o trigine pch dispe rs ta blet 2m g

150,00 stuk

0,19829

0N03AXAO

K 29708

Lam o trigine pch dispe rs ta blet 5m g

60,00 stuk

0,38133

0N03AXAO

K 32065

Lam o trigine rp dispe rs ta blet 5m g

60,00 stuk

0,38133

0N03AXAO

V 19116

Lam icta l dispe rs table t 25m g

12,00 stuk

0,58651

0N03AXAO

V 19117

Lam icta l dispe rs table t 100m g

3,00 stuk

1,46626

0N03AXAO 0N03AXAO

V 20926 V 20927

Lam icta l dispe rs table t 50m g Lam icta l dispe rs table t 200m g

6,00 stuk 1,50 stuk

0,73313 2,93253

0N03AXAO

V 29546

Lam o trigine sa ndo z dispe rs table t 25m g

12,00 stuk

0,58651

0N03AXAO

V 29547

Lam o trigine sa ndo z dispe rs table t 50m g

6,00 stuk

0,73313

0N03AXAO 0N03AXAO

V 29548 V 29549

Lam o trigine sa ndo z dispe rs table t 100m g Lam o trigine sa ndo z dispe rs table t 200m g

3,00 stuk 1,50 stuk

1,46626 2,93253

0N03AXAO

V 29666

Lam o trigine cf dispers ta ble t 25m g

12,00 stuk

0,58651

0N03AXAO

V 29667

Lam o trigine cf dispers ta ble t 50m g

6,00 stuk

0,73313

0N03AXAO 0N03AXAO

V 29668 V 29669

Lam o trigine cf dispers ta ble t 100m g Lam o trigine cf dispers ta ble t 200m g

3,00 stuk 1,50 stuk

1,46626 2,93253

0N03AXAO

V 29709

Lam o trigine pch dispe rs ta blet 25m g

12,00 stuk

0,58651

15,00 m l 15,00 m l

3,38634 3,38634

0N03AXAO 0N03AXAO

V 29711 V 29712

Lam o trigine pch dispe rs ta blet 100m g Lam o trigine pch dispe rs ta blet 200m g

0N03AXAO

V 30302

Lam o trigine m ylan dispe rs ta ble t 25m g

0N03AXAO

V 30303

LAMO TR IGINE MYLAN DISP ER S TABLET 50MG

0N03AXAO 0N03AXAO

V 30304 V 30305

Lam o trigine m ylan dispe rs ta ble t 100m g Lam o trigine m ylan dispe rs ta ble t 200m g

0N03AXAO

V 32066

0N03AXAO

V 32067

0N03AXAO 0N03AXAO

3,00 stuk 1,50 stuk

1,46626 2,93253

12,00 stuk

0,58651

6 STUK

0,73313

3,00 stuk 1,50 stuk

1,46626 2,93253

Lam o trigine rp dispe rs ta blet 25m g

12,00 stuk

0,58651

Lam o trigine rp dispe rs ta blet 50m g

6,00 stuk

0,73313

V 32068 V 32069

Lam o trigine rp dispe rs ta blet 100m g Lam o trigine rp dispe rs ta blet 200m g

3,00 stuk 1,50 stuk

1,46626 2,93253

0N03AXAO

V 32823

Lam o trigine actavis dispe rs ta ble t 25m g

12,00 stuk

0,58651

0N03AXAO

V 32824

Lam o trigine actavis dispe rs ta ble t 50m g

6,00 stuk

0,73313

0N03AXAO 0N03AXAO

V 32825 V 32826

Lam o trigine actavis dispe rs ta ble t 100m g Lam o trigine actavis dispe rs ta ble t 200m g

3,00 stuk 1,50 stuk

1,46626 2,93253

0N03AXC O

V 100678

Ga bape ntine ra nba x y ca psule 100m g

18,00 stuk

0,43563

0N03AXC O 0N03AXC O

V 100681 V 101519

Ga bape ntine ra nba x y ca psule 400m g Ga bape ntine a ca psule 100m g

4,50 stuk 18,00 stuk

0,87126 0,43563

0N03AXC O

V 101520

Ga bape ntine a ca psule 300m g

6,00 stuk

0,65344

0N03AXC O

V 101521

Ga bape ntine a ca psule 400m g

4,50 stuk

0,87126

0N03AXC O 0N03AXC O

V 22481 V 22482

Ne uro ntin capsule 100m g Ne uro ntin capsule 300m g

18,00 stuk 6,00 stuk

0,43563 0,65344

0N03AXC O

V 22483

Ne uro ntin capsule 400m g

4,50 stuk

0,87126

0N03AXC O

V 25247

Ne uro ntin ta blet film om huld 600m g

3,00 stuk

1,30689

0N03AXC O 0N03AXC O

V 25248 V 29941

Ne uro ntin ta blet film om huld 800m g GABAP ENTINE AP O TEX C AP SULE 100MG

2,25 stuk 18,00 stuk

1,74252 0,43563

0N03AXC O

V 29942

GABAP ENTINE AP O TEX C AP SULE 300MG

6,00 stuk

0,65344

0N03AXC O

V 29943

GABAP ENTINE AP O TEX C AP SULE 400MG

4,50 stuk

0,87126

0N03AXC O 0N03AXC O

V 29977 V 29978

Ga bape ntine sa ndoz ta ble t film o m huld 600m g Ga bape ntine sa ndoz ta ble t film o m huld 800m g

3,00 stuk 2,25 stuk

1,30689 1,74252

0N03AXC O

V 30194

Ga bape ntine rp ca psule 100m g

18,00 stuk

0,43563

0N03AXC O

V 30195

Ga bape ntine rp ca psule 300m g

6,00 stuk

0,65344

0N03AXC O 0N03AXC O

V 30196 V 30536

Ga bape ntine rp ca psule 400m g Ga bape ntine rp table t film o m huld 600m g

4,50 stuk 3,00 stuk

0,87126 1,30689

0N03AXC O

V 30537

Ga bape ntine rp table t film o m huld 800m g

2,25 stuk

1,74252

0N03AXC O

V 30736

Ga bape ntine sa ndoz ca psule 100m g

18,00 stuk

0,43563

0N03AXC O 0N03AXC O

V 30737 V 30738

Ga bape ntine sa ndoz ca psule 300m g Ga bape ntine sa ndoz ca psule 400m g

6,00 stuk 4,50 stuk

0,65344 0,87126

0N03AXC O

V 30739

Ga bape ntine cf ca psule 100m g

18,00 stuk

0,43563

0N03AXC O

V 30740

Ga bape ntine cf ca psule 300m g

6,00 stuk

0,65344

0N03AXC O 0N03AXC O

V 30741 V 30742

Ga bape ntine cf ca psule 400m g GABAP ENTINE MYLAN C AP SULE 100MG

4,50 stuk 18 STUK

0,87126 0,43563

0N03AXC O

V 30743

Ga bape ntine m yla n capsule 300m g

6,00 stuk

0,65344

0N03AXC O

V 30744

GABAP ENTINE MYLAN C AP SULE 400MG

4,50 STUK

0N03AXC O 0N03AXC O

V 31980 V 31981

Ga bape ntine pch ca psule 100m g Ga bape ntine pch ca psule 300m g

0N03AXC O

V 31982

Ga bape ntine pch ca psule 400m g

4,50 stuk

0,87126

0N03AXC O

V 31983

Ga bape ntine pch table t film o m huld 600m g

3,00 stuk

1,30689

0N03AXC O 0N03AXC O

V 31984 V 32940

Ga bape ntine pch table t film o m huld 800m g Ga bape ntine a cta vis capsule 100m g

2,25 stuk 18,00 stuk

1,74252 0,43563

0N03AXC O

V 32941

Ga bape ntine a cta vis capsule 300m g

6,00 stuk

0,65344

0N03AXC O

V 32942

Ga bape ntine a cta vis capsule 400m g

4,50 stuk

0,87126

18,00 stuk 6,00 stuk

0,87126 0,43563 0,65344

0N03AXC O 0N03AXC O

V 32943 V 32944

Ga bape ntine a cta vis ta blet film om huld 600m g Ga bape ntine a cta vis ta blet film om huld 800m g

3,00 stuk 2,25 stuk

1,30689 1,74252

0N03AXC O

V 32992

0N03AXC O

V 32993

Ga bape ntine m yla n capsule 100m g

18,00 stuk

0,43563

Ga bape ntine m yla n capsule 300m g

6,00 stuk

0N03AXC O 0N03AXC O

0,65344

V 32994 V 32995

Ga bape ntine m yla n capsule 400m g Ga bape ntine m yla n ta blet film om huld 600m g

4,50 stuk 3,00 stuk

0,87126 1,30689

0N03AXC O

V 32996

GABAP ENTINE MYLAN TABLET FILMO MHULD 800MG

2,25 STUK

1,74252

0N03AXC O

V 34332

GABAP ENTINE AP O TEX TABLET FILMO MHULD 600MG

3,00 stuk

1,30689

0N03AXC O 0N03AXC O

V 34333 GABAP ENTINE AP O TEX TABLET FILMO MHULD 800MG V EU/1/04/279/011 Lyrica ca psule 75m g

2,25 stuk 4,00 stuk

1,74252 1,17620

0N03AXC O

V EU/1/04/279/012 Lyrica ca psule 75m g

4,00 stuk

1,17620

0N03AXC O

V EU/1/04/279/013 Lyrica ca psule 75m g

4,00 stuk

1,17620

0N03AXC O 0N03AXC O

V EU/1/04/279/017 Lyrica ca psule 150m g V EU/1/04/279/018 Lyrica ca psule 150m g

2,00 stuk 2,00 stuk

1,96033 1,96033

0N03AXC O

V EU/1/04/279/019 Lyrica ca psule 150m g

2,00 stuk

1,96033

0N03AXC O

V EU/1/04/279/024 Lyrica ca psule 300m g

1,00 stuk

3,92066

0N03AXC O 0N03AXC O

V EU/1/04/279/025 Lyrica ca psule 300m g V EU/1/04/279/027 Lyrica ca psule 75m g

1,00 stuk 4,00 stuk

3,92066 1,17620

0N03AXC O

V EU/1/04/279/028 Lyrica ca psule 150m g

2,00 stuk

1,96033

0N03AXC O

V EU/1/04/279/029 Lyrica ca psule 300m g

1,00 stuk

3,92066

0N03AXDO

V EU/1/00/146/004 Ke ppra ta ble t film o m huld 250m g

6,00 stuk

0,95330

0N03AXDO

V EU/1/00/146/005 Ke ppra ta ble t film o m huld 250m g

6,00 stuk

0,95330

0N03AXDO

V EU/1/00/146/010 Ke ppra ta ble t film o m huld 500m g

3,00 stuk

1,19163

0N03AXDO 0N03AXDO

V EU/1/00/146/024 Ke ppra ta ble t film o m huld 1000m g V EU/1/00/146/027 Ke ppra o plo ssing voo r o ra al ge bruik 100m g/m l

1,50 stuk 15,00 m l

2,38325 0,23833

0N03AXDO

V EU/1/08/470/002 Vim pa t ta ble t o m huld 50m g

6,00 stuk

0,83414

0N03AXDO

V EU/1/08/470/008 Vim pa t ta ble t o m huld 150m g

2,00 stuk

1,78744

0N03AXDO 0N04BAAO

V EU/1/08/470/014 Vim pa t stro o p 15m g/m l V 101003//12489 Ma do pa r hbs ca psule m ga 125m g

20,00 m l 6,00 stuk

0,17874 0,18944

0N04BAAO

V 101007//11605

Ma do pa r ta ble t 250m g

3,00 stuk

0,37886

0N04BAAO

V 11605

Ma do pa r ta ble t 250m g

3,00 stuk

0,37886

0N04BAAO 0N04BAAO

V 12059 V 12489

Ma do pa r ta ble t 125m g Ma do pa r hbs ca psule m ga 125m g

6,00 stuk 6,00 stuk

0,18944 0,18944

0N04BAAO

V 12858

Sine m e t 62,5 ta ble t 50/12,5m g

0N04BAAO

V 13706

Sine m e t cr 250 ta ble t m ga 200/50m g

0N04BAAO 0N04BAAO

V 15000 V 15175

Levo do pa /ca rbido pa pch 62,5 ta blet 50/12,5m g Sine m e t cr 125 ta ble t m ga 100/25m g

0N04BAAO

V 19428

Ma do pa r dispe r table t 125m g

6,00 stuk

0,18944

0N04BAAO

V 21676

Levo do pa /ca rbido pa pch 110 ta blet 100/10m g

6,00 stuk

0,18943

0N04BAAO 0N04BAAO

V 21677 V 21678

Levo do pa /ca rbido pa pch 125 ta blet 100/25m g Levo do pa /ca rbido pa pch 275 ta blet 250/25m g

6,00 stuk 2,40 stuk

0,18944 0,47358

0N04BAAO

V 23344//12489

Ma do pa r hbs ca psule m ga 125m g

6,00 stuk

0,18944

0N04BAAO

V 26892

Levo do pa /ca rbido pa sdz 125 re t ta ble t m ga 100/25m g

6,00 stuk

0,18944

0N04BAAO 0N04BAAO

V 26893 V 27059

Levo do pa /ca rbido pa sdz 250 re t ta ble t m ga 200/50m g Levo do pa /ca rbido pa pch 125 re t ta ble t m ga 100/25m g

3,00 stuk 6,00 stuk

0,37886 0,18944

0N04BAAO

V 27060

Levo do pa /ca rbido pa pch 250 re t ta ble t m ga 200/50m g

3,00 stuk

0,37886

0N04BAAO

V 30654

Levo do pa /ca rbido pa rp 125 re t ta ble t m ga 100/25m g

6,00 stuk

0,18944

0N04BAAO 0N04BAAO

V 30655 V 32051//11605

Levo do pa /ca rbido pa rp 250 re t ta ble t m ga 200/50m g Ma do pa r ta ble t 250m g

3,00 stuk 3,00 stuk

0,37886 0,37886

0N04BAAO

V 6706

Sine m e t 110 ta ble t 100/10m g

6,00 stuk

0,18943

0N04BAAO

V 6707

Sine m e t 275 ta ble t 250/25m g

2,40 stuk

0,47358

12,00 stuk

0,11366

3,00 stuk

0,37886

12,00 stuk 6,00 stuk

0,11366 0,18944

0N04BAAO

V 8740

Sine m e t 125 ta ble t 100/25m g

6,00 stuk

0,18944

0N04BC AO

V 100571

R e quip m oduta b ta blet m va 2m g

3,00 stuk

1,56609

0N04BC AO 0N04BC AO

V 100574 V 100576

R e quip m oduta b ta blet m va 4m g R e quip m oduta b ta blet m va 8m g

1,50 stuk 0,75 stuk

2,61014 5,22029

0N04BC AO

V 103700//100571 R e quip m oduta b ta blet m va 2m g

3,00 stuk

1,56609

0N04BC AO

V 103701//100574 R e quip m oduta b ta blet m va 4m g

1,50 stuk

2,61014

0N04BC AO 0N04BC AO

V 103702//100576 R e quip m oduta b ta blet m va 8m g V 104884//100574 R e quip m oduta b ta blet m va 4m g

0,75 stuk 1,50 stuk

5,22029 2,61014

0N04BC AO

V 20761

R e quip ta ble t o m huld 0,25m g

24,00 stuk

0,39152

0N04BC AO

V 20763

R e quip ta ble t o m huld 1m g

6,00 stuk

0,65254

0N04BC AO 0N04BC AO

V 20764 V 20765

R e quip ta ble t o m huld 2m g R e quip ta ble t o m huld 5m g

3,00 stuk 1,20 stuk

1,30507 3,26268

0N04BC AO

V 30484

P e rgo lide a ta ble t 0,05m g

60,00 stuk

0,31322

0N04BC AO

V 30485

P ER GO LIDE MYLAN TABLET 0,25MG

12,00 stuk

0,32627

0N04BC AO 0N04BC AO

V 30486 V 30820

P ER GO LIDE MYLAN TABLET 1MG P e rgo lide pch ta ble t 0,25m g

3,00 stuk 12,00 stuk

1,30507 0,32627

0N04BC AO

V 30822

P e rgo lide pch ta ble t 1m g

3,00 stuk

1,30507

0N04BC AO

V 31670

Adartre l sta rtverpa k k ing table t film o m huld 0,25m g

24,00 stuk

0,39152

0N04BC AO 0N04BC AO

V 31671 V 31673

Adartre l ta ble t film o m huld 0,5m g Adartre l ta ble t film o m huld 2m g

12,00 stuk 3,00 stuk

0,32627 1,30507

0N04BC AO

V 34856

R o piniro l m yla n ta ble t film o m huld 0,25m g

24,00 stuk

0,39152

0N04BC AO

V 34857

R o piniro l m yla n ta ble t film o m huld 0,5m g

12,00 stuk

0,32627

0N04BC AO 0N04BC AO

V 34858 V 34859

R o piniro l m yla n ta ble t film o m huld 1m g R o piniro l m yla n ta ble t film o m huld 2m g

6,00 stuk 3,00 stuk

0,65254 1,30507

0N04BC AO

V 34860

R o piniro l m yla n ta ble t film o m huld 5m g

1,20 stuk

3,26268

0N04BC AO

V 35192

R o piniro l cf table t film o m huld 0,25m g

24,00 stuk

0,39152

0N04BC AO 0N04BC AO

V 35193 V 35194

R o piniro l cf table t film o m huld 0,5m g R o piniro l cf table t film o m huld 1m g

12,00 stuk 6,00 stuk

0,32627 0,65254

0N04BC AO

V 35195

R o piniro l cf table t film o m huld 2m g

3,00 stuk

1,30507

0N04BC AO

V 7862

P a rlo de l capsule 10m g

3,00 stuk

1,30507

0N04BC AO 0N04BC AO

V 9355 P a rlo de l capsule 5m g V EU/1/05/331/001 Ne upro ple iste r 2m g/24uur

6,00 stuk 3,00 stuk

0,65254 1,82710

0N04BC AO

V EU/1/05/331/002 Ne upro ple iste r 2m g/24uur

3,00 stuk

1,82710

0N04BC AO

V EU/1/05/331/004 Ne upro ple iste r 4m g/24uur

1,50 stuk

2,61014

0N04BC AO 0N04BC AO

V EU/1/05/331/005 Ne upro ple iste r 4m g/24uur V EU/1/05/331/007 Ne upro ple iste r 6m g/24uur

1,50 stuk 1,00 stuk

2,61014 3,91522

0N04BC AO

V EU/1/05/331/008 Ne upro ple iste r 6m g/24uur

1,00 stuk

3,91522

0N04BC AO

V EU/1/05/331/010 Ne upro ple iste r 8m g/24uur

0,75 stuk

5,22029

0N04BC AO 0N04BC AO

V EU/1/05/331/011 Ne upro ple iste r 8m g/24uur V EU/1/97/050/001 Sifrol ta ble t 0,125m g (0,088m g ba se )

0,75 stuk 20,00 stuk

5,22029 0,46983

0N04BC AO

V EU/1/97/050/002 Sifrol ta ble t 0,125m g (0,088m g ba se )

20,00 stuk

0,46983

0N04BC AO

V EU/1/97/050/006 Sifrol ta ble t 1m g (0,7m g ba se)

0N04BC AO 0N04BC AO

V EU/1/97/051/001 Mira pex in table t 0,125m g (0,088m g base ) V EU/1/97/051/005 Mira pex in table t 1m g (0,7m g ba se )

0N04BDAO

V 13720

Elde pryl ta ble t 5m g

1,00 stuk

0,60171

0N04BDAO 0N04BDAO

V 19007 V 19325

Se le giline hcl sa ndo z ta blet 5m g Se le giline hcl pch ta ble t 5m g

1,00 stuk 1,00 stuk

0,60171 0,60171

0N04BDAO

V 19637

Se le giline hcl cf table t 5m g

1,00 stuk

0,60171

0N04BDAO

V 20925

SELEGILINE HC L MYLAN TABLET 5MG

1,00 STUK

0,60171

0N04BDAO

V 21139

Se le giline hcl flx ta ble t 5m g

1,00 stuk

0,60171

2,50 stuk

1,56609

20,00 stuk 2,50 stuk

0,46983 1,56609

0N04BDAO

V EU/1/04/304/003 Azile ct ta ble t 1m g

1,00 stuk

0,60171

0N05AHAO

V 10459

0N05AHAO 0N05AHAO

V 10460 V 21823

Lepo nex ta ble t 25m g

12,00 stuk

0,18242

Lepo nex ta ble t 100m g C lo za pine ta ble t 25m g

3,00 stuk 12,00 stuk

0,72968 0,18242

0N05AHAO

V 21825

C lo za pine ta ble t 100m g

3,00 stuk

0,72968

0N05AHAO

V 23635=21823

C LO ZAP INE MYLAN TABLET 25MG

12,00 STUK

0,18242

0N05AHAO 0N05AHAO

V 23636=21825 V 23677=21823

C LO ZAP INE MYLAN TABLET 100MG C LO ZAP INE TEVA TABLET 25MG

3,00 stuk 12,00 stuk

0,72968 0,18242

0N05AHAO

V 23678=21825

C LO ZAP INE TEVA TABLET 100MG

3,00 stuk

0,72968

0N05AHAO

V 25049

C lo za pine sa ndoz ta ble t 25m g

12,00 stuk

0,18242

0N05AHAO 0N05AHAO

V 25051 V 26334

C lo za pine sa ndoz ta ble t 100m g C lo za pine a cta vis ta blet 25m g

3,00 stuk 12,00 stuk

0,72968 0,18242

0N05AHAO

V 26336

C lo za pine a cta vis ta blet 100m g

3,00 stuk

0,72968

0N05AHAO

V 35271

C lo za pine sa ndoz ta ble t 200m g

1,50 stuk

1,45936

0N05ANAO

V 52076

Lithium carbo naa t pch ta ble t 200m g

4,44 stuk

0,02621

0N05ANAO

V 52503

Lithium carbo naa t rp ta ble t 200m g

4,44 stuk

0,02621

0N05ANAO

V 55991

Lithium carbo naa t pch ta ble t 300m g

2,96 stuk

0,03574

0N05ANAO 0N05ANAO

V 55992 V 5821

Lithium carbo naa t pch ta ble t 400m g P riade l table t m ga 400m g

2,22 stuk 2,22 stuk

0,04765 0,04765

0N05ANAO

V 9013

C a m co lit ta ble t 400m g

2,22 stuk

0,04765

0N05BAAO 0N05BAAO

V 10044 V 10045

Lora zepa m pch ta blet 1m g Lora zepa m pch ta blet 2,5m g

2,50 stuk 1,00 stuk

0,09681 0,24201

0N05BAAO

V 10537

Tra nx e ne ta blet 50m g

0,40 stuk

0,60503

0N05BAAO

V 11812

O x a ze pa m um ta ble t 10m g

5,00 stuk

0,04840

0N05BAAO 0N05BAAO

V 12323 V 12324

O x a ze pa m sa ndo z ta blet 10m g O x a ze pa m sa ndo z ta blet 50m g

5,00 stuk 1,00 stuk

0,04840 0,24201

0N05BAAO

V 12327

Lora zepa m sa ndo z table t 1m g

2,50 stuk

0,09681

0N05BAAO

V 12328

Lora zepa m sa ndo z table t 2,5m g

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 12453=7045 V 12454=7046

Dia ze pam a cta vis table t 2m g Dia ze pam a cta vis table t 5m g

5,00 stuk 2,00 stuk

0,04840 0,12101

0N05BAAO

V 12455=7047

Dia ze pam a cta vis table t 10m g

1,00 stuk

0,24201

0N05BAAO

V 12490

Dia ze pam sando z ta ble t 2m g

5,00 stuk

0,04840

0N05BAAO 0N05BAAO

V 12491 V 12492

Dia ze pam sando z ta ble t 5m g Dia ze pam sando z ta ble t 10m g

2,00 stuk 1,00 stuk

0,12101 0,24201

0N05BAAO

V 12923

O x a ze pa m a cta vis ta ble t 10m g

5,00 stuk

0,04840

0N05BAAO

V 12924

O x a ze pa m a cta vis ta ble t 50m g

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 12991 V 12992

Bro m a zepa m sa ndo z table t 3m g Bro m a zepa m sa ndo z table t 6m g

3,33 stuk 1,67 stuk

0,07260 0,14521

0N05BAAO

V 13589//6120

Tra nx e ne capsule 10m g

2,00 stuk

0,12101

0N05BAAO

V 14409

Xa na x ta ble t 0,25m g

4,00 stuk

0,07260

0N05BAAO 0N05BAAO

V 14410 V 16979

Xa na x ta ble t 0,5m g Tra nx e ne m b ta ble t 20m g

2,00 stuk 1,00 stuk

0,12101 0,24201

0N05BAAO

V 19695

Lora zepa m um ta ble t 1m g

2,50 stuk

0,09681

0N05BAAO

V 19696

Lora zepa m um ta ble t 2,5m g

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 19886 V 19887

Xa na x re tard ta ble t m ga 0,5m g Xa na x re tard ta ble t m ga 1m g

2,00 stuk 1,00 stuk

0,12101 0,24201

0N05BAAO

V 19888

Xa na x re tard ta ble t m ga 2m g

0,50 stuk

0,48403

0N05BAAO

V 19904=52658

O x a ze pa m a ta ble t 10m g

5,00 stuk

0,04840

0N05BAAO 0N05BAAO

V 19905=52659 V 20263=52640

O x a ze pa m a ta ble t 50m g DIAZEP AM MYLAN TABLET 2MG

1,00 stuk 5,00 stuk

0,24201 0,04840

0N05BAAO

V 20264=52641

DIAZEP AM MYLAN TABLET 5MG

2,00 stuk

0,12101

0N05BAAO

V 20265=52642

DIAZEP AM MYLAN TABLET 10MG

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 20333 V 20334

Lora zepa m actavis ta ble t 1m g Lora zepa m actavis ta ble t 2,5m g

2,50 stuk 1,00 stuk

0,09681 0,24201

0N05BAAO

V 20608

Bro m a zepa m um ta ble t 3m g

3,33 stuk

0,07260

0N05BAAO

V 20609

Bro m a zepa m um ta ble t 6m g

1,67 stuk

0,14521

0N05BAAO 0N05BAAO

V 20953 V 20954

Alpra zola m m ylan ta ble t 0,25m g Alpra zola m m ylan ta ble t 0,5m g

4,00 stuk 2,00 stuk

0,07260 0,12101

0N05BAAO

V 21150=12991

Bro m a zepa m pch ta blet 3m g

3,33 stuk

0,07260

0N05BAAO

V 21151=12992

Bro m a zepa m pch ta blet 6m g

1,67 stuk

0,14521

0N05BAAO 0N05BAAO

V 21199=55830 V 21200=55831

C hloo rdiaze po x ide cf dra gee 5m g C hloo rdiaze po x ide cf dra gee 10m g

6,00 stuk 3,00 stuk

0,04034 0,08067

0N05BAAO

V 21201=55832

C hloo rdiaze po x ide cf dra gee 25m g

1,20 stuk

0,20168

0N05BAAO

V 21272=12991

BR O MAZEP AM MYLAN TABLET 3MG

3,33 STUK

0,07260

0N05BAAO 0N05BAAO

V 21273=12992 V 21560=12991

BR O MAZEP AM MYLAN TABLET 6MG Bro m a zepa m actavis ta ble t 3m g

1,67 stuk 3,33 stuk

0,14521 0,07260

0N05BAAO

V 21561=12992

Bro m a zepa m actavis ta ble t 6m g

1,67 stuk

0,14521

0N05BAAO

V 21619

Alpra zola m actavis ta ble t 0,25m g

4,00 stuk

0,07260

0N05BAAO 0N05BAAO

V 21620 V 21819

Alpra zola m actavis ta ble t 0,5m g Alpra zola m pch ta blet 0,25m g

2,00 stuk 4,00 stuk

0,12101 0,07260

0N05BAAO

V 21820

Alpra zola m pch ta blet 0,5m g

2,00 stuk

0,12101

0N05BAAO

V 23268

ALP R AZO LAM AP O TEX TABLET 0,25MG

4,00 stuk

0,07260

0N05BAAO 0N05BAAO

V 23269 V 23484=55830

ALP R AZO LAM AP O TEX TABLET 0,5MG C hloo rdiaze po x ide sando z dra ge e 5m g

2,00 stuk 6,00 stuk

0,12101 0,04034

0N05BAAO

V 23485=55831

C hloo rdiaze po x ide sando z dra ge e 10m g

3,00 stuk

0,08067

0N05BAAO

V 23486=55832

C hloo rdiaze po x ide sando z dra ge e 25m g

1,20 stuk

0,20168

0N05BAAO 0N05BAAO

V 25684=6119 V 25685=6120

C lo raze pa a tdik a lium pch ca psule 5m g C lo raze pa a tdik a lium pch ca psule 10m g

4,00 stuk 2,00 stuk

0,06050 0,12101

0N05BAAO

V 26944=55928

O x a ze pa m m yla n ta ble t 10m g

5,00 stuk

0,04840

0N05BAAO

V 26945=55969

O XAZEP AM MYLAN TABLET 50MG

1,00 STUK

0,24201

0N05BAAO 0N05BAAO

V 27673=12991 V 27674=12992

Bro m a zepa m cf ta ble t 3m g Bro m a zepa m cf ta ble t 6m g

3,33 stuk 1,67 stuk

0,07260 0,14521

0N05BAAO

V 27941

Alpra zola m sa ndo z table t 0,25m g

4,00 stuk

0,07260

0N05BAAO

V 27942

Alpra zola m sa ndo z table t 0,5m g

2,00 stuk

0,12101

0N05BAAO 0N05BAAO

V 28500=6119 V 28501=6120

C lo raze pa a tdik a lium cf ca psule 5m g C lo raze pa a tdik a lium cf ca psule 10m g

4,00 stuk 2,00 stuk

0,06050 0,12101

0N05BAAO

V 28844=19695

Lora zepa m m ylan ta ble t 1m g

2,50 stuk

0,09681

0N05BAAO

V 28845=19696

Lora zepa m m ylan ta ble t 2,5m g

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 29017=23566 V 29018=23567

Alpra zola m a ta blet 0,25m g Alpra zola m a ta blet 0,5m g

4,00 stuk 2,00 stuk

0,07260 0,12101

0N05BAAO

V 30098

Alpra zola m rp ta blet 0,5m g

2,00 stuk

0,12101

0N05BAAO

V 31119

Alpra zola m cf ta ble t 0,25m g

4,00 stuk

0,07260

0N05BAAO 0N05BAAO

V 31120 V 50280

Alpra zola m cf ta ble t 0,5m g DIAZEP AM AP O TEX TABLET 2MG

2,00 stuk 5,00 stuk

0,12101 0,04840

0N05BAAO

V 50281

DIAZEP AM AP O TEX TABLET 5MG

2,00 stuk

0,12101

0N05BAAO

V 50282

DIAZEP AM AP O TEX TABLET 10MG

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 5181 V 51901

Se resta table t 10m g Dia ze pam um table t 2m g

5,00 stuk 5,00 stuk

0,04840 0,04840

0N05BAAO

V 51902

Dia ze pam um table t 5m g

2,00 stuk

0,12101

0N05BAAO

V 51903

Dia ze pam um table t 10m g

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 52640 V 52641

Dia ze pam rp ta ble t 2m g Dia ze pam rp ta ble t 5m g

5,00 stuk 2,00 stuk

0,04840 0,12101

0N05BAAO

V 52642

Dia ze pam rp ta ble t 10m g

1,00 stuk

0,24201

0N05BAAO

V 52658

O x a ze pa m rp ta ble t 10m g

5,00 stuk

0,04840

0N05BAAO 0N05BAAO

V 52659 V 53369

O x a ze pa m rp ta ble t 50m g O XAZEP AM APO TEX TABLET 10MG

1,00 stuk 5 STUK

0,24201 0,04840

0N05BAAO

V 53370

O XAZEP AM APO TEX TABLET 50MG

0N05BAAO

V 55372

Lora zepa m flx ta ble t 1m g

2,50 stuk

0,09681

0N05BAAO 0N05BAAO

V 55373 V 55374

Lora zepa m flx ta ble t 2,5m g Dia ze pam flx table t 2m g

1,00 stuk 5,00 stuk

0,24201 0,04840

0N05BAAO

V 55375

Dia ze pam flx table t 5m g

2,00 stuk

0,12101

0N05BAAO

V 55376

Dia ze pam flx table t 10m g

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 55554=6119 V 55555=6120

C lo raze pa tum ca psule 5m g C lo raze pa a t ca psule 10m g

4,00 stuk 2,00 stuk

0,06050 0,12101

0N05BAAO

V 55581

O XAZEP AM AC C O R D TABLET 10MG

5,00 stuk

0,04840

0N05BAAO

V 55582

O XAZEP AM AC C O R D TABLET 50MG

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 55791 V 55829

O x a ze pa m pch ta ble t 50m g O x a ze pa m pch ta ble t 10m g

1,00 stuk 5,00 stuk

0,24201 0,04840

0N05BAAO

V 55830

C hloo rdiaze po x ide pch drage e 5m g

6,00 stuk

0,04034

0N05BAAO

V 55831

C hloo rdiaze po x ide pch drage e 10m g

3,00 stuk

0,08067

0N05BAAO 0N05BAAO

V 55832 V 55928

C hloo rdiaze po x ide pch drage e 25m g O x a ze pa m cf table t 10m g

1,20 stuk 5,00 stuk

0,20168 0,04840

0N05BAAO

V 55938

Lora zepa m cf ta ble t 1m g

2,50 stuk

0,09681

0N05BAAO

V 55939

Lora zepa m cf ta ble t 2,5m g

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 55969 V 56252

O x a ze pa m cf table t 50m g Dia ze pam pch ta ble t 2m g

1,00 stuk 5,00 stuk

0,24201 0,04840

0N05BAAO

V 56253

Dia ze pam pch ta ble t 5m g

2,00 stuk

0,12101

0N05BAAO

V 56254

Dia ze pam pch ta ble t 10m g

1,00 stuk

0,24201

0N05BAAO 0N05BAAO

V 5649 V 56544

Se resta forte ta ble t 50m g C hloo rdiaze po x ide flx dra ge e 5m g

1,00 stuk 6,00 stuk

0,24201 0,04034

0N05BAAO

V 56545

C hloo rdiaze po x ide flx dra ge e 10m g

3,00 stuk

0,08067

0N05BAAO

V 56546

C hloo rdiaze po x ide flx dra ge e 25m g

1,20 stuk

0,20168

0N05BAAO 0N05BAAO

V 56628 V 56629

Lora zepa m rp ta blet 1m g Lora zepa m rp ta blet 2,5m g

2,50 stuk 1,00 stuk

0,09681 0,24201

0N05BAAO

V 56679

Dia ze pam cf ta blet 2m g

5,00 stuk

0,04840

0N05BAAO

V 56680

Dia ze pam cf ta blet 5m g

2,00 stuk

0,12101

0N05BAAO 0N05BAAO

V 56681 V 57220

Dia ze pam cf ta blet 10m g Lora zepa m um ta ble t 1m g

1,00 stuk 2,50 stuk

0,24201 0,09681

0N05BAAO

V 57221

Lora zepa m um ta ble t 2,5m g

1,00 stuk

0,24201

0N05BAAO

V 57222

O x a ze pa m um ta ble t 10m g

5,00 stuk

0,04840

0N05BAAO 0N05BAAO

V 57223 V 57547

O x a ze pa m um ta ble t 50m g LO R AZEP AM AP O TEX TABLET 1MG

1,00 stuk 2,50 stuk

0,24201 0,09681

0N05BAAO

V 57548

LO R AZEP AM AP O TEX TABLET 2,5MG

1,00 stuk

0,24201

0N05BAAO

V 6119

Tra nx e ne capsule 5m g

4,00 stuk

0,06050

0N05BAAO 0N05BAAO

V 6120 V 6994

Tra nx e ne capsule 10m g R e a pa m ta ble t 10m g

2,00 stuk 2,00 stuk

0,12101 0,12101

0N05BAAO

V 7045

Ste so lid ta ble t 2m g

5,00 stuk

0,04840

0N05BAAO

V 7046

Ste so lid ta ble t 5m g

2,00 stuk

0,12101

0N05BAAO 0N05BAAO

V 7047 V 9600

Ste so lid ta ble t 10m g Frisium ta ble t 10m g

1,00 stuk 2,00 stuk

0,24201 0,12101

0N05BAAO

V 9601

Frisium ta ble t 20m g

1,00 stuk

0,24201

0N05BAAR R K 19798 0N05BAAR R K 7606

DIAZEP AM AP O TEX R EKTIO LE 5MG Ste so lid re k tio o l 5m g

4,00 stuk 4,00 stuk

0,96928 0,96928

0N05BAAR R V 19799

DIAZEP AM AP O TEX R EKTIO LE 10MG

2,00 STUK

1,18256

1 STUK

0,24201

0N05BAAR R V 7607

Ste so lid re k tio o l 10m g

2,00 stuk

1,18256

0N05BABP

V 56691

Dia ze pam cf injvlst 5m g/m l a m p 2m l

2,00 m l

0,35622

0N05BABP

V 7841

Dia ze m uls injvlst 5m g/m l am pul 2m l

2,00 m l

0,35622

0N05BBAO 0N05BBAO

V 50109 V 50110

Hydro x yzini hcl ta ble t o m huld 10m g Hydro x yzini hcl ta ble t o m huld 25m g

7,50 stuk 3,00 stuk

0,04085 0,07855

0N05BEAO

V 19732

Buspiron hcl cf ta ble t 10m g

3,00 stuk

0,54681

0N05BEAO

V 21782=19732

Buspiron hcl a cta vis ta blet 10m g

3,00 stuk

0,54681

0N05BEAO 0N05BEAO

V 21900 V 27118

Buspiron hcl sa ndoz ta ble t 10m g BUSPIR O N HC L MYLAN TABLET 10MG

3,00 stuk 3 STUK

0,54681 0,54681

0N05BEAO

V 27844=21900

Buspiron hcl pch table t 10m g

3,00 stuk

0,54681

0N05C DAP 0N05C DAP

V 10064 V 21391

Do rm icum injvlst 5m g/m l a m pul Injvlst m ida zo lam i hcl 1m g/m l am pul 5m l

0N05C DAP

V 21393

Injvlst m ida zo lam i hcl 5m g/m l

3,00 m l

0,89939

0N05C DAP

V 22579

Mida zo lam ha m e ln injvlst 1m g/m l am pul 5m l

15,00 m l

0,17988

0N05C DAP 0N05C DAP

V 22581 V 22582

Mida zo lam ha m e ln injvlst 5m g/m l am pul Mida zo lam phg injvlst 1m g/m l a m pul 5m l

3,00 m l 15,00 m l

0,89939 0,17988

0N05C DAP

V 22584

Mida zo lam phg injvlst 5m g/m l

3,00 m l

0,89939

0N05C DAP

V 22588

Mida zo lam fre se nius injvlst 1m g/m l a m pul 5m l

15,00 m l

0,17988

0N05C DAP 0N05C DAP

V 22590 V 22591

Mida zo lam fre se nius injvlst 5m g/m l a m pul Mida zo lam cura sa n injvlst 1m g/m l a m pul 5m l

3,00 m l 15,00 m l

0,89939 0,17988

0N05C DAP

V 22593

Mida zo lam cura sa n injvlst 5m g/m l

0N05C DAP

V 22594

Mida zo lam a cta vis injvlst 1m g/m l am pul

0N05C DAP

V 22596

Mida zo lam a cta vis injvlst 5m g/m l

0N06AAAO

V 11407

No rtrile n table t 50m g

1,50 stuk

0,29485

0N06AAAO

V 15575

C lo m ipra m ine hcl m yla n ta ble t o m huld 10m g

10,00 stuk

0,05750

0N06AAAO 0N06AAAO

V 15576 V 16711=52947

C lo m ipra m ine hcl m yla n ta ble t o m huld 25m g Am itriptyline hcl sando z ta ble t 10m g

4,00 stuk 7,50 stuk

0,11057 0,07666

0N06AAAO

V 16712=52948

Am itriptyline hcl sando z ta ble t 25m g

3,00 stuk

0,14743

0N06AAAO

V 17054=57516

Ma pro tiline hcl cf ta blet 25m g

4,00 stuk

0,11057

0N06AAAO 0N06AAAO

V 17055=57517 V 17056=57518

Ma pro tiline hcl cf ta blet 50m g Ma pro tiline hcl cf ta blet 75m g

2,00 stuk 1,33 stuk

0,22114 0,33171

0N06AAAO

V 18240=52947

Am itriptyline hcl a cta vis table t 10m g

7,50 stuk

0,07666

0N06AAAO

V 18241=52948

Am itriptyline hcl a cta vis table t 25m g

3,00 stuk

0,14743

0N06AAAO 0N06AAAO

V 21929=52947 V 21930=52948

Am itriptyline hcl pch ta ble t 10m g Am itriptyline hcl pch ta ble t 25m g

7,50 stuk 3,00 stuk

0,07666 0,14743

0N06AAAO

V 23924

C lo m ipra m ine hcl sa ndo z ta blet o m huld 10m g

10,00 stuk

0,05750

0N06AAAO

V 23925

C lo m ipra m ine hcl sa ndo z ta blet o m huld 25m g

4,00 stuk

0,11057

0N06AAAO 0N06AAAO

V 24107 V 2418

C lo m ipra m ine hcl sa ndo z re ta rd table t m ga 75m g Tryptizo l ta ble t 25m g

1,33 stuk 3,00 stuk

0,33171 0,14743

0N06AAAO

V 24304=57516

MAP R O TILINE HC L MYLAN TABLET 25MG

4 STUK

0N06AAAO

V 24305=57517

MAP R O TILINE HC L MYLAN TABLET 50MG

2 STUK

0,22114

0N06AAAO 0N06AAAO

V 24306=57518 V 24831=50113

MAP R O TILINE HC L MYLAN TABLET 75MG Im ipram ine hcl pch o m hulde ta ble t 10m g

1,33 STUK 10,00 stuk

0,33171 0,05750

0N06AAAO

V 24832=50116

Im ipram ine hcl pch o m hulde ta ble t 25m g

4,00 stuk

0,11057

0N06AAAO

V 25461=23924

C lo m ipra m ine hcl pch ta ble t o m huld 10m g

10,00 stuk

0,05750

0N06AAAO 0N06AAAO

V 25462=23925 V 25645=23924

C lo m ipra m ine hcl pch ta ble t o m huld 25m g C lo m ipra m ine hcl a cta vis ta ble t o m huld 10m g

4,00 stuk 10,00 stuk

0,11057 0,05750

0N06AAAO

V 25646=23925

C lo m ipra m ine hcl a cta vis ta ble t o m huld 25m g

4,00 stuk

0,11057

3,00 m l 15,00 m l

0,89939 0,17988

3,00 m l

0,89939

15,00 m l

0,17988

3,00 m l

0,89939

0,11057

0N06AAAO 0N06AAAO

V 25715=24107 V 26857=23924

C lo m ipra m ine hcl a cta vis re tard ta ble t m ga 75m g C lo m ipra m ine hcl cf table t om huld 10m g

1,33 stuk 10,00 stuk

0,33171 0,05750

0N06AAAO

V 26858=23925

0N06AAAO

V 26859=24107

C lo m ipra m ine hcl cf table t om huld 25m g

4,00 stuk

0,11057

C lo m ipra m ine hcl cf reta rd ta ble t m ga 75m g

1,33 stuk

0N06AAAO 0N06AAAO

0,33171

V 29213//3286 V 29397

No rtrile n table t 25m g C LO MIP R AMINE HC L MYLAN R ETAR D TABLET MGA 75MG

3,00 stuk 1,33 STUK

0,14743 0,33171

0N06AAAO

V 30294//3286

No rtrile n table t 25m g

3,00 stuk

0,14743

0N06AAAO

V 30336//3286

No rtrile n table t 25m g

3,00 stuk

0,14743

0N06AAAO 0N06AAAO

V 3285 V 3286

No rtrile n table t 10m g No rtrile n table t 25m g

7,50 stuk 3,00 stuk

0,07666 0,14743

0N06AAAO

V 34996

C lo m ipra m ine hcl rp re ta rd ta blet m ga 75m g

1,33 stuk

0,33171

0N06AAAO

V 50113

Im ipram ine hcl cf o m hulde table t 10m g

10,00 stuk

0,05750

0N06AAAO 0N06AAAO

V 50116 V 52186

Im ipram ine hcl cf dra gee 25m g AMITR IP TYLINE HC L AP O TEX TABLET 10MG

0N06AAAO

V 52187

AMITR IP TYLINE HC L AP O TEX TABLET 25MG

3,00 STUK

0,14743

0N06AAAO

V 52631

Am itriptyline hcl rp ta ble t 25m g

3,00 stuk

0,14743

0N06AAAO 0N06AAAO

V 52947 V 52948

Am itriptyline hcl cf ta blet 10m g Am itriptyline hcl cf ta blet 25m g

7,50 stuk 3,00 stuk

0,07666 0,14743

0N06AAAO

V 55187

Am itriptylini hcl ta ble t 10m g film coa te d

7,50 stuk

0,07666

0N06AAAO

V 57431

Ma pro tiline hcl pch ta ble t 75m g

1,33 stuk

0,33171

0N06AAAO 0N06AAAO

V 57470 V 57471

Ma pro tiline hcl pch ta ble t 25m g Ma pro tiline hcl pch ta ble t 50m g

4,00 stuk 2,00 stuk

0,11057 0,22114

0N06AAAO

V 57516

Ma pro tiline hcl rp ta ble t 25m g

4,00 stuk

0,11057

0N06AAAO

V 57517

Ma pro tiline hcl rp ta ble t 50m g

2,00 stuk

0,22114

0N06AAAO 0N06AAAO

V 57518 V 5781

Ma pro tiline hcl rp ta ble t 75m g Anafra nil dra gee 25m g

1,33 stuk 4,00 stuk

0,33171 0,11057

0N06AAAO

V 5845

Tryptizo l ta ble t 50m g

1,50 stuk

0,29485

0N06AAAO

V 5899

Sine quan ca psule 10m g

10,00 stuk

0,12384

0N06AAAO 0N06AAAO

V 5908 V 6059

Sine quan ca psule 25m g Sine quan ca psule 50m g

4,00 stuk 2,00 stuk

0,11057 0,22114

0N06AAAO

V 6353

Anafra nil dra gee 10m g

10,00 stuk

0,05750

0N06AAAO

V 6480

Sa rote x re tard 25 ca psule m ga 25m g

3,00 stuk

0,14743

0N06AAAO 0N06AAAO

V 6481 V 9857

Sa rote x re tard 50 ca psule m ga 50m g Anafra nil re ta rd table t 75m g

1,50 stuk 1,33 stuk

0,29485 0,33171

0N06AAAO

V 9997

P ro thia den m itis ca psule 25m g

6,00 stuk

0,10320

0N06AAAO

V 9998

P ro thia den dra ge e 75m g

2,00 stuk

0,22114

0N06BAAO

V 100389

Stra ttera ca psule 80m g

1,00 stuk

0,36348

0N06BAAO

V 101739

C o nce rta ta blet m va 27m g

1,11 stuk

0,32713

0N06BAAO

V 103158//31494

Stra ttera ca psule 10m g

8,00 stuk

0,04544

0N06BAAO 0N06BAAO

V 103159//31496 V 103160//31497

Stra ttera ca psule 25m g Stra ttera ca psule 40m g

3,20 stuk 2,00 stuk

0,11359 0,18174

0N06BAAO

V 103161//31498

Stra ttera ca psule 60m g

1,33 stuk

0,27261

0N06BAAO

V 26470

Me thylfe nida a t hcl rp ta ble t 10m g

3,00 stuk

0,12116

0N06BAAO 0N06BAAO

V 27033=3957 V 27252

Me thylfe nida a t hcl sa ndo z ta blet 10m g Me thylfe nida a t hcl pch ta ble t 10m g

3,00 stuk 3,00 stuk

0,12116 0,12116

0N06BAAO

V 27253

Me thylfe nida ti hcl ta blet 10m g

3,00 stuk

0,12116

0N06BAAO

V 28073

C o nce rta ta blet m va 18m g

1,67 stuk

0,21809

0N06BAAO 0N06BAAO

V 28074 V 28075

C o nce rta ta blet m va 36m g C o nce rta ta blet m va 54m g

0,83 stuk 0,56 stuk

0,43618 0,65426

0N06BAAO

V 29553

Me thylfe nida ti hcl ta blet 5m g

6,00 stuk

0,07270

0N06BAAO

V 29554

Me thylfe nida ti hcl ta blet 10m g

3,00 stuk

0,12116

4,00 stuk 7,50 STUK

0,11057 0,07666

0N06BAAO 0N06BAAO

V 31494 V 31495

Stra ttera ca psule 10m g Stra ttera ca psule 18m g

8,00 stuk 4,44 stuk

0,04544 0,08178

0N06BAAO

V 31496

Stra ttera ca psule 25m g

3,20 stuk

0,11359

0N06BAAO

V 31497

Stra ttera ca psule 40m g

2,00 stuk

0,18174

0N06BAAO 0N06BAAO

V 31498 V 33227

Stra ttera ca psule 60m g Equa sym x l ca psule m ga 10m g

1,33 stuk 3,00 stuk

0,27261 0,12116

0N06BAAO

V 33228

Equa sym x l ca psule m ga 20m g

1,50 stuk

0,24232

0N06BAAO

V 33229

Equa sym x l ca psule m ga 30m g

1,00 stuk

0,36348

0N06BAAO 0N06BAAO

V 33906//31496 V 33907//31497

Stra ttera ca psule 25m g Stra ttera ca psule 40m g

3,20 stuk 2,00 stuk

0,11359 0,18174

0N06BAAO

V 33908//31498

Stra ttera ca psule 60m g

1,33 stuk

0,27261

0N06BAAO

V 34024

Me dik ine t table t 5m g

6,00 stuk

0,07270

0N06BAAO 0N06BAAO

V 34025 V 34026

Me dik ine t table t 10m g Me dik ine t table t 20m g

3,00 stuk 1,50 stuk

0,12116 0,24232

0N06BAAO

V 34027

MEDIKINET C R C AP SULE MGA 10MG

3,00 stuk

0,12116

0N06BAAO

V 34028

MEDIKINET C R C AP SULE MGA 20MG

1,50 stuk

0,24232

0N06BAAO 0N06BAAO

V 34029 V 34030

MEDIKINET C R C AP SULE MGA 30MG MEDIKINET C R C AP SULE MGA 40MG

1,00 stuk 0,75 stuk

0,36348 0,48464

0N06BAAO

V 3957

R ita lin ta ble t 10m g

3,00 stuk

0,12116

0N06BXAO 0N06BXAO

V 11783 V 18655

No otro pil ta blet 1200m g P IR AC ETAM TEVA TABLET 800MG

2,00 stuk 3,00 stuk

0,27499 0,18333

0N06BXAO

V 7353

No otro pil ta blet 800m g

3,00 stuk

0,18333

0N07AAAO

V 101229//31372

R e m inyl re ta rd ca psule m va 8m g

2,00 stuk

2,38235

0N07AAAO 0N07AAAO

V 101230//31373 V 102663//31372

R e m inyl re ta rd ca psule m va 16m g R e m inyl re ta rd ca psule m va 8m g

1,00 stuk 2,00 stuk

4,76470 2,38235

0N07AAAO

V 102664//31373

R e m inyl re ta rd ca psule m va 16m g

1,00 stuk

4,76470

0N07AAAO

V 102665//31374

R e m inyl re ta rd ca psule m va 24m g

0,67 stuk

7,14704

0N07AAAO 0N07AAAO

V 29073 V 29074

R e m inyl ta blet o m huld 4m g R e m inyl ta blet o m huld 8m g

4,00 stuk 2,00 stuk

1,42941 2,38235

0N07AAAO

V 29075

R e m inyl ta blet o m huld 12m g

1,33 stuk

3,57352

0N07AAAO

V 31372

R e m inyl re ta rd ca psule m va 8m g

2,00 stuk

2,38235

0N07AAAO 0N07AAAO

V 31373 V 31374

R e m inyl re ta rd ca psule m va 16m g R e m inyl re ta rd ca psule m va 24m g

1,00 stuk 0,67 stuk

4,76470 7,14704

0N07AAAO

V 33261//31373

R e m inyl re ta rd ca psule m va 16m g

1,00 stuk

4,76470

0N07AAAO

V 33262//31374

R e m inyl re ta rd ca psule m va 24m g

0,67 stuk

7,14704

0N07AAAO 0N07AAAO

V 34450//31372 V 34451//31373

R e m inyl re ta rd ca psule m va 8m g R e m inyl re ta rd ca psule m va 16m g

2,00 stuk 1,00 stuk

2,38235 4,76470

0N07AAAO

V 34452//31374

R e m inyl re ta rd ca psule m va 24m g

0,67 stuk

7,14704

0N07AAAO

V EU/1/98/066/001 Ex e lo n capsule 1,5m g

6,00 stuk

1,11176

0N07AAAO 0N07AAAO

V EU/1/98/066/002 Ex e lo n capsule 1,5m g V EU/1/98/066/004 Ex e lo n capsule 3m g

6,00 stuk 3,00 stuk

1,11176 1,58823

0N07AAAO

V EU/1/98/066/005 Ex e lo n capsule 3m g

3,00 stuk

1,58823

0N07AAAO

V EU/1/98/066/007 Ex e lo n capsule 4,5m g

2,00 stuk

2,38235

0N07AAAO 0N07AAAO

V EU/1/98/066/008 Ex e lo n capsule 4,5m g V EU/1/98/066/010 Ex e lo n capsule 6m g

2,00 stuk 1,50 stuk

2,38235 3,17646

0N07AAAO

V EU/1/98/066/011 Ex e lo n capsule 6m g

1,50 stuk

3,17646

0N07AAAO

V EU/1/98/066/020 Ex e lo n ple iste r transde rm a al 4,6m g/24uur

1,96 stuk

2,43529

0N07AAAO 0N07AAAO

V EU/1/98/066/024 Ex e lo n ple iste r transde rm a al 9,5m g/24uur V EU/1/98/092/011 P ro m e ta x ca psule 6m g

0,95 stuk 1,50 stuk

5,02940 3,17646

0N07BC AO

V 33034

Me tha do n re ge nboo g ta ble t 5m g

5,00 stuk

0,08867

0N07C AAO

V 13612

Be tase rc ta ble t 16m g

1,50 stuk

0,25684

0N07C AAO

V 15445

BETAHISTINE DIHC L TEVA TABLET 8MG

3,00 stuk

0,12842

0N07C AAO 0N07C AAO

V 15446 V 19312

BETAHISTINE DIHC L TEVA TABLET 16MG Be tahistini dihydro chloridum ta blet 8m g

1,50 stuk 3,00 stuk

0,25684 0,12842

0N07C AAO

V 19313

Be tahistini dihydro chloridum ta blet 16m g

1,50 stuk

0,25684

0N07C AAO

V 20444=5852

Be tahistine 2hcl a ta ble t 8m g

3,00 stuk

0,12842

0N07C AAO 0N07C AAO

V 20445=13612 V 23156

Be tahistine 2hcl a ta ble t 16m g Be tahistine 2hcl sando z ta ble t 8m g

1,50 stuk 3,00 stuk

0,25684 0,12842

0N07C AAO

V 23157

Be tahistine 2hcl sando z ta ble t 16m g

1,50 stuk

0,25684

0N07C AAO

V 23266

BETAHISTINE DIHC L APO TEX TABLET 8MG

3,00 stuk

0,12842

0N07C AAO 0N07C AAO

V 23267 V 23424

BETAHISTINE DIHC L APO TEX TABLET 16MG Be tahistini dihydro chloridum ta blet 8m g

1,50 stuk 3,00 stuk

0,25684 0,12842

0N07C AAO

V 23425

Be tahistini dihydro chloridum ta blet 16m g

1,50 stuk

0,25684

0N07C AAO

V 23471

Be tahistini dihydro chloridum ta blet 8m g

3,00 stuk

0,12842

0N07C AAO 0N07C AAO

V 23472 V 24028

Be tahistini dihydro chloridum ta blet 16m g Be tahistine 2hcl a cco rd ta ble t 8m g

1,50 stuk 3,00 stuk

0,25684 0,12842

0N07C AAO

V 24029

Be tahistine 2hcl a cco rd ta ble t 16m g

1,50 stuk

0,25684

0N07C AAO

V 24681

Be tahistine dihcl m yla n ta blet 8m g

3,00 stuk

0,12842

0N07C AAO 0N07C AAO

V 24682 V 33110

Be tahistine dihcl m yla n ta blet 16m g Be tahistine dihcl a cta vis ta blet 8m g

1,50 stuk 3,00 stuk

0,25684 0,12842

0N07C AAO

V 33111

Be tahistine dihcl a cta vis ta blet 16m g

1,50 stuk

0,25684

0N07C AAO

V 56227

Be tahistine dihcl cf ta ble t 8m g

3,00 stuk

0,12842

0N07C AAO 0N07C AAO

V 57626 V 5852

Be tahistine dihcl cf ta ble t 16m g Be tase rc ta ble t 8m g

1,50 stuk 3,00 stuk

0,25684 0,12842

0N07C ABO

V 10579

Sibe lium ta ble t 10m g

1,00 stuk

0,33126

0N07C ABO 0N07C ABO

V 17317 V 17318

Fluna rizinum ca psule 5m g Fluna rizinum ca psule 10m g

2,00 stuk 1,00 stuk

0,16563 0,33126

0N07C ABO

V 27606=56977

Fluna rizine a cta vis ca psule 5m g

2,00 stuk

0,16563

0N07C ABO

V 56977

Fluna rizine cf capsule 5m g

2,00 stuk

0,16563

0P 01ABAO

V 11478

Me tro nida zo l laga p table t 500m g

3,00 stuk

0,28157

0P 01ABAO

V 11479

Me tro nida zo l laga p table t 250m g

6,00 stuk

0,16894

0P 01ABAO

V 17827=11478

METR O NIDAZO L AP O TEX TABLET 500MG

3,00 STUK

0,28157

0P 01ABAO 0P 01ABAO

V 17848=7074 V 17849=8652

Me tro nida zo l sa ndoz ta ble t 250m g Me tro nida zo l sa ndoz ta ble t 500m g

6,00 stuk 3,00 stuk

0,16894 0,28157

0P 01ABAO

V 21419=7074

Me tro nida zo l pch table t 250m g

6,00 stuk

0,16894

0P 01ABAO

V 21420=8652

Me tro nida zo l pch table t 500m g

3,00 stuk

0,28157

0P 01ABAO 0P 01ABAO

V 7074 V 8652

Me tro nida zo l a cta vis ta blet 250m g Me tro nida zo l a cta vis ta blet 500m g

6,00 stuk 3,00 stuk

0,16894 0,28157 0,30000;

0P 01BAAO

V 303

Niva quine table t 100m g

2,50 stuk

0R 01AC AN 0R 01AC AN

V 14285 V 15592

Lom uso l fo rte ne usspra y 40m g/m l Alle rgo -co m od ne usspra y 20m g/m l

1,00 m l 2,00 m l

0,67227 0,40336

0R 01AC AN

V 16906=57340

C ro m oglica at dinatrium cf neusspra y 20m g/m l

2,00 m l

0,40336

0R 01AC AN

V 17319

P re va lin dina trium cr ne usspray 20m g/m l

2,00 m l

0,40336

0R 01AC AN 0R 01AC AN

V 19679 V 20980

Na trium cro m oglica at sudco ne usspra y 40m g/m l Na trium cro m oglica at sa ndo z ne usspra y 20m g/m l

1,00 m l 2,00 m l

0,67227 0,40336

0R 01AC AN

V 21372=57340

NATR IUMC R O MO GLIC AAT AP O TEX NEUSSP R AY 20MG/ML

2,00 m l

0,40336

0R 01AC AN

V 21467

Na trium cro m oglica at rp ne usspra y 20m g/m l

2,00 m l

0,40336

0R 01AC AN 0R 01AC AN

V 22046=57340 V 22284

Na trium cro m oglica at pch ne usspra y 20m g/m l P re va lin dina trium cr ne usspray e x tra sterk 40m g/m l

2,00 m l 1,00 m l

0,40336 0,67227

0R 01AC AN

V 23398=20980

0R 01AC AN

V 26556=19679

Na trium cro m oglica at a ne usspra y 20m g/m l

2,00 m l

0,40336

Na trium cro m oglica at pch ne usspra y 40m g/m l

1,00 m l

0R 01AC AN 0R 01AC AN

0,67227

V 28911=17319 V 57340

Na trium cro m oglica at sa n ne usspra y 20m g/m l Na trium cro m oglica at sudco ne usspra y 20m g/m l

2,00 m l 2,00 m l

0,40336 0,40336

0R 01AC AN

V 7163

Lom uso l neusspra y 20m g/m l

2,00 m l

0,40336

0R 01AC BN 0R 01AC BN

V 13967 V 17886

Livo ca b ne usspra y 0,5 m g/m l Alle rgo dil neve l ne usspra y 1m g/m l

1,20 m l 0,56 m l

0,31553 0,67613

0R 01AC BN

V 26128

O trivin ne usa lle rgie a ze la stine ne usspra y 1m g/m l

0,56 m l

0,67613

0R 01ADAN 0R 01ADAN

V 100876//15821 V 101231//23837

R hino co rt turbuha ler inhpdr na sa a l 0,1m g/do 200do R hino co rt ne ve l ne usspray 32m cg/do 120do

2,00 do 6,25 do

0,16850 0,07684

0R 01ADAN

V 101256

Flutica so npropio na a t a ct neusspr 50m cg/do fl 150do

4,00 do

0,08425

0R 01ADAN

V 104080//21613

Na so nex ne usspra y 50m cg/do 140do

4,00 do

0,08425

0R 01ADAN 0R 01ADAN

V 104630//21837 V 10728

Na sa co rt neusspra y 55m cg/do 120do Be co na se ne ve l neusspra y 50m cg/do fla co n 200do ses

4,00 do 8,00 do

0,08425 0,04213

0R 01ADAN

V 10728

Be co na se ne ve l neusspra y 50m cg/do fla co n 200do ses

8,00 do

0,04213

0R 01ADAN

V 10957

Be clom e ta so n ne vel sando z ne ussp 50m cg/do fl 200do

8,00 do

0,04213

0R 01ADAN 0R 01ADAN

V 14424 V 15716

Flix o na se ne usspra y 50m cg/do Be clom e ta so n ne vel pch neusspra y 50m cg/do fl 200do

4,00 do 8,00 do

0,08425 0,04213

0R 01ADAN

V 15821

R hino co rt turbuha ler inhpdr na sa a l 0,1m g/do 200do

2,00 do

0,16850

0R 01ADAN

V 21040

Bude sonide pch ne ve l ne usspray 50m cg/do 200do

4,00 do

0,08425

0R 01ADAN 0R 01ADAN

V 21613 V 21837

Na so nex ne usspra y 50m cg/do Na sa co rt neusspra y 55m cg/do 120do

4,00 do 4,00 do

0,08425 0,08425

0R 01ADAN

23477

FLIXO NASE NEUSDR UP P ELS 1 MG/ ML P ATR O O N 0,4 ML

0,50 do

0,67402

0R 01ADAN

V 23837

R hino co rt ne ve l ne usspray 32m cg/do 120do

6,25 do

0,07684

0R 01ADAN 0R 01ADAN

V 23838 V 24012

R hino co rt ne ve l ne usspray 64m cg/do 120do BUDESO NIDE APO TEX NEVEL NEUSSP R AY 50MC G/DO 200DO

3,12 do 4,00 do

0,10784 0,08425

0R 01ADAN

V 24013

BUDESO NIDE APO TEX NEVEL NEUSSP R AY 100MC G/DO 200DO

2 DO

0,16850

0R 01ADAN

V 25302

Bude sonide ph&t ne vel ne usspra y 50m cg/do 200do

4,00 do

0,08425

0R 01ADAN 0R 01ADAN

V 26290 V 26291

Bude sonide m yla n neve l ne usspra y 50m cg/do 200do Bude sonide m yla n neve l ne usspra y 100m cg/do 200do

4,00 do 2,00 do

0,08425 0,16850

0R 01ADAN

V 27395

Bude sonide ph&t ne vel ne usspra y 50m cg/do 200do

4,00 do

0,08425

0R 01ADAN

V 27456

Bude sonide rp ne ve l ne usspray 100m cg/do 200do

2,00 do

0,16850

0R 01ADAN 0R 01ADAN

V 27648 V 27649

Bude sonide sa ndo z ne ve l neusspra y 50m cg/do 200do Bude sonide sa ndo z ne ve l neusspra y 100m cg/do 200do

4,00 do 2,00 do

0,08425 0,16850

0R 01ADAN

V 28086=10957

Be clom e ta so n ne vel rp neusspra y 50m cg/do fl 200do

8,00 do

0,04213

0R 01ADAN

V 28181=24013

Bude sonide pch ne ve l ne usspray 100m cg/do 200do

2,00 do

0,16850

0R 01ADAN 0R 01ADAN

V 28897=14424 V 29767

Flutica so npropio na a t neusspra y 50m cg/do fl 200do Bude sonide a cta vis neve l ne usspra y 50m cg/do 200do

4,00 do 4,00 do

0,08425 0,08425

0R 01ADAN

V 29768

Bude sonide a cta vis neve l ne usspra y 100m cg/do 200do

2,00 do

0,16850

0R 01ADAN

V 30962//21613

Na so nex ne usspra y 50m cg/do 140do

4,00 do

0,08425

0R 01ADAN 0R 01ADAN

V 31010//23838 V 32154

R hino co rt ne ve l ne usspray 64m cg/do 120do Flutica so npropio na a t rp ne usspr 50m cg/do fl 200do

3,12 do 4,00 do

0,10784 0,08425

0R 01ADAN

V 32157

Flutica so npropio na a t sdz ne usspr 50m cg/do fl 200do

4,00 do

0,08425

0R 01ADAN

V 32896

Flutica so npropio na a t a ne usspray 50m cg/do fl 150do

4,00 do

0,08425

0R 01ADAN 0R 01ADAN

V 33656 V 34488

Flutica so npropio na a t pch ne usspr 50m cg/do fl 150do Flutica so npropio na a t cf ne usspr 50m cg/do fl 150do

4,00 do 4,00 do

0,08425 0,08425

0R 01ADAN

V 34718

FLUTIC ASO NPR O PIO NAAT MYL NEUSSP R 50MC G/DO FL 150DO

4,00 do

0,08425

0R 01ADAN

V 35115//23837

R hino co rt ne ve l ne usspray 32m cg/do 120do

6,25 do

0,07684

0R 03AC AIDA V 18353

Airom ir 100 a e roso l 100m cg/do spbs 200do+inhala to r

8,00 do

0,01654

0R 03AC AIDA V 21440 0R 03AC AIDA V 27018=26833

Ve nto lin 100 ae r cfk vr 100m cg/do spbs 200do +inha l Sa lbuta m o l sdz ae r cfk vr 100m cg/do spbs 200do +inh

8,00 do 8,00 do

0,01654 0,01654

0R 03AC AIDA V 27084=26833

SALBUTAMO L MYL AER C FKVR 100MC G/DO SP BS 200DO +INH

8,00 do

0,01654

0R 03AC AIDA V 27085=26833

Sa lbuta m o l cf a e r cfk vr 100m cg/do spbs 200do + inh

8,00 do

0,01654

0R 03AC AIDA V 27362=26833 0R 03AC AIDA V 28235

Sa lbuta m o l pch ae r cfk vr 100m cg/do spbs 200do +inh Airom ir 200 a e roso l 200m cg/do spbs 100do+inhala to r

8,00 do 4,00 do

0,01654 0,02757

0R 03AC AIDA V 28299=26833

Sa lbuta m o l a ct a er cfk vr 100m cg/do spb 200do+inh

8,00 do

0,01654

0R 03AC AIDC V 101219//12480 0R 03AC AIDC V 101220//12480

Brica nyl turbuhale r inha lpdr 0,5m g/do 200do Brica nyl turbuhale r inha lpdr 0,5m g/do 200do

4,00 do 4,00 do

0,09620 0,09620

0R 03AC AIDC V 101855//12480

Te rbuta line sulf delphi turb inha lpdr 0,5m g/do 200d

4,00 do

0,09620

0R 03AC AIDC V 12480

Brica nyl turbuhale r inha lpdr 0,5m g/do

4,00 do

0,09620

0R 03AC AIDC V 12939 0R 03AC AIDC V 12940

Sa lbuta m o l pch cyclo ca ps inhalpdr 200m cg Sa lbuta m o l pch cyclo ca ps inhalpdr 400m cg

4,00 stuk 2,00 stuk

0,09620 0,19240

0R 03AC AIDC V 15959

Brica nyl turbuhale r inha lpdr 0,250m g/do 200do

8,00 do

0,05772

0R 03AC AIDC V 19496

Ve nto lin disk us inhpdr 200m cg 60do

4,00 do

0,09620

0R 03AC AIDC V 22393 0R 03AC AIDC V 26971

Airom ir a uto ha le r a e roso l 100m cg/do spbs 200do SALBUTAMO L 100 R EDIHALER 100MC G/DO SP B 200D+INH

8,00 do 8,00 do

0,05772 0,05772

0R 03AC AIDC V 29458

Sa lbuta m o l novo lizer inhalpdr 100m cg/do

8,00 do

0,05772

0R 03AC AIDH V 21441

Ve nto lin 100 ae r cfk vr 100m cg/do spbs 200do +vo lum

8,00 do

0,09310

0R 03AC AII

V 12587

Ve nto lin 2,5 inhvlst 1m g/m l nebule 2,5m l

8,00 m l

0,06872

0R 03AC AII

V 14590

Ve nto lin 5,0 inhvlst 2m g/m l nebule 2,5m l

4,00 m l

0,11453

0R 03AC AII 0R 03AC AII

V 18093=57416 V 56751

Sa lbuta m o l sa ndoz inha latie vlo e isto f 5m g/m l Sa lbuta m o l pch inha la tie vlo eistof 5m g/m l

1,60 m l 1,60 m l

0,28634 0,28634

0R 03AC AII

V 57416

Sa lbuta m o l cf inha la tie vlo e isto f 5m g/m l

1,60 m l

0,28634

0R 03AC AII

V 6676

Ve nto lin o plossing inha la tie vlo eistof 5m g/m l

1,60 m l

0,28634

0R 03AC C IDA V 102315//33735

Se reve nt a e ro so l 25m cg/do cfk vr spbs 120do + inh

4,00 do

0,23086

0R 03AC C IDA V 102316//33735

Se reve nt a e ro so l 25m cg/do cfk vr spbs 120do + inh

4,00 do

0,23086

0R 03AC C IDA V 104697//33735

Se reve nt a e ro so l 25m cg/do cfk vr spbs 120do + inh

4,00 do

0,23086

0R 03AC C IDA V 30073//14821 0R 03AC C IDA V 31993

Se reve nt a e ro so l 25m cg/do spbs 120do + inha lato r Fora dil a e ro so l cfk vr 12m cg/do spbs 100dose s+inh

4,00 do 2,00 do

0,23086 0,46172

0R 03AC C IDA V 31994

Atim o s ae ro so l 12m cg/do sis spuitbus 100do

2,00 do

0,46172

0R 03AC C IDA V 33735

Se reve nt a e ro so l 25m cg/do cfk vr spbs 120do + inh

4,00 do

0,23086

0R 03AC C IDC V 101761//21026

O x is turbuha le r inha lpdr 6m cg/do 60do

4,00 do

0,36607

0R 03AC C IDC V 101762//21027

O x is turbuha le r inha lpdr 12m cg/do 60do

2,00 do

0,61011

0R 03AC C IDC V 102246//21027

O x is turbuha le r inha lpdr 12m cg/do 60do

2,00 do

0,61011

0R 03AC C IDC V 102247//21026 0R 03AC C IDC V 102291//21026

O x is turbuha le r inha lpdr 6m cg/do 60do O x is turbuha le r inha lpdr 6m cg/do 60do

4,00 do 4,00 do

0,36607 0,36607

0R 03AC C IDC V 102292//21027

O x is turbuha le r inha lpdr 12m cg/do 60do

2,00 do

0,61011

0R 03AC C IDC V 103114//18150

SALMETER O L ER C DISKUS INHP DR 50MC G 60DO

2,00 DO

0,61011

0R 03AC C IDC V 103931//18150 0R 03AC C IDC V 17158

Se reve nt disk us inhpdr 50m cg 60do Fora dil inhala tiepdr 12m cg + inha la tor

2,00 do 2,00 stuk

0,61011 0,61011

0R 03AC C IDC V 18150

Se reve nt disk us inhpdr 50m cg 60do

2,00 do

0,61011

0R 03AC C IDC V 21026

O x is turbuha le r inha lpdr 6m cg/do 60do

4,00 do

0,36607

0R 03AC C IDC V 21027

O x is turbuha le r inha lpdr 12m cg/do 60do

2,00 do

0,61011

0R 03AC C IDC V 23814//18150

Se reve nt disk us inhpdr 50m cg 60do

2,00 do

0,61011

0R 03AC C IDC V 24249//18150

Se reve nt disk us inhpdr 50m cg 60do

2,00 do

0,61011

0R 03AC C IDC V 24325//18150

Se reve nt disk us inhpdr 50m cg 60do

2,00 do

0,61011

0R 03AC C IDC V 24449//17158 0R 03AC C IDC V 26950//18150

Fora dil inhala tiepdr 12m cg + inha la tor Se reve nt disk us inhpdr 50m cg 60do

2,00 stuk 2,00 do

0,61011 0,61011

0R 03AC C IDC V 28063//21026

O x is turbuha le r inha lpdr 6m cg/do 60do

4,00 do

0,36607

0R 03AC C IDC V 28221//18150

Se reve nt disk us inhpdr 50m cg 60do

2,00 do

0,61011

0R 03AC C IDC V 28680 0R 03AC C IDC V 30867

Form o te rol m e rck click ha ler inhalpd 12m cg/do 60do Form o te rolum inha lpdr ca psule 12m cg + inha la to r

2,00 do 2,00 stuk

0,61011 0,61011

0R 03AC C IDC V 32586

Form o te rol sando z e a syha le r inha lpd 12m cg/do 120do

2,00 do

0,61011

0R 03AC C IDC V 32642//21027

O x is turbuha le r inha lpdr 12m cg/do 60do

2,00 do

0,61011

0R 03AC C IDC V 32660 0R 03AC C IDC V 32968

FO R MO TER O L MYLAN INHALPDR C AP SULE 12MC G+INHALATO R Form o te rol no vo lize r pdr 6m cg/do 60do+inh

2,00 stuk 4,00 do

0,61011 0,36607

0R 03AC C IDC V 32969

Form o te rol no vo lize r inha lpdr 12m cg/do

2,00 do

0,61011

0R 03AC C IDC V 33470

Form o te rol cyclo ca ps inha lpdr 12m cg + cyclo hale r

2,00 stuk

0,61011

0R 03AKAID

V 14123

Be rodua l cfk vr a ero sol spuitbus 200do + inha la to r

8,00 do

0,04086

0R 03BAAII

V 104435//14196

P ULMIC O R T 500 VER NEVELSUSP 0,250MG/ML R ESP ULE 2ML

6,00 m l

0,96281

0R 03BAAII 0R 03BAAII

V 14196 V 14197

P ULMIC O R T 500 VER NEVELSUSP 0,250MG/ML R ESP ULE 2ML P ULMIC O R T 1000 VER NEVELSUSP 0,500MG/ML R ESP ULE 2ML

6,00 m l 3,00 m l

0,96281 1,92562

0R 03BAAII

V 15730

P ulm ico rt 250 inhvlst 0,125m g/m l re spule 2m l

12,00 m l

0,57768

0R 03BAAII

V 21834

Flix o tide 500 inhvlst 0,25m g/m l ne bule 2m l

6,00 m l

0,96281

0R 03BAAII 0R 03BAAII

V 21835 V 24528//14196

Flix o tide 2000 inhvlst 1m g/m l nebule 2m l P ULMIC O R T 500 VER NEVELSUSP 0,250MG/ML R ESP ULE 2ML

1,50 m l 6,00 m l

3,85123 0,96281

0R 03BAAII

V 24529//14197

P ULMIC O R T 1000 VER NEVELSUSP 0,500MG/ML R ESP ULE 2ML

3,00 m l

1,92562

0R 03BAAII

V 30604//21834

Flix o tide 500 inhvlst 0,25m g/m l ne bule 2m l

6,00 m l

0,96281

0R 03BAAII 0R 03BAAII

V 31459//21834 V 32731//21835

Flix o tide 500 inhvlst 0,25m g/m l ne bule 2m l Flutide 2000 inhvlst 1m g/m l ne bule 2m l

6,00 m l 1,50 m l

0,96281 3,85123

0R 03BAAII

V 33483//14196

P ULMIC O R T 500 VER NEVELSUSP 0,250MG/ML R ESP ULE 2ML

6,00 m l

0,96281

0R 03BAAII

V 33484//14197

P ULMIC O R T 1000 VER NEVELSUSP 0,500MG/ML R ESP ULE 2ML

3,00 m l

1,92562

0R 03BABID

V 101708

BEC LO METASO N MYL AER C FKVR 50MC G/DO SP B 200DO +INH

16,00 do

0,07886

0R 03BABID

V 101709

BEC LO METASO N MYL AER C FKVR 100MC G/DO SPB 200DO +INH

8,00 do

0,08763

0R 03BABID

V 101710

BEC LO METASO N MYL AER C FKVR 250MC G/DO SPB 200DO +INH

3,20 do

0,21906

0R 03BABID 0R 03BABID

V 102736//31632 V 103091//16214

Alve sco 80 a ero sol 80m cg/do spbs 120do + inh Flix o tide a er cfk vr 250m cg/do spbs 120 do + inha l

2,00 do 2,40 do

0,42060 0,29208

0R 03BABID

V 103514//31632

Alve sco 80 a ero sol 80m cg/do spbs 120do + inh

2,00 do

0,42060

0R 03BABID

V 103516//31633

ALVESC O 160 AER O SO L 160MC G/DO SPBS+INH

1,00 do

0,70100

0R 03BABID 0R 03BABID

V 104544//31633 V 104631//21937

Alve sco 160 ae ro so l 160m cg/do spbs 60do + inh Q va r 50 e fa inha la to r 50m cg/do spbs 200do

1,00 do 8,00 do

0,70100 0,10515

0R 03BABID

V 104632//21938

Q va r 100 e fa inhala to r 100m cg/do spbs 200do

4,00 do

0,17525

0R 03BABID

V 16212

Flix o tide a er cfk vr 50m cg/do spbs 120 do + inha l

0R 03BABID 0R 03BABID

V 16213 V 16214

Flix o tide a er cfk vr 125m cg/do spbs 120 do + inha l Flix o tide a er cfk vr 250m cg/do spbs 120 do + inha l

0R 03BABID

V 21937

Q va r 50 e fa inha la to r 50m cg/do spbs 200do

8,00 do

0,10515

0R 03BABID

V 21938

Q va r 100 e fa inhala to r 100m cg/do spbs 200do

4,00 do

0,17525

0R 03BABID 0R 03BABID

V 27482 V 27483

Be clom e ta so n a a e r cfk vr 50m cg/do spbs 200do +inh Be clom e ta so n a a e r cfk vr 100m cg/do spbs 200do+inh

16,00 do 8,00 do

0,07886 0,08763

0R 03BABID

V 27484

Be clom e ta so n a a e r cfk vr 250m cg/do spbs 200do+inh

3,20 do

0,21906

0R 03BABID

V 27761

Be clodin m o dulite a ero sol 100m cg/do spbs 200do +inh

8,00 do

0,08763

0R 03BABID

V 28880=27482

Be clom e ta so n rp a e r cfk vr 50m cg/do spbs 200do +inh

16,00 do

0,07886

12,00 do

0,10515

4,80 do 2,40 do

0,14604 0,29208

0R 03BABID

V 28882=27484

Be clom e ta so n rp a e r cfk vr 250m cg/do spbs 200do+inh

0R 03BABID

V 28920=27482

Be clom e ta so n act ae r cfk vr 50m cg/do spb 200do+inh

3,20 do

0,21906

16,00 do

0R 03BABID 0R 03BABID

V 28921=27483 V 28922=27484

Be clom e ta so n act ae r cfk vr 100m cg/do spb 200do +inh Be clom e ta so n act ae r cfk vr 250m cg/do spb 200do +inh

0,07886

8,00 do 3,20 do

0,08763 0,21906

0R 03BABID

V 30099

Be clom e ta so n pch a e r cfk vr 50m cg/do spb 200do +inh

0R 03BABID

V 30101

Be clom e ta so n pch a e r cfk vr 250m cg/do spb 200do +inh

16,00 do

0,07886

3,20 do

0R 03BABID 0R 03BABID

V 31632 V 31633

ALVESC O 80 AER O SO L 80MC G/DO SP BS ALVESC O 160 AER O SO L 160MC G/DO SPBS

0,21906

2,00 do 1,00 do

0,42060 0,70100

0R 03BABID

V 32251

Bude sonide a llge n a ero sol cfk v 200m cg/do 200do

4,00 do

0,17525

0R 03BABID

V 32252

R ibuspir 200 ae r cfk vr 200m cg/do spbs 200do +inh

4,00 do

0,17525

0R 03BABID 0R 03BABID

V 33316 V 33317

Be clom e ta so n all a er cfk vr 50m cg/do spb 200do +inh Be clom e ta so n all a er cfk vr 100m cg/do spb 200do+inh

16,00 do 8,00 do

0,07886 0,08763

0R 03BABID

V 33318

Be clom e ta so n all a er cfk vr 250m cg/do spb 200do+inh

3,20 do

0,21906

0R 03BABID

V 33372

Be clom e ta so n cf a er cfk vr 50m cg/do spb 200do +inh

16,00 do

0,07886

0R 03BABID 0R 03BABID

V 33375 V 34150

Be clom e ta so n cf a er cfk vr 250m cg/do spb 200do+inh Be clom e ta so n sa ndo z ae r 50m cg/do spbs 200do+inh

3,20 do 16,00 do

0,21906 0,07886

0R 03BABID

V 34151

Be clom e ta so n sa ndo z ae r 100m cg/do spbs 200do +inh

8,00 do

0,08763

0R 03BABID

V 34152

Be clom e ta so n sa ndo z ae r 250m cg/do spbs 200do +inh

3,20 do

0,21906

0R 03BABID

V 34330

BUDESO NIDE MYLAN AER C FKVR 200MC G/DO 200DO

4,00 do

0,17525

0R 03BAC ID

V 16216

Flix o tide a er cfk vr 50m cg/do spbs 120 do + volum

12,00 do

0,19556

0R 03BAC ID

V 16217

Flix o tide a er cfk vr 125m cg/do spbs 120 do + vo lum

4,80 do

0,27161

0R 03BAC ID 0R 03BAC ID

V 16218 V 29141

Flix o tide a er cfk vr 250m cg/do spbs 120 do + vo lum Q va r 50 e fa ae ro cha m b m o ndst 50m cg/do spbs 200do

2,40 do 8,00 do

0,54321 0,19556

0R 03BAC ID

V 29142

Q va r 100 e fa a e ro cham b m ondst 100m cg/do spbs 200do

4,00 do

0,32593

0R 03BAC ID

V 29143

Q va r 50 e fa ae ro cha m b m a sk e r 50m cg/do spbs 200do

8,00 do

0,19556

0R 03BAC ID 0R 03BAC ID

V 29144 V 32355

Q va r 100 e fa a e ro cham b m ask er 100m cg/do spbs 200do Bude sonide a llge n a ero sol cfk v 200m cg/do 200do +je t

4,00 do 4,00 do

0,32593 0,32593

0R 03BAC ID

V 32948

Alve sco 160 ae ro ch plus ae ro s 160m cg/do spbs 60do

1,00 do

1,30371

0R 03BADID

V 100634//13699

P ulm ico rt 400 turbuha ler inhalpdr 400m cg/do 200do

2,00 do

0,35631

0R 03BADID 0R 03BADID

V 102734//18195 V 102742//18194

Flutide fo rte disk us inhpdr 500m cg 60do Flutide disk us inhpdr 250m cg 60do

1,20 do 2,40 do

0,59385 0,29692

0R 03BADID

V 102771//13699

P ulm ico rt 400 turbuha ler inhalpdr 400m cg/do 200do

2,00 do

0,35631

0R 03BADID

V 104517//18195

Flutide disk us inhpdr 500m cg 60do

1,20 do

0,59385

0R 03BADID 0R 03BADID

V 104698//18195 V 13390

Flutide fo rte disk us inhpdr 500m cg 60do Be clom e ta so n pch cyclo ca ps inha lpdr 100m cg

1,20 do 8,00 stuk

0,59385 0,08908

0R 03BADID

V 13391

Be clom e ta so n pch cyclo ca ps inha lpdr 200m cg

4,00 stuk

0,17815

0R 03BADID

V 13392

Be clom e ta so n pch cyclo ca ps inha lpdr 400m cg

2,00 stuk

0,35631

0R 03BADID 0R 03BADID

V 13698 V 13699

P ulm ico rt 200 turbuha ler inhalpdr 200m cg/do 200do P ulm ico rt 400 turbuha ler inhalpdr 400m cg/do

4,00 do 2,00 do

0,17815 0,35631

0R 03BADID

V 14758

P ulm ico rt 100 turbuha ler inhalpdr 100m cg/do 200do

8,00 do

0,10689

0R 03BADID

V 18062

Bude sonide cyclo ca ps inha lpoe de r 200m cg

4,00 stuk

0,17815

0R 03BADID 0R 03BADID

V 18063 V 18193

Bude sonide cyclo ca ps inha lpoe de r 400m cg Flix o tide disk us inhpdr 100m cg 60do

2,00 stuk 6,00 do

0,35631 0,15440

0R 03BADID

V 18194

Flix o tide disk us inhpdr 250m cg 60do

2,40 do

0,29692

0R 03BADID

V 18195

Flix o tide disk us inhpdr 500m cg 60do

1,20 do

0,59385

0R 03BADID 0R 03BADID

V 21633//13699 V 21939

P ulm ico rt 400 turbuha ler inhalpdr 400m cg/do Q va r 50 e fa auto hale r 50m cg/do spbs 200do

2,00 do 8,00 do

0,35631 0,10689

0R 03BADID

V 21940

Q va r 100 e fa a uto ha le r 100m cg/do spbs 200do

4,00 do

0,17815

0R 03BADID

V 22998//13699

P ulm ico rt 400 turbuha ler inhalpdr 400m cg/do

2,00 do

0,35631

0R 03BADID 0R 03BADID

V 25532 V 28795

Bude sonide cyclo ca ps inha lpdr 800m cg +cyclo hale r Bude sonide no vo lize r pdr 200m cg/do

1,00 stuk 4,00 do

0,71262 0,17815

0R 03BADID

V 30315

Bude sonide sa ndo z 200 ea syh inha lpd 200m cg/do

4,00 do

0,17815

0R 03BADID

V 30316

Bude sonide sa ndo z 400 ea syh inha lpd 400m cg/do

2,00 do

0,35631

0R 03BADID 0R 03BADID

V 30319//21940 V 30356

Q va r 100 e fa a uto ha le r 100m cg/do spbs 200do Bude sonide click ha le r k r inhpdr 100m cg/do 200do

4,00 do 8,00 do

0,17815 0,10689

0R 03BADID

V 30357

Bude sonide click ha le r k r inhpdr 200m cg/do 200do

4,00 do

0,17815

0R 03BADID

V 30358

Bude sonide click ha le r k r inhpdr 400m cg/do 100do

2,00 do

0,35631

0R 03BADID 0R 03BADID

V 30636//21940 V 32454

Q va r 100 e fa a uto ha le r 100m cg/do spbs 200do Bude sonide no vo lize r pdr 400m cg/do

4,00 do 2,00 do

0,17815 0,35631

0R 03BADID

V 33768//13699

P ulm ico rt 400 turbuha ler inhalpdr 400m cg/do 200do

2,00 do

0,35631

0R 03BADID

V 33833//18193

Flutica so n disk us inhpdr 100m cg 60do

6,00 do

0,15440

0R 03BADID 0R 03BADID

V 33836//18194 V 34470//18195

Flutide disk us inhpdr 250m cg 60do Flutide disk us inhpdr 500m cg 60do

2,40 do 1,20 do

0,29692 0,59385

0R 03BADID

V 34693//13699

P ulm ico rt 400 turbuha ler inhalpdr 400m cg/do 200do

2,00 do

0,35631

0R 03BBAII 0R 03BBAII

V 12869 V 16015

ATR O VENT UNIT DO SE VER NEVELO P L 250MC G/ML FL 2ML ATR O VENT UNIT DO SE VER NEVELO P L 125MC G/ML FL 2ML

1,20 m l 2,40 m l

0,28668 0,14334

0R 03BBAII

V 27815

Ipra x a ste ri-ne b inha latie vlst 250m cg/m l fl 1m l

1,20 m l

0,28668

0R 03BBAII

V 27816

Ipra x a ste ri-ne b inha latie vlst 250m cg/m l fl 2m l

1,20 m l

0,28668

0R 03BBAII

V 32721//12869

ATR O VENT UNIT DO SE VER NEVELO P L 250MC G/ML FL 2ML

1,20 m l

0,28668

0R 03BBBID

V 11565

Atro ve nt inha le tte inha lpdr 0,04m g

3,00 stuk

0,21391

0R 03BBBID

V 26267

Ipra tro pium cyclo ca ps inhalpo ede r 0,04m g

3,00 stuk

0,21391

0R 03BC BID

V 11746

Tila de ae ro so l 2m g/do spbs 112do + inha la tor

4,00 do

0,20258

0R 03BC BID

V 11817

Lom udal fo rte ae ro so l 5m g/do spbs 112do

8,00 do

0,10129

0R 03BC C ID

V 5719

Lom udal inha lpdr 20m g

4,00 stuk

0,18151

0R 03C C AO

K 6450

Ve nto lin dra nk 0,4m g/m l

0R 03C C AO

V 57411

Sa lbuta m o l cf ta ble t 2m g

6,00 stuk

0,04783

0R 03C C AO

V 57412

Sa lbuta m o l cf ta ble t 4m g

3,00 stuk

0,07971

0R 03DABO

V 56267//8816

Theo la ir la ta ble t m ga 350m g

2,14 stuk

0,14074

0R 03DABO

V 8391

Theo la ir re ta rd table t m ga 250m g

3,00 stuk

0,10053

0R 03DABO 0R 03DABO

V 8816 V 9107

Theo la ir re ta rd table t m ga 350m g Theo la ir re ta rd table t m ga 175m g

2,14 stuk 4,29 stuk

0,14074 0,07037

0R 03DABO

V 9849//8391

Theo la ir la ta ble t m ga 250m g

3,00 stuk

0,10053

0R 06ADBO

V 23441=50250

P R O METHAZINE TEVA TABLET O MHULD 25MG

1,00 stuk

0,02042

0R 06ADBO

V 50250

P ro m e tha zine cf table t om huld 25m g

1,00 stuk

0,02042

0R 06AXBO

K 14490

Za dite n druppelvlo e isto f 1m g/m l

0R 06AXBO

K 14771

Ke totife n pch suik e rvrij stro o p 0,2m g/m l

0R 06AXBO

K 16339=57533

Ke totife n actavis stroo p 0,2m g/m l

10,00 m l

0,04202

0R 06AXBO 0R 06AXBO

K 24217=14771 K 57533

Ke totife n rp suik e rvrij stro o p 0,2m g/m l Ke totife n cf suik ervrij stro op 0,2m g/m l

10,00 m l 10,00 m l

0,04202 0,04202

0R 06AXBO

K 9520

Za dite n stro o p 0,2m g/m l zonde r suik e r

10,00 m l

0,04202

0S01AAAG 0S01AAAG

V 101187//11902 V 10164

Fucitha lm ic o o gge l tube 5g Minim s chloo ra m fenico l oo gdr 5m g/m l tube 0,5m l

0,40 gra m 10,00 stuk

0,83224 0,03329

30,00 m l

0,01319

2,00 m l

0,21010

10,00 m l

0,04202

0S01AAAG

V 16005

Fucitha lm ic unit do se o o gge l 10m g/g tube 0,2g

4,00 stuk

0,08322

0S01AAAG 0S01AAAG

V 1767 V 23440//11902

C hloo ra m fenico l the a o ogdr 4m g/m l fl 10m l Fucitha lm ic o o gge l tube 5g

1,00 m l 0,40 gra m

0,33290 0,83224

0S01AAAG

V 26008//11902

Fucitha lm ic o o gge l tube 5g

0,40 gra m

0,83224

0S01AAAG

V 27853//11902

Fucitha lm ic o o gge l tube 5g

0,40 gra m

0,83224

0S01AAAG 0S01AAAG

V 30125//11902 V 56086

Fucitha lm ic o o gge l tube 5g C HLO O R AMFENIC O L TEVA O O GDR UP P ELS 0,5% FLAC O N 10ML

0,40 gra m 1,00 m l

0,83224 0,33290

0S01AAAZ

V 17418

C hloo ra m fenico l po s oo gza lf 10m g/g tube 5g

0,12 gra m

0,57268

0S01AAAZ

V 57557

C hloo ra m fenico l rp o o gza lf 10m g/g

0,12 gra m

0,57268

0S01AABG

V 17832

GENTAMIC INE P O S O O GDR UP P ELS 3MG/ML FLAC O N 5ML

0,50 m l

0,76670

0S01AABG

V 26393

To bra ba ct o ogdruppe ls 3m g/m l fla co n 5m l

0,60 m l

0,63892

0S01AABG 0S01AABZ

V 28141 V 10225

To bre x bid o o gdruppe ls 3m g/m l fla co n 5m l To bre x o ogzalf tube 3,5g

0,30 m l 0,28 gra m

1,27784 0,22624

0S01ADBZ

V 22477

Aciclo vir rp oo gza lf 30m g/g tube 4,5g

0,20 gra m

2,70251

0S01ADBZ

V 22569

Aciclo virum o o gza lf 30m g/g tube 4,5g

0,20 gra m

2,70251

0S01ADBZ

V 9248

Zo vira x o o gza lf 30m g/g tube 4,5g

0,20 gra m

2,70251

0S01AXAG

V 29805

Tra flo x a l e do oo gdruppe ls 3m g/m l tube 0,5m l

4,00 stuk

0,46833

0S01AXAG

V 34031

Azyte r single dose oo gdruppe ls 15m g/g tube 0,25g

2,00 stuk

0,93667

0S01AXBG

V 13708

C hibro x o l o o gdruppels 3m g/m l fla co n 5m l

0,40 m l

0,62258

0S01BAAG

V 100998//6539

Fm l liquifilm o o gdruppe ls 0,1% fla co n 5m l

0,40 m l

0,51278

0S01BAAG 0S01BAAG

V 101950//6539 V 103154//11271

Fm l liquifilm o o gdruppe ls 0,1% fla co n 5m l P re d fo rte o ogdruppe ls 10m g/m l flacon 5m l

0,40 m l 0,40 m l

0,51278 0,51278

0S01BAAG

V 11271

P re d fo rte o ogdruppe ls 10m g/m l flacon 5m l

0,40 m l

0,51278

0S01BAAG

V 18087

Ve x o l o ogdruppe ls 10m g/m l flacon 5m l

0,40 m l

0,51278

0S01BAAG 0S01BAAG

V 22679 V 30482//6539

De x a po s o o gdruppels 1m g/m l fla co n 10m l Fm l liquifilm o o gdruppe ls 0,1% fla co n 5m l

0,40 m l 0,40 m l

0,51278 0,51278

0S01BAAG

V 33164//6539

Fm l liquifilm o o gdruppe ls 0,1% fla co n 5m l

0,40 m l

0,51278

0S01BAAG

V 56003

De x am e thaso n rp o o gdruppe ls 0,1%

0,40 m l

0,51278

0S01BAAG

V 6539

Fm l liquifilm o o gdruppe ls 0,1% fla co n 5m l

0,40 m l

0,51278

0S01BABG

V 10169

Minim s predniso lonna trium o ogdr 5m g/m l tube 0,5m l

4,00 stuk

0,39116

0S01BABG

V 18658

Mo no free de x a m e tha son o o gdr 1m g/m l m inim 0,4m l

4,00 stuk

0,39116

0S01BC AG 0S01BC AG

V 12800 V 13381

Na clof o o gdruppels 1m g/m l fla co n 5m l Acular o o gdruppels 5m g/m l fla co n 5m l

0,40 m l 0,30 m l

1,42850 1,90467

0S01BC AG

V 16363

Indo co llyre o o gdruppels 1m g/m l fla co n 5m l

0,40 m l

1,42850

0S01BC AG

V 16483

Na clof unido se o o gdruppels 1m g/m l am pul 0,3m l

4,00 stuk

0,14285

0S01BC AG 0S01BC AG

V 24663//13381 V 24717//13381

Acular o o gdruppels 5m g/m l fla co n 5m l Acular o o gdruppels 5m g/m l fla co n 5m l

0,30 m l 0,30 m l

1,90467 1,90467

0S01BC AG

V 28174

Indo co llyre unido se o o gdruppels 1m g/m l tube 0,35m l

4,00 stuk

0,14285

0S01BC AG

V 29588//12800

Na clof o o gdruppels 1m g/m l fla co n 5m l

0,40 m l

1,42850

0S01BC AG 0S01BC AG

V 32539//12800 V 34473

Na clof o o gdruppels 1m g/m l fla co n 5m l Diclo aba k oo gdruppe ls 1m g/m l flacon 10m l

0,40 m l 0,40 m l

1,42850 1,42850

0S01BC AG

V EU/1/07/433/001 Ne va nac oo gdruppe ls 1m g/m l flacon 5m l

0,30 m l

1,90467

0S01EADG 0S01EADG

V 100036 V 100260

Brim o nidine tartra a t pch oo gdr 2m g/m l fl 5m l Brim o nidine tartra a t m yla n o o gdr 2m g/m l fl 5m l

0,20 m l 0,20 m l

2,52574 2,52574

0S01EADG

V 103574

Brim o nidine tartra a t sa ndoz o ogdr 2m g/m l fl 5m l

0,20 m l

2,52574

0S01EADG

V 21754

Alpha gan o o gdruppe ls 2m g/m l fla co n 5m l

0,20 m l

2,52574

0S01EBBG

V 57399

P ilo ca rpine hcl rp oo gdruppe ls 2%

0,20 m l

0,26183

0S01EC AG

V 17618

Truso pt oo gdruppe ls 20m g/m l fla co n 5m l

0,30 m l

2,19630

0S01EC AG

V 30148//17618

Truso pt oo gdruppe ls 20m g/m l fla co n 5m l

0,30 m l

2,19630

0S01EC AG 0S01EC AG

V EU/1/00/129/001 Azo pt o ogdruppe ls 10m g/m l flacon 5m l V EU/1/00/129/003 Azo pt o ogdruppe ls 10m g/m l flacon 5m l

0,20 m l 0,20 m l

3,29445 3,29445

0S01EC AO

V 11753

Dia m o x sustet capsule m ga 250m g

3,00 stuk

0,19534

0S01EC AO 0S01EC AO

V 5155 V 643

Dia m o x sustet capsule m ga 500m g Dia m o x ta ble t 250m g

1,50 stuk 3,00 stuk

0,39069 0,19534

0S01EC AO

V 9291

Ace ta zo lam ide sa ndo z ta blet 250m g

3,00 stuk

0,19534

0S01EC AO

V 9292

Gla upa x reta rd ca psule m ga 250m g

3,00 stuk

0,19534

0S01EDAG

V 11203

Be taga n liquifilm oo gdruppe ls 0,50% flacon 5m l

0,20 m l

0,93750

0S01EDAG

V 12996

Be taga n liquifilm oo gdruppe ls 0,25% flacon 5m l

0,20 m l

0,93750

0S01EDAG

V 13378

Te optic o o gdruppe ls 10m g/m l fla co n 5m l

0,20 m l

0,93750

0S01EDAG 0S01EDAG

V 13379 V 15045

Te optic o o gdruppe ls 20m g/m l fla co n 5m l Tim o lo l pch o o gdruppe ls 1m g/m l fla co n 5m l

0,20 m l 0,20 m l

0,93750 0,93750

0S01EDAG

V 15699

Tim o lo l pch o o gdruppe ls 2,5m g/m l fla co n 5m l

0,20 m l

0,93750

0S01EDAG

V 15700

Tim o lo l pch o o gdruppe ls 5m g/m l fla co n 5m l

0,20 m l

0,93750

0S01EDAG 0S01EDAG

V 17017 V 17018

Tim o pto l x e o ogdruppe ls 2,5m g/m l flacon 2,5m l Tim o pto l x e o ogdruppe ls 5m g/m l fla co n 2,5m l

0,10 m l 0,10 m l

1,87500 1,87500

0S01EDAG

V 20426=57607

O culo gutta e tim o lo li m a le a s 1,0m g/m l fla co n 5m l

0,20 m l

0,93750

0S01EDAG

V 20427=57608

TIMO LO L APO TEX O O GDR UP P ELS 2,5MG/ML

0,20 m l

0,93750

0S01EDAG 0S01EDAG

V 20428=57609 V 21351=56895

TIMO LO L APO TEX O O GDR UP P ELS 5MG/ML Tim o lo l a cta vis o ogdruppe ls 2,5m g/m l flacon 5m l

0,20 m l 0,20 m l

0,93750 0,93750

0S01EDAG

V 21352=56896

Tim o lo l a cta vis o ogdruppe ls 5m g/m l fla co n 5m l

0,20 m l

0,93750

0S01EDAG

V 21539//11203

Be taga n liquifilm oo gdruppe ls 0,50% flacon 5m l

0,20 m l

0,93750

0S01EDAG 0S01EDAG

V 25176 V 34842

Nyo ge l o o gge l 1m g/g fla co n 5m l Tim o lo l a o o gdruppe ls 2,5m g/m l fla co n 5m l

0,20 m l 0,20 m l

0,93750 0,93750

0S01EDAG

V 34843

Tim o lo l a o o gdruppe ls 5m g/m l fla co n 5m l

0,20 m l

0,93750

0S01EDAG

V 35126

TIMO LO L MYLAN O O GDR UP P ELS 2,5MG/ML FLAC O N 5ML

0,20 ML

0,93750

0S01EDAG 0S01EDAG

V 35127 V 56895

TIMO LO L MYLAN O O GDR UP P ELS 5MG/ML FLAC O N 5ML Tim o lo l cf oo gdruppe ls 2,5m g/m l fla co n 5m l

0,20 ML 0,20 m l

0,93750 0,93750

0S01EDAG

V 56896

Tim o lo l cf oo gdruppe ls 5m g/m l flacon 5m l

0,20 m l

0,93750

0S01EDAG

V 57323

Tim o lo l o o gdruppels 2,5m g/m l

0,20 m l

0,93750

0S01EDAG 0S01EDAG

V 57324 V 57498

Tim o lo l o o gdruppels 5m g/m l fla co n 5m l Tim o lo l rp o o gdruppe ls 5m g/m l

0,20 m l 0,20 m l

0,93750 0,93750

0S01EDAG

V 57607

Tim o lo l sa ndo z o o gdruppels 1m g/m l

0,20 m l

0,93750

0S01EDAG

V 57608

Tim o lo l sa ndo z o o gdruppels 2,5m g/m l

0,20 m l

0,93750

0S01EDAG 0S01EDAG

V 57609 V 7630

Tim o lo l sa ndo z o o gdruppels 5m g/m l fla co n 5m l Tim o pto l o o gdruppels 2,5m g/m l fla co n 5m l

0,20 m l 0,20 m l

0,93750 0,93750

0S01EDAG

V 7631

Tim o pto l o o gdruppels 5m g/m l fla co n 5m l

0,20 m l

0,93750

0S01EDC G

V 21644

Tim o -com o d oo gdruppe ls 2,5m g/m l fla co n 10m l

0,20 m l

1,49747

0S01EDC G 0S01EDC G

V 21645 V 29950

Tim o -com o d oo gdruppe ls 5m g/m l flacon 10m l C a rte aba k oo gdruppe ls 20m g/m l fl 5m l

0,20 m l 0,20 m l

1,49747 1,49747

0S01EXAG

V 21304

Xa la ta n oo gdruppe ls 50m cg/m l flacon 2,5m l

0,20 m l

8,54016

0S01EXAG 0S01EXAG

V 25960//21304 V 31429//21304

Xa la ta n oo gdruppe ls 50m cg/m l flacon 2,5m l Xa la ta n oo gdruppe ls 50m cg/m l flacon 2,5m l

0,20 m l 0,20 m l

8,54016 8,54016

0S01EXAG

V EU/1/01/199/002 Tra va ta n o o gdruppels 40m cg/m l fla co n 2,5m l

0,20 m l

8,54016

0S01EXAG

V EU/1/02/205/001 Lum igan o o gdruppe ls 0,3m g/m l fla co n 3m l

0,20 m l

8,54016

0S01FAAG

V 6851

C yclogyl o o gdruppels 1% fla co n 15m l

0,30 m l

0,35909

0S01FABG 0S01FABG

V 50101 V 57398

Atro pine sulfaa t pch o ogdruppe ls 1% fla co n 10m l Atro pine sulfaa t rp o ogdruppe ls 1% fla co n 10m l

0,10 m l 0,10 m l

0,31992 0,31992

0S01FAC G

V 10167

Minim s tro pica m ide o o gdruppe ls 10m g/m l tube 0,5m l

1,00 stuk

0,02519

0S01FAC G

V 56688

Tro pica m ide o o gdruppe ls 0,5% fla co n 10m l

0,10 m l

0,25185

0S01FBAG

V 14872

Minim s fe nylefrine hcl o o gdr 25m g/m l tube 0,5m l

1,00 stuk

0,62917

0S01GAAG

V 11572

O x ylin liquifilm o ogdruppe ls 0,25m g/m l fla co n 5m l

0,20 m l

0,40160

0S01GAAG 0S01GAAG

V 1764 V 4518

Bo radrine o o gdruppels 2,5m g/m l fla co n 10m l Visa dron o o gdruppe ls 1,25m g/m l flacon 10m l

0,20 m l 0,30 m l

0,40160 0,26773

0S01GXAG

V 15593

Tila vist o ogdruppe ls 2% fla co n 5m l

0,30 m l

0,80923

0S01GXAG 0S01GXAG

V 17237=57336 V 17824=57576

P re va lin dina trium cr oo gdruppe ls 20m g/m l fl 10m l Na trium cro m oglica at gf o o gdruppe ls 20m g/m l fl 10m l

0,50 m l 0,50 m l

0,48554 0,48554

0S01GXAG

V 20981

Na trium cro m oglica at sdz o o gdruppe ls 20m g/m l fl10m l

0,50 m l

0,48554

0S01GXAG

V 22380=57336

Na trium cro m oglica at pch o o gdruppe ls 20m g/m l fl10m l

0,50 m l

0,48554

0S01GXAG 0S01GXAG

V 23399=20981 V 23703

NATR IUMC R O MO GLIC AAT MYLAN O O GDR UP P 20MG/ML FL 10ML Na trium cro m oglica at k a tw oo gdruppe l 20m g/m l fl10m l

0,50 m l 0,50 m l

0,48554 0,48554

0S01GXAG

V 57336

Na trium cro m oglica at flx o ogdr 20m g/m l

0,50 m l

0,48554

0S01GXAG

V 57576

Na trium cro m oglica at rp o o gdr 20m g/m l fl10m l

0,50 m l

0,48554

0S01GXAG

V 7564

O pticro m oo gdruppe ls 20m g/m l fla co n 10m l

0,50 m l

0,48554

0S01GXBG

V 13968

Livo ca b o o gdruppels 0,5m g/m l fla co n 4m l

0,20 m l

1,85595

0S01GXBG

V 22946

Alle rgo dil o ogdruppe ls 0,5m g/m l flacon 6m l

0,20 m l

1,85595

0S01GXBG 0S01GXBG

V 22947 V 23091//13968

O cula stin o ogdruppe ls 0,5m g/m l flacon 6m l Livo ca b o o gdruppels 0,5m g/m l fla co n 4m l

0,20 m l 0,20 m l

1,85595 1,85595

0S01GXBG

V 25726

Za dite n oo gdruppe ls 0,25m g/m l fla co n 5m l

0,20 m l

1,85595

0S01GXBG

V 25727

Za dite n unidose oo gdruppe ls 0,25m g/m l tube 0,4m l

0,20 m l

1,85595

0S01GXBG 0S01GXBG

V 33485//22946 Alle rgo dil o ogdruppe ls 0,5m g/m l flacon 6m l V EU/1/02/217/001 O pa ta no l o ogdruppe ls 1m g/m l fla co n 5m l

0,20 m l 0,20 m l

1,85595 1,85595

0S01GXBG

V EU/1/98/095/001 Em a dine o o gdruppe ls 0,5m g/m l fla co n 5m l

0,20 m l

1,85595

0S01GXBG

V EU/1/98/095/003 Em a dine single do se o o gdr 0,5m g/m l tube 0,35m l

0,20 m l

1,85595

0S01GXC G

V 12039

O pticro m unit dose oo gdruppe ls 20m g/m l am p 0,35m l

5,00 stuk

0,06385

0S01GXC G

V 15461

Alle rgo -co m od o o gdruppe ls 20m g/m l fla co n 10m l

0,50 m l

0,63847

0S01GXC G

V 29812

Alle rg-a bak o o gdruppe ls 20m g/m l fla co n 10m l

0,50 m l

0,63847

0S01JABG

V 34461

Fluo re scite injvlst 100m g/m l fla co n 5m l

5,00 m l

1,95125

0S01JABG

V 51727

Injvlst fluo re sce ine dinatrium 100m g/m l a m p 5m l

5,00 m l

1,95125

0S01XAAG 0S01XAAG

V 10187 V 10513

Dura tea rs oo gdruppe ls P ro tage ns o o gdruppe ls 20m g/m l

0,60 m l 0,50 m l

0,26471 0,31765

0S01XAAG

V 14227

Thilo te ars o ogge l tube 10g

0,40 gra m

0,39706

0S01XAAG

V 14862

VIDISIC C AR BO GEL O O GGEL 2MG/G TUBE 10G

0,40 gra m

0,39706

0S01XAAG 0S01XAAG

V 15881=14227 V 19304

Dry eye ge l o ogge l tube 10g O culo te ct o ogdruppe ls 50m g/m l flacon 10m l

0,40 gra m 0,40 m l

0,39706 0,39706

0S01XAAG

V 19923

Hypro m e llo se the a o o gdruppels 0,3% fl 10m l

1,80 m l

0,08824

0S01XAAG

V 20003

Me thylce llulo se the a o o gdr 0,5% fla c 10m l

0,40 m l

0,39706

0S01XAAG 0S01XAAG

V 20004 V 21699

Me thylce llulo se the a o o gdr 1,25% fla c 10m l Lacrino rm oo ggel 2m g/g tube 10g

0,40 m l 0,40 gra m

0,39706 0,39706

0S01XAAG

V 27286//14862

Vidisic ca rbo ge l o o gge l 2m g/g

0,40 gra m

0,39706

0S01XAAG

V 56314

Hypro m e llo se rp o ogdruppe ls 0,3%

1,80 m l

0,08824

0S01XAAG

V 9018

Vidisic pvp ophtiole o ogdruppe ls 50m g/m l flac 10m l

0,40 m l

0,39706

0S01XAAZ

V 10380

Dura tea rs z o o gza lf tube 3,5g

0,24 gra m

0,85440

0S01XABG 0S01XABG

V 101972//18218 V 15188

C e lluvisc unit do se o o gdruppe ls 10m g/m l tube 0,4m l P ro tage ns m o no o o gdruppe ls 20m g/m l tube 0,4m l

5,00 stuk 5,00 stuk

0,17679 0,17679

0S01XABG

V 16194=15188

Dura tea rs free single do se o o gdr 20m g/m l tub 0,4m l

5,00 stuk

0,17679

0S01XABG

V 18218

C e lluvisc unit do se o o gdruppe ls 10m g/m l tube 0,4m l

5,00 stuk

0,17679

0S01XABG 0S01XABG

V 19305 V 19924

O culo te ct unido se o ogdruppe ls 50m g/m l a m p 0,4m l Mo no free hypro m ello se o ogdr 3m g/m l m inim 0,4m l

4,00 stuk 4,50 stuk

0,22099 0,19644

0S01XABG

V 29773

Vidisic ca rbo ge l e do oo ggel 2m g/g 0,6m l

4,00 stuk

0,22099

0S01XABG

V 33936//18218

C e lluvisc unit do se o o gdruppe ls 10m g/m l tube 0,4m l

5,00 stuk

0,17679

0S01XABG 0S01XABG

V 34287//18218 V 34478//18218

C e lluvisc unit do se o o gdruppe ls 10m g/m l tube 0,4m l C e lluvisc unit do se o o gdruppe ls 10m g/m l tube 0,4m l

5,00 stuk 5,00 stuk

0,17679 0,17679

0V03AAAO

V 1032

Antabus dispe rgette bruista ble t 400m g

0,38 stuk

0,20583

0V03AAAO

V 3182

R e fusa l table t 250m g

0,60 stuk

0,12865

0V03ABAO

V 24788

Na ltre x o n hcl sando z ta ble t o m huld 50m g

1,00 stuk

2,45981

0V03ABAO

V 30958

Na ltre x o n hcl pch ta ble t o m huld 50m g

1,00 stuk

2,45981

0V03AEAO

V 101782//31929

Fosre no l k auwta ble t 750m g

3,00 stuk

2,97866

0V03AEAO

V 102682//31928

Fosre no l k auwta ble t 500m g

4,50 stuk

2,18435

0V03AEAO

V 31928

Fosre no l k auwta ble t 500m g

4,50 stuk

2,18435

0V03AEAO 0V03AEAO

V 31929 V 31930

Fosre no l k auwta ble t 750m g Fosre no l k auwta ble t 1000m g

3,00 stuk 2,25 stuk

2,97866 3,97155

0V03AEAO

V EU/1/99/123/002 R e nage l ca psule 403m g

15,88 stuk

0,56269

0V03AEAO

V EU/1/99/123/005 R e nage l table t film o m huld 400m g

16,00 stuk

0,55850

0V03AEAO 0V03AEAO

V EU/1/99/123/008 R e nage l table t film o m huld 800m g V EU/1/99/123/012 R e nage l table t film o m huld 800m g

8,00 stuk 8,00 stuk

1,11700 1,11700

0V03AFBO

V 11274

Leuco vorine teva table t 15m g

4,00 stuk

4,47064

0V03AFBO 0V03AFBO

V 15828 V 17268=11274

C a lcium fo lina a t euro ce pt ca psule 15m g Leuco vorine abic ta ble t 15m g

4,00 stuk 4,00 stuk

4,47064 4,47064

0V03AFBO

V 8997

R e scuvo lin ta ble t 15m g

4,00 stuk

4,47064

0V03AFBP 0V03AFBP

V 15827 V 17416

FO LINEZUUR SANDO Z INJVLST 10MG/ML R e scuvo lin inje ctie vlo eistof 10m g/m l fla co n

6,00 m l 6,00 m l

5,67316 5,67316

0V03AFBP

V 22722

Vo rina injvlst 25m g/m l fla co n

2,40 m l

14,18290

0V03AFBP

V 28140

C a lcium fo lina a t cf injvlst 10m g/m l fla co n 10m l

6,00 m l

0V03AFBP 0V03AFBP

V 8998 V 8998

R e scuvo lin inje ctie po e der fla co n 500m g R e scuvo lin inje ctie po e der fla co n 15m g

0,12 stuk 4,00 stuk

283,65800 8,50974

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 300m g

0,20 stuk

170,19480

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 300m g

0,20 stuk

170,19480

0V03AFBP 0V03AFBP

V 8998 V 8998

R e scuvo lin inje ctie po e der fla co n 200m g R e scuvo lin inje ctie po e der fla co n 200m g

0,30 stuk 0,30 stuk

113,46320 113,46320

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 500m g

0,12 stuk

283,65800

5,67316

0V03AFBP 0V03AFBP

V 8998 V 8998

R e scuvo lin inje ctie po e der fla co n 50m g R e scuvo lin inje ctie po e der fla co n 100m g

1,20 stuk 0,60 stuk

28,36580 56,73160

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 300m g

0,20 stuk

170,19480

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 100m g

0,60 stuk

56,73160

0V03AFBP 0V03AFBP

V 8998 V 8998

R e scuvo lin inje ctie po e der fla co n 300m g R e scuvo lin inje ctie po e der fla co n 100m g

0,20 stuk 0,60 stuk

170,19480 56,73160

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 100m g

0,60 stuk

56,73160

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 100m g

0,60 stuk

56,73160

0V03AFBP 0V03AFBP

V 8998 V 8998

R e scuvo lin inje ctie po e der fla co n 15m g R e scuvo lin inje ctie po e der fla co n 300m g

4,00 stuk 0,20 stuk

8,50974 170,19480

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 500m g

0,12 stuk

283,65800

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 50m g

1,20 stuk

28,36580

0V03AFBP 0V03AFBP

V 8998 V 8998

R e scuvo lin inje ctie po e der fla co n 200m g R e scuvo lin inje ctie po e der fla co n 500m g

0,30 stuk 0,12 stuk

113,46320 283,65800

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 200m g

0,30 stuk

113,46320

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 15m g

4,00 stuk

8,50974

0V03AFBP 0V03AFBP

V 8998 V 8998

R e scuvo lin inje ctie po e der fla co n 200m g R e scuvo lin inje ctie po e der fla co n 50m g

0,30 stuk 1,20 stuk

113,46320 28,36580

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 200m g

0,30 stuk

113,46320

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 50m g

1,20 stuk

28,36580

0V03AFBP 0V03AFBP

V 8998 V 8998

R e scuvo lin inje ctie po e der fla co n 50m g R e scuvo lin inje ctie po e der fla co n 100m g

1,20 stuk 0,60 stuk

28,36580 56,73160

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 15m g

4,00 stuk

8,50974

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 15m g

4,00 stuk

8,50974

0V03AFBP 0V03AFBP

V 8998 V 8998

R e scuvo lin inje ctie po e der fla co n 300m g R e scuvo lin inje ctie po e der fla co n 500m g

0,20 stuk 0,12 stuk

170,19480 283,65800

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 500m g

0,12 stuk

283,65800

0V03AFBP

V 8998

R e scuvo lin inje ctie po e der fla co n 50m g

1,20 stuk

28,36580

1A06AC AO

V 12273

Fibe rfo rm po e de r 3,5g in sa che t

1A06AC AO

V 13960

Me ta m ucil sk vr lem o n po e der 586m g/g

1A06AC AO

V 13961

1A06AC AO 1A06AC AO

V 13962 V 13963

1A06AC AO

V 19707

P syllium ve ze ls pch gra nula at sk vr 3,6g in sa che t

1,94 stuk

0,21218

1A06AC AO

V 21186

P syllium ve ze ls sdz gra nula at o ra ng sk vr 3,25g sach

2,15 stuk

0,19155

1A06AC AO 1A06AC AO

V 25718=21186 V 25744//9259

P syllium ve ze ls pch gra nula at o ra ng sk vr 3,25g sach No rm a co l granulaa t 620m g/g sa che t 10g

2,15 stuk 1,33 stuk

0,19155 0,30943

1A06AC AO

V 27436//9259

No rm a co l granulaa t 620m g/g sa che t 10g

1,33 stuk

0,30943

1A06AC AO

V 30472//13961

Me ta m ucil sk vr lem o n po e der 3,4g in sache t

2,06 stuk

0,20039

1A06AC AO 1A06AC AO

V 30473//13963 V 32556//13961

Me ta m ucil sk vr o range po e der 3,4g in sache t Me ta m ucil sk vr lem o n po e der 3,4g in sache t

2,06 stuk 2,06 stuk

0,20039 0,20039

1A06AC AO

V 32562//13963

Me ta m ucil sk vr o range po e der 3,4g in sache t

2,06 stuk

0,20039

1A06AC AO

V 33781//13961

Me ta m ucil sk vr lem o n po e der 3,4g in sache t

2,06 stuk

0,20039

1A06AC AO 1A06AC AO

V 33782//13963 V 7716

Me ta m ucil sk vr o range po e der 3,4g in sache t Vo lcolo n gra nula a t 6g in sa che t

2,06 stuk 1,77 stuk

0,20039 0,23340

1A06AC AO

V 7716

Vo lcolo n gra nula a t

10,61 gra m

0,03890

1A06AC AO

V 7716

Vo lcolo n gra nula a t

10,61 gra m

0,03890

1A06AC AO 1A06AC AO

V 7716 V 9171

Vo lcolo n gra nula a t 6g in sa che t Vo lcolo n gra nula a t suik ervrij 980m g/g

1,77 stuk 7,14 gra m

0,23340 0,05776

1A06AC AO

V 9171

Vo lcolo n gra nula a t suik ervrij 980m g/g

7,14 gra m

0,05776

1A06AC AO

V 9171

Vo lcolo n gra nula a t suik ervrij 4g in sa chet

1,77 stuk

0,23340

2,86 stuk

0,14440

12,05 gra m

0,03424

Me ta m ucil sk vr lem o n po e der in sa che t

2,06 stuk

0,20039

Me ta m ucil sk vr o range po e der 586m g/g Me ta m ucil sk vr o range po e der in sa che t

12,05 gra m 2,06 stuk

0,03424 0,20039

1A06AC AO 1A06AC AO

V 9171 V 9259

Vo lcolo n gra nula a t suik ervrij 4g in sa chet No rm a co l granulaa t

1A06AC AO

V 9259

No rm a co l granulaa t 620m g/g sa che t 10g

1A06AC AO

V 9259

No rm a co l granulaa t

1A06AC AO 1A06ADAO

V 9259 V 100495//19006

1A06ADAO 1A06ADAO

1,77 stuk 13,33 gra m

0,23340 0,03094

1,33 stuk

0,30943

13,33 gra m

0,03094

No rm a co l granulaa t 620m g/g sa che t 10g Mo vicolo n po e der vo or dra nk in sa che t

1,33 stuk 0,76 stuk

0,30943 0,54285

V 100633//19006

Mo vicolo n po e der vo or dra nk in sa che t

0,76 stuk

0,54285

V 101226//19006

Mo vicolo n po e der vo or dra nk in sa che t

0,76 stuk

0,54285

1A06ADAO 1A06ADAO

V 101421//32357 V 101960//32357

Mo vicolo n junior na turel po ede r v dra nk in sa che t Mo vicolo n junior na turel po ede r v dra nk in sa che t

1,52 stuk 1,52 stuk

0,32571 0,32571

1A06ADAO

V 17247

Tra nsipe g poe de r vo o r dra nk in sache t

2,00 stuk

0,20628

1A06ADAO

V 19006

Mo vicolo n po e der vo or dra nk in sa che t

0,76 stuk

0,54285

1A06ADAO 1A06ADAO

V 27897=23013 V 28166//19006

Forla x po e der vo or dra nk sa chet 10g Mo vicolo n po e der vo or dra nk in sa che t

1,00 stuk 0,76 stuk

0,41257 0,54285

1A06ADAO

V 28913

Forla x junior po e de r voo r dra nk sache t 4g

2,50 stuk

0,21453

1A06ADAO

V 29318

MO VIC O LO N JUNIO R C HO C O LATE P DR V DR ANK IN SAC HET

1,52 stuk

0,32571

1A06ADAO 1A06ADAO

V 31699//19006 V 31960

Mo vicolo n po e der vo or dra nk in sa che t Mo vicolo n na ture l po e de r voo r dra nk in sa che t

0,76 stuk 0,76 stuk

0,54285 0,54285

1A06ADAO

V 32357

Mo vicolo n junior na turel po ede r v dra nk in sa che t

1,52 stuk

0,32571

1A06ADAO

V 33764//28913

Forla x junior po e de r voo r dra nk sache t 4g

2,50 stuk

0,21453

1A06ADAO 1A06ADAO

V 33765//23013 V 33837//23013

Forla x po e der vo or dra nk sa chet 10g Forla x po e der vo or dra nk sa chet 10g

1,00 stuk 1,00 stuk

0,41257 0,41257

1A06ADAO

V 34483//23013

Forla x po e der vo or dra nk sa chet 10g

1,00 stuk

0,41257

1A06ADAO

V 34506//28913

Forla x junior po e de r voo r dra nk sache t 4g

2,50 stuk

0,21453

1A06ADAO

V 34931//19006

Mo vicolo n po e der vo or dra nk in sa che t

0,76 stuk

0,54285

1A06ABAR

V 3844

Dulco la x ze tpil 10m g

1,00 stuk

0,14267

1A06ABAR

V 50687

Bisa co dyl cf zetpil 10m g

1,00 stuk

0,14267

1A06ABAR

V 55062

Bisa co dyl pch ze tpil 10m g

1,00 stuk

0,14267

1A07AAAO S V 6065

Fungizo ne suspe nsie 100m g/m l

4,00 m l

0,10380

1A07AAAO S V 6771

Nysta tine laba z suspe nsie 100.000e /m l

4,00 m l

0,10380

1A07AC AO S V 30452//7490 1A07AC AO S V 7490

Da k tarin o rale gel 20m g/g Da k tarin o rale gel 20m g/g

1C 01DAAO

V 100342//20822

1C 01DAAO 1C 01DAAO

V 101796//13645 V 11396

1C 01DAAO 1C 01DAAO

20,00 gra m 20,00 gra m

0,02076 0,02076

Iso so rbide m ono nitra a t re tard ca psule m ga 100m g

0,60 stuk

0,90756

Iso so rbide m ono nitra a t re tard ca psule m ga 50m g P ro m o ca rd dure tte 60m g

1,20 stuk 1,00 stuk

0,45378 0,54454

V 13418

Iso so rbide m ono nitra a t sa ndoz ta ble t 20m g

3,00 stuk

0,18151

V 13419

Iso so rbide m ono nitra a t sa ndoz ta ble t 40m g

1,50 stuk

0,36302

1C 01DAAO 1C 01DAAO

V 13645 V 14153

Mo no ce do ca rd re tard ca psule m ga 50m g Iso so rbide m ono nitra a t pch table t 10m g

1,20 stuk 6,00 stuk

0,45378 0,10891

1C 01DAAO

V 14154

Iso so rbide m ono nitra a t pch table t 20m g

3,00 stuk

0,18151

1C 01DAAO

V 14155

Iso so rbide m ono nitra a t pch table t 40m g

1,50 stuk

0,36302

1C 01DAAO 1C 01DAAO

V 14396 V 15054

C e docard re ta rd ta blet m ga 40m g Iso so rbide m ono nitra a t rp table t 20m g

1,50 stuk 3,00 stuk

0,36302 0,18151

1C 01DAAO

V 15055

Iso so rbide m ono nitra a t rp table t 40m g

1,50 stuk

0,36302

1C 01DAAO

V 15779

C e docard re ta rd ta blet m ga 10m g

6,00 stuk

0,10891

1C 01DAAO 1C 01DAAO

V 15864 V 15865

Minitran 5 ple iste r m ga 18m g Minitran 10 ple iste r m ga 36m g

1,00 stuk 0,50 stuk

0,54454 1,08907

1C 01DAAO

V 15866

Minitran 15 ple iste r m ga 54m g

0,33 stuk

1,63361

1C 01DAAO

V 15987

Nitro dur 5 ple iste r 40m g

1,00 stuk

0,54454

1C 01DAAO

V 15989

Nitro dur 15 ple iste r 120m g

0,33 stuk

1,63361

1C 01DAAO

V 16196=56834

Iso so rbide dinitra at a cta vis re tard ta bl m ga 20m g

3,00 stuk

0,18151

1C 01DAAO

V 16495

Tra nside rm nitro 15 ple iste r m ga 75m g

0,33 stuk

1,63361

1C 01DAAO 1C 01DAAO

V 16764 V 16765

Iso so rbide m ono nitra a t sa ndoz ta ble t 20m g Iso so rbide m ono nitra a t sa ndoz ta ble t 40m g

3,00 stuk 1,50 stuk

0,18151 0,36302

1C 01DAAO

V 17157

P ro m o ca rd dure tte ta ble t m ga 30m g

2,00 stuk

0,27227

1C 01DAAO

V 17199

Nitro dur 7,5 ple iste r 60m g

0,67 stuk

0,81681

1C 01DAAO 1C 01DAAO

V 17289 V 17464

Mo no ce do ca rd re tard ca psule m ga 25m g De ponit t 5 ple iste r tra nsderm a a l 18,7m g

2,40 stuk 1,00 stuk

0,22689 0,54454

1C 01DAAO

V 17465

De ponit t 10 ple iste r transde rm a al 37,4m g

0,50 stuk

1,08907

1C 01DAAO

V 17466

De ponit t 15 ple iste r transde rm a al 56,2m g

0,33 stuk

1,63361

1C 01DAAO 1C 01DAAO

V 18582=56834 V 19173

Iso so rbide dinitra at pch re ta rd ta blet m ga 20m g P ro m o ca rd dure tte ta ble t m ga 120m g

3,00 stuk 0,50 stuk

0,18151 1,08907

1C 01DAAO

V 19511

Trinipa tch 5 ple iste r 22,4m g

1,00 stuk

0,54454

1C 01DAAO

V 19512

Trinipa tch 10 pleister 44,8m g

0,50 stuk

1,08907

1C 01DAAO 1C 01DAAO

V 19513 V 20660

Trinipa tch 15 pleister 67,2m g ISO SO R BIDEDINITR AAT AP O TEX R ETAR D TABLET MGA 20MG

0,33 stuk 3,00 stuk

1,63361 0,18151

1C 01DAAO

V 20822

Mo no ce do ca rd re tard ca psule m ga 100m g

0,60 stuk

0,90756

1C 01DAAO

V 20915

Iso so rbide m ono nitra a t a cta vis ta blet 10m g

6,00 stuk

0,10891

1C 01DAAO 1C 01DAAO

V 20916 V 20917

Iso so rbide m ono nitra a t a cta vis ta blet 20m g Iso so rbide m ono nitra a t a cta vis ta blet 40m g

3,00 stuk 1,50 stuk

0,18151 0,36302

1C 01DAAO

V 20964//9673

Tra nside rm tts 10 ple iste r m ga 50m g

0,50 stuk

1,08907

1C 01DAAO

V 21002

Iso so rbide m ono nitra a t diffuta b a ta blet m ga 60m g

1,00 stuk

0,54454

1C 01DAAO 1C 01DAAO

V 21862//17465 V 23196//15988

De ponit t 10 ple iste r transde rm a al 37,4m g Nitro dur 10 ple iste r 80m g

0,50 stuk 0,50 stuk

1,08907 1,08907

1C 01DAAO

V 23515

Iso so rbide m ono nitra a t a cta v re ta rd ta blet m ga 60m g

1,00 stuk

0,54454

1C 01DAAO

V 24085=15054

ISO SO R BIDEMO NO NITR AAT MYLAN TABLET 20MG

1C 01DAAO 1C 01DAAO

V 24086=15055 V 26933=23515

1C 01DAAO 1C 01DAAO

3 STUK

0,18151

ISO SO R BIDEMO NO NITR AAT MYLAN TABLET 40MG Iso so rbide m ono nitra a t cf re ta rd ta blet m ga 60m g

1,5 STUK 1,00 stuk

0,36302 0,54454

V 27105

Iso so rbide m ono nitra a t m yla n re ta rd table t m ga 60m g

1,00 stuk

0,54454

V 27903=56834

Iso so rbide dinitra at a re ta rd ta blet m ga 20m g

3,00 stuk

0,18151

1C 01DAAO 1C 01DAAO

V 28051=20660 V 28384=14155

ISO SO R BIDEDINITR AAT MYLAN R ETAR D TABLET MGA 20MG Iso so rbide m ono nitra a t cf ta ble t 40m g

3,00 stuk 1,50 stuk

0,18151 0,36302

1C 01DAAO

V 28974=20660

Iso so rbide dinitra at sa ndo z re ta rd table t m ga 20m g

3,00 stuk

0,18151

1C 01DAAO

V 29602//17464

De ponit 5 ple iste r tra nsderm a a l 18,7m g

1,00 stuk

0,54454

1C 01DAAO 1C 01DAAO

V 29829 V 29929

Iso so rbide m ono nitra a t sa ndoz re tard ta bl m ga 60m g Iso so rbide m ono nitra a t rp reta rd ta ble t m ga 60m g

1,00 stuk 1,00 stuk

0,54454 0,54454

1C 01DAAO

V 30215//17464

De ponit t 5 ple iste r tra nsderm a a l 18,7m g

1,00 stuk

0,54454

1C 01DAAO

V 30285//13645

Iso so rbide m ono nitra a t re tard ca psule m ga 50m g

1,20 stuk

0,45378

1C 01DAAO 1C 01DAAO

V 30483 V 30668//17465

ISO SO R BIDEMO NO NITR AAT AP O TEX R ETAR D TABL MGA 60MG De ponit t 10 ple iste r transde rm a al 37,4m g

1,00 stuk 0,50 stuk

0,54454 1,08907

1C 01DAAO

V 30797//13645

Iso so rbide m ono nitra a t re tard ca psule m ga 50m g

1,20 stuk

0,45378

1C 01DAAO

V 31062//13645

Iso so rbide m ono nitra a t re tard ca psule m ga 50m g

1,20 stuk

0,45378

1C 01DAAO 1C 01DAAO

V 31573//17465 V 31575//17466

De ponit t 10 ple iste r transde rm a al 37,4m g De ponit t 15 ple iste r transde rm a al 56,2m g

0,50 stuk 0,33 stuk

1,08907 1,63361

1C 01DAAO

V 31841//13645

Iso so rbide m ono nitra a t re tard ca psule m ga 50m g

1,20 stuk

0,45378

1C 01DAAO

V 32465//13645

Iso so rbide m ono nitra a t re tard ca psule m ga 50m g

1,20 stuk

0,45378

1C 01DAAO 1C 01DAAO

V 32718//13645 V 34504//17466

Iso so rbide m ono nitra a t re tard ca psule m ga 50m g De ponit t 15 ple iste r transde rm a al 56,2m g

1,20 stuk 0,33 stuk

0,45378 1,63361

1C 01DAAO

V 56053

Iso so rbide m ono nitra a t cf ta ble t 20m g

3,00 stuk

0,18151

1C 01DAAO

V 56834

Iso so rbide dinitra at cf reta rd ta ble t m ga 20m g

3,00 stuk

0,18151

1C 01DAAO

V 56948

ISO SO R BIDEMO NO NITR AAT AC C O R D TABLET 20MG

3,00 stuk

0,18151

1C 01DAAO

V 56949

ISO SO R BIDEMO NO NITR AAT AC C O R D TABLET 40MG

1,50 stuk

0,36302

1C 01DAAO

V 57237

Iso so rbidi m ono nitra s table t 20m g

3,00 stuk

0,18151

1C 01DAAO

V 57238

Iso so rbidi m ono nitra s table t 40m g

1,50 stuk

0,36302

1C 01DAAO 1C 01DAAO

V 5784 V 8809

C e docard re ta rd ta blet m ga 20m g Iso rdil titrado se ta ble t 30m g

3,00 stuk 2,00 stuk

0,18151 0,27227

1C 01DAAO

V 9672

Tra nside rm nitro 5 ple iste r 25m g

1,00 stuk

0,54454

1C 01DAAO

V 9673

Tra nside rm nitro 10 ple iste r 50m g

0,50 stuk

1,08907

1C 01DXAO 1C 01DXAO

V 15221 V 15222

Ik o re l ta blet 10m g Ik o re l ta blet 20m g

4,00 stuk 2,00 stuk

0,16336 0,27227

1C 03AAAO

V 19040=9640

Hydro chlo orthia zide a cta vis ta ble t 25m g

1,00 stuk

0,10346

1C 03AAAO 1C 03AAAO

V 19041=9641 V 21777=9640

Hydro chlo orthia zide a cta vis ta ble t 50m g HYDR O C HLO O R THIAZIDE AP O TEX TABLET 25MG

0,50 stuk 1,00 stuk

0,20692 0,10346

1C 03AAAO

V 21778=9641

HYDR O C HLO O R THIAZIDE AP O TEX TABLET 50MG

0,50 STUK

0,20692

1C 03AAAO

V 24071=52650

Hydro chlo orthia zide sa ndo z ta blet 25m g

1,00 stuk

0,10346

1C 03AAAO 1C 03AAAO

V 26806=50726 V 26807=50727

Hydro chlo orthia zide m yla n ta ble t 25m g Hydro chlo orthia zide m yla n ta ble t 50m g

1,00 stuk 0,50 stuk

0,10346 0,20692

1C 03AAAO

V 27965=50726

Hydro chlo orthia zide a ta ble t 25m g

1,00 stuk

0,10346

1C 03AAAO

V 27966=50727

Hydro chlo orthia zide a ta ble t 50m g

0,50 stuk

0,20692

1C 03AAAO 1C 03AAAO

V 29569 V 50726

Hydro chlo orthia zide pch ta ble t 12,5m g Hydro chlo orthia zide cf table t 25m g

2,00 stuk 1,00 stuk

0,06208 0,10346

1C 03AAAO

V 50727

Hydro chlo orthia zide cf table t 50m g

0,50 stuk

0,20692

1C 03AAAO

V 51856

Hydro chlo orthia zidum ta ble t 25m g

1,00 stuk

0,10346

1C 03AAAO 1C 03AAAO

V 51857 V 52638

Hydro chlo rothia zidum ta ble t 50m g C HLO O R THIAZIDE MAE TABLET 500MG

0,50 stuk 1,00 stuk

0,20692 0,10346

1C 03AAAO

V 52650

Hydro chlo orthia zide rp ta ble t 25m g

1,00 stuk

0,10346

1C 03AAAO

V 52651

Hydro chlo orthia zide rp ta ble t 50m g

0,50 stuk

0,20692

1C 03AAAO 1C 03AAAO

V 9640 V 9641

Hydro chlo orthia zide pch ta ble t 25m g Hydro chlo orthia zide pch ta ble t 50m g

1,00 stuk 0,50 stuk

0,10346 0,20692

1C 03BAAO

V 15348

Inda pa m ide rp ta ble t 2,5m g

1,00 stuk

0,10346

1C 03BAAO

V 15740=57417

Inda pa m ide pch drage e 2,5m g

1,00 stuk

0,10346

1C 03BAAO 1C 03BAAO

V 15753=57417 V 16520

Inda pa m ide a cta vis dra ge e 2,5m g C HLO O R TALIDO N AP O TEX TABLET 50MG

1,00 stuk 0,50 stuk

0,10346 0,20692

1C 03BAAO

V 17010=15348

INDAP AMIDE AP O TEX TABLET 2,5MG

1,00 stuk

0,10346

1C 03BAAO

V 20358

C hloo rta lido n rp ta blet 25m g

1,00 stuk

0,10346

1C 03BAAO 1C 03BAAO

V 20359 V 20846=20358

C hloo rta lido n rp ta blet 50m g C hloo rta lido n a ta blet 25m g

0,50 stuk 1,00 stuk

0,20692 0,10346

1C 03BAAO

V 20847=20359

C hloo rta lido n a ta blet 50m g

0,50 stuk

0,20692

1C 03BAAO

V 21025

Inda pa m ide sando z ta ble t 2,5m g

1,00 stuk

0,10346

1C 03BAAO 1C 03BAAO

V 24281=20358 V 25749

C hloo rta lido n sa ndo z table t 25m g Inda pa m ide k a twijk table t 2,5m g

1,00 stuk 1,00 stuk

0,10346 0,10346

1C 03BAAO

V 26088=15348

Inda pa m ide m yla n table t 2,5m g

1,00 stuk

0,10346

1C 03BAAO

V 26525=53388

C hloo rta lido n m ylan ta ble t 25m g

1,00 stuk

0,10346

1C 03BAAO 1C 03BAAO

V 26526=16520 V 28635

C hloo rta lido n m ylan ta ble t 50m g C hloo rta lido n pch ta blet 12,5m g

0,50 stuk 2,00 stuk

0,20692 0,06208

1C 03BAAO

V 28730=20359

C hloo rta lido n sa ndo z table t 50m g

0,50 stuk

0,20692

1C 03BAAO

V 53388

C HLO O R TALIDO N AP O TEX TABLET 25MG

1,00 STUK

0,10346

1C 03BAAO 1C 03BAAO

V 56098 V 56285

C hlorta lido num ta blet 50m g C hloo rta lido n pch ta blet 25m g

0,50 stuk 1,00 stuk

0,20692 0,10346

1C 03BAAO

V 56286

C hloo rta lido n flx ta ble t 50m g C hloo rta lido n pch ta blet 50m g

0,50 stuk

0,20692

1C 03BAAO

V 56726

C HLO O R TALIDO N AC C O R D TABLET 50MG

0,50 stuk

0,20692

1C 03BAAO

V 56898

C hlorta lido num ta blet 25m g

1,00 stuk

0,10346

1C 03BAAO

V 56899

C HLO O R TALIDO N AC C O R D TABLET 25MG

1,00 stuk

0,10346

1C 03BAAO

V 57417

Inda pa m ide cf dra gee 2,5m g

1,00 stuk

0,10346

1C 03BAAO

V 6787

Flude x ta blet 2,5m g

1,00 stuk

0,10346

1C 04ADAO

V 11175

Tre nta l ta ble t m ga 400m g

2,50 stuk

0,19835

1C 04AXAO

V 13909

Loftyl table t 150m g

4,00 stuk

0,12397

1C 04AXAO

V 18753

Ta vo nin ta ble t o m huld 40m g

3,00 stuk

0,16529

1C 07AAAO

V 10216

P ro pra no lo l hcl pch ta blet 10m g

16,00 stuk

0,09076

1C 07AAAO

V 10217

P ro pra no lo l hcl pch ta blet 40m g

4,00 stuk

0,15126

1C 07AAAO

V 10218

P ro pra no lo li hydrochlo ridum pch table t 80m g

2,00 stuk

0,30252

1C 07AAAO 1C 07AAAO

V 11308 V 11309

P ro pra no lo l hcl rp ta blet 10m g P ro pra no lo l hcl rp ta blet 40m g

16,00 stuk 4,00 stuk

0,09076 0,15126

1C 07AAAO

V 11310

P ro pra no lo l hcl rp ta blet 80m g

2,00 stuk

0,30252

1C 07AAAO

V 11330

P ro pra no lo l laga p table t 10m g

16,00 stuk

0,09076

1C 07AAAO 1C 07AAAO

V 11331 V 11332

P ro pra no lo l laga p table t 40m g P ro pra no lo l laga p table t 80m g

4,00 stuk 2,00 stuk

0,15126 0,30252

1C 07AAAO

V 12421

Arte x ta blet 5m g

1,00 stuk

0,60504

1C 07AAAO

V 12636

P ro pra no lo l hcl sa ndo z table t 10m g

16,00 stuk

0,09076

1C 07AAAO 1C 07AAAO

V 12637 V 12638

P ro pra no lo l hcl sa ndo z table t 40m g P ro pra no lo l hcl sa ndo z table t 80m g

4,00 stuk 2,00 stuk

0,15126 0,30252

1C 07AAAO

V 12821

P ro pra no lo l hcl pch re ta rd ca psule m ga 160m g

1,00 stuk

0,60504

1C 07AAAO

V 13598

P ro pra no lo l hcl actavis ta ble t 10m g

16,00 stuk

0,09076

1C 07AAAO 1C 07AAAO

V 13599 V 13600

P ro pra no lo l hcl actavis ta ble t 40m g P ro pra no lo l hcl actavis ta ble t 80m g

4,00 stuk 2,00 stuk

0,15126 0,30252

1C 07AAAO

V 14353

P ro pra no lo l hcl pch re ta rd ca psule m ga 80m g

2,00 stuk

0,30252

1C 07AAAO

V 15488=14353

P ro pra no lo l hcl actavis re ta rd capsule m ga 80m g

2,00 stuk

0,30252

1C 07AAAO 1C 07AAAO

V 15489=12821 V 16045=14353

P ro pra no lo l hcl actavis re ta rd capsule m ga 160m g P ro pra no lo l hcl sa ndo z reta rd ca psule m ga 80m g

1,00 stuk 2,00 stuk

0,60504 0,30252

1C 07AAAO

V 16071=12821

P ro pra no lo l hcl sa ndo z reta rd ca psule m ga 160m g

1,00 stuk

0,60504

1C 07AAAO

V 17890=14353

P R O P R ANO LO L HC L AP O TEX R ETAR D C AP SULE MGA 80MG

2,00 stuk

0,30252

1C 07AAAO 1C 07AAAO

V 17891=12821 V 19475=11330

P R O P R ANO LO L HC L AP O TEX R ETAR D C AP SULE MGA 160MG P R O P R ANO LO L HC L AP O TEX TABLET 10MG

1 STUK 16,00 stuk

0,60504 0,09076

1C 07AAAO

V 19476=11331

P R O P R ANO LO L HC L AP O TEX TABLET 40MG

4,00 stuk

0,15126

1C 07AAAO

V 19477=11332

P R O P R ANO LO L HC L AP O TEX TABLET 80MG

1C 07AAAO 1C 07AAAO

V 20331=57202 V 27302=11308

P ro pra no lo l hcl a re ta rd ca psule m ga 160m g P R O P R ANO LO L HC L MYLAN TABLET 10MG

1C 07AAAO

V 27303=11309

1C 07AAAO

V 27304=11310

1C 07AAAO 1C 07AAAO

V 55387 V 55388

1C 07AAAO 1C 07AAAO

2 STUK

0,30252

1,00 stuk 16,00 stuk

0,60504 0,09076

P R O P R ANO LO L HC L MYLAN TABLET 40MG

4,00 stuk

0,15126

P ro pra no lo l hcl a ta blet 80m g

2,00 stuk

0,30252

P R O P R ANO LO L HC L AC C O R D TABLET 10MG P R O P R ANO LO L HC L AC C O R D TABLET 40MG

16,00 stuk 4,00 stuk

0,09076 0,15126

V 55617

P ro pra no lo l hcl cf ta ble t 10m g

16,00 stuk

0,09076

V 55618

P ro pra no lo l hcl cf ta ble t 40m g

4,00 stuk

0,15126

1C 07AAAO 1C 07AAAO

V 55619 V 55880

P ro pra no lo l hcl cf ta ble t 80m g P R O P R ANO LO L HC L AC C O R D TABLET 80MG

2,00 stuk 2,00 stuk

0,30252 0,30252

1C 07AAAO

V 55975

P indo lol cf ta blet 5m g

3,00 stuk

0,20168

1C 07AAAO

V 55976

P indo lol cf ta blet 10m g

1,50 stuk

0,40336

1C 07AAAO 1C 07AAAO

V 55977 V 56520

P indo lol cf ta blet 15m g P indo lol pch ta ble t 5m g

1,00 stuk 3,00 stuk

0,60504 0,20168

1C 07AAAO

V 56521

P indo lol pch ta ble t 10m g

1,50 stuk

0,40336

1C 07AAAO

V 56522

P indo lol pch ta ble t 15m g

1,00 stuk

0,60504

1C 07AAAO

V 57202

P ro pra no lo l hcl rp re ta rd ca psule m ga 160m g

1,00 stuk

0,60504

1C 07AAAO

V 57679=14353

P ro pra no lo l hcl rp re ta rd ca psule m ga 80m g

2,00 stuk

1C 07AAAO

V 6158

Visk e en ta ble t 5m g

3,00 stuk

0,30252 0,20168

1C 07AAAO 1C 07AAAO

V 7471 V 8337

Visk e en ta ble t 15m g Visk e en ta ble t 10m g

1,00 stuk 1,50 stuk

0,60504 0,40336

1C 07AAAO

V 9325

Visk e en re ta rd ta blet m ga 20m g

0,75 stuk

0,80672

1C 07AGAO

V 14491

Eucardic ta ble t 25m g

1,50 stuk

0,40336

1C 07AGAO 1C 07AGAO

V 19808 V 28745

Eucardic ta ble t 6,25m g C a rve dilo l sa ndoz ta ble t 3,125m g

6,00 stuk 12,00 stuk

0,10084 0,12101

1C 07AGAO

V 28746

C a rve dilo l sa ndoz ta ble t 6,25m g

6,00 stuk

0,10084

1C 07AGAO

V 28747

C a rve dilo l sa ndoz ta ble t 12,5m g

3,00 stuk

0,20168

1C 07AGAO 1C 07AGAO

V 28748 V 28749

C a rve dilo l sa ndoz ta ble t 25m g C a rve dilo l sa ndoz ta ble t 50m g

1,50 stuk 0,75 stuk

0,40336 0,80672

1C 07AGAO

V 29077

C a rve dilo l pch table t 3,125m g

12,00 stuk

0,12101

1C 07AGAO

V 29078

C a rve dilo l pch table t 6,25m g

6,00 stuk

0,10084

1C 07AGAO 1C 07AGAO

V 29079 V 29080

C a rve dilo l pch table t 12,5m g C a rve dilo l pch table t 25m g

3,00 stuk 1,50 stuk

0,20168 0,40336

1C 07AGAO

V 30015

C a rve dilo l a cta vis ta blet 6,25m g

6,00 stuk

0,10084

1C 07AGAO

V 30016

C a rve dilo l a cta vis ta blet 25m g

1,50 stuk

0,40336

1C 07AGAO 1C 07AGAO

V 30018 V 30019

C AR VEDILO L MYLAN TABLET 6,25MG C AR VEDILO L MYLAN TABLET 25MG

6,00 stuk 1,5 STUK

0,10084 0,40336

1C 07AGAO

V 30121

C a rve dilo l cf ta ble t 6,25m g

6,00 stuk

0,10084

1C 07AGAO

V 30122

C a rve dilo l cf ta ble t 25m g

1,50 stuk

0,40336

1C 07AGAO 1C 07AGAO

V 31947 V 31948

C AR VEDILO L AP O TEX TABLET 6,25MG C AR VEDILO L AP O TEX TABLET 25MG

6,00 STUK 1,50 stuk

0,10084 0,40336

1C 08DBAO

V 100833

DILTIAZEM HC L MYLAN R ETAR D C AP SULE MGA 200MG

1,20 stuk

0,51764

1C 08DBAO 1C 08DBAO

V 10192 V 13875

Tildie m ta blet 60m g Tildie m cr table t m ga 90m g

4,00 stuk 2,67 stuk

0,15529 0,23294

1C 08DBAO

V 13876

Tildie m cr table t m ga 120m g

2,00 stuk

0,31059

1C 08DBAO

V 14145

DILTIAZEM HC L AP O TEX TABLET 60MG

4,00 stuk

0,15529

1C 08DBAO 1C 08DBAO

V 16538 V 16539

Tildie m x r ca psule m ga 200m g Tildie m x r ca psule m ga 300m g

1,20 stuk 0,80 stuk

0,51764 0,77647

1C 08DBAO

V 17462

DILTIAZEM HC L AP O TEX TABLET MGA 90MG

2,67 stuk

0,23294

1C 08DBAO

V 17463

DILTIAZEM HC L AP O TEX TABLET MGA 120MG

2,00 stuk

0,31059

1C 08DBAO 1C 08DBAO

V 18110 V 18593

Diltia zem hcl a cta vis ta blet 60m g Diltia zem i hydro chlo ridum cr ta blet m ga 90m g

4,00 stuk 2,67 stuk

0,15529 0,23294

1C 08DBAO

V 18594

Diltia zem i hydro chlo ridum cr ta blet m ga 120m g

2,00 stuk

0,31059

1C 08DBAO

V 18695

Diltia zem hcl sa ndoz ta ble t 60m g

4,00 stuk

0,15529

1C 08DBAO 1C 08DBAO

V 19031 V 21145

Diltia zem hcl rp table t 60m g Diltia zem hcl a reta rd ca psule m ga 120m g

4,00 stuk 2,00 stuk

0,15529 0,31059

1C 08DBAO

V 21146

Diltia zem hcl a reta rd ca psule m ga 180m g

1,33 stuk

0,46588

1C 08DBAO

V 21147

Diltia zem hcl a reta rd ca psule m ga 240m g

1,00 stuk

0,62117

1C 08DBAO 1C 08DBAO

V 21148 V 21305=18593

Diltia zem hcl a reta rd ca psule m ga 300m g Diltia zem hcl rp table t m ga 90m g

0,80 stuk 2,67 stuk

0,77647 0,23294

1C 08DBAO

V 21306=18594

Diltia zem hcl rp table t m ga 120m g

2,00 stuk

0,31059

1C 08DBAO

V 21374=17462

Diltia zem hcl a cta vis re ta rd table t m ga 90m g

2,67 stuk

0,23294

1C 08DBAO 1C 08DBAO

V 21375=17463 V 21417=18593

Diltia zem hcl a cta vis re ta rd table t m ga 120m g DILTIAZEM HC L MYLAN R ETAR D TABLET MGA 90MG

2,00 stuk 2,67 stuk

0,31059 0,23294

1C 08DBAO

V 21418=18594

DILTIAZEM HC L MYLAN R ETAR D TABLET MGA 120MG

2,00 stuk

0,31059

1C 08DBAO

V 21479=18593

Diltia zem hcl cf re ta rd ta blet m ga 90m g

2,67 stuk

0,23294

1C 08DBAO 1C 08DBAO

V 21480=18594 V 21502=18593

Diltia zem hcl cf re ta rd ta blet m ga 120m g Diltia zem hcl sa ndoz cr ta ble t m ga 90m g

2,00 stuk 2,67 stuk

0,31059 0,23294

1C 08DBAO

V 21503=18594

Diltia zem hcl sa ndoz cr ta ble t m ga 120m g

2,00 stuk

0,31059

1C 08DBAO

V 22517//16538

Tildie m x r ca psule m ga 200m g

1,20 stuk

0,51764

1C 08DBAO 1C 08DBAO

V 22526 V 22527

Tiadil ca psule m ga 120m g DILTIAZEM HC L MYLAN R ETAR D C AP SULE MGA 180MG

2,00 stuk 1,33 stuk

0,31059 0,46588

1C 08DBAO

V 22528

DILTIAZEM HC L MYLAN R ETAR D C AP SULE MGA 240MG

1,00 stuk

0,62117

1C 08DBAO

V 22529

DILTIAZEM HC L MYLAN R ETAR D C AP SULE MGA 300MG

0,80 stuk

0,77647

1C 08DBAO 1C 08DBAO

V 22530 V 25593=18593

Tiadil ca psule m ga 360m g Diltia zem hcl pch reta rd ta ble t m ga 90m g

0,67 stuk 2,67 stuk

0,93176 0,23294

1C 08DBAO

V 25594=18594

Diltia zem hcl pch reta rd ta ble t m ga 120m g

2,00 stuk

0,31059

1C 08DBAO

V 27985=17462

DILTIAZEM HC L MYLAN R ETAR D TABLET MGA 90MG

2,67 STUK

0,23294

1C 08DBAO 1C 08DBAO

V 27986=17463 V 33122//16538

DILTIAZEM HC L MYLAN R ETAR D TABLET MGA 120MG Tildie m x r ca psule m ga 200m g

2 STUK 1,20 stuk

0,31059 0,51764

1C 08DBAO

V 57052

Diltia zem hcl cf ta ble t 60m g

4,00 stuk

0,15529

1C 08DBAO

V 57367

Diltia zem hcl pch table t 60m g

4,00 stuk

0,15529

1D01AC ADC V 10364

Myco spo r cre m e 10m g/g

1,00 gra m

0,22749

1D01AC ADC V 10470

Nizo ra l crem e 20m g/g

1,00 gra m

0,22749

1D01AC ADC V 22750=10470

Ke tocona zo l jc cre m e 20m g/g

1,00 gra m

0,22749

1D01AC ADC V 23788=10470 1D01AC ADC V 24760//10470

Ke tocona zo l pch cre m e 20m g/g Nizo ra l crem e 20m g/g

1,00 gra m 1,00 gra m

0,22749 0,22749

1D01AC ADC V 26528//10470

Nizo ra l crem e 20m g/g

1,00 gra m

0,22749

1D01AEADC V 15466

Lopro x hydrofie le crem e 10m g/g

1,00 gra m

0,22749

1D01AEADC V 24945

Lam isil derm ge l 10m g/g

1,00 gra m

0,22749

1D07ABADC V 15680//5911

Locoid hydro fie le cre m e 0,1%

1,00 gra m

0,15580

1D07ABADC V 19042=51893

TR IAMC INO LO NAC ETO NIDE AP O TEX C R EME 1MG/G

1,00 gra m

0,15580

1D07ABADC V 20730 1D07ABADC V 23502//9344

Triam cino lo na ce tonide fa gro n fna cre m e 1m g/g Locoid ve tcre m e 1m g/g

1,00 gra m 1,00 gra m

0,15580 0,15580

1D07ABADC V 25498//7519

Em o vate cre m e 0,5m g/g

1,00 gra m

0,15580

1D07ABADC V 25981//5911

Locoid cre m e 1m g/g

1,00 gra m

0,15580

1D07ABADC V 25982//9344 1D07ABADC V 29072=51893

Locoid ve tcre m e 1m g/g TR IAMC INO LO NAC ETO NIDE MYLAN FNA C R EME 1MG/G

1,00 gra m 1 GR AM

0,15580 0,15580

1D07ABADC V 30643//7519

Em o vate cre m e 0,5m g/g

1,00 gra m

0,15580

1D07ABADC V 32692//7519

C lo be ta so n-17-butyra at crem e 0,5m g/g

1,00 gra m

0,15580

1D07ABADC V 33659 1D07ABADC V 4475

Triam cino lo na ce tonide a cre m e 1m g/g Locacorte n cre m e 0,2m g/g

1,00 gra m 1,00 gra m

0,15580 0,15580

1D07ABADC V 50801

Triam cino lo na ce tonide cf cre m e 1m g/g

1,00 gra m

0,15580

1D07ABADC V 51531

Triam cino lo na ce tonide pch cre m e 1m g/g

1,00 gra m

0,15580

1D07ABADC V 51893 1D07ABADC V 53333

C re m or tria m cino lo n a ce to nide 1m g/g Triam cino lo na ce tonide rp fna cre m e 1m g/g

1,00 gra m 1,00 gra m

0,15580 0,15580

1D07ABADC V 56785

Triam cino lo na ce tonide flx cre m e 1m g/g

1,00 gra m

0,15580

1D07ABADC V 5911

Locoid cre m e 1m g/g

1,00 gra m

0,15580

1D07ABADC V 7519 1D07ABADC V 9344

Em o vate cre m e 0,5m g/g Locoid ve tcre m e 1m g/g

1,00 gra m 1,00 gra m

0,15580 0,15580

1G01AFBV

V 102310//10634

Gyno da k ta rin-1 va gina a lcapsule 1200m g

1,00 stuk

5,89654

1G01AFBV 1G01AFBV

V 10633 V 10634

Gyno da k ta rin-3 va gina a lcapsule 400m g Gyno da k ta rin-1 va gina a lcapsule 1200m g

3,00 stuk 1,00 stuk

1,96551 5,89654

1G01AFBV

V 10972

C a neste n gyno 1 va gina a lcre m e 100m g/g

5,00 gra m

1,17931

1G01AFBV

V 15813

Gyno m yk o vule 100m g

3,00 stuk

1,96551

1G01AFBV 1G01AFBV

V 15814 V 20639=6221

Gyno m yk vaginaa lcre m e 20m g/g +3 a pplica to rs Mico na zo lnitra a t jc va gina a lcrem e 20m g/g+16 a pplic

15,00 gra m 70,00 gra m

0,70759 0,08424

1G01AFBV

V 29445//8934

C a neste n gyno 3 va gina a ltable t 200m g + a pplica to r

1G01AFBV 1G01AFBV

V 30144//8934 V 32557//8935

C a neste n va gina alta ble t 200m g + a pplica tor C lo trim a zo l va gina a lcre m e 20m g/g 3a ppl

1G01AFBV

V 33486//10634

Gyno da k ta rin-1 va gina a lcapsule 1200m g

1G01AFBV

V 6221

Gyno da k ta rin va gina a lcrem e 20m g/g +16 a pplica to rs

1G01AFBV 1G01AFBV

V 6517 V 8934

1G01AFBV

3,00 stuk

1,96551

3,00 stuk 15,00 gra m

1,96551 0,39310

1,00 stuk

5,89654

70,00 gra m

0,08424

C a neste n gyno vaginaa lta ble t 100m g C a neste n gyno 3 va gina a ltable t 200m g + a pplica to r

6,00 stuk 3,00 stuk

0,98276 1,96551

V 8935

C a neste n gyno 3 va gina a lcre m e 20m g/g + 3 a pplic

15,00 gra m

0,39310

1G03C AAV 1G03C AAV

V 16492 V 27610//8977

Va gife m va gina a lta blet 25m cg Estrio l va gina alcre m e 1m g/g + a pplica tor

1,00 stuk 0,20 gra m

0,18446 0,92231

1G03C AAV

V 28167//8977

Syna pause e 3 va gina a lcre m e 1m g/g + a pplica to r

0,20 gra m

0,92231

1G03C AAV

V 28533//8977

Syna pause e 3 va gina a lcre m e 1m g/g + a pplica to r

0,20 gra m

0,92231

1G03C AAV 1G03C AAV

V 29100//8978 V 29715//8978

Estrio l o vule 0,5m g Estrio l o vule 0,5m g

0,40 stuk 0,40 stuk

0,46116 0,46116

1G03C AAV

V 29778//8977

Estrio l va gina alcre m e 1m g/g + a pplica tor

0,20 gra m

0,92231

1G03C AAV

V 30193//8978

Syna pause e 3 o vule 0,5m g

0,40 stuk

0,46116

1G03C AAV 1G03C AAV

V 30514//8978 V 31402//8978

Syna pause e 3 o vule 0,5m g Estrio l o vule 0,5m g

0,40 stuk 0,40 stuk

0,46116 0,46116

1G03C AAV

V 32014//8977

Syna pause e 3 va gina a lcre m e 1m g/g + a pplica to r

0,20 gra m

0,92231

1G03C AAV

V 35076//16492

Va gife m va gina a lta blet 25m cg

1,00 stuk

0,18446

1G03C AAV 1G03C AAV

V 8977 V 8978

Syna pause e 3 va gina a lcre m e 1m g/g + a pplica to r Syna pause e 3 o vule 0,5m g

0,20 gra m 0,40 stuk

0,92231 0,46116

1G03DABO

V 11473

Utro gesta n capsule 100m g

3,00 stuk

0,09573

1G03DBBO

V 5619

DUP HASTO N TABLET O MHULD 10MG

1,00 stuk

0,28718

1H02ABDP

V 1591

Ke na co rt a 10 injectie suspensie 10m g/m l

0,75 m l

1,54286

1H02BXDP

V 7066

De po m e drol + lido ca ine inj 40/10m g/m l

0,50 m l

2,31429

1H03BAAO

V 52115

P ro pylthio uracil pch ta ble t 50m g

2,00 stuk

0,02823

1H03BAAO

V 52546

P ro pylthio uracil rp ta ble t 50m g

2,00 stuk

0,02823

1H03BBAO

V 11908

Strum a zol ta ble t 30m g

0,33 stuk

0,16935

1H03BBAO 1H03BBAO

V 2224 V 50906

Strum a zol ta ble t 10m g C a rbim a zo l pch table t 5m g

1,00 stuk 3,00 stuk

0,05645 0,01882

1M01BAAO

K 14436

Ascal sache t 100m g

36,00 stuk

0,03517

1M01ABAO

V 101952//13245

C a ta fla m 50 ta blet o m huld 50m g

2,00 stuk

0,27832

1M01ABAO

V 10809

INDO METAC INE TEVA C APSULE MGA 75MG

1,33 stuk

0,41748

1M01ABAO

V 10939

Indo m e ta cine rp ca psule 25m g

4,00 stuk

0,16699

1M01ABAO 1M01ABAO

V 10940 V 11985

INDO METAC INE TEVA C APSULE 50MG Diclo fena c na trium pch table t m sr 25m g

2,00 stuk 4,00 stuk

0,27832 0,16699

1M01ABAO

V 11986

Diclo fena c na trium pch table t m sr 50m g

2,00 stuk

0,27832

1M01ABAO

V 13244

C a ta fla m 25 dra gee 25m g

4,00 stuk

0,16699

1M01ABAO 1M01ABAO

V 13245 V 15028

C a ta fla m 50 ta blet o m huld 50m g Sulindac rp ta blet 100m g

2,00 stuk 4,00 stuk

0,27832 0,16699

1M01ABAO

V 15029

Sulindac rp ta blet 200m g

2,00 stuk

0,27832

1M01ABAO

V 15235

Vo lta re n reta rd ta ble t m va 75m g

1,33 stuk

0,41748

1M01ABAO 1M01ABAO

V 16273 V 16274

Diclo fena c na trium a cta vis ta blet m sr 25m g Diclo fena c na trium a cta vis ta blet m sr 50m g

4,00 stuk 2,00 stuk

0,16699 0,27832

1M01ABAO

V 16275

Diclo fena c na trium a cta vis re t ta ble t m ga 100m g

1,00 stuk

0,55664

1M01ABAO

V 17257

Diclo fena c na trium cf ta ble t m sr 25m g

4,00 stuk

0,16699

1M01ABAO 1M01ABAO

V 17258 V 17417

Diclo fena c na trium cf ta ble t m sr 50m g DIC LO FENAC UM NATR IC UM R ETAR D TABLET MGA 100MG

2,00 stuk 1 STUK

0,27832 0,55664

1M01ABAO

V 17504

Diclo fena c na trium cf re ta rd ta blet m ga 100m g

1,00 stuk

0,55664

1M01ABAO

V 18338

Diclo fena cum na tricum table t m sr 25m g

4,00 stuk

0,16699

1M01ABAO 1M01ABAO

V 18339 V 18340

Diclo fena cum na tricum table t m sr 50m g Diclo fena cum na tricum reta rd ta ble t m ga 100m g

2,00 stuk 1,00 stuk

0,27832 0,55664

1M01ABAO

V 19207

Biofe na c ta ble t o m huld 100m g

2,00 stuk

0,27832

1M01ABAO

V 20306=10939

INDO METAC INE MYLAN C AP SULE 25MG

4,00 stuk

0,16699

1M01ABAO 1M01ABAO

V 20307=10940 V 20308=10809

INDO METAC INE MYLAN C AP SULE 50MG INDO METAC INE MYLAN R ETAR D C AP SULE MGA 75MG

2,00 stuk 1,33 stuk

0,27832 0,41748

1M01ABAO

V 20800

Diclo fena cum na tricum reta rd ta ble t m ga 75m g

1,33 stuk

0,41748

1M01ABAO

V 20801

Diclo fena cum na tricum reta rd ta ble t m ga 100m g

1,00 stuk

0,55664

1M01ABAO 1M01ABAO

V 21813 V 21814

Indo m e ta cine a cta vis ca psule 25m g Indo m e ta cine a cta vis ca psule 50m g

4,00 stuk 2,00 stuk

0,16699 0,27832

1M01ABAO

V 22572=20800

Diclo fena c na trium a reta rd ta ble t m ga 75m g

1,33 stuk

0,41748

1M01ABAO

V 22602=20800

Diclo fena c na trium rp reta rd ta ble t m ga 75m g

1,33 stuk

0,41748

1M01ABAO 1M01ABAO

V 22690 V 23147

Diclo fena c na trium a cta vis re t ta ble t m ga 75m g Diclo fena c na trium sa ndoz re tard ta ble t m ga 75m g

1,33 stuk 1,33 stuk

0,41748 0,41748

1M01ABAO

V 23148

Diclo fena c na trium sa ndoz re tard ta ble t m ga 100m g

1,00 stuk

0,55664

1M01ABAO

V 23152

Diclo fena c na trium cf re ta rd ta blet m ga 75m g

1,33 stuk

0,41748

1M01ABAO 1M01ABAO

V 23242 V 23243

Diclo fena c na trium sa ndoz ta ble t m sr 25m g Diclo fena c na trium sa ndoz ta ble t m sr 50m g

4,00 stuk 2,00 stuk

0,16699 0,27832

1M01ABAO

V 23575

Diclo fena cum na tricum table t m sr 25m g

4,00 stuk

0,16699

1M01ABAO

V 23576

Diclo fena cum na tricum table t m sr 50m g

2,00 stuk

0,27832

1M01ABAO 1M01ABAO

V 24004=20800 V 24030

DIC LO FENAC NATR IUM AP O TEX R ETAR D TABLET MGA 75MG Diclo fena c na trium flx ta blet m sr 25m g

1,33 stuk 4,00 stuk

0,41748 0,16699

1M01ABAO

V 24031

Diclo fena c na trium flx ta blet m sr 50m g

2,00 stuk

0,27832

1M01ABAO

V 24053

Diclo fena cum na tricum reta rd ta ble t m ga 100m g

1,00 stuk

0,55664

1M01ABAO 1M01ABAO

V 24130=56270 V 24131=56271

INDO METAC INE AP O TEX C APSULE 25MG INDO METAC INE AP O TEX C APSULE 50MG

4,00 stuk 2,00 stuk

0,16699 0,27832

1M01ABAO

V 24442

Diclo fena cum na tricum reta rd ta ble t m ga 75m g

1,33 stuk

0,41748

1M01ABAO

V 25748=20801

Diclo fena c na trium a reta rd ta ble t m ga 100m g

1,00 stuk

0,55664

1M01ABAO 1M01ABAO

V 26014 V 26213=20738

Diclo fena c na trium pch reta rd ta ble t m ga 75m g Diclo fena c na trium m yla n ta blet m sr 25m g

1,33 stuk 4,00 stuk

0,41748 0,16699

1M01ABAO

V 26214=20739

Diclo fena c na trium m yla n ta blet m sr 50m g

2,00 stuk

0,27832

1M01ABAO

V 26215=23014

Diclo fena c na trium m yla n re ta rd table t m ga 75m g

1,33 stuk

0,41748

1M01ABAO 1M01ABAO

V 26216=20740 V 52225

Diclo fena c na trium m yla n re ta rd table t m ga 100m g Indo m e ta cine capsule 25m g

1,00 stuk 4,00 stuk

0,55664 0,16699

1M01ABAO

V 55366

Indo m e ta cine flx ca psule 25m g

4,00 stuk

0,16699

1M01ABAO

V 55494

Indo m e ta cine flx ca psule 50m g

2,00 stuk

0,27832

1M01ABAO 1M01ABAO

V 55652 V 56270

Indo m e ta cine cf ca psule 25m g Indo m e ta cine pch ca psule 25m g

4,00 stuk 4,00 stuk

0,16699 0,16699

1M01ABAO

V 56271

Indo m e ta cine pch ca psule 50m g

2,00 stuk

0,27832

1M01ABAO

V 56766

Diclo fena cum na tricum table t m sr 25m g

4,00 stuk

0,16699

1M01ABAO 1M01ABAO

V 56767 V 56776

Diclo fena cum na tricum table t m sr 50m g DIC LO FENAC NATR IUM AP O TEX TABLET MSR 25MG

2,00 stuk 4,00 STUK

0,27832 0,16699

1M01ABAO

V 56777

DIC LO FENAC NATR IUM AP O TEX TABLET MSR 50MG

1M01ABAO

V 56778

Diclo fena c na trium k atwijk re ta rd table t m ga 100m g

1,00 stuk

0,55664

1M01ABAO 1M01ABAO

V 57044 V 57045

Diclo fena c na trium rp table t m sr 25m g Diclo fena c na trium rp table t m sr 50m g

4,00 stuk 2,00 stuk

0,16699 0,27832

1M01ABAO

V 57138

Diclo fena c na trium pch reta rd ta ble t m ga 100m g

1,00 stuk

0,55664

2 STUK

0,27832

1M01ABAO 1M01ABAO

V 57402 V 57631

Sulindac pch ta blet 200m g Indo m e ta cinum ca psule 50m g

2,00 stuk 2,00 stuk

0,27832 0,27832

1M01ABAO 1M01AC AO

V 7003

Vo lta re n table t 25m g ente ric co a ted

4,00 stuk

0,16699

V 100494

Me lo x ica m a table t 7,5m g

2,00 stuk

0,33398

1M01AC AO 1M01AC AO

V 100512 V 100623

Me lo x ica m a table t 15m g Me lo x ica m rp table t 7,5m g

1,00 stuk 2,00 stuk

0,55664 0,33398

1M01AC AO

V 100628

Me lo x ica m rp table t 15m g

1,00 stuk

0,55664

1M01AC AO

V 103607

Me lo x ica m a po te x table t 7,5m g

2,00 stuk

0,33398

1M01AC AO 1M01AC AO

V 103610 V 12198

Me lo x ica m a po te x table t 15m g P irox ica m rp capsule 10m g

1,00 stuk 2,00 stuk

0,55664 0,33398

1M01AC AO

V 12199

P irox ica m rp capsule 20m g

1,00 stuk

0,55664

1M01AC AO

V 14672

P irox ica m pch dispe r ta ble t 20m g

1,00 stuk

0,55664

1M01AC AO 1M01AC AO

V 14673 V 14674

P irox ica m pch capsule 10m g P irox ica m pch capsule 20m g

2,00 stuk 1,00 stuk

0,33398 0,55664

1M01AC AO

V 15933

P irox ica m rp dispe rgee rba ar ta blet 20m g

1,00 stuk

0,55664

1M01AC AO

V 17038

P irox ica m sa ndo z dispe r ta ble t 10m g

2,00 stuk

0,33398

1M01AC AO 1M01AC AO

V 17039 V 19375

P irox ica m sa ndo z dispe r ta ble t 20m g Mo vicox ta ble t 7,5m g

1,00 stuk 2,00 stuk

0,55664 0,33398

1M01AC AO

V 19376

Mo vicox ta ble t 15m g

1,00 stuk

0,55664

1M01AC AO

V 28770=57428

P IR O XIC AM MYLAN DISP ER TABLET 20MG

1,00 stuk

0,55664

1M01AC AO 1M01AC AO

V 31426//19375 V 31824

Mo valis ta blet 7,5m g Me lo x ica m cf ta ble t 7,5m g

2,00 stuk 2,00 stuk

0,33398 0,33398

1M01AC AO

V 31825

Me lo x ica m cf ta ble t 15m g

1,00 stuk

0,55664

1M01AC AO

V 32621

Me lo x ica m pch table t 7,5m g

2,00 stuk

0,33398

1M01AC AO 1M01AC AO

V 32622 V 32715

Me lo x ica m pch table t 15m g Me lo x ica m sa ndoz ta ble t 7,5m g

1,00 stuk 2,00 stuk

0,55664 0,33398

1M01AC AO

V 32716

Me lo x ica m sa ndoz ta ble t 15m g

1,00 stuk

0,55664

1M01AC AO

V 32722

Me lo x ica m a cta vis ta blet 7,5m g

2,00 stuk

0,33398

1M01AC AO 1M01AC AO

V 32723 V 34185

Me lo x ica m a cta vis ta blet 15m g Me lo x ica m m yla n ta blet 7,5m g

1,00 stuk 2,00 stuk

0,55664 0,33398

1M01AC AO

V 34186

Me lo x ica m m yla n ta blet 15m g

1,00 stuk

0,55664

1M01AC AO

V 57428

P irox ica m cf disper ta blet 20m g

1,00 stuk

0,55664

1M01AC AO 1M01AC AO

V 57448 V 57449

P irox ica m cf ca psule 10m g P irox ica m cf ca psule 20m g

2,00 stuk 1,00 stuk

0,33398 0,55664

1M01AEAO

V 10574

O rudis re ta rd ta blet m ga 200m g

0,75 stuk

0,74219

1M01AEAO

V 10895

Ibuprofe n pch table t 600m g

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 11195 V 11196

NAPR O XEN MYLAN TABLET 250MG NAPR O XEN MYLAN TABLET 500MG

1M01AEAO

V 12570

Na pro x e n pch ta ble t 250m g

2,00 stuk

1M01AEAO

V 12571

Na pro x e n pch ta ble t 500m g

1,00 stuk

0,55664

1M01AEAO 1M01AEAO

V 13331 V 13478

Brufen bruis 600m g bruisgra nula a t in sache t Brufen re ta rd ta blet m ga 800m g

2,00 stuk 1,50 stuk

0,27832 0,37109

1M01AEAO

V 13677=12197

O sco re l capsule m ga 200m g

0,75 stuk

0,74219

1M01AEAO

V 13903

Za fen gra nula at 400m g in sa che t

3,00 stuk

0,18555

1M01AEAO 1M01AEAO

V 13907 V 14420

Ibuprofe n rp table t 600m g Surga m re tard ca psule m ga 300m g

2,00 stuk 2,00 stuk

0,27832 0,27832

1M01AEAO

V 14484

Na pro vite ta ble t 550m g

1,00 stuk

0,55664

1M01AEAO

V 15062

Ke topro fe n pch re ta rd capsule m ga 100m g

1,50 stuk

0,37109

1M01AEAO 1M01AEAO

V 15063 V 16417=15063

Ke topro fe n pch re ta rd capsule m ga 200m g Ke topro fe n a cta vis re tard ca psule m ga 200m g

0,75 stuk 0,75 stuk

0,74219 0,74219

1M01AEAO

V 16705=15063

Ke topro fe n rp re ta rd capsule m ga 200m g

0,75 stuk

0,74219

1M01AEAO

V 18336=17667

O sco re l capsule m ga 150m g

1,00 stuk

0,55664

2 STUK 1 STUK

0,27832 0,55664 0,27832

1M01AEAO 1M01AEAO

V 18545 V 19697

Ibuprofe num ta blet 600m g Na pro x e n rx ta ble t 250m g

2,00 stuk 2,00 stuk

1M01AEAO

V 19698

Na pro x e n rx ta ble t 500m g

1,00 stuk

0,55664

1M01AEAO

V 20319

Na pro x e n sa ndo z ta blet 250m g

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 20320 V 20324

Na pro x e n sa ndo z ta blet 500m g Na pro x e n a cta vis ta ble t 250m g

1,00 stuk 2,00 stuk

0,55664 0,27832

1M01AEAO

V 20325

Na pro x e n a cta vis ta ble t 500m g

1,00 stuk

0,55664

1M01AEAO

V 20758

Na pro x e num ta ble t 250m g

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 20759 V 20923

Na pro x e num ta ble t 500m g Ke topro fe n sa ndo z re ta rd ca psule m ga 100m g

1,00 stuk 1,50 stuk

0,55664 0,37109

1M01AEAO

V 20924

Ke topro fe n sa ndo z re ta rd ca psule m ga 200m g

0,75 stuk

0,74219

1M01AEAO

V 21278

Ibuprofe n a cta vis ta blet 600m g

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 21931 V 21932

Na pro x e n a cta vis e c ta ble t m sr 250m g Na pro x e n a cta vis e c ta ble t m sr 500m g

2,00 stuk 1,00 stuk

0,27832 0,55664

1M01AEAO

V 22082

Sta dium table t 25m g

3,00 stuk

0,18555

1M01AEAO

V 22094

Na pro x e n sa ndo z ta blet m sr 250m g

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 22095 V 22395

Na pro x e n sa ndo z ta blet m sr 500m g Na pro x e n sa ndo z ta blet 250m g

1,00 stuk 2,00 stuk

0,55664 0,27832

1M01AEAO

V 22396

Na pro x e num ta ble t 500m g

1,00 stuk

0,55664

1M01AEAO

V 23735

Ibuprofe n ta ble t 600m g

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 24058 V 24059

NAPR O XEN AC C O R D TABLET 250MG NAPR O XEN AC C O R D TABLET 500MG

2,00 stuk 1,00 stuk

0,27832 0,55664

1M01AEAO

V 24629//13331

Brufen bruis 600m g bruisgra nula a t in sache t

2,00 stuk

0,27832

1M01AEAO

V 24967

Na pro x e n m yla n e c ta ble t m sr 250m g

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 24968 V 25474

NAPR O XEN MYLAN EC TABLET MSR 500MG Se ractil ta ble t o m huld 200m g

1 STUK 4,00 stuk

0,55664 0,16699

1M01AEAO

V 25476

Se ractil ta ble t o m huld 400m g

2,00 stuk

0,27832

1M01AEAO

V 25652=20758

Na pro x e n a ta ble t 250m g

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 25653=20759 V 25895//13331

Na pro x e n a ta ble t 500m g Brufen bruis 600m g bruisgra nula a t in sache t

1,00 stuk 2,00 stuk

0,55664 0,27832

1M01AEAO

V 25937

IBUP R O FEN MYLAN TABLET O MHULD 600MG

1M01AEAO

V 26228//13331

Brufen bruis 600m g bruisgra nula a t in sache t

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 27847=22256 V 27848=22257

Na pro x e n cf ec table t m sr 250m g Na pro x e n cf ec table t m sr 500m g

2,00 stuk 1,00 stuk

0,27832 0,55664

1M01AEAO

V 29871//25476

Se ractil ta ble t o m huld 400m g

2,00 stuk

0,27832

1M01AEAO

V 30325

NAPR O XEN TEVA TABLET MSR 250MG

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 30326 V 31926//13331

NAPR O XEN TEVA TABLET MSR 500MG Brufen bruis 600m g bruisgra nula a t in sache t

1,00 stuk 2,00 stuk

0,55664 0,27832

1M01AEAO

V 33294//13331

Brufen bruis 600m g bruisgra nula a t in sache t

2,00 stuk

0,27832

1M01AEAO

V 56004

Ibuprofe n cf ta ble t 600m g

2,00 stuk

0,27832

1M01AEAO 1M01AEAO

V 56436 V 56775

Na pro x e n rp ta ble t 250m g IBUP R O FEN APO TEX TABLET O MHULD 600MG

2,00 stuk 2 STUK

0,27832 0,27832

1M01AEAO

V 56913

Na pro x e n cf table t 250m g

2,00 stuk

0,27832

1M01AEAO

V 56914

Na pro x e n cf table t 500m g

1,00 stuk

0,55664

1M01AEAO 1M01AEAO

V 57090 V 57265

Na pro x e n rp ta ble t 500m g Na pro x e num ta ble t 250m g

1,00 stuk 2,00 stuk

0,55664 0,27832

1M01AEAO

V 57297

Na pro x e num ta ble t 250m g

2,00 stuk

0,27832

1M01AEAO

V 57298

Na pro x e num ta ble t 500m g

1,00 stuk

0,55664

1M01AEAO 1M01AEAO

V 57558 V 57559

NAPR O XEN AP O TEX TABLET 250MG NAPR O XEN AP O TEX TABLET 500MG

2,00 stuk 1 STUK

0,27832 0,55664

1M01AEAO

V 8503

Surga m ta ble t 200m g

3,00 stuk

0,18555

1M01AEAO

V 9729

Surga m ta ble t 300m g

2,00 stuk

0,27832

2 STUK

0,27832 0,27832

0,27832

1M01AXAO

V 12603

Me butan dispe r table t 1 gra m

1,00 stuk

0,55664

1M01AXAO

V 16993

Me butan ta ble t 1g

1,00 stuk

0,55664

1M01AXAO

V 23264

Na bum e ton a cta vis table t 500m g

2,00 stuk

0,33398

1M01AXAO 1M01AXAO

V 24728=23264 V 24912=23264

Na bum e ton sando z ta ble t 500m g Na bum e ton a ta ble t 500m g

2,00 stuk 2,00 stuk

0,33398 0,33398

1M01AXAO

V 26497

NABUMETO N MYLAN TABLET 500MG

2,00 stuk

0,33398

1M01AXAO

V 27046=23264

Na bum e ton cf ta blet 500m g

2,00 stuk

0,33398

1M01AXAO

V 27157

Na bum e ton pch ta ble t 500m g

2,00 stuk

0,33398

1M01ABAR

V 10215

Indo m e ta cine sa ndo z ze tpil 100m g

1,00 stuk

0,51096

1M01ABAR

V 10428

Indo m e ta cine sa ndo z ze tpil 50m g

2,00 stuk

0,25548

1M01ABAR 1M01ABAR

V 13769 V 13770

Diclo fena c na trium pch ze tpil 50m g Diclo fena c na trium pch ze tpil 100m g

2,00 stuk 1,00 stuk

0,25548 0,51096

1M01ABAR

V 16277

Diclo fena c na trium a cta vis ze tpil 50m g

2,00 stuk

0,25548

1M01ABAR

V 16278

Diclo fena c na trium a cta vis ze tpil 100m g

1,00 stuk

0,51096

1M01ABAR 1M01ABAR

V 16521 V 16522

INDO METAC INE AP O TEX ZETP IL 50MG INDO METAC INE AP O TEX ZETP IL 100MG

2,00 stuk 1,00 STUK

0,25548 0,51096

1M01ABAR

V 17260

Diclo fena c na trium cf zetpil 50m g

2,00 stuk

0,25548

1M01ABAR

V 17261

Diclo fena c na trium cf zetpil 100m g

1,00 stuk

0,51096

1M01ABAR 1M01ABAR

V 18342 V 18343

Diclo fena c na trium ze tpil 50m g Diclo fena c na trium ze tpil 100m g

2,00 stuk 1,00 stuk

0,25548 0,51096

1M01ABAR

V 22929=20742

Diclo fena c na trium sa ndoz ze tpil 50m g

2,00 stuk

0,25548

1M01ABAR

V 22930=20743

Diclo fena c na trium sa ndoz ze tpil 100m g

1,00 stuk

0,51096

1M01ABAR 1M01ABAR

V 26218=20742 V 26219=20743

Diclo fena c na trium m yla n ze tpil 50m g DIC LO FENAC NATR IUM MYLAN ZETP IL 100MG

2,00 stuk 1 STUK

0,25548 0,51096

1M01ABAR

V 27604=57149

Diclo fena c na trium a ze tpil 50m g

2,00 stuk

0,25548

1M01ABAR

V 27605=57150

Diclo fena c na trium a ze tpil 100m g

1,00 stuk

0,51096

1M01ABAR 1M01ABAR

V 55712 V 55879

Indo m e ta cine cf ze tpil 100m g Indo m e ta cine cf ze tpil 50m g

1,00 stuk 2,00 stuk

0,51096 0,25548

1M01ABAR

V 56779

DIC LO FENAC NATR IUM AP O TEX ZETP IL 100MG

1,00 stuk

0,51096

1M01ABAR

V 57082

Indo m e ta cine pch zetpil 50m g

2,00 stuk

0,25548

1M01ABAR 1M01ABAR

V 57083 V 57149

Indo m e ta cine pch zetpil 100m g Diclo fena c na trium rp ze tpil 50m g

1,00 stuk 2,00 stuk

0,51096 0,25548

1M01ABAR

V 57150

Diclo fena c na trium rp ze tpil 100m g

1,00 stuk

0,51096

1M01ABAR

V 57385

DIC LO FENAC NATR IUM AP O TEX ZETP IL 50MG

2,00 stuk

0,25548

1M01ABAR 1M01ABAR

V 57670 V 57671

Diclo fena c na trium gf ze tpil 50m g Diclo fena c na trium gf ze tpil 100m g

2,00 stuk 1,00 stuk

0,25548 0,51096

1M01AC AR

V 19379

Mo vicox zetpil 15m g

1,00 stuk

0,51096

1M01AEAR

V 12572

Na pro x e n pch zetpil 250m g

2,00 stuk

0,25548

1M01AEAR 1M01AEAR

V 12573 V 19983

Na pro x e n pch zetpil 500m g Na pro x e n a lpha rm a ze tpil 250m g

1,00 stuk 2,00 stuk

0,51096 0,25548

1M01AEAR

V 19984

Na pro x e n a cta vis ze tpil 500m g

1,00 stuk

0,51096

1M01AEAR

V 20276=57089

Na pro x e n a zetpil 500m g

1,00 stuk

0,51096

1M01AEAR 1M01AEAR

V 20321 V 20322

Na pro x e n sa ndo z ze tpil 250m g Na pro x e n sa ndo z ze tpil 500m g

2,00 stuk 1,00 stuk

0,25548 0,51096

1M01AEAR

V 56920

Na pro x e n cf ze tpil 250m g

2,00 stuk

0,25548

1M01AEAR

V 56921

Na pro x e n cf ze tpil 500m g

1,00 stuk

0,51096

1M01AEAR 1M01AEAR

V 57089 V 57649

Na pro x e n rp zetpil 500m g Na pro x e n k a twijk ze tpil 250m g

1,00 stuk 2,00 stuk

0,51096 0,25548

1M01AEAR

V 57650

Na pro x e n k a twijk ze tpil 500m g

1,00 stuk

0,51096

1M01AEAR

V 57763=9551

Ibuprofe n

3,00 stuk

0,17032

1M01AEAR

V 57796

Ibuprofe n ze tpil 500m g

3,00 stuk

0,17032

1M01AEAR

V 9551

Ibuprofe n pch ze tpil 500m g

3,00 stuk

0,17032

1N02ADAP

V 6322

Fortra l injvlst 30m g/m l am pul 1,5m l

4,44 stuk

1,87865

1N02AEAP

V 8725

Te m ge sic injvlst 0,3m g/m l a m pul 1m l

4,00 m l

2,08739

1N03AAAO

V 52098

Feno barbita l pch ta ble t 25m g

4,00 stuk

0,02641

1N03AAAO

V 52101

Feno barbita l pch ta ble t 50m g

2,00 stuk

0,04402

1N03AAAO 1N03AAAO

V 52104 V 52531

Feno barbita l pch ta ble t 100m g Feno barbita l rp ta ble t 25m g

1,00 stuk 4,00 stuk

0,08803 0,02641

1N03AAAO

V 52534

Feno barbita l rp ta ble t 50m g

2,00 stuk

0,04402

1N03AAAO

V 52537

Feno barbita l rp ta ble t 100m g

1,00 stuk

0,08803

1N03AXC O

V 379

Myso line ta ble t 250m g

3,00 stuk

0,02934

1N04AAAO

V 2196

Ak ine to n ta blet 2m g

5,00 stuk

0,03539

1N04AAAO

V 26450//2196

Ak ine to n ta blet 2m g

5,00 stuk

0,03539

1N04AAAO 1N04AAAO

V 640 V 641

Arta ne ta ble t 2m g Arta ne ta ble t 5m g

5,00 stuk 2,00 stuk

0,04601 0,08849

1N05ABAP D V 102579//6170

Anate nso l decano a at injvlst 25m g/m l a m pul 1,0m l

0,04 stuk

17,90175

1N05ABAP D V 6170 1N05ABAP D V 6170

Anate nso l decano a at injvlst 25m g/m l a m pul 0,5m l Anate nso l decano a at injvlst 25m g/m l fla co n 10m l

0,08 stuk 0,00 stuk

8,95088 179,01750

1N05ABAP D V 6170

Anate nso l decano a at injvlst 25m g/m l fla co n 10m l

0,00 stuk

179,01750

1N05ABAP D V 6170

Anate nso l decano a at injvlst 25m g/m l fla co n 10m l

0,00 stuk

179,01750

1N05ABAP D V 6170 1N05ABAP D V 6170

Anate nso l decano a at injvlst 25m g/m l a m pul 1,0m l Anate nso l decano a at injvlst 25m g/m l a m pul 0,5m l

0,04 stuk 0,08 stuk

17,90175 8,95088

1N05ABAP D V 6170

Anate nso l decano a at injvlst 25m g/m l a m pul 0,5m l

0,08 stuk

8,95088

1N05ABAP D V 6170

Anate nso l decano a at injvlst 25m g/m l a m pul 1,0m l

0,04 stuk

17,90175

1N05ABAP D V 6170 1N05ABAP D V 8468

Anate nso l decano a at injvlst 25m g/m l a m pul 1,0m l Anate nso l decano a at conc inj 100m g/m l a m pul 0,5m l

0,04 stuk 0,02 stuk

17,90175 35,80350

1N05ABAP D V 8468

Anate nso l decano a at conc inj 100m g/m l a m pul 1,0m l

0,01 stuk

71,60700

1N05ABAP D V 8468

Anate nso l decano a at conc inj 100m g/m l a m pul 1,0m l

0,01 stuk

71,60700

1N05ABAP D V 8468 1N05ADAPD V 10194

Anate nso l decano a at conc inj 100m g/m l a m pul 0,5m l Im pro m e n decano a s injvlst 50m g/m l a m pul 1m l

0,02 stuk 0,07 stuk

35,80350 10,84955

1N05ADAPD V 104434//8994

Ha ldo l decano a at injvlst 50m g/m l a m pul 1m l

0,07 stuk

10,84955

1N05ADAPD V 11298//8994

Ha ldo l decano a at injvlst 50m g/m l a m pul 1m l

0,07 stuk

10,84955

1N05ADAPD V 15531//9323 1N05ADAPD V 33025//9323

Ha ldo l decano a at injvlst 100m g/m l a m pul 1m l Ha ldo l decano a at injvlst 100m g/m l a m pul 1m l

0,03 stuk 0,03 stuk

21,69909 21,69909

1N05ADAPD V 8994

Ha ldo l decano a at injvlst 50m g/m l a m pul 1m l

0,07 stuk

10,84955

1N05ADAPD V 8994

Ha ldo l decano a at injvlst 50m g/m l a m pul 1m l

0,07 stuk

10,84955

1N05ADAPD V 8994 1N05ADAPD V 8994

Ha ldo l decano a at injvlst 50m g/m l a m pul 3m l Ha ldo l decano a at injvlst 50m g/m l a m pul 3m l

0,02 stuk 0,02 stuk

32,54864 32,54864

1N05ADAPD V 9323

Ha ldo l decano a at injvlst 100m g/m l a m pul 1m l

0,03 stuk

21,69909

1N05AFAP D V 13150

C iso rdino l depo t injvlst co nc 500m g/m l a m pul 1m l

0,03 stuk

23,86900

1N05AFAP D V 14175 1N05AFAP D V 14175

C iso rdino l a cutard injvlst 50m g/m l a m pul 2m l C iso rdino l a cutard injvlst 50m g/m l a m pul 1m l

0,15 stuk 0,30 stuk

4,77380 2,38690

1N05AFAP D V 14175

C iso rdino l a cutard injvlst 50m g/m l a m pul 1m l

0,30 stuk

2,38690

1N05AFAP D V 14175

C iso rdino l a cutard injvlst 50m g/m l a m pul 2m l

0,15 stuk

4,77380

1N05AFAP D V 14242//7288 1N05AFAP D V 30422//7288

C lo pix o l de pot injvlst 200m g/m l a m pul 1m l C lo pix o l de pot injvlst 200m g/m l a m pul 1m l

0,08 stuk 0,08 stuk

9,54760 9,54760

1N05AFAP D V 6051

Flua nx o l depo t injvlst 20m g/m l am pul 2m l

0,10 stuk

7,16070

1N05AFAP D V 6051

Flua nx o l depo t injvlst 20m g/m l am pul 2m l

0,10 stuk

7,16070

1N05AFAP D V 6051 1N05AFAP D V 6051

Flua nx o l depo t injvlst 20m g/m l fla co n 10m l Flua nx o l depo t injvlst 20m g/m l fla co n 10m l

0,02 stuk 0,02 stuk

35,80350 35,80350

1N05AFAP D V 6051

Flua nx o l depo t injvlst 20m g/m l am pul 1m l

0,20 stuk

3,58035

1N05AFAP D V 6051

Flua nx o l depo t injvlst 20m g/m l fla co n 10m l

0,02 stuk

35,80350

1N05AFAP D V 6051 1N05AFAP D V 6051

Flua nx o l depo t injvlst 20m g/m l am pul 1m l Flua nx o l depo t injvlst 20m g/m l am pul 1m l

0,20 stuk 0,20 stuk

3,58035 3,58035

1N05AFAP D V 6051

Flua nx o l depo t injvlst 20m g/m l am pul 2m l

0,10 stuk

7,16070

1N05AFAP D V 7228

Flua nx o l depo t injvlst 100m g/m l a m pul 0,5m l

0,08 stuk

8,95088

1N05AFAP D V 7228 1N05AFAP D V 7228

Flua nx o l depo t injvlst 100m g/m l a m pul 1m l Flua nx o l depo t injvlst 100m g/m l a m pul 1m l

0,04 stuk 0,04 stuk

17,90175 17,90175

1N05AFAP D V 7228

Flua nx o l depo t injvlst 100m g/m l a m pul 0,5m l

0,08 stuk

8,95088

1N05AFAP D V 7288

C iso rdino l depo t injvlst 200m g/m l fla c 10m l (im )

0,01 stuk

95,47600

1N05AFAP D V 7288 1N05AFAP D V 7288

C iso rdino l depo t injvlst 200m g/m l fla c 10m l (im ) C iso rdino l depo t injvlst 200m g/m l a m pul 1m l (im )

0,01 stuk 0,08 stuk

95,47600 9,54760

1N05AFAP D V 7288

C iso rdino l depo t injvlst 200m g/m l a m pul 1m l (im )

0,08 stuk

9,54760

1N05AGAPD V 6151

Im a p injvlst 2m g/m l am pul 1m l (im )

0,35 stuk

2,04591

1N05AGAPD V 6151 1N05AGAPD V 6151

Im a p injsusp 2m g/m l a m pul 0,75m l (im ) Im a p injsusp 2m g/m l a m pul 6m l (im )

0,47 stuk 0,06 stuk

1,53444 12,27549

1N05AGAPD V 6151

Im a p injsusp 2m g/m l a m pul 0,75m l (im )

0,47 stuk

1,53444

1N05AGAPD V 6151

Im a p injsusp 2m g/m l a m pul 6m l (im )

0,06 stuk

12,27549

1N05AGAPD V 6151 1N05AGAPD V 6151

Im a p injsusp 2m g/m l a m pul 0,75m l (im ) Im a p injvlst 2m g/m l am pul 1m l (im )

0,47 stuk 0,35 stuk

1,53444 2,04591

1N05AGAPD V 6151

Im a p injvlst 2m g/m l am pul 1m l (im )

0,35 stuk

2,04591

1N05AGAPD V 6151

Im a p injsusp 2m g/m l a m pul 6m l (im )

0,06 stuk

12,27549

1R 06ABAO

K 1528

FENISTIL DIMETINDEENW ATER STO FMALEAAT DR UP 1MG/ML

4,00 m l

1R 06AAAO

V 103076//5621

Ta ve gyl ta ble t 1m g

2,00 stuk

0,14913

1R 06AAAO 1R 06AAAO

V 28222//5621 V 5621

Ta ve gil ta ble t 1m g Ta ve gyl ta ble t 1m g

2,00 stuk 2,00 stuk

0,14913 0,14913

1R 06ABAO

V 1848

P o la ra m ine ta ble t 2m g

3,00 stuk

0,13919

1R 06AEAO

V 8664

Tinse t table t 30m g

2,00 stuk

0,14913

2D07ABADZ V 19043=52672 2D07ABADZ V 23103

Ungue ntum tria m cino lo ni a ce to nid 1m g/g Triam cino lo na ce tonide fa gro n fna za lf 1m g/g

1,00 gra m 1,00 gra m

0,13568 0,13568

2D07ABADZ V 25402=52672

TR IAMC INO LO NAC ETO NIDE MYLAN ZALF 1MG/G

1,00 gra m

0,13568

2D07ABADZ V 25492//7520

Em o vate zalf 0,5m g/g

1,00 gra m

0,13568

2D07ABADZ V 31698//7520 2D07ABADZ V 32693//7520

Em o vate zalf 0,5m g/g C lo be ta so n-17-butyra at za lf 0,5m g/g

1,00 gra m 1,00 gra m

0,13568 0,13568

2D07ABADZ V 50060

Triam cino lo na ce tonide pch zalf 1m g/g

1,00 gra m

0,13568

2D07ABADZ V 52672

Ungue ntum tria m cino lo ni a ce to nid 1m g/g

1,00 gra m

0,13568

2D07ABADZ V 53334 2D07ABADZ V 5909

Triam cino lo na ce tonide rp fna za lf 1m g/g Locoid o le o gel 1m g/g

1,00 gra m 1,00 gra m

0,13568 0,13568

2D07ABADZ V 7520

Em o vate zalf 0,5m g/g

1,00 gra m

0,13568

2G03FBBO 2G03FBBO

V 17490 V 20311

Fem o sto n ta ble t 2/10m g Fem o sto n ta ble t 1/10m g

1,00 verp 1,00 stuk

6,02620 6,02620

2G03FBBO

V 24588//17490

Fem o sto n ta ble t 2/10m g

1,00 verp

6,02620

2G03FBBO

V 9812

Trise que ns ta blet

1,00 verp

6,02620

2G03HBBO

V 17122

C lim e ne 28 ta ble t

1,00 verp

6,02620

2N05ABAO

K 50757

P e rfena zine cf drage e 2m g

12,00 stuk

0,06273

2N05ABAO

V 22216=50758

P e rfena zine pch dra gee 4m g

6,00 stuk

0,10982

2N05ABAO 2N05ABAO

V 22217=50759 V 50758

P e rfena zine pch dra gee 8m g P e rfena zine cf drage e 4m g

3,00 stuk 6,00 stuk

0,18304 0,10982

0,10573

2N05ABAO

V 50759

P e rfena zine cf drage e 8m g

3,00 stuk

0,18304

2N05ABAO

V 50760

P e rfena zine cf drage e 16m g

1,50 stuk

0,36608

2N05AC AO 2N05AC AO

V 301 V 5227

Ne ule ptil ca psule 10m g Ne ule ptil ca psule 5m g

5,00 stuk 10,00 stuk

0,10982 0,06589

2N05ADAO

V 100049//183

Dipipe ro n ta blet 40m g

5,00 stuk

0,10982

2N05ADAO

V 183

Dipipe ro n ta blet 40m g

5,00 stuk

0,10982

2N05ADAO 2N05ADAO

V 24409=55776 V 24410=55601

Ha lope rido l sa ndoz ta ble t 1m g Ha lope rido l sa ndoz ta ble t 5m g

8,00 stuk 1,60 stuk

0,12355 0,34320

2N05ADAO

V 25225//8411

Im pro m e n ta ble t 5m g

2,00 stuk

0,27456

2N05ADAO

V 25510//5340

Frena ctil druppels 1m g/m l

1,50 m l

0,36608

2N05ADAO 2N05ADAO

V 29879 V 3186

P ipa m pero n sa ndoz ta ble t 40m g Ha ldo l druppe ls 2m g/m l

5,00 stuk 4,00 m l

0,10982 0,13728

2N05ADAO

V 3187

Ha ldo l ta ble t 1m g

8,00 stuk

0,12355

2N05ADAO

V 55601

Ha lope rido l cf ta ble t 5m g

1,60 stuk

0,34320

2N05ADAO 2N05ADAO

V 55776 V 56277

Ha lope rido l cf ta ble t 1m g Ha lope rido l pch table t 1m g

8,00 stuk 8,00 stuk

0,12355 0,12355

2N05ADAO

V 56278

Ha lope rido l pch table t 5m g

1,60 stuk

0,34320

2N05ADAO

V 8413

Im pro m e n druppe lvloe isto f 2m g/m l

5,00 m l

0,10982

2N05ADAO 2N05ADAO

V 8840 V 9847//183

Ha ldo l ta ble t 10m g Dipipe ro n ta blet 40m g

0,80 stuk 5,00 stuk

0,68640 0,10982

2N05ADAO

V 9964

Dipipe ro n druppe ls 40m g/m l

5,00 m l

0,10982

2N05AFAO

V 14239//4294

C lo pix o l ta blet 2m g

15,00 stuk

0,06589

2N05AFAO 2N05AFAO

V 14240//4295 V 4294

C lo pix o l ta blet 10m g C iso rdino l ta ble t 2m g

3,00 stuk 15,00 stuk

0,18304 0,06589

2N05AFAO

V 4295

C iso rdino l ta ble t 10m g

3,00 stuk

0,18304

2N05AFAO

V 4296

C iso rdino l ta ble t 25m g

1,20 stuk

0,45760

2N05AFAO 2N05AFAO

V 4299 V 4299

Trux a l ta ble t o m huld 50m g Trux a l ta ble t o m huld 50m g

6,00 stuk 6,00 stuk

0,09152 0,09152

2N05AFAO

V 4300

Trux a l ta ble t o m huld 15m g

20,00 stuk

0,04027

2N05AFAO

V 4300

Trux a l ta ble t o m huld 15m g

20,00 stuk

0,04027

2N05AFAO 2N05AFAO

V 5376 V 5377

Flua nx o l drage e 0,5m g Flua nx o l drage e 1m g

12,00 stuk 6,00 stuk

0,05491 0,09152

2N05AFAO

V 5992

Flua nx o l drage e 5m g

1,20 stuk

0,45760

2N05AFAO

V 9287

C iso rdino l druppe ls 20m g/m l

1,50 m l

0,36608

2N05AGAO 2N05AGAO

V 14085//6149 V 26097//6149

O ra p ta ble t 1m g O ra p ta ble t 1m g

4,00 stuk 4,00 stuk

0,21965 0,21965

2N05AGAO

V 26185//6150

O ra p ta ble t 4m g

1,00 stuk

0,54912

2N05AGAO

V 26480//6149

O ra p ta ble t 1m g

4,00 stuk

0,21965

2N05AGAO 2N05AGAO

V 26481//6150 V 6149

O ra p ta ble t 4m g O ra p ta ble t 1m g

1,00 stuk 4,00 stuk

0,54912 0,21965

2N05AGAO

V 6150

O ra p ta ble t 4m g

1,00 stuk

0,54912

2N05AGAO

V 6603

Se m a p ta ble t 20m g

0,30 stuk

1,83040

2N05AGAO 2N05ADAP

V 9479//6150 V 103083//3185

O ra p ta ble t 4m g Ha ldo l injvlst 5m g/m l a m pul 1m l

1,00 stuk 1,60 stuk

0,54912 1,16139

2N05ADAP

V 3185

Ha ldo l injvlst 5m g/m l a m pul 1m l

1,60 stuk

1,16139

2N06AAAO 2N06AAAO

V 100004 V 100007

Ve nla fa x ine m ylan re ta rd capsule m va 37,5m g Ve nla fa x ine m ylan re ta rd capsule m va 75m g

2,67 stuk 1,33 stuk

0,47987 0,79979

2N06AAAO

V 100014

Ve nla fa x ine m ylan re ta rd capsule m va 150m g

0,67 stuk

1,59958

2N06AAAO

V 100765

Ve nla fa x ine sa ndo z reta rd ca psule m va 75m g

1,33 stuk

0,79979

2N06AAAO 2N06AAAO

V 100766 V 101048

Ve nla fa x ine sa ndo z reta rd ca psule m va 150m g Ve nla fa x ine actavis x r ca psule m va 37,5m g

0,67 stuk 2,67 stuk

1,59958 0,47987

2N06AAAO

V 101050

Ve nla fa x ine actavis x r ca psule m va 75m g

1,33 stuk

0,79979

2N06AAAO

V 101051

Ve nla fa x ine actavis x r ca psule m va 150m g

0,67 stuk

1,59958

2N06AAAO 2N06AAAO

V 101426 V 101427

Ve nla fa x ine apo te x x r ca psule m va 37,5m g Ve nla fa x ine apo te x x r ca psule m va 75m g

2,67 stuk 1,33 stuk

0,47987 0,79979

2N06AAAO

V 101428

Ve nla fa x ine apo te x x r ca psule m va 150m g

0,67 stuk

1,59958

2N06AAAO

V 102453

Ve nla fa x ine pch re ta rd ca psule m va 37,5m g

2,67 stuk

0,47987

2N06AAAO 2N06AAAO

V 102454 V 102455

Ve nla fa x ine pch re ta rd ca psule m va 75m g Ve nla fa x ine pch re ta rd ca psule m va 150m g

1,33 stuk 0,67 stuk

0,79979 1,59958

2N06AAAO

V 102896

Ve nla fa x ine sa ndo z reta rd ca psule m va 37,5m g

2,67 stuk

0,47987

2N06AAAO

V 103486

VENLAFAXINE MYLAN R ETAR D C APSULE MVA 37,5MG

2,67 STUK

0,47987

2N06AAAO 2N06AAAO

V 103488 V 103489

VENLAFAXINE MYLAN R ETAR D C APSULE MVA 75MG VENLAFAXINE MYLAN R ETAR D C APSULE MVA 150MG

1,33 STUK 0,67 STUK

0,79979 1,59958

2N06AAAO

V 20862

EFEXO R XR C AP SULE MVA 75 MG

1,33 stuk

0,79979

2N06AAAO

V 20863

EFEXO R XR C AP SULE MVA 150 MG

0,67 stuk

1,59958

2N06AAAO 2N06AAAO

V 26661 V 32981

EFEXO R XR C AP SULE MVA 37,5 MG Ve nla fa x ine cf re tard ta ble t m va 75m g

2,67 stuk 1,33 stuk

0,47987 0,79979

2N06AAAO

V 32982

Ve nla fa x ine cf re tard ta ble t m va 150m g

0,67 stuk

1,59958

2N06AAAO

V 32987

Ve nla fa x ine cf ta ble t 37,5m g

2,67 stuk

0,47987

2N06AAAO 2N06AAAO

V 35105 V 35106

Ve nla fa x ine rp re ta rd ca psule m va 37,5m g Ve nla fa x ine rp re ta rd ca psule m va 75m g

2,67 stuk 1,33 stuk

0,47987 0,79979

2N06AAAO

V 35107

Ve nla fa x ine rp re ta rd ca psule m va 150m g

0,67 stuk

1,59958

2N06ABAO

V 100569//30497

Escita lopra m table t film o m huld 20m g

0,50 stuk

2,13277

2N06ABAO 2N06ABAO

V 102243//19593 V 10245

C ipram il table t om huld 20m g Feva rin ta ble t 50m g

1,00 stuk 2,00 stuk

1,06638 0,63983

2N06ABAO

V 103082//30497

C iprale x table t film o m huld 20m g

0,50 stuk

2,13277

2N06ABAO

V 11619

Feva rin ta ble t 100m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 14668 V 16292

Se rox a t ta ble t film o m huld 20m g Zo lo ft ta ble t film o m huld 50m g

1,00 stuk 1,00 stuk

1,06638 1,06638

2N06ABAO

V 19429

P ro za c disp ta ble t 20m g

1,00 stuk

1,06638

2N06ABAO

V 19593

C ipram il table t om huld 20m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 19594 V 20557

C ipram il table t om huld 40m g Se rox a t suspe nsie 2m g/m l

0,50 stuk 10,00 m l

2,13277 0,10664

2N06ABAO

V 20570

Fluvox a m ine m ale a at sa ndo z ta blet 50m g

2,00 stuk

0,63983

2N06ABAO

V 20571

Fluvox a m ine m ale a at sa ndo z ta blet 100m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 20579 V 20580

Fluvox a m ini m ale a s ta ble t 50m g Fluvox a m ini m ale a s ta ble t 100m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06ABAO

V 20604=10245

Fluvox a m ine m ale a at a ta ble t 50m g

2,00 stuk

0,63983

2N06ABAO

V 20605=11619

Fluvox a m ine m ale a at a ta ble t 100m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 21331 V 21332

Fluvox a m ine m ale a at a cta vis ta ble t 50m g Fluvox a m ine m ale a at a cta vis ta ble t 100m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06ABAO

V 22136

FLUVO XAMINE MALEAAT AP O TEX TABLET 50MG

2,00 stuk

0,63983

2N06ABAO

V 22137

FLUVO XAMINE MALEAAT AP O TEX TABLET 100MG

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 22440 V 22441

Fluvox a m ine m ale a at cf table t 50m g Fluvox a m ine m ale a at cf table t 100m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06ABAO

V 22687

C ipram il druppelvlo e isto f 40m g/m l

0,50 m l

2,13277

2N06ABAO

V 23696

FLUO XETINE MYLAN C APSULE 20MG

2N06ABAO 2N06ABAO

V 24014 V 24403

FLUO XETINE APO TEX C AP SULE 20MG Fluo x etine rp capsule 20m g

2N06ABAO

V 24444

Fluo x etine a capsule 20m g

1,00 stuk

1,06638

2N06ABAO

V 24467

Fluo x etine pch capsule 20m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 24609 V 24641

Fluo x etine cf disp table t 20m g Zo lo ft co nc voo r o plo ssing 20m g/m l

1,00 stuk 2,50 m l

1,06638 0,42655

2N06ABAO

V 25142

C ita lo pra m sa ndo z ta blet o m huld 20m g

1,00 stuk

1,06638

1 stuk

1,06638

1,00 stuk 1,00 stuk

1,06638 1,06638

2N06ABAO 2N06ABAO

V 25147 V 25148

C ita lo pra m cf table t om huld 10m g C ita lo pra m cf table t om huld 20m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06ABAO

V 25149

C ita lo pra m cf table t om huld 40m g

0,50 stuk

2,13277

2N06ABAO

V 25150

C ita lo pra m rp ta ble t o m huld 10m g

2,00 stuk

0,63983

2N06ABAO 2N06ABAO

V 25151 V 25152

C ita lo pra m rp ta ble t o m huld 20m g C ita lo pra m rp ta ble t o m huld 40m g

1,00 stuk 0,50 stuk

1,06638 2,13277

2N06ABAO

V 25420

C ita lo pra m a cta vis ta ble t o m huld 20m g

1,00 stuk

1,06638

2N06ABAO

V 25421

C ita lo pra m a cta vis ta ble t o m huld 40m g

0,50 stuk

2,13277

2N06ABAO 2N06ABAO

V 26382 V 26558=14668

P a rox e tinum ta ble t film o m h 20m g (als m e sila a t) P a rox e tine o f ta ble t film o m huld 20m g

1,00 stuk 1,00 stuk

1,06638 1,06638

2N06ABAO

V 26613

P a rox e tine sando z ta ble t film o m h 20m g(a ls hcl anh)

1,00 stuk

1,06638

2N06ABAO

V 26734

C ita lo pra m sa ndo z ta blet o m huld 20m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 26735 V 26736

C ita lo pra m sa ndo z ta blet o m huld 30m g C ita lo pra m sa ndo z ta blet o m huld 40m g

0,67 stuk 0,50 stuk

1,59958 2,13277

2N06ABAO

V 26737

C ita lo pra m sa ndo z ta blet o m huld 60m g

0,33 stuk

3,19915

2N06ABAO

V 26816

Fluo x etine actavis ca psule 20m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 26841 V 26951=14668

P a rox e tine m e rck table t film o m h 20m g(a ls hcl a nhy) P a rox e tine a ta ble t film o m huld 20m g(a ls hcl he m i)

1,00 stuk 1,00 stuk

1,06638 1,06638

2N06ABAO

V 27106

P a rox e tine sando z ta ble t film o m huld 20m g

1,00 stuk

1,06638

2N06ABAO

V 27135

Se rox a t ta ble t film o m huld 30m g

0,67 stuk

1,59958

2N06ABAO 2N06ABAO

V 27409 V 27410

Fluvox a m ine m ale a at pch ta ble t 50m g Fluvox a m ine m ale a at pch ta ble t 100m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06ABAO

V 27622

C ita lo pra m a ta ble t o m huld 20m g

1,00 stuk

1,06638

2N06ABAO

V 27623

C ita lo pra m a ta ble t o m huld 40m g

0,50 stuk

2,13277

2N06ABAO 2N06ABAO

V 27840 V 27849=26577

P a rox e tine cf ta blet film om huld 20m g(a ls hcl a nhy) P a rox e tine a ta ble t 20m g(a ls hcl a nhy)

1,00 stuk 1,00 stuk

1,06638 1,06638

2N06ABAO

V 28139

Fluo x etine pch disp ta ble t 20m g

1,00 stuk

2N06ABAO

V 28261

Fluo x etinum ta blet 20m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 28401 V 28402

Se rtraline pch ta ble t film o m huld 50m g Se rtraline pch ta ble t film o m huld 100m g

1,00 stuk 0,50 stuk

1,06638 2,13277

2N06ABAO

V 28417

P a rox e tine a cta v ta blet film om h 20m g(a ls hcl a nhy)

1,00 stuk

1,06638

2N06ABAO

V 28418

P a rox e tine a cta v ta blet film om h 30m g(a ls hcl a nhy)

0,67 stuk

1,59958

2N06ABAO 2N06ABAO

V 28672 V 28673

C ita lo pra m m yla n ta ble t o m huld 20m g C ita lo pra m m yla n ta ble t o m huld 40m g

1,00 stuk 0,50 stuk

1,06638 2,13277

2N06ABAO

V 28924

P AR O XETINE MYLAN TABLET FILMO MHULD 30MG

0,67 STUK

1,59958

2N06ABAO

V 29009=26577

P a rox e tinum ta ble t 20m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 29189 V 29190

Fluvox a m ine m ale a at m yla n ta ble t 50m g Fluvox a m ine m ale a at m yla n ta ble t 100m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06ABAO

V 29755

C ita lo pra m bluefish ta blet o m huld 10m g

2,00 stuk

0,63983

2N06ABAO

V 29756

C ita lo pra m bluefish ta blet o m huld 20m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 29757 V 30007

C ita lo pra m bluefish ta blet o m huld 40m g Fluo x etine sa ndo z ca psule 20m g

0,50 stuk 1,00 stuk

2,13277 1,06638

2N06ABAO

V 30134

Fluo x etinum ta blet 20m g

1,00 stuk

1,06638

2N06ABAO

V 30173

P a rox e tine rp ta ble t film o m h 30m g(als hcl he m i)

0,67 stuk

1,59958

2N06ABAO 2N06ABAO

V 30279 V 30288

Se rtraline cf table t film o m huld 50m g Se rtraline ra nbax y table t film o m huld 50m g

1,00 stuk 1,00 stuk

1,06638 1,06638

2N06ABAO

V 30495

Lex a pro ta blet film om huld 10m g

1,00 stuk

1,06638

2N06ABAO

V 30496

Lex a pro ta blet film om huld 15m g

0,67 stuk

1,59958

2N06ABAO 2N06ABAO

V 30497 V 31054

Lex a pro ta blet film om huld 20m g Se rtraline sa ndo z ta blet film om huld 50m g

0,50 stuk 1,00 stuk

2,13277 1,06638

2N06ABAO

V 31087

C ita lo pra m ra nbax y table t om huld 20m g

1,00 stuk

1,06638

1,06638

2N06ABAO

V 31088

C ita lo pra m ra nbax y table t om huld 40m g

0,50 stuk

2,13277

2N06ABAO 2N06ABAO

V 31114 V 31115

C ita lo pra m cf table t om huld 30m g C ita lo pra m cf table t om huld 60m g

0,67 stuk 0,33 stuk

1,59958 3,19915

2N06ABAO

V 31125

C ita lo pra m pch ta ble t o m huld 10m g

2,00 stuk

0,63983

2N06ABAO

V 31126

C ita lo pra m pch ta ble t o m huld 20m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 31127 V 31529

C ita lo pra m pch ta ble t o m huld 40m g Se rtraline a ta ble t film o m huld 50m g

0,50 stuk 1,00 stuk

2,13277 1,06638

2N06ABAO

V 32174

P a rox e tinum ta ble t film o m h 30m g (als hcl he m ihydr)

0,67 stuk

1,59958

2N06ABAO

V 32315

P a rox e tine pch ta ble t film o m h 20m g(als hcl a nhy)

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 32369 V 32515

FLUO XETINE MYLAN DISP TABLET 20MG P AR O XETINE AP O TEX TABLET FILMO MHULD 20MG

1,00 stuk 1,00 stuk

1,06638 1,06638

2N06ABAO

V 32678

Se rtraline m yla n ta ble t film o m huld 50m g

1,00 stuk

1,06638

2N06ABAO

V 32679

Se rtraline m yla n ta ble t film o m huld 100m g

0,50 stuk

2,13277

2N06ABAO 2N06ABAO

V 33643 V 33644

Se rtraline a uro bindo ta blet film om huld 50m g Se rtraline a uro bindo ta blet film om huld 100m g

1,00 stuk 0,50 stuk

1,06638 2,13277

2N06ABAO

V 33722

P a rox e tine sando z ta ble t film o m huld 10m g

2,00 stuk

0,63983

2N06ABAO

V 33723

P a rox e tine sando z ta ble t film o m huld 30m g

0,67 stuk

1,59958

2N06ABAO 2N06ABAO

V 34110 V 34112

P a rox e tine pch ta ble t 10m g(a ls hcl a nhy) P a rox e tine pch ta ble t film o m h 30m g(als hcl a nhy)

2,00 stuk 0,67 stuk

0,63983 1,59958

2N06ABAO

V 34377

P a rox e tine m yla n table t film o m h 20m g(a ls hcl a nhy)

1,00 stuk

1,06638

2N06ABAO

V 34944

P a rox e tine a urobindo ta ble t film o m huld 20m g

1,00 stuk

1,06638

2N06ABAO 2N06ABAO

V 34945 V 35339

P a rox e tine a urobindo ta ble t film o m huld 30m g Lex a pro druppe ls 20m g/m l

0,67 stuk 0,50 m l

1,59958 2,13277

2N06ABAO

V EU/1/04/296/001 C ym ba lta capsule m sr 30m g

2,00 stuk

0,63983

2N06ABAO

V EU/1/04/296/002 C ym ba lta capsule m sr 60m g

1,00 stuk

1,06638

2N06AGAO 2N06AGAO

V 14904 V 17493

Aurorix ta ble t o m huld 150m g Aurorix ta ble t o m huld 300m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06AGAO

V 26120

MO C LO BEMIDE MYLAN TABLET O MHULD 150MG

2N06AGAO

V 26122

Mo clo bem ide a cta vis ta ble t o m huld 150m g

2,00 stuk

0,63983

2N06AGAO 2N06AGAO

V 26123 V 27049

Mo clo bem ide a cta vis ta ble t o m huld 300m g Mo clo bem ide cf table t om huld 150m g

1,00 stuk 2,00 stuk

1,06638 0,63983

2N06AGAO

V 27050

Mo clo bem ide cf table t om huld 300m g

1,00 stuk

1,06638

2N06AGAO

V 27287

Mo clo bem ide sa ndo z ta blet o m huld 150m g

2,00 stuk

0,63983

2N06AGAO 2N06AGAO

V 27288 V 27823

Mo clo bem ide sa ndo z ta blet o m huld 300m g Mo clo bem ide pch ta ble t o m huld 150m g

1,00 stuk 2,00 stuk

1,06638 0,63983

2N06AGAO

V 27824

Mo clo bem ide pch ta ble t o m huld 300m g

1,00 stuk

1,06638

2N06AXAO

V 16686

R e m ero n ta ble t 30m g

1,00 stuk

1,06638

2N06AXAO 2N06AXAO

V 18217 V 24466

R e m ero n ta ble t 45m g R e m ero n drank 15m g/m l

0,67 stuk 2,00 m l

1,59958 0,53319

2N06AXAO

V 25780

R e m ero n so lta b o ro disp table t 15m g

2,00 stuk

0,63983

2N06AXAO

V 25781

R e m ero n so lta b o ro disp table t 30m g

1,00 stuk

1,06638

2N06AXAO 2N06AXAO

V 25782 V 30645

R e m ero n so lta b o ro disp table t 45m g Mirta za pine cf ta blet 15m g

0,67 stuk 2,00 stuk

1,59958 0,63983

2N06AXAO

V 30646

Mirta za pine cf ta blet 30m g

1,00 stuk

1,06638

2N06AXAO

V 30647

Mirta za pine cf ta blet 45m g

0,67 stuk

1,59958

2N06AXAO 2N06AXAO

V 30665 V 30666

Mirta za pine a ta ble t 15m g Mirta za pine a ta ble t 30m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06AXAO

V 30667

Mirta za pine a ta ble t 45m g

0,67 stuk

1,59958

2N06AXAO

V 30694

Mirta za pine a cta vis table t 15m g

2,00 stuk

0,63983

2N06AXAO 2N06AXAO

V 30695 V 30696

Mirta za pine a cta vis table t 30m g Mirta za pine a cta vis table t 45m g

1,00 stuk 0,67 stuk

1,06638 1,59958

2N06AXAO

V 30697

Mirta za pine sando z ta ble t 15m g

2,00 stuk

0,63983

2 STUK

0,63983

2N06AXAO 2N06AXAO

V 30699 V 30721

Mirta za pine sando z ta ble t 45m g Mirta za pine rp ta ble t 15m g

0,67 stuk 2,00 stuk

1,59958 0,63983

2N06AXAO

V 30722

Mirta za pine rp ta ble t 30m g

1,00 stuk

1,06638

2N06AXAO

V 30723

Mirta za pine rp ta ble t 45m g

0,67 stuk

1,59958

2N06AXAO 2N06AXAO

V 30732 V 30733

Mirta za pine m yla n table t 15m g Mirta za pine m yla n table t 30m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06AXAO

V 30734

Mirta za pine m yla n table t 45m g

0,67 stuk

1,59958

2N06AXAO

V 30772

MIR TAZAPINE APO TEX TABLET 15MG

2,00 stuk

0,63983

2N06AXAO 2N06AXAO

V 30773 V 30774

MIR TAZAPINE APO TEX TABLET 30MG MIR TAZAPINE APO TEX TABLET 45MG

1,00 stuk 0,67 stuk

1,06638 1,59958

2N06AXAO

V 31131

Mirta za pine sando z ta ble t 15m g

2,00 stuk

0,63983

2N06AXAO

V 31132

Mirta za pine sando z ta ble t 30m g

1,00 stuk

1,06638

2N06AXAO 2N06AXAO

V 31133 V 31844

Mirta za pine sando z ta ble t 45m g Mirta za pine pch ta ble t 15m g

0,67 stuk 2,00 stuk

1,59958 0,63983

2N06AXAO

V 31845

Mirta za pine pch ta ble t 30m g

1,00 stuk

1,06638

2N06AXAO

V 31846

Mirta za pine pch ta ble t 45m g

0,67 stuk

1,59958

2N06AXAO 2N06AXAO

V 32400 V 32401

Mirta za pine a urobindo o ro disp ta blet 15m g Mirta za pine a urobindo o ro disp ta blet 30m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06AXAO

V 32402

Mirta za pine a urobindo o ro disp ta blet 45m g

0,67 stuk

1,59958

2N06AXAO

V 33192

Mirta za pine pch o rodisp ta ble t 15m g

2,00 stuk

0,63983

2N06AXAO 2N06AXAO

V 33193 V 33194

Mirta za pine pch o rodisp ta ble t 30m g Mirta za pine pch o rodisp ta ble t 45m g

1,00 stuk 0,67 stuk

1,06638 1,59958

2N06AXAO

V 34052

MIR TAZAPINE SMELTTAB MYLAN O R O DISP TABLET 15MG

2,00 stuk

0,63983

2N06AXAO

V 34053

MIR TAZAPINE SMELTTAB MYLAN O R O DISP TABLET 30MG

1,00 stuk

1,06638

2N06AXAO 2N06AXAO

V 34054 V 34642

MIR TAZAPINE SMELTTAB MYLAN O R O DISP TABLET 45MG Mirta za pine blue fish o ro disp ta blet 15m g

0,67 stuk 2,00 stuk

1,59958 0,63983

2N06AXAO

V 34643

Mirta za pine blue fish o ro disp ta blet 30m g

1,00 stuk

1,06638

2N06AXAO

V 34644

Mirta za pine blue fish o ro disp ta blet 45m g

0,67 stuk

1,59958

2N06AXAO 2N06AXAO

V 34984 V 34985

Mirta za pine rp o rodisp ta ble t 15m g Mirta za pine rp o rodisp ta ble t 30m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2N06AXAO

V 34986

Mirta za pine rp o rodisp ta ble t 45m g

0,67 stuk

1,59958

2N06AXBO

V 9145

Tra zo lan ta ble t 100m g

3,00 stuk

0,35546

2N06BAAO 2N06BAAO

V 33668 V 33669

W e llbutrin x r ta ble t m ga 150m g W e llbutrin x r ta ble t m ga 300m g

2,00 stuk 1,00 stuk

0,63983 1,06638

2R 06AEAO

K 14635

Zyrte c dra nk 1m g/m l

10,00 m l

0,09461

2R 06AEAO 2R 06AEAO

K 28085 K 32486

Te lfa st junior ta blet o m huld 30m g C e tirizine dihcl pch dra nk 1m g/m l

4,00 stuk 10,00 m l

0,23653 0,09461

4,00 stuk

0,23653

2R 06AEAO

K 33180//28085

Te lfa st junior ta blet o m huld 30m g

2R 06AXAO

K 103683//33414

Xyza l dra nk 0,5m g/m l

10,00 m l

0,09461

2R 06AXAO 2R 06AXAO

K 13492 K 33414

C la ritine siro op 1m g/m l Xyza l dra nk 0,5m g/m l

10,00 m l 10,00 m l

0,09461 0,09461

2R 06AXAO

K EU/1/00/160/016 Ae rius siro op 0,5m g/m l

10,00 m l

0,09461

2R 06AXAO

K EU/1/00/160/018 Ae rius siro op 0,5m g/m l

10,00 m l

0,09461

2R 06AXAO 2R 06AXAO

K EU/1/00/160/019 Ae rius siro op 0,5m g/m l K EU/1/00/160/044 Ae rius oro dispe rge e rbare ta ble t 2,5m g

10,00 m l 2,00 stuk

0,09461 0,47307

2R 06AXAO

K EU/1/00/160/063 Ae rius dra nk 0,5m g/m l

10,00 m l

0,09461

2R 06AXAO

K EU/1/00/160/066 Ae rius dra nk 0,5m g/m l

10,00 m l

0,09461

2R 06AEAO

V 13010

ZYR TEC TABLET FILMO MHULD 10MG

1,00 stuk

0,50499

2R 06AEAO

V 17708

Ke stine ta blet 10m g

1,00 stuk

0,50499

2R 06AEAO

V 25270

C e tirizine dihcl sa ndo z ta blet 10m g

1,00 stuk

0,50499

2R 06AEAO 2R 06AEAO

V 25810 V 26384

HO O IKO O R TSTABLET C ETIR IZINE DIHC L AP O TEX TABL 10MG C e tirizine dihcl a pe x ta blet 10m g

1 STUK 1,00 stuk

0,50499 0,50499

2R 06AEAO

V 26723

C e tirizine dihcl m yla n ta ble t 10m g

1,00 stuk

0,50499

2R 06AEAO

V 26770

Xyza l ta blet film om huld 5m g

1,00 stuk

0,50499

2R 06AEAO 2R 06AEAO

V 26981 V 27149

C e tirizine dihcl cf table t 10m g C ETIR IZINE DIHC L AC TAVIS TABLET FILMO MHULD 10MG

1,00 stuk 1,00 stuk

0,50499 0,50499

2R 06AEAO

V 27454

C e tirizine dihcl rp ta ble t 10m g

1,00 stuk

0,50499

2R 06AEAO

V 27499

C e tirizine dihcl gf ta ble t 10m g

1,00 stuk

0,50499

2R 06AEAO 2R 06AEAO

V 27759 V 29225

C e tirizine dihcl pch ta ble t 10m g C ETIR IZINE DIHC L HTP TABLET 10MG

1,00 stuk 1,00 stuk

0,50499 0,50499

2R 06AEAO

V 29446

R e a ctine ta ble t 10m g

1,00 stuk

0,50499

2R 06AEAO

V 34946

Levo ce tirizine dihcl pch ta ble t fo 5m g

1,00 stuk

0,50499

2R 06AEAO 2R 06AEAO

V 35017 V 35212

C ETIR IZINE DIHC L SAM TABLET 10MG C e tirizine dihcl sa n ta blet 10m g

1,00 stuk 1,00 stuk

0,50499 0,50499

1,00 stuk

0,50499

2R 06AEAO

V 35213

P re va lin a lle rstop ta ble t film o m huld 10m g

2R 06AXAO

V 100529

FEXO FENADINE HC L MYLAN TABLET O MHULD 120MG

2R 06AXAO 2R 06AXAO

V 100530 V 13308

Fex o fe na dine hcl m yla n ta blet o m huld 180m g Se m pre x ca psule 8m g

2R 06AXAO

V 13388

C la ritine table t 10m g

1,00 stuk

0,50499

2R 06AXAO

V 19982

Mizolle n ta blet m ga 10m g

1,00 stuk

0,50499

2R 06AXAO 2R 06AXAO

V 21625 V 23912//21625

Te lfa st table t om huld 180m g Te lfa st table t om huld 180m g

0,67 stuk 0,67 stuk

0,75748 0,75748

2R 06AXAO

V 24710

Lora ta dine cf ta ble t 10m g

1,00 stuk

0,50499

2R 06AXAO

V 25632

HO O IKO O R TSTABLET LO R ATADINE AP O TEX TABLET 10MG

1,00 stuk

0,50499

2R 06AXAO 2R 06AXAO

V 25765 V 27517

Lora ta dine sa ndoz ta ble t 10m g LO R ATADINE MER C K TABLET FILMO MHULD 10MG

1,00 stuk 1 STUK

0,50499 0,50499

2R 06AXAO

V 28076

Lora ta dine a cta vis ta blet 10m g

1,00 stuk

0,50499

2R 06AXAO

V 28337

Lora ta dine pch table t 10m g

1,00 stuk

0,50499

2R 06AXAO 2R 06AXAO

V 28514=25632 V 28872=24710

Alle rfre ta ble t 10m g Lora ta dine neusalle rgie ta ble t 10m g

1,00 stuk 1,00 stuk

0,50499 0,50499

2R 06AXAO

V 28873=24710

HO O IKO O R TSTABLET LO R ATADINE HTP TABLET 10MG

1,00 stuk

0,50499

2R 06AXAO

V 33303

Lora ta dine sa ndoz o rodisp ta ble t 10m g

1,00 stuk

0,50499

2R 06AXAO 2R 06AXAO

V 34132 V 35226

Ho o ik o o rtsta ble t lo rata dine le ida pha rm ta ble t 10m g Fex o fe na dine hcl rp table t om huld 120m g

1,00 stuk 1,00 stuk

0,50499 0,50499

2R 06AXAO

V 35227

Fex o fe na dine hcl rp table t om huld 180m g

0,67 stuk

0,75748

2R 06AXAO

V 35228

Fex o fe na dine hcl a table t om huld 120m g

1,00 stuk

0,50499

2R 06AXAO 2R 06AXAO

V 35229 V 35246

Fex o fe na dine hcl a table t om huld 180m g Fex o fe na dine hcl pch table t om huld 120m g

0,67 stuk 1,00 stuk

0,75748 0,50499

2R 06AXAO

V 35247

Fex o fe na dine hcl pch table t om huld 180m g

0,67 stuk

0,75748

2R 06AXAO

V EU/1/00/160/008 Ae rius table t film o m huld 5m g

1,00 stuk

0,50499

2R 06AXAO 2R 06AXAO

V EU/1/00/160/009 Ae rius table t film o m huld 5m g V EU/1/00/160/011 Ae rius table t film o m huld 5m g

1,00 stuk 1,00 stuk

0,50499 0,50499

2R 06AXAO

V EU/1/00/160/036 Ae rius table t film o m huld 5m g

1,00 stuk

0,50499

2R 06AXAO

V EU/1/00/160/056 Ae rius oro dispe rge e rbare ta ble t 5m g

1,00 stuk

0,50499

2R 06AXAO

V EU/1/00/161/011 Ne ocla rityn ta ble t film o m huld 5m g

1,00 stuk

0,50499

1 STUK 0,67 stuk 3,00 stuk

0,50499 0,75748 0,16833

3D07AC ADC

V 11173

Diprole ne hydro ge l 0,5m g/g

1,00 gra m

0,16599

3D07ADADC

V 24492//6932

De rm ova te hydro fie le cre m e 0,5m g/g

1,00 gra m

0,16599

3D07ADADC 3D07ADADC

V 30644//6932 V 31424//6932

De rm ova te hydro fie le cre m e 0,5m g/g De rm ova te hydro fie le cre m e 0,5m g/g

1,00 gra m 1,00 gra m

0,16599 0,16599

3D07ADADC

V 32696//6932

C lo be ta so l-17-propio na a t cre m e 0,5m g/g

1,00 gra m

0,16599

3D07ADADC

V 6932

De rm ova te hydro fie le cre m e 0,5m g/g

1,00 gra m

0,16599

3N05C DAO

V 10015

Lendo rm in ta ble t 0,25m g

1,00 stuk

3N05C DAO

V 10539

Do rm icum ta ble t 15m g

1,00 stuk

0,19558

3N05C DAO

V 10623

Flunitraze pa m pch table t 1m g

1,00 stuk

0,19558

3N05C DAO 3N05C DAO

V 10624 V 11092

Flunitraze pa m pch table t 2m g Flunitraze pa m rp table t 2m g

0,50 stuk 0,50 stuk

0,39116 0,39116

3N05C DAO

V 12475

Nitraze pa m sa ndoz ta ble t 5m g

1,00 stuk

0,19558

3N05C DAO

V 12905

Te m a zepa m actavis ca psule 10m g

2,00 stuk

0,09779

3N05C DAO 3N05C DAO

V 12906 V 12950

Te m a zepa m actavis ca psule 20m g Flunitraze pa m a cta vis ta blet 1m g

1,00 stuk 1,00 stuk

0,19558 0,19558

3N05C DAO

V 12951

Flunitraze pa m a cta vis ta blet 2m g

0,50 stuk

0,39116

3N05C DAO

V 13027

Do rm icum ta ble t 7,5m g

2,00 stuk

0,11735

3N05C DAO 3N05C DAO

V 14354 V 14355

TEMAZEPAM AP O TEX TABLET 10MG TEMAZEPAM AP O TEX TABLET 20MG

3N05C DAO

V 15284

No cta m id 2 table t 2m g

0,50 stuk

0,39116

3N05C DAO

V 16364

Lorm e ta ze pam sando z ta ble t 1m g

1,00 stuk

0,19558

3N05C DAO 3N05C DAO

V 16365 V 18246

Lorm e ta ze pam sando z ta ble t 2m g Lorm e ta ze pam a cta vis table t 1m g

0,50 stuk 1,00 stuk

0,39116 0,19558

3N05C DAO

V 18247

Lorm e ta ze pam a cta vis table t 2m g

0,50 stuk

0,39116

3N05C DAO

V 19403=56928

TEMAZEPAM AP O TEX C AP SULE 10MG

2,00 STUK

0,09779

3N05C DAO 3N05C DAO

V 19404=56929 V 19999=52656

TEMAZEPAM AP O TEX C AP SULE 20MG Nitraze pa m a table t 5m g

1,00 STUK 1,00 stuk

0,19558 0,19558

3N05C DAO

V 20133=56649

Te m a zepa m a capsule 10m g

2,00 stuk

0,09779

3N05C DAO

V 20134=56650

Te m a zepa m a capsule 20m g

1,00 stuk

0,19558

3N05C DAO 3N05C DAO

V 21481=56480 V 21482=56481

Flura ze pa m hcl a cta vis ca psule 15m g Flura ze pa m hcl a cta vis ca psule 30m g

2,00 stuk 1,00 stuk

0,11735 0,19558

3N05C DAO

V 22230

Lorm e ta ze pam cf ta blet 1m g

1,00 stuk

0,19558

3N05C DAO

V 22231

Lorm e ta ze pam cf ta blet 2m g

0,50 stuk

0,39116

3N05C DAO 3N05C DAO

V 23363=14354 V 23364=14355

Te m a zepa m pch ta blet 10m g Te m a zepa m pch ta blet 20m g

2,00 stuk 1,00 stuk

0,09779 0,19558

3N05C DAO

V 23514

Nitraze pa m a cta vis ta blet 5m g

1,00 stuk

0,19558

3N05C DAO

V 24657

LO R METAZEP AM AP O TEX TABLET 1MG

1,00 stuk

0,19558

3N05C DAO 3N05C DAO

V 24658 V 25166=23458

LO R METAZEP AM AP O TEX TABLET 2MG Lorm e ta ze pam a ta ble t 1m g

0,50 stuk 1,00 stuk

0,39116 0,19558

3N05C DAO

V 25167=23459

Lorm e ta ze pam a ta ble t 2m g

0,50 stuk

0,39116

3N05C DAO

V 25275

Lorm e ta ze pam flx table t 1m g

1,00 stuk

0,19558

3N05C DAO 3N05C DAO

V 25276 V 25956=23458

Lorm e ta ze pam flx table t 2m g Lorm e ta ze pam m yla n table t 1m g

0,50 stuk 1,00 stuk

0,39116 0,19558

3N05C DAO

V 25957=23459

Lorm e ta ze pam m yla n table t 2m g

0,50 stuk

0,39116

3N05C DAO

V 26554=56480

Flura ze pa m hcl pch ca psule 15m g

2,00 stuk

0,11735

3N05C DAO 3N05C DAO

V 26555=56481 V 26890=14356

Flura ze pa m hcl pch ca psule 30m g Te m a zepa m a ta blet 10m g

1,00 stuk 2,00 stuk

0,19558 0,09779

3N05C DAO

V 26891=14357

Te m a zepa m a ta blet 20m g

1,00 stuk

0,19558

3N05C DAO

V 28052=50283

Nitraze pa m m yla n ta blet 5m g

1,00 stuk

0,19558

3N05C DAO 3N05C DAO

V 28071=14356 V 28072=14357

Te m a zepa m cf ta ble t 10m g Te m a zepa m cf ta ble t 20m g

2,00 stuk 1,00 stuk

0,09779 0,19558

3N05C DAO

V 28642=56756

TEMAZEPAM MYLAN C AP SULE 10MG

2 STUK

0,09779

3N05C DAO

V 28643=56757

TEMAZEPAM MYLAN C AP SULE 20MG

1 STUK

0,19558

3N05C DAO 3N05C DAO

V 5001 V 50283

Mo ga do n ta ble t 5m g NITR AZEP AM AP O TEX TABLET 5MG

1,00 stuk 1,00 STUK

0,19558 0,19558

3N05C DAO

V 52656

Nitraze pa m rp table t 5m g

1,00 stuk

0,19558

3N05C DAO

V 56066

Flura ze pa m sa ndo z capsule 15m g

2,00 stuk

0,11735

3N05C DAO

V 56128

Te m a zepa m pch capsule 10m g

2,00 stuk

0,09779

2 STUK 1 STUK

0,19558

0,09779 0,19558

3N05C DAO

V 56129

Te m a zepa m pch capsule 20m g

1,00 stuk

0,19558

3N05C DAO

V 56223

Flura ze pa m sa ndo z capsule 30m g

1,00 stuk

0,19558

3N05C DAO

V 56236

Nitraze pa m pch table t 5m g

1,00 stuk

0,19558

3N05C DAO 3N05C DAO

V 56447 V 56448

Flura ze pa m hcl rp ca psule 15m g Flura ze pa m hcl rp ca psule 30m g

2,00 stuk 1,00 stuk

0,11735 0,19558

3N05C DAO

V 56480

Flura ze pa m cf ca psule 15m g

2,00 stuk

0,11735

3N05C DAO

V 56481

Flura ze pa m cf ca psule 30m g

1,00 stuk

0,19558

3N05C DAO 3N05C DAO

V 56577 V 56578

Te m a zepa m sa ndo z ca psule 10m g Te m a zepa m sa ndo z ca psule 20m g

2,00 stuk 1,00 stuk

0,09779 0,19558

3N05C DAO

V 56597

Te m a zepa m flx ca psule 20m g

1,00 stuk

0,19558

3N05C DAO

V 56598

Te m a zepa m flx ca psule 10m g

2,00 stuk

0,09779

3N05C DAO 3N05C DAO

V 56649 V 56650

Te m a zepa m rp capsule 10m g Te m a zepa m rp capsule 20m g

2,00 stuk 1,00 stuk

0,09779 0,19558

3N05C DAO

V 56702

Nitraze pa m cf ta ble t 5m g

1,00 stuk

0,19558

3N05C DAO

V 56756

Te m a zepa m cf ca psule 10m g

2,00 stuk

0,09779

3N05C DAO 3N05C DAO

V 56757 V 56771

Te m a zepa m cf ca psule 20m g Lorm e ta ze pam pch ta ble t 1m g

1,00 stuk 1,00 stuk

0,19558 0,19558

3N05C DAO

V 56772

Lorm e ta ze pam pch ta ble t 2m g

0,50 stuk

0,39116

3N05C DAO

V 56928

Te m a zepa m um ca psule 10m g

2,00 stuk

0,09779

3N05C DAO 3N05C DAO

V 56929 V 57032

Te m a zepa m um ca psule 20m g Flunitraze pa m cf ta ble t 1m g

1,00 stuk 1,00 stuk

0,19558 0,19558

3N05C DAO

V 57033

Flunitraze pa m cf ta ble t 2m g

0,50 stuk

0,39116

3N05C DAO

V 57224

Te m a zepa m um ca psule 10m g

2,00 stuk

0,09779

3N05C DAO 3N05C DAO

V 57225 V 6308

Te m a zepa m um ca psule 20m g Da lm a do rm m e dium ca psule 15m g

1,00 stuk 2,00 stuk

0,19558 0,11735

3N05C DAO

V 6309

Da lm a do rm capsule 30m g

1,00 stuk

0,19558

3N05C DAO

V 8496

No rm ison ca psule 10m g

2,00 stuk

0,09779

3N05C DAO 3N05C DAO

V 8497 V 8606

No rm ison ca psule 20m g No cta m id 1 table t 1m g

1,00 stuk 1,00 stuk

0,19558 0,19558

3N05C DAO

V 8687

Nitraze pa m flx ta blet 5m g

1,00 stuk

0,19558

3N05C DAO

V 9142

Flura ze pa m hcl flx ca psule 15m g

2,00 stuk

0,11735

3N05C DAO 3N05C DAO

V 9143 V 9882

Flura ze pa m hcl flx ca psule 30m g Do rm ono ct ta ble t 1m g

1,00 stuk 1,00 stuk

0,19558 0,19558

3N05C FAO

V 11063

Im o va ne table t 7,5m g

1,00 stuk

0,19558

3N05C FAO

V 21434

Zo piclo n table t 7,5m g

1,00 stuk

0,19558

3N05C FAO 3N05C FAO

V 22397 V 23614=21437

Zo piclo n cf ta ble t 7,5m g Zo piclo n sa ndo z table t 7,5m g

1,00 stuk 1,00 stuk

0,19558 0,19558

3N05C FAO

V 23713=21437

Zo piclo n actavis ta ble t 7,5m g

1,00 stuk

0,19558

3N05C FAO

V 23877

Zo piclo n table t 7,5m g

1,00 stuk

0,19558

3N05C FAO 3N05C FAO

V 24660 V 25628

Zo piclo n m ylan ta ble t 7,5m g Zo piclo n pch ta blet 7,5m g

1,00 stuk 1,00 stuk

0,19558 0,19558

3N05C FAO

V 26268

Zo piclo n rp ta blet 7,5m g

1,00 stuk

0,19558

3N05C FAO

V 29536

Zo piclo n a ta blet 7,5m g

1,00 stuk

0,19558

3N05C FAO 3N05C GAO

V 31802 V 13223

ZO P IC LO N AP O TEX TABLET 7,5MG Stilno ct ta ble t film o m huld 10m g

1,00 stuk 1,00 stuk

0,19558 0,19558

3N05C GAO

V 25030

Zo lpidem ta rtra at sa ndo z ta blet film om huld 10m g

1,00 stuk

0,19558

3N05C GAO

V 25107

Zo lpidem ta rtra at a cta vis ta ble t film o m huld 10m g

1,00 stuk

0,19558

3N05C GAO 3N05C GAO

V 25109 V 25111

Zo lpidem ta rtra at sa ndo z ta blet film om huld 10m g Zo lpidem ta rtra at rp ta ble t film o m huld 10m g

1,00 stuk 1,00 stuk

0,19558 0,19558

3N05C GAO

V 25353

Zo lpidem ta rtra at pch ta ble t film o m huld 10m g

1,00 stuk

0,19558

3N05C GAO

V 26420

Zo lpidem i ta rtras ta ble t film o m huld 10m g

1,00 stuk

0,19558

3N05C GAO

V 26424

Zo lpidem ta rtra at cf table t film o m huld 10m g

1,00 stuk

0,19558

3N05C GAO

V 28486

Zo lpidem ta rtra at m yla n ta ble t film o m huld 10m g

1,00 stuk

0,19558

3N05C GAO

V 33829

ZO LPIDEMTAR TR AAT APO TEX TABLET FILMO MHULD 10MG

1,00 stuk

0,19558

3N06AXAO

V 12862

To lvo n ta blet 60m g

1,00 stuk

0,60504

3N06AXAO

V 23980=57407

Mia nse rine hcl k atwijk ta blet 10m g

6,00 stuk

0,20168

3N06AXAO

V 23981=57408

Mia nse rine hcl k atwijk ta blet 30m g

2,00 stuk

0,30252

3N06AXAO 3N06AXAO

V 57407 V 57408

MIANSER INE HC L TEVA TABLET 10MG MIANSER INE HC L TEVA TABLET 30MG

6,00 stuk 2,00 stuk

0,20168 0,30252

3N06AXAO

V 9041

To lvo n ta blet 10m g

6,00 stuk

0,20168

3N06AXAO

V 9042

To lvo n ta blet 30m g

2,00 stuk

0,30252

4D07AC ADZ

V 9522

Diprole ne za lf 0,5m g/g

1,00 gra m

0,14530

4D07ADADZ

V 101885//6933

De rm ova te hydro fo be za lf 0,05%

1,00 gra m

0,14530

4D07ADADZ

V 31037//6933

De rm ova te hydro fo be za lf 0,05%

1,00 gra m

0,14530

4D07ADADZ 4D07ADADZ

V 32694//6933 V 6933

C lo be ta so l-17-propio na a t za lf 0,5m g/g De rm ova te hydro fo be za lf 0,05%

1,00 gra m 1,00 gra m

0,14530 0,14530

4N05AEAO

V 20610

Se rdo le ct ta ble t film o m huld 4m g

4,00 stuk

1,58521

4N05AEAO 4N05AEAO

V 20613 V 20614

Se rdo le ct ta ble t film o m huld 16m g Se rdo le ct ta ble t film o m huld 20m g

1,00 stuk 0,80 stuk

3,96302 4,95377

4N05AHAO

V EU/1/96/022/002 Zypre x a ta blet 2,5m g

4,00 stuk

1,58521

4N05AHAO

V EU/1/96/022/004 Zypre x a ta blet 5m g

2,00 stuk

1,98151

4N05AHAO 4N05AHAO

V EU/1/96/022/006 Zypre x a ta blet 7,5m g V EU/1/96/022/009 Zypre x a ta blet 10m g

1,33 stuk 1,00 stuk

2,97226 3,96302

4N05AHAO

V EU/1/96/022/010 Zypre x a ta blet 10m g

1,00 stuk

3,96302

4N05AHAO

V EU/1/96/022/012 Zypre x a ta blet 15m g

0,67 stuk

5,94453

4N05AHAO 4N05AHAO

V EU/1/96/022/014 Zypre x a ta blet 20m g V EU/1/96/022/020 Zypre x a ta blet 5m g

0,50 stuk 2,00 stuk

7,92603 1,98151

4N05AHAO

V EU/1/99/125/001 Zypre x a ve lo ta b oro disp ta ble t 5m g

2,00 stuk

1,98151

4N05AHAO

V EU/1/99/125/002 Zypre x a ve lo ta b oro disp ta ble t 10m g

1,00 stuk

3,96302

4N05AHAO 4N05AHAO

V EU/1/99/125/003 Zypre x a ve lo ta b oro disp ta ble t 15m g V EU/1/99/125/004 Zypre x a ve lo ta b oro disp ta ble t 20m g

0,67 stuk 0,50 stuk

5,94453 7,92603

4N05ALAO

V 103957//6279

Do gm a til ca psule 50m g

16,00 stuk

0,24769

4N05ALAO

V 14701//6279

Do gm a til ca psule 50m g

16,00 stuk

0,24769

4N05ALAO 4N05ALAO

V 19811 V 22427//19811

Do gm a til table t 400m g Do gm a til table t 400m g

2,00 stuk 2,00 stuk

1,98151 1,98151

4N05ALAO

V 6278

Do gm a til dra nk 5m g/m l

4N05ALAO

V 6279

Do gm a til ca psule 50m g

16,00 stuk

0,24769

4N05AXAO 4N05AXAO

V 100097//19127 V 100170

R ispe rdal dra nk 1m g/m l R ispe rido n a cco rd table t om huld 0,5m g

5,00 m l 10,00 stuk

0,79260 0,63408

4N05AXAO

V 100172

R ispe rido n a cco rd table t om huld 1m g

5,00 stuk

0,79260

4N05AXAO

V 100173

R ispe rido n a cco rd table t om huld 2m g

2,50 stuk

1,58521

4N05AXAO 4N05AXAO

V 100174 V 100175

R ispe rido n a cco rd table t om huld 3m g R ispe rido n a cco rd table t om huld 4m g

1,67 stuk 1,25 stuk

2,37781 3,17041

4N05AXAO

V 100176

R ispe rido n a cco rd table t om huld 6m g

0,83 stuk

4,75562

4N05AXAO

V 100340

R ISP ER IDO N SMELTTAB MYLAN O R O DISP TABLET 1MG

5,00 STUK

0,79260

4N05AXAO 4N05AXAO

V 100341 V 102464//25603

R ISP ER IDO N SMELTTAB MYLAN O R O DISP TABLET 2MG Se roque l ta blet film om huld 300m g

2,50 STUK 1,00 stuk

1,58521 3,96302

4N05AXAO

V 103853//34628

Se roque l x r ta ble t m va 400m g

0,75 stuk

5,28402

4N05AXAO

V 103854//34627

Se roque l x r ta ble t m va 300m g

1,00 stuk

3,96302

4N05AXAO 4N05AXAO

V 103856//34626 V 104638//34627

Se roque l x r ta ble t m va 200m g Se roque l x r ta ble t m va 300m g

1,50 stuk 1,00 stuk

2,64201 3,96302

160,00 m l

0,02477

4N05AXAO

V 104639//34628

Se roque l x r ta ble t m va 400m g

0,75 stuk

5,28402

4N05AXAO

V 16096

R ispe rdal ta ble t o m huld 1m g

5,00 stuk

0,79260

4N05AXAO 4N05AXAO

V 16097 V 16098

R ispe rdal ta ble t o m huld 2m g R ispe rdal ta ble t o m huld 3m g

2,50 stuk 1,67 stuk

1,58521 2,37781

4N05AXAO

V 16099

R ispe rdal ta ble t o m huld 4m g

1,25 stuk

3,17041

4N05AXAO

V 19127

R ispe rdal dra nk 1m g/m l

5,00 m l

0,79260

4N05AXAO 4N05AXAO

V 20826 V 20827

Se roque l ta blet film om huld 25m g Se roque l ta blet film om huld 100m g

12,00 stuk 3,00 stuk

0,52840 1,32101

4N05AXAO

V 20828

Se roque l ta blet film om huld 200m g

1,50 stuk

2,64201

4N05AXAO

V 22714

R ispe rdal ta ble t o m huld 0,5m g

4N05AXAO 4N05AXAO

V 25128 V 25603

Se roque l sta rtve rpak k ing (6x 25m g+3x 100m g+1x 200m g) Se roque l ta blet film om huld 300m g

4N05AXAO

V 26324//19127

R ispe rdal dra nk 1m g/m l

5,00 m l

0,79260

4N05AXAO

V 27791

R ispe rdal quick le t o rodisp ta ble t 1m g

5,00 stuk

0,79260

4N05AXAO 4N05AXAO

V 27792 V 28456//20827

R ispe rdal quick le t o rodisp ta ble t 2m g Se roque l ta blet film om huld 100m g

2,50 stuk 3,00 stuk

1,58521 1,32101

4N05AXAO

V 30913

R ispe rido n cf ta ble t o m huld 0,5m g

10,00 stuk

0,63408

4N05AXAO

V 30914

R ispe rido n cf ta ble t o m huld 1m g

5,00 stuk

0,79260

4N05AXAO 4N05AXAO

V 30915 V 30916

R ispe rido n cf ta ble t o m huld 2m g R ispe rido n cf ta ble t o m huld 3m g

2,50 stuk 1,67 stuk

1,58521 2,37781

4N05AXAO

V 30917

R ispe rido n cf ta ble t o m huld 4m g

1,25 stuk

3,17041

4N05AXAO

V 31775

R ispe rdal quick le t o rodisp ta ble t 3m g

1,67 stuk

2,37781

4N05AXAO 4N05AXAO

V 31776 V 32040//20828

R ispe rdal quick le t o rodisp ta ble t 4m g Se roque l ta blet film om huld 200m g

1,25 stuk 1,50 stuk

3,17041 2,64201

4N05AXAO

V 32414

R ispe rido n m yla n ta blet o m huld 0,5m g

10,00 stuk

0,63408

4N05AXAO

V 32415

R ispe rido n m yla n ta blet o m huld 1m g

5,00 stuk

0,79260

4N05AXAO 4N05AXAO

V 32416 V 32417

R ispe rido n m yla n ta blet o m huld 2m g R ispe rido n m yla n ta blet o m huld 3m g

2,50 stuk 1,67 stuk

1,58521 2,37781

4N05AXAO

V 32418

R ispe rido n m yla n ta blet o m huld 4m g

1,25 stuk

3,17041

4N05AXAO

V 32500//25603

Se roque l ta blet film om huld 300m g

1,00 stuk

3,96302

4N05AXAO 4N05AXAO

V 32937//20828 V 32938//25603

Se roque l ta blet film om huld 200m g Se roque l ta blet film om huld 300m g

1,50 stuk 1,00 stuk

2,64201 3,96302

4N05AXAO

V 32939//25603

Se roque l ta blet film om huld 300m g

1,00 stuk

3,96302

4N05AXAO

V 33215

R ispe rido n rp table t om huld 0,5m g

10,00 stuk

0,63408

4N05AXAO 4N05AXAO

V 33216 V 33217

R ispe rido n rp table t om huld 1m g R ispe rido n rp table t om huld 2m g

5,00 stuk 2,50 stuk

0,79260 1,58521

4N05AXAO

V 33218

R ispe rido n rp table t om huld 3m g

1,67 stuk

2,37781

4N05AXAO

V 33219

R ispe rido n rp table t om huld 4m g

1,25 stuk

3,17041

4N05AXAO 4N05AXAO

V 33271 V 33495

R ispe rido n pch table t om huld 0,5m g R ispe rido n a uro bindo ta ble t o m huld 0,5m g

10,00 stuk 10,00 stuk

0,63408 0,63408

4N05AXAO

V 33496

R ispe rido n a uro bindo ta ble t o m huld 1m g

5,00 stuk

0,79260

4N05AXAO

V 33497

R ispe rido n a uro bindo ta ble t o m huld 2m g

2,50 stuk

1,58521

4N05AXAO 4N05AXAO

V 33498 V 33499

R ispe rido n a uro bindo ta ble t o m huld 3m g R ispe rido n a uro bindo ta ble t o m huld 4m g

1,67 stuk 1,25 stuk

2,37781 3,17041

4N05AXAO

V 33796

R ispe rido n sa ndoz drank 1m g/m l

5,00 m l

0,79260

4N05AXAO

V 34202

R ISP ER IDO N SANDO Z TABLET O MHULD 1MG

5,00 stuk

0,79260

4N05AXAO 4N05AXAO

V 34203 V 34204

R ISP ER IDO N SANDO Z TABLET O MHULD 2MG R ISP ER IDO N SANDO Z TABLET O MHULD 3MG

2,50 stuk 1,67 stuk

1,58521 2,37781

4N05AXAO

V 34205

R ISP ER IDO N SANDO Z TABLET O MHULD 4MG

1,25 stuk

3,17041

4N05AXAO

V 34381

R ispe rido n rp dra nk 1m g/m l

5,00 m l

0,79260

4N05AXAO 4N05AXAO

V 34507//20827 V 34625

Se roque l ta blet film om huld 100m g Se roque l x r ta ble t m va 50m g

3,00 stuk 6,00 stuk

1,32101 0,66050

10,00 stuk

0,63408

0,41 verp 1,00 stuk

9,77544 3,96302

4N05AXAO

V 34627

Se roque l x r ta ble t m va 300m g

1,00 stuk

3,96302

4N05AXAO 4N05AXAO

V 34628 V 34630

Se roque l x r ta ble t m va 400m g R ISP ER IDO N MYLAN DR ANK 1MG/ML

0,75 stuk 5,00 ML

5,28402 0,79260

4N05AXAO

V 34778

R ispe rido n a cta vis ta blet o m huld 0,5m g

10,00 stuk

0,63408

4N05AXAO

V 34779

R ispe rido n a cta vis ta blet o m huld 1m g

5,00 stuk

0,79260

4N05AXAO 4N05AXAO

V 34780 V 34781

R ispe rido n a cta vis ta blet o m huld 2m g R ispe rido n a cta vis ta blet o m huld 3m g

2,50 stuk 1,67 stuk

1,58521 2,37781

4N05AXAO

V 34782

R ispe rido n a cta vis ta blet o m huld 4m g

1,25 stuk

3,17041

4N05AXAO

V 35118//20827

Se roque l ta blet film om huld 100m g

3,00 stuk

1,32101

4N05AXAO 4N05AXAO

V 35119//20828 V 35242

Se roque l ta blet film om huld 200m g R ispe rido n pch table t om huld 1m g

1,50 stuk 5,00 stuk

2,64201 0,79260

4N05AXAO

V 35243

R ispe rido n pch table t om huld 2m g

2,50 stuk

1,58521

4N05AXAO

V 35244

R ispe rido n pch table t om huld 3m g

1,67 stuk

2,37781

4N05AXAO 4N05AXAO

V 35245 V 79999

R ispe rido n pch table t om huld 4m g Se roque l sta rtve rpak k ing (6x 25m g+2x 100m g)

1,25 stuk 0,68 verp

3,17041 5,81242

4N05AXAO

V EU/1/04/276/007 Abilify ta blet 10m g

1,50 stuk

2,90621

4N05AXAO

V EU/1/04/276/012 Abilify ta blet 15m g

1,00 stuk

3,96302

4N05AXAO 4N05AXAO

V EU/1/04/276/017 Abilify ta blet 30m g V EU/1/07/395/006 Invega ta ble t m va 6m g

0,50 stuk 1,00 stuk

7,92603 3,96302

4N05AXAO

V EU/1/07/395/011 Invega ta ble t m va 9m g

0,67 stuk

5,94453

4N05AXAO

V EU/1/07/395/026 Invega ta ble t m va 6m g

1,00 stuk

3,96302

AC 03EAAO

V 13605

Triam te re en/e pitizide sando z ca psule 50/4m g

1,00 stuk

0,16018

AC 03EAAO

V 17145=56065

TR IAMTER EEN/EP ITIZIDE AP O TEX C AP SULE 50/4MG

1,00 STUK

0,16018

AC 03EAAO

V 29034=13605

TR IAMTER EEN/EP ITIZIDE MYLAN C AP SULE 50/4MG

1,00 stuk

0,16018

AC 03EAAO AC 03EAAO

V 4558 V 56065

Dyta ure se ca psule Triam te re en/e pitizide pch ca psule 50/4m g

1,00 stuk 1,00 stuk

0,16018 0,16018

AC 03EAAO

V 57247

Epitizide /triam te re en ca psule 4/50m g

1,00 stuk

0,16018

AC 03EAAO

V 9832=4558

Triam te re en/e pitizide o f ca psule 50/4m g

1,00 stuk

0,16018

AC 03EABO AC 03EABO

V 11095 V 11128

Am ilo ride hcl/hydro chloo rthiazide rp ta ble t 5/50m g Am ilo ride co m p cf ta ble t 5/50m g

1,00 stuk 1,00 stuk

0,16018 0,16018

AC 03EABO

V 11802

Am ilo ride hcl/hydro chloo rthiazide pch ta bl 5/50m g

1,00 stuk

0,16018

AC 03EABO

V 11803

Am ilo ride hcl/hydro chloo rthiazide pch ta b 2,5/25m g

2,00 stuk

0,09611

AC 03EABO AC 03EABO

V 23568 V 24024

Am ilo ride /hydro chlo orthia zide ta blet 5/50m g AMILO R IDI HC L/HYDR O C HLO R O THIAZIDUM 5/50MG TABLET

1,00 stuk 1,00 STUK

0,16018 0,16018

AC 03EABO

V 24084=11095

AMILO R IDE HC L/HYDR O C HLO O R THIAZIDE MYLAN TAB 5/50MG

1 STUK

0,16018

AC 03EABO

V 25714=11128

Am ilo ride hcl/hydro chloo rthiazide a ct ta bl 5/50m g

1,00 stuk

0,16018

AC 03EABO AC 03EABO

V 57243 V 57527

Am ilo ride hcl/hydro chloo rthiazide ta ble t 5/50m g Am ilo ride hcl/hydro chloo rthiazide sdz ta b 2,5/25m g

1,00 stuk 2,00 stuk

0,16018 0,09611

AC 03EABO

V 57528

Am ilo ride hcl/hydro chloo rthiazide sdz ta bl 5/50m g

1,00 stuk

0,16018

AC 03EABO

V 57555

Am ilo ride hcl/hydro chloo rthiazide flx tabl 5/50m g

1,00 stuk

0,16018

AC 03EABO AC 03EABO

V 57560 V 5857

AMILO R IDE HC L/HYDR O C HLO O R THIAZIDE APO TEX TB 5/50MG Mo duretic ta blet

1,00 stuk 1,00 stuk

0,16018 0,16018

AC 03EAC O

V 10159

Triam te re en/hydro chlo orthia zide pch ta bl 50/25m g

1,00 stuk

0,16018

AC 03EAC O

V 29039=56658

Triam te re en/hydro chlo orthia zide sa ndo z ta b 50/25m g

1,00 stuk

0,16018

AC 03EAC O AC 03EAC O

V 55610 V 55632

Triam te re en/hydro chlo orthia zide flx ta bl 50/25m g Triam te re en/hydro chlo orthia zide cf table t 50/25m g

1,00 stuk 1,00 stuk

0,16018 0,16018

AC 03EAC O

V 56658

TR IAMTER EEN/HYDR O C HLO O R THIAZIDE AP O TEX TAB 50/25MG

1,00 stuk

0,16018

AC 03EAC O

V 57418

Triam te re en/hydro chlo orthia zide m yla n ta bl 50/25m g

1,00 stuk

0,16018

AC 03EAC O AC 03EAC O

V 7104 V 9831=7104

Dytenzide ta ble t Triam te re en/hydro chlo orthia zide o f ta ble t 50/25m g

1,00 stuk 1,00 stuk

0,16018 0,16018

YA10ABAP D

V EU/1/96/007/016 Hum alo g m ix 25 pe n injsusp 100e/m l wwsp 3m l

1,00 m l

2,48974

YA10ABAP D

V EU/1/96/007/033 Hum alo g m ix 25 k wik pe n injsusp 100e/m l wwsp 3m l

1,00 m l

2,48974

YA10ABAP I

V EU/1/96/007/006 Hum alo g m ix 50 injsusp 100e /m l patro o n 3m l

1,00 m l

2,17784

YA10ABAP I

V EU/1/96/007/008 Hum alo g m ix 25 injsusp 100e /m l patro o n 3m l

1,00 m l

2,13503

YA10ABBP D

V EU/1/96/007/035 Hum alo g m ix 50 k wik pe n injsusp 100e/m l wwsp 3m l

1,00 m l

2,48974

YA10ADAPD

V EU/1/02/231/020 Mix ta rd 10 novo le t 100ie /m l wwsp 3m l

0,40 m l

2,48974

YA10ADAPI

V EU/1/02/231/006 Mix ta rd 10 penfill 100ie /m l patro o n 3m l

0,40 m l

2,09247

YA10ADBPD

V EU/1/97/030/075 Insum a n co m b 15 opt inj 100ie /m l wwsp 3m l

0,40 m l

2,48974

YA10ADBPI

V EU/1/97/030/040 Insum a n co m b 15 inj 100ie /m l pa tro on 3m l

1,00 m l

2,09259

YA10ADC P D

V EU/1/02/231/022 Mix ta rd 20 novo le t 100ie /m l wwsp 3m l

0,40 m l

2,48974

YA10ADC P I

V EU/1/02/231/009 Mix ta rd 20 penfill 100ie /m l patro o n 3m l

1,00 m l

2,09271

YA10ADDP

V EU/1/97/030/043 Insum a n co m b 25 inj 100ie /m l fla co n 5m l

1,00 m l

1,88228

YA10ADDP D

V EU/1/97/030/079 Insum a n co m b 25 opt inj 100ie /m l wwsp 3m l

1,00 m l

2,48974

YA10ADDP I

V EU/1/97/030/045 Insum a n co m b 25 inj 100ie /m l pa tro on 3m l

1,00 m l

2,09283

YA10ADEP

V EU/1/02/231/003 Mix ta rd 30 injvlst 100ie /m l fla co n 10m l

0,40 m l

1,88228

YA10ADEP D YA10ADEP D

V EU/1/02/229/024 Actra pha ne 30 no vo let injsusp 100ie /m l wwsp 3m l V EU/1/02/231/024 Mix ta rd 30 novo le t 100ie /m l wwsp 3m l

1,00 m l 1,00 m l

2,48974 2,48974

YA10ADEP I

V 14894

1,00 m l

2,09295

YA10ADEP I YA10ADEP I

V 33007//14894 Hum uline 30/70 inj 100ie /m l pa tro on 3m l V EU/1/02/229/012 Actra pha ne 30 pe nfill injsusp 100ie /m l patro o n 3m l

0,40 m l 0,40 m l

2,09295 2,09295

YA10ADEP I

V EU/1/02/231/012 Mix ta rd 30 penfill 100ie /m l patro o n 3m l

0,40 m l

2,09295

YA10ADFP D

V EU/1/02/231/026 Mix ta rd 40 novo le t 100ie /m l wwsp 3m l

0,40 m l

2,48974

YA10ADFP I

V EU/1/02/229/015 Actra pha ne 40 pe nfill injsusp 100ie /m l patro o n 3m l

0,40 m l

2,09319

YA10ADFP I

V EU/1/02/231/015 Mix ta rd 40 penfill 100ie /m l patro o n 3m l

0,40 m l

2,09319

YA10ADGP

V EU/1/97/030/048 Insum a n co m b 50 inj 100ie /m l fla co n 5m l

0,40 m l

1,88228

YA10ADGP D YA10ADGP D

V EU/1/02/231/028 Mix ta rd 50 novo le t 100ie /m l wwsp 3m l V EU/1/97/030/083 Insum a n co m b 50 opt inj 100ie /m l wwsp 3m l

1,00 m l 0,40 m l

2,48974 2,48974

YA10ADGP I

V EU/1/02/229/018 Actra pha ne 50 pe nfill injsusp 100ie /m l patro o n 3m l

0,40 m l

2,09344

YA10ADGP I YA10ADGP I

V EU/1/02/231/018 Mix ta rd 50 penfill 100ie /m l patro o n 3m l V EU/1/97/030/050 Insum a n co m b 50 inj 100ie /m l pa tro on 3m l

0,40 m l 1,00 m l

2,09344 2,09344

Hum uline 30/70 inj 100ie /m l pa tro on 3m l

YA10BDAO

V 27246

YA10BDC O YA10BDC O

Gluco va nce table t film o m huld 500/5m g

1,00 stuk

0,19376

V EU/1/07/425/002 Eucrea s table t om huld 50/ 850m g

1,00 stuk

1,70386

V EU/1/07/425/003 Eucrea s table t om huld 50/ 850m g

1,00 stuk

1,70386

YA10BDC O YA10BDC O

V EU/1/07/425/008 Eucrea s table t om huld 50/1000m g V EU/1/07/425/009 Eucrea s table t om huld 50/1000m g

1,00 stuk 1,00 stuk

1,72042 1,72042

YA10BDDO

V EU/1/08/455/003 Ja num e t ta ble t film o m huld 50m g/ 850m g

1,00 stuk

1,70386

YA10BDDO

V EU/1/08/455/010 Ja num e t ta ble t film o m huld 50m g/1000m g

1,00 stuk

1,72042

YA10BGBO

V EU/1/06/354/005 C o m pe ta ct ta ble t film o m huld 15/850m g

1,00 stuk

0,90264

YB01AC AO YB01AC AO

V 21171 V 30543//21171

Asa santin reta rd ca psule m ga 25/200m g Asa santin reta rd ca psule m ga 25/200m g

1,00 stuk 1,00 stuk

0,29095 0,29095

YB01AC AO

V 32300//21171

Asa santin reta rd ca psule m ga 25/200m g

1,00 stuk

0,29095

YB01AC AO

V 33850//21171

Asa santin reta rd ca psule m ga 25/200m g

1,00 stuk

0,29095

YC 07BBAO

V 13648

Se lo k o m b zoc 100 ta ble t m ga

1,00 stuk

0,32248

YC 07BBAO

V 16200

Em core tic ta ble t 5/12,5m g

1,00 stuk

0,25480

YC 07BBAO YC 07BBAO

V 16201 V 29881

Em core tic ta ble t 10/25m g Biso prolo lfum a ra at/hydrochlo o rthia cf ta 10/25m g

1,00 stuk 1,00 stuk

0,50959 0,50959

YC 07BBAO

V 30620

Me to prolo lsuccina at/hct sa ndo z tabl m ga 95/12,5m g

1,00 stuk

0,32248

YC 07BBAO

V 33890

Biso prolo lfum a ra at/hydrochlo o rthia pch t 5/12,5m g

1,00 stuk

0,25480

YC 07BBAO YC 07BBAO

V 33891 V 9187

Biso prolo lfum a ra at/hydrochlo o rthia pch t 10/25m g Se lo k o m b 200 dure tte ta blet m ga

1,00 stuk 1,00 stuk

0,50959 0,64497

YC 07C BAO

V 15842

Ate no lo l/chlo o rta lido n sa ndo z ta blet 50/12,5m g

1,00 stuk

0,32248

YC 07C BAO YC 07C BAO

V 15843 V 15855

Ate no lo l/chlo o rta lido n sa ndo z ta blet 100/25m g Ate no lo l/chlo o rta lido n pch ta ble t 50/12,5m g

1,00 stuk 1,00 stuk

0,64497 0,32248

YC 07C BAO

V 15856

Ate no lo l/chlo o rta lido n pch ta ble t 100/25m g

1,00 stuk

0,64497

YC 07C BAO

V 17035

Ate no lo l/chlo o rta lido n sa ndo z ta blet 50/12,5m g

1,00 stuk

0,32248

YC 07C BAO YC 07C BAO

V 17036 V 18617

Ate no lo l/chlo o rta lido n sa ndo z ta blet 100/25m g ATENO LO L/C HLO O R TALIDO N APO TEX TABLET 50/12,5MG

1,00 stuk 1,00 stuk

0,64497 0,32248

YC 07C BAO

V 18618

ATENO LO L/C HLO O R TALIDO N APO TEX TABLET 100/25MG

1,00 stuk

0,64497

YC 07C BAO

V 19467=15842

Ate no lo l/chlo o rta lido n cf table t 50/12,5m g

1,00 stuk

0,32248

YC 07C BAO YC 07C BAO

V 19468=15843 V 21832

Ate no lo l/chlo o rta lido n cf table t 100/25m g Ate no lo l/chlo o rta lido n a cta vis ta ble t 50/12,5m g

1,00 stuk 1,00 stuk

0,64497 0,32248

YC 07C BAO

V 21833

Ate no lo l/chlo o rta lido n a cta vis ta ble t 100/25m g

1,00 stuk

YC 07C BAO

V 24098=57118

ATENO LO L/C HLO O R TALIDO N MYLAN TABLET 50/12,5MG

YC 07C BAO YC 07C BAO

V 24099=57119 V 57118

YC 07C BAO

0,64497

1 STUK

0,32248

ATENO LO L/C HLO O R TALIDO N MYLAN TABLET 100/25MG Ate no lo l/chlo o rta lido n rp ta ble t 50/12,5m g

1 STUK 1,00 stuk

0,64497 0,32248

V 57119

Ate no lo l/chlo o rta lido n rp ta ble t 100/25m g

1,00 stuk

0,64497

YC 09BAAO

V 103776//33663

C O VER SYL PLUS AR G TABLET FILMO MHULD 5/1,25MG

1 STUK

0,78183

YC 09BAAO

V 104883//33663

C O VER SYL PLUS AR G TABLET FILMO MHULD 5/1,25MG

1 STUK

0,78183

YC 09BAAO

V 11825

C o re nite c ta ble t 20/12,5m g

1,00 stuk

1,21989

YC 09BAAO YC 09BAAO

V 15230 V 15231

C ibadre x table t 10/12,5m g C ibadre x table t 20/25m g

1,00 stuk 1,00 stuk

0,83050 1,66100

YC 09BAAO

V 15551

Tritazide ta ble t 5/25m g

1,00 stuk

1,27162

YC 09BAAO

V 15835

Acuzide table t 20/12,5m g

1,00 stuk

0,83050

YC 09BAAO YC 09BAAO

V 20734 V 22912

R e nite c plus ta ble t 20/6m g C o ve rsyl plus table t 4/1,25m g

1,00 stuk 1,00 stuk

1,19299 0,63581

YC 09BAAO

V 23512

C AP TO PR IL/HYDR O C HLO O R THIAZIDE AP O T TABLET 50/25MG

1,00 stuk

0,68754

YC 09BAAO

V 23698

C a ptopril/hydro chlo o rthia zide sa ndoz ta bl 50/25m g

1,00 stuk

0,68754

YC 09BAAO YC 09BAAO

V 24539 V 25418

C a ptopril/hydro chlo o rthia zide m yla n ta blet 50/25m g Ena la pril/hydro chloo rthiazide sando z ta b 20/12,5m g

1,00 stuk 1,00 stuk

0,68754 1,21989

YC 09BAAO

V 25728

Ena la pril/hydro chloo rthiazide sando z ta b 20/12,5m g

1,00 stuk

1,21989

YC 09BAAO

V 25939

C a ptopril/hydro chlo o rthia zide cf ta ble t 50/25m g

1,00 stuk

0,68754

YC 09BAAO YC 09BAAO

V 26500 V 27119

Ena la pril/hydro chloo rthiazide rp ta ble t 20/12,5m g C a ptopril/hydro chlo o rthia zide a cta v ta ble t 50/25m g

1,00 stuk 1,00 stuk

1,21989 0,68754

YC 09BAAO

V 27608=23512

C a ptopril/hydro chlo o rthia zide pch table t 50/25m g

1,00 stuk

0,68754

YC 09BAAO

V 27810

ENALAP R IL/HYDR O C HLO O R THIAZIDE AP O TEX TAB 20/12,5MG

1,00 stuk

1,21989

YC 09BAAO YC 09BAAO

V 28048 V 28296

Ena la pril/hydro chloo rthiazide cf ta blet 20/12,5m g Ena la pril/hydro chloo rthiazide pch ta ble t 20/12,5m g

1,00 stuk 1,00 stuk

1,21989 1,21989

YC 09BAAO

V 28471=25418

Ena la pril/hydro chloo rthiazide a ta ble t 20/12,5m g

1,00 stuk

1,21989

YC 09BAAO

V 28614

Ena la pril/hydro chloo rthiazide a ct ta bl 20/12,5m g

1,00 stuk

1,21989

YC 09BAAO YC 09BAAO

V 28684=25728 V 30083

Ena la pril/hydro chloo rthiazide m yla n tabl 20/12,5m g Ena la pril/hydro chloo rthiazide cf ta blet 20/ 6 m g

1,00 stuk 1,00 stuk

1,21989 1,19299

YC 09BAAO

V 30085

R a m ipril/hydro chlo o rthia zide sa ndoz ta ble t 5/25m g

1,00 stuk

1,27162

YC 09BAAO

V 30297

Q uinapril/hydro chlo o rthia zide sdz tabl 20/12,5m g

1,00 stuk

0,83050

YC 09BAAO YC 09BAAO

V 30391 V 31412

Q uinapril/hydro chlo o rthia zide a ct ta bl 20/12,5m g Q uinapril/hydro chlo o rthia zide cf ta ble t 20/12,5m g

1,00 stuk 1,00 stuk

0,83050 0,83050

YC 09BAAO

V 31563

Fosino pril/hydrochlo o rthia zide pch ta bl 20/12,5m g

1,00 stuk

0,83050

YC 09BAAO

V 32851

Ena la pril/hydro chloo rthiazide sando z ta b 20/6m g

1,00 stuk

1,19299

YC 09BAAO YC 09BAAO

V 33358 V 33663

Q uinapril/hydro chlo o rthia zide pch tabl 20/12,5m g C O VER SYL PLUS AR G TABLET FILMO MHULD 5/1,25MG

1,00 stuk 1 STUK

0,83050 0,78183

YC 09BAAO

V 33838//22912

P e rindo pril te rt-butyl/inda pam ide ta blet 4/1,25m g

1,00 stuk

0,63581

YC 09BAAO

V 35319

R a m ipril/hydro chlo o rthia zide a cta vis ta blet 5/25m g

1,00 stuk

1,27162

YC 09BABO

V 13611

Ze sto re tic table t

1,00 stuk

1,21989

YC 09BABO

V 22386//13611

Ze sto re tic table t

1,00 stuk

1,21989

YC 09BABO

V 27891

Lisino pril/hydrochlo o rth a cta vis ta bl 20/12,5m g

1,00 stuk

1,21989

YC 09BABO YC 09BABO

V 28302 V 29136

Lisino pril/hydrochlo o rth pch ta ble t 20/12,5m g LISINO P R IL/HYDR O C HLO O R TH AP O TEX TABLET 20/12,5MG

1,00 stuk 1,00 stuk

1,21989 1,21989

YC 09BABO

V 29673

Lisino pril/hydrochlo o rth sa ndo z ta blet 20/12,5m g

1,00 stuk

1,21989

YC 09BABO

V 29994

Lisino pril/hydrochlo o rth cf table t 20/12,5m g

1,00 stuk

YC 09BABO

V 30613

LISINO P R IL/HYDR O C HLO O R TH MYLAN TABLET 20/12,5MG

YC 09BBAO

V 16830

Ta rk a ca psule m ga 180/2m g

1,00 stuk

0,81870

YC 09BBAO

V 22449

Triapin table t om huld 2,5/2,5m g

0,00

0,91133

YC 09BBAO

V 22490//16830

Ta rk a ca psule m ga 180/2m g

1,00 stuk

0,81870

YC 09BBBO

V 100139

C o ve ra m arg ta ble t 5m g/ 5m g

1,00 stuk

1,38460

YC 09BBBO

V 100140

C o ve ra m arg ta ble t 5m g/10m g

1,00 stuk

2,03910

YC 09BBBO YC 09BBBO

V 100141 V 100142

C o ve ra m arg ta ble t 10m g/ 5m g C o ve ra m arg ta ble t 10m g/10m g

1,00 stuk 1,00 stuk

2,11470 2,76920

YC 09BBC O

V 101314

Lerte c ta blet film om huld 10/10m g

1,00 stuk

1,23858

YC 09BBC O

V 101315

Lerte c ta blet film om huld 20/10m g

1,00 stuk

1,82266

YC 09DAAO

V 100453

C o dio van ta ble t o m huld 320/12,5m g

1,00 stuk

3,02853

YC 09DAAO

V 100454

C o dio van ta ble t o m huld 320/25m g

1,00 stuk

3,08026

1 STUK

1,21989 1,21989

YC 09DAAO

V 101348//19269

C o za a r plus table t om huld 50/12,5m g

1,00 stuk

0,79593

YC 09DAAO

V 103109//22365

C o dio van ta ble t o m huld 80/12,5m g

1,00 stuk

0,79593

YC 09DAAO

V 103697//100454 C o dio van ta ble t o m huld 320/25m g

1,00 stuk

3,08026

YC 09DAAO YC 09DAAO

V 103699//100453 C o dio van ta ble t o m huld 320/12,5m g V 104464//100453 C o dio van ta ble t o m huld 320/12,5m g

1,00 stuk 1,00 stuk

3,02853 3,02853

YC 09DAAO

V 104543//100454 C o dio van ta ble t o m huld 320/25m g

1,00 stuk

3,08026

YC 09DAAO

V 19269

Hyza a r table t 50/12,5m g

1,00 stuk

0,79593

YC 09DAAO YC 09DAAO

V 22365 V 23597

C o dio van ta ble t o m huld 80/12,5m g Fortza ar ta blet o m huld 100/25m g

1,00 stuk 1,00 stuk

0,79593 1,59186

YC 09DAAO

V 24995

Ata ca nd plus ta ble t 16/12,5m g

1,00 stuk

1,54013

YC 09DAAO

V 29491

C o dio van ta ble t o m huld 160/12,5m g

1,00 stuk

1,54013

YC 09DAAO YC 09DAAO

V 31122 V 31423//29491

C o dio van ta ble t o m huld 160/25m g C o ta reg ta ble t o m huld 160/12,5m g

1,00 stuk 1,00 stuk

1,59186 1,54013

YC 09DAAO

V 31742//22365

C o ta reg ta ble t o m huld 80/12,5m g

1,00 stuk

0,79593

YC 09DAAO

V 32134//29491

C o dio van ta ble t o m huld 160/12,5m g

1,00 stuk

1,54013

YC 09DAAO YC 09DAAO

V 32298//29491 V 32433

C o dio van ta ble t o m huld 160/12,5m g C o za a r plus table t om huld 100/12,5m g

1,00 stuk 1,00 stuk

1,54013 1,54013

YC 09DAAO

V 32651//24995

C a nde sarta n cilex e til/hydrochlo o rth ta bl 16/12,5m g

1,00 stuk

1,54013

YC 09DAAO

V 32929//24995

Blopre sid ta ble t 16/12,5m g

1,00 stuk

1,54013

YC 09DAAO YC 09DAAO

V 33125//31122 V 34471//31122

C o ta reg ta ble t o m huld 160/25m g C o ta reg ta ble t o m huld 160/25m g

1,00 stuk 1,00 stuk

1,59186 1,59186

YC 09DAAO

V 34505//31122

C o dio van ta ble t o m huld 160/25m g

1,00 stuk

1,59186

YC 09DAAO

V EU/1/02/213/002 Mica rdisplus ta ble t 40/12,5m g

1,00 stuk

0,79593

YC 09DAAO YC 09DAAO

V EU/1/02/213/007 Mica rdisplus ta ble t 80/12,5m g V EU/1/02/213/018 Mica rdisplus ta ble t 80/25m g

1,00 stuk 1,00 stuk

1,54013 1,59186

YC 09DAAO

V EU/1/02/214/002 Kinza lk o m b ta blet 40/12,5m g

1,00 stuk

0,79593

YC 09DAAO

V EU/1/02/214/007 Kinza lk o m b ta blet 80/12,5m g

1,00 stuk

1,54013

YC 09DAAO YC 09DAAO

V EU/1/98/086/001 C o a pro vel ta ble t 150/12,5m g V EU/1/98/086/004 C o a pro vel ta ble t 300/12,5m g

1,00 stuk 1,00 stuk

0,79593 1,54013

YC 09DAAO

V EU/1/98/086/012 C o a pro vel ta ble t film o m huld 150/12,5m g

1,00 stuk

0,79593

YC 09DAAO

V EU/1/98/086/014 C o a pro vel ta ble t film o m huld 150/12,5m g

1,00 stuk

0,79593

YC 09DAAO YC 09DAAO

V EU/1/98/086/017 C o a pro vel ta ble t film o m huld 300/12,5m g V EU/1/98/086/019 C o a pro vel ta ble t film o m huld 300/12,5m g

1,00 stuk 1,00 stuk

1,54013 1,54013

YC 09DAAO

V EU/1/98/086/024 C o a pro vel ta ble t film o m huld 300/25m g

1,00 stuk

1,59186

YC 09DAAO

V EU/1/98/086/029 C o a pro vel ta ble t film o m huld 150/12,5m g

1,00 stuk

0,79593

YC 09DAAO YC 09DAAO

V EU/1/98/086/030 C o a pro vel ta ble t film o m huld 300/12,5m g V EU/1/98/086/031 C o a pro vel ta ble t film o m huld 300/25m g

1,00 stuk 1,00 stuk

1,54013 1,59186

YC 09DAAO

V EU/1/98/086/032 C o a pro vel ta ble t film o m huld 150/12,5m g

1,00 stuk

0,79593

YC 09DAAO

V EU/1/98/086/033 C o a pro vel ta ble t film o m huld 300/12,5m g

1,00 stuk

1,54013

YC 09DAAO

V EU/1/98/086/034 C o a pro vel ta ble t film o m huld 300/25m g

1,00 stuk

1,59186

YC 09DABO

V 32740

O lm e tec hctz ta ble t film o m huld 20/12,5m g

1,00 stuk

0,79593

YC 09DABO

V 32741

O lm e tec hctz ta ble t film o m huld 20/25m g

1,00 stuk

0,84766

YC 09DAC O

V 25926

Te ve te n plus ta ble t film o m huld

1,00 stuk

0,79593

YC 09DBAO

V EU/1/06/370/002 Ex fo rge table t film o m huld 5/ 80m g

1,00 stuk

1,39870

YC 09DBAO YC 09DBAO

V EU/1/06/370/003 Ex fo rge table t film o m huld 5/ 80m g V EU/1/06/370/010 Ex fo rge table t film o m huld 5/160m g

1,00 stuk 1,00 stuk

1,39870 2,14290

YC 09DBAO

V EU/1/06/370/011 Ex fo rge table t film o m huld 5/160m g

1,00 stuk

2,14290

YC 09DBAO

V EU/1/06/370/018 Ex fo rge table t film o m huld 10/160m g

1,00 stuk

2,79741

YC 09DBAO

V EU/1/06/370/019 Ex fo rge table t film o m huld 10/160m g

1,00 stuk

2,79741

YC 09DBBO

V 100984

Se vik ar ta blet film om huld 20/ 5m g

1,00 stuk

1,39870

YC 09DBBO

V 100986

Se vik ar ta blet film om huld 40/ 5m g

1,00 stuk

2,14290

YC 09DBBO

V 100987

Se vik ar ta blet film om huld 40/10m g

1,00 stuk

2,79741

YC 09XAAO

V EU/1/08/491/012 R a sile z hct ta ble t film o m huld 150/12,5m g

1,00 stuk

0,79593

YC 09XAAO

V EU/1/08/491/032 R a sile z hct ta ble t film o m huld 150/25m g

1,00 stuk

0,84766

YC 09XAAO YC 09XAAO

V EU/1/08/491/052 R a sile z hct ta ble t film o m huld 300/12,5m g V EU/1/08/491/072 R a sile z hct ta ble t film o m huld 300/25m g

1,00 stuk 1,00 stuk

1,54013 1,59186

YC 10AXAO

V 101422//30928

Ine gy ta ble t 10/20m g

1,00 stuk

2,64369

YC 10AXAO YC 10AXAO

V 101424//30929 V 102680//30930

Ine gy ta ble t 10/40m g Ine gy ta ble t 10/80m g

1,00 stuk 1,00 stuk

3,56638 5,41175

YC 10AXAO

V 103534//30928

Ine gy ta ble t 10/20m g

1,00 stuk

2,64369

YC 10AXAO

V 103535//30929

Ine gy ta ble t 10/40m g

1,00 stuk

3,56638

YC 10AXAO YC 10AXAO

V 103536//30929 V 104385//30928

Ine gy ta ble t 10/40m g Ine gy ta ble t 10/20m g

1,00 stuk 1,00 stuk

3,56638 2,64369

YC 10AXAO

V 104386//30929

Ine gy ta ble t 10/40m g

1,00 stuk

3,56638

YC 10AXAO

V 104387//30930

Ine gy ta ble t 10/80m g

1,00 stuk

5,41175

YC 10AXAO YC 10AXAO

V 30928 V 30929

Ine gy ta ble t 10/20m g Ine gy ta ble t 10/40m g

1,00 stuk 1,00 stuk

2,64369 3,56638

YC 10AXAO

V 30930

Ine gy ta ble t 10/80m g

1,00 stuk

5,41175

YD05AXADZ

V 27095

Do vo be t za lf

1,00 gra m

0,52271

YJ01C AAO

V 23316

P a nto pa c co m bina tie verpa k k ing

1,00 verp

69,19165

YM05BBAO YM05BBAO

V 100996//31634 V 31634

AC TO NEL PLUS C ALC IUM TABLET FILMO MHULD 35MG 28 ST AC TO KIT (1TAB AC TO NEL 35MG+6TAB C ALC IUM 500MG)28ST

1,00 verp 1,00 verp

40,59628 40,59628

YR 03AC C IDA

V 102666//25865

Se retide ae ro so l 25/ 50m cg/do cfk vr spbs 120do+inh

1,00 do

0,28928

YR 03AC C IDA YR 03AC C IDA

V 103959//34610 V 25865

Foste r ae ro so l 100/6m cg/do sis spuitbus 120do Se retide ae ro so l 25/ 50m cg/do cfk vr spbs 120do+inh

1,00 do 1,00 do

0,40611 0,28928

YR 03AC C IDA

V 25866

Se retide ae ro so l 25/125m cg/do cfk vr spbs 120do +inh

1,00 do

0,37690

YR 03AC C IDA

V 25867

Se retide ae ro so l 25/250m cg/do cfk vr spbs 120do +inh

1,00 do

0,52294

YR 03AC C IDA YR 03AC C IDA

V 32325//25867 V 32326//25867

Se retide ae ro so l 25/250m cg/do cfk vr spbs 120do +inh Se retide ae ro so l 25/250m cg/do cfk vr spbs 120do +inh

1,00 do 1,00 do

0,52294 0,52294

YR 03AC C IDA

V 32537//25866

Se retide ae ro so l 25/125m cg/do cfk vr spbs 120do +inh

1,00 do

0,37690

YR 03AC C IDA

V 34105//25867

Se retide ae ro so l 25/250m cg/do cfk vr spbs 120do +inh

1,00 do

0,52294

YR 03AC C IDA

V 34610

Foste r ae ro so l 100/6m cg/do sis spuitbus 120do

1,00 do

0,40611

YR 03AC C IDC

V 101907//23530

Se retide disk us inhpdr 50/250m cg 60do

1,00 do

0,90703

YR 03AC C IDC

V 101910//23531

Se retide disk us inhpdr 50/500m cg 60do

1,00 do

1,20396

YR 03AC C IDC YR 03AC C IDC

V 101911//23530 V 101912//23530

Se retide disk us inhpdr 50/250m cg 60do Se retide disk us inhpdr 50/250m cg 60do

1,00 do 1,00 do

0,90703 0,90703

YR 03AC C IDC

V 101916//23529

Se retide disk us inhpdr 50/100m cg 60do

1,00 do

0,72888

YR 03AC C IDC

V 101921//23531

Se retide disk us inhpdr 50/500m cg 60do

1,00 do

1,20396

YR 03AC C IDC YR 03AC C IDC

V 101924//23531 V 102185//23530

Se retide disk us inhpdr 50/500m cg 60do Se retide disk us inhpdr 50/250m cg 60do

1,00 do 1,00 do

1,20396 0,90703

YR 03AC C IDC

V 102186//23531

Se retide disk us inhpdr 50/500m cg 60do

1,00 do

1,20396

YR 03AC C IDC

V 104633//23530

Se retide disk us inhpdr 50/250m cg 60do

1,00 do

0,90703

YR 03AC C IDC YR 03AC C IDC

V 104634//23531 V 104635//23531

Se retide disk us inhpdr 50/500m cg 60do Se retide disk us inhpdr 50/500m cg 60do

1,00 do 1,00 do

1,20396 1,20396

YR 03AC C IDC

V 23529

Se retide disk us inhpdr 50/100m cg 60do

1,00 do

0,72888

YR 03AC C IDC

V 23530

Se retide disk us inhpdr 50/250m cg 60do

1,00 do

0,90703

YR 03AC C IDC YR 03AC C IDC

V 23531 V 25673//23530

Se retide disk us inhpdr 50/500m cg 60do Se retide disk us inhpdr 50/250m cg 60do

1,00 do 1,00 do

1,20396 0,90703

YR 03AC C IDC

V 25674//23531

Se retide disk us inhpdr 50/500m cg 60do

1,00 do

1,20396

YR 03AC C IDC V V 26878//23530

Se retide disk us inhpdr 50/250m cg 60do

1,00 do

0,90703

YR 03AC C IDC V V 26879//23531 YR 03AC C IDC V V 27283//23530

Se retide disk us inhpdr 50/500m cg 60do Se retide disk us inhpdr 50/250m cg 60do

1,00 do 1,00 do

1,20396 0,90703

YR 03AC C IDC V V 27874//23529

Se retide disk us inhpdr 50/100m cg 60do

1,00 do

0,72888

YR 03AC C IDC V V 28201//23530

Se retide disk us inhpdr 50/250m cg 60do

1,00 do

0,90703

YR 03AC C IDC V V 28202//23531 YR 03AC C IDC V 28220//23531

Se retide disk us inhpdr 50/500m cg 60do Se retide disk us inhpdr 50/500m cg 60do

1,00 do 1,00 do

1,20396 1,20396

YR 03AC C IDC

V 31702//23529

Se retide disk us inhpdr 50/100m cg 60do

1,00 do

0,72888

YR 03AC C IDC

V 32249//23531

Se retide disk us inhpdr 50/500m cg 60do

1,00 do

1,20396

YR 03AC C IDC YR 03AC C IDC

V 33063//23531 V 34861//23530

Se retide disk us inhpdr 50/500m cg 60do Sa lm e te rol/flutica so npro pion inhpdr 50/250m cg 60do

1,00 do 1,00 do

1,20396 0,90703

YR 03AC C IDC

V 35036//23530

Se retide disk us inhpdr 50/250m cg 60do

1,00 do

0,90703

YR 03AKAIDC YR 03AKAIDC

V 100572//27690 V 100620//25887

Sym bico rt turbuhale r inha lpdr 400/12m cg/do 60do Sym bico rt turbuhale r inha lpdr 200/6m cg/do 120do

1,00 do 1,00 do

0,96642 0,48321

YR 03AKAIDC

V 101886//25887

Sym bico rt turbuhale r inha lpdr 200/6m cg/do 60do

1,00 do

0,48321

YR 03AKAIDC

V 102318//27690

Sine stic turbuhale r inha lpdr 400/12m cg/do 60do

1,00 do

0,96642

YR 03AKAIDC YR 03AKAIDC

V 102578//25887 V 102737//27690

Sine stic turbuhale r inha lpdr 200/6m cg/do 120do Sym bico rt turbuhale r inha lpdr 400/12m cg/do 60do

1,00 do 1,00 do

0,48321 0,96642

YR 03AKAIDC

V 25886

Sym bico rt turbuhale r inha lpdr 100/6m cg/do 120do

1,00 do

0,39413

YR 03AKAIDC

V 25887

Sym bico rt turbuhale r inha lpdr 200/6m cg/do 120do

1,00 do

0,48321

YR 03AKAIDC YR 03AKAIDC

V 27285//25887 V 27690

Sym bico rt turbuhale r inha lpdr 200/6m cg/do 120do Sym bico rt turbuhale r inha lpdr 400/12m cg/do 60do

1,00 do 1,00 do

0,48321 0,96642

YR 03AKAIDC

V 28096//25887

Sym bico rt turbuhale r inha lpdr 200/6m cg/do 120do

1,00 do

0,48321

YR 03AKAIDC

V 29331//25887

Sym bico rt turbuhale r inha lpdr 200/6m cg/do 120do

1,00 do

0,48321

YR 03AKAIDC YR 03AKAIDC

V 29436//25887 V 29470//27690

Sym bico rt turbuhale r inha lpdr 200/6m cg/do 120do Sym bico rt turbuhale r inha lpdr 400/12m cg/do 60do

1,00 do 1,00 do

0,48321 0,96642

YR 03AKAIDC

V 29643//25886

Sym bico rt turbuhale r inha lpdr 100/6m cg/do 120do

1,00 do

0,39413

YR 03AKAIDC

V 30033//27690

Sym bico rt turbuhale r inha lpdr 400/12m cg/do 60do

1,00 do

0,96642

YR 03AKAIDC YR 03AKAIDC

V 30875//25887 V 31454//27690

Assiem e turbuha le r inha lpdr 200/6m cg/do 120do Sym bico rt turbuhale r inha lpdr 400/12m cg/do 60do

1,00 do 1,00 do

0,48321 0,96642

YR 03AKAIDC

V 31705//25887

Sym bico rt turbuhale r inha lpdr 200/6m cg/do 120do

1,00 do

0,48321

YR 03AKAIDC

V 32136//27690

Sym bico rt turbuhale r inha lpdr 400/12m cg/do 60do

1,00 do

0,96642

YR 03AKAIDC YR 03AKAIDC

V 32354//25886 V 32677//25886

Sym bico rt turbuhale r inha lpdr 100/6m cg/do 120do Sym bico rt turbuhale r inha lpdr 100/6m cg/do 120do

1,00 do 1,00 do

0,39413 0,39413

YR 03AKAIDC

V 32739//25886

Sym bico rt turbuhale r inha lpdr 100/6m cg/do 120do

1,00 do

0,39413

YR 03AKAIDC

V 33045//27690

Assiem e turbuha le r inha lpdr 400/12m cg/do 60do

1,00 do

0,96642

YR 03AKAIDC YR 03AKAIDC

V 33191//27690 V 33859//27690

Sym bico rt turbuhale r inha lpdr 400/12m cg/do 60do Sym bico rt turbuhale r inha lpdr 400/12m cg/do 60do

1,00 do 1,00 do

0,96642 0,96642

YR 03AKAIDC

V 34469//25887

Sym bico rt turbuhale r inha lpdr 200/6m cg/do 120do

1,00 do

0,48321

YR 03AKAIDC

V 34538//25887

Assiem e turbuha le r inha lpdr 200/6m cg/do 120do

1,00 do

0,48321

YR 03AKAIDC YR 03AKAIDC

V 34582//25886 V 35038//25887

Sym bico rt turbuhale r inha lpdr 100/6m cg/do 120do Sine stic turbuhale r inha lpdr 200/6m cg/do 120do

1,00 do 1,00 do

0,39413 0,48321

YR 03AKAII

V 20233

C O MBIVENT UNIT DO SE VER NEVELO P LO SSING FLAC O N 2,5 ML

1,00 m l

0,28661

YR 03AKAII YR 03AKAII

V 29338//20233 V 33224

C o m bivent unit do se inha la tie vlo e isto f fl 2,5m l Ipra m ol steri-ne b ve rneve lo pl 0,2/1m g/m l fl2,5m l

1,00 m l 1,00 m l

0,28661 0,28661

YS01C ADG

V 11302

De x am ytrex o o gdruppe ls fla co n 5m l

1,00 m l

1,27948

YS01C ADG

V 16759

De x age nta po s o o gdruppels fla co n 5m l

1,00 m l

1,27948

YS01C AEG

V 14223

TO BR ADEX O O GDR UP P ELS FLAC O N 5ML

1 ML

1,15170

YS01C AEG

V 28162//14223

TO BR ADEX O O GDR UP P ELS FLAC O N 5ML

1 ML

1,15170

YS01C AEG YS01C AEG

V 29111//14223 V 32480//14223

TO BR ADEX O O GDR UP P ELS FLAC O N 5ML TO BR ADEX O O GDR UP P ELS FLAC O N 5ML

1 ML 1 ML

1,15170 1,15170

YS01EDAG

V 26592

Xa la co m o ogdruppe ls fla co n 2,5m l

1,00 m l

9,47766

YS01EDAG YS01EDAG

V 29364//26592 V 33155//26592

Xa la co m o ogdruppe ls fla co n 2,5m l Xa la co m o ogdruppe ls fla co n 2,5m l

1,00 m l 1,00 m l

9,47766 9,47766

YS01EDAG

V 33710//26592

Xa la co m o ogdruppe ls fla co n 2,5m l

1,00 m l

9,47766

YS01EDAG

V EU/1/06/340/001 Ga nfort o o gdruppels fla co n 3m l

1,00 m l

9,47766

YS01EDBG

V EU/1/06/338/001 Duo trav o ogdruppe ls fla co n 2,5m l

1,00 m l

9,47766

YS01EDBG

V EU/1/06/338/002 Duo trav o ogdruppe ls fla co n 2,5m l

1,00 m l

9,47766

YS01EDC G YS01EDC G

V 22871 V 29694//22871

C o so pt o ogdruppe ls fla co n 5m l C o so pt o ogdruppe ls fla co n 5m l

1,00 m l 1,00 m l

3,13380 3,13380

YS01EDEG

V EU/1/08/482/001 Aza rga oo gdruppe ls flacon 5m l

1,00 m l

4,23195

YS01EDEG

V EU/1/08/482/002 Aza rga oo gdruppe ls flacon 5m l

1,00 m l

YA10BDDO YA10BDDO

V EU/1/08/455/002 JANUMET TABLET FILMO MHULD 50MG/ 850MG V EU/1/08/455/009 JANUMET TABLET FILMO MHULD 50MG/1000MG

1 STUK 1 STUK

1,70386 1,72042

0C 02C AAO

V 101671

DO XAZO SINE P C H R ETAR D TABLET MVA 4MG

1 STUK

0,84322

0C 07ABAO

V 100439

METO P R O LO LSUC C INAAT AC TAVIS R ET 25 TB MVA 23,75MG

6 STUK

0,10830

0C 07ABAO

V 100446

METO P R O LO LSUC C INAAT AC TAVIS R ET 50 TB MVA 47,5MG

3 STUK

0,13538

0C 07ABAO

V 100447

METO P R O LO LSUC C INAAT AC TAVIS R ET 100 TABL MVA 95MG

1,5 STUK

0,27075

0C 07ABAO

V 100448

METO P R O LO LSUC C INAAT AC TAVIS R ET 200 TABL MVA 190MG

0,75 STUK

0,54151

0C 09C AAO

V 103001

C O ZAAR PO EDER VO O R SUSP ENSIE 2,5MG/ML + SO LV 200ML

0C 09C AAO

V 33986

LO SAR TAN KALIUM MYLAN TABLET O MHULD 100MG

0C 09C AAO

V 33985

YC 09BAAO YC 09BAAO

4,23195

20 ML

0,03721

0,50 STUK

1,48840

LO SAR TAN KALIUM MYLAN TABLET O MHULD 50MG

1 STUK

0,74420

V 103269

P ER INDO PR IL TER T-BUTYL/INDAP AMIDE A TABL 2/0,625MG

1 STUK

0,31790

V 103270

P ER INDO PR IL TER T-BUTYL/INDAP AMIDE A TABL 4/1,25MG

1 STUK

0,63581

YC 09BAAO

V 102257

C O VER SYL PLUS AR G TABLET FILMO MHULD 10/2,5MG

1 STUK

1,56366

0D06AXADZ

V EU/1/07/390/002 ALTAR GO 1% ZALF

1 GR AM

0,22477

0D06AXADZ 0D06AXADZ

V 19957//8813 V 20842//8813

FUC IDIN C R EME 20MG/G FUC IDIN C R EME 20MG/G

1 GR AM 1 GR AM

0,22477 0,22477

0D06AXADZ

V 27430//8813

FUC IDIN C R EME 20MG/G

1 GR AM

0,22477

0D06AXADZ

V 8813

FUC IDIN LEO C R EME 20MG/G

1 GR AM

0,22477

0D06AXADZ 0D06AXADZ

V 5617 V 22749//8813

FUC IDIN LEO ZALF 20MG/G FUC IDINE C R EME 20MG/G

1 GR AM 1 GR AM

0,22477 0,22477

0D06AXADZ

V 27924//8813

FUC IDINE C R EME 20MG/G

1 GR AM

0,22477

0D06AXADZ

V 101189//8813

FUC IDINE C R EME 20MG/G

1 GR AM

0,22477

0D06AXADZ 0D06AXADZ

V 27545//5617 V 28698//5617

FUC IDINE ZALF 20MG/G FUC IDINE ZALF 20MG/G

1 GR AM 1 GR AM

0,22477 0,22477

0D06AXADZ

V 101188//5617

FUC IDINE ZALF 20MG/G

1 GR AM

0,22477

3D07ADADC

V 104905//6932

C LO BETASO L-17-P R O P IO NAAT FISHER C R EME 0,5MG/G

1 GR AM

0,16599

4D07ADADZ

V 104901//6933

C LO BETASO L-17-P R O P IO NAAT FISHER ZALF 0,5MG/G

1 GR AM

0,14530

0G03AC AIM

V 35305

SAYANA INJSUSP 160MG/ML W W SP 0,65ML

0G03AC BO

V 32253

P O STINO R TABLET 1500MC G

0H02ABBO

V 104785

0J01C R AO

0,01 ML

10,69644

1 STUK

5,32280

P R EDNISO LO N MYLAN TABLET 30MG

0,33 STUK

0,29950

V 103894

AMO XI/C LAV AC TAVIS TABLET O MHULD 875/125MG

1,71 STUK

1,36112

0J01FAAO

V 104629//21555

C LAR ITR O MYC INE ER C TABLET MGA 500MG

1 STUK

2,43031

0L01XXBO

V 34495//6387

HYDR EA C AP SULE 500MG

2,00 STUK

0,33076

0L01XXBO

V 35100//6387

HYDR EA C AP SULE 500MG

2,00 STUK

0,33076

0L04AADO

V EU/1/07/387/012 ADVAGR AF C AP SULE MVA 3MG

1,67 STUK

8,54775

0M05BABO

V EU/1/05/310/008 FO SAVANC E TABLET 70MG/5600IE

0,14 STUK

8,57645

0N02AEADP

V 100975

BUTR ANS P LEISTER TR ANSDER MAAL 5MC G/UUR

0,27 STUK

7,30463

0N02AEADP

V 100978

BUTR ANS P LEISTER TR ANSDER MAAL 10MC G/UUR

0,14 STUK

14,60925

0N02AEADP

V 100979

BUTR ANS P LEISTER TR ANSDER MAAL 20MC G/UUR

0,07 STUK

29,21850

4N05AXAO

V 104636//34626

SER O Q UEL XR TABLET MVA 200MG

1,5 STUK

2,64201

0R 03AC AII 0R 03AC AII

V 100332 V 100333

SALBUTAMO L P C H STER I-NEB VER NO P L 1MG/ML AMP 2,5ML SALBUTAMO L P C H STER I-NEB VER NO P L 2MG/ML AMP 2,5ML

0S01XAAG

V 32371

0S01XAAG

V 29145

0S01XABG

V 32370

AR TELAC EDO O O GDR UPP ELS 3,2 MG/ ML TUBE 0,6 ML

0V03AEAO 0V03AEAO

V EU/1/09/521/007 R ENVELA P O EDER VO O R SUSPENSIE 2,4G IN SAC HET V EU/1/09/521/003 R ENVELA TABLET FILMO MHULD 800MG

0A02BC AO

V 33071

0A02BC AO

V 33072

0A02BC AO

V 105104//23210

0B01AC DO

V EU/1/08/503/002 EFIENT TABLET FILMO MHULD 5MG

2 STUK

1,12826

0B01AC DO

V EU/1/08/503/009 EFIENT TABLET FILMO MHULD 10MG

1 STUK

1,88043

0B03XAAP

V EU/1/01/185/091 AR ANESP 100 INJVLST 200MC G/ML W W SP 0,5ML

0,05 ML

0B03XAAP

V EU/1/01/185/093 AR ANESP 130 INJVLST 200MC G/ML W W SP 0,65ML

0,05 ML

491,44032

0B03XAAP

V EU/1/01/185/095 AR ANESP 150 INJVLST 500MC G/ML W W SP 0,3ML

0,02 ML

1228,60080

0B03XAAP 0B03XAAP

V EU/1/01/185/079 AR ANESP 20 INJVLST 40MC G/ML W W SP 0,5ML V EU/1/01/185/081 AR ANESP 30 INJVLST 100MC G/ML W W SP 0,3ML

0,25 ML 0,1 ML

98,28806 245,72016

0B03XAAP

V EU/1/01/185/096 AR ANESP 300 INJVLST 500MC G/ML W W SP 0,6ML

0,02 ML

1228,60080

8 4

ML ML

0,06872 0,11453

AR TELAC O O GDR UP PELS 3,2 MG/ ML FLAC O N 10 ML

0,4

ML

0,39706

SIC C AFLUID O O GGEL 2,5MG/G FLAC O N 10G

0,4 GR AM

0,39706

4 STUK

0,22099

2,67 STUK 8 STUK

3,35099 1,11700

LANSO P R AZO L BLUEFISH 15 MG C AP SULES MSR

2 STUK

1,00866

LANSO P R AZO L BLUEFISH 30 MG C AP SULES MSR

1 STUK

1,68111

P AR IET TABLET MSR 10MG

2 STUK

1,00866

491,44032

0B03XAAP 0B03XAAP

V EU/1/01/185/085 AR ANESP 50 INJVLST 100MC G/ML W W SP 0,5ML V EU/1/01/185/098 AR ANESP 500 INJVLST 500MC G/ML W W SP 1ML

0,1 ML 0,02 ML

245,72016 1228,60080

0B03XAAP

V EU/1/01/185/087 AR ANESP 60 INJVLST 200MC G/ML W W SP 0,3ML

0,05 ML

491,44032

0B03XAAP

V EU/1/01/185/089 AR ANESP 80 INJVLST 200MC G/ML W W SP 0,4ML

0,05 ML

491,44032

0C 07ABAO

V 102323

METO P R O LO LSUC C INAAT A R ETAR D 200 TABLET MGA 190MG

0,75 STUK

0C 09AAAO

V 32951

ENALAP R IL MALEAAT R P TABLET 5MG

2 STUK

0,35045

0C 09AAAO 0C 09AAAO

V 32952 V 32953

ENALAP R IL MALEAAT R P TABLET 10MG ENALAP R IL MALEAAT R P TABLET 20MG

1 STUK 0,5 STUK

0,58408 1,16816

0C 09C AAO

V 34213

KALIUMLO SAR TAN AC TAVIS TABLET FILMO MHULD 100MG

0,5 STUK

1,48840

0C 09C AAO

V 34212

KALIUMLO SAR TAN AC TAVIS TABLET FILMO MHULD 50MG

1 STUK

0,74420

YC 09BAAO

V 34391

FO SINO P R IL/HYDR O C HLO O R THIAZIDE AC T TABL 20/12,5MG

1 STUK

0,83050

0D01BABO

V 104074

TER BINAFINE APO TEX TABLET 250MG

1 STUK

2,33152

0D06BXADC

V 33518

NIDAZEA GEL 7,5MG/G

1 GR AM

0,32733

0D07AC ADZ

V 100972

MO METASO N FUR O AAT A ZALF 1MG/G

1 GR AM

0,14526

0G03AABO

V 100532

ETHINYLESTR ADIO L/DESO GESTR R IC H TB O MH 0,02/0,15MG

0,75 STUK

0,13253

0G03AABO

V 100508

ETHINYLESTR ADIO L/DESO GESTR R IC H TB O MH 0,03/0,15MG

0,75 STUK

0,13253

0J01DABP

V 35184

C EFUR O XIM FR ESENIUS KABI INFUSIEP O EDER FL 1500MG

2 STUK

20,78320

0J01DABP

V 35182

C EFUR O XIM FR ESENIUS KABI INJEC TIEP O EDER FL 750MG

4 STUK

10,39160

0J01DABP

V 35183

C EFUR O XIM FR ESENIUS KABI INJEC TIEP O EDER FL 1500MG

2 STUK

20,78320

0J05ABAO

V 103802

FAMC IC LO VIR SANDO Z TABLET FILMO MHULD 125MG

6 STUK

2,49579

0J05ABAO

V 103803

FAMC IC LO VIR SANDO Z TABLET FILMO MHULD 500MG

1,5 STUK

9,98316

0L01DBC P

V 103859

EPIR UBIC INE HC L FR ES KABI INJVLST 2MG/ML

3,5 ML

5,81928

0L02AEADI

V EU/1/08/504/001 FIR MAGO N INJP DR FLAC O N 80MG

1 STUK

184,07590

0L02AEADI

V EU/1/08/504/002 FIR MAGO N INJP DR FLAC O N 120MG + SO LV 6ML + TO EBEH

0,67 STUK

276,11385

0L02AEADI

V 34737

0,33 STUK

552,22770

0L03AAC P

V EU/1/02/227/004 NEULASTA INJVLST 10MG/ML W W SP 0,6ML

0,09 STUK 1442,52179

0L04AAAP

V EU/1/99/126/020 ENBR EL MYC LIC INJVLST 50MG/ML PEN 1ML

0,14 STUK

271,73720

0M01AHBO

V 105051//34279

2 STUK

0,67913

0M05BABO

V EU/1/06/364/007 ADR O VANC E TABLET 70MG/5600IE

0,14 STUK

8,57645

0N01BBAP

V 20949

BUP IVAC AINE AC TAVIS INJVLST 2,5MG/ML

56 ML

0,12070

0N01BBAP

V 20950

BUP IVAC AINE AC TAVIS INJVLST 5MG/ML

28 ML

0,24141

0N01BBAP

V 20951

BUP IVAC AINE AC TAVIS INJVLST 7,5MG/ML

18,67 ML

0,36212

0N02C C AO

V 35089

SUMATR IP TAN AC TAVIS TABLET O MHULD 50MG

SALVAC YL INJEC TIEP O EDER 11,25MG + SO LVENS 2ML

AR C O XIA TABLET FILMO MHULD 30MG

1 STUK

0,54151

6,21227

0N02C C BO

V 104877//19853

IMIGR AN ZETP IL 25MG

1 STUK

10,43468

0N03AXC O

V 33681

GABAP ENTINE SANDO Z C APSULE 300MG

6 STUK

0,65344

2N06ABAO 2N06ABAO

V 101124 V 101123

SER TR ALINE BLUEFISH TABLET FILMO MHULD 100MG SER TR ALINE BLUEFISH TABLET FILMO MHULD 50MG

0,50 STUK 1,00 STUK

2,13277 1,06638

0R 01ADAN

V 105052//23937

BUDESO NIDE ER C NEVEL NEUSSP R AY 32MC G/DO 120DO

6,25 DO

0,07684

0R 01ADAN

V 104885//15821

R HINO C O R T TUR BUHALER INHPDR NASAAL 0,1MG/DO 200DO

2 DO

0,16850

0R 03AC C IDC

V 105277//18150

SER EVENT DISKUS INHP DR 50MC G 60DO

2 DO

0,61011

0R 03BABID

V 105055//16214

FLIXO TIDE AER C FKVR 250MC G/DO SP BS 120 DO + INHAL

2,4 DO

0,29208

YR 03AC C IDA

V 105056//34610

FO STER AER O SO L 100/6MC G/DO SIS SP UITBUS 120DO

1 DO

0,40611

YR 03AC C IDA

V 105059//25865

SER ETIDE AER O SO L 25/ 50MC G/DO C FKVR SP BS 120DO +INH

1 DO

0,28928

0S01AXAG

V 102202

VIGAMO X O O GDR UPP ELS 5MG/ML FLAC O N 5ML

0,3 ML

6,24444

0S01XABG

V 32027

SIC C AFLUID UNIDO SE O O GGEL 2,5MG/G AMP UL 0,5G

4 STUK

0,22099

0B01AC DO

V EU/1/09/559/004 C LO P IDO GR EL MYLAN TABLET FILMO MHULD 75MG(ALS HC L)

1,00 STUK

1,88043

0B01AC DO

V EU/1/09/541/003 C LO P IDO GR EL R P TABLET FILMO MHULD 75MG

1,00 STUK

1,88043

0B01AC DO 0B01AC DO

V EU/1/09/535/002 GR EPID TABLET FILMO MHULD 75MG V EU/1/09/535/003 GR EPID TABLET FILMO MHULD 75MG

1,00 STUK 1,00 STUK

1,88043 1,88043

0A02BC AO

V 32893

O MEP R AZO L SANDO Z C AP SULE MSR 20MG

1,00 STUK

1,68111

0A02BC AO

V 32894

O MEP R AZO L SANDO Z C AP SULE MSR 40MG

0,50 STUK

3,36221

0A07EC C R

V 105270//15064

P ENTASA ZETP IL 1G

1,50 STUK

2,02053

0A09AAAO

V 105058//16134

P ANC R EASE HL C AP SULE MSR

2,40 STUK

1,00796

0A10BBAO

V 33707

GLIMEPIR IDE R P TABLET 6MG

0,33 STUK

0,83132

0A10BBAO

V 32800

GLIMEPIR IDUM TABLET 1MG

2,00 STUK

0,16626

0A10BBAO 0A10BBAO

V 32801 V 32802

GLIMEPIR IDUM TABLET 2MG GLIMEPIR IDUM TABLET 3MG

1,00 STUK 0,67 STUK

0,27711 0,41566

0B01AC DO

V 103071

C LO P IDO GR EL SANDO Z TABLET FILMO MHULD 75MG

1,00 STUK

1,88043

0C 01C AAP

V 105054//32727

EPIPEN INJVLST 1MG/ML W W SP 0,3ML

1,00 ML

1C 01DAAO 1C 01DAAO

V 105346//17289 V 105347//13645

ISO SO R BIDEMO NO NITR AAT ER C R ETAR D C APSULE 25MG ISO SO R BIDEMO NO NITR AAT ER C R ETAR D C APSULE 50MG

2,40 STUK 1,20 STUK

0,22689 0,45378

0C 02C AAO

V 105341//22689

C AR DUR A XL TABLET MGA 8MG

0,50 STUK

1,68644

0C 07ABAO

V 102065

METO P R O LO LSUC C INAAT C F R ETAR D 100 TABLET MGA 95MG

1,50 STUK

0,27075

0C 07ABAO

V 102302

METO P R O LO LSUC C INAAT C F R ETAR D 200 TABLET MGA 190MG

0,75 STUK

0,54151

148,23500

YC 09BAAO

V 103277

P ER INDO PR IL TER T-BUTYL/INDAP AMIDE MYLAN T 4/1,25MG

1,00 STUK

0,63581

YC 09BAAO

V 101971

P ER INDO PR IL TER T-BUTYL/INDAP AMIDE R P TABL 4/1,25MG

1,00 STUK

0,63581

0C 10AAAO

V 100112

FLUVASTATINE MYLAN C AP SULE 20MG

3,00 STUK

0,55361

0C 10AAAO

V 100114

FLUVASTATINE MYLAN C AP SULE 40MG

1,50 STUK

0,92269

0D07AC ADZ

V 100967

MO METASO N FUR O AAT VET MYLAN ZALF 1MG/G

1,00 GR AM

0,14526

0G03AABO

V 105352//23827

YASMIN TABLET O MHULD

0,75 STUK

0,13253

0G03AC AIM 0G03AC AIM

V 6602 V 23557//6602

DEPO PR O VER A 150 INJSUSP 150MG/ML W W SP 1ML DEPO PR O VER A 150 INJSUSP 150MG/ML W W SP 1ML

0,01 ML 0,01 ML

6,96550 6,96550

0G03AC AIM

V 33124//6602

DEPO PR O VER A 150 INJSUSP 150MG/ML W W SP 1ML

0,01 ML

6,96550

0G03AC BO 0G03AC BO

V 24996 V 32303

NO R LEVO TABLET 0,75MG NO R LEVO TABLET 1,5MG

2,00 STUK 1,00 STUK

2,66140 5,32280

0G03AC BO

V 102312//32303

NO R LEVO TABLET 1,5MG

1,00 STUK

5,32280

0G03AC BO

V 104101//32303

NO R LEVO TABLET 1,5MG

1,00 STUK

5,32280

0G04BDBO

V 104948

O XYBUTYNINE HC L P C H TABLET 2,5MG

6,00 STUK

0,16596

0J07BC AP

K EU/1/01/183/024 HBVAXP R O 5 INJSUSP 10MC G/ML W W SP 0,5ML

0,50 ML

0L02AEADI

V 105258//18562

ZO LADEX IMP LANTATIESTIFT 10,8MG IN W W SP

0,33 STUK

0L04AAAO

V 34432

C IC LO SP O R INE AC TAVIS C AP SULE 25MG

12,00 STUK

1,57244

0L04AAAO 0L04AAAO

V 34434 V 34435

C IC LO SP O R INE AC TAVIS C AP SULE 100MG C IC LO SP O R INE P C H C AP SULE 25MG

3,00 STUK 12,00 STUK

3,93110 1,57244

0L04AAAO

V 34437

C IC LO SP O R INE P C H C AP SULE 100MG

3,00 STUK

3,93110

0N02AXAO 0N02AXAO

V 34128 V 34129

TR AMADO L HC L C F R ETAR D TABLET MGA 100MG TR AMADO L HC L C F R ETAR D TABLET MGA 150MG

3,00 STUK 2,00 STUK

0,41294 0,61941

0N02AXAO

V 34130

TR AMADO L HC L C F R ETAR D TABLET MGA 200MG

1,50 STUK

0,82588

0N02C C AO 0N02C C AO

V 105211//21818 V 105351//31917

MAXALT SMELTTABLET 10MG ZO MIG TABLET O MHULD 2,5MG

1,00 STUK 1,00 STUK

6,21227 6,21227

0N04BC AO

V 105276//100576 R EQ UIP MO DUTAB TABLET MVA 8MG

0,75 STUK

5,22029

0N05AHAO

V 103903

C LO ZAP INE LEYDEN DELTA TABLET 25MG

12,00 STUK

0,18242

4N05AXAO

V 105348//34627

SER O Q UEL XR TABLET MVA 300MG

1,00 STUK

3,96302

4N05AXAO

V 105349//34628

SER O Q UEL XR TABLET MVA 400MG

0,75 STUK

5,28402

0N06BAAO

V 105062//31495

STR ATTER A C AP SULE 18MG

4,44 STUK

0,08178

0N07BC AO

V 33035

METHADO N R EGENBO O G TABLET 10MG

2,50 STUK

0,17734

0N07BC AO

V 33036

METHADO N R EGENBO O G TABLET 20MG

1,25 STUK

0,35468

0R 01ADAN

V 105052//23837

BUDESO NIDE ER C NEVEL NEUSSP R AY 32MC G/DO 120DO

6,25 DO

0,07684

0R 01ADAN

V 104856//23477

FLIXO NASE NEUSDR UP P ELS 1MG/ML NASULE 0,4ML

0,50 DO

0,67402

0R 01ADAN

V 103003

FLUTIC ASO NPR O PIO NAAT MYL NEUSSP R 50MC G/DO FL 150DO

4,00 DO

0,08425

44,28000 552,22770

0R 03BAAII

V 104934//21834

FLIXO TIDE 500 INHVLST 0,25MG/ML NEBULE 2ML

6,00 ML

0,96281

0R 03BABID 0R 03BABID

V 105330//31632 V 105331//31633

ALVESC O 80 AER O SO L 80MC G/DO SP BS 120DO + INH ALVESC O 160 AER O SO L 160MC G/DO SPBS

2,00 DO 1,00 DO

0,42060 0,70100

YR 03AC C IDC YR 03AC C IDC

V 104996//23529 V 104841//23531

ALIFLUS DISKUS INHP DR 50/100MC G 60DO SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO 1,00 DO

0,72888 1,20396

0V03AEAO

V 105507//31929

FO SR ENO L KAUW TABLET 750MG

3,00 STUK

2,97866

0N03AXEO 0N03AXEO

V 34569 V 34570

TO P IR AMAAT C F TABLET FILMO MHULD 25MG TO P IR AMAAT C F TABLET FILMO MHULD 50MG

0N03AXEO

V 34571

0N03AXEO

V 34572

0N03AXEO 0N03AXEO

V 33418 V 33420

0N03AXEO 0N03AXEO

12,00 6,00

STUK 0,39720 STUK 0,79440

TO P IR AMAAT C F TABLET FILMO MHULD 100MG

3,00

STUK 1,58880

TO P IR AMAAT C F TABLET FILMO MHULD 200MG

1,50

STUK 3,17760

TO P IR AMAAT MYLAN TABLET FILMO MHULD 25MG TO P IR AMAAT MYLAN TABLET FILMO MHULD 100MG

12,00 3,00

STUK 0,39720 STUK 1,58880

V 101527

TO P IR AMAAT P C H TABLET FILMO MHULD 25MG

12,00

STUK 0,39720

V 101529

TO P IR AMAAT P C H TABLET FILMO MHULD 50MG

6,00

STUK 0,79440

0N03AXEO 0N03AXEO

V 101530 V 101533

TO P IR AMAAT P C H TABLET FILMO MHULD 100MG TO P IR AMAAT P C H TABLET FILMO MHULD 200MG

3,00 1,50

STUK 1,58880 STUK 3,17760

0N03AXEO

V 33540

TO P IR AMAAT R P TABLET FILMO MHULD 15MG

20,00

STUK 0,50842

0N03AXEO

V 33541

TO P IR AMAAT R P TABLET FILMO MHULD 25MG

12,00

STUK 0,39720

0N03AXEO 0N03AXEO

V 33542 V 33543

TO P IR AMAAT R P TABLET FILMO MHULD 50MG TO P IR AMAAT R P TABLET FILMO MHULD 100MG

6,00 3,00

STUK 0,79440 STUK 1,58880

0N03AXEO

V 33544

TO P IR AMAAT R P TABLET FILMO MHULD 200MG

0N03AXEO

V 33976

TO P IR AMAAT SANDO Z TABLET FILMO MHULD 25MG

0N03AXEO 0A04AAAP

V 33977 V 30524

TO P IR AMAAT SANDO Z TABLET FILMO MHULD 100MG O NDANSETR O N R P INJVLST 2MG/ML AMP UL 2ML

3,00 4,00

0A04AAAP

V 30525

O NDANSETR O N R P INJVLST 2MG/ML AMP UL 4ML

4,00

ML

7,13682

1A06ADAO

V 101716

MO VIC O LO N C HO C O LATE P O EDER V DR ANK IN SAC HET

0,76

STUK

0,54285

0A10BBAO

V 33706

GLIMEPIR IDE R P TABLET 4MG

0,50

STUK

0,55421

0B01AC DO 0B01AC DO

V EU/1/09/561/004 C LO P IDO GR EL TEVA TABLET FILMO MHULD 75MG V EU/1/09/561/008 C LO P IDO GR EL TEVA TABLET FILMO MHULD 75MG

1,00 1,00

STUK STUK

1,88043 1,88043

0B03XAAP

V EU/1/07/410/025 BINO C R IT 40000 INJVLST 40000IE/ML W W SP 1ML

0,05

ML

491,44032

1C 01DAAO

V 100635

ISO SO R BIDEMO NO NITR AAT P C H R ETAR D TABLET MGA 60MG

1,00

STUK

0,54454

0C 02C AAO

V 103546

DO XAZO SINE AC TAVIS R ETAR D TABLET MVA 4MG

1,00

STUK

0,84322

1C 07AGAO

V 102897

C AR VEDILO L R P TABLET FILMO MHULD 6,25MG

6,00

STUK

0,10084

1C 07AGAO

V 102899

C AR VEDILO L R P TABLET FILMO MHULD 25MG

1,50

STUK

0,40336

0C 09AAAO

V 100687

LISINO P R IL AUR O BINDO TABLET 5MG

2,00

STUK

0,35045

0C 09C AAO

V 103825

ENTR IZEN TABLET FILMO MHULD 100MG

0,50

STUK

1,48840

0C 09C AAO

V 103824

ENTR IZEN TABLET FILMO MHULD 50MG

1,00

STUK

0,74420

1,50

STUK 3,17760

12,00

STUK 0,39720 STUK 1,58880 ML 7,13682

YC 09DAAO

V 103820

ENTR IZEN/HC T TABLET FILMO MHULD 100/25MG

1,00

STUK

1,59186

YC 09DAAO

V 103818

ENTR IZEN/HC T TABLET FILMO MHULD 50/12,5MG

1,00

STUK

0,79593

0C 10AAAO

V 101169

FLUVASTATINE C F C AP SULE 20MG

3,00

STUK

0,55361

0C 10AAAO

V 101175

FLUVASTATINE C F C AP SULE 40MG

1,50

STUK

0,92269

0D06AXADZ V V 105508//8813

FUC IDIN C R EME 20MG/G

1,00

GR AM

0,22477

3D07ADADC V V 105355//6932

DER MO VATE HYDR O FIELE C R EME 0,5MG/G

1,00

GR AM

0,16599

0G03XC AO

V EU/1/09/511/002 C O NBR IZA TABLET FILMO MHULD 20MG

1,00

STUK

1,11176

0G04BDBO

V 105278//29152

VESIC AR E TABLET FILMO MHULD 10MG

0,50

STUK

1,65963

0G04C BAO

V 100578

FINASTER IDE AC C O R D TABLET FILMO MHULD 5MG

1,00

STUK

1,12371

0H01BAAN

V 33078

DESMO P R ESSINE A NEUSSPR AY 10MC G/DO FLAC O N 60DO

2,50

DO

0,71389

0H02ABBO

V 105828

P R EDNISO LO N MYLAN TABLET 20MG

0,50

STUK

0,19967

0J05ABAO

V 102099

VALAC IC LO VIR BLUEFISH TABLET FILMO MHULD 500MG

6,00

STUK

2,49579

0L01DBC P

V 33117

EPIR UBIC INE HC L PC H INFVLST 2MG/ML

3,50

ML

5,81928

0L02BBAO

V 101586

BIC ALUTAMIDE BLUEFISH 150 MG FILMO MHULDE TABLET

0,33

STUK

16,33609

0L02BBAO

V 101578

BIC ALUTAMIDE BLUEFISH TABLET FILMO MHULD 50MG

1,00

STUK

5,44536

0L04AAAO

V 30943

C IC LO SP O R INE SANDO Z C AP SULE 25MG

12,00

STUK

1,57244

0L04AAAO

V 30945

C IC LO SP O R INE SANDO Z C AP SULE 100MG

3,00

STUK

3,93110

0L04AADO

V 105605//18107

P R O GR AFT C AP SULE 1MG

5,00

STUK

2,84925

0N01BBAP

V 8028

MAR C AINE INJVLST 2,5MG/ML FLAC O N 20ML

56,00

ML

0,12070

0N01BBAP

V 8029

MAR C AINE INJVLST 5,0MG/ML FLAC O N 20ML

28,00

ML

0,24141

MAR C AINE SP INAAL INJVLST 5MG/ML AMP UL 4ML

28,00

ML

0,24141

0N01BBAP

10970

0N02AXAO

V 33553

TR AMADO L HC L AC TAVIS R ETAR D TABLET MGA 100MG

3,00

STUK

0,41294

0N02AXAO

V 33554

TR AMADO L HC L AC TAVIS R ETAR D TABLET MGA 150MG

2,00

STUK

0,61941

0N02AXAO

V 33555

TR AMADO L HC L AC TAVIS R ETAR D TABLET MGA 200MG

1,50

STUK

0,82588

0N04BC AO

V 105545//100576 R EQ UIP MO DUTAB TABLET MVA 8MG

0,75

STUK

5,22029

3N05C DAO

V 14357

TEMAZEPAM P C H TABLET 20MG

1,00

STUK

0,19558

0R 03AC C IDC

V 105373//21026

O XIS TUR BUHALER INHALPDR 6MC G/DO 60DO

4,00

DO

0,36606

0R 03AC C IDC 0R 03AC C IDC

V 105333//18150 V 105500//18150

SER EVENT DISKUS INHP DR 50MC G 60DO SER EVENT DISKUS INHP DR 50MC G 60DO

2,00 2,00

DO DO

0,61011 0,61011

YR 03AKAII

V 105702//20233

C O MBIVENT UNIT DO SE INHALATIEVLO EISTO F FL 2,5ML

1,00

ML

0,28661

0S01EXAG

V 105557//21304

XALATAN O O GDR UPP ELS 50MC G/ML FLAC O N 2,5ML

0,20

ML

8,54016

YS01EDAG

V 105394//26592

XALAC O M O O GDR UP PELS FLAC O N 2,5ML

1,00

ML

9,47766

0A02BC AO

V 32963

O MEP R AZO LUM C AP SULE MSR 20MG

1,00 STUK

1,68111

0A02BC AO

V 32964

O MEP R AZO LUM C AP SULE MSR 40MG

0,50 STUK

3,36221

0A04AAAP

V 102042

GR ANISETR O N FR ES KABI INFVLST C O NC 1MG/ML AMP

3,00 ML

9,51577

1A06ADAO

V 105511//31960

MO VIC O LO N NATUR EL PO EDER VO O R DR ANK IN SAC HET

0,76 STUK

0,54285

0A07DAAO

V 105345//6945

IMO DIUM C AP SULE 2MG

5,00 STUK

0,23143

0A07EC C O

V 105267//18706

P ENTASA GR ANULAAT MGA 1G IN SAC HET

1,50 STUK

1,25116

0A07EC C O

V 105269//31379

P ENTASA GR ANULAAT MGA 2G IN SAC HET

0,75 STUK

2,50233

0A07EC C O

V 105212//14797

P ENTASA TABLET MVA 500MG

3,00 STUK

0,62558

0B01AC BO

V 102604

AC ETYLSALIC YLZUUR NEUR O AC TAVIS DISP TABLET 30MG

1,00 STUK

0,06353

0B03XAAP

V EU/1/09/573/001 EPO R ATIO 1000 INJVLST 2000IE/ML W W SP 0,5ML

1,00 ML

24,57202

0B03XAAP

V EU/1/09/573/003 EPO R ATIO 2000 INJVLST 4000IE/ML W W SP 0,5ML

0,50 ML

49,14403

0B03XAAP

V EU/1/09/573/005 EPO R ATIO 3000 INJVLST 6000IE/ML W W SP 0,5ML

0,33 ML

73,71605

0B03XAAP

V EU/1/09/573/007 EPO R ATIO 4000 INJVLST 8000IE/ML W W SP 0,5ML

0,25 ML

98,28806

0B03XAAP

V EU/1/09/573/009 EPO R ATIO 5000 INJVLST 10000IE/ML W W SP 0,5ML

0,20 ML

122,8601

0B03XAAP

V EU/1/09/573/015 EPO R ATIO 10000 INJVLST 10000IE/ML W W SP 1ML

0,20 ML

122,8601

0B03XAAP

V EU/1/09/573/019 EPO R ATIO 20000 INJVLST 20000IE/ML W W SP 1ML

0,10 ML

245,7202

0B03XAAP

V EU/1/09/573/025 EPO R ATIO 30000 INJVLST 30000IE/ML W W SP 1ML

0,07 ML

368,5802

0C 07ABAO

V 28143

BISO P R O LO LFUMAR AAT C F TABLET FILMO MHULD 5MG

2,00 STUK

0,20306

0C 07ABAO

V 28144

BISO P R O LO LFUMAR AAT C F TABLET FILMO MHULD 10MG

1,00 STUK

0,40613

0C 07ABAO

V 105921

METO P R O LO LSUC C INAAT C F R ETAR D 25 TABL MGA 23,75MG

6,00 STUK

0,1083

0C 07ABAO

V 105922

METO P R O LO LSUC C INAAT C F R ETAR D 50 TABL MGA 47,5MG

3,00 STUK

0,13538

1C 08DBAO

V 105555//16539

TILDIEM XR C AP SULE MGA 300MG

0,80 STUK

0,77647

0C 09AAAO

V 105602//31958

P ER INDO PR IL AR GININE FISHER TABLET FILMO MH 5MG

0,80 STUK

0,7301

0C 09AAAO

V 105604//31959

P ER INDO PR IL AR GININE FISHER TABLET FILMO MH 10MG

0,40 STUK

1,4602

YC 09BAAO

V 105576//33663

P ER INDO PR IL AR G/INDAP AMIDE FISHER TABL FO 5/1,25MG

1,00 STUK

0,78183

0G03AABO

V 105506//12582

FEMO DEEN DR AGEE

0,75 STUK

0,13253

0G03DAAO

V 105392//9986

P R O VER A TABLET 10MG

0,50 STUK

0,23143

0J01DAC P

V 101834

C EFTAZIDIM AC TAVIS INJEC TIEP O EDER FLAC O N 1000MG

4,00 STUK

21,98565

0J01DAC P

V 101835

C EFTAZIDIM AC TAVIS INJEC TIEP O EDER FLAC O N 2000MG

2,00 STUK

43,9713

0J01DAC P

V 101815

C EFTAZIDIM FR ESENIUS KABI INJP DR FLAC O N 500MG

8,00 STUK

10,99282

0J01DAC P

V 101820

C EFTAZIDIM FR ESENIUS KABI INJP DR FLAC O N 2000MG

2,00 STUK

43,9713

0J01DHAP

V 101614

IMIP ENEM/C ILASTATINE FR ES KABI INFPDR FL 500/500MG

4,00 STUK

18,31911

0J01MAAP

V 102414

C IP R O FLO XAC INE MYLAN INFVLST 2MG/ML ZAK 100ML

250,00 ML

0,24779

0J01MAAP

V 102417

C IP R O FLO XAC INE MYLAN INFVLST 2MG/ML ZAK 200ML

250,00 ML

0,24779

0J01XAAP

V 26388

VANC O MYC INE XELLIA INFUSIEP O EDER FLAC O N 500MG

2000,00 MG

0,02389

0J01XAAP

V 26389

VANC O MYC INE AXELLIA INFUSIEP O EDER FLAC O N 1000MG

2000,00 MG

0,02389

0J05ABAO

V 103840

VALAC IC LO VIR SANDO Z TABLET 250MG

12,00 STUK

1,49747

0J05ABAO

V 103843

VALAC IC LO VIR SANDO Z TABLET 500MG

6,00 STUK

2,49579

0N02ABADP

K 105070

FENTANYL MATR IX C F PLEISTER 12MC G/UUR

1,33 STUK

5,69800

0N02ABADP

V 105082

FENTANYL MATR IX C F PLEISTER 25MC G/UUR

0,67 STUK

5,39635

0N02ABADP

V 105084

FENTANYL MATR IX C F PLEISTER 50MC G/UUR

0,33 STUK

10,79271

0N02ABADP

V 105085

FENTANYL MATR IX C F PLEISTER 75MC G/UUR

0,22 STUK

16,18906

0N02ABADP

V 105086

FENTANYL MATR IX C F PLEISTER 100MC G/UUR

0,17 STUK

21,58541

0N02C C AO

V 105354//31919

ZO MIG ZIP SMELTTABLET 2,5MG

1,00 STUK

6,21227

0N03AXEO

V 28453//24168

EPITO MAX TABLET O MHULD 200MG

1,50 STUK

3,1776

0N04BC AO

V EU/1/97/050/014 SIFR O L TABLET MVA 0,375MG (0,26MG BASE)

6,67 STUK

0,58728

0N04BC AO

V EU/1/97/050/020 SIFR O L TABLET MVA 1,5MG (1,05MG BASE)

1,67 STUK

2,34913

0N04BC AO

V EU/1/97/050/023 SIFR O L TABLET MVA 3MG (2,1MG BASE)

0,83 STUK

4,69826

0N04BC AO

V EU/1/97/050/026 SIFR O L TABLET MVA 4,5MG (3,15MG BASE)

0,56 STUK

7,04739

0N05AHAO

V 103904

C LO ZAP INE LEYDEN DELTA TABLET 100MG

3,00 STUK

0,72968

2N06ABAO

V 101021

P AR O XETINE 30 MG P C H, FILMO MHULDE TABLETTEN

0,67 STUK

1,59958

0R 01ADAN

V 105726//23477

FLIXO NASE NEUSDR UP P ELS 1MG/ML NASULE 0,4ML

0,50 DO

0,67402

0R 03BABID

V 105905//16213

FLIXO TIDE AER C FKVR 125MC G/DO SP BS 120 DO + INHAL

4,80 DO

0,14604

0R 03BABID

V 105939//16214

FLUTIDE AER O SO L 250MC G/DO SP BS 120 DO + INHAL

2,40 DO

0,29208

YR 03AC C IDA V 105748//25866

SER ETIDE AER O SO L 25/125MC G/DO C FKVR SP BS 120DO +INH

1,00 DO

0,3769

YR 03AC C IDA V 105749//25867

SER ETIDE AER O SO L 25/250MC G/DO C FKVR SP BS 120DO +INH

1,00 DO

0,52294

0S01EC AG

V 101121

DO R ZO LAMIDE PC H O O GDR UP PELS 20MG/ML FLAC O N 5ML

0,30 ML

2,1963

0S01EC AG

V 34840

DO R ZO LAMIDE SANDO Z O O GDR UP P ELS 20MG/ML FLAC O N 5ML

0,30 ML

2,1963

0V03AEAO

V 105727//31928

FO SR ENO L KAUW TABLET 500MG

0N05AXAP

V EU/1/08/479/001 ZYPADHER A INJPDR MVA FLAC O N 210MG +SO LV 3ML

0,05 STUK 265,40136

0N05AXAP

V EU/1/08/479/002 ZYPADHER A INJPDR MVA FLAC O N 300MG +SO LV 3ML

0,03 STUK 379,14480

0N05AXAP

V EU/1/08/479/003 ZYPADHER A INJPDR MVA FLAC O N 405MG +SO LV 3ML

0,03 STUK 511,84548

0N05AXAP

V 27178

R ISP ER DAL C O NSTA INJP DR FLAC O N 25MG + SO LV 2ML

0,11 STUK 117,02000

0N05AXAP

V 27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07 STUK 175,53000

4,50 STUK

2,18435

0N05AXAP

V 32734//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07 STUK 175,53000

0N05AXAP

V 32735//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05 STUK 234,04000

0N05AXAP

V 32998//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07 STUK 175,53000

0N05AXAP

V 32999//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05 STUK 234,04000

0N05AXAP

V 34453//27178

R ISP ER DAL C O NSTA INJP DR FLAC O N 25MG + SO LV 2ML

0,11 STUK 117,02000

0N05AXAP

V 100084//27178

R ISP ER DAL C O NSTA INJP DR FLAC O N 25MG + SO LV 2ML

0,11 STUK 117,02000

0N05AXAP

V 100087//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07 STUK 175,53000

0N05AXAP

V 100092//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05 STUK 234,04000

0N05AXAP

V 100217//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05 STUK 234,04000

0N05AXAP

V 100230//27178

R ISP ER DAL C O NSTA INJP DR FLAC O N 25MG + SO LV 2ML

0,11 STUK 117,02000

0N05AXAP

V 100231//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07 STUK 175,53000

0N05AXAP

V 101009//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05 STUK 234,04000

0N05AXAP

V 101010//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07 STUK 175,53000

1A06ADAO V

23013

FO R LAX P O EDER VO O R DR ANK SAC HET 10G

1,00 STUK

0,41257

1A06ADAO V

100287

MO LAXO LE P O EDER VO O R SUSPENSIE IN SAC HET

0,76 STUK

0,54285

1A07AC AO S V 100685

LO R AMYC 50 MG, MUC O -ADHESIEVE BUC C ALE TABLETTEN

1,00 STUK

0,41521

0C 07ABAO V

METO P R O LO LSUC C INAAT R ET P C H 150 TAB MGA 142,50 MG

1,00 STUK

0,39161

0D05AXADL V 101239

C ALC IPO TR IO L SANDO Z LO TIO N 0,05MG/ML O P LO SSING

1,00 ML

0,49840

0H03AAAO V

101391

EUTHYR O X TABLET 88MC G

1,70 STUK

0,03760

0H03AAAO V

101393

EUTHYR O X TABLET 112MC G

1,34 STUK

0,04785

0H03AAAO V

101394

EUTHYR O X TABLET 137MC G

1,09 STUK

0,05853

0J05ABAO V

34645

VALAC IC LO VIR P C H TABLET 500MG

6,00 STUK

2,49579

0L01DBC P V

101490

EPIR UBIC IN HC L P C H INJVLST 2MG/ML

3,50 ML

5,81928

0L01XEAO V

EU/1/06/363/004 SP R YC EL 20 MG, FILMO MHULDE TABLET(BLISTER 56 STUK)

0L01XEAO V

EU/1/06/363/005 SP R YC EL 50 MG, FILMO MHULDE TABLETTEN(56 ST BLIST)

2,00 STUK 66,32000

0L01XEAO V

EU/1/06/363/006 SP R YC EL 70 MG, FILMO MHULDE TABLET (BLISTER 56STUK)

1,43 STUK 92,84800

0L01XXBO V

25876

HYDR O XYUR EA MEDAC C AP SULE 500MG

2,00 STUK

0,33076

0N02C C AO V

35041

SUMATR IP TAN BLUEFISH TABLET 50MG

1,00 STUK

6,21227

0N02C C AO V

35042

SUMATR IP TAN BLUEFISH TABLET 100MG

0,50 STUK 12,42453

0N03AXDO V

EU/1/08/470/005 VIMP AT 100 MG, FILMO MHULDE TABLETTEN (56 STUKS)

3,00 STUK

1,19163

0N03AXDO V

EU/1/08/470/011 VIMP AT 200 MG, FILMO MHULDE TABLETTEN (56 STUKS)

1,50 STUK

2,38325

4N05AXAO V

102408

2,00 STUK

30132

SER O Q UEL XR TABLET MVA 150MG

5,00 STUK 39,79200

1,98151

0R 03BABID V 30100

BEC LO METASO N P C H AER C FKVR 100MC G/DO SP B 200DO +INH 8,00 DO

0,08763

0S01EDC G V

TIMO GEL O O GGEL 1MG/G TUBE 0,4G

0,29949

0A02BC AO V

32892

33801

O MEP R AZO L SANDO Z C AP SULE MSR 10MG

1,00 STUK 2,00 STUK

1,00866

0A02BC AP V

33902

P ANTO P R AZO L SANDO Z INJP DR FLAC O N 40MG

1,00 STUK

9,48400

0A04AAAP V

31378

GR ANISETR O N C F INFVLST C O NC 1MG/ML AMP UL 3ML

3,00 ML

9,51577

0A04AAAP V

34563

GR ANISETR O N SANDO Z INFVLST C O NC 1MG/ML

3,00 ML

9,51577

0A07EC C O V

105795//18706

P ENTASA GR ANULAAT MGA 1G IN SAC HET

1,50 STUK

1,25116

0A07EC C O V

105796//31379

P ENTASA GR ANULAAT MGA 2G IN SAC HET

0,75 STUK

2,50233

0A10BBAO V

32835

GLIMEPIR IDE MYLAN TABLET 2MG

1,00 STUK

0,27711

0B01ABAP V

11878

FR AXIP AR INE INJVLST 9500IE/ML W W SP 1ML

0,30 ML

5,92940

0B01ABAP V

23796

FR AXO DI INJVLST 19000 IE/ML W W SP 1ML

0,15 ML

11,85880

0C 09C AAO V

105791//22260

TEVETEN TABLET O MHULD 400MG

1,50 STUK

0,49613

YC 09DAAO V

106188//100453 C O DIO VAN TABLET O MHULD 320/12,5MG

1,00 STUK

3,02853

YC 09DBAO V

EU/1/09/569/014 EXFO R GE HC T TABLET FILMO MHULD 10/160/12,5MG

1,00 STUK

2,84914

YC 09DBAO V

EU/1/09/569/038 EXFO R GE HC T TABLET FILMO MHULD 10/160/25MG

1,00 STUK

2,90087

YC 09DBAO V

EU/1/09/569/050 EXFO R GE HC T TABLET FILMO MHULD 10/320/25MG

1,00 STUK

4,38927

YC 09DBAO V

EU/1/09/569/002 EXFO R GE HC T TABLET FILMO MHULD 5/160/12,5MG

1,00 STUK

2,19463

YC 09DBAO V

EU/1/09/569/026 EXFO R GE HC T TABLET FILMO MHULD 5/160/25MG

1,00 STUK

2,24637

0C 10AAAO V

106189//26872

C R ESTO R TABLET FILMO MHULD 10MG

1,00 STUK

1,38403

0C 10AAAO V

105841//26873

C R ESTO R TABLET FILMO MHULD 20MG

0,50 STUK

2,76806

0C 10AAAO V

106190//26873

C R ESTO R TABLET FILMO MHULD 20MG

0,50 STUK

2,76806

0C 10AAAO V

106196//26872

R O SUVASTATINE ER C TABLET FILMO MHULD 10MG

1,00 STUK

1,38403

0C 10AAAO V

106199//26872

R O SUVASTATINE ER C TABLET FILMO MHULD

1,00 STUK

1,38403

10MG 0C 10AAAO V

106198//26874

R O SUVASTATINE ER C TABLET FILMO MHULD 40MG

0,25 STUK

5,53612

0C 10AC AO V

105607//28626

EZETR O L TABLET 10MG

1,00 STUK

1,72101

YC 10AXAO V

105603//30929

INEGY TABLET 10/40MG

1,00 STUK

3,56638

0D01BABO V

34144

TER BINAFINE TER BANO TABLET 250MG

1,00 STUK

2,33152

0D07ADADL V

106112//33440

C LO BEX SHAMPO O 0,5MG/G

1,00 GR AM

0,18635

0G03AABO V

106195//11508

MER C ILO N TABLET

0,75 STUK

0,13253

0G04C AAO V

102424

ALFUZO SINE HC L PC H R ETAR D TABLET MVA 10MG

0,75 STUK

1,28268

0J01AABO V

33759

EFR AC EA C AP S MGA 40MG

1,00 STUK

0,59289;

0J01C R AO V

103893

AMO XI/C LAV AC TAVIS TABLET O MHULD 500/125MG

3,00 STUK

0,77778

0J01FAAO K

34294

AZITR O MYC INE C F P O EDER VO O R SUSPENSIE 200MG/5ML

7,50 ML

0,41094

0J01FAAO V

101499

AZITR O MYC INE AP O TEX TABLET O MHULD 250MG

1,20 STUK

2,02526

0J01FAAO V

101500

AZITR O MYC INE AP O TEX TABLET O MHULD 500MG

0,60 STUK

4,05052

0J05ABAO V

100590

VALAC IC LO VIR AC TAVIS TABLET 250MG

12,00 STUK

1,49747

0J05ABAO V

100591

VALAC IC LO VIR AC TAVIS TABLET 500MG

6,00 STUK

2,49579

0J05ABAO V

100108

VALAC IC LO VIR MYLAN TABLET FILMO MHULD 500MG

6,00 STUK

2,49579

0J05ABAO V

100061

VALAC IC LO VIR R ANBAXY TABLET 500MG

6,00 STUK

2,49579

0L03AAC P V

EU/1/08/495/003 ZAR ZIO 30 INJVLST 60MILJ E/ML W W SP 0,5ML

0,58 ML

224,62125

0L03AAC P V

EU/1/08/495/007 ZAR ZIO 48 INJVLST 96MILJ E/ML W W SP 0,5ML

0,36 ML

359,39400

0M05BABO V

105453//28338

0,14 STUK

AC TO NEL W EKELIJKS

8,57645

TABLET FILMO MHULD 35MG 0N02AAAO V

100654

O XYC O DO N HC L SANDO Z TABLET MVA 20MG

1,50 STUK

1,38689

0N03AXC O V

101079

GABAP ENTINE C F TABLET FILMO MHULD 600MG

3,00 STUK

1,30689

0N03AXC O V

101081

GABAP ENTINE C F TABLET FILMO MHULD 800MG

2,25 STUK

1,74252

0N03AXC O V

33682

GABAP ENTINE SANDO Z C AP SULE 400MG

4,50 STUK

0,87126

0N03AXEO V

104812

TO P IR AMAAT AC TAVIS TABLET FILMO MHULD 25MG

12,00 STUK

0,39720

0N03AXEO V

104817

TO P IR AMAAT AC TAVIS TABLET FILMO MHULD 100MG

3,00 STUK

1,58880

0N03AXEO V

104818

TO P IR AMAAT AC TAVIS TABLET FILMO MHULD 200MG

1,50 STUK

3,17760

0N04BAAO V

106040//8740

SINEMET 125 TABLET 100/25MG

6,00 STUK

0,18944

0N04BAAO V

34752

LEVO DO P A/BENSER AZIDE P C H C APSULE 50/12,5MG

12,00 STUK

0,11366

0N04BAAO V

34753

LEVO DO P A/BENSER AZIDE P C H C APSULE 100/25MG

6,00 STUK

0,18944

0N04BC AO V

35131

R O P INIR O L AC C O R D TABLET FILMO MHULD 0,25MG

24,00 STUK

0,39152

0N04BC AO V

35132

R O P INIR O L AC C O R D TABLET FILMO MHULD 0,5MG

12,00 STUK

0,32627

0N04BC AO V

35133

R O P INIR O L AC C O R D TABLET FILMO MHULD 1MG

6,00 STUK

0,65254

0N04BC AO V

35134

R O P INIR O L AC C O R D TABLET FILMO MHULD 2MG

3,00 STUK

1,30507

0N04BC AO V

101690

R O P INIR O L P C H TABLET FILMO MHULD 0,25MG

24,00 STUK

0,39152

0N04BC AO V

101691

R O P INIR O L P C H TABLET FILMO MHULD 0,5MG

12,00 STUK

0,32627

0N04BC AO V

101692

R O P INIR O L P C H TABLET FILMO MHULD 1MG

6,00 STUK

0,65254

0N04BC AO V

101693

R O P INIR O L P C H TABLET FILMO MHULD 2MG

3,00 STUK

1,30507

0N04BC AO V

EU/1/97/050/005 SIFR O L TABLET 1MG (0,7MG BASE)

2,50 STUK

1,56609

0N05AXAP V

100013//27178

0,11 STUK 117,02000

R ISP ER DAL C O NSTA INJP DR FLAC O N 25MG +

SO LV 2ML 0N05AXAP V

32559//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07 STUK 175,53000

0N05AXAP V

33006//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07 STUK 175,53000

0N05AXAP V

31410//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05 STUK 234,04000

0N05AXAP V

32560//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05 STUK 234,04000

4N05AXAO V

106201//34626

SER O Q UEL XR TABLET MVA 200MG

1,50 STUK

2,64201

0N07BC AO V

105797

METHADO N HC L SANDO Z TABLET 5MG

5,00 STUK

0,08867

0N07BC BO V

102355

BUP R ENO R FINE MYLAN TABLET SUBLINGUAAL 2MG

4,00 STUK

0,90429

0N07BC BO V

102356

BUP R ENO R FINE MYLAN TABLET SUBLINGUAAL 8MG

1,00 STUK

3,61714

0A02BC AO

V

101193

P ANTO P R AZO L NYC O MED TABLET MSR 20MG

2,00 STUK

1,00866

1A06ADAO

V

103747

LAXTR A NEUTR AAL PO EDER VO O R DR ANK IN SAC HET

0,76 STUK

0,54285

1A06ADAO

V

103756

LAXTR A O R ANGE P O EDER VO O R DR ANK IN SAC HET

0,76 STUK

0,54285

0A07DAAO

K

106193//8423

IMO DIUM DR ANK

0A10BBAO

V

34589

GLIC LAZIDE C F R ETAR D TABLET MGA 30MG

2,00 STUK

0A10BXAP

V

EU/1/09/529/002

VIC TO ZA INJVLST 6MG/ML W W SP 3ML

0,20 ML

0B01AC DO

V

103173

C LO P IDO GR EL A TABLET FILMO MHULD 75MG

1,00 STUK

0C 07ABAO

V

16050

ATENO LO L C F TABLET 50MG

1,50 STUK

0,27075

0C 07ABAO

V

16051

ATENO LO L C F TABLET 100MG

0,75 STUK

0,54151

0C 07ABAO

V

106205

METO P R O LO LSUC C INAAT A R ETAR D 25 TABL MGA 23,75MG

6,00 STUK

0,10830

0C 07ABAO

V

106206

METO P R O LO LSUC C INAAT A R ETAR D 50 TABL MGA 47,5MG

3,00 STUK

0,13538

0C 07ABAO

V

103182

METO P R O LO LSUC C INAAT MYLAN R ET 25 TABL MVA 23,75MG

6,00 STUK

0,10830

0C 07ABAO

V

103183

METO P R O LO LSUC C INAAT MYLAN R ET 50 TABL MVA 47,5MG

3,00 STUK

0,13538

0C 07ABAO

V

103184

METO P R O LO LSUC C INAAT MYLAN R ET 100 TABL MVA 95MG

1,50 STUK

0,27075

0C 07ABAO

V

103185

METO P R O LO LSUC C INAAT MYLAN R ET 200 TABL MVA 190MG

0,75 STUK

0,54151

0C 08C AAO

V

101997

LER C ANIDIP INE HC L AC TAVIS TABLET

1,00 STUK

0,65450

50,00 ML

0,03989 0,13855 24,05000 1,88043

O MHULD 10MG 0C 08C AAO

V

101998

LER C ANIDIP INE HC L AC TAVIS TABLET O MHULD 20MG

0,50 STUK

1,30901

0C 08C AAO

V

102330

LER C ANIDIP INE HC L MYLAN TABLET O MHULD 10MG

1,00 STUK

0,65450

0C 08C AAO

V

102333

LER C ANIDIP INE HC L MYLAN TABLET O MHULD 20MG

0,50 STUK

1,30901

0C 08C AAO

V

103614

LER C ANIDIP INE HC L P C H TABLET O MHULD 10MG

1,00 STUK

0,65450

0C 08C AAO

V

103615

LER C ANIDIP INE HC L P C H TABLET O MHULD 20MG

0,50 STUK

1,30901

0C 08C AAO

V

103300

LER C ANIDIP INE HC L R P TABLET O MHULD 10MG

1,00 STUK

0,65450

0C 08C AAO

V

102327

LER C ANIDIP INE HC L SANDO Z TABLET O MHULD 10MG

1,00 STUK

0,65450

0C 08C AAO

V

102328

LER C ANIDIP INE HC L SANDO Z TABLET O MHULD 20MG

0,50 STUK

1,30901

0C 10AAAO

V

106197//26873

R O SUVASTATINE ER C TABLET FILMO MHULD 20MG

0,50 STUK

2,76806

0D06AXADZ

V

106192//5617

FUC IDIN ZALF 20MG/G

1,00 GR AM

0,22477

0D07ADADL

V

106098//7579

C LO BETASO L-17-P R O P IO NAAT FISHER LO TIO N 0,5MG/G

1,00 GR AM

0,18635

0G03AABO

V

102388

ETHINYLESTR ADIO L/LEVO NO R GES R P TAB O MH 0,02/0,1MG

0,75 STUK

0,13253

0G03AABO

V

105767//23827

YASMIN TABLET O MHULD

0,75 STUK

0,13253

0G03ABBO

V

105792//8663

TR IGYNO N DR AGEE

0,75 STUK

0,12515

0G03XC AO

V

EU/1/98/073/002

EVISTA TABLET 60MG

1,00 STUK

1,11176

0G04BDBO

V

104949

O XYBUTYNINE HC L P C H TABLET 5MG

3,00 STUK

0,27660

0J02AC AO

V

105793//21024

TR ISP O R AL O S DR ANK 10MG/ML

0L01C AAP

V

101349

VINBLASTINESULFAAT P C H INJVLST 1MG/ML FL 10ML

0,15 STUK

24,95790

0L02AEADI

V

103585

P AMO R ELIN INJP DR FLAC O N 22,5MG + SO LVENS 2ML

0,17 STUK

1104,45540

0N02ABC O

V

EU/1/09/531/001

INSTANYL NEUSSP R AY 50MC G/DO FLAC O N 10DO SES

3,00 DO

6,04440

0N02ABC O

V

EU/1/09/531/003

INSTANYL NEUSSP R AY 50MC G/DO FLAC O N 40DO SES

3,00 DO

6,04440

0N02ABC O

V

EU/1/09/531/004

INSTANYL NEUSSP R AY 100MC G/DO FLAC O N 10DO SES

1,50 DO

10,07400

0N02ABC O

V

EU/1/09/531/006

INSTANYL NEUSSP R AY 100MC G/DO FLAC O N

1,50 DO

10,07400

20,00 ML

0,62141

0N02ABC O

V

EU/1/09/531/007

INSTANYL NEUSSP R AY 200MC G/DO FLAC O N 10DO SES

0,75 DO

20,14800

0N02ABC O

V

EU/1/09/531/009

INSTANYL NEUSSP R AY 200MC G/DO FLAC O N 40DO SES

0,75 DO

20,14800

0N03AFBO

V

101681

O XC AR BAZEPINE P C H TABLET FILMO MHULD 300MG

3,33 STUK

0,29201

0N03AFBO

V

101683

O XC AR BAZEPINE P C H TABLET FILMO MHULD 600MG

1,67 STUK

0,58402

0N04BAAO

V

106103//12489

MADO P AR HBS C AP SULE MGA 125MG

6,00 STUK

0,18944

1N05ABAP D

V

106278//6170

ANATENSO L DEC ANO AAT INJVLST 25MG/ML AMP UL 1,0ML

0,04 STUK

17,90175

3N05C DAO

V

14356

TEMAZEPAM P C H TABLET 10MG

2,00 STUK

0,09779

4N05AXAO

V

104474

R ISP ER IDO N SANDO Z TABLET O MHULD 0,5MG

10,00 STUK

0,63408

2N06ABAO

V

EU/1/08/499/003

VALDO XAN TABLET FILMO MHULD 25MG

1,00 STUK

1,06638

YR 03AC C IDC

V

106272//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00 DO

0,90703

YR 03AKAIDC

V

106287//25887

SYMBIC O R T TUR BUHALER INHALP DR 200/6MC G/DO 120DO

1,00 DO

0,48321

YR 03AKAIDC

V

106288//27690

SYMBIC O R T TUR BUHALER INHALP DR 400/12MC G/DO 60DO

1,00 DO

0,96642

2R 06AEAO

V

102859

LEVO C ETIR IZINE DIHC L SANDO Z TABLET FO 5MG

1,00 STUK

0,50499

YS01EDC G

V

102367

DO R ZO LAMIDE/TIMO LO L SANDO Z O O GDR 20/5MG/ML FL 5ML

1,00 ML

3,13380

0A02BAAO

V

101659

R ANITIDINE AC C O R D BR UISTABLET 150MG

2,00 STUK

0,65942

0A02BAAO

V

101660

R ANITIDINE AC C O R D BR UISTABLET 300MG

1,00 STUK

1,31884

0A03FABO

V

104454

DO MPER IDO N MDQ TABLET 10MG

3,00 STUK

0,22689

0A10BHAO

V

EU/1/09/545/001

O NGLYZA 5 MG FILMO MHULDE TABLET 14 STUKS

1,00 STUK

3,22000

0A10BHAO

V

EU/1/09/545/005

O NGLYZA 5 MG FILMO MHULDE TABLET 14 STUKS

1,00 STUK

3,22000

0A10BHAO

V

EU/1/09/545/002

O NGLYZA 5 MG FILMO MHULDE TABLET 28 STUKS

1,00 STUK

3,22000

0A10BHAO

V

EU/1/09/545/006

O NGLYZA TABLET 5MG

1,00 STUK

3,22000

0A10BHAO

V

EU/1/09/545/003

O NGLYZA 5 MG FILMO MHULDE TABLET 56 STUKS

1,00 STUK

3,22000

0A10BHAO

V

EU/1/09/545/007

O NGLYZA 5 MG FILMO MHULDE TABLET 56 STUKS

1,00 STUK

3,22000

STUKS

1,00 STUK

3,22000

0A10BHAO

V

EU/1/09/545/004

O NGLYZA 5 MG FILMO MHULDE TABLET 98 STUKS

1,00 STUK

3,22000

0A10BHAO

V

EU/1/09/545/008

O NGLYZA 5 MG FILMO MHULDE TABLET 98 STUKS

1,00 STUK

3,22000

0A10BHAO V

V

EU/1/09/545/009

O NGLYZA TABLET 5MG

1,00 STUK

3,22000

0B01AC DO

V

103348

C LO P IDO GR EL AC TAVIS TABLET FILMO MHULD 75MG

1,00 STUK

1,88043

0B01AC DO

V

EU/1/09/568/004

C LO P IDO GR EL AP O TEX TABLET FILMO MHULD 75MG

1,00 STUK

1,88043

0B01AC DO

V

103440

C LO P IDO GR EL C F TABLET FILMO MHULD 75MG

1,00 STUK

1,88043

0B03XAAP

V

EU/1/07/431/024

R ETAC R IT 40000 INJVLST 40000IE/ML W W SP 1ML

0,05 ML

0C 09C AAO

V

EU/1/97/046/017

AP R O VEL TABLET FILMO MHULD 75MG

2,00 STUK

0,44652

0C 09C AAO

V

106438//21704

C ANDESAR TAN ER C TABLET 4MG

2,00 STUK

0,44652

0C 09C AAO

V

33995

KALIUMLO SAR TAN R P TABLET FILMO MHULD 50MG

1,00 STUK

0,74420

0C 09C AAO

V

31869

KALIUMLO SAR TAN SANDO Z TABLET FILMO MHULD 50MG

1,00 STUK

0,74420

0C 09C AAO

V

31871

KALIUMLO SAR TAN SANDO Z TABLET FILMO MHULD 100MG

0,50 STUK

1,48840

0C 09C AAO

V

104953

LO SAR TAN KALIUM A TABLET O MHULD 50MG

1,00 STUK

0,74420

0C 09C AAO

V

104957

LO SAR TAN KALIUM A TABLET O MHULD 100MG

0,50 STUK

1,48840

0C 09C AAO

V

100044

LO SAR TAN KALIUM AC C O R D TABLET O MHULD 50MG

1,00 STUK

0,74420

0C 09C AAO

V

100045

LO SAR TAN KALIUM AC C O R D TABLET O MHULD 100MG

0,50 STUK

1,48840

0C 09C AAO

V

35332

LO SAR TAN KALIUM AP O TEX TABLET O MHULD 50MG

1,00 STUK

0,74420

0C 09C AAO

V

35333

LO SAR TAN KALIUM AP O TEX TABLET O MHULD 100MG

0,50 STUK

1,48840

0C 09C AAO

V

34401

LO SAR TAN KALIUM C F TABLET O MHULD 50MG

1,00 STUK

0,74420

0C 09C AAO

V

34402

LO SAR TAN KALIUM C F TABLET O MHULD 100MG

0,50 STUK

1,48840

0C 09C AAO

V

34188

LO SAR TAN KALIUM P C H TABLET O MHULD 25MG

2,00 STUK

0,44652

0C 09C AAO

V

34189

LO SAR TAN KALIUM P C H TABLET O MHULD 50MG

1,00 STUK

0,74420

0C 09C AAO

V

34190

LO SAR TAN KALIUM P C H TABLET O MHULD 100MG

0,50 STUK

1,48840

YC 09BAAO

V

105559//33663

C O VER SYL PLUS AR G TABLET FILMO MHULD 5/1,25MG

1,00 STUK

0,78183

YC 09BAAO

V

106525//102257

C O VER SYL PLUS AR G TABLET FILMO MHULD 10/2,5MG

1,00 STUK

1,56366

YC 09BBBO

V

106389//100139

C O VER AM AR G TABLET 5MG/ 5MG

1,00 STUK

1,38460

YC 09BBBO

V

106402//100140

C O VER AM AR G TABLET 5MG/10MG

1,00 STUK

2,03910

491,44032

YC 09BBBO

V

106390//100142

C O VER AM AR G TABLET 10MG/10MG

1,00 STUK

2,76920

YC 09DAAO

V

100343

KALIUMLO SAR TAN/HC T SANDO Z TABL FILMO MH 50/12,5MG

1,00 STUK

0,79593

YC 09DAAO

V

100367

KALIUMLO SAR TAN/HC T SANDO Z TABL FILMO MH 100/25MG

1,00 STUK

1,59186

YC 09DAAO

V

35322

LO SAR TAN KALIUM/HC T AP O TEX TABL FILMO MH 50/12,5MG

1,00 STUK

0,79593

YC 09DAAO

V

35323

LO SAR TAN KALIUM/HC T AP O TEX TABL FILMO MH 100/25MG

1,00 STUK

1,59186

YC 09DAAO

V

100214

LO SAR TAN KALIUM/HC T C F TABLET FILMO MH 50/12,5MG

1,00 STUK

0,79593

YC 09DAAO

V

100221

LO SAR TAN KALIUM/HC T C F TABLET FILMO MH 100/25MG

1,00 STUK

1,59186

YC 09DAAO

V

100065

LO SAR TAN KALIUM/HC T MYLAN TABL FILMO MH 50/12,5MG

1,00 STUK

0,79593

YC 09DAAO

V

100067

LO SAR TAN KALIUM/HC T MYLAN TABL FILMO MH 100/25MG

1,00 STUK

1,59186

YC 09DAAO

V

34061

LO SAR TAN KALIUM/HC T P C H TABLET FILMO MH 50/12,5MG

1,00 STUK

0,79593

YC 09DAAO

V

34062

LO SAR TAN KALIUM/HC T P C H TABLET FILMO MH 100/25MG

1,00 STUK

1,59186

0C 10AAAO

V

35300

FLUVASTATINE AC TAVIS C AP SULE 20MG

3,00 STUK

0,55361

0C 10AAAO

V

35301

FLUVASTATINE AC TAVIS C AP SULE 40MG

1,50 STUK

0,92269

YC 10AXAO

V

106461//30928

INEGY TABLET 10/20MG

1,00 STUK

2,64369

YC 10AXAO

V

106462//30929

INEGY TABLET 10/40MG

1,00 STUK

3,56638

0G03BABO

V

106359//7531

ANDR IO L C AP SULE 40MG

3,00 STUK

0,60504

0J05ABAO

V

102701

FAMC IC LO VIR AC TAVIS TABLET FILMO MHULD 125MG

6,00 STUK

2,49579

0J05ABAO

V

102703

FAMC IC LO VIR AC TAVIS TABLET FILMO MHULD 500MG

1,50 STUK

9,98316

0L01DC AP

V

105266

BLEO MYC INE PC H INJPDR FLAC O N 15U

0,43 STUK

46,96625

0L04AAAO

V

106281//17497

NEO R AL DR ANK 100MG/ML

3,00 ML

0L04AAAP

V

EU/1/09/544/001

C IMZIA INJVLST 200MG/ML W W SP 1ML

0,07 STUK

554,34389

0L04AADO

V

102092

ADP O R T C AP SULE 0,5MG

10,00 STUK

1,70955

0L04AADO

V

102094

ADP O R T C AP SULE 1MG

5,00 STUK

2,84925

0L04AADO

V

102095

ADP O R T C AP SULE 5MG

1,00 STUK

14,24625

0M01AHBO

V

105448//27705

AR C O XIA TABLET FILMO MHULD 60MG

1,00 STUK

1,13188

0M01AHBO

V

105452//27706

AR C O XIA TABLET FILMO MHULD 90MG

0,67 STUK

1,69782

0N02C C AP

V

102601

SUMATR IP TAN SUN INJVLST 12MG/ML W W SP 0,5ML

0,50 ML

3,93110

51,93060

0N03AXDO

V

EU/1/00/146/031

KEP P R A O P L VO O R O R AAL GEBR UIK 100MG/ML+DO S SP 3ML

15,00 ML

0,23833

0N03AXDO

V

EU/1/00/146/032

KEP P R A O P L VO O R O R AAL GEBR UIK 100MG/ML+DO S SP 1ML

15,00 ML

0,23833

0N04BC AO

V

27893

P ER GO LIDE TEVA TABLET 0,25MG

12,00 STUK

0,32627

0N04BC AO

V

27892

P ER GO LIDE TEVA TABLET 0,05MG

60,00 STUK

0,31322

0N04BC AO

V

27894

P ER GO LIDE TEVA TABLET 1MG

3,00 STUK

1,30507

4N05AXAO

V

106447//34626

SER O Q UEL XR TABLET MVA 200MG

1,50 STUK

2,64201

4N05AXAO

V

106448//34626

SER O Q UEL XR TABLET MVA 200MG

1,50 STUK

2,64201

4N05AXAO

V

106449//34627

SER O Q UEL XR TABLET MVA 300MG

1,00 STUK

3,96302

4N05AXAO

V

106450//34627

SER O Q UEL XR TABLET MVA 300MG

1,00 STUK

3,96302

4N05AXAO

V

106451//34628

SER O Q UEL XR TABLET MVA 400MG

0,75 STUK

5,28402

4N05AXAO

V

106452//34628

SER O Q UEL XR TABLET MVA 400MG

0,75 STUK

5,28402

0R 01ADAN

V

106130

BUDESO NIDE C F NEVEL NEUSSP R AY 50MC G/DO 200DO

4,00 DO

0,08425

0S01EXAG

V

EU/1/02/205/003

LUMIGAN O O GDR UP P ELS 0,1MG/ML FLAC O N 3ML

0,20 ML

8,54016

0A03AAAO

V

106595//11657

MEBEVER INEHYDR O C HLO R IDE ER C R ETAR D C AP S MGA 200MG

2,00 STUK

0,35055

0A03FABO

V

104463

DO MPER IDO N 10 MG P C H TABLETTEN

3,00 STUK

0,22689

0A07DAAO

V

105493

LO P ER AMIDE HC L MDQ C APSULE 2MG

5,00 STUK

0,23143

0A07EC C O

V

105712

P ENTASA TABLET MVA 1G

1,50 STUK

1,25116

0A09AAAO

V

105393//16055

C R EO N FO R TE C AP SULE MSR (P ANC R EATINE 300MG)

2,40 STUK

1,00796

0A10BXAP

V

EU/1/06/362/001

BYETTA 5 INJVLST 0,25MG/ML W W SP 1,2ML

0,06 ML

80,16667

0A10BXAP

V

EU/1/06/362/003

BYETTA 10 INJVLST 0,25MG/ML W W SP 2,4ML

0,06 ML

80,16667

0A12AABO

V

106575//14032

C ALC I C HEW KAUW TABLET 500MG

2,00 STUK

0,26210

1C 03AAAO

V

104323

HYDR O C HLO O R THIAZIDE SANDO Z TABLET 12,5MG

2,00 STUK

0,06208

0C 07ABAO

V

100482

BISO P R O LO LFUMAR AAT R P TABLET 2,5MG

4,00 STUK

0,10153

YC 07BBAO

V

100073

BISO P R O LO LFUMAR AAT/HYDR O C HLO O R THIA SDZ T 5/12,5MG

1,00 STUK

0,25480

YC 07BBAO

V

100074

BISO P R O LO LFUMAR AAT/HYDR O C HLO O R THIA SDZ T 10/25MG

1,00 STUK

0,50959

0C 09AAAO

V

101236

ENALAP R IL MALEAAT AC TAVIS TABLET 5MG

2,00 STUK

0,35045

0C 09AAAO

V

101237

ENALAP R IL MALEAAT AC TAVIS TABLET 10MG

1,00 STUK

0,58408

0C 09AAAO

V

101238

ENALAP R IL MALEAAT AC TAVIS TABLET 20MG

0,50 STUK

1,16816

O MHULD 50MG 0C 09C AAO

V

103971

LO SAR TAN KALIUM R ANBAXY TABLET O MHULD 100MG

0,50 STUK

1,48840

YC 09BAAO

V

101179

ENALAP R IL/HYDR O C HLO O R THIAZIDE A TABLET 20/12,5MG

1,00 STUK

1,21989

YC 09DAAO

V

106134

KALIUMLO SAR TAN/HC T AC TAVIS TABL FILMO MH 50/12,5MG

1,00 STUK

0,79593

YC 09DAAO

V

106135

KALIUMLO SAR TAN/HC T AC TAVIS TABL FILMO MH 100/25MG

1,00 STUK

1,59186

YC 09DAAO

V

105781

LO SAR TAN KALIUM/HC T A TABLET FILMO MH 50/12,5MG

1,00 STUK

0,79593

YC 09DAAO

V

105783

LO SAR TAN KALIUM/HC T A TABLET FILMO MH 100/25MG

1,00 STUK

1,59186

0C 10AAAO

V

106576//30823

C R ESTO R TABLET FILMO MHULD 5MG

2,00 STUK

0,83042

0H02ABBO

V

106136

P R EDNISO LO N SANDO Z TABLET 30MG

0,33 STUK

0,29950

0J07BC AP

V

105064//17316

ENGER IX-B VAC C IN 20MC G/ML

1,00 ML

0L03AAC P

V

EU/1/02/227/002

NEULASTA INJVLST 10MG/ML W W SP 0,6ML

0,09 STUK

0L03AAC P

V

EU/1/08/445/001

TEVAGR ASTIM 30 INJVLST 60MILJ E/ML W W SP 0,5ML

0,58 ML

224,62125

0L03AAC P

V

EU/1/08/445/005

TEVAGR ASTIM 48 INJVLST 60MILJ E/ML W W SP 0,8ML

0,58 ML

224,62125

0M01AHBO

V

27713

AUXIB 120 MG FILMO MHULDE TABLETTEN

0,50 STUK

2,26376

0M01AHBO

V

34280

AUXIB 30 MG FILMO MHULDE TABLETTEN

2,00 STUK

0,67913

0M01AHBO

V

27712

AUXIB 90 MG FILMO MHULDE TABLETTEN

0,67 STUK

1,69782

0N02ABC O

V

26571

AC TIQ ZUIGTABLET 200MC G

3,00 STUK

8,05920

0N02ABC O

V

26572

AC TIQ ZUIGTABLET 400MC G

1,50 STUK

10,07400

0N02ABC O

V

26573

AC TIQ ZUIGTABLET 600MC G

1,00 STUK

15,11100

0N02ABC O

V

26574

AC TIQ ZUIGTABLET 800MC G

0,75 STUK

20,14800

0N02C C AO

V

106623//31917

ZO MIG TABLET O MHULD 2,5MG

1,00 STUK

6,21227

0N02C C AO

V

106627//31919

ZO MIG ZIP O R O DISP TABLET 2,5MG

1,00 STUK

6,21227

0N03AXC O

V

33680

GABAP ENTINE SANDO Z C APSULE 100MG

18,00 STUK

0,43563

4N05AXAO

V

EU/1/07/395/001

INVEGA TABLET MVA 3MG

2,00 STUK

2,37781

4N05AXAO

V

33504

R ISP ER IDO N AP O TEX DR ANK 1MG/ML

5,00 ML

0,79260

2N06ABAO

V

106578//30496

ESC ITALO P R AM ER C TABLET FILMO MHULD 15MG

0,67 STUK

1,59958

2N06BAAO

V

106532//33668

W ELLBUTR IN XR TABLET MGA 150MG

2,00 STUK

0,63983

0N07BC BO

V

EU/1/06/359/001

SUBO XO NE TABLET SUBLINGUAAL 2MG/0,5MG

4,00 STUK

0,90429

0N07BC BO

V

EU/1/06/359/003

SUBO XO NE TABLET SUBLINGUAAL 8MG/2MG

1,00 STUK

3,61714

29,51840 1442,52179

YR 03AC C IDC

V

106536//23530

ALIFLUS DISKUS INHP DR 50/250MC G 60DO

1,00 DO

0,90703

YR 03AC C IDC

V

106700//23529

SER ETIDE DISKUS INHP DR 50/100MC G 60DO

1,00 DO

0,72888

YR 03AC C IDC

V

106662//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

2R 06AXAO

V

106443//19982

MIZO LLEN TABLET MGA 10MG

1,00 STUK

0,50499

0A02BC AO

V

106681//23211

P AR IET TABLET MSR 20MG

1,00 STUK

1,68111

0A03FABO

V

104582

DO MPER IDO N SAN TABLET 10MG

3,00 STUK

0,22689

0A05AAAO

V

106477//8384

UR SO FALK C AP SULE 250MG

2,40 STUK

0,77044

1A06AC AO

V

106284//9259

NO R MAC O L GR ANULAAT 620MG/G SAC HET 10G

1,33 STUK

0,30943

1A06ADAO

V

106774//32357

MO VIC O LO N JUNIO R NATUR EL P O EDER V DR ANK IN SAC HET

1,52 STUK

0,32571

0A09AAAO

V

106677//13760

P ANZYTR AT 25000 C APSULE MSR

2,40 STUK

1,00796

YA10ADEP I V

V

106643//14894

HUMULINE 30/70 INJ 100IE/ML P ATR O O N 3ML

1,00 ML

2,09295

YB01AC BO

V

EU/1/10/619/009

DUO P LAVIN TABLET FILMO MHULD 75/100MG

1,00 STUK

1,93292

1C 01DAAO

V

106589//20822

ISO SO R BIDEMO NO NITR AAT ER C R ETAR D C AP SULE 100MG

0,60 STUK

0,90756

0C 08C AAO

V

106230

AMLO DIP INE BLUEFISH TABLET 10MG

0,50 STUK

1,30901

0C 08C AAO

V

106229

AMLO DIP INE BLUEFISH TABLET 5MG

1,00 STUK

0,65450

YC 09BAAO

V

100450

R AMIP R IL/HYDR O C HLO O R THIAZIDE P C H TABLET 5/25MG

1,00 STUK

1,27162

0C 10AAAO

V

106631//21081

LIP ITO R TABLET O MHULD 10MG

2,00 STUK

0,83042

0C 10AC AO

V

EU/1/03/268/004

C HO LESTAGEL TABLET FILMO MHULD 625MG

6,00 STUK

0,28683

0C 10ADAO

V

EU/1/08/459/001

TR EDAP TIVE 1000 MG/ 20 MG TABLET MGA

2,00 STUK

0,49523

0C 10ADAO

V

EU/1/08/459/002

TR EDAP TIVE 1000 MG/ 20 MG TABLET MGA

2,00 STUK

0,49523

0C 10ADAO

V

EU/1/08/459/008

TR EDAP TIVE 1000 MG/ 20 MG TABLET MGA

2,00 STUK

0,49523

0C 10ADAO

V

EU/1/08/459/003

TR EDAP TIVE TABLET MGA 1000/20MG

2,00 STUK

0,49523

0D01BABO

V

106137

TER BINAFINE A TABLET 250MG

1,00 STUK

2,33152

0G03AABO

V

102384

ETHINYLESTR ADIO L/LEVO NO R GES A TAB O MH 0,02/0,1MG

0,75 STUK

0,13253

0G04BDBO

V

106644//26670

DETR USITO L SR C AP SULE MVA 4MG

1,00 STUK

0,82981

0H01C BBP

V

32592

O C TR EO TIDE SANDO Z INJVLST 0,05MG/ML AMP UL 1ML

14,00 ML

8,68027

0H01C BBP

V

32593

O C TR EO TIDE SANDO Z INJVLST 0,1MG/ML AMP UL 1ML

7,00 ML

10,85034

0H01C BBP

V

34198

O C TR EO TIDE SANDO Z INJVLST 0,2MG/ML FLAC O N 5ML

3,50 ML

21,70068

0H01C BBP

V

32594

O C TR EO TIDE SANDO Z INJVLST 0,5MG/ML AMP UL 1ML

1,40 ML

54,25170

0J01MAAO

V

106526//19341

C IP R O XIN SUSPENSIE 50MG/ML

20,00 ML

0,18340

0L01AXAO

V

EU/1/10/615/003

TEMO ZO LO MIDE HO SPIR A C AP SULE 5MG

13,40 STUK

8,65384

0L01AXAO

V

EU/1/10/615/007

TEMO ZO LO MIDE HO SPIR A C AP SULE 20MG

3,35 STUK

21,63461

0L01AXAO

V

EU/1/10/615/011

TEMO ZO LO MIDE HO SPIR A C AP SULE 100MG

0,67 STUK

108,17304

0L01AXAO

V

EU/1/10/615/015

TEMO ZO LO MIDE HO SPIR A C AP SULE 140MG

0,48 STUK

151,44226

0L01AXAO

V

EU/1/10/615/019

TEMO ZO LO MIDE HO SPIR A C AP SULE 180MG

0,37 STUK

194,71147

0L01AXAO

V

EU/1/10/615/023

TEMO ZO LO MIDE HO SPIR A C AP SULE 250MG

0,27 STUK

270,43260

0L01AXAO

V

EU/1/10/617/001

TEMO ZO LO MIDE SANDO Z C APSULE 5MG

0L01AXAO

V

EU/1/10/617/005

0L01AXAO

V

0L01AXAO

V

0L01AXAO

13,40 STUK

8,65384

TEMO ZO LO MIDE SANDO Z C APSULE 20MG

3,35 STUK

21,63461

EU/1/10/617/009

TEMO ZO LO MIDE SANDO Z C APSULE 100MG

0,67 STUK

108,17304

EU/1/10/617/013

TEMO ZO LO MIDE SANDO Z C APSULE 140MG

0,48 STUK

151,44226

V

EU/1/10/617/017

TEMO ZO LO MIDE SANDO Z C APSULE 180MG

0,37 STUK

194,71147

0L01AXAO

V

EU/1/10/617/021

TEMO ZO LO MIDE SANDO Z C APSULE 250MG

0,27 STUK

270,43260

0L01AXAO

V

EU/1/09/606/001

TEMO ZO LO MIDE TEVA C AP SULE 5MG

0L01AXAO

V

EU/1/09/606/003

0L01AXAO

V

0L01AXAO

V

0L01AXAO

13,40 STUK

8,65384

TEMO ZO LO MIDE TEVA C AP SULE 20MG

3,35 STUK

21,63461

EU/1/09/606/005

TEMO ZO LO MIDE TEVA C AP SULE 100MG

0,67 STUK

108,17304

EU/1/09/606/007

TEMO ZO LO MIDE TEVA C AP SULE 140MG

0,48 STUK

151,44226

V

EU/1/09/606/009

TEMO ZO LO MIDE TEVA C AP SULE 180MG

0,37 STUK

194,71147

0L01AXAO

V

EU/1/09/606/011

TEMO ZO LO MIDE TEVA C AP SULE 250MG

0,27 STUK

270,43260

0L02BBAO

V

106690//18805

ANANDR O N TABLET 150MG

1,00 STUK

5,44536

0L04AAAP

V

EU/1/09/546/001

SIMP O NI 50 MG O P LO SSING VO O R INJEC TIE 1 P EN

0,02 ML

2366,10196

0L04AAAP

V

EU/1/09/546/003

SIMP O NI 50 MG O P LO SSING VO O R INJEC TIE 1 W W SP

0,02 ML

2366,10196

0L04AAAP

V

EU/1/09/546/004

SIMP O NI 50 MG O P LO SSING VO O R INJEC TIE 3 W W SP

0,02 ML

2366,10196

0L04AAAP

V

EU/1/09/546/002

SIMP O NI INJVLST 100MG/ML P EN 0,5ML

0,02 ML

2366,10196

0L04AXAO

V

105722

AZATHIO PR INE C F TABLET 25MG

6,00 STUK

0,33652

0L04AXAO

V

105723

AZATHIO PR INE C F TABLET 50MG

3,00 STUK

0,56087

0N02C C AP

V

15009

IMIGR AN INJVLST 12MG/ML

0,50 ML

51,93060

0N02C C AP

V

24322//15009

IMIGR AN INJVLST 12MG/ML

0,50 ML

51,93060

0N02C C AP

V

26130//15009

IMIGR AN INJVLST 12MG/ML

0,50 ML

51,93060

0N02C C AP

V

26313//15009

IMIGR AN INJVLST 12MG/ML

0,50 ML

51,93060

0N02C C AP

V

26399//15009

IMIGR AN INJVLST 12MG/ML

0,50 ML

51,93060

0N02C C AP

V

25899//15009

IMIGR AN INJVLST 12MG/ML P ENFILLP ATR 0,5ML

0,50 ML

51,93060

0N02C C AP

V

103119//15009

IMIGR AN INJVLST 12MG/ML P ENFILLP ATR 0,5ML

0,50 ML

51,93060

0N02C C AP

V

25948//15009

IMIGR AN INJVLST 12MG/ML P ENFILLP ATR

0,50 ML

51,93060

0N02C C AP

V

100632//15009

IMIGR AN INJVLST 12MG/ML P ENFILLP ATR 0,5ML+GLAXO PEN

0,50 ML

0N03AXDO

V

EU/1/00/146/022

KEP P R A TABLET FILMO MHULD 1000MG

1,50 STUK

2,38325

0N06BAAO

V

106865//31494

STR ATTER A C AP SULE 10MG

8,00 STUK

0,04544

2N06ABAO

V

101016

P AR O XETINE P C H TABLET FILMO MH 20MG (ALS HC L HEMI)

1,00 STUK

1,06638

0N07C AAO

V

101754

BETAHISTINE DIHC L TEVA TABLET 24MG

1,00 STUK

0,38526

0R 01ADAN

V

106903//21613

NASO NEX NEUSSP R AY 50MC G/DO 140DO

4,00 DO

0,08425

0R 01ADAN

V

106697//23838

R HINO C O R T NEVEL NEUSSP R AY 64MC G/DO 120DO

3,13 DO

0,10784

0R 01ADAN

V

106952//23838

R HINO C O R T NEVEL NEUSSP R AY 64MC G/DO 120DO

3,13 DO

0,10784

YR 03AC C IDC V V

106906//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00 DO

0,90703

YR 03AC C IDC V V

106905//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

2R 06AEAO

V

101132

LEVO C ETIR IZINE DIHC L MYLAN TABLET 5MG

1,00 STUK

0,50499

2R 06AEAO

V

101129

LEVO C ETIR IZINE DIHC L R P TABLET FO 5MG

1,00 STUK

0,50499

O MEP R AZO LUM C AP SULE MSR 20MG

51,93060

0A02BC AO

V 31078

1,00 STUK

1,68111

1A06ADAO

V 106950//100287 MO LAXO LE P O EDER VO O R SUSPENSIE IN SAC HET

0,76 STUK

0,54285

0A10BBAO

V 105175

GLIMEPIR IDE C F TABLET 6MG

0,33 STUK

0,83132

0A10BBAO

V 32834

GLIMEPIR IDE MYLAN TABLET 1MG

2,00 STUK

0,16626

0A10BBAO

V 32836

GLIMEPIR IDE MYLAN TABLET 3MG

0,67 STUK

0,41566

0A10BBAO

V 32837

GLIMEPIR IDE MYLAN TABLET 4MG

0,50 STUK

0,55421

0B03XAAP

V EU/1/07/410/023 BINO C R IT 30000 INJVLST 40000IE/ML W W SP 0,75ML

0,05 ML

0C 09AAAO

V 33698

P ER INDO PR IL TER T-BUTYLAMINE GLENMAR K TABLET 2MG

2,00 STUK

0,35045

0C 09AAAO

V 33699

P ER INDO PR IL TER T-BUTYLAMINE GLENMAR K TABLET 4MG

1,00 STUK

0,58408

0C 09AAAO

V 33700

P ER INDO PR IL TER T-BUTYLAMINE GLENMAR K TABLET 8MG

0,50 STUK

1,16816

YC 09DAAO

V 103199

LO SAR TAN KALIUM/HC T R ANBAXY TAB FILMO MH 50/12,5MG

1,00 STUK

0,79593

YC 09DABO

V 104240

O LMETEC HC TZ TABLET FILMO MHULD 40/12,5MG

1,00 STUK

1,54013

YC 09DABO

V 104241

O LMETEC HC TZ TABLET FILMO MHULD 40/25MG

1,00 STUK

1,59186

0C 10AAAO

V 106930//21081

ATO R VASTATINE ER C TABLET FILMO MHULD 10MG

2,00 STUK

0,83042

0C 10AAAO

V 106931//21081

ATO R VASTATINE ER C TABLET FILMO MHULD 10MG

2,00 STUK

0,83042

0C 10AAAO

V 106932//21081

ATO R VASTATINE ER C TABLET FILMO MHULD 10MG

2,00 STUK

0,83042

0C 10AAAO

V 106943//21082

ATO R VASTATINE ER C TABLET FILMO MHULD 20MG

1,00 STUK

1,38403

0C 10AAAO

V 106944//21082

ATO R VASTATINE ER C TABLET FILMO MHULD 20MG

1,00 STUK

1,38403

491,44032

0C 10AAAO

V 106945//21082

ATO R VASTATINE ER C TABLET FILMO MHULD 20MG

1,00 STUK

1,38403

0C 10AAAO

V 106946//21083

ATO R VASTATINE ER C TABLET FILMO MHULD 40MG

0,50 STUK

2,76806

0C 10AAAO

V 106947//21083

ATO R VASTATINE ER C TABLET FILMO MHULD 40MG

0,50 STUK

2,76806

0C 10AAAO

V 106948//21083

ATO R VASTATINE ER C TABLET FILMO MHULD 40MG

0,50 STUK

2,76806

0C 10AAAO

V 105735

FLUVASTATINE P C H R ETAR D TABLET MVA 80MG

0,75 STUK

1,84537

0G04BDBO

V 106951//26670

DETR USITO L SR C AP SULE MVA 4MG

1,00 STUK

0,82981

0G04C BAO

V 106904//28317

AVO DAR T C AP SULE 0,5MG

1,00 STUK

1,12371

0G04C BAO

V 106993//28317

AVO DAR T C AP SULE 0,5MG

1,00 STUK

1,12371

YG04C AAO

V 104130

C O MBO DAR T C AP SULE 0,5/0,4MG

1,00 STUK

2,08572

0H05AAAP

V EU/1/03/247/001 FO R STEO INJVLST 250MC G/ML W W SP 2,4ML

0,09 ML

181,66083

0J01GBAII

V 106867//25484

TO BI INHVLST 60MG/ML AMPUL 5ML

5,00 ML

9,01888

0L01AXAO

V 104502

TEMO ZO LO MIDE R P C AP SULE 5MG

13,40 STUK

8,65384

0L01AXAO

V 104510

TEMO ZO LO MIDE R P C AP SULE 20MG

3,35 STUK

21,63461

0L01AXAO

V 104511

TEMO ZO LO MIDE R P C AP SULE 100MG

0,67 STUK 108,17304

0L01AXAO

V 104512

TEMO ZO LO MIDE R P C AP SULE 140MG

0,48 STUK 151,44226

0L01AXAO

V 104513

TEMO ZO LO MIDE R P C AP SULE 180MG

0,37 STUK 194,71147

0L01AXAO

V 104514

TEMO ZO LO MIDE R P C AP SULE 250MG

0,27 STUK 270,43260

0L01XXBO

V 35100//25876

HYDR EA C AP SULE 500MG

2,00 STUK

0,33076

0L02BGAO

V 103067

ANASTR O ZO L BLUEFISH TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L03AAC P

V EU/1/08/445/009 TEVAGR ASTIM 30 INJVLST 60MILJ E/ML W W SP 0,5ML

0,58 ML

224,62125

0L03AAC P

V EU/1/08/445/012 TEVAGR ASTIM 48 INJVLST 60MILJ E/ML W W SP 0,8ML

0,58 ML

224,62125

0M01AHBO

V 107116//34279

AR C O XIA TABLET FILMO MHULD 30MG

2,00 STUK

0,67913

1M01AC AO

V 100167

MELO XIC AM AUR O BINDO TABLET 7,5MG

2,00 STUK

0,33398

0N02C C AO

V 107162//21818

MAXALT SMELTTABLET 10MG

1,00 STUK

6,21227

0N03AGAO

V 106692//13157

DEPAKINE C HR O NO TABLET MGA 300MG

5,00 STUK

0,15928

0N03AGAO

V 107020//11775

DEPAKINE C HR O NO TABLET MGA 500MG

3,00 STUK

0,26546

0N03AXEO

V 102978

TO P IR AMAAT AC C O R D TABLET FILMO MHULD 25MG

12,00 STUK

0,39720

0N03AXEO

V 102979

TO P IR AMAAT AC C O R D TABLET FILMO MHULD 50MG

6,00 STUK

0,79440

0N03AXEO

V 102980

TO P IR AMAAT AC C O R D TABLET FILMO MHULD 100MG

3,00 STUK

1,58880

0N03AXEO

V 102981

TO P IR AMAAT AC C O R D TABLET FILMO MHULD 200MG

1,50 STUK

3,17760

0N03AXEO

V 103239

TO P IR AMAAT BLUEFISH TABLET FILMO MHULD 100MG

3,00 STUK

1,58880

0N03AXEO

V 103240

TO P IR AMAAT BLUEFISH 200 MG, FILMO MHULDE TABLETTEN

1,50 STUK

3,17760

0N03AXEO

V 103235

TO P IR AMAAT BLUEFISH TABLET FILMO MHULD 25MG

0N03AXEO

V 103238

TO P IR AMAAT BLUEFISH 50 MG, FILMO MHULDE TABLETTEN

0N03AXEO

V 103742

TO P IR AMAAT GLENMAR K TABLET FILMO MHULD 25MG

12,00 STUK

0,39720

6,00 STUK

0,79440

12,00 STUK

0,39720

0N03AXEO

V 103743

TO P IR AMAAT GLENMAR K TABLET FILMO MHULD 50MG

6,00 STUK

0,79440

0N03AXEO

V 103744

TO P IR AMAAT GLENMAR K TABLET FILMO MHULD 100MG

3,00 STUK

1,58880

0N03AXEO

V 103745

TO P IR AMAAT GLENMAR K TABLET FILMO MHULD 200MG

1,50 STUK

3,17760

0N04BAAO

V 106702//15175

SINEMET C R 125 TABLET MGA 100/25MG

6,00 STUK

0,18944

0N04BC AO

V 107046//100571 R EQ UIP MO DUTAB TABLET MVA 2MG

3,00 STUK

1,56609

0N04BC AO

V 107054//100574 R EQ UIP MO DUTAB TABLET MVA 4MG

1,50 STUK

2,61014

0N04BC AO

V 107055//100576 R EQ UIP MO DUTAB TABLET MVA 8MG

0,75 STUK

5,22029

0N04BC AO

V 103720

R O P INIR O L GLENMAR K TABLET FILMO MHULD 0,25MG

24,00 STUK

0,39152

0N04BC AO

V 103721

R O P INIR O L GLENMAR K TABLET FILMO MHULD 0,5MG

12,00 STUK

0,32627

0N04BC AO

V 103722

R O P INIR O L GLENMAR K TABLET FILMO MHULD 1MG

6,00 STUK

0,65254

0N04BC AO

V 103723

R O P INIR O L GLENMAR K TABLET FILMO MHULD 2MG

3,00 STUK

1,30507

2N05AGAO

V 106689//6149

O R AP TABLET 1MG

4,00 STUK

0,21965

0N06BABO

V 104118

MO DAFINIL MYLAN TABLET 100MG

3,00 STUK

2,81344

0R 03AC C IDC V EU/1/09/593/002 O NBR EZ BR EEZHALER INHALPDR 150MC G MET BR EEZHALER

1,00 STUK

1,22022

0R 03AC C IDC V EU/1/09/593/007 O NBR EZ BR EEZHALER INHALPDR 300MC G MET BR EEZHALER

0,50 STUK

2,44043

YR 03AC C IDA V 107070//25866

SER ETIDE AER O SO L 25/125MC G/DO C FKVR SP BS 120DO +INH

1,00 DO

0,37690

YR 03AC C IDA V 107069//25867

SER ETIDE AER O SO L 25/250MC G/DO C FKVR SP BS 120DO +INH

1,00 DO

0,52294

YR 03AC C IDC V 106907//23529

SER ETIDE DISKUS INHP DR 50/100MC G 60DO

1,00 DO

0,72888

YR 03AC C IDC V 107010//23529

SER ETIDE DISKUS INHP DR 50/100MC G 60DO

1,00 DO

0,72888

YR 03AC C IDC V 107014//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00 DO

0,90703

YR 03AC C IDC V 107016//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

YR 03AC C IDC V 107087//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

YR 03AC C IDC V 107095//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

2R 06AEAO

V 102860

LEVO C ETIR IZINE DIHC L AC TAVIS TABLET FO 5MG

1,00 STUK

0,50499

0S01BC AG

V 106910//16363

INDO C O LLYR E O O GDR UP P ELS 1MG/ML FLAC O N 5ML

0,40 ML

1,42850

0S01XAAG

V 104871//10187

TEAR S NATUR ALE O O GDR UP P ELS FLAC O N 15ML

0,60 ML

0,26471

0L01BAC P

V 104433

METHO TR EXAAT SDZ INJVLST 10MG/ML W W SP

0,25 ML

12,59200

0L01BAC P

V 101493

METHO TR EXAAT SDZ INJVLST 20MG/ML W W SP

0,13 ML

25,18400

0L01BAC P

V 100943

METO JEC T INJVLST 50MG/ML

0,05 ML

62,96000

0A02BC AO

V 107017//101600 NEXIUM GR ANULAAT MSR V SUSP IN SAC HET 10MG

2,00 STUK

1,00866

0A02BC AO

V 107173//23210

2,00 STUK

1,00866

1A06ADAO

V 107164//101716 MO VIC O LO N C HO C O LATE P O EDER V DR ANK IN SAC HET

0,76 STUK

0,54285

0A07EC C O

V 106839//100059 SALO FALK GR ANU-STIX GR ANULAAT MGA 1,5G IN SAC HET

1,00 STUK

1,87674

0A07EC C O

V 107266//100059 SALO FALK GR ANU-STIX GR ANULAAT MGA 1,5G IN SAC HET

1,00 STUK

1,87674

0A07EC C O

V 106838//28131

1,50 STUK

1,25116

P AR IET TABLET MSR 10MG

SALO FALK GR ANU-STIX GR ANULAAT MGA 1000MG IN SAC HET

0A07EC C O

V 107180//28131

SALO FALK GR ANU-STIX GR ANULAAT MGA 1000MG IN SAC HET

1,50 STUK

1,25116

0C 08C AAO

V 103860

0C 08C AAO

V 103861

AMLO DIP INE MYLAN TABLET 5MG (ALS BESILAAT)

1,00 STUK

0,65450

AMLO DIP INE MYLAN TABLET 10MG (ALS BESILAAT)

0,50 STUK

0C 08C AAO

1,30901

V 104027

LER C ANIDIP INE HC L C F TABLET O MHULD 10MG

1,00 STUK

0,65450

0C 08C AAO

V 104028

LER C ANIDIP INE HC L C F TABLET O MHULD 20MG

0,50 STUK

1,30901

0C 09C AAO

V EU/1/07/405/022 R ASILEZ TABLET FILMO MHULD 150MG

1,00 STUK

0,74420

0C 09C AAO

V EU/1/07/405/032 R ASILEZ TABLET FILMO MHULD 300MG

0,50 STUK

1,48840

YC 09DAAO

V EU/1/02/214/001 KINZALKO MB TABLET 40/12,5MG

1,00 STUK

0,79593

YC 09DAAO

V EU/1/02/214/006 KINZALKO MB TABLET 80/12,5MG

1,00 STUK

1,54013

0G03AABO

V 106566//23827

YASMIN TABLET O MHULD

0,75 STUK

0,13253

0G04C BAO

V 106890//28317

AVO DAR T C AP SULE 0,5MG

1,00 STUK

1,12371

0L01AXAO

V EU/1/98/096/001 TEMO DAL C AP SULE 5MG

13,40 STUK

8,65384

0L01AXAO

V EU/1/98/096/024 TEMO DAL C AP SULE 5MG

13,40 STUK

8,65384

0L01AXAO

V EU/1/98/096/003 TEMO DAL C AP SULE 20MG

3,35 STUK

21,63461

0L01AXAO

V EU/1/98/096/013 TEMO DAL C AP SULE 20MG

3,35 STUK

21,63461

0L01AXAO

V EU/1/98/096/005 TEMO DAL C AP SULE 100MG

0,67 STUK

108,17304

0L01AXAO

V EU/1/98/096/015 TEMO DAL C AP SULE 100MG

0,67 STUK

108,17304

0L01AXAO

V EU/1/98/096/009 TEMO DAL C AP SULE 140MG

0,48 STUK

151,44226

0L01AXAO

V EU/1/98/096/017 TEMO DAL C AP SULE 140MG

0,48 STUK

151,44226

0L01AXAO

V EU/1/98/096/011 TEMO DAL C AP SULE 180MG

0,37 STUK

194,71147

0L01AXAO

V EU/1/98/096/019 TEMO DAL C AP SULE 180MG

0,37 STUK

194,71147

0L01AXAO

V EU/1/98/096/007 TEMO DAL C AP SULE 250MG

0,27 STUK

270,43260

0L01AXAO

V EU/1/98/096/021 TEMO DAL C AP SULE 250MG

0,27 STUK

270,43260

0L04AADO

V 107175//18107

P R O GR AF C AP SULE 1MG

5,00 STUK

2,84925

0M01AHBO

V 107033//27706

ETO R IC O XIB FISHER TABLET FILMO MHULD 90MG

0,67 STUK

1,69782

1M01ABAO

V 107160//13245

DIC LO FENAC KALIUM ER C TABLET O MHULD 50MG

2,00 STUK

0,27832

0M03AXAP

V 107150//17379

BO TO X INJEC TIEP O EDER FLAC O N 100E

0,02 STUK

272,26810

0M05BABO

V 35326

ALENDR O NINEZUUR SANDO Z TABLET 70MG

0,14 STUK

8,57645

0N02AAAO

V 106916//27536

O XYC O NTIN TABLET MVA 5MG

6,00 STUK

0,41607

0N02AAAO

V 106912//22107

O XYC O NTIN TABLET MVA 10MG

3,00 STUK

0,69344

0N04BC AO

V 106445

R O P INIR O L SANDO Z TABLET FILMO MHULD 0,25MG

24,00 STUK

0,39152

0N04BC AO

V 106455

R O P INIR O L SANDO Z TABLET FILMO MHULD 0,5MG

12,00 STUK

0,32627

0N04BC AO

V 106456

R O P INIR O L SANDO Z TABLET FILMO MHULD 1MG

6,00 STUK

0,65254

1N05ADAPD

V 107161//8994

HALDO L DEC ANO AAT INJVLST 50MG/ML AMP UL 1ML

0,07 STUK

10,84955

2N06AAAO

V 102234

VENLAFAXINE BLUEFISH C AP SULE MVA 150MG

0,67 STUK

1,59958

2N06AAAO

V 102231

VENLAFAXINE BLUEFISH C AP SULE MVA 37,5MG

2,67 STUK

0,47987

2N06AAAO

V 102233

VENLAFAXINE BLUEFISH C AP SULE MVA 75MG

1,33 STUK

0,79979

2N06AAAO

V 33889

VENLAFAXINE LIC O NSA 225 MG TABLETTEN MVA

0,44 STUK

2,39936

2N06ABAO

V 107157//22687

C IP R AMIL DR UP PELVLO EISTO F 40MG/ML

0,50 ML

2,13277

0R 01ADAN

V 107036

BUDESO NIDE SANDO Z NEVEL NEUSSP R AY 50MC G/DO 200DO

4,00 DO

0,08425

0R 01ADAN

V 107038

BUDESO NIDE SANDO Z NEVEL NEUSSP R AY 100MC G/DO 200DO

2,00 DO

0,16850

0R 03AC C IDC V 107145//18150

SER EVENT DISKUS INHP DR 50MC G 60DO

2,00 DO

0,61011

0R 03BAAII V V 107037//14196

P ULMIC O R T 500 VER NEVELSUSP 0,250MG/ML R ESP ULE 2ML

6,00 ML

0,96281

0R 03BAAII

P ULMIC O R T 1000 VER NEVELSUSP 0,500MG/ML R ESP ULE 2ML

3,00 ML

1,92562

YR 03AC C IDA V 107181//25867

SER ETIDE AER O SO L 25/250MC G/DO C FKVR SP BS 120DO +INH

1,00 DO

0,52294

YR 03AC C IDC V 107097//23529

SER ETIDE DISKUS INHP DR 50/100MC G 60DO

1,00 DO

0,72888

YR 03AC C IDC V 107086//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00 DO

0,90703

YR 03AC C IDC V 107090//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

0S01EXAG

V 107182//21304

XALATAN O O GDR UPP ELS 50MC G/ML FLAC O N 2,5ML

0,20 ML

8,54016

0A03FAC O

V 11811

METO C LO PR AMIDE HC L AC C O R D TABLET 10MG

3,00 STUK

0,10422

0A06ABAO

V 34426

NO UR ILAX LAXEER MIDDEL TABLET MSR 5MG

2,00 STUK

0,03276

1A06ADAO

V 107355//28913

FO R LAX JUNIO R P O EDER VO O R DR ANK SAC HET 4G

2,50 STUK

0,21453

1A06ADAO

V 107330//23013

FO R LAX P O EDER VO O R DR ANK SAC HET 10G

1,00 STUK

0,41257

0A07EC BO

V 106909//5705

SALAZO P YR INE EC TABLET MSR 500MG

6,00 STUK

0,12434

0,05521

V 107040//14197

0A10BAAO

103638

METFO R MINE HC L MYLAN TABLET 500MG

4,00 STUK

0A10BAAO

V 103639

METFO R MINE HC L MYLAN TABLET 850MG

2,35 STUK

0,09386

0A10BAAO

103640

METFO R MINE HC L MYLAN TABLET 1000MG

2,00 STUK

0,11042

1C 03AAAO

V 106653

HYDR O C HLO O R THIAZIDE SANDO Z TABLET 25MG

1,00 STUK

0,10346

0C 07ABAO

V 34887

NEBIVO LO L AC TAVIS TABLET 5MG

1,00 STUK

0,40613

0C 09AAAO

V 34001

FO SINO P R ILNATR IUM MYLAN TABLET 10MG

1,50 STUK

0,38939

0C 09AAAO

V 34002

FO SINO P R ILNATR IUM MYLAN TABLET 20MG

0,75 STUK

0,77877

YC 09BAAO

V 103773

P ER INDO PR IL TER T-BUTYL/INDAP AMIDE SDZ TAB 4/1,25MG

1,00 STUK

0,63581

0H01C BAP

V 103684//18237

SANDO STATINE LAR INJPDR FL 30MG + SO LV 2ML

0,02 STUK 1633,60875

0L01BC AP

V 100701

FLUO R O UR AC IL AC C O R D INJVLST 50MG/ML

0,50 ML

0L01DBC P

V 100134

EPIR UBIC INE HC L AC C O R D INFVLST 2MG/ML

3,50 ML

5,81928

0L03AAC P

V EU/1/10/631/005 NIVESTIM 30 INJVLST 60MILJ E/ML W W SP 0,5ML

0,58 ML

224,62125

0L03AAC P

V EU/1/10/631/008 NIVESTIM 48 INJVLST 96MILJ E/ML W W SP 0,5ML

0,36 ML

359,39400

0L04AXAO

V 106268

AZATHIO PR INE P C H TABLET 25MG

6,00 STUK

0,33652

O XYC O NTIN TABLET MVA 15MG

2,00 STUK

1,04017

0N02AAAO V

100819

0,34487

0N04BAAO

V 102235

LEVO DO P A/BENSER AZIDE PC H TABLET 100/25MG

6,00 STUK

0,18944

0N04BAAO

V 102236

LEVO DO P A/BENSER AZIDE PC H TABLET 200/50MG

3,00 STUK

0,37886

0N04BC AO

V EU/1/97/050/029 SIFR O L TABLET MVA 2,25MG (1,57MG BASE)

1,11 STUK

3,52369

0N04BC AO

V EU/1/97/050/032 SIFR O L TABLET MVA 3,75MG (2,62MG BASE)

0,67 STUK

5,87282

0N04BC AP

V 105824

AP O MO R FINE AR C HIMEDES 10 MG/ML O P LO SSING VO O R INJ.

2,00 ML

5,00973

0N05C DAP

V 100470

MIDAZO LAM AC C O R D INJVLST 1MG/ML AMP UL 5ML

15,00 ML

0,17988

0N05C DAP

V 100485

MIDAZO LAM AC C O R D INJVLST 5MG/ML

3,00 ML

0,89939

4N05ALAO

V 107109//19811

DO LMATIL TABLET 400MG

2,00 STUK

1,98151

4N05AXAO

V 107188//20827

SER O Q UEL TABLET FILMO MHULD 100MG

3,00 STUK

1,32101

0N06BABO

V 18535

MO DIO DAL TABLET 100MG

3,00 STUK

2,81344

0N06BABO

V 29246//18535

MO DIO DAL TABLET 100MG

3,00 STUK

2,81344

0N06BABO

V 100380//18535

MO DIO DAL TABLET 100MG

3,00 STUK

2,81344

0S01GXBG

V 107052//22946

ALLER GO DIL O O GDR UP PELS 0,5MG/ML FLAC O N 6ML

0,20 ML

1,85595

0V01AAAO

V 105376

O R ALAIR STAR TVER P AKKING (3TABL 100IR +28TABL 300IR )

0,03 VER P

97,02000

0V01AAAO

V 105380

O R ALAIR TABLET SUBLINGUAAL 300IR

1,00 STUK

3,30000

1,00 STUK

2,45981

0V03ABAO

V 102900

NALTR EXO N HC L AC C O R D TABLET O MHULD 50MG

0A04AAAO

V 101545

O NDANSETR O N BLUEFISH O R O DISP TABLET 4MG

4,00

STUK 5,81918

0A04AAAO

V 101551

O NDANSETR O N BLUEFISH O R O DISP TABLET 8MG

2,00

STUK 9,69864

1A06AC AO

V 107554//13961

METAMUC IL SKVR LEMO N P O EDER 3,4G IN SAC HET

2,06

STUK 0,20039

1A06AC AO

V 107557//13963

METAMUC IL SKVR O R ANGE P O EDER 3,4G IN SAC HET

2,06

STUK 0,20039

0A10ABAP D

V EU/1/97/030/142 INSUMAN R AP ID SO LO STAR INJ 100IE/ML W W SP 3ML

0,40

ML

2,48974

YA10ADDP D

V EU/1/97/030/160 INSUMAN C O MB 25 SO LO STAR INJ 100IE/ML W W SP 3ML

1,00

ML

2,48974

0B03XAAP

V EU/1/01/185/033 AR ANESP 10 INJVLST 25MC G/ML W W SP 0,4ML

0,40

ML

61,43004

0B03XAAP

V EU/1/01/185/035 AR ANESP 20 INJVLST 40MC G/ML W W SP 0,5ML

0,25

ML

98,28806

0B03XAAP

V EU/1/01/185/036 AR ANESP 30 INJVLST 100MC G/ML W W SP 0,3ML

0,10

ML

245,72016

0B03XAAP

V EU/1/01/185/037 AR ANESP 40 INJVLST 100MC G/ML W W SP 0,4ML

0,10

ML

245,72016

0B03XAAP

V EU/1/01/185/039 AR ANESP 60 INJVLST 200MC G/ML W W SP 0,3ML

0,05

ML

491,44032

0C 09C AAO

V 107481

DIO VAN DR ANK 3MG/ML

13,33 ML

0,05582

YC 09DAAO

V 103898

KALIUMLO SAR TAN/HC T R P TABL FILMO MH 100/12,5MG

1,00

STUK 1,54013

YC 09DAAO

V 103200

LO SAR TAN KALIUM/HC T C F TABLET FILMO MH 100/12,5MG

1,00

STUK 1,54013

0D06AXADZ

V 107394//8813

FUC IDIN C R EME 20MG/G

1,00

GR AM 0,22477

0D06AXADZ

V 107392//5617

FUC IDIN ZALF 20MG/G

1,00

GR AM 0,22477

0G03DC AO

V 106901//278

O R GAMETR IL TABLET 5MG

1,00

STUK 0,11783

0H02ABAO

V 107151//22557

BUDENO FALK C APSULE MGA 3MG

3,00

STUK 1,02100

0L02AEADI

V 33195

LEUP R O R ELINE SANDO Z DEP O T 1 MND IMP L 3,6MG IN W W SP

1,00

STUK 184,07590

0L02AEADI

V 30594

LEUP R O R ELINE SANDO Z DEP O T 3 MND IMP L 5MG IN W W SP

0,33

STUK 552,11728

0M05BABO

V 102073

ALENDR O NINEZUUR BLUEFISH TABLET 70MG

0,14

STUK 8,57645

0N02AAAO

V 100824

O XYC O NTIN TABLET MVA 120MG

0,25

STUK 8,32133

0N02AAAO

V 100825

O XYC O NTIN 160 MG TABLETTEN MET VER LENGDE AFGIFTE

0,19

STUK 11,09511

0N02AAAO

V 100820

O XYC O NTIN TABLET MVA 30MG

1,00

STUK 2,08033

0N02AAAO

V 100821

O XYC O NTIN TABLET MVA 60MG

0,50

STUK 4,16067

0N02AAAO

V 107254//27536

O XYC O NTIN TABLET MVA 5MG

6,00

STUK 0,41607

0N02AAAO

V 107258//22107

O XYC O NTIN TABLET MVA 10MG

3,00

STUK 0,69344

0N02AAAO

V 107267//22108

O XYC O NTIN TABLET MVA 20MG

1,50

STUK 1,38689

0N02AAAO

V 107268//22109

O XYC O NTIN TABLET MVA 40MG

0,75

STUK 2,77378

0N02AAAO

V 107269//22110

O XYC O NTIN TABLET MVA 80MG

0,38

STUK 5,54756

0N02AAAO

V 34776

O XYNO R M INSTANT O R O DISP TABLET 10MG

3,00

STUK 0,69344

0N02AAAO

V 34777

O XYNO R M INSTANT O R O DISP TABLET 20MG

1,50

STUK 1,38689

0N02AAAO

V 34775

O XYNO R M INSTANT O R O DISP TABLET 5MG

6,00

STUK 0,41607

0N02C C BO

V 107259//19853

IMIGR AN ZETP IL 25MG

1,00

STUK 10,43468

0N05AXAP

V 107446//27178

R ISP ER DAL C O NSTA INJP DR FLAC O N 25MG + SO LV 2ML

0,11

STUK 117,02000

0N05AXA

V 107462//27178

R ISP ER DAL C O NSTA INJP DR FLAC O N 25MG + SO LV 2ML

0,11

STUK 117,02000

0N05AXAP

V 107448//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07

STUK 175,53000

0N05AXAP

V 107463//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07

STUK 175,53000

0N05AXAP

V 107447//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05

STUK 234,04000

0N05AXAP

V 107464//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05

STUK 234,04000

2N05AGAO

V 107232//6150

O R AP TABLET 4MG

1,00

STUK 0,54912

0R 03AC C IDA V 107572//33735

SER EVENT AER O SO L 25MC G/DO C FKVR SPBS 120DO + INH

4,00

DO

0,23086

YR 03AC C IDA V 107615//25866

SER ETIDE AER O SO L 25/125MC G/DO C FKVR SP BS 120DO +INH 1,00

DO

0,37690

YR 03AC C IDA V 107221//25867

SER ETIDE AER O SO L 25/250MC G/DO C FKVR SP BS 120DO +INH 1,00

DO

0,52294

0A02BC AO

V 104959

O MEP R AZO L SANDO Z MUT TABLET MSR 10MG

2,00 STUK 1,00866

0A02BC AO

V 104960

O MEP R AZO L SANDO Z MUT TABLET MSR 20MG

1,00 STUK 1,68111

0A02BC AO

V 104961

O MEP R AZO L SANDO Z MUT TABLET MSR 40MG

0,50 STUK 3,36221

0A06AGBR C

V 107703//5069

MIC R O LAX KLYSMA FLAC O N 5ML

5,00 ML

0,16518

0A07EC C O

V 107705//33600

MEZAVANT TABLET MVA 1200MG

1,25 STUK 1,50140

0A07EC C O

V 107795//33600

MEZAVANT TABLET MVA 1200MG

1,25 STUK 1,50140

0C 03C AAO

V 23651

BUMETANIDE PC H TABLET 1MG

1,00 STUK 0,07538

0C 03C AAO

V 23652

BUMETANIDE PC H TABLET 5MG

0,20 STUK 0,37690

0C 07ABAO

V 102002

BISO P R O LO LFUMAR AAT AC TAVIS TABLET 2,5MG

4,00 STUK 0,10153

0C 07ABAO

V 25445

BISO P R O LO LFUMAR AAT BG TABLET 5MG

2,00 STUK 0,20307

0C 07ABAO

V 25446

BISO P R O LO LFUMAR AAT BG TABLET 10MG

1,00 STUK 0,40613

0C 07ABAO

V 102391

BISO P R O LO LFUMAR AAT C F TABLET 2,5MG

4,00 STUK 0,10153

0C 07ABAO

V 102044

NEBIVO LO L AP O TEX TABLET 5MG

1,00 STUK 0,40613

0C 07ABAO

V 101114

NEBIVO LO L MYLAN TABLET 5MG

1,00 STUK 0,40613

0C 07ABAO

V 104681

NEBIVO LO L R P TABLET 5MG

1,00 STUK 0,40613

0C 07ABAO

V 34556

NEBIVO LO L SANDO Z TABLET 5MG

1,00 STUK 0,40613

YC 09DAAO

V 107158//22365

C O DIO VAN TABLET O MHULD 80/12,5MG

1,00 STUK 0,79593

YC 09DAAO

V 107159//31122

C O DIO VAN TABLET O MHULD 160/25MG

1,00 STUK 1,59186

0C 10AAAO

V 107570//26873

C R ESTO R TABLET FILMO MHULD 20MG

0,50 STUK 2,76806

0D07ADADL

V 107569//33440

C LO BEX SHAMPO O 0,5MG/G

1,00 GR AM 0,18635

0G03AABO

V 107127//23827

YASMIN TABLET O MHULD

0,75 STUK 0,13253

0G04BEAO

V EU/1/08/476/005 ADC IR C A TABLET FILMO MHULD 20MG

2,00 STUK 9,51000

0G04BEAO

V EU/1/08/476/006 ADC IR C A TABLET FILMO MHULD 20MG

2,00 STUK 9,51000

0G04C BAO

V 107768//28317

AVO DAR T C AP SULE 0,5MG

1,00 STUK 1,12371

0G04C BAO

V 107771//28317

AVO DAR T C AP SULE 0,5MG

1,00 STUK 1,12371

0H02ABBO

V 34417

LO DO TR A TABLET MGA 5MG

2,00 STUK 0,04992

0L04AABO

V 102222

MYC O FENO LAAT MO FETIL AC TAVIS C AP SULE 250MG

8,00 STUK 1,77337

0L04AABO

V 101400

MYC O FENO LAAT MO FETIL AC TAVIS TABLET FILMO MH 500MG

4,00 STUK 2,95562

0N02C C AO

V 107119//31917

ZO MIG TABLET O MHULD 2,5MG

1,00 STUK 6,21227

0R 03AC AIDA V 107701//21440

VENTO LIN 100 AER C FKVR 100MC G/DO SP BS 200DO +INHAL

8,00 DO

0,01654

0R 03AC C IDA V 107893//31993

FO R ADIL AER O SO L C FKVR 12MC G/DO SP BS 100DO SES+INH

2,00 DO

0,46172

0R 03BABID

FLIXO TIDE AER C FKVR 125MC G/DO SP BS 120 DO + INHAL

4,80 DO

0,14604

YR 03AC C IDA V 107702//25866

SER ETIDE AER O SO L 25/125MC G/DO C FKVR SP BS 120DO +INH 1,00 DO

0,37690

YR 03AC C IDC V 107716//23529

SER ETIDE DISKUS INHP DR 50/100MC G 60DO

1,00 DO

0,72888

YR 03AC C IDC V 107540//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00 DO

0,90703

V 107329//16213

YR 03AC C IDC V 107547//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

YR 03AC C IDC V 107715//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

YR 03AKAIDC V 107685//25887

SYMBIC O R T TUR BUHALER INHALP DR 200/6MC G/DO 120DO

1,00 DO

0,48321

YR 03AKAIDC V 107695//27690

SYMBIC O R T TUR BUHALER INHALP DR 400/12MC G/DO 60DO

1,00 DO

0,96642

YR 03AKAIDC V 107699//27690

SYMBIC O R T TUR BUHALER INHALP DR 400/12MC G/DO 60DO

1,00 DO

0,96642

0S01AABZ

V 107766//10225

TO BR EX O O GZALF TUBE 5G

0,28 GR AM 0,22624

0S01XAAG

V 107633//10187

TEAR S NATUR ALE O O GDR UP P ELS FLAC O N 15ML

0,60 ML

0V01AAAO

V 33788

GR AZAX LYO PHILISAAT V O R AAL GEBR UIK 75000 SQ -T

1,00 STUK 3,30000

0V01AAAO

V 101994//33788

GR AZAX LYO PHILISAAT V O R AAL GEBR UIK 75000 SQ -T

1,00 STUK 3,30000

0V01AAAO

V 105057//33788

GR AZAX LYO PHILISAAT V O R AAL GEBR UIK 75000 SQ -T

1,00 STUK 3,30000

0V01AAAO

V 106102//33788

GR AZAX LYO PHILISAAT V O R AAL GEBR UIK 75000 SQ -T

1,00 STUK 3,30000

0V03AEAO

V 107844//31928

FO SR ENO L KAUW TABLET 500MG

4,50 STUK 2,18435

0V03AEAO

V 107878//31929

FO SR ENO L KAUW TABLET 750MG

3,00 STUK 2,97866

0V03AEAO

V EU/1/09/521/006 R ENVELA P O EDER VO O R SUSPENSIE 2,4G IN SAC HET

2,67 STUK 3,35099

0,26471

0A02BC AO

V 107203

ESO MEP R AZO L R P C AP SULE MSR 20MG

1,00 STUK

0A02BC AO

V 107204

ESO MEP R AZO L R P C AP SULE MSR 40MG

0,50 STUK

3,36221

0A02BC AO

V 107193

ESO MEP R AZO L SANDO Z C AP SULE MSR 20MG

1,00 STUK

1,68111

0A02BC AO

V 107194

ESO MEP R AZO L SANDO Z C AP SULE MSR 40MG

0,50 STUK

3,36221

0A02BC AO

V 107756//101600 NEXIUM GR ANULAAT MSR V SUSP IN SAC HET 10MG

2,00 STUK

1,00866

0A02BC AP

V 102490

P ANTO P R AZO L SUN INJP DR FLAC O N 40MG

1,00 STUK

9,48400

0A03AAAO V V 107631//11657

MEBEVER INEHYDR O C HLO R IDE FISHER C AP SULE MGA 200MG

2,00 STUK

0,35055

0A06ABAO

V 34427

BISAC O DYL SAN BIJ MO EILIJKE STO ELGANG TABL MSR 5MG

2,00 STUK

0,03276

0A06ADBO

V 105789

MO VIPR EP O R ANGE P O EDER VO O R DR ANK IN SAC HET A+B

4,00 STUK

4,43003

0A06ADBO

V 107153//34072

MO VIPR EP PO EDER VO O R DR ANK IN SAC HET A+B

4,00 STUK

4,43003

0A06ADBO

V 107775//34072

MO VIPR EP PO EDER VO O R DR ANK IN SAC HET A+B

4,00 STUK

4,43003

1A06ADAO

V 107079//32357

MO VIC O LO N JUNIO R NATUR EL P O EDER V DR ANK IN SAC HET

1,52 STUK

0,32571

0A07EC C R

V 102870

SALO FALK ZETP IL 1G

1,50 STUK

2,02053

0A07EC C R

V 107624//11836

SALO FALK ZETP IL 500MG

3,00 STUK

1,01027

0A09AAAO

V 107202//16134

P ANC R EASE HL C AP SULE MSR

2,40 STUK

1,00796

0A09AAAO

V 107776//13760

P ANZYTR AT 25000 C APSULE MSR

2,40 STUK

1,00796

0A09AAAO

V 107811//13760

P ANZYTR AT C AP SULE MSR

2,40 STUK

1,00796

0A10BGAO

V EU/1/00/150/020 AC TO S TABLET 30MG

1,00 STUK

1,61756

0C 02C AAO

V 34492

1,00 STUK

0,84322

DO XAZO SINE AUR O BINDO TABLET 4MG

1,68111

0C 07ABAO

V 101999

BISO P R O LO LFUMAR AAT A TABLET 2,5MG

4,00 STUK

0C 07ABAO

V 102000

BISO P R O LO LFUMAR AAT A TABLET 5MG

2,00 STUK

0,10153 0,20307

0C 07ABAO

V 102001

BISO P R O LO LFUMAR AAT P HAR MASO LVE TABLET 10MG

1,00 STUK

0,40613

0C 07ABAO

V 25804

BISO P R O LO LI FUMAR AS TABLET 5MG

2,00 STUK

0,20307

0C 07ABAO

V 25805

BISO P R O LO LI FUMAR AS TABLET 10MG

1,00 STUK

0,40613

0C 07ABAO

V 33885

NEBIVO LO L C F TABLET 5MG

1,00 STUK

0,40613

0C 07ABAO

V 101615

NEBIVO LO L GLENMAR K TABLET 5MG

1,00 STUK

0,40613

0C 08C AAO

V 107144//20554

C YR ESS C APSULE MGA 10MG

1,00 STUK

0,65450

0C 08C AAO

V 107149//20555

C YR ESS C APSULE MGA 20MG

0,50 STUK

1,30901

0C 08C AAO

V 107148//15099

LO MIR SR O C AP SULE MGA 5MG

1,00 STUK

0,65450

0C 09AAAO

V 103807

R AMIP R IL AUR O BINDO TABLET 5MG

0,50 STUK

1,16816

0C 09AAAO

V 103808

R AMIP R IL AUR O BINDO TABLET 10MG

0,25 STUK

2,33631

0C 09AAAO

V 107353//23722

ZO FIL TABLET O MHULD 30MG

1,00 STUK

0,58408

0C 09C AAO

V EU/1/07/405/033 R ASILEZ TABLET FILMO MHULD 300MG

0,50 STUK

1,48840

0C 09C AAO

V 107393//22260

TEVETEN TABLET O MHULD 400MG

1,50 STUK

0,49613

YC 09BAAO

V 100771

Q UINAP R IL/HYDR O C HLO O R THIAZIDE AUR O B TABL 20/12,5MG

1,00 STUK

0,83050

YC 09BBBO

V 107260//100139 C O VER AM AR G TABLET 5MG/ 5MG

1,00 STUK

1,38460

YC 09BBBO

V 107263//100140 C O VER AM AR G TABLET 5MG/10MG

1,00 STUK

2,03910

YC 09DAAO

V 107711//100453 C O DIO VAN TABLET O MHULD 320/12,5MG

1,00 STUK

3,02853

YC 09DAAO

V 107713//100454 C O DIO VAN TABLET O MHULD 320/25MG

1,00 STUK

3,08026

YC 09DABO

V 107573//32740

O LMETEC HC TZ TABLET FILMO MHULD 20/12,5MG

1,00 STUK

0,79593

0C 10AAAO

V 107564//26872

C R ESTO R TABLET FILMO MHULD 10MG

1,00 STUK

1,38403

0D01BABO

V 100337

TER BINAFINE AUR O BINDO TABLET 250MG

1,00 STUK

2,33152

4D07ADADZ

V 107334//6933

DER MO VATE HYDR O FO BE ZALF 0,05%

1,00 GR AM

0,14530

0G03ABBO

V 107539//8663

LEVO NO R GESTR EL/ETHINYLESTR ADIO L FISHER TABLET O MH

0,75 STUK

0,12515

0G04BDBO

V 107896//29151

VESIC AR E TABLET FILMO MHULD 5MG

1,00 STUK

0,82981

0G04BDBO

V 107894//29152

VESIC AR E TABLET FILMO MHULD 10MG

0,50 STUK

1,65963

0G04C BAO

V 31134

FINASTER IDE C F TABLET FILMO MHULD 5MG

1,00 STUK

1,12371

YG04C AAO

V 108059//104130 C O MBO DAR T C AP SULE 0,5/0,4MG

1,00 STUK

2,08572

0H01BAAO

V 32000

DESMO P R ESSINE AC ETAAT P C H TABLET 0,1MG

4,00 STUK

0,94769

0J01DHAP

V 105437

MER O P ENEM FR ESENIUS KABI INF/INJP DR FLAC O N 500MG

4,00 STUK

18,31911

0J01DHAP

V 105441

MER O P ENEM FR ESENIUS KABI INF/INJP DR FLAC O N 1000MG

2,00 STUK

36,63822

0J01GBAII

V 107926//25484

TO BI INHVLST 60MG/ML AMPUL 5ML

5,00 ML

9,01888

0J07BC AP

K 107877//24290

ENGER IX-B JUNIO R VAC C IN 20MC G/ML W W SP 0,5ML

0,50 ML

44,28000

0J07BC AP

K 107879//24290

ENGER IX-B JUNIO R VAC C IN 20MC G/ML W W SP 0,5ML

0,50 ML

44,28000

0J07BC AP

V 107880//17316

ENGER IX-B VAC C IN 20MC G/ML W W SP 1ML

1,00 ML

29,51840

0J07BC AP

V 107881//17316

ENGER IX-B VAC C IN 20MC G/ML W W SP 1ML

1,00 ML

29,51840

0L04AABO

V 35019

MYC O FENO LAAT MO FETIL AC C O R D TABLET FILMO MH 500MG

4,00 STUK

0L04AABO

V 104308

MYC O FENO LAAT MO FETIL C F C AP SULE 250MG

8,00 STUK

1,77337

0L04AABO

V 104309

MYC O FENO LAAT MO FETIL C F TABLET FILMO MHULD 500MG

4,00 STUK

2,95562

0L04AABO

V 106588

MYC O FENO LAAT MO FETIL SANDO Z TABLET FILMO MH 500MG

4,00 STUK

2,95562

0L04AADO

V 102496

TAC R O LIMUS AC C O R D C AP SULE 0,5MG

10,00 STUK

1,70955

0L04AADO

V 102497

TAC R O LIMUS AC C O R D C AP SULE 1MG

5,00 STUK

2,84925

0M01AHBO

V 107700//34279

AR C O XIA TABLET FILMO MHULD 30MG

2,00 STUK

0,67913

1M01AC AO

V 100168

MELO XIC AM AUR O BINDO TABLET 15MG

1,00 STUK

0,55664

0M05BABO

V 106297

NATR IUMR ISEDR O NAAT SANDO Z W EKELIJKS TABL O MH 35MG

0,14 STUK

8,57645

YM05BBAO

V 107238//31634

AC TO KIT (1TAB AC TO NEL 35MG+6TAB C ALC 500MG) 112 ST

1,00 VER P

162,38513

0N02C C AO

V 107128//31919

ZO MIG O R O O R O DISP TABLET 2,5MG

1,00 STUK

6,21227

0N02C C BO

V 108061//19469

IMIGR AN NEUSSP R AY 10MG

2,00 STUK

6,26081

0N03AXAO

K 105238

LAMO TR IGINE AUR O BINDO DISP ER GEER BAAR TABLET 5MG

60,00 STUK

0,38133

0N03AXAO

V 105240

LAMO TR IGINE AUR O BINDO DISP ER GEER BAAR TABLET 25MG

12,00 STUK

0,58651

0N03AXAO

V 105241

LAMO TR IGINE AUR O BINDO DISP ER GEER BAAR TABLET 50MG

6,00 STUK

0,73313

0N03AXAO

V 105242

LAMO TR IGINE AUR O BINDO DISP ER GEER BAAR TABLET 100MG

3,00 STUK

1,46626

0N03AXAO

V 105243

LAMO TR IGINE AUR O BINDO DISP ER GEER BAAR TABLET 200MG

1,50 STUK

2,93253

0N04BAAO

V 107627//8740

SINEMET 125 TABLET 100/25MG

6,00 STUK

0,18944

4N05AXAO

V 33500

R ISP ER IDO N AUR O BINDO TABLET O MHULD 6MG

0,83 STUK

4,75562

4N05AXAO

V 106227

R ISP ER IDO N PC H DR ANK 1MG/ML

5,00 ML

0,79260

2N06ABAO

V 107543//30495

ESC ITALO P R AM FISHER TABLET FILMO MHULD 10MG

1,00 STUK

1,06638

2N06ABAO

V 107767//30496

ESC ITALO P R AM FISHER TABLET FILMO MHULD 15MG

0,67 STUK

1,59958

2N06ABAO

V 107757//30497

ESC ITALO P R AM FISHER TABLET FILMO MHULD 20MG

0,50 STUK

2,13277

0N07BC AO

V 104280

METHADO N TIO FAR MA TABLET 10MG

2,50 STUK

0,17734

0N07BC AO

V 104281

METHADO N TIO FAR MA TABLET 20MG

1,25 STUK

0,35468

0R 01ADAN

V 108056//23477

FLIXO NASE NEUSDR UP P ELS 1MG/ML NASULE 0,4ML

0,50 DO

0,67402

SER EVENT AER O SO L 25MC G/DO C FKVR SPBS 120DO + INH

4,00 DO

0,23086

0R 03AC C IDA V 108058//33735

2,95562

0R 03BAAII

V 108054//21835

FLIXO TIDE 2000 INHVLST 1MG/ML NEBULE 2ML

1,50 ML

3,85123

0R 03BABID

V 108053//31633

ALVESC O 160 AER O SO L 160MC G/DO SPBS

1,00 DO

0,70100

YR 03AC C IDA V 108055//34610

FO STER AER O SO L 100/6MC G/DO SIS SP UITBUS 120DO

1,00 DO

0,40611

2R 06AEAO

V 35129

C ETIR IZINE DIHC L MDQ TABLET 10MG

1,00 STUK

0,50499

0A02BC AO

V 107196

ESO MEP R AZO L P C H C AP SULE MSR 20MG

0A02BC AO

V 107201

ESO MEP R AZO L P C H C AP SULE MSR 40MG

0,50

STUK 3,36221

0A02BC AO

V 108001//101600 NEXIUM GR ANULAAT MSR V SUSP IN SAC HET 10MG

2,00

STUK 1,00866

0A02BC AO

V 104560

O MO Q UIS C AP SULE MSR 10MG

2,00

STUK 1,00866

0A02BC AO

V 104561

O MO Q UIS C AP SULE MSR 20MG

1,00

STUK 1,68111

0A02BC AO

V 104562

O MO Q UIS C AP SULE MSR 40MG

0,50

STUK 3,36221

0A06ADAO

V 102789

LAC TULO SESTR O O P AC TAVIS 667MG/ML O TC

10,00

ML

0,01566

0A06ADAO

V 107559

LAC TULO SESTR O O P FR ESENIUS 670MG/ML

10,00

ML

0,01566

1A06ADAO

V 108047//101716 MO VIC O LO N C HO C O LATE P O EDER V DR ANK IN SAC HET

0,76

STUK 0,54285

0A07EC C R

V 108201//15064

P ENTASA ZETP IL 1G

1,50

STUK 2,02053

0B01ABAP

V 106542//12788

FR AGMIN 5000 INJVLST 25.000IE/ML W W SP 0,2ML

0,10

ML

0B01AC DO

V 103473

VATO UD TABLET FILMO MHULD 75MG

1,00

STUK 1,88043

0B03AAAO V V 108270//5752

FER O GR ADUMET TABLET MGA 105MG FE

1,90

STUK 0,08266

1C 01DAAO

V 108057//17289

ISO SO R BIDEMO NO NITR AAT ER C R ETAR D C APSULE 25MG

2,40

STUK 0,22689

0C 08C AAO

V 106617

AMLO DIP INE A TABLET 5MG

1,00

STUK 0,65450

0C 08C AAO

V 106618

AMLO DIP INE A TABLET 10MG

0,50

STUK 1,30901

0C 08C AAO

V 105652

AMLO DIP INE JUBILANT TABLET 5MG (ALS BESILAAT)

1,00

STUK 0,65450

0C 08C AAO

V 105654

AMLO DIP INE JUBILANT TABLET 10MG (ALS BESILAAT)

0,50

STUK 1,30901

0C 09AAAO

V 33560

LISINO P R IL JUBILANT TABLET 5MG

2,00

STUK 0,35045

0C 09AAAO

V 33561

LISINO P R IL JUBILANT TABLET 10MG

1,00

STUK 0,58408

0C 09AAAO

V 33562

LISINO P R IL JUBILANT TABLET 20MG

0,50

STUK 1,16816

0C 09C AAO

V 103657

LO SAR TAN KALIUM JUBILANT TABLET O MHULD 50MG

1,00

STUK 0,74420

0C 09C AAO

V 103659

LO SAR TAN KALIUM JUBILANT TABLET O MHULD 100MG

0,50

STUK 1,48840

YC 09DAAO

V 104378

LO SAR TAN KALIUM/HC T JUBILANT TAB FILMO M 50/12,5MG

1,00

STUK 0,79593

YC 09DAAO

V 104379

LO SAR TAN KALIUM/HC T JUBILANT TAB FILMO MH 100/25MG

1,00

STUK 1,59186

YC 09DAAO

V 103390

LO SAR TAN KALIUM/HC T BLUEFISH TAB FILMO MH 100/25MG

1,00

STUK 1,59186

YC 09DAAO

V 103388

LO SAR TAN KALIUM/HC T BLUEFISH TAB FILMO M 50/12,5MG

1,00

STUK 0,79593

0C 10AAAO

V 107567//26872

R O SUVASTATINE FISHER TABLET FILMO MHULD 10MG

1,00

STUK 1,38403

1,00

STUK 1,68111

17,78820

0C 10AAAO

V 107762//26872

R O SUVASTATINE FISHER TABLET FILMO MHULD 10MG

1,00

STUK 1,38403

0C 10AAAO

V 107566//26873

R O SUVASTATINE FISHER TABLET FILMO MHULD 20MG

0,50

STUK 2,76806

0C 10AAAO

V 107764//26873

R O SUVASTATINE FISHER TABLET FILMO MHULD 20MG

0,50

STUK 2,76806

0D01BABO

V 34141

TER BINAFINE R O MIKIN FAR MA TABLET 250MG

1,00

STUK 2,33152

0G03AABO

V 104891

ETHINYLESTR ADIO L/DESO GESTR W EC TABLET 0,02/0,15MG

0,75

STUK 0,13253

0G03AABO

V 104897

ETHINYLESTR ADIO L/DESO GESTR W EC TABLET 0,03/0,15MG

0,75

STUK 0,13253

0G03AABO

V 102226

ETHINYLESTR ADIO L/LEVO NO R G W EC TAB O MH 0,03/0,15MG

0,75

STUK 0,13253

0G03GABP

V 107630//24536

MENO P UR INJP DR FLAC O N 75IE + SO LV 1ML

1,00

STUK 33,54345

0G04BEAO

V EU/1/05/318/001 R EVATIO TABLET FILMO MHULD 20MG

3,00

STUK 6,34000

0J01DHAP

V 102741

IMIP ENEM/C ILASTATINE AC TAVIS INFP DR FL 500/500MG

4,00

STUK 18,31911

0J01DHAP

V 105153

MER O P ENEM SANDO Z INF/INJP DR FLAC O N 500MG

4,00

STUK 18,31911

0J01DHAP

V 105155

MER O P ENEM SANDO Z INF/INJP DR FLAC O N 1000MG

2,00

STUK 36,63822

0J02AC AO

V 108111//21024

TR ISP O R AL O S DR ANK 10MG/ML

20,00

ML

0,62141

0J02AC AP

V 101844

FLUC O NAZO L FR ES KABI INFVLST 2MG/ML FLAC O N

100,00 ML

0,41657

0L04AABO

V 35327

MYC O FENO LAAT MO FETIL AP O TEX C APSULE 250MG

8,00

STUK 1,77337

0L04AABO

V 35328

MYC O FENO LAAT MO FETIL AP O TEX TABLET FILMO MH 500MG

4,00

STUK 2,95562

0L04AABO

V 107171

MYC O FENO LAAT MO FETIL MYLAN TABLET FILMO MH 500MG

4,00

STUK 2,95562

0M05BABO

V 106365

R ISEDR O NAATNATR IUM C F TABLET FILMO MHULD 5MG

1,00

STUK 1,22521

0M05BABO

V 106368

R ISEDR O NAATNATR IUM C F W EKELIJKS TABL FILMO MH 35MG

0,14

STUK 8,57645

0M05BABO

V 107445

R ISEDR O NAATNATR IUM PC H W EKELIJKS TABL FILMO MH 35MG

0,14

STUK 8,57645

0N02C C AO

V 108345//21818

MAXALT SMELTTABLET 10MG

1,00

STUK 6,21227

0N04BC AO

V 101257

P R AMIP EXO L C F TABLET 0,125MG (0,088MG BASE)

20,00

STUK 0,46983

0N04BC AO

V 101258

P R AMIP EXO L C F TABLET 1MG (0,7MG BASE)

2,50

STUK 1,56609

0N04BC AO

V 102813

P R AMIP EXO L SANDO Z TABLET 0,125MG (0,088MG BASE)

20,00

STUK 0,46983

0N04BC AO

V 102816

P R AMIP EXO L SANDO Z TABLET 1MG (0,7MG BASE)

2,50

STUK 1,56609

0N04BC AO

V EU/1/08/490/003 P R AMIP EXO L TEVA TABLET 0,125MG (0,088MG BASE)

20,00

STUK 0,46983

0N04BC AO

V EU/1/08/490/007 P R AMIP EXO L TEVA TABLET 0,25MG (0,18MG BASE)

10,00

STUK 0,39152

0N04BC AO

V EU/1/08/490/011 P R AMIP EXO L TEVA TABLET 0,5MG (0,35MG BASE)

5,00

STUK 0,78304

0N04BC AO

V EU/1/08/490/015 P R AMIP EXO L TEVA TABLET 1MG (0,7MG BASE)

2,50

STUK 1,56609

0N04BC AO

V EU/1/08/490/001 P R AMIP EXO LE TEVA 0,088 MG TABLET 30 STUKS

20,00

STUK 0,46983

0N04BC AO

V EU/1/08/490/002 P R AMIP EXO LE TEVA 0,088 MG TABLET 50 STUKS

20,00

STUK 0,46983

0N04BC AO

V EU/1/08/490/004 P R AMIP EXO LE TEVA 0,088 MG TABLET 90 STUKS

20,00

STUK 0,46983

0N04BC AO

V EU/1/08/490/005 P R AMIP EXO LE TEVA 0,18 MG TABLET 30 STUKS

10,00

STUK 0,39152

0N04BC AO

V EU/1/08/490/006 P R AMIP EXO LE TEVA 0,18 MG TABLET 50 STUKS

10,00

STUK 0,39152

0N04BC AO

V EU/1/08/490/008 P R AMIP EXO LE TEVA 0,18 MG TABLET 90 STUKS

10,00

STUK 0,39152

0N04BC AO

V EU/1/08/490/009 P R AMIP EXO LE TEVA 0,35 MG TABLET 30 STUKS

5,00

STUK 0,78304

0N04BC AO

V EU/1/08/490/010 P R AMIP EXO LE TEVA 0,35 MG TABLET 50 STUKS

5,00

STUK 0,78304

0N04BC AO

V EU/1/08/490/012 P R AMIP EXO LE TEVA 0,35 MG TABLET 90 STUKS

5,00

STUK 0,78304

0N04BC AO

V EU/1/08/490/014 P R AMIP EXO LE TEVA 0,7 MG TABLET 50 STUKS

2,50

STUK 1,56609

0N04BC AO

V EU/1/08/490/016 P R AMIP EXO LE TEVA 0,7 MG TABLET 90 STUKS

2,50

STUK 1,56609

2N06ABAO

V 33739

SER TR ALINE AC TAVIS TABLET FILMO MHULD 50MG

1,00

STUK 1,06638

2N06BAAO

V 107710//33668

W ELLBUTR IN XR TABLET MGA 150MG

2,00

STUK 0,63983

2N06BAAO

V 107706//33669

W ELLBUTR IN XR TABLET MGA 300MG

1,00

STUK 1,06638

2N06BAAO

V 107895//33669

W ELLBUTR IN XR TABLET MGA 300MG

1,00

STUK 1,06638

0N07C AAO

V 101753

BETALO SE TABLET 24MG

1,00

STUK 0,38526

0R 03BAAII

V 108060//14196

P ULMIC O R T 500 VER NEVELSUSP 0,250MG/ML R ESP ULE 2ML

6,00

ML

0,96281

0R 03BAAII

V 108062//14197

P ULMIC O R T 1000 VER NEVELSUSP 0,500MG/ML R ESP ULE 2ML

3,00

ML

1,92562

0R 03BABID

V 108273//16212

FLIXO TIDE AER C FKVR 50MC G/DO SP BS 120 DO + INHAL

12,00

DO

0,10515

YR 03AKAIDC V 108162//25887

SYMBIC O R T TUR BUHALER INHALP DR 200/6MC G/DO 60DO

1,00

DO

0,48321

0S01AABG

V 107769//28141

TO BR EX BID O O GDR UPP ELS 3MG/ML FLAC O N 5ML

0,30

ML

1,27784

0S01BAAG

V 107755//11271

P R ED FO R TE O O GDR UP PELS 10MG/ML FLAC O N 5ML

0,40

ML

0,51278

0S01GXBG

V 105250

ALTR IABAK O O GDR UP PELS 0,25MG/ML FLAC O N 5ML

0,20

ML

1,85595

0A02BC AO V 107663//25387

NEXIUM TABLET MSR 20MG

1,00 STUK

0A02BC AO V 107686//25388

NEXIUM TABLET MSR 40MG

0,50 STUK

1,68111 3,36221

0A02BC AO V 29766

O MEP R AZO LUM C AP SULE MSR 10MG

2,00 STUK

1,00866

0A02BC AO V 103167

P ANTO P R AZO L FO C US TABLET MSR 20MG

2,00 STUK

1,00866

0A03AAAO V 108357//11657

DUSP ATAL R ETAR D C AP SULE MGA 200MG

2,00 STUK

0,35055

0B01AC DO V 107726//103348 C LO P IDO GR EL DELP HI TABLET FILMO MHULD 75MG

1,00 STUK

1,88043

0C 01C AAP K 106307

JEXT INJVLST 1MG/ML W W SP 0,15ML

3,33 STUK

44,47050

0C 01C AAP V 106309

JEXT INJVLST 1MG/ML W W SP 0,3ML

3,33 STUK

44,47050

0C 03C AAO V 33924

BUMETANIDE PC H TABLET 2MG

0,50 STUK

0,15076

0C 09C AAO V 107772//21706

BLO PR ESS TABLET 16MG

0,50 STUK

1,48840

0C 09C AAO V 103651

LO SAR TAN KALIUM JUBILANT TABLET O MHULD 25MG

2,00 STUK

0,44652

0C 09C AAO V 107999//28783

O LMETEC TABLET FILMO MHULD 20MG

1,00 STUK

0,74420

YC 09BBBO V 108614//100141 C O VER AM AR G TABLET 10MG/ 5MG

1,00 STUK

2,11470

YC 09BBBO V 108615//100142 C O VER AM AR G TABLET 10MG/10MG

1,00 STUK

2,76920

YC 09DAAO V 108399//24995

ATAC AND P LUS TABLET 16/12,5MG

1,00 STUK

1,54013

YC 09DABO V 108133//32740

O LMETEC HC TZ TABLET FILMO MHULD 20/12,5MG

1,00 STUK

0,79593

YC 09DABO V 108134//32741

O LMETEC HC TZ TABLET FILMO MHULD 20/25MG

1,00 STUK

0,84766

0C 10AAAO V 107665//21081

LIP ITO R TABLET O MHULD 10MG

2,00 STUK

0,83042

0C 10AAAO V 107664//21082

LIP ITO R TABLET O MHULD 20MG

1,00 STUK

1,38403

0C 10AC AO V 107882//28626

EZETR O L TABLET 10MG

1,00 STUK

1,72101

0C 10ADAO V 107561//13159

O LBETAM C APSULE 250MG

2,00 STUK

0,49523

YC 10AXAO V 107900//30928

INEGY TABLET 10/20MG

1,00 STUK

2,64369

YC 10AXAO V 107905//30929

INEGY TABLET 10/40MG

1,00 STUK

3,56638

0D01BABO V 107763//29654

TER BINAFINE DELP HI TABLET 250MG

1,00 STUK

2,33152

0G03AABO V 107117

ETHINYLESTR ADIO L/LEVO NO R G PC H TAB O MH 0,03/0,15MG

0,75 STUK

0,13253

1G03DABO V 102442

LUTINUS VAGINAALTABLET 100MG

3,00 STUK

0,09573

1G03DABO V 108421//11473

UTR O GESTAN C AP SULE 100MG

3,00 STUK

0,09573

0J01C R AO V 107747//21693

AMO XI/C LAV TABLET FILMO MHULD 500/125MG

3,00 STUK

0,77778

0J01DAAP V

25307

SER VAZO LIN INJEC TIEPO EDER FLAC O N 1000MG

3,00 STUK

4,53780

0J01XAAP V

101505

VANC O MYC INE SANDO Z INFUSIEP O EDER FLAC O N 500MG

2000,00 MG

0,02389

0J01XAAP V

101509

VANC O MYC INE SANDO Z INFUSIEP O EDER FLAC O N 1000MG

2000,00 MG

0,02389

0L04AABO V

104917

MYC O FENO LAAT MO FETIL R P C APSULE 250MG

8,00 STUK

1,77337

0L04AABO V

104918

MYC O FENO LAAT MO FETIL R P TABLET FILMO MHULD 500MG

4,00 STUK

2,95562

0L04AAEO V

106093

LEFLUNO MIDE SANDO Z TABLET FILMO MHULD 10MG

2,00 STUK

2,08285

0L04AAEO V

106094

LEFLUNO MIDE SANDO Z TABLET FILMO MHULD 20MG

1,00 STUK

3,47142

0M01AHBO V 108398//34279

AR C O XIA TABLET FILMO MHULD 30MG

2,00 STUK

0,67913

0M01AHBO V 108048//27705

AR C O XIA TABLET FILMO MHULD 60MG

1,00 STUK

1,13188

0M01AHBO V 108423//27706

AR C O XIA TABLET FILMO MHULD 90MG

0,67 STUK

1,69782

0M05BABO V 106244

NATR IUMR ISEDR O NAAT R ANBAXY TABLET FILMO MHULD 35MG

0,14 STUK

8,57645

YM05BBAO V 100996//31634

AC TO NEL PLUS C ALC IUM TABLET FILMO MHULD 35MG 112 ST

1,00 VER P 162,38513

YM05BBAO V 108370//31634

AC TO NEL PLUS C ALC IUM TABLET FILMO MHULD 35MG 28 ST

1,00 VER P

40,59628

0N02ABC O V EU/1/08/441/002 EFFENTO R A TABLET BUC C AAL 100MC G

4,00 STUK

6,04440

0N02ABC O V EU/1/08/441/001 EFFENTO R A TABLET BUC C AAL 100MC G

4,00 STUK

6,04440

0N02ABC O V EU/1/08/441/004 EFFENTO R A TABLET BUC C AAL 200MC G

2,00 STUK

7,55550;

0N02ABC O V EU/1/08/441/003 EFFENTO R A TABLET BUC C AAL 200MC G

2,00 STUK

7,55550

0N02ABC O V EU/1/08/441/006 EFFENTO R A TABLET BUC C AAL 400MC G

1,00 STUK 15,11100;

0N02ABC O V EU/1/08/441/005 EFFENTO R A 400 UG BUC C ALE TABLETTEN 4 STUKS

1,50 STUK

20,14800

0N02ABC O V EU/1/08/441/008 EFFENTO R A TABLET BUC C AAL 600MC G

1,00 STUK

30,22200

0N02ABC O V EU/1/08/441/007 EFFENTO R A 600 UG BUC C ALE TABLETTEN 4 STUKS

0,67 STUK 22,66650;

0N02ABC O V EU/1/08/441/010 EFFENTO R A TABLET BUC C AAL 800MC G

0,75 STUK

0N02ABC O V EU/1/08/441/009 EFFENTO R A 800 UG BUC C ALE TABLETTEN 4 STUKS

0,50 STUK 30,22200;

40,29600

0N02BEAO V

105822

P AR AC ETAMO L MYLAN TABLET 1000MG

3,00 STUK

0,11300

0N02C C AO V 108401//21818

MAXALT SMELTTABLET 10MG

1,00 STUK

6,21227

0N02C C AO V 108400//21816

MAXALT TABLET 10MG

1,00 STUK

6,21227

0N04BAAO V 108381//15175

SINEMET C R 125 TABLET MGA 100/25MG

6,00 STUK

0,18944

3N05C GAO V 100814

ZO LPIDEMTAR TR AAT APO TEX TABLET FILMO MHULD 10MG

1,00 STUK

0,19558

2N06AAAO V 33647

VENLAFAXINE FO C US C AP SULE MVA 37,5MG

2,67 STUK

0,47987

2N06AAAO V 33648

VENLAFAXINE FO C US C AP SULE MVA 75MG

1,33 STUK

0,79979

2N06AAAO V 33649

VENLAFAXINE FO C US C AP SULE MVA 150MG

0,67 STUK

1,59958

0N07XXAO V 102458

TETMO DIS TABLET 25MG

4,00 STUK

2,23214

0V03AEAO V

108333//31928

FO SR ENO L KAUW TABLET 500MG

4,50 STUK

2,18435

0V03AEAO V

108328//31929

FO SR ENO L KAUW TABLET 750MG

3,00 STUK

2,97866

0A02BC AO

V 108347//101600 NEXIUM GR ANULAAT MSR V SUSP IN SAC HET 10MG

2,00 STUK

1,00866

0A02BC AO

V 29770

O MEP R AZO LUM C AP SULE MSR 20MG

1,00 STUK

1,68111

0A02BC AO

V 29769

O MEP R AZO LUM C AP SULE MSR 40MG

0,50 STUK

3,36221

0A06ABAO

V 107968

BISAC O DYL MDQ TABLET MSR 5MG

2,00 STUK

0,03276

0A06ADBO

V 106616

P IC O P R EP P O EDER VO O R DR ANK SAC HET 16,1G

2,00 STUK

8,86005

1A06ADAO

V 108344//103756 LAXTR A O R ANGE P O EDER VO O R DR ANK IN SAC HET

0,76 STUK

0,54285

0B01AC C O

V 108371//10186

P ER SANTIN R ETAR D C AP SULE MGA 150MG

2,67 STUK

0,17057

0C 09AAAO

V 33329

P ER INDO PR IL TER T-BUTYLAMINE FO C US TABLET 2MG

2,00 STUK

0,35045

0C 09AAAO

V 33330

P ER INDO PR IL TER T-BUTYLAMINE FO C US TABLET 4MG

1,00 STUK

0,58408

YC 09BAAO

V 106267

C AP TO PR IL/HYDR O C HLO O R THIAZIDE PC H TABLET 50/25MG

1,00 STUK

0,68754

0C 10AAAO

V 108112//21083

ATO R VASTATINE FISHER TABLET FILMO MHULD 40MG

0,50 STUK

2,76806

0D01BABO

V 108690

TER BINAFINE FO C US FAR MA TABLET 250MG

1,00 STUK

2,33152

0G03AABO

V 107891//23827

YASMIN TABLET O MHULD

0,75 STUK

0,13253

0G03DC AO

V 104058

VISANNE 2 MG TABLETTEN

1,00 STUK

0,11783

0G03GABP

V 108180//24536

MENO P UR INJP DR FLAC O N 75IE + SO LV 1ML

1,00 STUK

33,54345

1G03DABO

V 108719//11473

UTR O GESTAN C AP SULE 100MG

3,00 STUK

0,09573

1G03DBBO

V 107765//5619

DUP HASTO N TABLET O MHULD 10MG

1,00 STUK

0,28718

0J01FAAO

V 104436

C LAR ITR O MYC INE MYLAN R ETAR D TABLET MGA 500MG

1,00 STUK

2,43031

0J07AGAP

K 108490//17508

AC T HIB INJEC TIEP O EDER FLAC 10MC G +SO LV 0,5ML W W SP

1,00 STUK

24,73100

0L01XEC O

V EU/1/10/628/002 VO TR IENT 200 MG FILMO MHULDE TABLETTEN 90 STUKS

4,00 STUK

35,91481

0L01XEC O

V EU/1/10/628/003 VO TR IENT 400 MG FILMO MHULDE TABLETTEN 30 STUKS

2,00 STUK

59,85801

0L04AAAP

V EU/1/07/389/002 O R ENC IA 250 MG P DR V C O NC V O PL V INFUSIE 2 FLAC O N

0,107 STUK 362,16748

0L04AAAP

V EU/1/07/389/003 O R ENC IA 250 MG P DR V C O NC V O PL V INFUSIE 3 FLAC O N

0,107 STUK 362,16748

0L04AAAP

V EU/1/07/389/001 O R ENC IA INFP DR FLAC O N 250MG

0,107 STUK 362.16748

0L04AAEO

V EU/1/10/654/001 LEFLUNO MIDE R P TABLET FILMO MHULD 10MG

2,00 STUK

2,08285

0L04AAEO

V EU/1/10/654/003 LEFLUNO MIDE R P TABLET FILMO MHULD 20MG

1,00 STUK

3,47142

YM01AEAO

V 106235

VIMO VO TABLET MGA 500/20MG

1,00 STUK

2,23775

0M05BABO

V 106386

R ISEDR O NAATNATR IUM MYLAN W EKELIJKS TABL O MH 35MG

0,14 STUK

8,57645

0M05BABO

V 106398

R ISEDR O NAATNATR IUM R P W EKELIJKS TABL FILMO MH 35MG

0,14 STUK

8,57645

0N02C C AO

V 108619//27212

FR O VATR IP TAN ER C TABLET FILMO MHULD 2,5MG

1,00 STUK

6,21227

0N02C C AO

V 108627//21818

MAXALT SMELTTABLET 10MG

1,00 STUK

6,21227

0N02C C AO

V 108610//21444

NAR AMIG TABLET O MHULD 2,5MG

1,00 STUK

6,21227

0N02C C AO

V 108621//21444

NAR AMIG TABLET O MHULD 2,5MG

1,00 STUK

6,21227

0N02C C BO

V 108810//19470

IMIGR AN NEUSSP R AY 20MG

1,00 STUK

10,43468

0N04BC AO

V 104991

P R AMIP EXO L MYLAN TABLET 0,125MG (0,088MG BASE)

20,00 STUK

0,46983

0N04BC AO

V 104999

P R AMIP EXO L MYLAN TABLET 1MG (0,7MG BASE)

0N04BC AO

V 101346

P R AMIP EXO L R P TABLET 0,125MG (0,088MG BASE)

0N04BC AO

V 101347

2N05ADAP

2,50 STUK

1,56609

20,00 STUK

0,46983

P R AMIP EXO L R P TABLET 1MG (0,7MG BASE)

2,50 STUK

1,56609

V 107892//3185

HALDO L INJVLST 5MG/ML AMP UL 1ML

1,60 STUK

1,16139

2N06BAAO

V 108611//33668

W ELLBUTR IN XR TABLET MGA 150MG

2,00 STUK

0,63983

0R 01ADAN

V 108487//23477

FLIXO NASE NEUSDR UP P ELS 1MG/ML NASULE 0,4ML

0,50

DO

0,67402

0R 03AC AIDAV V 108660//21440

VENTO LIN 100 AER C FKVR 100MC G/DO SP BS 200DO +INHAL

8,00

DO

0,01654

0R 03BABID V

V 108355//31633

ALVESC O 160 AER O SO L 160MC G/DO SPBS 60DO + INH

1,00

DO

0,70100

0R 03BABID V

V 108664//31633

ALVESC O 160 AER O SO L 160MC G/DO SPBS 60DO + INH

1,00

DO

0,70100

YR 03AC C IDA

V 108051//34610

FO STER AER O SO L 100/6MC G/DO SIS SP UITBUS 120DO

1,00

DO

YR 03AKAIDC

V 108361//27690

SYMBIC O R T TUR BUHALER INHALP DR 400/12MC G/DO 60DO

1,00

DO

0,96642

2R 06AXAO

V EU/1/00/160/012 AER IUS TABLET FILMO MHULD 5MG

1,00 STUK

0,50499

0V03AEAO

V 108617//31928

FO SR ENO L KAUW TABLET 500MG

4,50 STUK

2,18435

0V03AEAO

V 108618//31929

FO SR ENO L KAUW TABLET 750MG

3,00 STUK

2,97866

0A02BC AO

V 108346//101600 NEXIUM GR ANULAAT MSR V SUSP IN SAC HET 10MG

2,00 STUK

1,00866

0A02BC AO

V 108339//25387

NEXIUM TABLET MSR 20MG

1,00 STUK

1,68111

0A02BC AO

V 108348//25388

NEXIUM TABLET MSR 40MG

0,50 STUK

3,36221

0A02BC AO

V 108858//23211

P AR IET TABLET MSR 20MG

1,00 STUK

1,68111

0A07EABR C

V 108860//15660

ENTO C O R T TABLET VO O R KLYSMA + SO LVENS 115ML

1,00 STUK

7,42126

0A07EABR C

V 108862//15660

ENTO C O R T TABLET VO O R KLYSMA + SO LVENS 115ML

1,00 STUK

7,42126

0A07EC C R

V 108859//15064

P ENTASA ZETP IL 1G

1,50 STUK

2,02053

0A10BBAO

V 108863//25617

DIAMIC R O N MR TABLET MGA 30MG

2,00 STUK

0,13855

0C 02C AAO

V 108002//22689

C AR DUR A XL TABLET MGA 8MG

0,50 STUK

1,68644

0C 09AAAO

V 108630//23722

ZO FIL TABLET O MHULD 30MG

1,00 STUK

0,58408

0C 09C AAO

V 108866//28783

O LMETEC TABLET FILMO MHULD 20MG

1,00 STUK

0,74420

YC 09DXAO

V 106667

SEVIKAR HC T TABLET FILMO MHULD 20/ 5/12,5 MG

1,00 STUK

1,45043

YC 09DXAO

V 106672

SEVIKAR HC T TABLET FILMO MHULD 40/10/12,5 MG

1,00 STUK

2,84914

YC 09DXAO

V 106674

SEVIKAR HC T TABLET FILMO MHULD 40/10/25 MG

1,00 STUK

2,90087

YC 09DXAO

V 106671

SEVIKAR HC T TABLET FILMO MHULD 40/ 5/12,5 MG

1,00 STUK

2,19463

YC 09DXAO

V 106673

SEVIKAR HC T TABLET FILMO MHULD 40/ 5/25 MG

1,00 STUK

2,24637

0C 10AAAO

V 108864//21081

LIP ITO R TABLET O MHULD 10MG

2,00 STUK

0,83042

0C 10AAAO

V 108865//21082

LIP ITO R TABLET O MHULD 20MG

1,00 STUK

1,38403

0C 10AAAO

V 26339

SIMVASTATINE P SI TABLET FILMO MHULD 20MG

1,50 STUK

0,92269

0G03AC AIM

V 23557//6602

DEPO PR O VER A 150 INJSUSP 150MG/ML W W SP 1ML

0,01 ML

6,96550

0G03GABP

V 107897//24536

MENO P UR INJP DR FLAC O N 75IE + SO LV 1ML

1,00 STUK

33,54345

0G04AC BO

V 108889

NITR O FUR ANTO INE MC AC TAVIS C APSULE 50MG

4,00 STUK

0,14294

0G04AC BO

V 108890

NITR O FUR ANTO INE MC AC TAVIS C APSULE 100MG

2,00 STUK

0,28588

0H02ABAO

V 108613//22557

BUDENO FALK C APSULE MGA 3MG

3,00 STUK

1,02100

0H02ABAO

V 108616//18765

ENTO C O R T C AP SULE MGA 3MG

3,00 STUK

1,02100

0H02ABBO

V 106140

P R EDNISO LO N SANDO Z TABLET 20MG

0,50 STUK

0,19967

0J01GBAII

V 106362

TADIM P DR V VER NEVELO P L FL 1 MILJ IE + TADIM DISC

3,00 STUK

15,03147

0L02BGAO

V 106400

ANASTR O ZO L AC C O R D TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L02BGAO

V 34012

ANASTR O ZO L AC TAVIS TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L02BGAO

V 103601

ANASTR O ZO L AP O TEX TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L02BGAO

V 35340

ANASTR O ZO L C F TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L02BGAO

V 34008

ANASTR O ZO L MYLAN TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L02BGAO

V 34122

ANASTR O ZO L PC H TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L02BGAO

V 34004

ANASTR O ZO L R P TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L02BGAO

V 34011

ANASTR O ZO L SANDO Z TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L02BGAO

V 105752

ANASTR O ZO L SUN TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L04AABO

V EU/1/07/438/001 MYFENAX 250 MG HAR DE C AP SULES

8,00 STUK

1,77337

0L04AABO

V EU/1/07/438/003 MYFENAX 500 MG FILMO MHULDE TABLETTEN

4,00 STUK

2,95562

0L04AABO

V EU/1/07/438/006 MYFENAX C AP SULE 250MG

8,00 STUK

1,77337

0L04AABO

V EU/1/07/438/005 MYFENAX TABLET FILMO MHULD 500MG

4,00 STUK

2,95562

0L04AAEO

V EU/1/99/118/003 AR AVA TABLET O MHULD 10MG

2,00 STUK

2,08285

0L04AAEO

V EU/1/99/118/007 AR AVA TABLET O MHULD 20MG

1,00 STUK

3,47142

0L04AAEO

V EU/1/99/118/009 AR AVA TABLET O MHULD 100MG

0,20 STUK

17,35710

0M05BABP

V EU/1/10/618/003 P R O LIA 60 INJVLST 60MG/ML W W SP 1ML

1,00 ML

297,27600

0M05BABP

V EU/1/10/618/001 P R O LIA 60 MG/ML O PL V INJEC TIE 1 VO O R GEVULDE SP UIT

1,00 ML

297,27600

0M05BABP

V EU/1/10/618/002 P R O LIA 60 MG/ML O PL V INJEC TIE 1 VO O R GEVULDE SP UIT

1,00 ML

297,27600

O XYNO R M INJVLST 50 MG/ ML AMP UL 1 ML

0,60 ML

6,52500

0N02AAC P

101605

0N02BEDO

V 26161

P ANADO L AR TR O SE TABLET O MHULD 1000MG

3,00 STUK

0,11300

0N02C C AO

V 108861//21816

MAXALT TABLET 10MG

1,00 STUK

6,21227

0N07AAAO

V EU/1/09/599/002 R IVASTIGMINE SANDO Z 1,5 MG HAR DE C AP SULES

6,00 STUK

1,11176

0N07AAAO

V EU/1/09/599/003 R IVASTIGMINE SANDO Z 1,5 MG HAR DE C AP SULES

6,00 STUK

1,11176

0N07AAAO

V EU/1/09/599/004 R IVASTIGMINE SANDO Z 1,5 MG HAR DE C AP SULES

6,00 STUK

1,11176

0N07AAAO

V EU/1/09/599/006 R IVASTIGMINE SANDO Z 3 MG HAR DE C APSULES

3,00 STUK

1,58823

0N07AAAO

V EU/1/09/599/007 R IVASTIGMINE SANDO Z 3 MG HAR DE C APSULES

3,00 STUK

1,58823

0N07AAAO

V EU/1/09/599/008 R IVASTIGMINE SANDO Z 3 MG HAR DE C APSULES

3,00 STUK

1,58823

0N07AAAO

V EU/1/09/599/010 R IVASTIGMINE SANDO Z 4,5 MG HAR DE C AP SULES

2,00 STUK

2,38235

0N07AAAO

V EU/1/09/599/011 R IVASTIGMINE SANDO Z 4,5 MG HAR DE C AP SULES

2,00 STUK

2,38235

0N07AAAO

V EU/1/09/599/012 R IVASTIGMINE SANDO Z 4,5 MG HAR DE C AP SULES

2,00 STUK

2,38235

0N07AAAO

V EU/1/09/599/014 R IVASTIGMINE SANDO Z 6 MG HAR DE C APSULES

1,50 STUK

3,17646

0N07AAAO

V EU/1/09/599/015 R IVASTIGMINE SANDO Z 6 MG HAR DE C APSULES

1,50 STUK

3,17646

0N07AAAO

V EU/1/09/599/016 R IVASTIGMINE SANDO Z 6 MG HAR DE C APSULES

1,50 STUK

3,17646

0N07AAAO

V EU/1/09/599/001 R IVASTIGMINE SANDO Z C AP SULE 1,5MG

6,00 STUK

1,11176

0N07AAAO

V EU/1/09/599/005 R IVASTIGMINE SANDO Z C AP SULE 3MG

3,00 STUK

1,58823

0N07AAAO

V EU/1/09/599/009 R IVASTIGMINE SANDO Z C AP SULE 4,5MG

2,00 STUK

2,38235

0N07AAAO

V EU/1/09/599/013 R IVASTIGMINE SANDO Z C AP SULE 6MG

1,50 STUK

3,17646

0N07XXAO

V 29852

4,00 STUK

2,23214

XENAZINE TABLET 25MG

YR 03AC C IDC V 108737//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00 DO

0,90703

YR 03AC C IDC V 108746//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

YR 03AKAIDC V 108797//25887

SYMBIC O R T TUR BUHALER INHALP DR 200/6MC G/DO 60DO

1,00 DO

0,48321

YR 03AKAIDC V 108796//27690

SYMBIC O R T TUR BUHALER INHALP DR 400/12MC G/DO 60DO

1,00 DO

0,96642

0S01FAAG

V 108488//6851

C YC LO GYL O O GDR UP P ELS 1% FLAC O N 15ML

0,30 ML

0,35909

0S01XAAG

V 107234

LIP O SIC O O GGEL 2MG/G TUBE 10G

0,40 GR AM

0,39706

0A09AAAO

V 108899//13760

P ANZYTR AT 25000 C APSULE MSR

2,40 STUK

1,00796

0C 07ABAO

V 24513

BISO P R O LO LFUMAR AAT DEC O MYLAN TABLET 10 MG

1,00 STUK

0,40613

0C 10AAAO

V 108703//26872

C R ESTO R TABLET FILMO MHULD 10 MG

1,00 STUK

1,38403

0C 10AAAO

V 108702//26873

C R ESTO R TABLET FILMO MHULD 20 MG

0,50 STUK

2,76806

0C 10AAAO

V 108704//26874

C R ESTO R TABLET FILMO MHULD 40 MG

0,25 STUK

5,53612

YG04C AAO

V 109040//104130 C O MBO DAR T C AP SULE 0,5/0,4 MG

1,00 STUK

2,08572

0H02ABAO

V 106117

BUDENO FALK GR ANULAAT MSR 9MG IN SAC HET

1,00 STUK

3,06301

0J01DHAP

V 104478

MER O P ENEM HO SP IR A INF/INJPDR FLAC O N 500 MG

4,00 STUK

18,31911

0J01DHAP

V 104479

MER O P ENEM HO SP IR A INF/INJPDR FLAC O N 1000 MG

2,00 STUK

36,63822

0L04AAAO

V 109045//17495

NEO R AL C APSULE 25 MG

12,00 STUK

1,57244

0L04AAAO

V 109044//17496

NEO R AL C APSULE 100 MG

3,00 STUK

3,93110

0L04AABO

V 106665

MYC O FENO LAAT MO FETIL MYLAN C AP SULE 250 MG

8,00 STUK

1,77337

0L04AADO

V 103862

TAC NI C AP SULE 0,5 MG

10,00 STUK

1,70955

0L04AADO

V 103864

TAC NI C AP SULE 1 MG

5,00 STUK

2,84925

0L04AADO

V 103865

TAC NI C AP SULE 5 MG

1,00 STUK

14,24625

0M05BABO

V 106295

R ISEDR O NAATNATR IUM BLUEFISH W EKELIJKS TAB O MH 35MG

0,14 STUK

8,57645

0N02C C AO

V 109046//21817

MAXALT SMELTTABLET 5 MG

2,00 STUK

3,72736

0N02C C AO

V 109047//21818

MAXALT SMELTTABLET 10 MG

1,00 STUK

6,21227

0N02C C AO

V 109038//21816

MAXALT TABLET 10 MG

1,00 STUK

6,21227

0N06BAAO

V 108026

MEDIKINET C R C AP SULE MGA 5 MG

6,00 STUK

0,07270

2N06AAAO

V 108592

VENLAFAXINE FO C US TABLET MVA 225 MG

0,44 STUK

2,39936

0N07AAAO

V 102799

R IVASTIGMINE C F C APSULE 1,5 MG

6,00 STUK

1,11176

0N07AAAO

V 102800

R IVASTIGMINE C F C APSULE 3 MG

3,00 STUK

1,58823

0N07AAAO

V 102801

R IVASTIGMINE C F C APSULE 4,5 MG

2,00 STUK

2,38235

0N07AAAO

V 102802

R IVASTIGMINE C F C APSULE 6 MG

1,50 STUK

3,17646

0N07AAAO

V 102862

R IVASTIGMINE R P C AP SULE 1,5 MG

6,00 STUK

1,11176

0N07AAAO

V 102864

R IVASTIGMINE R P C AP SULE 3 MG

3,00 STUK

1,58823

0N07AAAO

V 102865

R IVASTIGMINE R P C AP SULE 4,5 MG

2,00 STUK

2,38235

0N07AAAO

V 102866

R IVASTIGMINE R P C AP SULE 6 MG

0N07BC AO

V 108677

METHADO N HC L SANDO Z TABLET 10 MG

2,50 STUK

0,17734

0N07BC AO

108682

METHADO N HC L SANDO Z TABLET 20 MG

1,25 STUK

0,35468

SYMBIC O R T TUR BUHALER INHALP DR 100/6MC G/DO 60DO

1,00 DO

0,39413

YR 03AKAIDC V 109176//25886

1,50 STUK

3,17646

0A01AAADA V

11455

EN DE KAY THIXO TR O P E FLUO GEL 0,4% FR UITSMAAK

1,00

ML

0,05696

0A01AAADA V

11454

EN DE KAY THIXO TR O P E FLUO GEL 0,4% MINTSMAAK

1,00

ML

0,05696

0A02BC AP V

34735

O MEP R AZO L P C H INFP DR FLAC O N 40MG

1,00

STUK

9,48400

1A06ADAO V 105941

MAC R O GO L EN ELEKTR SANDO Z C ITR O EN PDR V DR SAC HET

0,76

STUK

0,54285

0A07EABR C

BUDENO FALK SC HUIM 2MG/DO FLAC O N 14DO

1,00

DO

7,42126

MEZAVANT TABLET MVA 1200MG

1,25

STUK

1,50140

0A10BHAO V EU/1/09/545/011 O NGLYZA 2,5 MG FILMO MHULDE TABLET

2,00

STUK

1,93200

0A10BHAO V EU/1/09/545/012 O NGLYZA 2,5 MG FILMO MHULDE TABLET

2,00

STUK

1,93200

0A10BHAO V EU/1/09/545/013 O NGLYZA 2,5 MG FILMO MHULDE TABLET

2,00

STUK

1,93200

0A10BHAO V EU/1/09/545/015 O NGLYZA 2,5 MG FILMO MHULDE TABLET

2,00

STUK

1,93200

0A10BHAO V EU/1/09/545/014 O NGLYZA TABLET 2,5MG

2,00

STUK

1,93200

0C 02C AAO V 100581

TER AZO SINE AC C O R D TABLET 2MG

2,50

STUK

0,33729

0C 02C AAO V 100582

TER AZO SINE AC C O R D TABLET 5MG

1,00

STUK

0,84322

0C 07ABAO V 106070

BISO P R O LO LFUMAR AAT MYLAN TABLET 2,5MG

4,00

STUK

0,10153

YC 09BAAO V 104000

P ER INDO PR IL TER TBUTYL/INDAP AMIDE C F TABL 4/1,25MG

1,00

STUK

0,63581

YC 09DAAO V 109236//24995

C ANDESAR TAN C ILEXETIL/HC T FISHER TABLET 16/12,5MG

1,00

STUK

1,54013

0H02ABEP V

107717

DEXAMETHASO N C F INJVLST 4MG/ML 0,29 AMP UL 1ML

ML

3,62806

0J01DHAP V

105213

IMIP ENEM/C ILASTATINE HO SP IR A INFPDR FL 500/500MG

4,00

STUK

18,31911

0J01MAAO V

104267

LEVO FLO XAC INE AC TAVIS TABLET

1,00

STUK

3,05666

102383

0A07EC C O V 109143//33600

FILMO MHULD 250MG 0J01MAAO V

104268

LEVO FLO XAC INE AC TAVIS TABLET FILMO MHULD 500MG

0,50

STUK

6,11332

0J01MAAO V

106367

LEVO FLO XAC INE BLUEFISH TABLET FILMO MHULD 250MG

1,00

STUK

3,05666

0J01MAAO V

106370

LEVO FLO XAC INE BLUEFISH TABLET FILMO MHULD 500MG

0,50

STUK

6,11332

0J01MAAP V

105445

C IP R O FLO XAC INE C F INFVLST 2MG/ML FLAC O N

250,00

ML

0,24779

0J05ABC O V

EU/1/09/527/003 R IBAVIR INE TEVA TABLET FILMO MHULD 200MG

5,00

STUK

6,67057

0J05ABC O V

EU/1/09/527/005 R IBAVIR INE TEVA TABLET FILMO MHULD 200MG

5,00

STUK

6,67057

0J05ABC O V

EU/1/09/527/009 R IBAVIR INE TEVA TABLET FILMO MHULD 400MG

2,50

STUK

11,11761

0J05ABC O V

EU/1/09/527/012 R IBAVIR INE TEVA TABLET FILMO MHULD 400MG

2,50

STUK

11,11761

0L02AEADI V 30197

LUC R IN PDS DEPO T INJPDR W W SP 3,75MG + SO LVENS 1ML

1,00

STUK

184,07590

0L02AEADI V 34476//30197

LUC R IN PDS DEPO T INJPDR W W SP 3,75MG + SO LVENS 1ML

1,00

STUK

184,07590

0L02AEADI V 100042//30197

LUC R IN PDS DEPO T INJPDR W W SP 3,75MG + SO LVENS 1ML

1,00

STUK

184,07590

0L02AEADI V 100350//30197

LUC R IN PDS DEPO T INJPDR W W SP 3,75MG + SO LVENS 1ML

1,00

STUK

184,07590

0L02AEADI V 105152//30197

LUC R IN PDS DEPO T INJPDR W W SP 3,75MG + SO LVENS 1ML

1,00

STUK

184,07590

0L02AEADI V 30198

LUC R IN PDS DEPO T INJPDR W W SP 11,25MG + SO LVENS 1ML

0,33

STUK

552,22770

0L02AEADI V 34475//30198

LUC R IN PDS DEPO T INJPDR W W SP 11,25MG + SO LVENS 1ML

0,33

STUK

552,22770

0L02AEADI V 101420//30198

LUC R IN PDS DEPO T INJPDR W W SP 11,25MG + SO LVENS 1ML

0,33

STUK

552,22770

0L02AEADI V 105154//30198

LUC R IN PDS DEPO T INJPDR W W SP 11,25MG + SO LVENS 1ML

0,33

STUK

552,22770

0L02AEADI V 105210//30198

LUC R IN PDS DEPO T INJPDR W W SP 11,25MG + SO LVENS 1ML

0,33

STUK

552,22770

1M01AEAO V 109172//13331

BR UFEN BR UIS 600MG BR UISGR ANULAAT IN SAC HET

2,00

STUK

0,27832

0N02C C AO V 109173//21818

MAXALT SMELTTABLET 10MG

1,00

STUK

6,21227

0N04BC AO V 101915

GLEP AR K TABLET 0,125MG (0,088MG BASE)

20,00

STUK

0,46983

0N04BC AO V 101920

GLEP AR K TABLET 1MG (0,7MG BASE) 2,50

STUK

1,56609

0N05AXAP V

EU/1/11/672/001 XEP LIO N 25 INJVLST 100MG/ML W W SP 0,25ML

0,10

STUK

176,93424

0N05AXAP V

EU/1/11/672/002 XEP LIO N 50 INJVLST 100MG/ML W W SP 0,5ML

0,05

STUK

252,76320

0N05AXAP V

EU/1/11/672/003 XEP LIO N 75 INJVLST 100MG/ML W W SP 0,75ML

0,03

STUK

379,14480

0N05AXAP V

EU/1/11/672/004 XEP LIO N 100 INJVLST 100MG/ML W W SP 1ML

0,03

STUK

505,52640

0N05AXAP V

EU/1/11/672/005 XEP LIO N 150 INJVLST 100MG/ML W W SP 1,5ML

0,02

STUK

758,28960

2N05AFAO V

109213//4294

ZUC LO PENTHIXO L FISHER TABLET FILMO MHULD 2MG

15,00

STUK

0,06589

0N06BAAO V

108349//31495

STR ATTER A C AP SULE 18MG

4,44

STUK

0,08178

0N06BAAO V

108350//31496

STR ATTER A C AP SULE 25MG

3,20

STUK

0,11359

0N06BAAO V

108351//31497

STR ATTER A C AP SULE 40MG

2,00

STUK

0,18174

2N06ABAO V

33740

SER TR ALINE AC TAVIS TABLET FILMO MHULD 100MG

0,50

STUK

2,13277

0S01AAAG V

109196//11902

FUC ITHALMIC O O GGEL TUBE 5G

0,40

GR AM

0,83224

0S01EC AG V

105562

DO R ZO LAMIDE AC TAVIS O O GDR UPP ELS 20MG/ML FLAC O N 5ML

0,30

ML

2,19630

YS01EDC G V

102594

DO R ZO LAMIDE/TIMO LO L PC H O O GDR 20/5MG/ML FL 5ML

1,00

ML

3,13380

1A06AC AO

V

109376//13961

METAMUC IL SKVR LEMO N P O EDER 3,4G IN SAC HET

2,06 STUK

0,20039

1A06AC AO

V

109380//13963

METAMUC IL SKVR O R ANGE P O EDER 3,4G IN SAC HET

2,06 STUK

0,20039

0A09AAAO

V

34948

P ANC R EATINE MYLAN 300MG MSR C AP SULE HAR D

2,40 STUK

1,00796

0A10AC API

V

109254//14896

HUMULINE NP H INJ 100IE/ML P ATR O O N 3ML

0,40 ML

2,09223

0A10BBAO

V

103964

GLIC LAZIDE AC TAVIS TABLET MGA 30MG

2,00 STUK

0,13855

0A10BHAO

V

EU/1/07/414/008

GALVUS TABLET 50MG

2,00 STUK

1,61000

0B03XAAP

V

EU/1/01/185/078

AR ANESP 20 INJVLST 40MC G/ML W W SP 0,5ML

0,25 ML

98,28806

0C 02C AAO

V

109474//22688

C AR DUR A XL TABLET MGA 4MG

1,00 STUK

0,84322

0C 02C AAO

V

109476//22689

C AR DUR A XL TABLET MGA 8MG

0,50 STUK

1,68644

0C 02C AAO

V

109484//22689

DO XAZO SINE ER C XL TABLET MGA 8MG

0,50 STUK

1,68644

0C 07ABAO

V

106073

BISO P R O LO LFUMAR AAT MYLAN TABLET 5MG

2,00 STUK

0,20307

0C 07ABAO

V

106076

BISO P R O LO LFUMAR AAT MYLAN TABLET 10MG

1,00 STUK

0,40613

0C 09AAAO

V

105088//31958

C O VER SYL AR G TABLET FILMO MHULD 5MG

0,80 STUK

0,73010

0C 09AAAO

V

105081//31959

C O VER SYL AR G TABLET FILMO MHULD 10MG

0,40 STUK

1,46020

0C 09AAAO

V

106740

ZO FENO P R ILC ALC IUM MYLAN

1,00 STUK

0,58408

TABLET FILMO MHULD 30MG 0C 09C AAO

V

109477//17617

C O ZAAR TABLET FILMO MHULD 50MG

1,00 STUK

0,74420

0C 09C AAO

V

104967

VALSAR TAN SANDO Z TABLET FILMO MHULD 160MG

0,50 STUK

1,48840

0C 09C AAO

V

104968

VALSAR TAN SANDO Z TABLET FILMO MHULD 320MG

0,25 STUK

2,97680

0C 09C AAO

V

104965

VALSAR TAN SANDO Z TABLET FILMO MHULD 80MG

1,00 STUK

0,74420

YC 09BAAO

V

105089//33663

C O VER SYL PLUS AR G TABLET FILMO MHULD 5/1,25MG

1,00 STUK

0,78183

YC 09DAAO

V

105017

VALSAR TAN/HC T SANDO Z TABL FILMO MHULD 160MG/12,5MG

1,00 STUK

1,54013

YC 09DAAO

V

105018

VALSAR TAN/HC T SANDO Z TABL FILMO MHULD 160MG/25MG

1,00 STUK

1,59186

YC 09DAAO

V

105019

VALSAR TAN/HC T SANDO Z TABL FILMO MHULD 320MG/12,5MG

1,00 STUK

3,02853

YC 09DAAO

V

105021

VALSAR TAN/HC T SANDO Z TABL FILMO MHULD 320MG/25MG

1,00 STUK

3,08026

YC 09DAAO

V

105005

VALSAR TAN/HC T SANDO Z TABL FILMO MHULD 80MG/12,5MG

1,00 STUK

0,79593

0C 10AAAO

V

109412//26872

C R ESTO R TABLET FILMO MHULD 10MG

1,00 STUK

1,38403

0C 10AAAO

V

109319//21081

LIP ITO R TABLET O MHULD 10MG

2,00 STUK

0,83042

0G03AABO

V

109239//23827

YASMIN TABLET O MHULD

0,75 STUK

0,13253

0G03FAAO

V

109462//22819

AC TIVELLE TABLET O MHULD

1,00 STUK

0,38944

0G03FAAO

V

103887

FEMO STO N C O NTINU TABLET O MHULD 0,5/2,5MG

1,00 STUK

0,38944

0G04BDBO

V

109325//29151

VESIC AR E TABLET FILMO MHULD 5MG

1,00 STUK

0,82981

0G04BDBO

V

109328//29152

VESIC AR E TABLET FILMO MHULD 10MG

0,50 STUK

1,65963

0G04C AAO

V

EU/1/09/607/004

SILO DYX C AP SULE 4MG

2,00 STUK

0,57721

0G04C AAO

V

EU/1/09/607/011

SILO DYX C AP SULE 8MG

1,00 STUK

0,96201

0J01FFAO

V

108229

C LINDAMYC INE C F C AP SULE 300MG

4,00 STUK

0,91648

0J01GBAII

V

EU/1/09/543/001

C AYSTO N 75 MG P DR +O P L VO O R VER NEVELO PLO SSING

1,50 STUK

30,06294;

0J01GBAII

V

EU/1/09/543/002

C AYSTO N P DR V VER NEVELO P L FL 75MG+SO LV 1ML+ALTER A

1,50 STUK

30,06294;

0L01XAAP

V

104068

C ISP LATINE AC C O R D INFVLST C O NC 1MG/ML

175,00 ML

1,53396

0L02AEADI

V

109208//12277

ZO LADEX IMP LANTATIESTIFT 3,6MG IN W W SP

1,00 STUK

184,07590

0L02AEADI

V

109209//18562

ZO LADEX IMP LANTATIESTIFT 10,8MG IN W W SP

0,33 STUK

552,22770

0L02BBAO

V

109354//18805

ANANDR O N TABLET 150MG

1,00 STUK

5,44536

0L02BGAO

V

105553

EXEMESTAAN AC TAVIS TABLET FILMO MHULD 25MG

1,00 STUK

4,71931

0L02BGAO

V

102322

LETR O ZO L AC TAVIS TABLET FILMO MHULD 2,5MG

1,00 STUK

4,71931

0L02BGAO

V

106321

LETR O ZO L SANDO Z TABLET FILMO MHULD 2,5MG

1,00 STUK

4,71931

0L04AAC O

V

109317//30043

C ER TIC AN TABLET 0,75MG

2,00 STUK

14,23305

0M01AHBO

V

109402//34279

AR C O XIA TABLET FILMO MHULD 30MG

2,00 STUK

0,67913

1M01AEAO

V

109374//13331

BR UFEN BR UIS 600MG BR UISGR ANULAAT IN SAC HET

2,00 STUK

0,27832

0N04BAAO

V

109322//15175

SINEMET C R 125 TABLET MGA 100/25MG

6,00 STUK

0,18944

0N04BC AO

V

103241

P R AMIP EXO L APO TEX TABLET 0,125MG (0,088MG BASE)

20,00 STUK

0,46983

0R 03AC C IDC V

109449//21026

O XIS TUR BUHALER INHALPDR 6MC G/DO 60DO

4,00 DO

0,36607

0R 03BABID

V

108738//31633

ALVESC O 160 AER O SO L 160MC G/DO SP BS 60DO + INH

1,00 DO

0,70100

0R 03BABID

V

109352//31633

ALVESC O 160 AER O SO L 160MC G/DO SP BS 60DO + INH

1,00 DO

0,70100

0R 03BADID

V

27111

ASMANEX TW ISTHALER 200 MIC R O GR AM/DO S INHALATIEPDR

2,00 DO

0,42757

0R 03BADID

V

27112

ASMANEX TW ISTHALER 400 MIC R O GR AM/DO S INHALATIEPDR

1,00 DO

0,71262

0R 03BADID

V

109358//18194

FLIXO TIDE DISKUS INHP DR 250MC G 60DO

2,40 DO

0,29692

0R 03BADID

V

109360//18195

FLIXO TIDE DISKUS INHP DR 500MC G 60DO

1,20 DO

0,59385

YR 03AC C IDA V

109253//34610

FO STER AER O SO L 100/6MC G/DO SIS SPUITBUS 120DO

1,00 DO

0,40611

0S01BABG

V

109370//18658

MO NO FR EE DEXAMETHASO N O O GDR 1MG/ML MINIM 0,4ML

4,00 STUK

0,39116

0S01EXAG

V

109362//21304

XALATAN O O GDR UPP ELS 50MC G/ML FLAC O N 2,5ML

0,20 ML

8,54016

YS01EDAG

V

109361//26592

XALAC O M O O GDR UP PELS FLAC O N

1,00 ML

9,47766

0A02BC AO

V 103169

P ANTO P R AZO L FO C US TABLET MSR 40MG

1,00 STUK

1,68111

0A06ADBO

V 109478//34072

MO VIPR EP PO EDER VO O R DR ANK IN SAC HET A+B

4,00 STUK

4,43003

0A07EC C O

V 109359//100059 SALO FALK GR ANU-STIX GR ANULAAT MGA 1,5G IN SAC HET

1,00 STUK

1,87674

0B01ABAP

V 109679//21896

FR AGMIN 10000 INJVLST 25.000IE/ML W W SP 0,4ML

0,10 ML

17,78820

0B01ABAP

V 109680//21897

FR AGMIN 12500 INJVLST 25.000IE/ML W W SP 0,5ML

0,10 ML

17,78820

0B01ABAP

V 109681//21898

FR AGMIN 15000 INJVLST 25.000IE/ML W W SP 0,6ML

0,10 ML

17,78820

0B01ABAP

V 109683//21899

FR AGMIN 18000 INJVLST 25.000IE/ML W W SP 0,72ML

0,10 ML

17,78820

0B01AC AP

V 105855

EPO PR O STENO L P H&T INFP DR FL 0,5MG + SO LV 100ML

8,60 STUK 145,83590

0B01AC AP

V 105856

EPO PR O STENO L P H&T INFP DR FL 1,5MG + SO LV 100ML

2,87 STUK 437,50770

YC 09BBBO

V 109688//100139 C O VER AM AR G TABLET 5MG/ 5MG

1,00 STUK

1,38460

YC 09BBBO

V 109695//100140 C O VER AM AR G TABLET 5MG/10MG

1,00 STUK

2,03910

YC 09BBBO

V 109690//100141 C O VER AM AR G TABLET 10MG/ 5MG

1,00 STUK

2,11470

YC 09BBBO

V 109678//100142 C O VER AM AR G TABLET 10MG/10MG

1,00 STUK

2,76920

0C 10AAAO

V 109242//21083

LIP ITO R TABLET O MHULD 40MG

0,50 STUK

2,76806

0C 10AAAO

V 109321//26872

R O SUVASTATINE ER C TABLET FILMO MHULD 10MG

1,00 STUK

1,38403

0C 10AAAO

V 109481//13194

ZO C O R TABLET 20MG

1,50 STUK

0,92269

0C 10AAAO

V 109482//13195

ZO C O R TABLET 40MG

0,75 STUK

1,84537

0C 10AC AO

V 109507//28626

EZETR O L TABLET 10MG

1,00 STUK

1,72101

YC 10AXAO

V 109509//30929

INEGY TABLET 10/40MG

1,00 STUK

3,56638

0D07ADADL

V 109547//33440

C LO BEX SHAMPO O 0,5MG/G

1,00 GR AM

0,18635

0G03AC BO

V 109092//32303

NO R LEVO TABLET 1,5MG

1,00 STUK

5,32280

0G03DC AO

V 109327//2179

P R IMO LUT N TABLET 5MG

1,50 STUK

0,07855

0G03GAAP

V 109257//33178

FO STIMO N INJP DR FL 75IE + SO LV 1ML

1,00 STUK

23,00000

1G03C AAV

V 109297//8977

SYNAP AUSE E3 VAGINAALC R EME 1MG/G + AP PLIC ATO R

0,20 GR AM

0,92231

0G04AC BO

V 109333//13066

MO NUR IL GR ANULAAT 3000MG/8G IN SAC HET

0,25 STUK

2,28706

0G04AC BO

V 109356//13066

MO NUR IL GR ANULAAT 3000MG/8G IN SAC HET

0,25 STUK

2,28706

0H02ABEP

V 109288//605

DEPO MEDR O L INJVLST 40MG/ML FLAC O N 1ML

0,50 ML

2,06924

0J01MAAO

V 102704

LEVO FLO XAC INE P C H TABLET FILMO MHULD 250MG

1,00 STUK

3,05666

0J01MAAO

V 102705

LEVO FLO XAC INE P C H TABLET FILMO MHULD 500MG

0,50 STUK

6,11332

0J01MAAO

V 104005

LEVO FLO XAC INE C F TABLET FILMO MHULD 250MG

1,00 STUK

3,05666

0J01MAAO

V 104011

LEVO FLO XAC INE C F TABLET FILMO MHULD 500MG

0,50 STUK

6,11332

0J01MAAO

V 100261

LEVO FLO XAC INE MYLAN TABLET FILMO MHULD 250MG

1,00 STUK

3,05666

0J01MAAO

V 100262

LEVO FLO XAC INE MYLAN TABLET FILMO MHULD 500MG

0,50 STUK

6,11332

0J01MAAO

V 100799

LEVO FLO XAC INE SANDO Z TABLET FILMO MHULD 250MG

1,00 STUK

3,05666

0J01MAAO

V 100802

LEVO FLO XAC INE SANDO Z TABLET FILMO MHULD 500MG

0,50 STUK

6,11332

0J07BC BP

V EU/1/04/299/001 FENDR IX INJSUSP 40MC G/ML W W SP 0,5ML

1,00 DO

66,03860

0L01BAC P

V 109320//100943 METO JEC T INJVLST 50MG/ML W W SP

0,05 ML

62,96000

0L02BGAO

V 109241//19123

AR IMIDEX TABLET FILMO MHULD 1MG

1,00 STUK

0L02BGAO

V 105407

EXEMESTAAN MYLAN TABLET FILMO MHULD 25MG

1,00 STUK

4,71931

0L02BGAO

V 104036

LETR O ZO L MYLAN TABLET FILMO MHULD 2,5MG

1,00 STUK

4,71931

0M05BABO

V 109568//28338

AC TO NEL W EKELIJKS TABLET FILMO MHULD 35MG

0,14 STUK

8,57645

0N02ABC O

V 108843

ABSTR AL TABLET SUBLINGUAAL 100MC G

6,00 STUK

6,04440

0N02ABC O

V 108844

ABSTR AL TABLET SUBLINGUAAL 200MC G

3,00 STUK

10,07400

0N02ABC O

V 108845

ABSTR AL TABLET SUBLINGUAAL 300MC G

2,00 STUK

15,11100

0N02ABC O

V 108846

ABSTR AL TABLET SUBLINGUAAL 400MC G

1,50 STUK

20,14800

0N02ABC O

V 108847

ABSTR AL TABLET SUBLINGUAAL 600MC G

1,00 STUK

30,22200

0N02ABC O

V 108848

ABSTR AL TABLET SUBLINGUAAL 800MC G

0,75 STUK

40,29600

0N02C C BO

V 109465//19470

IMIGR AN NEUSSP R AY 20MG

1,00 STUK

10,43468

0N03AXC O

V 108587

GABAP ENTINE SANDO Z TABLET FILMO MHULD 600MG

3,00 STUK

1,30689

0N04BC AO

V EU/1/97/051/020 MIR AP EXIN TABLET MVA 1,5MG (1,05MG BASE)

1,67 STUK

2,34913

0N04BC AO

V EU/1/97/051/023 MIR AP EXIN TABLET MVA 3MG (2,1MG BASE)

0,83 STUK

4,69826

0N04BC AO

V EU/1/97/051/026 MIR AP EXIN TABLET MVA 4,5MG (3,15MG BASE)

0,56 STUK

7,04739

0N06BAAO

V 109531//31494

STR ATTER A C AP SULE 10MG

8,00 STUK

0,04544

0N06BAAO

V 109533//31495

STR ATTER A C AP SULE 18MG

4,44 STUK

0,08178

0N06BAAO

V 109534//31496

STR ATTER A C AP SULE 25MG

3,20 STUK

0,11359

0N06BAAO

V 109536//31497

STR ATTER A C AP SULE 40MG

2,00 STUK

0,18174

2N06ABAO

V EU/1/04/297/006 XER ISTAR C APSULE MSR 30MG

2,00 STUK

0,63983

2N06ABAO

V EU/1/04/297/002 XER ISTAR C APSULE MSR 60MG

1,00 STUK

1,06638

2N06BAAO

V 109512//33668

W ELLBUTR IN XR TABLET MGA 150MG

2,00 STUK

0,63983

2N06BAAO

V 109508//33669

W ELLBUTR IN XR TABLET MGA 300MG

1,00 STUK

1,06638

0N07AAAO

V 102697

R IVASTIGMINE MYLAN C AP SULE 1,5MG

6,00 STUK

1,11176

0N07AAAO

V 102698

R IVASTIGMINE MYLAN C AP SULE 3MG

3,00 STUK

1,58823

0N07AAAO

V 102699

R IVASTIGMINE MYLAN C AP SULE 4,5MG

2,00 STUK

2,38235

0N07AAAO

V 102700

R IVASTIGMINE MYLAN C AP SULE 6MG

1,50 STUK

3,17646

0R 03AC C IDA V 109373//33735

SER EVENT AER O SO L 25MC G/DO C FKVR SPBS 120DO + INH

4,00 DO

0,23086

0R 03BAAII

V 100826

LAR BEX STER I-NEB VER NEVELO P L 0,25MG/ML AMP UL 2ML

6,00 ML

0,96281

0R 03BABID

V 109558//31633

ALVESC O 160 AER O SO L 160MC G/DO SPBS 60DO + INH

1,00 DO

0,70100

4,71931

YR 03AC C IDC V 109212//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00 DO

0,90703

0S01EC AG

V 101854

DO R ZO LAMIDE MYLAN O O GDR UP P ELS 20MG/ML FLAC O N 5ML 0,30 ML

2,19630

0S01GXAG

V 109517//15593

TILAVIST O O GDR UP P ELS 20MG/ML FLAC O N 5ML

0,30 ML

0,80923

0S01GXBG

V 106263

AZELASTIN P O S O O GDR UP P ELS 0,5MG/ML FLAC O N 10ML

0,20 ML

1,85595

0S01XAAZ

V 109492//10380

DUR ATEAR S Z O O GZALF TUBE 3,5G

0,24 GR AM

0,85440

YS01EDC G

V 109463//22871

C O SO P T O O GDR UP P ELS FLAC O N 5ML

1,00 ML

3,13380

YS01EDC G

V 109567//22871

C O SO P T O O GDR UP P ELS FLAC O N 5ML

1,00 ML

3,13380

0V01AAAO

V 109552//33788

GR AZAX LYO PHILISAAT V O R AAL GEBR UIK 75000 SQ -T

1,00 STUK

3,30000

0A06ADBO

V 109557//34072

MO VIPR EP PO EDER VO O R DR ANK IN SAC HET A+B

4,00

STUK 4,43003

1A06ADAO

V 109712//19006

MO VIC O LO N P O EDER VO O R DR ANK IN SAC HET

0,76

STUK 0,54285

0A07EC C O

V 109686//28131

SALO FALK GR ANU-STIX GR ANULAAT MGA 1000MG IN SAC HET

1,50

STUK 1,25116

0A12AABO

V 109214//13261

C AC IT BR UISTABLET 500MG

2,00

STUK 0,26210

0B01ABAP

V 109701//11876

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,3ML

0,30

ML

5,92940

0B01ABAP

V 109702//15963

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,4ML

0,30

ML

5,92940

0B01ABAP 0B01ABAP

V 109703//11877 V 109704//15965

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,6ML FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,8ML

0,30 0,30

ML ML

5,92940 5,92940

0B01AC AO

V 102646

AC ETYLSALIC YLZUUR C AR DIO SANDO Z DISP TABLET 80MG

1,00

STUK 0,05249

0B01AC DO

V EU/1/08/503/008 EFIENT TABLET FILMO MHULD 10MG

1,00

STUK 1,88043

0C 07ABAO

V 109713//13197

SELO KEEN ZO C 50 TABLET MGA 47,5MG

3,00

STUK 0,13538

0C 07ABAO

V 109716//12149

SELO KEEN ZO C 100 TABLET MGA 95MG

1,50

STUK 0,27075

0C 08C AAO

V 109834//15099

LO MIR SR O C AP SULE MGA 5MG

1,00

STUK 0,65450

YC 09BAAO

V 109510//102257 P ER INDO PR IL AR G/INDAP AMIDE FISHER TABL FO 10/2,5MG

1,00

STUK 1,56366

YC 09XABO

V EU/1/11/686/015 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,05321

YC 09XABO

V EU/1/11/686/017 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,05321

YC 09XABO YC 09XABO

V EU/1/11/686/018 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN V EU/1/11/686/019 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 2,05321 STUK 2,05321

YC 09XABO

V EU/1/11/686/020 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,05321

YC 09XABO

V EU/1/11/686/021 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,05321

YC 09XABO YC 09XABO

V EU/1/11/686/022 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN V EU/1/11/686/023 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 2,05321 STUK 2,05321

YC 09XABO

V EU/1/11/686/024 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,05321

YC 09XABO

V EU/1/11/686/025 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,05321

YC 09XABO

V EU/1/11/686/026 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,05321

YC 09XABO

V EU/1/11/686/028 R ASILAMLO 150 MG/10 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,05321

YC 09XABO

V EU/1/11/686/001 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 1,39870

YC 09XABO YC 09XABO

V EU/1/11/686/003 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN V EU/1/11/686/004 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 1,39870 STUK 1,39870

YC 09XABO

V EU/1/11/686/005 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 1,39870

YC 09XABO

V EU/1/11/686/006 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 1,39870

YC 09XABO YC 09XABO

V EU/1/11/686/007 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN V EU/1/11/686/008 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 1,39870 STUK 1,39870

YC 09XABO

V EU/1/11/686/009 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 1,39870

YC 09XABO

V EU/1/11/686/010 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 1,39870

YC 09XABO YC 09XABO

V EU/1/11/686/011 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN V EU/1/11/686/012 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 1,39870 STUK 1,39870

YC 09XABO

V EU/1/11/686/013 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 1,39870

YC 09XABO

V EU/1/11/686/014 R ASILAMLO 150 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 1,39870

YC 09XABO YC 09XABO

V EU/1/11/686/043 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN V EU/1/11/686/045 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 2,79741 STUK 2,79741

YC 09XABO

V EU/1/11/686/046 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN

1,00

STUK 2,79741

YC 09XABO

V EU/1/11/686/047 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN

1,00

STUK 2,79741

YC 09XABO YC 09XABO

V EU/1/11/686/048 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN V EU/1/11/686/049 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 2,79741 STUK 2,79741

YC 09XABO

V EU/1/11/686/050 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN

1,00

STUK 2,79741

YC 09XABO

V EU/1/11/686/051 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN

1,00

STUK 2,79741

YC 09XABO YC 09XABO

V EU/1/11/686/052 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN V EU/1/11/686/053 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 2,79741 STUK 2,79741

YC 09XABO

V EU/1/11/686/054 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN

1,00

STUK 2,79741

YC 09XABO

V EU/1/11/686/055 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN

1,00

STUK 2,79741

YC 09XABO YC 09XABO

V EU/1/11/686/056 R ASILAMLO 300 MG/10MG FILMO MHULDE TABLETTEN V EU/1/11/686/029 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 2,79741 STUK 2,14290

YC 09XABO

V EU/1/11/686/031 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,14290

YC 09XABO

V EU/1/11/686/032 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,14290

YC 09XABO YC 09XABO

V EU/1/11/686/033 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN V EU/1/11/686/034 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 2,14290 STUK 2,14290

YC 09XABO

V EU/1/11/686/035 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,14290

YC 09XABO

V EU/1/11/686/036 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,14290

YC 09XABO YC 09XABO

V EU/1/11/686/037 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN V EU/1/11/686/038 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 2,14290 STUK 2,14290

YC 09XABO

V EU/1/11/686/039 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,14290

YC 09XABO

V EU/1/11/686/040 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN

1,00

STUK 2,14290

YC 09XABO YC 09XABO

V EU/1/11/686/041 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN V EU/1/11/686/042 R ASILAMLO 300 MG/5 MG FILMO MHULDE TABLETTEN

1,00 1,00

STUK 2,14290 STUK 2,14290

YC 09XABO

V EU/1/11/686/002 R ASILAMLO TABLET FILMO MHULD 150/ 5MG

1,00

STUK 1,39870

YC 09XABO

V EU/1/11/686/016 R ASILAMLO TABLET FILMO MHULD 150/10MG

1,00

STUK 2,05321

YC 09XABO YC 09XABO

V EU/1/11/686/030 R ASILAMLO TABLET FILMO MHULD 300/ 5MG V EU/1/11/686/044 R ASILAMLO TABLET FILMO MHULD 300/10MG

1,00 1,00

STUK 2,14290 STUK 2,79741

0D05AXADZ

V 109576//16330

SILKIS ZALF 3MC G/G

1,00

GR AM 0,37745

0G03AABO

V 107761

ETHINYLESTR ADIO L/LEVO NO R GES A TAB O MH 0,02/0,1MG

0,75

STUK 0,13253

0G04C BAO

V 109511//28317

AVO DAR T C AP SULE 0,5MG

1,00

STUK 1,12371

0J01C R AO

V 105076

AMO XI/C LAV PC H TABLET 500/125MG

3,00

STUK 0,77778

0L01XEAO

V EU/1/06/363/007 SP R YC EL TABLET FILMO MHULD 20MG

5,00

STUK 47,75040

0L01XEAO 0L01XEAO

V EU/1/06/363/008 SP R YC EL TABLET FILMO MHULD 50MG V EU/1/06/363/009 SP R YC EL TABLET FILMO MHULD 70MG

2,00 1,43

STUK 66,32000 STUK 92,84800

0L02BGAO

V 104320

EXEMESTAAN AC C O R D TABLET FILMO MHULD 25MG

1,00

STUK 4,71931

0L02BGAO 0L02BGAO

V 104598 V 104488

EXEMESTAAN C F TABLET FILMO MHULD 25MG EXEMESTAAN TEVA TABLET FILMO MHULD 25MG

1,00 1,00

STUK 4,71931 STUK 4,71931

0L02BGAO

V 104327

EXEMESTAAN SANDO Z TABLET FILMO MHULD 25MG

1,00

STUK 4,71931

0L02BGAO

V 102826

LETR O ZO L TEVA TABLET FILMO MHULD 2,5MG

1,00

STUK 4,71931

0L04AAAP

V EU/1/03/256/001 HUMIR A 40 KIND INJVLST 50MG/ML FLAC O N 0,8ML

0,07

STUK 543,28418

0L04AAEO

V 106344

LEFLUNO MIDE MYLAN TABLET FILMO MHULD 10MG

2,00

STUK 2,08285

0L04AAEO

V 106346

LEFLUNO MIDE MYLAN TABLET FILMO MHULD 20MG

1,00

STUK 3,47142

1M01AEAO

V 109566//13331

BR UFEN BR UIS 600MG BR UISGR ANULAAT IN SAC HET

2,00

STUK 0,27832

0M05BABO

V 106292

R ISEDR O NAATNATR IUM AC TAVIS W EKELIJKS TABL O MH 35MG

0,14

STUK 8,57645

0N04BC AO

V 35163

R O P INIR O L AC TAVIS TABLET FILMO MHULD 0,25MG

24,00 STUK 0,39152

0N04BC AO

V 35164

R O P INIR O L AC TAVIS TABLET FILMO MHULD 0,5MG

12,00 STUK 0,32627

0N04BC AO 0N04BC AO

V 35165 V 35166

R O P INIR O L AC TAVIS TABLET FILMO MHULD 1MG R O P INIR O L AC TAVIS TABLET FILMO MHULD 2MG

6,00 3,00

STUK 0,65254 STUK 1,30507

0N04BC AO

V 106214

R O P INIR O L SANDO Z R ETAR D TABLET MGA 2MG

3,00

STUK 1,56609

0N04BC AO

V 106215

R O P INIR O L SANDO Z R ETAR D TABLET MGA 4MG

1,50

STUK 2,61014

0N04BC AO

V 106216

R O P INIR O L SANDO Z R ETAR D TABLET MGA 8MG

0,75

STUK 5,22029

2N05AFAO

V 109737//4295

ZUC LO PENTHIXO L FISHER TABLET FILMO MHULD 10MG

3,00

STUK 0,18304

4N05ALAO

V 109582//6279

DO GMATYL C AP SULE 50MG

16,00 STUK 0,24769

2N06ABAO

V 25419

C ITALO PR AM AC TAVIS TABLET O MHULD 10MG

2,00

STUK 0,63983

0R 03AC C IDAV V 109694//31994

ATIMO S AER O SO L 12MC G/DO SIS SP UITBUS 100DO

2,00

DO

0S01AABZ

V 109689//10225

TO BR EX O O GZALF TUBE 3,5G

0,28

GR AM 0,22624

0S01BC AG

V EU/1/11/692/001 YELLO X O O GDR UP PELS 0,9MG/ML FLAC O N 5ML

0,20

ML

2,85700

0S01EC AG

V 105443

DO R ZO LAMIDE C F O O GDR UPP ELS 20MG/ML FLAC O N 5ML

0,30

ML

2,19630

YS01EDAG

V 109685//26592

XALAC O M O O GDR UP PELS FLAC O N 2,5ML

1,00

ML

9,47766

YS01EDC G

V 105541

DO R ZO LAMIDE/TIMO LO L AC TAVIS O O GDR 20/5MG/ML FL 5ML

1,00

ML

3,13380

YS01EDC G

V 105416

DO R ZO LAMIDE/TIMO LO L C F O O GDR 20/5MG/ML FL 5ML

1,00

ML

3,13380

YS01EDC G 0A02BC AO

V 105655 V 107343

DO R ZO LAMIDE/TIMO LO L MYLAN O O GDR 20/5MG/ML FL 5ML ESO MEP R AZO L C F C APSULE MSR 20MG

1,00 1,00

ML 3,13380 STUK 1,68111

0A02BC AO

V 107345

ESO MEP R AZO L C F C APSULE MSR 40MG

0,50

STUK 3,36221

0A02BC AO

V 106962

O MEP R AZO L AUR O BINDO C AP SULE MSR 10MG

2,00

STUK 1,00866

0A02BC AO 0A02BC AO

V 106963 V 106964

O MEP R AZO L AUR O BINDO C AP SULE MSR 20MG O MEP R AZO L AUR O BINDO C AP SULE MSR 40MG

1,00 0,50

STUK 1,68111 STUK 3,36221

0,46172

0A04AAAO

V 105989

O NDANSETR O N AUR O BINDO O R O DISP TABLET 4MG

4,00

STUK 5,81918

0A04AAAO

V 105990

O NDANSETR O N AUR O BINDO O R O DISP TABLET 8MG

2,00

STUK 9,69864

0A04AAAP

V 101235

O NDANSETR O N C LAR IS INJVLST 2MG/ML AMP UL

4,00

ML

1A06AC AO

V 109957//13963

METAMUC IL SKVR O R ANGE P O EDER 3,4G IN SAC HET

2,06

STUK 0,20039

0A07EC C O

V 107302

SALO FALK GR ANU-STIX GR ANULAAT MGA 3G IN SAC HET

0,50

STUK 3,75349

0A09AAAO

V 33166

C R EO N XTR A FO R TE C APSULE MSR (P ANC R EATINE 400MG)

1,50

STUK 1,61274

0B01ABAP

V 109929//12787

FR AGMIN 2500 INJVLST 12.500IE/ML W W SP 0,2ML

0,20

ML

8,89410

0B01ABAP

V 109930//12788

FR AGMIN 5000 INJVLST 25.000IE/ML W W SP 0,2ML

0,10

ML

17,78820

0B01ABAP 0B01ABAP

V 109947//12788 V 109706//11877

FR AGMIN 5000 INJVLST 25.000IE/ML W W SP 0,2ML FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,6ML

0,10 0,30

ML ML

17,78820 5,92940

0B01AC DO

V 106384

C LO P IDO GR EL AUR O BINDO TABLET FILMO MHULD 75MG

1,00

STUK 1,88043

1C 03AAAO

V 106654

HYDR O C HLO O R THIAZIDE SANDO Z TABLET 50MG

0,50

STUK 0,20692

1C 07AGAO

V 107593

C AR VEDILO L AUR O BINDO TABLET FILMO MHULD 3,125MG

12,00 STUK 0,12101

1C 07AGAO 1C 07AGAO

V 107594 V 107595

C AR VEDILO L AUR O BINDO TABLET FILMO MHULD 6,25MG C AR VEDILO L AUR O BINDO TABLET FILMO MHULD 12,5MG

6,00 3,00

STUK 0,10084 STUK 0,20168

1C 07AGAO

V 107596

C AR VEDILO L AUR O BINDO TABLET FILMO MHULD 25MG

1,50

STUK 0,40336

0C 09AAAO 0C 09AAAO

V 105776 V 105777

FO SINO P R ILNATR IUM AUR O BINDO TABLET 10MG FO SINO P R ILNATR IUM AUR O BINDO TABLET 20MG

1,50 0,75

STUK 0,38939 STUK 0,77877

0C 09AAAO

V 105834

P ER INDO PR IL TER T-BUTYLAMINE AUR O BINDO TABLET 2MG

2,00

STUK 0,35045

0C 09AAAO

V 105835

P ER INDO PR IL TER T-BUTYLAMINE AUR O BINDO TABLET 4MG

1,00

STUK 0,58408

0C 09AAAO 0C 09AAAO

V 105836 V 105268

P ER INDO PR IL TER T-BUTYLAMINE AUR O BINDO TABLET 8MG R AMIP R IL AUR O BINDO C APSULE 1,25MG

0,50 2,00

STUK 1,16816 STUK 0,35045

0C 09AAAO

V 105271

R AMIP R IL AUR O BINDO C APSULE 2,5MG

1,00

STUK 0,58408

0C 09AAAO

V 105272

R AMIP R IL AUR O BINDO C APSULE 5MG

0,50

STUK 1,16816

0C 09AAAO

V 105274

R AMIP R IL AUR O BINDO C APSULE 10MG

0,25

STUK 2,33631

0C 09C AAO

V 105815

LO SAR TAN KALIUM AUR O BINDO TABLET O MHULD 25MG

2,00

STUK 0,44652

0C 09C AAO

V 105818

LO SAR TAN KALIUM AUR O BINDO TABLET O MHULD 50MG

1,00

STUK 0,74420

0C 09C AAO 0C 09C AAO

V 105819 LO SAR TAN KALIUM AUR O BINDO TABLET O MHULD 100MG V EU/1/07/405/002 R ASILEZ TABLET FILMO MHULD 150MG

0,50 1,00

STUK 1,48840 STUK 0,74420

0C 09C AAO

V EU/1/07/405/012 R ASILEZ TABLET FILMO MHULD 300MG

0,50

STUK 1,48840

YC 09DAAO YC 09DAAO

V 109740//100453 VALSAR TAN/HC T FISHER TABL FILMO MHULD 320MG/12,5MG V 109738//100454 VALSAR TAN/HC T FISHER TABL FILMO MHULD 320MG/25MG

1,00 1,00

STUK 3,02853 STUK 3,08026

0D01BABO

V 31580

TER BINAFINE AC TAVIS TABLET 250MG

1,00

STUK 2,33152

0G02C BAO

V 109763//15375

DO STINEX TABLET 0,5MG

0,10

STUK 7,96341

0G03AABO

V 100827

ETHINYLESTR ADIO L/DR O SPIR ENO N 0,02MG/3MG BER LIPHAR M

0,86

STUK 0,11597

0G03AABO 0G03AABO

V 25414 V 109699//23827

ETHINYLESTR ADIO L/DR O SPIR BER LIPH TABL O MH 0,03/3MG YASMIN TABLET O MHULD

0,75 0,75

STUK 0,13253 STUK 0,13253

7,13683

0G03AC BO

V 109357//32303

NO R LEVO TABLET 1,5MG

1,00

STUK 5,32280

0G04BDBO

V 109760//22148

DETR USITO L TABLET O MHULD 1MG

4,00

STUK 0,24894

0G04BDBO

V 109754//29151

VESIC AR E TABLET FILMO MHULD 5MG

1,00

STUK 0,82981

0G04BDBO

V 109755//29151

VESIC AR E TABLET FILMO MHULD 5MG

1,00

STUK 0,82981

0G04BDBO

V 109753//29152

VESIC AR E TABLET FILMO MHULD 10MG

0,50

STUK 1,65963

0G04C AAO

V 103826

ALFUZO SINE HC L AUR O BINDO TABLET FILMO MHULD 2,5MG

3,00

STUK 0,32067

0H01BAAO

V 32001

DESMO P R ESSINE AC ETAAT P C H TABLET 0,2MG

2,00

STUK 1,57948

0J01DAAP

V 34535

C EFAZO LINE AUR O BINDO INJEC TIEP O EDER FLAC 1000MG

3,00

STUK 4,53780

0J01DAAP

V 34536

C EFAZO LINE AUR O BINDO INJEC TIEP O EDER FLAC 2000MG

1,50

STUK 9,07561

0J01DABP

V 33021

C EFO TAXIM AUR O BINDO INJEC TIEP O EDER FLAC O N 250MG

16,00 STUK 4,15664

0J01DABP

V 33022

C EFO TAXIM AUR O BINDO INJEC TIEP O EDER FLAC O N 500MG

8,00

STUK 5,19580

0J01DABP

V 33023

C EFO TAXIM AUR O BINDO INJEC TIEP O EDER FLAC O N 1000MG

4,00

STUK 10,39160

0J01DABP 0J01DABP

V 33024 V 32857

C EFO TAXIM AUR O BINDO INJEC TIEP O EDER FLAC O N 2000MG C EFTR IAXO N AUR O BINDO INJP DR FLAC O N 250MG

2,00 8,00

STUK 20,78320 STUK 5,19580

0J01DABP

V 32858

C EFTR IAXO N AUR O BINDO INJP DR FLAC O N 500MG

4,00

STUK 10,39160

0J01DABP

V 32859

C EFTR IAXO N AUR O BINDO INJP DR FLAC O N 1000MG

2,00

STUK 20,78320

0J01DABP

V 32860

C EFTR IAXO N AUR O BINDO INJP DR FLAC O N 2000MG

1,00

STUK 41,56640

0J01DHAP

V 109767//17864

MER O NEM INJEC TIEP O EDER FLAC O N 1000MG

2,00

STUK 36,63822

0J01GBAII

V EU/1/10/652/002 TO BI P O DHALER INHALP DR 28MG MET P O DHALER

4,00

STUK 11,27360

0J02AC AO

V 101649

FLUC O NAZO L AUR O BINDO C AP SULE 50MG

4,00

STUK 3,10703

0J02AC AO

V 101650

FLUC O NAZO L AUR O BINDO C AP SULE 150MG

1,33

STUK 9,32110

0J02AC AO 0J02AC AO

V 101651 V 105358

FLUC O NAZO L AUR O BINDO C AP SULE 200MG ITR AC O NAZO L P C H C APSULE 100MG

1,00 2,00

STUK 12,42813 STUK 6,21407

0J05ABC O

V 109722//26746

C O P EGUS TABLET FILMO MHULD 200MG

5,00

STUK 6,67057

0J05ABDO

V 109700//25992

VALC YTE TABLET FILMO MHULD 450MG

2,00

STUK 24,63379

0L02AEAD

V 104389

P LENAXIS INJP DR FLAC O N 100MG + SO LVENS 3ML

1,00

STUK 184,07590

0L02BGAO

V 109884//19123

AR IMIDEX TABLET FILMO MHULD 1MG

1,00

STUK 4,71931

0L02BGAO

V 102441

LETR O ZO L AC C O R D TABLET FILMO MHULD 2,5MG

1,00

STUK 4,71931

0L02BGAO

V 106401

LETR O ZO L C F TABLET FILMO MHULD 2,5MG

1,00

STUK 4,71931

0L02BGAO

V 105802

LETR O ZO L SUN TABLET FILMO MHULD 2,5MG

1,00

STUK 4,71931

0M03AXAP

V 109468//17379

BO TO X INJEC TIEP O EDER FLAC O N 100E

0,02

STUK 272,26810

0M04AAAO 0M04AAAO

V 104252 V 104257

ALLO P UR INO L PC H TABLET 100MG ALLO P UR INO L PC H TABLET 300MG

4,00 1,33

STUK 0,06025 STUK 0,18076

0M05BABO

V 103205

ALENDR O NINEZUUR AUR O BINDO TABLET 10MG

1,00

STUK 1,22521

0M05BABO 0M05BABO

V 103208 V 106807

ALENDR O NINEZUUR AUR O BINDO TABLET 70MG R ISEDR O NAATNATR IUM AUR O BINDO TABL FILMO MHULD 5MG

0,14 1,00

STUK 8,57645 STUK 1,22521

0M05BABO

V 106809

R ISEDR O NAATNATR IUM AUR O BINDO W EKELIJKS TB O MH 35MG 0,14

STUK 8,57645

0N01BBAP 0N01BBAP

V 102423 V 102425

BUP IVAC AINE HC L C LAR IS INJVLST 2,5MG/ML BUP IVAC AINE HC L C LAR IS INJVLST 5MG/ML

56,00 ML 28,00 ML

0,12071 0,24141

0N02ABC O

V EU/1/09/531/011 INSTANYL SINGLE DO SE NEUSSP R AY 50MC G

3,00

DO

6,04440

0N02ABC O 0N02ABC O

V EU/1/09/531/015 INSTANYL SINGLE DO SE NEUSSP R AY 100MC G V EU/1/09/531/019 INSTANYL SINGLE DO SE NEUSSP R AY 200MC G

1,50 0,75

DO DO

10,07400 20,14800

0N02C C BO

V 109964//19470

IMIGR AN NEUSSP R AY 20MG

1,00

STUK 10,43468

0N03AXC O 0N03AXC O

V 100396 V 100398

GABAP ENTINE AUR O BINDO C AP SULE 100MG GABAP ENTINE AUR O BINDO C AP SULE 300MG

18,00 STUK 0,43563 6,00 STUK 0,65344

0N03AXC O

V 100399

GABAP ENTINE AUR O BINDO C AP SULE 400MG

4,50

0N03AXEO 0N03AXEO

V 105862 V 105863

TO P IR AMAAT AUR O BINDO TABLET FILMO MHULD 25MG TO P IR AMAAT AUR O BINDO TABLET FILMO MHULD 50MG

12,00 STUK 0,39720 6,00 STUK 0,79440

0N03AXEO

V 105864

TO P IR AMAAT AUR O BINDO TABLET FILMO MHULD 100MG

3,00

STUK 1,58880

0N03AXEO

V 105865

TO P IR AMAAT AUR O BINDO TABLET FILMO MHULD 200MG

1,50

STUK 3,17760

0N03AXEO 0N03AXEO

V EU/1/11/681/003 TR O BALT 50 MG FILMO MHULDE TABLETTEN 168 STUKS V EU/1/11/681/006 TR O BALT 100 MG FILMO MHULDE TABLETTEN 168 STUKS

18,00 STUK 0,52960 9,00 STUK 0,52960

0N03AXEO

V EU/1/11/681/008 TR O BALT 200 MG FILMO MHULDE TABLETTEN 168 STUKS

4,50

STUK 1,05920

0N03AXEO

V EU/1/11/681/010 TR O BALT 300 MG FILMO MHULDE TABLETTEN 168 STUKS

3,00

STUK 1,58880

0N03AXEO 0N03AXEO

V EU/1/11/681/012 TR O BALT 400 MG FILMO MHULDE TABLETTEN 168 STUKS V EU/1/11/681/013 TR O BALT STAR TVER P AKKING (21TABL 50MG+42TABL 100MG)

2,25 0,14

STUK 2,11840 VER P 33,36477

0N03AXEO

V EU/1/11/681/001 TR O BALT TABLET FILMO MHULD 50MG

18,00 STUK 0,52960

0N03AXEO

V EU/1/11/681/002 TR O BALT TABLET FILMO MHULD 50MG

18,00 STUK 0,52960

0N03AXEO 0N03AXEO

V EU/1/11/681/004 TR O BALT TABLET FILMO MHULD 100MG V EU/1/11/681/005 TR O BALT TABLET FILMO MHULD 100MG

9,00 9,00

STUK 0,52960 STUK 0,52960

0N03AXEO

V EU/1/11/681/007 TR O BALT TABLET FILMO MHULD 200MG

4,50

STUK 1,05920

0N03AXEO

V EU/1/11/681/009 TR O BALT TABLET FILMO MHULD 300MG

3,00

STUK 1,58880

0N03AXEO

V EU/1/11/681/011 TR O BALT TABLET FILMO MHULD 400MG

2,25

STUK 2,11840

4N05AHAO

V 107197

O LANZAP INE BLUEFISH O R O DISP TABLET 10MG

1,00

STUK 3,96302

4N05AHAO

V 107198

O LANZAP INE BLUEFISH O R O DISP TABLET 15MG

0,67

STUK 5,94453

4N05AHAO 4N05AHAO

V 107199 V 107195

O LANZAP INE BLUEFISH O R O DISP TABLET 20MG O LANZAP INE BLUEFISH O R O DISP TABLET 5MG

0,50 2,00

STUK 7,92603 STUK 1,98151

4N05AHAO

V 102282

O LANZAP INE AC TAVIS TABLET FILMO MHULD 10MG

1,00

STUK 3,96302

4N05AHAO

V 102283

O LANZAP INE AC TAVIS TABLET FILMO MHULD 15MG

0,67

STUK 5,94453

4N05AHAO 4N05AHAO

V 102278 V 102284

O LANZAP INE AC TAVIS TABLET FILMO MHULD 2,5MG O LANZAP INE AC TAVIS TABLET FILMO MHULD 20MG

4,00 0,50

STUK 1,58521 STUK 7,92603

4N05AHAO

V 102280

O LANZAP INE AC TAVIS TABLET FILMO MHULD 5MG

2,00

STUK 1,98151

4N05AHAO

V 35015

O LANZAP INE NYZO L TABLET FILMO MHULD 10MG

1,00

STUK 3,96302

4N05AHAO 4N05AHAO

V 103398 V 35012

O LANZAP INE NYZO L TABLET FILMO MHULD 15MG O LANZAP INE NYZO L TABLET FILMO MHULD 2,5MG

0,67 4,00

STUK 5,94453 STUK 1,58521

4N05AHAO

V 103399

O LANZAP INE NYZO L TABLET FILMO MHULD 20MG

0,50

STUK 7,92603

4N05AHAO

V 35013

O LANZAP INE NYZO L TABLET FILMO MHULD 5MG

2,00

STUK 1,98151

0P 01BAAO

V 106659

A-C Q 100 C HLO R O Q UINE TABLET 100MG

2,50

STUK 0,30000;

STUK 0,87126

0R 01ADAN

V 109751//15821

R HINO C O R T TUR BUHALER INHPDR NASAAL 0,1MG/DO 200DO

2,00

DO

0,16850

0R 03AC C IDA

V 109752//31993

FO R ADIL AER O SO L C FKVR 12MC G/DO SP BS 100DO SES+INH

2,00

DO

0,46172

YR 03AC C IDA

V 109831//34610

BEC LO METASO N/FO R MO TER O L FISH AER 100/6MC G/DO 120DO 1,00

DO

0,40611

YR 03AKAIDC YR 03AKAIDC

V 110101//25887 V 110105//27690

SYMBIC O R T TUR BUHALER INHALP DR 200/6MC G/DO SYMBIC O R T TUR BUHALER INHALP DR 400/12MC G/DO 60DO

1,00 1,00

DO DO

0,48321 0,96642

0S01AABZ

V 109693//10225

TO BR EX O O GZALF TUBE 5G

0,28

GR AM 0,22624

0S01XAAG

V 110177//107234 LIP O SIC O O GGEL 2MG/G TUBE 10G

0,40

GR AM 0,39706

0A02BC AO V

109875//23211

P AR IET TABLET MSR 20MG

1,00

STUK 1,68111

0A02BC AO V

109879//23211

P AR IET TABLET MSR 20MG

1,00

STUK 1,68111

0A04AAAO V

105867

O NDANSETR O N AUR O BINDO TABLET FILMO MHULD 4MG

4,00

STUK 5,81918

0A04AAAO V

105868

O NDANSETR O N AUR O BINDO TABLET FILMO MHULD 8MG

2,00

STUK 9,69864

1A06ADAO V

108115

MAC R O GO L EN ELEKTR TR AMEDIC O NATUR EL P DR V DR SAC H

0,76

STUK 0,54285

1A06ADAO V

106666

MO VIC O LO N LIQ UID O R ANGE C O NC ENTR AAT VO O R DR ANK

19,05

ML

1A06ADAO V

109723//31960

MO VIC O LO N NATUR EL PO EDER VO O R DR ANK IN SAC HET

0,76

STUK 0,54285

0A07EC C R V

109851//10115

SALO FALK ZETP IL 250MG

6,00

STUK 0,60616

0A07EC C R V

109854//11836

SALO FALK ZETP IL 500MG

3,00

STUK 1,01027

0A10BXAP V

EU/1/11/696/002 BYDUR EO N 2 MG P DR +O P LMID V SUSP V INJ MVA 3X(4X1)

0,14

DO

33,67003

0A10BXAP V

EU/1/11/696/001 BYDUR EO N INJP DR MVA FLAC O N 2MG +SO LV 0,65ML

0,14

DO

33,67003

0B01ABAP V

110050//23794

FR AXO DI INJVLST 19000 IE/ML W W SP 0,6ML

0,15

ML

11,85880

0B01ABAP V

110049//23795

FR AXO DI INJVLST 19000 IE/ML W W SP 0,8ML

0,15

ML

11,85880

0B01ABAP V

110047//23796

FR AXO DI INJVLST 19000 IE/ML W W SP 1ML

0,15

ML

11,85880

0B03XAAP V

EU/1/01/185/106 AR ANESP 100 INJVLST 100MC G/ML FLAC O N 1ML

0,10

ML

245,72016

0B03XAAP V

EU/1/01/185/107 AR ANESP 100 INJVLST 100MC G/ML FLAC O N 1ML

0,10

ML

245,72016

0B03XAAP V

EU/1/01/185/108 AR ANESP 200 INJVLST 200MC G/ML FLAC O N 1ML

0,05

ML

491,44032

0B03XAAP V

EU/1/01/185/109 AR ANESP 200 INJVLST 200MC G/ML FLAC O N 1ML

0,05

ML

491,44032

0B03XAAP V

EU/1/01/185/100 AR ANESP 25 INJVLST 25MC G/ML FLAC O N 1ML

0,40

ML

61,43004

0B03XAAP V

EU/1/01/185/101 AR ANESP 25 INJVLST 25MC G/ML FLAC O N 1ML

0,40

ML

61,43004

0B03XAAP V

EU/1/01/185/110 AR ANESP 300 INJVLST 300MC G/ML FLAC O N 1ML

0,03

ML

737,16048

0B03XAAP V

EU/1/01/185/111 AR ANESP 300 INJVLST 300MC G/ML FLAC O N 1ML

0,03

ML

737,16048

0B03XAAP V

EU/1/01/185/102 AR ANESP 40 INJVLST 40MC G/ML FLAC O N 1ML

0,25

ML

98,28806

0B03XAAP V

EU/1/01/185/103 AR ANESP 40 INJVLST 40MC G/ML FLAC O N 1ML

0,25

ML

98,28806

0B03XAAP V

EU/1/01/185/104 AR ANESP 60 INJVLST 60MC G/ML FLAC O N 1ML

0,17

ML

147,43210

0B03XAAP V

EU/1/01/185/105 AR ANESP 60 INJVLST 60MC G/ML FLAC O N 1ML

0,17

ML

147,43210

0C 01C AAP V

108932

ANAP EN 500 INJVLST 1,7MG/ML W W SP 0,3ML

0,59

ML

251,99950

1C 01DAAO V

109748//17289

ISO SO R BIDEMO NO NITR AAT FISHER R ETAR D C AP SULE 25MG

2,40

STUK 0,22689

0C 09C AAO V

EU/1/07/405/021 R ASILEZ TABLET FILMO MHULD 150MG

1,00

STUK 0,74420

0C 09C AAO V

EU/1/07/405/031 R ASILEZ TABLET FILMO MHULD 300MG

0,50

STUK 1,48840

0C 09C AAO V

101567

VALSAR TAN AC TAVIS TABLET FILMO MHULD 160MG

0,50

STUK 1,48840

0C 09C AAO V

101566

VALSAR TAN AC TAVIS TABLET FILMO MHULD 80MG

1,00

STUK 0,74420

0,02166;

0C 10AAAO V

109888//21081

ATO R VASTATINE FISHER TABLET FILMO MHULD 10MG

2,00

STUK 0,83042

0C 10AAAO V

109889//21082

ATO R VASTATINE FISHER TABLET FILMO MHULD 20MG

1,00

STUK 1,38403

0C 10AAAO V

109890//21083

ATO R VASTATINE FISHER TABLET FILMO MHULD 40MG

0,50

STUK 2,76806

0C 10AAAO V

105244

ATO R VASTATINE TEVA TABLET FILMO MHULD 10MG

2,00

STUK 0,83042

0C 10AAAO V

105245

ATO R VASTATINE TEVA TABLET FILMO MHULD 20MG

1,00

STUK 1,38403

0C 10AAAO V

105246

ATO R VASTATINE TEVA TABLET FILMO MHULD 40MG

0,50

STUK 2,76806

0C 10AAAO V

109991//26872

C R ESTO R TABLET FILMO MHULD 10MG

1,00

STUK 1,38403

0D01BABO V

106096

TER BINAFINE AUR O BINDO TABLET 250MG

1,00

STUK 2,33152

0D07ADADL V

110216//33440

C LO BEX SHAMPO O 0,5MG/G

1,00

GR AM 0,18635

1G01AFBV V

110153//8934

C ANESTEN GYNO 3 VAGINAALTABLET 200MG + AP P LIC ATO R

3,00

STUK 1,96551

1G01AFBV V

109793//10634

GYNO DAKTAR IN-1 VAGINAALC AP SULE 1200MG

1,00

STUK 5,89654

1G03DABO V

109696//11473

UTR O GESTAN C AP SULE 100MG

3,00

STUK 0,09573

0G04C AAO V

106165

TAMSULO SINE HC L MYLAN R ETAR D TABLET MVA 0,4MG

1,00

STUK 0,96201

0L02AEADI V

105446

VANTASSE 50 MG, IMP LANTAAT

0,08

STUK 2208,73410

0L02AEADI V

109739//18562

ZO LADEX IMP LANTATIESTIFT 10,8MG IN W W SP

0,33

STUK 552,22770

0L02AEADI V

109855//18562

ZO LADEX IMP LANTATIESTIFT 10,8MG IN W W SP

0,33

STUK 552,22770

0L02BGAO V

110053//19123

AR IMIDEX TABLET FILMO MHULD 1MG

1,00

STUK 4,71931

0L03AADP V

EU/1/02/221/011 P EGASYS 135 INJVLST 270MC G/ML P EN 0,5ML

0,10

ML

288,43726

0L03AADP V

EU/1/02/221/012 P EGASYS 135MC G/0,5ML O PL.VO O R INJ.IN VO O R GEV. P EN

0,10

ML

288,43726

0L03AADP V

EU/1/02/221/013 P EGASYS 135MC G/O ,5ML O P L.VO O R INJ.IN VO O R GEV. P EN

0,10

ML

288,43726

0L03AADP V

EU/1/02/221/014 P EGASYS 180 INJVLST 360MC G/ML P EN 0,5ML

0,07

ML

384,58302

0L03AADP V

EU/1/02/221/015 P EGASYS 180MC G/0,5ML O PL.VO O R INJ.IN VO O R GEV. P EN

0,07

ML

384,58302

0L03AADP V

EU/1/02/221/016 P EGASYS 180MC G/0,5ML O PL.VO O R INJ.IN VO O R GEV. P EN

0,07

ML

384,58302

0M01AHBO V

110164//34279

AR C O XIA TABLET FILMO MHULD 30MG

2,00

STUK 0,67913

1M01AEAO V

101715

IBUP R O FEN P C H BR UISGR ANULAAT 600MG IN SAC HET

2,00

STUK 0,27832

0N02BEDO V

109093

P AR AC ETAMO L TEVA TABLET 1000MG

3,00

STUK 0,11300

4N05AXAO V

109698//34628

SER O Q UEL XR TABLET MVA 400MG

0,75

STUK 5,28402

0N06AAAO V

110094//3285

NO R TR ILEN TABLET 10MG

7,50

STUK 0,07666

0N06AAAO V

110092//11407

NO R TR ILEN TABLET 50MG

1,50

STUK 0,29485

0R 01ADAN V

110126//23837

R HINO C O R T NEVEL NEUSSP R AY 32MC G/DO 120DO

6,25

DO

0,07684

YR 03AKAIDC V 110163//25886

SYMBIC O R T TUR BUHALER INHALP DR 100/6MC G/DO 60DO

1,00

DO

0,39413

YR 03AKAIDC V 109878//25886

SYMBIC O R T TUR BUHALER INHALP DR 100/6MC G/DO 120DO

1,00

oO

0,39413

2R 06AEAO V

110193//17708

KESTINE TABLET 10MG

1,00

STUK 0,50499

2R 06AEAO V

34425

R UP AFIN TABLET 10MG

1,00

STUK 0,50499

0S01BABG V

109981//18658

MO NO FR EE DEXAMETHASO N O O GDR 1MG/ML MINIM 0,4ML

4,00

STUK 0,39116

0S01EXAG V

110091//21304

XALATAN O O GDR UPP ELS 50MC G/ML FLAC O N 2,5ML

0,20

ML

8,54016

YS01C AEG V

110034//14223

TO BR ADEX O O GDR UP P ELS FLAC O N 5ML

1,00

ML

1,15170

0V01AAAO V

109980//33788

GR AZAX LYO PHILISAAT V O R AAL GEBR UIK 75000 SQ -T

1,00

STUK 3,30000

0V01AAAO V

110195//33788

GR AZAX LYO PHILISAAT V O R AAL GEBR UIK 75000 SQ -T

1,00

STUK 3,30000

0A06ABAO V

110033//3843

DULC O LAX TABLET MSR 5MG

2,00

STUK 0,03276

0A07EC C O V

110161//33600

MEZAVANT TABLET MVA 1200MG

1,25

STUK 1,50140

0A12AAC O V

100050

O SVAR EN TABLET FILMO MHULD

4,60

STUK 0,09915

YB01AC C O V

107516

AXANUM C AP SULE 81MG/20MG

1,00

STUK 1,73359

0C 08C AAO V

109577

AMLO DIP INE AC C O R D TABLET 5MG

1,00

STUK 0,65450

0C 08C AAO V

109579

AMLO DIP INE AC C O R D TABLET 10MG

0,50

STUK 1,30901

0C 09AAAO V

32685

LISINO P R IL AUR O BINDO TABLET 30MG

0,33

STUK 1,75224

0C 09C AAO V

100041

LO SAR TAN KALIUM AC C O R D TABLET O MHULD 25MG

2,00

STUK 0,44652

0C 09C AAO V

EU/1/07/405/023 R ASILEZ TABLET FILMO MHULD 150MG

1,00

STUK 0,74420

YC 09BAAO V

104334

P ER INDO PR IL TER T-BUTYL/INDAP AMIDE GLEN T 2/0,625MG

1,00

STUK 0,31790

YC 09BAAO V

104335

P ER INDO PR IL TER T-BUTYL/INDAP AMIDE GLEN T 4/1,25MG

1,00

STUK 0,63581

YC 09BBBO V

110096//100140 P ER INDO PR IL AR G/AMLO DIP INE FISHER TABL FO 5/10MG

1,00

STUK 2,03910

YC 09BBBO V

110097//100141 P ER INDO PR IL AR G/AMLO DIP INE FISHER TABL FO 10/ 5MG

1,00

STUK 2,11470

YC 09BBBO V

110098//100142 P ER INDO PR IL AR G/AMLO DIP INE FISHER TABL FO 10/10MG

1,00

STUK 2,76920

YC 09DAAO V

105983

KALIUMLO SAR TAN/HC T AUR O BINDO TAB FILMO M 50/12,5MG

1,00

STUK 0,79593

YC 09DAAO V

105984

KALIUMLO SAR TAN/HC T AUR O BINDO TAB FILMO M 100/12,5MG 1,00

STUK 1,54013

YC 09DAAO V

105985

KALIUMLO SAR TAN/HC T AUR O BINDO TAB FILMO M 100/25MG

1,00

STUK 1,59186

YC 09DAAO V

106510

KALIUMLO SAR TAN/HC T SANDO Z TABL FILMO MH 100/12,5MG

1,00

STUK 1,54013

YC 09DAAO V

110192//22365

VALSAR TAN/HC T FISHER TABL FILMO MHULD 80MG/12,5MG

1,00

STUK 0,79593

0C 10AAAO V

109900//21082

ATO R VASTATINE FISHER TABLET FILMO MHULD 20MG

1,00

STUK 1,38403

0C 10AAAO V

109901//21083

ATO R VASTATINE FISHER TABLET FILMO MHULD 40MG

0,50

STUK 2,76806

0C 10AAAO V

107607

LIP ITO R KAUW TABLET 10MG

2,00

STUK 0,83042

0C 10AAAO V

107608

LIP ITO R KAUW TABLET 20MG

1,00

STUK 1,38403

0C 10AAAO V

110085//30823

R O SUVASTATINE FISHER TABLET FILMO MHULD 5MG

2,00

STUK 0,83042

0C 10AAAO V

110088//26872

R O SUVASTATINE FISHER TABLET FILMO MHULD 10MG

1,00

STUK 1,38403

0C 10AAAO V

110086//26873

R O SUVASTATINE FISHER TABLET FILMO MHULD 20MG

0,50

STUK 2,76806

3D07ADADC V 110229//6932

DER MO VATE HYDR O FIELE C R EME 0,5MG/G

1,00

GR AM 0,16599

0G03AABO V

ETHINYLESTR ADIO L/DR O SPIR ENO N SDZ TABL O MH 0,03/3MG

0,75

STUK 0,13253

107873

0G03BABO V

110360//30653

TESTIM GEL 10MG/G TUBE 5G

1,00

STUK 1,81512

0G03BABO V

110361//33424

TO STR AN GEL 20MG/G

2,50

GR AM 0,72605

0G04C AAO V

103584

TAMSULO SINE HC L SANDO Z R ETAR D TABLET MVA 0,4MG

1,00

STUK 0,96201

0G04C AAO V

110187//23923

XATR AL XR TABLET MVA 10MG

0,75

STUK 1,28268

0H01C BBP V

108942

O C TR EO TIDE SUN INJVLST 0,05MG/ML AMP UL 1ML

14,00

ML

0H01C BBP V

108943

O C TR EO TIDE SUN INJVLST 0,1MG/ML AMPUL 1ML

7,00

ML

10,85034

0H01C BBP V

108945

O C TR EO TIDE SUN INJVLST 0,2MG/ML FLAC O N 5ML

3,50

ML

21,70068

0H01C BBP V

108944

O C TR EO TIDE SUN INJVLST 0,5MG/ML AMPUL 1ML

1,40

ML

54,25170

0H02ABAO V

109366//18765

ENTO C O R T C AP SULE MGA 3MG

3,00

STUK 1,02100

0J01MAAO V

103392

LEVO FLO XAC INE JUBILANT TABLET FILMO MHULD 250MG

1,00

STUK 3,05666

0J01MAAO V

103401

LEVO FLO XAC INE JUBILANT TABLET FILMO MHULD 500MG

0,50

STUK 6,11332

0J02AC AP V

100710

FLUC O NAZO L B.BR AUN INFVLST 2MG/ML FLAC O N

100,00 ML

0,41657

0J07BC AP V

109963//17316

ENGER IX-B VAC C IN 20MC G/ML W W SP 1ML

1,00

29,51840

0L01AXAO V

EU/1/11/697/001 TEMO ZO LO MIDE SUN C AP SULE 5MG

13,40

STUK 8,65384

0L01AXAO V

EU/1/11/697/003 TEMO ZO LO MIDE SUN C AP SULE 20MG

3,35

STUK 21,63461

0L01AXAO V

EU/1/11/697/005 TEMO ZO LO MIDE SUN C AP SULE 100MG

0,67

STUK 108,17304

0L01AXAO V

EU/1/11/697/007 TEMO ZO LO MIDE SUN C AP SULE 140MG

0,48

STUK 151,44226

0L01AXAO V

EU/1/11/697/009 TEMO ZO LO MIDE SUN C AP SULE 180MG

0,37

STUK 194,71147

0L01AXAO V

EU/1/11/697/011 TEMO ZO LO MIDE SUN C AP SULE 250MG

0,27

STUK 270,43260

0L01BAC P V

110154//100943 METO JEC T INJVLST 25MG/0,5ML (50MG/ML) W W SP

0,05

ML

0L02AEADI V

109619//30197

LUC R IN PDS DEPO T INJPDR W W SP 3,75MG + SO LVENS 1ML

1,00

STUK 184,07590

0L02AEADI V

109620//30198

LUC R IN PDS DEPO T INJPDR W W SP 11,25MG + SO LVENS 1ML

0,33

STUK 552,22770

0L02BBAO V

103196

BIC ALUTAMIDE SUN TABLET FILMO MHULD 50MG

1,00

STUK 5,44536

0M05BABP V

EU/1/01/176/007 ZO META INFVLST 0,04MG/ML FLAC O N 100ML

1,00

STUK 297,27600

ML

8,68027

62,96000

0N02BEDO V

110446//26161

P ANADO L AR TR O SE TABLET O MHULD 1000MG

3,00

STUK 0,11300

0N03AXDO V

108489

LEVETIR AC ETAM SANDO Z TABLET FILMO MHULD 250MG

6,00

STUK 0,95330

0N03AXDO V

108491

LEVETIR AC ETAM SANDO Z TABLET FILMO MHULD 500MG

3,00

STUK 1,19163

0N03AXDO V

108493

LEVETIR AC ETAM SANDO Z TABLET FILMO MHULD 1000MG

1,50

STUK 2,38325

0N03AXDO V

EU/1/11/701/004 LEVETIR AC ETAM TEVA TABLET FILMO MHULD 250MG

6,00

STUK 0,95330

0N03AXDO V

EU/1/11/701/011 LEVETIR AC ETAM TEVA TABLET FILMO MHULD 500MG

3,00

STUK 1,19163

0N03AXDO V

EU/1/11/701/025 LEVETIR AC ETAM TEVA TABLET FILMO MHULD 1000MG

1,50

STUK 2,38325

0N04BC AO V

101918

GLEP AR K TABLET 0,25MG (0,18MG BASE)

10,00

STUK 0,39152

0N04BC AO V

101919

GLEP AR K TABLET 0,5MG (0,35MG BASE)

5,00

STUK 0,78304

0N04BXAO V

EU/1/98/082/001 C O MTESS TABLET FILMO MHULD 200MG

5,00

STUK 0,87973

0N04BXAO V

EU/1/98/082/003 C O MTESS TABLET FILMO MHULD 200MG

5,00

STUK 0,87973

4N05AHAO V

102293

O LANZAP INE C F TABLET FILMO MHULD 5MG

2,00

STUK 1,98151

4N05AHAO V

102295

O LANZAP INE C F TABLET FILMO MHULD 10MG

1,00

STUK 3,96302

4N05AHAO V

102296

O LANZAP INE C F TABLET FILMO MHULD 15MG

0,67

STUK 5,94453

4N05AHAO V

102297

O LANZAP INE C F TABLET FILMO MHULD 20MG

0,50

STUK 7,92603

4N05AHAO V

EU/1/09/588/001 O LANZAP INE GLENMAR K SMELTTABLET 5MG

2,00

STUK 1,98151

4N05AHAO V

EU/1/09/588/004 O LANZAP INE GLENMAR K SMELTTABLET 10MG

1,00

STUK 3,96302

4N05AHAO V

EU/1/09/588/007 O LANZAP INE GLENMAR K SMELTTABLET 15MG

0,67

STUK 5,94453

4N05AHAO V

EU/1/09/588/010 O LANZAP INE GLENMAR K SMELTTABLET 20MG

0,50

STUK 7,92603

4N05AHAO V

EU/1/09/587/004 O LANZAP INE GLENMAR K TABLET 5MG

2,00

STUK 1,98151

4N05AHAO V

EU/1/09/587/010 O LANZAP INE GLENMAR K TABLET 10MG

1,00

STUK 3,96302

4N05AHAO V

EU/1/09/587/013 O LANZAP INE GLENMAR K TABLET 15MG

0,67

STUK 5,94453

4N05AHAO V

EU/1/09/587/016 O LANZAP INE GLENMAR K TABLET 20MG

0,50

STUK 7,92603

4N05AHAO V

EU/1/08/475/001 O LANZAP INE MYLAN TABLET FILMO MHULD 2,5MG

4,00

STUK 1,58521

4N05AHAO V

EU/1/08/475/006 O LANZAP INE MYLAN TABLET FILMO MHULD 2,5MG

4,00

STUK 1,58521

4N05AHAO V

EU/1/08/475/007 O LANZAP INE MYLAN TABLET FILMO MHULD 5MG

2,00

STUK 1,98151

4N05AHAO V

EU/1/08/475/012 O LANZAP INE MYLAN TABLET FILMO MHULD 5MG

2,00

STUK 1,98151

4N05AHAO V

EU/1/08/475/019 O LANZAP INE MYLAN TABLET FILMO MHULD 10MG

1,00

STUK 3,96302

4N05AHAO V

EU/1/08/475/024 O LANZAP INE MYLAN TABLET FILMO MHULD 10MG

1,00

STUK 3,96302

4N05AHAO V

EU/1/08/475/025 O LANZAP INE MYLAN TABLET FILMO MHULD 15MG

0,67

STUK 5,94453

4N05AHAO V

EU/1/08/475/030 O LANZAP INE MYLAN TABLET FILMO MHULD 20MG

0,50

STUK 7,92603

4N05AHAO V

102853

O LANZAP INE R ANBAXY O R O DISP TABLET 5MG

2,00

STUK 1,98151

4N05AHAO V

102854

O LANZAP INE R ANBAXY O R O DISP TABLET 10MG

1,00

STUK 3,96302

4N05AHAO V

102843

O LANZAP INE R ANBAXY TABLET 2,5MG

4,00

STUK 1,58521

4N05AHAO V

102845

O LANZAP INE R ANBAXY TABLET 5MG

2,00

STUK 1,98151

4N05AHAO V

102850

O LANZAP INE R ANBAXY TABLET 10MG

1,00

STUK 3,96302

4N05AHAO V

107681

O LANZAP INE SANDO Z O R O DISP TABLET 5MG

2,00

STUK 1,98151

4N05AHAO V

107682

O LANZAP INE SANDO Z O R O DISP TABLET 10MG

1,00

STUK 3,96302

4N05AHAO V

107683

O LANZAP INE SANDO Z O R O DISP TABLET 15MG

0,67

STUK 5,94453

4N05AHAO V

107684

O LANZAP INE SANDO Z O R O DISP TABLET 20MG

0,50

STUK 7,92603

4N05AHAO V

34684

O LANZAP INE SANDO Z TABLET FILMO MHULD 2,5MG

4,00

STUK 1,58521

4N05AHAO V

34685

O LANZAP INE SANDO Z TABLET FILMO MHULD 5MG

2,00

STUK 1,98151

4N05AHAO V

34687

O LANZAP INE SANDO Z TABLET FILMO MHULD 10MG

1,00

STUK 3,96302

4N05AHAO V

34688

O LANZAP INE SANDO Z TABLET FILMO MHULD 15MG

0,67

STUK 5,94453

4N05AHAO V

34689

O LANZAP INE SANDO Z TABLET FILMO MHULD 20MG

0,50

STUK 7,92603

4N05AHAO V

102517

O LANZAP INE SUN O R O DISP TABLET 5MG

2,00

STUK 1,98151

4N05AHAO V

102518

O LANZAP INE SUN O R O DISP TABLET 10MG

1,00

STUK 3,96302

4N05AHAO V

102519

O LANZAP INE SUN O R O DISP TABLET 15MG

0,67

STUK 5,94453

4N05AHAO V

102520

O LANZAP INE SUN O R O DISP TABLET 20MG

0,50

STUK 7,92603

4N05AHAO V

102521

O LANZAP INE SUN TABLET 2,5MG

4,00

STUK 1,58521

4N05AHAO V

102522

O LANZAP INE SUN TABLET 5MG

2,00

STUK 1,98151

4N05AHAO V

102524

O LANZAP INE SUN TABLET 10MG

1,00

STUK 3,96302

4N05AHAO V

102525

O LANZAP INE SUN TABLET 15MG

0,67

STUK 5,94453

4N05AHAO V

102526

O LANZAP INE SUN TABLET 20MG

0,50

STUK 7,92603

4N05AHAO V

EU/1/07/427/002 O LANZAP INE TEVA TABLET FILMO MHULD 2,5MG

4,00

STUK 1,58521

4N05AHAO V

EU/1/07/427/005 O LANZAP INE TEVA TABLET FILMO MHULD 5MG

2,00

STUK 1,98151

4N05AHAO V

EU/1/07/427/013 O LANZAP INE TEVA TABLET FILMO MHULD 10MG

1,00

STUK 3,96302

4N05AHAO V

EU/1/07/427/017 O LANZAP INE TEVA TABLET FILMO MHULD 15MG

0,67

STUK 5,94453

4N05AHAO V

EU/1/07/427/021 O LANZAP INE TEVA TABLET FILMO MHULD 20MG

0,50

STUK 7,92603

0N06AAAO V

110132

AMITR IP TYLINE HC L MYLAN TABLET 10MG

7,50

STUK 0,07666

0N06AAAO V

110133

AMITR IP TYLINE HC L MYLAN TABLET 25MG

3,00

STUK 0,14743

0N06AAAO V

110150

AMITR IP TYLINE HC L TEVA TABLET 25MG

3,00

STUK 0,14743

2N06AAAO V

105061

VENLAFAXINE SUN TABLET MVA 37,5MG

2,67

STUK 0,47987

2N06AAAO V

105065

VENLAFAXINE SUN TABLET MVA 75MG

1,33

STUK 0,79979

2N06AAAO V

105066

VENLAFAXINE SUN TABLET MVA 150MG

0,67

STUK 1,59958

0R 03AC C IDC V EU/1/09/593/001 O NBR EZ BR EEZHALER INHALPDR 150MC G MET BR EEZHALER

1,00

STUK 1,22022

0R 03AC C IDC V EU/1/09/593/006 O NBR EZ BR EEZHALER INHALPDR 300MC G MET BR EEZHALER

0,50

STUK 2,44043

YR 03AC C IDC V 110294//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00

DO

0,90703

YR 03AC C IDC V 110296//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00

DO

1,20396

0S01BC AG V

INDO C O LLYR E O O GDR UP P ELS 1MG/ML FLAC O N 5ML

0,40

ML

1,42850

110463//16363

0A02BC AO

V

108868

ESO MEP R AZO L MYLAN C AP SULE MSR 20MG

1,00 STUK

1,68111

0A02BC AO

V

108869

ESO MEP R AZO L MYLAN C AP SULE MSR 40MG

0,50 STUK

3,36221

0A02BC AO

V

107233

ESO MEP R AZO L R ANBAXY TABLET MSR 20MG

1,00 STUK

1,68111

0A02BC AO

V

107235

ESO MEP R AZO L R ANBAXY TABLET MSR 40MG

0,50 STUK

3,36221

0A02BC AO

V

31875

O MO LIN C AP SULE MSR 10MG

2,00 STUK

1,00866

0A02BC AO

V

31876

O MO LIN C AP SULE MSR 20MG

1,00 STUK

1,68111

0A02BC AO

V

31877

O MO LIN C AP SULE MSR 40MG

0,50 STUK

3,36221

0A04AAAP

V

100089

GR ANISETR O N HAMELN INFVLST C O NC 1MG/ML AMP UL

3,00 ML

9,51577

0A04AAAP

V

34955

O NDANSETR O N HAMELN INJVLST 2MG/ML AMP UL

4,00 ML

7,13683

0A06ADBO

V

110162//105789

MO VIPR EP O R ANGE P O EDER VO O R DR ANK IN SAC HET A+B

4,00 STUK

4,43003

0A06ADBO

V

110155//34072

MO VIPR EP PO EDER VO O R DR ANK IN SAC HET A+B

4,00 STUK

4,43003

0A06ADBO

V

110394//106616

P IC O P R EP P O EDER VO O R DR ANK SAC HET16,1G

2,00 STUK

8,86005

1A06ADAO

V

105943

MAC R O GO L EN ELEC TR TEVA P O EDER V DR ANK IN SAC HET

0,76 STUK

0,54285

1A06ADAO

V

110303//19006

MO VIC O LO N P O EDER VO O R DR ANK IN SAC HET

0,76 STUK

0,54285

0A07DAAO

V

110433//6945

IMO DIUM C AP SULE 2MG

5,00 STUK

0,23143

0A07EC C O

V

110188//33600

MESALAZINE FISHER TABLET MVA1200MG

1,25 STUK

1,50140

0A07EC C O

V

110103//33600

MEZAVANT TABLET MVA1200MG

1,25 STUK

1,50140

0A10BBAO

V

33879

GLIMEPIR IDE AC TAVIS TABLET1MG

2,00 STUK

0,16626

0A10BBAO

V

33880

GLIMEPIR IDE AC TAVIS TABLET 2MG

1,00 STUK

0,27711

0A10BBAO

V

33881

GLIMEPIR IDE AC TAVIS TABLET 3MG

0,67 STUK

0,41566

0A10BBAO

V

33882

GLIMEPIR IDE AC TAVIS TABLET 4MG

0,50 STUK

0,55421

0B01ABAP

V

110160//13068

C LEXANE INJVLST100MG/ML W W SP 0,8ML

0,20 ML

8,89410

0B01ABAP

V

110460//12787

FR AGMIN 2500 INJVLST12.500IE/ML W W SP 0,2ML

0,20 ML

8,89410

0B01ABAP

V

110453//12788

FR AGMIN 5000 INJVLST 25.000IE/ML W W SP 0,2ML

0,10 ML

17,78820

0B01AXBO

V

EU/1/11/691/001

ELIQ UIS 2,5 MG FILMO MHULDE TABLETTEN10 STUKS

4.00 STUK

1,86136

0B01AXBO

V

EU/1/11/691/004

ELIQ UIS 2,5 MG FILMO MHULDE TABLETTEN 60X1 STUK

4,00 STUK

1,86136

0C 01BC BO

V

110393//27134

TAMBO C O R C R C AP SULE MGA 200MG

1,00 STUK

1,03704

0C 09C AAO

V

33626

LO SANO X TABLET FILMO MHULD100MG

0,50 STUK

1,48840

0C 09C AAO

V

103736

VALSAR TAN C F TABLET FILMO MHULD 80MG

1,00 STUK

0,74420

0C 09C AAO

V

103737

VALSAR TAN C F TABLET FILMO MHULD160MG

0,50 STUK

1,48840

0C 09C AAO

V

103738

VALSAR TAN C F TABLET FILMO MHULD 320MG

0,25 STUK

2,97680

0C 09C AAO

V

107602

VALSAR TAN MYLAN TABLET FILMO MHULD 80MG

1,00 STUK

0,74420

0C 09C AAO

V

107603

VALSAR TAN MYLAN TABLET FILMO MHULD160MG

0,50 STUK

1,48840

0C 09C AAO

V

107604

VALSAR TAN MYLAN TABLET FILMO MHULD 320MG

0,25 STUK

2,97680

0C 09C AAO

V

102756

VALSAR TAN P C H TABLET FILMO MHULD 40MG

2,00 STUK

0,44652

0C 09C AAO

V

102762

VALSAR TAN P C H TABLET FILMO MHULD 80MG

1,00 STUK

0,74420

0C 09C AAO

V

102764

VALSAR TAN P C H TABLET FILMO MHULD160MG

0,50 STUK

1,48840

0C 09C AAO

V

102765

VALSAR TAN P C H TABLET FILMO MHULD 320MG

0,25 STUK

2,97680

0C 09C AAO

V

101105

VALSAR TAN R P TABLET FILMO MHULD 40MG

2,00 STUK

0,44652

0C 09C AAO

V

101108

VALSAR TAN R P TABLET FILMO MHULD 80MG

1,00 STUK

0,74420

0C 09C AAO

V

101109

VALSAR TAN R P TABLET FILMO MHULD160MG

0,50 STUK

1,48840

0C 09C AAO

V

105936

VALSAR TAN R P TABLET FILMO MHULD 320MG

0,25 STUK

2,97680

YC 09DAAO

V

34727

KALIUMLO SAR TAN/HC T LIC O NSA TABL FILMO MH 50/12,5MG

1,00 STUK

0,79593

YC 09DAAO

V

34728

KALIUMLO SAR TAN/HC T LIC O NSA TABL FILMO MH100/25MG

1,00 STUK

1,59186

YC 09DAAO

V

110301//29491

VALSAR TAN/HC T FISHER TABL FILMO MHULD160MG/12,5MG

1,00 STUK

1,54013

YC 09DAAO

V

110324//31122

VALSAR TAN/HC T FISHER TABL FILMO MHULD160MG/25MG

1,00 STUK

1,59186

YC 09DAAO

V

105289

VALSAR TAN/HC T MYLAN TABL FILMO MHULD 80MG/12,5MG

1,00 STUK

0,79593

YC 09DAAO

V

105290

VALSAR TAN/HC T MYLAN TABL FILMO MHULD160MG/12,5MG

1,00 STUK

1,54013

YC 09DAAO

V

105291

VALSAR TAN/HC T MYLAN TABL FILMO MHULD160MG/25MG

1,00 STUK

1,59186

YC 09XAAO

V

EU/1/08/491/013

R ASILEZ HC T TABLET FILMO MHULD150/12,5MG

1,00 STUK

0,79593

0C 10AAAO

V

103627

P R AVASTATINENATR IUM MYLAN TABLET10MG

3,00 STUK

0,55361

0C 10AAAO

V

103632

P R AVASTATINENATR IUM MYLAN TABLET 20MG

1,50 STUK

0,92269

0C 10AAAO

V

103633

P R AVASTATINENATR IUM MYLAN TABLET 40MG

0,75 STUK

1,84537

0C 10AAAO

V

106528

P R AVASTATINENATR IUM R P TABLET 10MG

3,00 STUK

0,55361

0C 10AAAO

V

106529

P R AVASTATINENATR IUM R P TABLET 20MG

1,50 STUK

0,92269

0C 10AAAO

V

106530

P R AVASTATINENATR IUM R P TABLET 40MG

0,75 STUK

1,84537

0C 10AC AO

V

110482//6761

Q UESTR AN P O EDER 4G IN SAC HET

3,50 STUK

0,49172

0D10ADADC

V

110300//32496

DIFFER IN GEL1MG/G

1,00 GR AM

0,23211

0D10AFBDL

V

110434//9728

DALAC IN T LO TIO N10MG/ML

1,00 ML

0,19528

1G01AFBV

V

110217//10634

GYNO DAKTAR IN-1 VAGINAALC AP SULE1200MG

1,00 STUK

5,89654

0G03AABO

V

102228

ETHINYLESTR ADIO L/LEVO NO R G W EC TAB O MH 0,02/0,1MG

0,75 STUK

0,13253

0G03HBAO

V

29728

ETHINYLESTR ADIO LUM/C YPR O TER O N TABL O MH0,035MG/2MG

0,75 STUK

0,26363

0G04BDBO

V

109993//22149

DETR USITO L TABLET O MHULD 2MG

2,00 STUK

0,41491

YG04C AAO

V

109962//104130

C O MBO DAR T C AP SULE0,5/0,4MG

1,00 STUK

2,08572

0J01C ADP

V

106886

AMO XIC ILLINE AUR O BINDO INFPDR FLAC O N 2000MG

0,56 STUK

7,31132

0J01C ADP

V

106883

AMO XIC ILLINE AUR O BINDO INJP DR FLAC O N 250MG

4,50 STUK

0,91392

0J01C ADP

V

106884

AMO XIC ILLINE AUR O BINDO INJP DR FLAC O N 500MG

2,25 STUK

1,82783

0J01C ADP

V

106885

AMO XIC ILLINE AUR O BINDO INJP DR FLAC O N1000MG

1,13 STUK

3,65566

O MHULD 250MG 0J01FAAO

V

106460

AZITR O MYC INE JUBILANT TABLET O MHULD 500MG

0,60 STUK

4,05052

0J01XAAP

V

107976

VANC O MYC INE FR ESENIUS KABI INFUSIEP O EDER FL 500MG

2000,00 MG

0,02389

0J01XAAP

V

107977

VANC O MYC INE FR ESENIUS KABI INFUSIEP O EDER FL1000MG

2000,00 MG

0,02389

0J02AC AO

V

107783

ITR AC O NAZO L SANDO Z C AP SULE100MG

2,00 STUK

6,21407

0J05ABC O

V

EU/1/10/634/001

R IBAVIR INE MYLAN C AP SULE 200MG

5,00 STUK

6,67057

0L02BGAO

V

107799

EXEMESTAAN P H&T TABLET FILMO MHULD 25MG

1,00 STUK

4,71931

0L04AADO

V

110288//22236

P R O GR AFT C AP SULE0,5MG

10,00 STUK

1,70955

0L04AADO

V

110289//18107

P R O GR AFT C AP SULE1MG

5,00 STUK

2,84925

YM01AEAO

V

110484//106235

VIMO VO TABLET MGA 500/20MG

1,00 STUK

2,23775

0M05BAAO

V

106743

R ISEDR O NAATNATR IUM JUBILANT TABL FILMO MHULD 30MG

1,00 STUK

8,19588

0M05BABO

V

106742

R ISEDR O NAATNATR IUM JUBILANT TABL FILMO MHULD 5MG

1,00 STUK

1,22521

0M05BABO

V

106744

R ISEDR O NAATNATR IUM JUBILANT W EKELIJKS TB O MH 35MG

0,14 STUK

8,57645

0N02ABADP

K

109226

FENTANYL MATR IX AP O TEX P LEISTER 12MC G/UUR

1,33 STUK

5,69800

0N02ABADP

V

109228

FENTANYL MATR IX AP O TEX P LEISTER 25MC G/UUR

0,67 STUK

5,39635

0N02ABADP

V

109229

FENTANYL MATR IX AP O TEX P LEISTER 50MC G/UUR

0,33 STUK

10,79271

0N02ABADP

V

109230

FENTANYL MATR IX AP O TEX P LEISTER 75MC G/UUR

0,22 STUK

16,18906

0N02ABADP

V

109231

FENTANYL MATR IX AP O TEX P LEISTER 100MC G/UUR

0,17 STUK

21,58541

0N02C C AO

V

110335//29413

SUMATR IP TAN FISHER DISP ER GEER BAR E TABLET 50MG

1,00 STUK

6,21227

0N03AXC O

V

108588

GABAP ENTINE SANDO Z TABLET FILMO MHULD 800MG

2,25 STUK

1,74252

0N03AXDO

V

EU/1/11/713/002

LEVETIR AC ETAM AC TAVIS TABLET FILMO MHULD 250MG

6,00 STUK

0,95330

0N03AXDO

V

EU/1/11/713/012

LEVETIR AC ETAM AC TAVIS TABLET FILMO MHULD 500MG

3,00 STUK

1,19163

0N03AXDO

V

EU/1/11/713/032

LEVETIR AC ETAM AC TAVIS TABLET

1,50 STUK

2,38325

0N03AXDO

V

108582

LEVETIR AC ETAM AUR O BINDO TABLET FILMO MHULD 250MG

6,00 STUK

0,95330

0N03AXDO

V

108583

LEVETIR AC ETAM AUR O BINDO TABLET FILMO MHULD 500MG

3,00 STUK

1,19163

0N03AXDO

V

108585

LEVETIR AC ETAM AUR O BINDO TABLET FILMO MHULD1000MG

1,50 STUK

2,38325

0N04BC AO

V

EU/1/11/728/002

P R AMIP EXO L AC C O R D TABLET 0,125MG (0,088MG BASE)

20,00 STUK

0,46983

0N04BC AO

V

EU/1/11/728/004

P R AMIP EXO L AC C O R D TABLET 0,25MG (0,18MG BASE)

10,00 STUK

0,39152

0N04BC AO

V

EU/1/11/728/006

P R AMIP EXO L AC C O R D TABLET 0,5MG (0,35MG BASE)

5,00 STUK

0,78304

0N04BC AO

V

EU/1/11/728/008

P R AMIP EXO L AC C O R D TABLET 1MG (0,7MG BASE)

2,50 STUK

1,56609

0N04BC AO

V

35169

R O P INIR O L AC TAVIS TABLET FILMO MHULD 5MG

1,20 STUK

3,26268

0N04BC AO

V

107154

R O P INIR O L JUBILANT TABLET FILMO MHULD 0,25MG

24,00 STUK

0,39152

0N04BC AO

V

107166

R O P INIR O L JUBILANT TABLET FILMO MHULD 0,5MG

12,00 STUK

0,32627

0N04BC AO

V

107167

R O P INIR O L JUBILANT TABLET FILMO MHULD 1MG

6,00 STUK

0,65254

0N04BC AO

V

107168

R O P INIR O L JUBILANT TABLET FILMO MHULD 2MG

3,00 STUK

1,30507

0N04BC AO

V

106222

R O P INIR O L TEVA R ETAR D TABLET MGA 2MG

3,00 STUK

1,56609

0N04BC AO

V

106223

R O P INIR O L TEVA R ETAR D TABLET MGA 4MG

1,50 STUK

2,61014

0N04BC AO

V

106224

R O P INIR O L TEVA R ETAR D TABLET MGA 8MG

0,75 STUK

5,22029

4N05AHAO

V

104371

O LANZAP INE JUBILANT TABLET FILMO MHULD 2,5MG

4,00 STUK

1,58521

4N05AHAO

V

104372

O LANZAP INE JUBILANT TABLET FILMO MHULD 5MG

2,00 STUK

1,98151

4N05AHAO

V

104376

O LANZAP INE JUBILANT TABLET FILMO MHULD 10MG

1,00 STUK

3,96302

4N05AHAO

V

104374

O LANZAP INE JUBILANT TABLET FILMO MHULD 15MG

0,67 STUK

5,94453

4N05AHAO

V

104375

O LANZAP INE JUBILANT TABLET FILMO MHULD 20MG

0,50 STUK

7,92603

0N06AAAO

V

110148

AMITR IP TYLINE HC L TEVA TABLET 10MG

7,50 STUK

0,07666

2N06BAAO

V

109332//33668

W ELLBUTR IN XR TABLET MGA 150MG

2,00 STUK

0,63983

2N06BAAO

V

110552//33669

W ELLBUTR IN XR TABLET MGA 300MG

1,00 STUK

1,06638

0N07AAAO

V

107575

GALANTAMINE AC TAVIS R ETAR D C AP SULE MVA 8MG

2,00 STUK

2,38235

0N07AAAO

V

107576

GALANTAMINE AC TAVIS R ETAR D C AP SULE MVA 16MG

1,00 STUK

4,76470

0N07AAAO

V

107577

GALANTAMINE AC TAVIS R ETAR D C AP SULE MVA 24MG

0,67 STUK

7,14704

0N07AAAO

V

110358//31373

R EMINYL R ETAR D C AP SULE MVA 16MG

1,00 STUK

4,76470

0R 01ADAN

V

110299//23837

BUDESO NIDE FISHER NEVEL NEUSSP R AY 32MC G/DO 120DO

6,25 DO

0,07684

0R 01ADAN

V

110524//14424

FLIXO NASE NEUSSP R AY 50MC G/DO FLAC O N120DO SES

4,00 DO

0,08425

0R 01ADAN

V

108927

FLUTIC ASO NPR O PIO NAAT FC NEUSSP R 50MC G/DO FL150DO

4,00 DO

0,08425

0R 01ADAN

V

110491//21837

NASAC O R T NEUSSP R AY 55MC G/DO 120DO

4,00 DO

0,08425

0R 01ADAN

V

110488//21613

NASO NEX NEUSSP R AY 50MC G/DO 140DO

4,00 DO

0,08425

0R 01ADAN

V

110532//15821

R HINO C O R T TUR BUHALER INHPDR NASAAL 0,1MG/DO 200DO

2,00 DO

0,16850

0R 01ADAN

V

110533//15821

R HINO C O R T TUR BUHALER INHPDR NASAAL 0,1MG/DO 200DO

2,00 DO

0,16850

0R 03AC C IDA

V

110490//33735

SER EVENT AER O SO L 25MC G/DO C FKVR SP BS120DO + INH

4,00 DO

0,23086

YR 03AC C IDC V V

110320//23529

SER ETIDE DISKUS INHP DR 50/100MC G 60DO

1,00 DO

0,72888

YR 03AC C IDC

V

110313//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00 DO

0,90703

YR 03AC C IDC

V

110323//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

2R 06AEAO

V

109243

LEVO C ETIR IZINE DIHC L KR KA TABLET FO 5MG

1,00 STUK

0,50499

0S01EDAG

V

29294

TIMO LO L FDC O O GDR UP PELS 2,5MG/ML FLAC O N 5ML

0,20 ML

0,93750

0S01EDAG

V

29295

TIMO LO L FDC O O GDR UP PELS 5MG/ML FLAC O N 5ML

0,20 ML

0,93750

0A02BC AO V

104919

P ANTO P R AZO L P C H TABLET MSR 20MG

2,00 STUK

1,00866

0A02BC AO V

104920

P ANTO P R AZO L P C H TABLET MSR 40MG

1,00 STUK

1,68111

0A04AAAO V

110634//21471

ZO FR AN ZYDIS SMELTTABLET 4MG

4,00 STUK

5,81918

0A04AAAO V

110633//21472

ZO FR AN ZYDIS SMELTTABLET 8MG

2,00 STUK

9,69864

0A06ADAO V

110046

LAC TULO SESTR O O P SANDO Z 670MG/ML

0A06ADBO V

110200//105789 MO VIPR EP O R ANGE P O EDER VO O R DR ANK IN SAC HET A+B

4,00 STUK

4,43003

0A06ADBO V

110561//106616 P IC O P R EP P O EDER VO O R DR ANK SAC HET 16,1G

2,00 STUK

8,86005

0A10BGAO V

108642

1,00 STUK

1,61756

P IO GLITAZO N SANDO Z TABLET 30MG

10,00 ML

0,01566

0A10BGAO V

108643

P IO GLITAZO N SANDO Z TABLET 45MG

0,67 STUK

2,42634

0A12AABO V

110059//10017

C ALC IUM ER C FO R TISSIMUM BR UISTABLET 1000MG

1,00 STUK

0,43684

0C 02C AAO V

110479//22688

C AR DUR A XL TABLET MGA 4MG

1,00 STUK

0,84322

0C 02C AAO V

110480//22689

C AR DUR A XL TABLET MGA 8MG

0,50 STUK

1,68644

0C 03C ABO V

106750

FUR O SEMIDE TEVA TABLET 500MG

1,00 STUK

0,81545

0C 09C AAO V

32137

DIO VAN TABLET O MHULD 40MG

2,00 STUK

0,44652

0C 09C AAO V

108912

VALSAR TAN R ANBAXY TABLET FILMO MHULD 80MG

1,00 STUK

0,74420

0C 09C AAO V

108917

VALSAR TAN R ANBAXY TABLET FILMO MHULD 160MG

0,50 STUK

1,48840

YC 09BAAO V

107051

P ER INDO PR IL TER TBUTYL/INDAP AMIDE TEVA T 8/2,5MG

1,00 STUK

1,27162

YC 09DAAO V

106540

LO SAR TAN KALIUM/HC T TEVA TABLET FILMO MH 100/12,5MG

1,00 STUK

1,54013

YC 09DAAO V

102399

VALSAR TAN/HC T P C H TABL FILMO MHULD 80MG/12,5MG

1,00 STUK

0,79593

YC 09DAAO V

102397

VALSAR TAN/HC T P C H TABL FILMO MHULD 160MG/12,5MG

1,00 STUK

1,54013

YC 09DAAO V

102398

VALSAR TAN/HC T P C H TABL FILMO MHULD 160MG/25MG

1,00 STUK

1,59186

0C 10AAAO V

110583//21081

ATO R VASTATINE FISHER TABLET FILMO MHULD 10MG

2,00 STUK

0,83042

0C 10AAAO V

110584//21082

ATO R VASTATINE FISHER TABLET FILMO MHULD 20MG

1,00 STUK

1,38403

0C 10AAAO V

110585//21083

ATO R VASTATINE FISHER TABLET FILMO MHULD 40MG

0,50 STUK

2,76806

0C 10AAAO V

110543//26874

C R ESTO R TABLET FILMO MHULD 40MG

0,25 STUK

5,53612

0C 10AAAO V

110564//21081

LIP ITO R TABLET O MHULD 10MG

2,00 STUK

0,83042

0C 10AAAO V

110565//21083

LIP ITO R TABLET O MHULD 40MG

0,50 STUK

2,76806

0C 10AC AO V

110590//6761

Q UESTR AN P O EDER 4G IN SAC HET

3,50 STUK

0,49172

YC 10AXAO V

110629//30928

INEGY TABLET 10/20MG

1,00 STUK

2,64369

YC 10AXAO V

110644//30930

INEGY TABLET 10/80MG

1,00 STUK

5,41175

0D06BBBDL V

109832//12093

C O NDYLINE AP PLIC ATIEVLO EISTO F 5MG/ML

1,00 ML

6,08974

0D07ADADL V

110523//33440

C LO BEX SHAMPO O 0,5MG/G

1,00 GR AM

0,18635

2D07ABADZ V

110230//7520

EMO VATE ZALF 0,5MG/G

1,00 GR AM

0,13568

0G02C BAO V

110527//8202

P AR LO DEL TABLET 2,5MG

2,00 STUK

0,37906

0G03AABO V

105543

ELEO NO R E TABLET FILMO MHULD 30/150MC G

0,75 STUK

0,13253

0G03FAAO V

110386//22819

AC TIVELLE TABLET O MHULD

1,00 STUK

0,38944

0G04C AAO V

32576

TAMSULO SINE HC L GENTHO N C AP SULE MGA 0,4MG

1,00 STUK

0,96201

0J01XAAP V

105369

VANC O MYC INE P FIZER INFUSIEP O EDER FLAC O N 500MG

2000,00 MG

0,02389

0J01XAAP V

105372

VANC O MYC INE P FIZER INFUSIEP O EDER FLAC O N 1000MG

2000,00 MG

0,02389

0L02BBAO V

102249

BILUR O N TABLET FILMO MHULD 50MG

1,00 STUK

5,44536

0L02BGAO V

34003

ANASTR O ZO L SYNTHO N TABLET FILMO MHULD 1MG

1,00 STUK

4,71931

0L02BGAO V

108035

EXEMESTAAN P FIZER TABLET FILMO MHULD 25MG

1,00 STUK

4,71931

0L02BGAO V

104889

LETR O MAN TABLET FILMO MHULD 2,5MG

1,00 STUK

4,71931

0L04AAC O V

110528//30043

C ER TIC AN TABLET 0,75MG

2,00 STUK

14,23305

0M01AHBO V

110522//27707

AR C O XIA TABLET FILMO MHULD 120MG

0,50 STUK

2,26376

1M01AEAO V

110202//25476

SER AC TIL TABLET O MHULD 400MG

2,00 STUK

0,27832

0M05BABO V

106825

R ISEDR O NAATNATR IUM TEVA TABLET FILMO MHULD 75MG

0,07 STUK

18,37810

0N02C C BO V

110343//19469

IMIGR AN NEUSSP R AY 10MG

2,00 STUK

6,26081

0N03AXDO V

EU/1/11/712/005 LEVETIR AC ETAM AC C O R D TABLET FILMO MHULD 250MG

6,00 STUK

0,95330

0N03AXDO V

EU/1/11/712/012 LEVETIR AC ETAM AC C O R D TABLET FILMO MHULD 500MG

3,00 STUK

1,19163

0N03AXDO V

EU/1/11/712/026 LEVETIR AC ETAM AC C O R D TABLET FILMO MHULD 1000MG

1,50 STUK

2,38325

0N03AXDO V

EU/1/08/470/001 VIMP AT TABLET O MHULD 50MG

6,00 STUK

0,83414

0N04BC AO V

EU/1/97/051/013 MIR AP EXIN TABLET MVA 0,375MG (0,26MG BASE)

6,67 STUK

0,58728

TABLETTEN, 500 TABLETTEN 0N04BXAO V

EU/1/98/081/001 C O MTAN TABLET 200MG

5,00 STUK

0,87973

0N04BXAO V

EU/1/98/081/002 C O MTAN TABLET 200MG

5,00 STUK

0,87973

0N04BXAO V

EU/1/98/081/003 C O MTAN TABLET 200MG

5,00 STUK

0,87973

0N05AXAP V

EU/1/11/672/006 XEP LIO N STAR TVP INJVLST (1X100MG/1ML+1X150MG/1,5ML)

0,01 VER P

1263,81600

1N05AFAP D V

110512//7288

0,08 STUK

9,54760

4N05AHAO V

EU/1/09/587/001 O LANZAP INE GLENMAR K TABLET 2,5MG

4,00 STUK

1,58521

2N06ABAO V

34111

P AR O XETINE P C H TABLET FILMO MH 20MG(ALS HC L ANHY)

1,00 STUK

1,06638

0N07AAAO V

107647

GALANTAMINE MYLAN R ETAR D C AP SULE MVA 8MG

2,00 STUK

2,38235

0N07AAAO V

107649

GALANTAMINE MYLAN R ETAR D C AP SULE MVA 16MG

1,00 STUK

4,76470

0N07AAAO V

107650

GALANTAMINE MYLAN R ETAR D C AP SULE MVA 24MG

0,67 STUK

7,14704

0N07AAAO V

107318

GALANTAMINE TEVA R ETAR D C AP SULE MVA 8MG

2,00 STUK

2,38235

0N07AAAO V

107320

GALANTAMINE TEVA R ETAR D C AP SULE MVA 16MG

1,00 STUK

4,76470

0N07AAAO V

107323

GALANTAMINE TEVA R ETAR D C AP SULE MVA 24MG

0,67 STUK

7,14704

0N07AAAO V

EU/1/11/693/001 R IVASTIGMINE AC TAVIS C AP SULE 1,5MG

6,00 STUK

1,11176

0N07AAAO V

EU/1/11/693/005 R IVASTIGMINE AC TAVIS C AP SULE 3MG

3,00 STUK

1,58823

0N07AAAO V

EU/1/11/693/009 R IVASTIGMINE AC TAVIS C AP SULE 4,5MG

2,00 STUK

2,38235

0N07AAAO V

EU/1/11/693/013 R IVASTIGMINE AC TAVIS C AP SULE 6MG

1,50 STUK

3,17646

0N07C AAO V

110628//13612

BETASER C TABLET 16MG

1,50 STUK

0,25684

0R 01ADAN V

110461//21613

NASO NEX NEUSSP R AY 50MC G/DO 140DO

4,00 DO

0,08425

0R 01ADAN V

110544//21613

NASO NEX NEUSSP R AY 50MC G/DO 140DO

4,00 DO

0,08425

0R 01ADAN V

110505//23838

R HINO C O R T NEVEL NEUSSP R AY 64MC G/DO 120DO

3,13 DO

0,10784

0R 03AC C IDC V EU/1/09/594/002 HIR O BR IZ BR EEZHALER INHALP DR 150MC G MET BR EEZHALER

1,00 STUK

1,22022

0R 03AC C IDC V EU/1/09/594/007 HIR O BR IZ BR EEZHALER INHALP DR 300MC G MET BR EEZHALER

0,50 STUK

2,44043

0R 03AC C IDC V 110525//21027

2,00 DO

0,61011

ZUC LO PENTIXO LDEC ANO AAT FIS INJVL 200MG/ML AMP 1ML

O XIS TUR BUHALER INHALPDR

0R 03BAAII V

110695//21835

FLIXO TIDE 2000 INHVLST 1MG/ML NEBULE 2ML

1,50 ML

3,85123

0R 03BADID V

110694//18194

FLIXO TIDE DISKUS INHP DR 250MC G 60DO

2,40 DO

0,29692

0R 03BADID V

110708//18195

FLIXO TIDE DISKUS INHP DR 500MC G 60DO

1,20 DO

0,59385

BUDESO NIDE/FO R MO T FIS TUR B INHP DR 400/12MC G/DO 60D

1,00 DO

0,96642

YR 03AKAIDC V 110319//27690

0S01AXAG V

110553//102202 VIGAMO X O O GDR UPP ELS 5MG/ML FLAC O N 5ML

0,30 ML

6,24444

0S01EXAG V

106487

LATANO P R O ST P O S O O GDR UPP ELS 50MC G/ML FLAC O N 2,5ML

0,20 ML

8,54016

0S01FAAG V

110052//6851

C YC LO GYL O O GDR UP P ELS 1% FLAC O N 15ML

0,30 ML

0,35909

0S01GXBG V

110643//25727

ZADITEN UNIDO SE O O GDR UPP ELS 0,25MG/ML TUBE 0,4ML

0,20 ML

1,85595

0V03AEAO V

110665//31930

FO SR ENO L KAUW TABLET 1000MG

2,25 STUK

3,97155

0A02BC AO

V 110649//25387

ESO MEP R AZO L FISHER TABLET MSR 20MG

1,00

STUK 1,68111

0A02BC AO

V 110657//25388

ESO MEP R AZO L FISHER TABLET MSR 40MG

0,50

STUK 3,36221

0A02BC AO

V 110653//25387

NEXIUM TABLET MSR 20MG

1,00

STUK 1,68111

0A02BC AO

V 110810

O MEP R AZO L FO C US FAR MA C APSULE MSR 40MG

0,50

STUK 3,36221

0A02BC AO

V 106475

P ANTO P R AZO L MYLAN TABLET MSR 20MG

2,00

STUK 1,00866

0A02BC AO

V 106476

P ANTO P R AZO L MYLAN TABLET MSR 40MG

1,00

STUK 1,68111

0A07EC C O

V 110055//33600

MESALAZINE ER C TABLET MVA 1200MG

1,25

STUK 1,50140

0A07EC C O

V 26915

MESALAZINE SANDO Z TABLET MSR 250MG

6,00

STUK 0,37535

0A07EC C O

V 26916

MESALAZINE SANDO Z TABLET MSR 500MG

3,00

STUK 0,62558

0A07EC C R

V 26913

MESALAZINE SANDO Z ZETP IL 250MG

6,00

STUK 0,60616

0A07EC C R

V 26914

MESALAZINE SANDO Z ZETP IL 500MG

3,00

STUK 1,01027

0A07EC C R C

V 109853//15845

SALO FALK KLYSMA 2G/60G FLAC O N 60G

2,00

STUK 5,12123

0A07EC C R C

V 109849//11469

SALO FALK KLYSMA 4G/60G FLAC O N 60G

1,00

STUK 10,24246

0A07EC C R C

V 109850//11469

SALO FALK KLYSMA 4G/60G FLAC O N 60G

1,00

STUK 10,24246

0A09AAAO

V 107907

C R EO N GR ANULAAT (P ANC R EATINE 60,12MG)

1,20

GR AM 2,01593

0B01ABAP

V 110676//13068

C LEXANE INJVLST 100MG/ML

0,20

ML

8,89410

0B01ABAP

V 110754//12788

FR AGMIN 5000 INJVLST 25.000IE/ML W W SP 0,2ML

0,10

ML

17,78820

0B01ABAP

V 110755//20607

FR AGMIN 7500 INJVLST 25.000IE/ML W W SP 0,3ML

0,10

ML

17,78820

0B01AC AO

V 110560//20952

0B01AXAO 0B01AXAO

ASPIR INE P R O TEC T EC TABLET MSR 100MG

1,00

STUK 0,05249

V EU/1/08/472/003 XAR ELTO TABLET FILMO MHULD 10MG

2,00

STUK 3,72273;

V EU/1/08/472/006 XAR ELTO TABLET FILMO MHULD 10MG

2,00

STUK 3,72273;

0B01AXAO

V EU/1/08/472/007 XAR ELTO TABLET FILMO MHULD 10MG

2,00

STUK 3,72273;

0B01AXAO

V EU/1/08/472/008 XAR ELTO TABLET FILMO MHULD 10MG

2 ,00

STUK 3,72273;

1C 01DAAO

V 110699//20822

ISO SO R BIDEMO NO NITR AAT FISHER R ETAR D C AP SULE 100MG

0,60

STUK 0,90756

0C 07ABAO

V 107724

BISO P R O LO LFUMAR AAT TEVA TABLET 2,5MG

4,00

STUK 0,10153

0C 09AAAO

V 110387//31958

C O VER SYL AR G TABLET FILMO MHULD 5MG

0,80

STUK 0,73010

0C 09AAAO

V 110388//31959

C O VER SYL AR G TABLET FILMO MHULD 10MG

0,40

STUK 1,46020

YC 09BAAO

V 110390//33663

C O VER SYL PLUS AR G TABLET FILMO MHULD 5/1,25MG

1,00

STUK 0,78183

YC 09DAAO

V 105141

KALIUMLO SAR TAN/HC T AC TAVIS TABL FILMO MH 100/25MG

1,00

STUK 1,59186

YC 09DAAO

V 105286

VALSAR TAN/HC T ABDI TABL FILMO MHULD 80MG/12,5MG

1,00

STUK 0,79593

YC 09DAAO

V 105287

VALSAR TAN/HC T ABDI TABL FILMO MHULD 160MG/12,5MG

1,00

STUK 1,54013

YC 09DAAO

V 105288

VALSAR TAN/HC T ABDI TABL FILMO MHULD 160MG/25MG

1,00

STUK 1,59186

YC 09DAAO

V 110732//100454 VALSAR TAN/HC T FISHER TABL FILMO MHULD 320MG/25MG

1,00

STUK 3,08026

0C 10AAAO

V 108085

ATO R VASTATINE P FIZER TABLET FILMO MHULD 10MG

2,00

STUK 0,83042

0C 10AAAO

V 108086

ATO R VASTATINE P FIZER TABLET FILMO MHULD 20MG

1,00

STUK 1,38403

0C 10AAAO

V 108088

ATO R VASTATINE P FIZER TABLET FILMO MHULD 40MG

0,50

STUK 2,76806

0C 10AAAO

V 108089

ATO R VASTATINE P FIZER TABLET FILMO MHULD 80MG

0,25

STUK 5,53612

0C 10AC AO

V 110753//28626

EZETR O L TABLET 10MG

1,00

STUK 1,72101

0G02C BAO

V 110696//16290

NO R P R O LAC TABLET 75MC G

1,00

STUK 0,75812

0G03GABP

V 110672//24536

MENO P UR INJP DR FLAC O N 75IE + SO LV 1ML

1,00

STUK 33,54345

0G04C BAO

V 110617//28317

AVO DAR T C AP SULE 0,5MG

1,00

STUK 1,12371

0H01BAAO

V 30506

DESMO P R ESSINE AC ETAAT P HT TABLET 0,1MG

4,00

STUK 0,94769

0H01BAAO

V 30507

DESMO P R ESSINE AC ETAAT P HT TABLET 0,2MG

2,00

STUK 1,57948

0J01DABP

V 110597//9913

R O C EP HIN INJP DR FLAC 1000MG + SO LV LIDO C 3,5ML(IM)

2,00

STUK 20,78320

0J01FAAO

V 107530

C LAR ITR O MYC INE C F R ETAR D TABLET MVA 500MG

1,00

STUK 2,43031

0J01GBAII

V 102949

C O LIFIN PAR I P DR V VER NEVELO P L FL 1 MILJ IE+SV 3ML

3,00

STUK 15,03147

0J01GBAII

V 102952

C O LIFIN PAR I P DR V VER NEVELO P L FL 2 MILJ IE+SV 4ML

1,50

STUK 30,06294

0N02AXAO

V 104528

TR AMADO L HC L AC TAVIS C APSULE 50MG

6,00

STUK 0,20647

0N03AGAO

V 110764//13157

DEPAKINE C HR O NO TABLET MGA 300MG

5,00

STUK 0,15928

0N03AGAO

V 110791//13157

DEPAKINE C HR O NO TABLET MGA 300MG

5,00

STUK 0,15928

0N03AGAO

V 110599//11775

DEPAKINE C HR O NO TABLET MGA 500MG

3,00

STUK 0,26546

0N03AGAO

V 110763//11775

DEPAKINE C HR O NO TABLET MGA 500MG

3,00

STUK 0,26546

0N03AGAO

V 110797//11775

DEPAKINE C HR O NO TABLET MGA 500MG

3,00

STUK 0,26546

0N03AXC O

V 101914

GABAP ENTINE MYLAN TABLET FILMO MHULD 600MG

3,00

STUK 1,30689

0N03AXC O

V 101923

GABAP ENTINE MYLAN TABLET FILMO MHULD 800MG

2,25

STUK 1,74252

0N03AXDO

V 108783

LEVETIR AC ETAM AUR O BINDO DR ANK 100MG/ML

15,00 ML

0N05AXAP

V 110555//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07

STUK 175,53000

0N05AXAP

V 110557//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05

STUK 234,04000

4N05AHAO

V EU/1/08/475/056 O LANZAP INE MYLAN TABLET FILMO MHULD 2,5MG

4,00

STUK 1,58521

4N05AHAO

V EU/1/08/475/053 O LANZAP INE MYLAN TABLET FILMO MHULD 5MG

2,00

STUK 1,98151

4N05AHAO

V EU/1/08/475/058 O LANZAP INE MYLAN TABLET FILMO MHULD 10MG

1,00

STUK 3,96302

4N05AHAO

V EU/1/08/475/059 O LANZAP INE MYLAN TABLET FILMO MHULD 15MG

0,67

STUK 5,94453

4N05AHAO

V EU/1/08/475/060 O LANZAP INE MYLAN TABLET FILMO MHULD 20MG

0,50

STUK 7,92603

0N06AAAO

V 110547//9998

P R O THIADEN DR AGEE 75MG

2,00

STUK 0,22114

0N06AAAO

V 110548//9998

P R O THIADEN DR AGEE 75MG

2,00

STUK 0,22114

0R 01ADAN

V 110733//23477

FLIXO NASE NEUSDR UP P ELS 1MG/ML P ATR O O N 0,4ML

0,50

DO

0,67402

0R 01ADAN

V 110808//21613

NASO NEX NEUSSP R AY 50MC G/DO 140DO

4,00

DO

0,08425

0R 03BABID

V 110807//31632

ALVESC O 80 AER O SO L 80MC G/DO SP BS 60DO + INH

2,00

DO

0,42060

0R 03BABID

V 110760//16214

FLIXO TIDE AER C FKVR 250MC G/DO SP BS 120 DO + INHAL

2,40

DO

0,29208

0R 03BABID

V 110806//16214

FLUTIC ASO NPR O P FISHER AER C FKVR 250MC G/DO 120D+INH

2,40

DO

0,29208

YR 03AC C IDA V 110936//25867

SER ETIDE AER O SO L 25/250MC G/DO C FKVR SP BS 120DO +INH

1,00

DO

0,52294

0,23833

2R 06AXAO

K EU/1/00/160/046 AER IUS O R O DISP ER GEER BAR E TABLET 2,5MG

2,00

STUK 0,47307

2R 06AXAO

K EU/1/00/160/047 AER IUS O R O DISP ER GEER BAR E TABLET 2,5MG

2,00

STUK 0,47307

2R 06AEAO

V 111002

2R 06AXAO

V EU/1/00/160/058 AER IUS O R O DISP ER GEER BAR E TABLET 5MG

2R 06AXAO

V EU/1/00/160/059 AER IUS O R O DISP ER GEER BAR E TABLET 5MG

1,00

STUK 0,50499

2R 06AXAO

V EU/1/11/732/007 DESLO R ATADINE TEVA TABLET FILMO MHULD 5MG

1,00

STUK 0,50499

2R 06AXAO

V EU/1/11/732/011 DESLO R ATADINE TEVA TABLET FILMO MHULD 5MG

1,00

STUK 0,50499

0S01EXAG

V 102633

LATANO P R O ST AC TAVIS O O GDR UP PELS 50MC G/ML FL 2,5ML

0,20

ML

0S01EXAG

V 103596

LATANO P R O ST BAUSC H&LO MB O O GDR 50MC G/ML FL 2,5ML

0,20

ML

8,54016

0S01EXAG

V 105910

LATANO P R O ST C F O O GDR UP P ELS 50MC G/ML FLAC O N 2,5ML

0,20

ML

8,54016

0A02BAAO

V 110194//13064

ZANTAC DR ANK 150MG/10ML

20,00 ML

0,06594

0A07EC C O

V 110916//105712 P ENTASA TABLET MVA 1G

1,50

STUK

1,25116

YA10BDEO

V EU/1/11/731/009 KO MBO GLYZE TABLET FILMO MHULD 2,5/1000MG

1,00

STUK

1,72042

LEVO C ETIR IZINE DIHC L FO C US TABLET FO 5MG

1,00

STUK 0,50499

1,00

STUK 0,50499

8,54016

0A12AABO

V 110789//13261

C AC IT BR UISTABLET 500MG

2,00

STUK

0,26210

0B01ABAP

V 111040//11876

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,3ML

0,30

ML

5,92940

0B01ABAP

V 111039//15963

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,4ML

0,30

ML

5,92940

0B01ABAP

V 111035//11877

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,6ML

0,30

ML

5,92940

0B01ABAP

V 111037//11877

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,6ML

0,30

ML

5,92940

0B01ABAP

V 111036//15965

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,8ML

0,30

ML

5,92940

0B01ABAP

V 111038//15965

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,8ML

0,30

ML

5,92940

0B03XAAP

V EU/1/07/410/051 BINO C R IT 40000 INJVLST 40000IE/ML W W SP 1ML

0,05

ML

491,44032

1C 01DAAO

V 110813//13645

1,20

STUK

0C 03C ABO

V 15018

LASIX TABLET 500MG

1,00

STUK

0,81545

0C 03C ABO

V 19961//15018

LASIX TABLET 500MG

1,00

STUK

0,81545

0C 03C ABO

V 23490//15018

LASIX TABLET 500MG

1,00

STUK

0,81545

0C 03C ABO

V 109294//15018

LASIX TABLET 500MG

1,00

STUK

0,81545

1C 07AGAO

V 30014

C AR VEDILO L AC TAVIS TABLET 3,125MG

12,00 STUK

0,12101

0C 08C AAO

V 105980

LAC IDIP INE TEVA TABLET FILMO MHULD 2MG

2,00

STUK

0,39270

0C 08C AAO

V 105981

LAC IDIP INE TEVA TABLET FILMO MHULD 4MG

1,00

STUK

0,65450

0C 09AAAO

V 34414

ENALAP R IL MALEAAT P C H TABLET 40MG

0,25

STUK

2,33631

0C 09C AAO

V 107560

VALSAR TAN MYLAN TABLET FILMO MHULD 40MG

2,00

STUK

0,44652

YC 09BBBO

V 110717//100139 P ER INDO PR IL AR G/AMLO DIP INE FISHER TABL FO 5/ 5MG

1,00

STUK

1,38460

YC 09DAAO

V 108378

VALSAR TAN/HC T AC TAVIS TABL FILMO MHULD 80MG/12,5MG

1,00

STUK

0,79593

YC 09DAAO

V 108379

VALSAR TAN/HC T AC TAVIS TABL FILMO MHULD 160MG/12,5MG

1,00

STUK

1,54013

YC 09DAAO

V 108380

VALSAR TAN/HC T AC TAVIS TABL FILMO MHULD 160MG/25MG

1,00

STUK

1,59186

0C 10AAAO

V 108977

ATO R AB TABLET FILMO MHULD 10MG

2,00

STUK

0,83042

0C 10AAAO

V 108978

ATO R AB TABLET FILMO MHULD 20MG

1,00

STUK

1,38403

0C 10AAAO

V 108979

ATO R AB TABLET FILMO MHULD 40MG

0,50

STUK

2,76806

0C 10AAAO

V 108980

ATO R AB TABLET FILMO MHULD 80MG

0,25

STUK

5,53612

0C 10AAAO

V 108981

ATO R VASTATINE R ANBAXY TABLET FILMO MHULD 10MG

2,00

STUK

0,83042

0C 10AAAO

V 108982

ATO R VASTATINE R ANBAXY TABLET FILMO MHULD 20MG

1,00

STUK

1,38403

0C 10AAAO

V 108983

ATO R VASTATINE R ANBAXY TABLET FILMO MHULD 40MG

0,50

STUK

2,76806

0C 10AAAO

V 108984

ATO R VASTATINE R ANBAXY TABLET FILMO MHULD 80MG

0,25

STUK

5,53612

1G01AFBV

V 110678//8934

C ANESTEN GYNO 3 VAGINAALTABLET 200MG + AP P LIC ATO R

3,00

STUK

1,96551

0G02C BAO

V 110933//15375

DO STINEX TABLET 0,5MG

0,10

STUK

7,96341

0G03AABO

V 110483//12846

C ILEST TABLET

0,75

STUK

0,13253

0G03GABIM

V EU/1/00/165/008 O VITR ELLE 250 INJVLST 500MC G/ML P EN 0,5ML

0,05

STUK

4,64067

MO NO C EDO C AR D R ETAR D C AP SULE MGA 50MG

0,45378

0G04BDBO

V 110995//29151

VESIC AR E TABLET FILMO MHULD 5MG

1,00

STUK

0,82981

0G04BDBO

V 110993//29152

VESIC AR E TABLET FILMO MHULD 10MG

0,50

STUK

1,65963

0J01DAC P

V 106826

C EFTAZIDIM AUR O BINDO INJEC TIEP O EDER FLAC O N 250MG

16,00 STUK

0J01DAC P

V 106824

C EFTAZIDIM AUR O BINDO INJEC TIEP O EDER FLAC O N 500MG

8,00

STUK

10,99283

0J01DAC P

V 106827

C EFTAZIDIM AUR O BINDO INJEC TIEP O EDER FLAC O N 1000MG

4,00

STUK

21,98565

0J01DAC P

V 106828

C EFTAZIDIM AUR O BINDO INJEC TIEP O EDER FLAC O N 2000MG

2,00

STUK

43,97130

0J01DAC P

V 106829

C EFTAZIDIM AUR O BINDO INJEC TIEP O EDER FLAC O N 3000MG

1,33

STUK

65,95695

0L04AADO

V EU/1/07/387/019 ADVAGR AF C AP SULE MVA 1MG

5,00

STUK

2,84925

0L04AADO

V EU/1/07/387/024 ADVAGR AF C AP SULE MVA 5MG

1,00

STUK

14,24625

0L04AADO

V 110982//22236

P R O GR AFT C AP SULE 0,5MG

10,00 STUK

1,70955

0L04AADO

V 110990//18107

P R O GR AFT C AP SULE 1MG

5,00

STUK

2,84925

YM01AEAO

V 111000//106235 VIMO VO TABLET MGA 500/20MG

1,00

STUK

2,23775

0M05BABO

V EU/1/09/572/002 VANTAVO TABLET 70MG/2800IE

0,14

STUK

8,57645

0M05BABP

V EU/1/11/703/001 XGEVA 120 INJVLST 70MG/ML FLAC O N 1,7ML

0,85

ML

349,73530

0M05BABP

V EU/1/11/703/002 XGEVA 120 MG/1,7 ML O P LO SSING V INJEC TIE 4 FLAC O NS

0,85

ML

349,73530

0N02ABADP

K 109217

FENTANYL TEVA P LEISTER 12MC G/UUR

1,33

STUK

0N02BEDO

V 110996//26161

P ANADO L AR TR O SE TABLET O MHULD 1000MG

3,00

STUK

0,11300

0N02C C AO

V 110998//29413

SUMATR IP TAN ER C DISP ER GEER BAR E TABLET 50MG

1,00

STUK

6,21227

0N03AFBO

V 106160

O XC AR BAZEPINE SANDO Z TABLET FILMO MHULD 300MG

3,33

STUK

0,29201

0N03AFBO

V 106161

O XC AR BAZEPINE SANDO Z TABLET FILMO MHULD 600MG

1,67

STUK

0,58402

0N03AFBO

V 111051//24751

TR ILEP TAL TABLET FILMO MHULD 300MG

3,33

STUK

0,29201

0N03AFBO

V 111052//24752

TR ILEP TAL TABLET FILMO MHULD 600MG

1,67

STUK

0,58402

0N03AXDO

V 108472

LEVETIR AC ETAM C F TABLET FILMO MHULD 250MG

6,00

STUK

0,95330

0N03AXDO

V 108475

LEVETIR AC ETAM C F TABLET FILMO MHULD 500MG

3,00

STUK

1,19163

0N03AXDO

V 108476

LEVETIR AC ETAM C F TABLET FILMO MHULD 1000MG

1,50

STUK

2,38325

0N03AXDO

V 108496

LEVETIR AC ETAM SANDO Z DR ANK 100MG/ML

15,00 ML

0,23833

0N03AXEO

V 104816

TO P IR AMAAT AC TAVIS TABLET FILMO MHULD 50MG

6,00

STUK

0,79440

1N04AAAO

V 110667//641

AR TANE TABLET 5MG

2,00

STUK

0,08849

4N05AXAO

V 110389//34626

Q UETIAPINE XR ER C TABLET MVA 200MG

1,50

STUK

2,64201

4N05AXAO

V 110385//34627

Q UETIAPINE XR ER C TABLET MVA 300MG

1,00

STUK

3,96302

4N05AXAO

V 110381//34628

Q UETIAPINE XR ER C TABLET MVA 400MG

0,75

STUK

5,28402

0N07AAAO

V 107501

GALANTAMINE SANDO Z R ETAR D C AP SULE MVA 8MG

2,00

STUK

2,38235

0N07AAAO

V 107502

GALANTAMINE SANDO Z R ETAR D C AP SULE MVA 16MG

1,00

STUK

4,76470

0N07AAAO

V 107503

GALANTAMINE SANDO Z R ETAR D C AP SULE MVA 24MG

0,67

STUK

7,14704

0R 01ADAN

V 110201//21613

NASO NEX NEUSSP R AY 50MC G/DO 140DO

4,00

DO

0,08425

5,49641

5,69800

YR 03AC C IDA V 111091//25867

SER ETIDE AER O SO L 25/250MC G/DO C FKVR SP BS 120DO +INH

1,00

DO

0,52294

YR 03AC C IDC V 110297//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00

DO

0,90703

YR 03AC C IDC V 110298//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00

DO

1,20396

2R 06AXAO

V EU/1/11/745/006 DESLO R ATADINE AC TAVIS TABLET FILMO MHULD 5MG

1,00

STUK

0,50499

2R 06AXAO

V EU/1/11/746/006 DESLO R ATADINE R P TABLET FILMO MHULD 5MG

1,00

STUK

0,50499

2R 06AXAO

V EU/1/11/746/012 DESLO R ATADINE R P TABLET FILMO MHULD 5MG

1,00

STUK

0,50499

0S01BC AG

V 110054//16363

INDO C O LLYR E O O GDR UP P ELS 1MG/ML FLAC O N 5ML

0,40

ML

1,42850

0S01EXAG

V 102638

LATANO P R O ST MYLAN O O GDR UP PELS 50MC G/ML FLAC 2,5ML

0,20

ML

8,54016

0S01EXAG

V 107918

LATANO P R O ST P FIZER O O GDR UPP ELS 50MC G/ML FLAC 2,5ML

0,20

ML

8,54016

0S01EXAG

V 101418

LATANO P R O ST R P O O GDR UPP ELS 50MC G/ML FLAC O N 2,5ML

0,20

ML

8,54016

0S01EXAG

V 104079

LATANO P R O ST SANDO Z O O GDR UP P ELS 50MC G/ML FLAC 2,5ML 0,20

ML

8,54016

0S01XAAG

V 110999//14862

VIDISIC C AR BO GEL O O GGEL 2MG/G TUBE 10G

GR AM

0,39706

YS01EDAG

V 110118

LATANO P R O ST/TIMO LO L MYL O O GDR 0,05/5MG/ML FL 2,5ML

1,00

ML

9,47766

YS01EDAG

V 109269

LATANO P R O ST/TIMO LO L SDZ O O GDR 0,05/5MG/ML FL 2,5ML

1,00

ML

9,47766

YS01EDC G

V 105627

DO R ZO LAMIDE/TIMO LO L B&L O O GDR 20/5MG/ML FL 5ML

1,00

ML

3,13380

0,40

0A02BC AP V

110983//22084

P ANTO ZO L INJEC TIEP O EDER FLAC O N 40MG

1,00

STUK 9,48400

1A06ADAO V

110794

MAC R O GO L EN ELEKTR MYLAN C ITR O EN P DR V DR SAC HET

0,76

STUK 0,54285

0A10BHAO V

EU/1/11/707/003 TR AJENTA TABLET 5MG

1,00

STUK 3,22000

0B01ABAP V

110930//12787

FR AGMIN 2500 INJVLST 12.500IE/ML W W SP 0,2ML

0,20

ML

8,89410

0B01ABAP V

110821//12788

FR AGMIN 5000 INJVLST 25.000IE/ML W W SP 0,2ML

0,10

ML

17,78820

0B01ABAP V

110939//12788

FR AGMIN 5000 INJVLST 25.000IE/ML W W SP 0,2ML

0,10

ML

17,78820

0B01ABAP V 0B01ABAP V

110944//20607 110948//21896

FR AGMIN 7500 INJVLST 25.000IE/ML W W SP 0,3ML FR AGMIN 10000 INJVLST 25.000IE/ML W W SP 0,4ML

0,10 0,10

ML ML

17,78820 17,78820

0B01ABAP V

110947//21897

FR AGMIN 12500 INJVLST 25.000IE/ML W W SP 0,5ML

0,10

ML

17,78820

0B01ABAP V

110946//21898

FR AGMIN 15000 INJVLST 25.000IE/ML W W SP 0,6ML

0,10

ML

17,78820

0B01ABAP V 0B01ABAP V

110825//21899 110945//21899

FR AGMIN 18000 INJVLST 25.000IE/ML W W SP 0,72ML FR AGMIN 18000 INJVLST 25.000IE/ML W W SP 0,72ML

0,10 0,10

ML ML

17,78820 17,78820

0C 01C AAP V

110932//32727

EPIPEN INJVLST 1MG/ML W W SP 0,3ML

1,00

ML

148,23500

0C 07ABAO V

105214

ATENO LO L AC TAVIS TABLET 25MG

3,00

STUK 0,16245

0C 07ABAO V

105225

ATENO LO L AC TAVIS TABLET 50MG

1,50

STUK 0,27075

0C 07ABAO V

105226

ATENO LO L AC TAVIS TABLET 100MG

0,75

STUK 0,54151

0C 07ABAO V

107723

BISO P R O LO LFUMAR AAT TEVA TABLET 1,25MG

8,00

STUK 0,12184

0C 09C AAO V

106751

C ANDESAR TAN C ILEXETIL AC TAVIS TABLET 16MG

0,50

STUK 1,48840

0C 09C AAO V

106752

C ANDESAR TAN C ILEXETIL AC TAVIS TABLET 32MG

0,25

STUK 2,97680

0C 09C AAO V 0C 09C AAO V

106746 106748

C ANDESAR TAN C ILEXETIL AC TAVIS TABLET 4MG C ANDESAR TAN C ILEXETIL AC TAVIS TABLET 8MG

2,00 1,00

STUK 0,44652 STUK 0,74420

0C 09C AAO V

109070

C ANDESAR TAN C ILEXETIL ASP EN TABLET 16MG

0,50

STUK 1,48840

0C 09C AAO V

109071

C ANDESAR TAN C ILEXETIL ASP EN TABLET 32MG

0,25

STUK 2,97680

0C 09C AAO V 0C 09C AAO V

109068 109069

C ANDESAR TAN C ILEXETIL ASP EN TABLET 4MG C ANDESAR TAN C ILEXETIL ASP EN TABLET 8MG

2,00 1,00

STUK 0,44652 STUK 0,74420

0C 09C AAO V

104701

C ANDESAR TAN C ILEXETIL MYLAN TABLET 16MG

0,50

STUK 1,48840

0C 09C AAO V

104702

C ANDESAR TAN C ILEXETIL MYLAN TABLET 32MG

0,25

STUK 2,97680

0C 09C AAO V 0C 09C AAO V

104699 104700

C ANDESAR TAN C ILEXETIL MYLAN TABLET 4MG C ANDESAR TAN C ILEXETIL MYLAN TABLET 8MG

2,00 1,00

STUK 0,44652 STUK 0,74420

YC 09BAAO V

110790//102257 C O VER SYL PLUS AR G TABLET FILMO MHULD 10/2,5MG

1,00

STUK 1,56366

YC 09DAAO V

EU/1/02/213/006 MIC AR DISP LUS TABLET 80/12,5MG

1,00

STUK 1,54013

YC 09DAAO V

104147

VALSAR TAN/HC T C F TABL FILMO MHULD 80MG/12,5MG

1,00

STUK 0,79593

YC 09DAAO V

104153

VALSAR TAN/HC T C F TABL FILMO MHULD 160MG/12,5MG

1,00

STUK 1,54013

YC 09DAAO V YC 09DAAO V

104158 104155

VALSAR TAN/HC T C F TABL FILMO MHULD 160MG/25MG VALSAR TAN/HC T C F TABL FILMO MHULD 320MG/12,5MG

1,00 1,00

STUK 1,59186 STUK 3,02853

YC 09DAAO V

104159

VALSAR TAN/HC T C F TABL FILMO MHULD 320MG/25MG

1,00

STUK 3,08026

0C 10AAAO V 0C 10AAAO V

101368 101370

ATO R VASTATINE AC TAVIS TABLET FILMO MHULD 10MG ATO R VASTATINE AC TAVIS TABLET FILMO MHULD 20MG

2,00 1,00

STUK 0,83042 STUK 1,38403

0C 10AAAO V

101371

ATO R VASTATINE AC TAVIS TABLET FILMO MHULD 40MG

0,50

STUK 2,76806

0C 10AAAO V

110203//30823

R O SUVASTATINE ER C TABLET FILMO MHULD 5MG

2,00

STUK 0,83042

0C 10AAAO V

110231//30823

R O SUVASTATINE ER C TABLET FILMO MHULD 5MG

2,00

STUK 0,83042

0D10AFBDL V

111088//9728

DALAC IN T LO TIO N 10MG/ML

1,00

ML

0G03AABO V 0G03AABO V

EU/1/11/690/001 ZO ELY 2,5 MG/1,5 MG FILMO MHULDE TABLET 24+4 STUKS EU/1/11/690/002 ZO ELY TABLET FILMO MHULD

0,86 0,86

STUK 0,11597 STUK 0,11597

0G03FAAO V

110701//25549

1,00

STUK 0,38944

YG04C AAO V

110918//104130 C O MBO DAR T C AP SULE 0,5/0,4MG

1,00

STUK 2,08572

0J01FAAO V

33804

AZITR O MYC INE AC TAVIS TABLET O MHULD 250MG

1,20

STUK 2,02526

0J01FAAO V

33805

AZITR O MYC INE AC TAVIS TABLET O MHULD 500MG

0,60

STUK 4,05052

0J01GBAII V

EU/1/11/747/001 C O LO BR EATHE INHALPDR 1662500IE + TUR BO SP IN

1,80

STUK 24,98982

0J02AC AO V 0J02AC AO V

108239 108243

FLUC O NAZO L AC TAVIS C AP SULE 50MG FLUC O NAZO L AC TAVIS C AP SULE 150MG

4,00 1,33

STUK 3,10703 STUK 9,32110

0J02AC AO V

108244

FLUC O NAZO L AC TAVIS C AP SULE 200MG

1,00

STUK 12,42813

0L02BBAO V

110749//18356

C ASO DEX TABLET 50MG

1,00

STUK 5,44536

0L03ABAO V

EU/1/11/720/001 INC IVO TABLET FILMO MHULD 375MG

1,50

STUK 47,86667

0L03ABAO V

EU/1/11/704/001 VIC TR ELIS C APSULE 200MG

8,00

STUK 8,97500

0L04AADO V

EU/1/07/387/015 ADVAGR AF C AP SULE MVA 0,5MG

10,00 STUK 3,98895

0L04AADO V

EU/1/07/387/018 ADVAGR AF C AP SULE MVA 1MG

5,00

STUK 2,84925

0L04AADO V

EU/1/07/387/022 ADVAGR AF C AP SULE MVA 3MG

1,67

STUK 8,54775

0L04AADO V

EU/1/07/387/025 ADVAGR AF C AP SULE MVA 5MG

1,00

STUK 14,24625

0L04AXAO V

107495

1,50

STUK 1,12174

FEMO STO N C O NTINU TABLET O MHULD 1/5MG

AZAFALK TABLET FILMO MHULD 100MG

0,19528

0L04AXAO V

107494

AZAFALK TABLET FILMO MHULD 75MG

2,00

STUK 0,84131

0M01AHBO V

110830//34279

AR C O XIA TABLET FILMO MHULD 30MG

2,00

STUK 0,67913

0M03AXAP V

110968//17505

DYSPO R T INJEC TIEPO EDER FLAC O N 500E

0,02

STUK 272,26810

0N02C C AO V

106987

NAR ATR IP TAN AC TAVIS TABLET FILMO MHULD 2,5MG

1,00

STUK 6,21227

0N02C C AO V

105205

NAR ATR IP TAN C F TABLET FILMO MHULD 2,5MG

1,00

STUK 6,21227

0N02C C AO V

106591

NAR ATR IP TAN MYLAN TABLET FILMO MHULD 2,5MG

1,00

STUK 6,21227

0N02C C AO V 0N02C C AO V

101278 103687

NAR ATR IP TAN TEVA TABLET FILMO MHULD 2,5MG NAR ATR IP TAN SANDO Z TABLET FILMO MHULD 2,5MG

1,00 1,00

STUK 6,21227 STUK 6,21227

0N02C C AO V

101894

ZO LMITR IP TAN AC TAVIS O R O DISP TABLET 2,5MG

1,00

STUK 6,21227

0N02C C AO V

105332

ZO LMITR IP TAN C F O R O DISP TABLET 2,5MG

1,00

STUK 6,21227

0N02C C AO V 0N02C C AO V

107303 106554

ZO LMITR IP TAN MYLAN O R O DISP TABLET 2,5MG ZO LMITR IP TAN SANDO Z O R O DISP TABLET 2,5MG

1,00 1,00

STUK 6,21227 STUK 6,21227

0N02C C AO V

106551

ZO LMITR IP TAN SANDO Z TABLET FILMO MHULD 2,5MG

1,00

STUK 6,21227

0N03AXDO V 0N03AXDO V

EU/1/11/738/001 LEVETIR AC ETAM AC TAVIS DR ANK 100MG/ML 108750 LEVETIR AC ETAM BLUEFISH TABLET FILMO MHULD 1000MG

15,00 ML 0,23833 1,50 STUK 2,38325

0N03AXDO V

108748

LEVETIR AC ETAM BLUEFISH TABLET FILMO MHULD 250MG

6,00

STUK 0,95330

0N03AXDO V

108749

LEVETIR AC ETAM BLUEFISH TABLET FILMO MHULD 500MG

3,00

STUK 1,19163

0N04BAAO V

110971//8740

SINEMET 125 TABLET 100/25MG

6,00

STUK 0,18944

4N05AXAO V

101321

Q UETIAPINE AC TAVIS 100 MG, FILMO MHULDE TABLETTEN

3,00

STUK 1,32101

4N05AXAO V 4N05AXAO V

101323 101318

Q UETIAPINE AC TAVIS 200 MG, FILMO MHULDE TABLETTEN Q UETIAPINE AC TAVIS 25 MG, FILMO MHULDE TABLETTEN

1,50 STUK 2,64201 12,00 STUK 0,52840

4N05AXAO V

101324

Q UETIAPINE AC TAVIS 300 MG, FILMO MHULDE TABLETTEN

1,00

STUK 3,96302

4N05AXAO V

108501

Q UETIAPINE R ETAR D 200 MG TEVA TABLETTEN MVA

1,50

STUK 2,64201

4N05AXAO V 4N05AXAO V

108502 108503

Q UETIAPINE R ETAR D 300 MG TEVA TABLETTEN MVA Q UETIAPINE R ETAR D 400 MG TEVA TABLETTEN MVA

1,00 0,75

STUK 3,96302 STUK 5,28402

4N05AXAO V

108482

Q UETIAPINE R ETAR D 50 MG TEVA TABLETTEN MVA

6,00

STUK 0,66050

4N05AXAO V

111024//20827

SER O Q UEL TABLET FILMO MHULD 100MG

3,00

STUK 1,32101

2N06ABAO V

110910//30497

ESC ITALO P R AM FISHER TABLET FILMO MHULD 20MG

0,50

STUK 2,13277

0R 01ADAN V

110780//15821

R HINO C O R T TUR BUHALER INHPDR NASAAL 0,1MG/DO 200DO 2,00

DO

0,16850

0R 03BADID V

110595//18194

FLUTIC ASO NPR O PIO N FISHER DISKUS INHP DR 250MC G 60DO 2,40

DO

0,29692

YR 03AC C IDC V 111054//23529

SER ETIDE DISKUS INHP DR 50/100MC G 60DO

1,00

DO

0,72888

0S01BC AG V

111229//34473

DIC LO ABAK O O GDR UPP ELS 1MG/ML FLAC O N 10ML

0,40

ML

1,42850

0S01XAAG V

111224//14862

VIDISIC C AR BO GEL O O GGEL 2MG/G TUBE 10G

0,40

GR AM 0,39706

0A06ADBO V 0A06ADBO V

110938//105789 MO VIPR EP O R ANGE P O EDER VO O R DR ANK IN SAC HET A+B 111226//105789 MO VIPR EP O R ANGE P O EDER VO O R DR ANK IN SAC HET A+B

4,00 STUK 4,43003 4,00 STUK 4,43003

0A10BGAO V

EU/1/12/755/012 P IO GLITAZO N AC TAVIS TABLET 30MG

1,00 STUK 1,61756

0A10BGAO V 0A10BGAO V

EU/1/12/755/021 P IO GLITAZO N AC TAVIS TABLET 45MG 108631 P IO GLITAZO N C F TABLET 30MG

0,67 STUK 2,42634 1,00 STUK 1,61756

0A10BGAO V

108632

0,67 STUK 2,42634

P IO GLITAZO N C F TABLET 45MG

0A10BGAO V 0A10BGAO V

108758 P IO GLITAZO N MYLAN TABLET 45MG EU/1/12/758/012 P IO GLITAZO N TEVA TABLET 30MG

0,67 STUK 2,42634 1,00 STUK 1,61756

0A10BGAO V

EU/1/12/758/022 P IO GLITAZO N TEVA TABLET 45MG

0,67 STUK 2,42634

0B01AC BO V

102615

AC ETYLSALIC YLZUUR NEUR O SANDO Z DISP TABLET 30MG

1,00 STUK 0,06353

0C 01C AAP V

111212//31435

ANAP EN 300 INJVLST 1MG/ML W W SP 0,3ML

1,00 ML

0C 07ABAO V

106067

BISO P R O LO LFUMAR AAT MYLAN TABLET 1,25MG

8,00 STUK 0,12184

0C 08C AAO V

101557

AMLO DIP INE P C H TABLET 5MG (ALS BESILAAT)

1,00 STUK 0,65450

0C 09C AAO V 0C 09C AAO V

111400//26939 111401//26940

DIO VAN TABLET O MHULD 80MG DIO VAN TABLET O MHULD 160MG

1,00 STUK 0,74420 0,50 STUK 1,48840

0C 09C AAO V

111402//34472

DIO VAN TABLET O MHULD 320MG

0,25 STUK 2,97680

0C 09C AAO V

105281

VALSAR TAN ABDI TABLET FILMO MHULD 80MG

1,00 STUK 0,74420

0C 09C AAO V 0C 09C AAO V

105282 111411//26939

VALSAR TAN ABDI TABLET FILMO MHULD 160MG VALSAR TAN ER C TABLET FILMO MHULD 80MG

0,50 STUK 1,48840 1,00 STUK 0,74420

YC 09DAAO V

105670

C ANDESAR TAN C ILEXETIL/HC T MYLAN TABLET 16/12,5MG

1,00 STUK 1,54013

YC 09DAAO V YC 09DAAO V

111397//29491 111398//31122

C O DIO VAN TABLET O MHULD 160/12,5MG C O DIO VAN TABLET O MHULD 160/25MG

1,00 STUK 1,54013 1,00 STUK 1,59186

YC 09DAAO V

108971

KALIUMLO SAR TAN/HC T AC TAVIS TABL FILMO MH 100/12,5MG

1,00 STUK 1,54013

YC 09DAAO V

111427

VALSAR TAN/HC T FO C US TABL FILMO MHULD 320MG/12,5MG

1,00 STUK 3,02853

YC 09DAAO V

111428

VALSAR TAN/HC T FO C US TABL FILMO MHULD 320MG/25MG

1,00 STUK 3,08026

0C 10AAAO V

111413//26873

C R ESTO R TABLET FILMO MHULD 20MG

0,50 STUK 2,76806

0C 10AAAO V

111388//26874

C R ESTO R TABLET FILMO MHULD 40MG

0,25 STUK 5,53612

0C 10ABBO V

111194//13827

LO P ID TABLET 600MG

2,00 STUK 0,38685

0C 10AC AO V

111332//28626

EZETR O L TABLET 10MG

1,00 STUK 1,72101

0G03ABBO V

110967//101491 Q LAIR A TABLET FILMO MHULD

0,93 STUK 0,10108

0G04BDBO V

110913//29151

VESIC AR E TABLET FILMO MHULD 5MG

1,00 STUK 0,82981

0G04BDBO V 0G04BDBO V

110994//29151 110911//29152

VESIC AR E TABLET FILMO MHULD 5MG VESIC AR E TABLET FILMO MHULD 10MG

1,00 STUK 0,82981 0,50 STUK 1,65963

0G04BDBO V

110992//29152

VESIC AR E TABLET FILMO MHULD 10MG

0,50 STUK 1,65963

0G04C BAO V

111225//28317

AVO DAR T C AP SULE 0,5MG

1,00 STUK 1,12371

0J01FAAO V

108434

C LAR ITR O MYC INE AC TAVIS SR TABLET MVA 500MG

1,00 STUK 2,43031

0L02BGAO V

111403//20755

FEMAR A TABLET O MHULD 2,5MG

1,00 STUK 4,71931

0L04AAAO V

111321//17495

NEO R AL C APSULE 25MG

0L04AAAO V

111320//17496

NEO R AL C APSULE 100MG

3,00 STUK 3,93110

0L04AAAO V

111322//17497

NEO R AL DR ANK 100MG/ML

3,00 ML

0L04AADO V

EU/1/07/387/026 ADVAGR AF C AP SULE MVA 5MG

1,00 STUK 14,24625

0L04AADO V

107939

5,00 STUK 2,84925

TAC R O LIMUS C F C AP SULE 1MG

148,23500

12,00 STUK 1,57244 3,93110

0M01AHBO V

111260//27705

ETO R IC O XIB FISHER TABLET FILMO MHULD 60MG

0M01AHBO V

111240//27706

ETO R IC O XIB FISHER TABLET FILMO MHULD 90MG

1,00 STUK 1,13188 0,67 STUK 1,69782

0M01AHBO V

111239//27707

ETO R IC O XIB FISHER TABLET FILMO MHULD 120MG

0,50 STUK 2,26376

YM05BBAO V

111495//31634

AC TO KIT (1TAB AC TO NEL 35MG+6TAB C ALC 500MG) 28 ST

1,00 VER P

40,59628

YM05BBAO V

107238//31634

AC TO KIT (1TAB AC TO NEL 35MG+6TAB C ALC 500MG) 28 ST

1,00 VER P

40,59628

0N02AAAO V 0N02AAAO V

111144//34775 111146//34776

O XYNO R M INSTANT O R O DISP TABLET 5MG O XYNO R M INSTANT O R O DISP TABLET 10MG

6,00 STUK 0,41607 3,00 STUK 0,69344

0N02ABADP V

109218

FENTANYL TEVA P LEISTER 25MC G/UUR

0,67 STUK 5,39635

0N02ABADP V

109221

FENTANYL TEVA P LEISTER 100MC G/UUR

0,17 STUK 21,58541

0N02C C AO V

111544//21818

MAXALT SMELTTABLET 10MG

1,00 STUK 6,21227

0N02C C AO V

107118

ZO LMITR IP TAN JUBILANT TABLET FILMO MHULD 2,5MG

1,00 STUK 6,21227

0N03AXDO V

108757

LEVETIR AC ETAM ASP EN TABLET FILMO MHULD 1000MG

1,50 STUK 2,38325

0N03AXDO V

108753

LEVETIR AC ETAM ASP EN TABLET FILMO MHULD 250MG

6,00 STUK 0,95330

0N03AXDO V

108755

LEVETIR AC ETAM ASP EN TABLET FILMO MHULD 500MG

3,00 STUK 1,19163

0N03AXDO V 0N03AXDO V

108756 108599

LEVETIR AC ETAM ASP EN 750 MG, FILMO MHULDE TABLETTEN LEVETIR AC ETAM MYLAN TABLET FILMO MHULD 250MG

2,00 STUK 1,78744 6,00 STUK 0,95330

0N03AXDO V

108600

LEVETIR AC ETAM MYLAN TABLET FILMO MHULD 500MG

3,00 STUK 1,19163

0N03AXDO V

108602

LEVETIR AC ETAM MYLAN TABLET FILMO MHULD 1000MG

1,50 STUK 2,38325

0N03AXDO V

EU/1/08/470/019 VIMP AT 10 MG/ML STR O O P

0N05AXAP V

110536//27178

R ISP ER DAL C O NSTA INJP DR FLAC O N 25MG + SO LV 2ML

0,11 STUK 117,02000

0N05AXAP V

110537//27179

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML

0,07 STUK 175,53000

0N05AXAP V

110538//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,05 STUK 234,04000

4N05AXAO V

105671

Q UETIAPINE AC C O R D TABLET FILMO MHULD 25MG

4N05AXAO V

105672

Q UETIAPINE AC C O R D TABLET FILMO MHULD 100MG

3,00 STUK 1,32101

4N05AXAO V 4N05AXAO V

105674 105675

Q UETIAPINE AC C O R D TABLET FILMO MHULD 200MG Q UETIAPINE AC C O R D TABLET FILMO MHULD 300MG

1,50 STUK 2,64201 1,00 STUK 3,96302

4N05AXAO V

103589

Q UETIAPINE C F TABLET FILMO MHULD 25MG

4N05AXAO V

103590

Q UETIAPINE C F TABLET FILMO MHULD 100MG

3,00 STUK 1,32101

4N05AXAO V 4N05AXAO V

103592 103591

Q UETIAPINE C F TABLET FILMO MHULD 200MG Q UETIAPINE C F TABLET FILMO MHULD 300MG

1,50 STUK 2,64201 1,00 STUK 3,96302

4N05AXAO V

104297

Q UETIAPINE JUBILANT TABLET FILMO MHULD 25MG

4N05AXAO V

104298

Q UETIAPINE JUBILANT TABLET FILMO MHULD 100MG

3,00 STUK 1,32101

4N05AXAO V 4N05AXAO V

104300 104301

Q UETIAPINE JUBILANT TABLET FILMO MHULD 200MG Q UETIAPINE JUBILANT TABLET FILMO MHULD 300MG

1,50 STUK 2,64201 1,00 STUK 3,96302

4N05AXAO V

104453

Q UETIAPINE MYLAN TABLET FILMO MHULD 25MG

4N05AXAO V

104455

Q UETIAPINE MYLAN TABLET FILMO MHULD 100MG

3,00 STUK 1,32101

4N05AXAO V 4N05AXAO V

104457 104458

Q UETIAPINE MYLAN TABLET FILMO MHULD 200MG Q UETIAPINE MYLAN TABLET FILMO MHULD 300MG

1,50 STUK 2,64201 1,00 STUK 3,96302

4N05AXAO V

101989

Q UETIAPINE SANDO Z TABLET FILMO MHULD 25MG

12,00 STUK 0,52840

4N05AXAO V

102974

Q UETIAPINE SANDO Z TABLET FILMO MHULD 100MG

3,00 STUK 1,32101

4N05AXAO V 4N05AXAO V

102992 102993

Q UETIAPINE SANDO Z TABLET FILMO MHULD 200MG Q UETIAPINE SANDO Z TABLET FILMO MHULD 300MG

1,50 STUK 2,64201 1,00 STUK 3,96302

4N05AXAO V

100746

Q UETIAPINE TEVA TABLET FILMO MHULD 25MG

4N05AXAO V

100752

Q UETIAPINE TEVA TABLET FILMO MHULD 100MG

30,00 ML

0,11916

12,00 STUK 0,52840

12,00 STUK 0,52840

12,00 STUK 0,52840

12,00 STUK 0,52840

12,00 STUK 0,52840 3,00 STUK 1,32101

4N05AXAO V

100761

Q UETIAPINE TEVA TABLET FILMO MHULD 300MG

1,00 STUK 3,96302

0N06AAAO V

110144

AMITR IP TYLINE HC L AC TAVIS TABLET 10MG

7,50 STUK 0,07666

0N06AAAO V 0N06AAAO V

110145 110146

AMITR IP TYLINE HC L AC TAVIS TABLET 25MG AMITR IP TYLINE HC L SANDO Z TABLET 10MG

3,00 STUK 0,14743 7,50 STUK 0,07666

2N06ABAO V

111055//22687

C IP R AMIL DR UP PELVLO EISTO F 40MG/ML

0,50 ML

0N07AAAO V

111092//31373

R EMINYL R ETAR D C AP SULE MVA 16MG

1,00 STUK 4,76470

0R 03BABID V

111406//16214

FLIXO TIDE AER C FKVR 250MC G/DO SP BS 120 DO + INHAL

2,40 DO

0,29208

BUDESO NIDE/FO R MO T FIS TUR B INHP DR 200/6MC G/DO 120D

1,00 DO

0,48321

YR 03AKAIDC V 111211//25887

2,13277

2R 06AXAO V

EU/1/11/739/004 DASSELTA TABLET FILMO MHULD 5MG

1,00 STUK 0,50499

2R 06AXAO V

109204

DESLO R ATADINE C F TABLET FILMO MHULD 5MG

1,00 STUK 0,50499

0S01EXAG V

111409//21304

XALATAN O O GDR UPP ELS 50MC G/ML FLAC O N 2,5ML

0,20 ML

8,54016

0S01GXBG V

111380//25726

ZADITEN O O GDR UP P ELS 0,25MG/ML FLAC O N 5ML

0,20 ML

1,85595

0S01XAAG V

111325//14862

VIDISIC C AR BO GEL O O GGEL 2MG/G TUBE 10G

0,40 GR AM 0,39706

YS01EDAG V 0A06ADBO V

111408//26592 111387//22626

XALAC O M O O GDR UP PELS FLAC O N 2,5ML C O LO FO R T PO EDER VO O R DR ANK IN SAC HET

0A06ADBO V

111318//106616 P IC O LAX P O EDER VO O R DR ANK SAC HET 16,1G

2,00

STUK 8,86005

1A06ADAO V

111241//31960

MO VIC O LO N NATUR EL PO EDER VO O R DR ANK IN SAC HET

0,76

STUK 0,54285

0A07EABR C V

111369//15660

BUDESO NIDE FISHER TABLET V KLYSMA + SO LVENS 115ML

1,00

STUK 7,42126

0A07EC C O V

111227//31379

P ENTASA C O MPAC T GR ANULAAT MVA 2G IN SAC HET

0,75

STUK 2,50233

0A07EC C R V

111371//15064

P ENTASA ZETP IL 1G

1,50

STUK 2,02053

0A07EC C R V

111488//10115

SALO FALK ZETP IL 250MG

6,00

STUK 0,60616

0B01ABAP V

111536//11876

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,3ML

0,30

ML

5,92940

0B01ABAP V

111537//15963

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,4ML

0,30

ML

5,92940

0B01ABAP V

111523//11877

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,6ML

0,30

ML

5,92940

0B01ABAP V 0B01ABAP V

111538//15965 111525//11878

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,8ML FR AXIP AR INE INJVLST 9500IE/ML W W SP 1ML

0,30 0,30

ML ML

5,92940 5,92940

1C 01DAAO V

110929//13645

ISO SO R BIDEMO NO NITR AAT FISHER R ETAR D C AP SULE 50MG

1,20

STUK 0,45378

0C 09C AAO V

107400

C ANDESAR TAN C ILEXETIL 4 MG TEVA TABLETTEN

2,00

STUK 0,44652

0C 09C AAO V

107276

C ANDESAR TAN C ILEXETIL C F TABLET 4MG

2,00

STUK 0,44652

0C 09C AAO V

107281

C ANDESAR TAN C ILEXETIL C F TABLET 8MG

1,00

STUK 0,74420

0C 09C AAO V 0C 09C AAO V

107282 107283

C ANDESAR TAN C ILEXETIL C F TABLET 16MG C ANDESAR TAN C ILEXETIL C F TABLET 32MG

0,50 0,25

STUK 1,48840 STUK 2,97680

0C 09C AAO V

111353//30755

C ANDESAR TAN C ILEXETIL FISHER TABLET 32MG

0,25

STUK 2,97680

0C 09C AAO V

105636

C ANDESAR TAN C ILEXETIL P C H TABLET 4MG

2,00

STUK 0,44652

0C 09C AAO V

105644

C ANDESAR TAN C ILEXETIL P C H TABLET 4MG

2,00

STUK 0,44652

1,00 ML 9,47766 4,00 STUK 4,43003

0C 09C AAO V

105637

C ANDESAR TAN C ILEXETIL R P TABLET 8MG

1,00

STUK 0,74420

0C 09C AAO V

105638

C ANDESAR TAN C ILEXETIL R P TABLET 16MG

0,50

STUK 1,48840

0C 09C AAO V

105639

C ANDESAR TAN C ILEXETIL R P TABLET 32MG

0,25

STUK 2,97680

0C 09C AAO V 0C 09C AAO V

100133 100135

C ANDESAR TAN C ILEXETIL SANDO Z TABLET 4MG C ANDESAR TAN C ILEXETIL SANDO Z TABLET 8MG

2,00 1,00

STUK 0,44652 STUK 0,74420

0C 09C AAO V

100143

C ANDESAR TAN C ILEXETIL SANDO Z TABLET 16MG

0,50

STUK 1,48840

0C 09C AAO V

100144

C ANDESAR TAN C ILEXETIL SANDO Z TABLET 32MG

0,25

STUK 2,97680

0C 09C AAO V 0C 09C AAO V

107413 107414

C ANDESAR TAN C ILEXETIL TEVA TABLET 8MG C ANDESAR TAN C ILEXETIL TEVA TABLET 16MG

1,00 0,50

STUK 0,74420 STUK 1,48840

0C 09C AAO V

107415

C ANDESAR TAN C ILEXETIL TEVA TABLET 32MG

0,25

STUK 2,97680

0C 09C AAO V

111522//17617

C O ZAAR TABLET FILMO MHULD 50MG

1,00

STUK 0,74420

0C 09C AAO V 0C 09C AAO V

111535//26791 C O ZAAR TABLET FILMO MHULD 100MG EU/1/09/576/016 IR BESAR TAN TEVA TABLET FILMO MHULD 150MG

0,50 1,00

STUK 1,48840 STUK 0,74420

0C 09C AAO V

EU/1/09/576/029 IR BESAR TAN TEVA TABLET FILMO MHULD 300MG

0,50

STUK 1,48840

0C 09C AAO V

EU/1/09/576/003 IR BESAR TAN TEVA TABLET FILMO MHULD 75MG

2,00

STUK 0,44652

YC 09BAAO V

34163

ENALAP R IL/HYDR O C HLO O R THIAZIDE P C H TABLET 20/12,5MG 1,00

STUK 1,21989

YC 09DAAO V

110973

C ANDESAR TAN C ILEXETIL/HC T AC TAVIS TABLET 16/12,5MG

1,00

STUK 1,54013

YC 09DAAO V YC 09DAAO V

107286 102913

C ANDESAR TAN C ILEXETIL/HC T C F TABLET 16/12,5MG C ANDESAR TAN C ILEXETIL/HC T SANDO Z TABLET 16/12,5MG

1,00 1,00

STUK 1,54013 STUK 1,54013

YC 09DAAO V

107418

C ANDESAR TAN C ILEXETIL/HC T TEVA TABLET 8/12,5MG

1,00

STUK 0,79593

YC 09DAAO V

107419

C ANDESAR TAN C ILEXETIL/HC T TEVA TABLET 16/12,5MG

1,00

STUK 1,54013

YC 09DAAO V YC 09DAAO V

EU/1/09/583/017 IR BESAR TAN/HC T TEVA 150MG/12,5MG FILMO MH. TABLET EU/1/09/583/041 IR BESAR TAN/HC T TEVA 300MG/12,5MG FILMO MH. TABLET

1,00 1,00

STUK 0,79593 STUK 1,54013

YC 09DAAO V

EU/1/09/583/065 IR BESAR TAN/HC T TEVA 300MG/25MG FILMO MH. TABLET

1,00

STUK 1,59186

YC 09DXAO V YC 09DXAO V

111493//106667 SEVIKAR HC T TABLET FILMO MHULD 20/ 5/12,5MG 111491//106671 SEVIKAR HC T TABLET FILMO MHULD 40/ 5/12,5MG

1,00 1,00

STUK 1,45043 STUK 2,19463

YC 09DXAO V

111489//106673 SEVIKAR HC T TABLET FILMO MHULD 40/ 5/25MG

1,00

STUK 2,24637

YC 09DXAO V

111500//106672 SEVIKAR HC T TABLET FILMO MHULD 40/10/12,5MG

1,00

STUK 2,84914

0C 10AAAO V

104143

ATO R VASTATINE APO TEX TABLET FILMO MHULD 10MG

2,00

STUK 0,83042

0C 10AAAO V

104160

ATO R VASTATINE APO TEX TABLET FILMO MHULD 20MG

1,00

STUK 1,38403

0C 10AAAO V

104161

ATO R VASTATINE APO TEX TABLET FILMO MHULD 40MG

0,50

STUK 2,76806

0C 10AAAO V 0C 10AAAO V

105734 105737

ATO R VASTATINE C F TABLET FILMO MHULD 10MG ATO R VASTATINE C F TABLET FILMO MHULD 20MG

2,00 1,00

STUK 0,83042 STUK 1,38403

0C 10AAAO V

105738

ATO R VASTATINE C F TABLET FILMO MHULD 40MG

0,50

STUK 2,76806

0C 10AAAO V

104243

ATO R VASTATINE MYLAN TABLET FILMO MHULD 10MG

2,00

STUK 0,83042

0C 10AAAO V 0C 10AAAO V

104246 104251

ATO R VASTATINE MYLAN TABLET FILMO MHULD 20MG ATO R VASTATINE MYLAN TABLET FILMO MHULD 40MG

1,00 0,50

STUK 1,38403 STUK 2,76806

0C 10AAAO V

107733

ATO R VASTATINE R P TABLET FILMO MHULD 10MG

2,00

STUK 0,83042

0C 10AAAO V

107736

ATO R VASTATINE R P TABLET FILMO MHULD 20MG

1,00

STUK 1,38403

0C 10AAAO V 0C 10AAAO V

107737 102140

ATO R VASTATINE R P TABLET FILMO MHULD 40MG ATO R VASTATINE SANDO Z TABLET FILMO MHULD 10MG

0,50 2,00

STUK 2,76806 STUK 0,83042

0C 10AAAO V

102144

ATO R VASTATINE SANDO Z TABLET FILMO MHULD 20MG

1,00

STUK 1,38403

0C 10AAAO V

102152

ATO R VASTATINE SANDO Z TABLET FILMO MHULD 40MG

0,50

STUK 2,76806

0C 10AAAO V 0C 10AAAO V

105247 111375//26872

ATO R VASTATINE TEVA TABLET FILMO MHULD 80MG C R ESTO R TABLET FILMO MHULD 10MG

0,25 1,00

STUK 5,53612 STUK 1,38403

0C 10AAAO V

111373//26873

C R ESTO R TABLET FILMO MHULD 20MG

0,50

STUK 2,76806

0C 10AAAO V

111374//26873

C R ESTO R TABLET FILMO MHULD 20MG

0,50

STUK 2,76806

1G01AFBV V

110812//10633

GYNO DAKTAR IN-3 VAGINAALC AP SULE 400MG

3,00

STUK 1,96551

0G04BDBO V

111485//29152

VESIC AR E TABLET FILMO MHULD 10MG

0,50

STUK 1,65963

0G04C AAO V

105908

ALFUZO SINE HC L AUR O BINDO TABLET MVA 10MG

0,75

STUK 1,28268

0H01C BAP V

110559//18237

SANDO STATINE LAR INJPDR FL 30MG + SO LV 2ML

0,02

STUK 1633,60875

0J07AGAP K

19510

HIBER IX INJP DR FLAC O N 10MC G + SO LV 0,5ML W W SP

1,00

STUK 24,73100

0L04AADO V

111407//22236

P R O GR AFT C AP SULE 0,5MG

10,00 STUK 1,70955

0L04AADO V

111405//18107

P R O GR AFT C AP SULE 1MG

5,00

STUK 2,84925

0L04AADO V

111499//18107

P R O GR AFT C AP SULE 1MG

5,00

STUK 2,84925

0L04AADO V

111410//18108

P R O GR AFT C AP SULE 5MG

1,00

STUK 14,24625

0M01AHBO V

111487//27707

AR C O XIA TABLET FILMO MHULD 120MG

0,50

STUK 2,26376

0M01AHBO V

111351//27705

ETO R IC O XIB FISHER TABLET FILMO MHULD 60MG

1,00

STUK 1,13188

0N02ABADP V

109219

FENTANYL TEVA P LEISTER 50MC G/UUR

0,33

STUK 10,79271

0N02C C AO V

111509//21818

MAXALT SMELTTABLET 10MG

1,00

STUK 6,21227

0N02C C AO V

111435//29413

SUMATR IP TAN FISHER DISP ER GEER BAR E TABLET 50MG

1,00

STUK 6,21227

0N03AXDO V

EU/1/08/470/018 VIMP AT STR O O P 10MG/ML

30,00 ML

2N06BAAO V 2N06BAAO V

111592//33668 111594//33668

W ELLBUTR IN XR TABLET MGA 150MG W ELLBUTR IN XR TABLET MGA 150MG

2,00 2,00

STUK 0,63983 STUK 0,63983

2N06BAAO V

111593//33669

W ELLBUTR IN XR TABLET MGA 300MG

1,00

STUK 1,06638

0N07AAAO V 0N07AAAO V

110937//31373 110934//31374

R EMINYL R ETAR D C AP SULE MVA 16MG R EMINYL R ETAR D C AP SULE MVA 24MG

1,00 0,67

STUK 4,76470 STUK 7,14704

0N07AAAO V

110935//31374

R EMINYL R ETAR D C AP SULE MVA 24MG

0,67

STUK 7,14704

0R 01ADAN V

111404//21613

NASO NEX NEUSSP R AY 50MC G/DO 140DO

4,00

DO

0,08425

0R 03BAAII V

111533//14197

P ULMIC O R T 1000 VER NEVELSUSP 0,500MG/ML R ESP ULE 2ML

3,00

ML

1,92562

0R 03BABID V 0R 03BABID V

111366//31633 111490//31633

ALVESC O 160 AER O SO L 160MC G/DO SPBS 60DO + INH ALVESC O 160 AER O SO L 160MC G/DO SPBS 60DO + INH

1,00 1,00

DO DO

0,70100 0,70100

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00

DO

0,90703

YR 03AC C IDC V 111569//23530

0,11916

2R 06AEAO K

108903

R UP AFIN DR ANK 1MG/ML

10,00 ML

0,09461

2R 06AXAO K

109202

DESLO R ATADINE SANDO Z DR ANK 0,5MG/ML

10,00 ML

0,09461

0S01GXBG V

111350//22946

ALLER GO DIL O O GDR UP PELS 0,5MG/ML FLAC O N 6ML

0,20

ML

1,85595

0S01XABG V

111777//32370

AR TELAC EDO O O GDR UPP ELS 3,2MG/ML TUBE 0,5ML

4,00

STUK 0,22099

YS01EDAG V 0A02BC AO V

109301 32670

LATANO P R O ST/TIMO LO L P FZ O O GDR 0,05/5MG/ML FL 2,5ML O MEP R AZO L TEVA C APSULE MSR 10MG

1,00 ML 9,47766 2,00 STUK 1,00866

0A02BC AO V

32614

O MEP R AZO L TEVA C APSULE MSR 20MG

1,00 STUK

1,68111

0A02BC AO V

109072

R ABEP R AZO LNATR IUM ASP EN 10 MG, MSR TABLET

2,00 STUK

1,00866

0A02BC AO V

109073

R ABEP R AZO LNATR IUM ASP EN 20 MG, MSR TABLET

1,00 STUK

1,68111

0A09AAAO V

108240

P ANZYTR AT GR ANULAAT MSR

1,15 GR AM

2,09656

0A10AC APD V EU/1/97/030/148 INSUMAN BASAL SO LO STAR INJ 100IE/ML W W SP 3ML

0,40 ML

2,48974

0A10BGAO V

EU/1/11/772/013 P IO GLITAZO N AC C O R D TABLET 30MG

1,00 STUK

1,61756

0A10BGAO V

EU/1/11/772/023 P IO GLITAZO N AC C O R D TABLET 45MG

0,67 STUK

2,42634

YC 09DAAO V

105663

C ANDESAR TAN C ILEXETIL/HC T R P TABLET 16/12,5MG

1,00 STUK

1,54013

YC 09DAAO V

106989

LO SAR TAN KALIUM/HC T MYLAN TABL FILMO MH 100/12,5MG

1,00 STUK

1,54013

YC 09DBAO V YC 09DBAO V

EU/1/09/569/001 EXFO R GE HC T TABLET FILMO MHULD 5/160/12,5MG EU/1/09/569/037 EXFO R GE HC T TABLET FILMO MHULD 10/160/25MG

1,00 STUK 1,00 STUK

2,19463 2,90087

0C 10AAAO V

111662//26872

C R ESTO R TABLET FILMO MHULD 10MG

1,00 STUK

1,38403

0C 10AAAO V

111658//26873

C R ESTO R TABLET FILMO MHULD 20MG

0,50 STUK

2,76806

YC 10AXAO V

111683//30929

INEGY TABLET 10/40MG

1,00 STUK

3,56638

YC 10AXAO V

111754//30929

INEGY TABLET 10/40MG

1,00 STUK

3,56638

0G03AABO V

108876

R O SAL TABLET FILMO MHULD

0,75 STUK

0,13253

1G03C AAV V

111641//8977

SYNAP AUSE E3 VAGINAALC R EME 1MG/G + AP PLIC ATO R

0,20 GR AM

0,92231

0G04BEAO V

EU/1/05/318/003 R EVATIO 10 MG/ML P O EDER VO O R O R ALE SUSP ENSIE

6,00 ML

3,17000

0H01C BAP V

111542//26302

SO MATULINE AUTO SO LUTIO N 90 INJ 300MG/ML W W S 0,3ML

0,02 STUK 1625,97507

0H01C BAP V 0H01C BAP V

111655//26302 111654//26303

SO MATULINE AUTO SO LUTIO N 90 INJ 300MG/ML W W S 0,3ML SO MATULINE AUTO SO LUTIO N 120 INJ 300MG/ML W W S 0,4ML

0,02 STUK 1625,97507 0,02 STUK 2167,96676

0H01C BAP V

111702//26303

SO MATULINE AUTO SO LUTIO N 120 INJ 300MG/ML W W S 0,4ML

0,02 STUK 2167,96676

0H02ABAO V

111492//18765

ENTO C O R T C AP SULE MGA 3MG

3,00 STUK

0L04AADO V

107938

TAC R O LIMUS C F C AP SULE 0,5MG

10,00 STUK

1,70955

0L04AADO V

107941

TAC R O LIMUS C F C AP SULE 5MG

1,00 STUK

14,24625

0M01AHBO V

111678//27705

AR C O XIA TABLET FILMO MHULD 60MG

1,00 STUK

1,13188

0M05BABO V

106029

IBANDR O NINEZUUR AC TAVIS TABLET FILMO MHULD 150MG

0,03 STUK

36,75620

0M05BABO V 0M05BABO V

102935 104554

IBANDR O NINEZUUR MYLAN TABLET FILMO MHULD 150MG IBANDR O NINEZUUR SANDO Z TABLET FILMO MHULD 150MG

0,03 STUK 0,03 STUK

36,75620 36,75620

0M05BABO V

EU/1/10/642/004 IBANDR O NINEZUUR TEVA TABLET FILMO MHULD 150MG

0,03 STUK

36,75620

0N02AAAO V 0N02AAAO V

106668 106669

O XYC O DO N HC L GL TABLET FILMO MHULD 5MG O XYC O DO N HC L GL TABLET FILMO MHULD 10MG

6,00 STUK 3,00 STUK

0,41607 0,69344

0N02AAAO V

104137

O XYC O DO N HC L LANNAC HER TABLET MVA 5MG

6,00 STUK

0,41607

0N02AAAO V

104139

O XYC O DO N HC L LANNAC HER TABLET MVA 10MG

3,00 STUK

0,69344

0N02AAAO V 0N02AAAO V

104140 104141

O XYC O DO N HC L LANNAC HER TABLET MVA 20MG O XYC O DO N HC L LANNAC HER TABLET MVA 40MG

1,50 STUK 0,75 STUK

1,38689 2,77378

1,02100

0N02AAAO V

111608

O XYC O DO N HC L MUNDIP HAR MA TABLET MVA 5MG

6,00 STUK

0,41607

0N02AAAO V 0N02AAAO V

111609 111611

O XYC O DO N HC L MUNDIP HAR MA TABLET MVA 10MG O XYC O DO N HC L MUNDIP HAR MA TABLET MVA 20MG

3,00 STUK 1,50 STUK

0,69344 1,38689

0N02AAAO V

111613

O XYC O DO N HC L MUNDIP HAR MA TABLET MVA 40MG

0,75 STUK

2,77378

0N02AAAO V

111615

O XYC O DO N HC L MUNDIP HAR MA TABLET MVA 80MG

0,38 STUK

5,54756

0N02ABADP V

109220

FENTANYL TEVA P LEISTER 75MC G/UUR

0,22 STUK

16,18906

0N02C C AO V

109138

ZO LMITR IP TAN GLENMAR K O R O DISP TABLET 2,5MG

1,00 STUK

6,21227

0N02C C AO V

107307

ZO LMITR IP TAN GLENMAR K TABLET FILMO MHULD 2,5MG

1,00 STUK

6,21227

0N03AXDO V

EU/1/11/711/004 MATEVER TABLET FILMO MHULD 250MG

6,00 STUK

0,95330

0N03AXDO V

EU/1/11/711/011 MATEVER TABLET FILMO MHULD 500MG

3,00 STUK

1,19163

0N03AXDO V

EU/1/11/711/027 MATEVER TABLET FILMO MHULD 1000MG

1,50 STUK

2,38325

4N05AXAO V

110767//34626

SER O Q UEL XR TABLET MVA 200MG

1,50 STUK

2,64201

4N05AXAO V

110768//34627

SER O Q UEL XR TABLET MVA 300MG

1,00 STUK

3,96302

4N05AXAO V

110770//34628

SER O Q UEL XR TABLET MVA 400MG

0,75 STUK

5,28402

2N06ABAO V

111521//30495

ESC ITALO P R AM FISHER TABLET FILMO MHULD 10MG

1,00 STUK

1,06638

2N06ABAO V

111779

ESC ITALO P R AM SANDO Z TABLET FILMO MHULD 10MG

1,00 STUK

1,06638

2N06ABAO V 2N06ABAO V

111780 111781

ESC ITALO P R AM SANDO Z TABLET FILMO MHULD 15MG ESC ITALO P R AM SANDO Z TABLET FILMO MHULD 20MG

0,67 STUK 0,50 STUK

1,59958 2,13277

0R 03BABID V

111721//31632

ALVESC O 80 AER O SO L 80MC G/DO SP BS 60DO + INH

2,00 DO

0,42060

0R 03DC AO K

109499

MO NTELUKAST ASPEN 4 MG KAUW TABLETTEN

2,50 STUK

1,10541

0R 03DC AO K

109500

MO NTELUKAST ASPEN 5 MG KAUW TABLETTEN

2,00 STUK

1,31596

0R 03DC AO V

109501

MO NTELUKAST ASPEN 10 MG TABLETTEN

1,00 STUK

1,31596

YR 03AC C IDC V 111519//23530

SALMETER O L/FLUTIC ASO N FISHER INHPDR 50/250MC G 60DO

1,00 DO

0,90703

YR 03AC C IDC V 111514//23531

SALMETER O L/FLUTIC ASO N FISHER INHPDR 50/500MC G 60DO

1,00 DO

1,20396

YR 03AC C IDC V 111727//23529

SER ETIDE DISKUS INHP DR 50/100MC G 60DO

1,00 DO

0,72888

YR 03AKAIDC V 111370//27690

BUDESO NIDE/FO R MO T FIS TUR B INHP DR 400/12MC G/DO 60D

1,00 DO

0,96642

2R 06AXAO V

109194

DESLO R ATADINE GLENMAR K TABLET 5MG

1,00 STUK

0,50499

YS01C AEG V

111668//14223

TO BR ADEX O O GDR UP P ELS FLAC O N 5ML

1,00 ML

1,15170

0A02BC AO V

110969

ESO MEP R AZO L AC TAVIS C AP SULE MSR 20MG

1,00 STUK

1,68111

0A02BC AO V 0A02BC AO V

110970 111372//25388

ESO MEP R AZO L AC TAVIS C AP SULE MSR 40MG ESO MEP R AZO L FISHER TABLET MSR 40MG

0,50 STUK 0,50 STUK

3,36221 3,36221

0A03AAAO V

111501//11657

DUSP ATAL R ETAR D C AP SULE MGA 200MG

2,00 STUK

0,35055

0A05AAAO V

111657//9307

UR SO C HO L TABLET 300MG

2,00 STUK

0,92453

0A06ADBO V

111524//106616 P IC O P R EP P O EDER VO O R DR ANK SAC HET 16,1G

2,00 STUK

8,86005

0A09AAAO V

110991//16055

2,40 STUK

1,00796

C R EO N FO R TE C AP SULE MSR (P ANC R EATINE 300MG)

0A10ABAP I V

EU/1/02/230/007 AC TR AP ID P ENFILL INJ 100IE/ML P ATR 3ML

0,40 ML

2,09465

0A10ABBP I V

EU/1/99/119/006 NO VO R AP ID P ENFILL INJVLST 100E/ML P ATR O O N 3ML

0,40 ML

2,26345

0A10AC API V

EU/1/02/233/007 INSULATAR D PENFILL INJ 100IE/ML PATR 3ML

0,40 ML

2,09223

0A10BBAO V

EU/1/11/743/001 R EPAGLINIDE AC C O R D TABLET 0,5MG

8,00 STUK

0,05542

0A10BBAO V

EU/1/11/743/006 R EPAGLINIDE AC C O R D TABLET 1MG

4,00 STUK

0,06928

0A10BBAO V

EU/1/11/743/011 R EPAGLINIDE AC C O R D TABLET 2MG

2,00 STUK

0,13855

0C 01C AAP K

111729//32726

EPIPEN JUNIO R INJVLST 0,5MG/ML W W SP 0,3ML

1,00 ML

1C 01DAAO V

111520//13645

ISO SO R BIDEMO NO NITR AAT FISHER R ETAR D C AP SULE 50MG

1,20 STUK

0,45378

0C 09C AAO V

108067

EPR O SAR TAN MYLAN TABLET O MHULD 400MG

1,50 STUK

0,49613

0C 09C AAO V

108070

EPR O SAR TAN MYLAN TABLET O MHULD 600MG

1,00 STUK

0,74420

YC 09BAAO V

103276

P ER INDO PR IL TER T-BUTYL/INDAP AMIDE MYL TB 2/0,625MG

1,00 STUK

0,31790

YC 09DAAO V

111947//23597

FO R TZAAR TABLET O MHULD 100/25MG

1,00 STUK

1,59186

0C 10AC AO V 0C 10AC AO V

112029//28626 112031//28626

EZETIMIBE ER C TABLET 10MG EZETR O L TABLET 10MG

1,00 STUK 1,00 STUK

1,72101 1,72101

YC 10AXAO V

111948//30928

INEGY TABLET 10/20MG

1,00 STUK

2,64369

0G04BDBO V

108953

TO LTER O DINE PFIZER C AP SULE MVA 2MG

2,00 STUK

0,41491

0G04BDBO V

108954

TO LTER O DINE PFIZER C AP SULE MVA 4MG

1,00 STUK

0,82981

0G04C AAO V

111725//30565

O MNIC O C AS TABLET MVA 0,4MG

1,00 STUK

0,96201

0G04C BAO V

111685//28317

AVO DAR T C AP SULE 0,5MG

1,00 STUK

1,12371

YG04C AAO V

111775//104130 C O MBO DAR T C AP SULE 0,5/0,4MG

1,00 STUK

2,08572

0L02BGAO V

111486//24443

1,00 STUK

4,71931

0L04AADO V

EU/1/07/387/023 ADVAGR AF C AP SULE MVA 3MG

1,67 STUK

8,54775

0N02AAC P V

104837

P ALLADO N INJEC TIE 20 MG/ML,O PLO SSING V.INJ.O F INF.

0,20 ML

19,57500

0N02AAC P V

104838

P ALLADO N INJEC TIE 50 MG/ML,O PLO SSING V.INJ.O F INF.

0,08 ML

48,93750

0N02AAC P V 0N02AAC P V

104833 104836

P ALLADO N INJVLST 2MG/ML AMP UL 1ML P ALLADO N INJVLST 10MG/ML AMP UL 1ML

2,00 ML 0,40 ML

1,95750 9,78750

0N02C C AO V

101503

ZO LMITR IP TAN P C H TABLET FILMO MHULD 2,5MG

1,00 STUK

6,21227

1N05ADAPD V 111349//8994

HALDO L DEC ANO AAT INJVLST 50MG/ML AMP UL 1ML

0,07 STUK

10,84955

4N05AXAO V

111726//20826

SER O Q UEL TABLET FILMO MHULD 25MG

12,00 STUK

0,52840

2N06AXBO V

109725

TR AZO DO N HC L SANDO Z TABLET 100MG

3,00 STUK

0,35546

AR O MASIN TABLET O MHULD 25MG

148,23500

0S01XABG V

111352//18218

C ELLUVISC UNIT DO SE O O GDR UP P ELS 10MG/ML TUBE 0,4ML

5,00 STUK 19,05 ML

0,17679

1A06ADAO V

111959//106666 MO VIC O LO N LIQ UID O R ANGE C O NC ENTR AAT VO O R DR ANK

0,02166

0A10BGAO V

108655

P IO GLITAZO N AUR O BINDO TABLET 30MG

1,00 STUK

1,61756

0A10BGAO V

108656

P IO GLITAZO N AUR O BINDO TABLET 45MG

0,67 STUK

2,42634

0C 01C AAP V

112030//31435

ANAP EN 300 INJVLST 1MG/ML W W SP 0,3ML

1,00 ML

0C 02C AAO V

107678

DO XAZO SINE MYLAN R ETAR D TABLET MVA 8MG

0,50 STUK

1,68644

0C 07ABAO V

105896

BISO P R O LO LFUMAR AAT AUR O BINDO TABLET FILMO MH 5MG

2,00 STUK

0,20307

0C 07ABAO V

105897

BISO P R O LO LFUMAR AAT AUR O BINDO TABLET FILMO MH 10MG

1,00 STUK

0,40613

0C 07ABAO V

106055

BISO P R O LO LFUMAR AAT DEC O AUR O B TABL FILMO MH 2,5MG

4,00 STUK

0,10153

0C 09AAAO V

112128//23720

ZO FIL TABLET O MHULD 7,5MG

4,00 STUK

0,23363

0C 09C AAO V

106369

IR BESAR TAN AUR O BINDO TABLET 75MG

2,00 STUK

0,44652

0C 09C AAO V

106371

IR BESAR TAN AUR O BINDO TABLET 150MG

1,00 STUK

0,74420

0C 09C AAO V

106372

IR BESAR TAN AUR O BINDO TABLET 300MG

0,50 STUK

1,48840

0C 09C AAO V

107321

IR BESAR TAN MYLAN TABLET 75MG

2,00 STUK

0,44652

0C 09C AAO V

107324

IR BESAR TAN MYLAN TABLET 150MG

1,00 STUK

0,74420

0C 09C AAO V

107325

IR BESAR TAN MYLAN TABLET 300MG

0,50 STUK

1,48840

0C 09C AAO V

102085

IR BESAR TAN R P TABLET FILMO MHULD 150MG

1,00 STUK

0,74420

0C 09C AAO V

102087

IR BESAR TAN R P TABLET FILMO MHULD 300MG

0,50 STUK

1,48840

0C 09C AAO V

108248

VALSAR TAN AUR O BINDO TABLET FILMO MHULD 40MG

2,00 STUK

0,44652

0C 09C AAO V

108250

VALSAR TAN AUR O BINDO TABLET FILMO MHULD 80MG

1,00 STUK

0,74420

0C 09C AAO V

108251

VALSAR TAN AUR O BINDO TABLET FILMO MHULD 160MG

0,50 STUK

1,48840

0C 09C AAO V

108252

VALSAR TAN AUR O BINDO TABLET FILMO MHULD 320MG

0,25 STUK

2,97680

YC 09BAAO V

105685

FO SINO P R IL/HYDR O C HLO O R THIAZIDE AUR TABL 20/12,5MG

1,00 STUK

0,83050

YC 09DAAO V

111945//22365

C O DIO VAN TABLET O MHULD 80/12,5MG

1,00 STUK

0,79593

0C 10AAAO V

106354

ATO R VASTATINE P HAR MATHEN TABLET FILMO MHULD 10MG

2,00 STUK

0,83042

0C 10AAAO V

106356

ATO R VASTATINE P HAR MATHEN TABLET FILMO MHULD 20MG

1,00 STUK

1,38403

0C 10AAAO V

106357

ATO R VASTATINE P HAR MATHEN TABLET FILMO MHULD 40MG

0,50 STUK

2,76806

0C 10AAAO V

106358

ATO R VASTATINE P HAR MATHEN TABLET FILMO MHULD 80MG

0,25 STUK

5,53612

0G03ABBO V

111950//101491 Q LAIR A TABLET FILMO MHULD

0,93 STUK

0,10108

0G04C BAO V

111518//28317

DUTASTER IDE FISHER C AP SULE 0,5MG

1,00 STUK

1,12371

0H03AAAO V

111671//9009

EUTHYR O X TABLET 100MC G

1,50 STUK

0,04272

0H03AAAO V

111672//15468

EUTHYR O X TABLET 125MC G

1,20 STUK

0,05340

0H03AAAO V

111673//11345

EUTHYR O X TABLET 150MC G

1,00 STUK

0,06408

0J01FAAO V

107044

C LAR ITR O MYC INE AUR O BINDO TABLET FILMO MHULD 250MG

2,00 STUK

1,21516

148,23500

0J01GBAII V

109928//102952 C O LISTIMETHAAT NATR TO P PH P DR V VER NO P L 2 MILJ IE

1,50 STUK

30,06294

0J01MAAO V

107787

LEVO FLO XAC INE AUR O BINDO TABLET FILMO MHULD 250MG

1,00 STUK

3,05666

0J01MAAO V

107790

LEVO FLO XAC INE AUR O BINDO TABLET FILMO MHULD 500MG

0,50 STUK

6,11332

0L04AABO V

110114

MYC O FENO LAAT MO FETIL AC C O R D C AP SULE 250MG

8,00 STUK

1,77337

1M01AC AO V

107063

MELO XIC AM AUR O BINDO TABLET 7,5MG

2,00 STUK

0,33398

1M01AC AO V

107068

MELO XIC AM AUR O BINDO TABLET 15MG

1,00 STUK

0,55664

0M05BAAO V

111776//20245

BO NEFO S TABLET 800MG

2,00 STUK

4,09794

0M05BAAO V

106808

NATR IUMR ISEDR O NAAT AUR O BINDO TABLET FILMO MH 30MG

1,00 STUK

8,19588

0N02C C AO V

112032//29413

IMIGR AN FTAB DISP ER GEER BAR E TABLET 50MG

1,00 STUK

6,21227

0N02C C AO V

112033//29414

IMIGR AN FTAB DISP ER GEER BAR E TABLET 100MG

0,50 STUK

12,42453

0N03AXC O V

108280

GABAP ENTINE AUR O BINDO TABLET FILMO MHULD 600MG

3,00 STUK

1,30689

0N03AXC O V

108287

GABAP ENTINE AUR O BINDO TABLET FILMO MHULD 800MG

2,25 STUK

1,74252

0N04BC AO V

109668

P R AMIP EXO L AUR O BINDO TABLET 0,125MG (0,088MG BASE)

20,00 STUK

0,46983

0N04BC AO V

109669

P R AMIP EXO L AUR O BINDO TABLET 1MG (0,7MG BASE)

2,50 STUK

1,56609

4N05AHAO V

108562

O LANZAP INE AUR O BINDO TABLET 2,5MG

4,00 STUK

1,58521

4N05AHAO V

108567

O LANZAP INE AUR O BINDO TABLET 5MG

2,00 STUK

1,98151

4N05AHAO V

108569

O LANZAP INE AUR O BINDO TABLET 10MG

1,00 STUK

3,96302

4N05AHAO V

108570

O LANZAP INE AUR O BINDO TABLET 15MG

0,67 STUK

5,94453

4N05AHAO V

108571

O LANZAP INE AUR O BINDO TABLET 20MG

0,50 STUK

7,92603

4N05AXAO V

105399

Q UETIAPINE AUR O BINDO TABLET FILMO MHULD 25MG

12,00 STUK

0,52840

4N05AXAO V

105401

Q UETIAPINE AUR O BINDO TABLET FILMO MHULD 100MG

3,00 STUK

1,32101

4N05AXAO V

105403

Q UETIAPINE AUR O BINDO TABLET FILMO MHULD 200MG

1,50 STUK

2,64201

4N05AXAO V

105404

Q UETIAPINE AUR O BINDO TABLET FILMO MHULD 300MG

1,00 STUK

3,96302

0N06BABO V

109974

MO DAFINIL AUR O BINDO TABLET 100MG

3,00 STUK

2,81344

0R 03AC C IDAV 111852//33735

SER EVENT AER O SO L 25MC G/DO C FKVR SPBS 120DO + INH

4,00 DO

0,23086

0R 03BADID V

111944//18193

FLIXO TIDE DISKUS INHP DR 100MC G 60DO

6,00 DO

0,15440

0R 03BADID V

111953//18194

FLIXO TIDE DISKUS INHP DR 250MC G 60DO

2,40 DO

0,29692

0R 03BADID V

111946//18195

FLIXO TIDE DISKUS INHP DR 500MC G 60DO

1,20 DO

0,59385

YR 03AC C IDAV 107222

FLUTIFO R M AER O SO L 50/ 5MC G/DO SP BS 120DO + INH

1,00 DO

0,25080

YR 03AC C IDAV 107242

FLUTIFO R M AER O SO L 125/ 5MC G/DO SP BS 120DO + INH

1,00 DO

0,33843

YR 03AC C IDAV 107243

FLUTIFO R M AER O SO L 250/10MC G/DO SPBS 120DO + INH

1,00 DO

0,67685

YR 03AC C IDAV 111850//25865

SER ETIDE AER O SO L 25/ 50MC G/DO C FKVR SP BS 120DO +INH

1,00 DO

0,28928

2R 06AEAO V

102276

C ETIR IZINE DIHC L AUR O BINDO TABLET FILMO MHULD 10MG

1,00 STUK

0,50499

2R 06AEAO V

110247

LEVO C ETIR IZINE DIHC L GLENMAR K TABLET FO 5MG

1,00 STUK

0,50499

2R 06AXAO V

109515

DESLO R ATADINE MYLAN TABLET FILMO MHULD 5MG

1,00 STUK

0,50499

2R 06AXAO V

109201

DESLO R ATADINE SANDO Z TABLET FILMO MHULD 5MG

1,00 STUK

0,50499

0V03AEAO V

109377

FO SR ENO L PO EDER IN SAC HET 750MG

3,00 STUK

2,97866

0V03AEAO V

109379

FO SR ENO L PO EDER IN SAC HET 1000MG

2,25 STUK

3,97155

0A02BC AO V

111618//101600 NEXIUM GR ANULAAT MSR V SUSP IN SAC HET 10MG

2,00

STUK 1,00866

1A06ADAO V

111859//106666 MO VIC O LO N LIQ UID O R ANGE C O NC ENTR AAT VO O R DR ANK

19,05 ML

0A07DAAO V

112009

LO P ER AMIDE HC L AC TAVIS C AP SULE 2MG

5,00

STUK 0,23143

0A09AAAO V

111001//10656

C R EO N C AP SULE MSR (P ANC R EATINE 150MG)

6,00

STUK 0,40319

YA10BDEO V

EU/1/12/780/006 JENTADUETO TABLET FILMO MHULD 2,5MG/ 850MG

1,00

STUK 1,70386

YA10BDEO V

EU/1/12/780/020 JENTADUETO TABLET FILMO MHULD 2,5MG/1000MG

1,00

STUK 1,72042

0B01ABAP V

112316//11876

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,3ML

0,30

ML

0B01AC DO V

106706

C LO P IDO GR EL MYLAN TABL FILMO M 75MG(ALS HBR MO NO H)

1,00

STUK 1,88043

1C 01DAAO V

112132//13645

MO NO C EDO C AR D R ETAR D C AP SULE MGA 50MG

1,20

STUK 0,45378

0C 08C AAO V

107646

FELO DIP INE AC TAVIS R ETAR D TABLET MGA 5MG

1,00

STUK 0,65450

0C 08C AAO V

107648

FELO DIP INE AC TAVIS R ETAR D TABLET MGA 10MG

0,50

STUK 1,30901

0C 09C AAO V

102535

IR BESAR TAN AC C O R D TABLET FILMO MHULD 75MG

2,00

STUK 0,44652

0C 09C AAO V

102541

IR BESAR TAN AC C O R D TABLET FILMO MHULD 150MG

1,00

STUK 0,74420

0C 09C AAO V

102542

IR BESAR TAN AC C O R D TABLET FILMO MHULD 300MG

0,50

STUK 1,48840

0C 09C AAO V

101598

IR BESAR TAN AC TAVIS TABLET FILMO MHULD 75MG

2,00

STUK 0,44652

0C 09C AAO V

101599

IR BESAR TAN AC TAVIS TABLET FILMO MHULD 150MG

1,00

STUK 0,74420

0C 09C AAO V

101602

IR BESAR TAN AC TAVIS TABLET FILMO MHULD 300MG

0,50

STUK 1,48840

0C 09C AAO V

104954

IR BESAR TAN C F TABLET FILMO MHULD 75MG

2,00

STUK 0,44652

0C 09C AAO V

104955

IR BESAR TAN C F TABLET FILMO MHULD 150MG

1,00

STUK 0,74420

0C 09C AAO V

104956

IR BESAR TAN C F TABLET FILMO MHULD 300MG

0,50

STUK 1,48840

0C 09C AAO V

104619

IR BESAR TAN JUBILANT TABLET FILMO MHULD 75MG

2,00

STUK 0,44652

0C 09C AAO V

104620

IR BESAR TAN JUBILANT TABLET FILMO MHULD 150MG

1,00

STUK 0,74420

0C 09C AAO V

104621

IR BESAR TAN JUBILANT TABLET FILMO MHULD 300MG

0,50

STUK 1,48840

0C 09C AAO V

101865

IR BESAR TAN SANDO Z TABLET FILMO MHULD 150MG

1,00

STUK 0,74420

0C 09C AAO V

101866

IR BESAR TAN SANDO Z TABLET FILMO MHULD 300MG

0,50

STUK 1,48840

0C 09C AAO V

EU/1/12/765/001 SABER VEL TABLET FILMO MHULD 75MG

2,00

STUK 0,44652

0C 09C AAO V

EU/1/12/765/003 SABER VEL TABLET FILMO MHULD 150MG

1,00

STUK 0,74420

0C 09C AAO V

EU/1/12/765/005 SABER VEL TABLET FILMO MHULD 300MG

0,50

STUK 1,48840

YC 09DAAO V

105140

KALIUMLO SAR TAN/HC T AC TAVIS TABL FILMO MH 50/12,5MG

1,00

STUK 0,79593

YC 10AXAO V

111698//30928

INEGY TABLET 10/20MG

1,00

STUK 2,64369

YC 10AXAO V

111699//30929

INEGY TABLET 10/40MG

1,00

STUK 3,56638

0D10AFBDL V

108315

C LINDAMYC INE TEVA O P L V C UTAAN GEBR UIK 10MG/ML

1,00

ML

0,02166

5,92940

0,19528

1G01AFBV V

112175//15814

GYNO MYK VAGINAALC R EME 20MG/G +3 AP PLIC ATO R S

15,00 GR AM 0,70759

0G03AABO V

108939

DESO GESTR EL/ETHINYLESTR ADIO L C F TABLET 0,15/0,02MG

0,75

STUK 0,13253

0G03AABO V

108940

DESO GESTR EL/ETHINYLESTR ADIO L C F TABLET 0,15/0,03MG

0,75

STUK 0,13253

0G04BDBO V

108822

TO LTER O DINETAR TR AAT MYLAN R ETAR D C AP SULE MVA 2MG

2,00

STUK 0,41491

0G04BDBO V

108823

TO LTER O DINETAR TR AAT MYLAN R ETAR D C AP SULE MVA 4MG

1,00

STUK 0,82981

0G04BDBO V

102817

TO LTER O DINETAR TR AAT P C H TABLET FILMO MHULD 1MG

4,00

STUK 0,24894

0G04BDBO V

102820

TO LTER O DINETAR TR AAT P C H TABLET FILMO MHULD 2MG

2,00

STUK 0,41491

0G04BDBO V

101609

TO LTER O DINETAR TR AAT SANDO Z TABLET FILMO MHULD 1MG

4,00

STUK 0,24894

0G04BDBO V

101613

TO LTER O DINETAR TR AAT SANDO Z TABLET FILMO MHULD 2MG

2,00

STUK 0,41491

YG04C AAO V

111399//104130 C O MBO DAR T C AP SULE 0,5/0,4MG

1,00

STUK 2,08572

YG04C AAO V

111887//104130 C O MBO DAR T C AP SULE 0,5/0,4MG

1,00

STUK 2,08572

0J01DABO V

111512//13226

ZINNAT 250 TABLET 250MG

2,00

STUK 2,09011

0J01FAAO V

28933

AZITR O MYC INE TEVA TABLET O MHULD 250MG

1,20

STUK 2,02526

0L01BAAP V

111355

METHO TR EXAAT AC C O R D INJVLST 25MG/ML FLAC O N 2ML

0,02

STUK 10,66725

0L01BAAP V

111355

METHO TR EXAAT AC C O R D INJVLST 25MG/ML FLAC O N 20ML

0,00

STUK 106,67250

0L01BAAP V

111355

METHO TR EXAAT AC C O R D INJVLST 25MG/ML FLAC O N 40ML

0,00

STUK 213,34500

0L04AABO V

112186//30203

MYFO R TIC TABLET MSR 360MG

4,00

STUK 2,95562

0N02BEDO V

111620

P AR AC ETAMO L SANDO Z TABLET 1000MG

3,00

STUK 0,11300

0N02C C AO V

112039//26579

R ELP AX TABLET FILMO MHULD 40MG

1,00

STUK 6,21227

0N06AAAO V

110147

AMITR IP TYLINE HC L SANDO Z TABLET 25MG

3,00

STUK 0,14743

0N06BAAO V

112022//108026 MEDIKINET C R C AP SULE MGA 5MG

6,00

STUK 0,07270

0N06BAAO V

112020//34027

MEDIKINET C R C AP SULE MGA 10MG

3,00

STUK 0,12116

2N06AXBO V

112236//9145

TR AZO LAN TABLET 100MG

3,00

STUK 0,35546

0R 01ADAN V

111697//21613

MO METASO NFUR O AAT FISHER NEUSSP R AY 50MC G/DO 140DO

4,00

DO

0,08425

0R 01ADAN V

112339//23837

R HINO C O R T NEVEL NEUSSP R AY 32MC G/DO 120DO

6,25

DO

0,07684

0R 01ADAN V

112341//23838

R HINO C O R T NEVEL NEUSSP R AY 64MC G/DO 120DO

3,13

DO

0,10784

0R 03AC C IDAV 111633//33735

SALMETER O L FISHER AER 25MC G/DO C FKVR 120DO +INH

4,00

DO

0,23086

0R 03BABID V

112318//31633

ALVESC O 160 AER O SO L 160MC G/DO SPBS 60DO + INH

1,00

DO

0,70100

0R 03BABID V

112129//16212

FLIXO TIDE AER C FKVR 50MC G/DO SP BS 120 DO + INHAL

12,00 DO

0,10515

YR 03AC C IDAV 112364//34610

BEC LO METASO N/FO R MO TER O L FISH AER 100/6MC G/DO 180DO 1,00

DO

0,40611

YR 03AKAII V

IP R ATR O BR /SALBUT SDZ UD VER NO P L 0,5/2,5MG FL2,5ML

ML

0,28661

100362

1,00

0A05AAAO V

111849//9307

UR SO C HO L TABLET 300MG

2,00 STUK 0,92453

0A10BAAO V

104259

METFO R MINE HC L AC TAVIS TABLET 500MG

4,00 STUK 0,05521

0A10BAAO V

104264

METFO R MINE HC L AC TAVIS TABLET 850MG

2,35 STUK 0,09386

0A12AABO V

112360//14032

C ALC I C HEW KAUW TABLET 500MG

2,00 STUK 0,26210

1C 04ADAO V

112185//11175

TR ENTAL TABLET MGA 400MG

2,50 STUK 0,19835

0C 08C AAO V

101560

AMLO DIP INE P C H TABLET 10MG (ALS BESILAAT)

0,50 STUK 1,30901

0C 09AAAO V

31945

FO SINO P R ILNATR IUM TEVA TABLET 10MG

1,50 STUK 0,38939

0C 09AAAO V

31946

FO SINO P R ILNATR IUM TEVA TABLET 20MG

0,75 STUK 0,77877

YC 09DABO V

112271//32740

O LMETEC HC TZ TABLET FILMO MHULD 20/12,5MG

1,00 STUK 0,79593

0C 10AAAO V

112385//13193

ZO C O R TABLET 10MG

3,00 STUK 0,46134

0D10ADADC V 112474//32496

DIFFER IN GEL 1MG/G

1,00 GR AM 0,23211

0G03C AAO V

112126//5861

P R O GYNO VA DR AGEE 1MG

2,00 STUK 0,11226

0G03C AAO V

112125//5311

P R O GYNO VA DR AGEE 2MG

1,00 STUK 0,18710

0G04BDBO V

112382//29151

VESIC AR E TABLET FILMO MHULD 5MG

1,00 STUK 0,82981

0G04BDBO V

112383//29152

VESIC AR E TABLET FILMO MHULD 10MG

0,50 STUK 1,65963

0H02ABEP V

112133//5341

KENAC O R T A 40 INJEC TIESUSP ENSIE 40MG/ML AMP UL 1ML

0,19 ML

0L01C BAO V

112429//10375

VEP ESID C AP SULE 50MG

8,00 STUK 8,38722

0L02AEADI V

111450//12277

ZO LADEX IMP LANTATIESTIFT 3,6MG IN W W SP

1,00 STUK 184,07590

0L02AEADI V

111637//18562

ZO LADEX IMP LANTATIESTIFT 10,8MG IN W W SP

0,33 STUK 552,22770

YM01AEAO V

112374//106235 VIMO VO TABLET MGA 500/20MG

1,00 STUK 2,23775

YM01AEAO V

112384//106235 VIMO VO TABLET MGA 500/20MG

1,00 STUK 2,23775

0N02AAAO V

108257

O XYC O DO N HC L TEVA TABLET MVA 5MG

6,00 STUK 0,41607

0N02ABC O V

102483

BR EAKYL TABLET MUC O -ADHESIEF BUC C AAL 200MC G

3,00 STUK 7,05180

0N02ABC O V

102485

BR EAKYL TABLET MUC O -ADHESIEF BUC C AAL 400MC G

1,50 STUK 10,07400

0N02ABC O V

102486

BR EAKYL TABLET MUC O -ADHESIEF BUC C AAL 600MC G

1,00 STUK 15,11100

0N02ABC O V

102487

BR EAKYL TABLET MUC O -ADHESIEF BUC C AAL 800MC G

0,75 STUK 20,14800

0N03AFBO V

112386//24751

TR ILEP TAL TABLET FILMO MHULD 300MG

3,33 STUK 0,29201

0N03AFBO V

112381//24752

TR ILEP TAL TABLET FILMO MHULD 600MG

1,67 STUK 0,58402

0N03AXC O V

107978

GABAP ENTINE MYLAN TABLET 600MG

3,00 STUK 1,30689

0N05ANAO V

112425//5821

P R IADEL TABLET MGA 400MG

2,22 STUK 0,04765

5,51796

0N05BAAO V

108992

DIAZEP AM AC TAVIS TABLET 2MG

0N05BAAO V

108995

DIAZEP AM AC TAVIS TABLET 5MG

5,00 STUK 0,04840 2,00 STUK 0,12101

0N05BAAO V

108996

DIAZEP AM AC TAVIS TABLET 10MG

1,00 STUK 0,24201

4N05AHAO V

102968

O LANZAP INE AC C O R D TABLET FILMO MHULD 2,5MG

4,00 STUK 1,58521

4N05AHAO V

102969

O LANZAP INE AC C O R D TABLET FILMO MHULD 5MG

2,00 STUK 1,98151

4N05AHAO V

102971

O LANZAP INE AC C O R D TABLET FILMO MHULD 10MG

1,00 STUK 3,96302

4N05AHAO V

102972

O LANZAP INE AC C O R D TABLET FILMO MHULD 15MG

0,67 STUK 5,94453

4N05AHAO V

102973

O LANZAP INE AC C O R D TABLET FILMO MHULD 20MG

0,50 STUK 7,92603

4N05AXAO V

111213//34626

SER O Q UEL XR TABLET MVA 200MG

1,50 STUK 2,64201

4N05AXAO V

111214//34627

SER O Q UEL XR TABLET MVA 300MG

1,00 STUK 3,96302

2N06ABAO V

111867//30495

LEXAPR O TABLET FILMO MHULD 10MG

1,00 STUK 1,06638

0N07AAAO V

107784

GALANTAMINE AUR O BINDO TABLET FILMO MHULD 4MG

4,00 STUK 1,42941

0R 01ADAN V

112387//21837

NASAC O R T NEUSSP R AY 55MC G/DO 120DO

4,00 DO

0,08425

0R 01ADAN V

111935//21613

NASO NEX NEUSSP R AY 50MC G/DO 120DO

4,00 DO

0,08425

0R 01ADAN V

111438//21613

NASO NEX NEUSSP R AY 50MC G/DO 140DO

4,00 DO

0,08425

0R 03AC AIDAV 112038//21440

VENTO LIN 100 AER C FKVR 100MC G/DO SP BS 200DO +INHAL

8,00 DO

0,01654

0R 03AC C IDC V 112243//17158

FO R ADIL INHALATIEP DR 12MC G + INHALATO R

2,00 STUK 0,61011

0R 03BABID V

112124//16214

FLIXO TIDE AER C FKVR 250MC G/DO SP BS 60 DO + INHAL

2,40 DO

0,29208

YS01EDAG V

110119

LATANO P R O ST/TIMO LO L TEV O O GDR 0,05/5MG/ML FL 2,5ML 1,00 ML

9,47766

0A02BC AO V

105048

R ABEP R AZO LNATR IUM AC TAVIS TABLET MSR 10MG

2,00

STUK 1,00866

0A02BC AO V

105071

R ABEP R AZO LNATR IUM AC TAVIS TABLET MSR 20MG

1,00

STUK 1,68111

0A02BC AO V

110043

R ABEP R AZO LNATR IUM MYLAN TABLET MSR 10MG

2,00

STUK 1,00866

0A02BC AO V

110044

R ABEP R AZO LNATR IUM MYLAN TABLET MSR 20MG

1,00

STUK 1,68111

0A02BC AO V

103372

R ABEP R AZO LNATR IUM SANDO Z TABLET MSR 10MG

2,00

STUK 1,00866

0A02BC AO V

103373

R ABEP R AZO LNATR IUM SANDO Z TABLET MSR 20MG

1,00

STUK 1,68111

0A06ADAO V

109594

LAC TULO SESTR O O P SANDO Z 670MG/ML O TC

10,00 ML

0A10BAAO V

100915

METFO R MINE HC L SANDO Z TABLET FILMO MHULD 500MG

4,00

STUK 0,05521

0B01AXBO V

EU/1/08/442/002 P R ADAXA C APSULE 75MG

4,00

STUK 1,86136

0B01AXBO V

EU/1/08/442/003 P R ADAXA C APSULE 75MG

4,00

STUK 1,86136

0B01AXBO V

EU/1/08/442/006 P R ADAXA C APSULE 110MG

2,73

STUK 2,27500

0B01AXBO V

EU/1/08/442/007 P R ADAXA C APSULE 110MG

2,73

STUK 2,27500

0B01AXBO V

EU/1/08/442/010 P R ADAXA C APSULE 150MG

2,00

STUK 3,10227

0B01AXBO V

EU/1/08/442/011 P R ADAXA C APSULE 150MG

2,00

STUK 3,10227

0B01AXBO V

EU/1/08/472/012 XAR ELTO TABLET FILMO MHULD 15MG

1,33

STUK 4,65341

0B01AXBO V

EU/1/08/472/013 XAR ELTO TABLET FILMO MHULD 15MG

1,33

STUK 4,65341

0B01AXBO V

EU/1/08/472/016 XAR ELTO TABLET FILMO MHULD 15MG

1,33

STUK 4,65341

0,01566

0B01AXBO V

EU/1/08/472/018 XAR ELTO TABLET FILMO MHULD 20MG

1,00

STUK 6,20455

0B01AXBO V

EU/1/08/472/021 XAR ELTO TABLET FILMO MHULD 20MG

1,00

STUK 6,20455

0C 01C AAP V

112245//106309 JEXT INJVLST 1MG/ML W W SP 0,3ML

3,33

STUK 44,47050

1C 04ADAO V

112459//11175

TR ENTAL TABLET MGA 400MG

2,50

STUK 0,19835

0C 08C AAO V

112633//20555

C YR ESS C APSULE MGA 20MG

0,50

STUK 1,30901

0C 09AAAO V

112644//31959

C O VER SYL AR G TABLET FILMO MHULD 10MG

0,40

STUK 1,46020

0C 09C AAO V

112264//28782

O LMETEC TABLET FILMO MHULD 10MG

2,00

STUK 0,44652

0C 09C AAO V

112270//28784

O LMETEC TABLET FILMO MHULD 40MG

0,50

STUK 1,48840

YC 09DAAO V

103784

IR BESAR TAN/HC T SANDO Z TABLET FILMO MHULD 150/12,5MG 1,00

STUK 0,79593

YC 09DAAO V

107105

IR BESAR TAN/HC T SANDO Z TABLET FILMO MHULD 300/12,5MG 1,00

STUK 1,54013

YC 09DAAO V

103788

IR BESAR TAN/HC T SANDO Z TABLET FILMO MHULD 300/25MG

1,00

STUK 1,59186

YC 09DBBO V

112269//100986 SEVIKAR TABLET FILMO MHULD 40/ 5MG

1,00

STUK 2,14290

0C 10AAAO V

112037//25187

LESC O L XL TABLET MVA 80MG

0,75

STUK 1,84537

0C 10AAAO V

112265//25187

LESC O L XL TABLET MVA 80MG

0,75

STUK 1,84537

0C 10AAAO V

110014

P R AVASTATINENATR IUM AUR O BINDO TABLET 10MG

3,00

STUK 0,55361

0C 10AAAO V

110015

P R AVASTATINENATR IUM AUR O BINDO TABLET 20MG

1,50

STUK 0,92269

0C 10AAAO V

110016

P R AVASTATINENATR IUM AUR O BINDO TABLET 40MG

0,75

STUK 1,84537

0D06AXADZ V

111682

AFFUSINE C R EME 20MG/G

1,00

GR AM 0,22477

0D06AXADZ V

111898

FUSIDINEZUUR C F C R EME 20MG/G

1,00

GR AM 0,22477

0D07ABADL V

112424//16163

LO C O ID C R ELO HUIDEMULSIE 1MG/G

1,00

GR AM 0,14143

0D07ABADL V

112447//5910

LO C O ID SC ALP LO TIO N 1MG/ML

1,00

ML

1G03C AAV V

103834

VAGIFEM VAGINAALTABLET 10MC G

1,00

STUK 0,18446

0G04C AAO V

112536//23923

XATR AL XR TABLET MVA 10MG

0,75

STUK 1,28268

0G04C BAO V

112244//28317

AVO DAR T C AP SULE 0,5MG

1,00

STUK 1,12371

0H01C BBP V

106379

O C TR EO TIDE TEVA INJVLST 0,05MG/ML AMPUL 1ML

14,00 ML

8,68027

0H01C BBP V

106380

O C TR EO TIDE TEVA INJVLST 0,1MG/ML AMP UL 1ML

7,00

ML

10,85034

0H01C BBP V

106381

O C TR EO TIDE TEVA INJVLST 0,5MG/ML AMP UL 1ML

1,40

ML

54,25170

0J01FAAO V

28934

AZITR O MYC INE TEVA TABLET O MHULD 500MG

0,60

STUK 4,05052

0J01FAAO V

107531

C LAR ITR O MYC INE SANDO Z R ETAR D TABLET MVA 500MG

1,00

STUK 2,43031

0J01GBAII V

109489

NEBR IS STER I-NEB VER NEVELO P LO SSING 60MG/ML AMP 5ML

5,00

ML

0L02AEADI V

112375//18562

ZO LADEX IMP LANTATIESTIFT 10,8MG IN W W SP

0,33

STUK 552,22770

0,14143

9,01888

0L02BGAO V

100407

0L03ABAO V

ANASTR O ZO L SANDO Z TABLET FILMO MHULD 1MG

1,00

STUK 4,71931

EU/1/11/720/002 INC IVO TABLET FILMO MHULD 375MG

1,50

STUK 47,86667

0L04AABO V

EU/1/10/647/001 MYC LAUSEN 500 MG FILMO MHULDE TABLETTEN 50 STUKS

4,00

STUK 2,95562

0M01AHBO V

112248//27705

AR C O XIA TABLET FILMO MHULD 60MG

1,00

STUK 1,13188

0M01AHBO V

112246//27706

AR C O XIA TABLET FILMO MHULD 90MG

0,67

STUK 1,69782

0M05BABO V

106025

IBANDR O NINEZUUR C F TABLET FILMO MHULD 150MG

0,03

STUK 36,75620

0N02AAAO V

112480

MO R FINESULFAAT SANDO Z TABLET 10MG

10,00 STUK 0,29125

0N02AAAO V

112481

MO R FINESULFAAT SANDO Z TABLET 20MG

5,00

STUK 0,41607

0N02BEDO V

112428//26161

P ANADO L AR TR O SE TABLET O MHULD 1000MG

3,00

STUK 0,11300

0N02C C AO V

104287

ZO LMITR IP TAN P C H O R O DISP TABLET 2,5MG

1,00

STUK 6,21227

0N03AGAO V

112498//13157

DEPAKINE C HR O NO TABLET MGA 300MG

5,00

STUK 0,15928

0N03AGAO V

112499//11775

DEPAKINE C HR O NO TABLET MGA 500MG

3,00

STUK 0,26546

0N03AXC O V

107979

GABAP ENTINE MYLAN TABLET 800MG

2,25

STUK 1,74252

0N04BAAO V

112452//12858

SINEMET 62,5 TABLET 50/12,5MG

12,00 STUK 0,11366

0N04BAAO V

112455//6707

SINEMET 275 TABLET 250/25MG

2,40

0N04BC AO V

EU/1/11/728/001 P R AMIP EXO L AC C O R D TABLET 0,125MG (0,088MG BASE)

20,00 STUK 0,46983

0N04BC AO V

EU/1/11/728/007 P R AMIP EXO L AC C O R D TABLET 1MG (0,7MG BASE)

2,50

STUK 1,56609

0N04BC AO V

109023

R O P INIR O L AC TAVIS R ETAR D TABLET MVA 2MG

3,00

STUK 1,56609

0N04BC AO V

109027

R O P INIR O L AC TAVIS R ETAR D TABLET MVA 4MG

1,50

STUK 2,61014

0N04BC AO V

109030

R O P INIR O L AC TAVIS R ETAR D TABLET MVA 8MG

0,75

STUK 5,22029

0N04BC AO V

106922

R O P INIR O L AUR O BINDO TABLET FILMO MHULD 0,25MG

24,00 STUK 0,39152

0N04BC AO V

106925

R O P INIR O L AUR O BINDO TABLET FILMO MHULD 0,5MG

12,00 STUK 0,32627

0N04BC AO V

106926

R O P INIR O L AUR O BINDO TABLET FILMO MHULD 1MG

6,00

STUK 0,65254

0N04BC AO V

106927

R O P INIR O L AUR O BINDO TABLET FILMO MHULD 2MG

3,00

STUK 1,30507

0N04BC AO V

106929

R O P INIR O L AUR O BINDO TABLET FILMO MHULD 5MG

1,20

STUK 3,26268

0N04BC AO V

108338

R O P INIR O L C F R ETAR D TABLET MVA 2MG

3,00

STUK 1,56609

0N04BC AO V

108340

R O P INIR O L C F R ETAR D TABLET MVA 4MG

1,50

STUK 2,61014

0N04BC AO V

108341

R O P INIR O L C F R ETAR D TABLET MVA 8MG

0,75

STUK 5,22029

2N06AAAO V

110349

VENLAFAXINE R ANBAXY C AP SULE MVA 150MG

0,67

STUK 1,59958

0N07XXBO V

109825

GLENTEK TABLET FILMO MHULD 50MG

2,00

STUK 6,07741

0N07XXBO V

101627

R ILUZO L AC TAVIS TABLET FILMO MHULD 50MG

2,00

STUK 6,07741

0N07XXBO V

106736

R ILUZO L C F TABLET FILMO MHULD 50MG

2,00

STUK 6,07741

0N07XXBO V

107112

R ILUZO L MYLAN TABLET FILMO MHULD 50MG

2,00

STUK 6,07741

0N07XXBO V

106635

R ILUZO L SANDO Z TABLET FILMO MHULD 50MG

2,00

STUK 6,07741

0N07XXBO V

107078

R ILUZO L SUN TABLET FILMO MHULD 50MG

2,00

STUK 6,07741

0N07XXBO V

106739

R ILUZO L TEVA TABLET FILMO MHULD 50MG

2,00

STUK 6,07741

STUK 0,47358

0R 03AC C IDAV 112535//33735

SER EVENT AER O SO L 25MC G/DO C FKVR SPBS 120DO + INH

4,00

DO

0,23086

0R 03BAAII V

32121

BUDESO NIDE SANDO Z VER NEVELSUSP 0,125MG/ML AMP 2ML

12,00 ML

0,57768

0R 03BAAII V

32122

BUDESO NIDE SANDO Z VER NEVELSUSP 0,25MG/ML AMP 2ML

6,00

ML

0,96281

0R 03BAAII V

32123

BUDESO NIDE SANDO Z VER NEVELSUSP 0,5MG/ML AMP 2ML

3,00

ML

1,92562

0R 03BABID V

112307//16212

FLIXO TIDE AER C FKVR 50MC G/DO SP BS 120 DO + INHAL

12,00 DO

0,10515

0R 03BADID V

112263//18195

FLIXO TIDE DISKUS INHP DR 500MC G 60DO

1,20

DO

0,59385

YR 03AC C IDAV 111634//25866

SALMET/FLUTIC FISH AER C FKVR 25/125MC G/DO 120D+INH

1,00

DO

0,37690

YR 03AC C IDC V 112433//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00

DO

0,90703

YR 03AC C IDC V 112432//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00

DO

1,20396

0A02BC AO V

102162

O MEP R AZO L C F C AP SULE MSR 10MG

2,00 STUK

0A02BC AO V

102165

O MEP R AZO L C F C AP SULE MSR 40MG

0,50 STUK

3,36221

0A02BC AO V

32671

O MEP R AZO L TEVA C APSULE MSR 40MG

0,50 STUK

3,36221

0A02BC AO V

106738

P ANTO P R AZO L AUR O BINDO TABLET MSR 20MG

2,00 STUK

1,00866

0A02BC AO V

106737

P ANTO P R AZO L AUR O BINDO TABLET MSR 40MG

1,00 STUK

1,68111

0A02BC AO V

109588

R ABEP R AZO LNATR IUM AUR O BINDO TABLET MSR 10MG

2,00 STUK

1,00866

0A02BC AO V

109589

R ABEP R AZO LNATR IUM AUR O BINDO TABLET MSR 20MG

1,00 STUK

1,68111

0A02BC AO V

102611

R ABEP R AZO LNATR IUM TEVA TABLET MSR 10MG

2,00 STUK

1,00866

0A02BC AO V

102618

R ABEP R AZO LNATR IUM TEVA TABLET MSR 20MG

1,00 STUK

1,68111

0A05AAAO V

112359//9307

UR SO C HO L TABLET 300MG

2,00 STUK

0,92453

0A05AAAO V

112533//8384

UR SO FALK C AP SULE 250MG

2,40 STUK

0,77044

0A05AAAO V

112534//8384

UR SO FALK C AP SULE 250MG

2,40 STUK

0,77044

0A06ADAO V

108879

LAC TULO SESTR O O P MDQ 670MG/ML

0A07EC C O V

112130//14797

P ENTASA TABLET MVA 500MG

3,00 STUK

0,62558

0A10AC API V

112641//14896

HUMULINE NP H INJ 100IE/ML P ATR O O N 3ML

0,40 ML

2,09223

YA10ADEP I V

112642//14894

HUMULINE 30/70 INJ 100IE/ML P ATR O O N 3ML

1,00 ML

2,09295

0B01ABAP V

112643//23795

FR AXO DI INJVLST 19000 IE/ML W W SP 0,8ML

0,15 ML

11,85880

0B01ABAP V

112645//23796

FR AXO DI INJVLST 19000 IE/ML W W SP 1ML

0,15 ML

11,85880

0B01AC C O V

112555//10186

P ER SANTIN R ETAR D C AP SULE MGA 150MG

2,67 STUK

0,17057

0C 08C AAO V

112272//20554

BAR NIDIP INE HC L C AP SULE MGA 10MG

1,00 STUK

0,65450

0C 09C AAO V

107831

C ANDESAR TAN C ILEXETIL KR KA TABLET 4MG

2,00 STUK

0,44652

0C 09C AAO V

107832

C ANDESAR TAN C ILEXETIL KR KA TABLET 8MG

1,00 STUK

0,74420

0C 09C AAO V

107833

C ANDESAR TAN C ILEXETIL KR KA TABLET 16MG

0,50 STUK

1,48840

0C 09C AAO V

107834

C ANDESAR TAN C ILEXETIL KR KA TABLET 32MG

0,25 STUK

2,97680

0C 09C AAO V

110614

VALSAR TAN AC TAVIS TABLET FILMO MHULD 320MG

0,25 STUK

2,97680

10,00 ML

1,00866

0,01566

YC 09DAAO V

106121

C ANDESAR TAN C ILEXETIL/HC TZ KR KA TABLET 16/12,5MG

1,00 STUK

1,54013

0C 10AC AO V

112570//14276

Q UESTR AN A PO EDER 4G IN SAC HET

3,50 STUK

0,49172

0D06AXADZ V

111974

FUSIDINEZUUR FO C US C R EME 20MG/G

1,00 GR AM

0,22477

0D07AC ADL V

112537//14332

MO METASO NFUR O AAT FISHER LO TIO N 1MG/ML

1,00 ML

0,15333

0D07AC ADZ V 112540//14173

MO METASO NFUR O AAT FISHER VET W ATER EMULG ZALF 1MG/G

1,00 GR AM

0,14526

0D07ADADL V

112616//30096

C LAR ELUX SC HUIM VO O R C UTAAN GEBR UIK 0,5MG/G

1,00 GR AM

0,18635

0G02C BAO V

112556//8202

P AR LO DEL TABLET 2,5MG

2,00 STUK

0,37906

0G03AAAO V

112042//8205

MIC R O GYNO N 50 TABLET O MHULD

0,75 STUK

0,09241

0G03AABO V

112475//23827

YASMIN TABLET O MHULD

0,75 STUK

0,13253

0G03AC AO V

106016

DESO GESTR EL AC TAVIS TABLET FILMO MHULD 0,075MG

1,00 STUK

0,08071

0G04BDBO V

111750

TO LTER O DINETAR TR AAT AC C O R D TABLET FILMO MHULD 1MG

4,00 STUK

0,24894

0G04BDBO V

111751

TO LTER O DINETAR TR AAT AC C O R D TABLET FILMO MHULD 2MG

2,00 STUK

0,41491

0G04BDBO V

109794

TO LTER O DINETAR TR AAT AC TAVIS SR C APSULE MVA 2MG

2,00 STUK

0,41491

0G04BDBO V

109795

TO LTER O DINETAR TR AAT AC TAVIS SR C APSULE MVA 4MG

1,00 STUK

0,82981

0J01FAAO V

108985

C LAR ITR O MYC INE TEVA R ETAR D TABLET MGA 500MG

1,00 STUK

2,43031

0L02AEADI V

111497//18562

ZO LADEX IMP LANTATIESTIFT 10,8MG IN W W SP

0,33 STUK 552,22770

0L02BGAO V

112430//19123

AR IMIDEX TABLET FILMO MHULD 1MG

1,00 STUK

0M03AXAP V

112497//17379

BO TO X INJEC TIEP O EDER FLAC O N 100E

0,02 STUK 272,26810

YM05BBAO V

106331

R ISEDR O N NA/C ALC MYL T O MH 35/500MG (1T R IS+6T C A)

1,00 VER P

40,59628

0N02AAAO V

109541

O XYC O DO N HC L AC C O R D TABLET MVA 5MG

6,00 STUK

0,41607

0N02AAAO V

109542

O XYC O DO N HC L AC C O R D TABLET MVA 10MG

3,00 STUK

0,69344

0N02AAAO V

109543

O XYC O DO N HC L AC C O R D TABLET MVA 20MG

1,50 STUK

1,38689

0N02AAAO V

109544

O XYC O DO N HC L AC C O R D TABLET MVA 40MG

0,75 STUK

2,77378

0N02AAAO V

109545

O XYC O DO N HC L AC C O R D TABLET MVA 80MG

0,38 STUK

5,54756

0N02AAAO V

112116

O XYC O DO N HC L MUNDIP HAR MA C AP SULE 5MG

6,00 STUK

0,41607

0N02AAAO V

112117

O XYC O DO N HC L MUNDIP HAR MA C AP SULE 10MG

3,00 STUK

0,69344

0N02AAAO V

112118

O XYC O DO N HC L MUNDIP HAR MA C AP SULE 20MG

1,50 STUK

1,38689

0N02AAAO V

109612

O XYC O DO N HC L SANDO Z TABLET MVA 40MG

0,75 STUK

2,77378

0N02AAAO V

109614

O XYC O DO N HC L SANDO Z TABLET MVA 80MG

0,38 STUK

5,54756

0N02ABC O V

EU/1/09/531/002 INSTANYL NEUSSP R AY 50MC G/DO FLAC O N 20DO SES

3,00 DO

6,04440

0N02ABC O V

EU/1/09/531/005 INSTANYL NEUSSP R AY 100MC G/DO FLAC O N 20DO SES

1,50 DO

10,07400

4,71931

0N02ABC O V

EU/1/09/531/008 INSTANYL NEUSSP R AY 200MC G/DO FLAC O N 20DO SES

0,75 DO

20,14800

0N02AEADP V

103490

BUP R ENO R FINE R ANBAXY PLEISTER TR ANSDER M 35MC G/UUR

0,36 STUK

5,60021

0N02AEADP V

103491

BUP R ENO R FINE R ANBAXY PLEIST TR ANSDER M 52,5MC G/UUR

0,24 STUK

8,40032

0N02AEADP V

103492

BUP R ENO R FINE R ANBAXY PLEISTER TR ANSDER M 70MC G/UUR

0,18 STUK

11,20043

0N02C C AO V

112631//29413

IMIGR AN FTAB DISP ER GEER BAR E TABLET 50MG

1,00 STUK

6,21227

0N02C C AO V

112647//29414

IMIGR AN FTAB DISP ER GEER BAR E TABLET 100MG

0,50 STUK

12,42453

0N04BAAO V

110060

LEVO DO P A/C AR BIDO P A MYLAN 110 TABLET 100/10MG

6,00 STUK

0,18943

0N04BAAO V

110061

LEVO DO P A/C AR BIDO P A MYLAN 125 TABLET 100/25MG

6,00 STUK

0,18944

0N04BAAO V

110062

LEVO DO P A/C AR BIDO P A MYLAN 275 TABLET 250/25MG

2,40 STUK

0,47358

0N04BXAO V

107812

ENTAC APO NE MYLAN TABLET FILMO MHULD 200MG

5,00 STUK

0,87973

0N04BXAO V

EU/1/10/665/001 ENTAC APO NE TEVA TABLET FILMO MHULD 200MG

5,00 STUK

0,87973

0N05BAAO V

112538//19886

ALP R AZO LAM FISHER R ETAR D TABLET MGA 0,5MG

2,00 STUK

0,12101

0N05BAAO V

112539//19887

ALP R AZO LAM FISHER R ETAR D TABLET MGA 1MG

1,00 STUK

0,24201

0N05BAAO V

109861

C LO BAZAM SANDO Z TABLET 10MG

2,00 STUK

0,12101

4N05AXAO V

112690//102408 SER O Q UEL XR TABLET MVA 150MG

2,00 STUK

1,98151

0N06BAAO V

100392

STR ATTER A C AP SULE 100MG

0,80 STUK

0,45435

0R 01ADAN V

112431//23837

R HINO C O R T NEVEL NEUSSP R AY 32MC G/DO 120DO

6,25 DO

0,07684

0R 03BABID V

112456//31632

ALVESC O 80 AER O SO L 80MC G/DO SP BS

2,00 DO

0,42060

YR 03AC C IDAV 112687//25866

SER ETIDE AER O SO L 25/125MC G/DO C FKVR SP BS 120DO +INH

1,00 DO

0,37690

YR 03AC C IDAV 112688//25866

SER ETIDE AER O SO L 25/125MC G/DO C FKVR SP BS 120DO +INH

1,00 DO

0,37690

YR 03AC C IDAV 112689//25867

SER ETIDE AER O SO L 25/250MC G/DO C FKVR SP BS 120DO +INH

1,00 DO

0,52294

2R 06AEAO V

107003

EBASTINE SMELT TEVA O R O DISP TABLET 10MG

1,00 STUK

0,50499

0S01XABG V

112684//32370

AR TELAC EDO O O GDR UPP ELS 3,2MG/ML TUBE 0,6ML

4,00 STUK

0,22099

0S01XABG V

112552//18218

C ELLUVISC UNIT DO SE O O GDR UP P ELS 10MG/ML TUBE 0,4ML

5,00 STUK

0,17679

YS01EDAG V

EU/1/06/340/002 GANFO R T O O GDR UPP ELS FLAC O N 3ML

1,00 ML

9,47766

0A04AAAO V

EU/1/12/766/001 SANC USO P LEISTER TR ANSDER MAAL 3,1MG/24UUR

0,14 STUK 135,78096

0A09AAAO V

111574//10656

C R EO N C AP SULE MSR (P ANC R EATINE 150MG)

6,00 STUK

0,40319

YB01AC AO V

109873

DIP YR IDAMO L/AC ETYLSALIC YLZUUR SDZ C AP MGA 200/25MG

1,00 STUK

0,29095

0C 02C AAO V

107680

DO XAZO SINE SANDO Z R ETAR D TABLET MVA 8MG

0,50 STUK

1,68644

1C 03AAAO V

112547

HYDR O C HLO O R THIAZIDE MYLAN TABLET 12,5MG

2,00 STUK

0,06208

0C 07ABAO V

108798

BISO P R O LO LFUMAR AAT AC C O R D TABLET FILMO MHULD 2,5MG

4,00 STUK

0,10153

0C 07ABAO V

108799

BISO P R O LO LFUMAR AAT AC C O R D TABLET FILMO MHULD 5MG

2,00 STUK

0,20307

0C 07ABAO V

108800

BISO P R O LO LFUMAR AAT AC C O R D TABLET FILMO MHULD 10MG

1,00 STUK

0,40613

0C 09C AAO V

112886//26791

C O ZAAR TABLET FILMO MHULD 100MG

0,50 STUK

1,48840

YC 09DAAO V

111745

VALSAR TAN/HC T AC TAVIS TABL FILMO MHULD 320MG/12,5MG

1,00 STUK

3,02853

YC 09DAAO V

111746

VALSAR TAN/HC T AC TAVIS TABL FILMO MHULD 320MG/25MG

1,00 STUK

3,08026

0C 10AAAO V

112827//30823

C R ESTO R TABLET FILMO MHULD 5MG

2,00 STUK

0,83042

0C 10AAAO V

112495//26872

C R ESTO R TABLET FILMO MHULD 10MG

1,00 STUK

1,38403

0C 10AAAO V

112426//26873

C R ESTO R TABLET FILMO MHULD 20MG

0,50 STUK

2,76806

0C 10AAAO V

112494//26874

C R ESTO R TABLET FILMO MHULD 40MG

0,25 STUK

5,53612

0D07AC ADZ V 112848//14174

MO METASO NFUR O AAT FISHER W ATER EMULGER ZALF 1MG/G

1,00 GR AM

0,14526

0G03AC AIM V

106064

SAYANA PR ESS INJSUSP 160MG/ML W W SP 0,65ML

0,01 ML

0G03AC AO V

110353

DESO GESTR EL C F TABLET 0,075MG

1,00 STUK

0,08071

0G03AC AO V

107754

DESO GESTR EL SANDO Z TABLET FILMO MHULD 0,075MG

1,00 STUK

0,08071

0G03AC AO V

111004

DESO GESTR EL TEVA TABLET FILMO MHULD 0,075MG

1,00 STUK

0,08071

0G03BAAP V

30794

NEBIDO INJVLST 250MG/ML AMP UL 4ML

0,05 ML

6,78400

0G03GAAP V

110120

FO STIMO N INJP DR FL 75IE + SO LV 1ML W W SP

1,00 STUK

23,00000

0G04AC BO V

112373//13066

MO NUR IL GR ANULAAT 3000MG/8G IN SAC HET

0,25 STUK

2,28706

0G04BDBO V

109788

TO LTER O DINETAR TR AAT TEVA R ETAR D C APSULE MVA 2MG

2,00 STUK

0,41491

0G04BDBO V

109789

TO LTER O DINETAR TR AAT TEVA R ETAR D C APSULE MVA 4MG

1,00 STUK

0,82981

0H02ABAO V

112543//18765

ENTO C O R T C AP SULE MGA 3MG

3,00 STUK

1,02100

0H02ABBO V

34415

LO DO TR A TABLET MGA 1MG

10,00 STUK

0,01797

0H02ABBO V

34416

LO DO TR A TABLET MGA 2MG

5,00 STUK

0,01997

0J01FAAO K

30440

AZITR O MYC INE TEVA P O EDER VO O R SUSP ENSIE 200MG/5ML

7,50 ML

0,41094

YM01AEAO V

112895//106235 VIMO VO TABLET MGA 500/20MG

1,00 STUK

2,23775

0N03AEAO V

109864

C LO NAZEPAM SANDO Z TABLET 0,5MG

16,00 STUK

0,03826

0N03AEAO V

109867

C LO NAZEPAM SANDO Z TABLET 2MG

4,00 STUK

0,09566

0N03AXDO V

EU/1/00/146/009 KEP P R A TABLET FILMO MHULD 500MG

3,00 STUK

1,19163

0N03AXDO V

EU/1/11/702/007 LEVETIR AC ETAM R P TABLET FILMO MHULD 250MG

6,00 STUK

0,95330

0N03AXDO V

EU/1/11/702/014 LEVETIR AC ETAM R P TABLET FILMO MHULD 500MG

3,00 STUK

1,19163

0N03AXDO V

EU/1/11/702/029 LEVETIR AC ETAM R P TABLET FILMO MHULD 1000MG

1,50 STUK

2,38325

4N05AXAO V

112892//34626

1,50 STUK

2,64201

SER O Q UEL XR TABLET MVA 200MG

10,69644

4N05AXAO V

112893//34627

SER O Q UEL XR TABLET MVA 300MG

1,00 STUK

3,96302

4N05AXAO V

112894//34628

SER O Q UEL XR TABLET MVA 400MG

0,75 STUK

5,28402

2N06AXBO V

109724

TR AZO DO N HC L SANDO Z TABLET 50MG

6,00 STUK

0,21328

2N06BAAO V

112249//33668

W ELLBUTR IN XR TABLET MGA 150MG

2,00 STUK

0,63983

2N06BAAO V

112247//33669

W ELLBUTR IN XR TABLET MGA 300MG

1,00 STUK

1,06638

0N07XXBO V

EU/1/96/010/001 R ILUTEK TABLET O MHULD 50MG

2,00 STUK

6,07741

0R 03BBC ID V

EU/1/12/778/002 EKLIR A GENUAIR INHALP DR 322MC G 60DO

2,00 DO

0,74500

0R 03BBC ID V

EU/1/12/788/003 SEEBR I BR EEZHALER INHALP DR 44MC G MET BR EEZHALER

1,00 DO

1,49000

1,00 DO

1,20396

YR 03AC C IDC V 111687//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

0S01EEAG V

EU/1/02/205/006 LUMIGAN O O GDR UP P ELS 0,3MG/ML MINIM 0,4ML

1,00 STUK

0,85267

0S01EEAG V

110246

MO NO PR O ST O O GDR UPP ELS 50MC G/ML MINIM 0,2ML

1,00 STUK

0,85267

0S01XAAG V

111636//10187

TEAR S NATUR ALE O O GDR UP P ELS FLAC O N 15ML

0,60 ML

0,26471

0A02BC AO V

102164

O MEP R AZO L C F C AP SULE MSR 20MG

1,00

STUK 1,68111

0A05AAAO V

101647

UR SO FALK SUSP ENSIE 50MG/ML

12,00 ML

0A10BAAO V

100934

METFO R MINE HC L SANDO Z TABLET FILMO MHULD 850MG

2,35

STUK 0,09386

0A10BHAO V

EU/1/11/707/004 TR AJENTA TABLET 5MG

1,00

STUK 3,22000

YA10BDEO V

EU/1/11/731/003 KO MBO GLYZE TABLET FILMO MHULD 2,5/ 850MG

1,00

STUK 1,70386

1C 03AAAO V

112548

HYDR O C HLO O R THIAZIDE MYLAN TABLET 25MG

1,00

STUK 0,10346

1C 03AAAO V

112549

HYDR O C HLO O R THIAZIDE MYLAN TABLET 50MG

0,50

STUK 0,20692

0C 07ABAO V

112532//12149

SELO KEEN ZO C 100 TABLET MGA 95MG

1,50

STUK 0,27075

0C 09AAAO V

113023//23720

ZO FIL TABLET O MHULD 7,5MG

4,00

STUK 0,23363

YC 09BAAO V

106100

P ER INDO PR IL TER T-BUTYL/INDAP AMIDE C F TABL 4/1,25MG

1,00

STUK 0,63581

YC 09BAAO V

104135

Q UINAP R IL/HYDR O C HLO O R THIAZIDE TEVA TABL 20/12,5MG

1,00

STUK 0,83050

YC 09DAAO V

105035

C ANDESAR TAN C ILEXETIL/HC T MYLAN TABLET 16/12,5MG

1,00

STUK 1,54013

YC 09DAAO V

112887//19269

HYZAAR TABLET 50/12,5MG

1,00

STUK 0,79593

0D06BBBDL V

110904

VER EGEN ZALF 100MG/G

1,00

GR AM 6,08974

0G02C BAO V

112880//15375

DO STINEX TABLET 0,5MG

0,10

STUK 7,96341

0G03AABO V

107177

DAYLETTE 24+4 TABLET FILMO MHULD

0,86

STUK 0,11597

0G03AABO V

107174

VO LINA TABLET FILMO MHULD 0,02/3MG

0,75

STUK 0,13253

0G03AABO V

107176

VO LINA TABLET FILMO MHULD 0,03/3MG

0,75

STUK 0,13253

0,15409

0G03GABIM V

112901//104

P R EGNYL INJEC TIEPO EDER AMPUL 5000IE + SO LVENS 1ML

0,05

STUK 4,64067

0G03GABP V

112825//24536

MENO P UR INJP DR FLAC O N 75IE + SO LV 1ML

1,00

STUK 33,54345

0J05ABDO V

111446//25992

VALC YTE TABLET FILMO MHULD 450MG

2,00

STUK 24,63379

0J05ABDO V

112036//25992

VALGANC IC LO VIR FISHER TABLET FILMO MHULD 450MG

2,00

STUK 24,63379

0L04AADO V

EU/1/09/523/001 MO DIGR AF GR ANULAAT V SUSPENSIE IN SAC HET 0,2MG

25,00 STUK 1,02573

0L04AADO V

EU/1/09/523/002 MO DIGR AF GR ANULAAT V SUSPENSIE IN SAC HET 1MG

5,00

STUK 2,84925

0M05BABO V

107797

NATR IUMR ISEDR O NAAT SANDO Z TABLET FILMO MHULD 75MG

0,07

STUK 18,37810

2N06AXAO V

112632//24466

R EMER O N DR ANK 15MG/ML

2,00

ML

2N06AXBO V

113007//9145

TR AZO LAN TABLET 100MG

3,00

STUK 0,35546

0N07AAAO V

EU/1/98/066/028 EXELO N 13,3MG/24 U PLEISTER V.TR ANSDER MAAL GEBR UIK

0,68

STUK 7,04116

0R 03BABID V

112500//16213

FLIXO TIDE AER C FKVR 125MC G/DO SP BS 120 DO + INHAL

4,80

DO

0,14604

0R 03BABID V

112530//16213

FLIXO TIDE AER C FKVR 125MC G/DO SP BS 120 DO + INHAL

4,80

DO

0,14604

0R 03BABID V

112531//16214

FLIXO TIDE AER C FKVR 250MC G/DO SP BS 120 DO + INHAL

2,40

DO

0,29208

0R 03DC AO K

100923

MO NTELUKAST TEVA KAUW TABLET 4MG

2,50

STUK 1,10541

0R 03DC AO K

100924

MO NTELUKAST TEVA KAUW TABLET 5MG

2,00

STUK 1,31596

0R 03DC AO K

104210

MO NTELUKAST AC TAVIS KAUW TABLET 4MG

2,50

STUK 1,10541

0R 03DC AO K

104214

MO NTELUKAST AC TAVIS KAUW TABLET 5MG

2,00

STUK 1,31596

0R 03DC AO K

107080

MO NTELUKAST MYLAN KAUW TABLET 4MG

2,50

STUK 1,10541

0R 03DC AO K

107081

MO NTELUKAST MYLAN KAUW TABLET 5MG

2,00

STUK 1,31596

0R 03DC AO V

100911

MO NTELUKAST TEVA TABLET FILMO MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

104209

MO NTELUKAST AC TAVIS TABLET FILMO MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

104690

MO NTELUKAST MYLAN TABLET FILMO MHULD 10MG

1,00

STUK 1,31596

0,53319

YR 03AC C IDAV 112629//25866

SER ETIDE AER O SO L 25/125MC G/DO C FKVR SP BS 120DO +INH 1,00

DO

0,37690

YR 03AC C IDC V 110104

FO STER NEXTHALER INHALPDR 100/6MC G/DO 120DO

1,00

DO

0,48321

0S01AXAG V

109912

O FLO XAC INE EBER TH UNIT DO S O O GDR 3MG/ML TUBE 0,5ML

4,00

STUK 0,46833

0S01AXC G V

109913

O FLO XAC INE EBER TH O O GDR UPP ELS 3MG/ML FLAC O N 5ML

0,40

ML

0,64074

0S01AXC G V

110894

O FLO XAC INE PO S O O GDR UP PELS 3MG/ML FLAC O N 5ML

0,40

ML

0,64074

0S01GXBG V

110580

KETO TIFEN EBER TH UNI DO O O GDR 0,25MG/ML TUBE 0,4ML

0,20

ML

1,85595

0A05AAAO V

113168//9307

UR SO C HO L TABLET 300MG

2,00

STUK 0,92453

0A07EC BO V

112891//5705

SALAZO P YR INE EC TABLET MSR 500MG

6,00

STUK 0,12434

0A07EC C O V

112119//31379

P ENTASA C O MPAC T GR ANULAAT MVA 2G IN SAC HET

0,75

STUK 2,50233

0A07EC C O V

112881//31379

P ENTASA GR ANULAAT MGA 2G IN SAC HET

0,75

STUK 2,50233

0C 02C AAO V

107688

DO XAZO SINE AC TAVIS R ETAR D TABLET MVA 8MG

0,50

STUK 1,68644

0C 09C AAO V

112964

C ANDESAR TAN C ILEXETIL FO C US TABLET 4MG

2,00

STUK 0,44652

0C 09C AAO V

112965

C ANDESAR TAN C ILEXETIL FO C US TABLET 8MG

1,00

STUK 0,74420

0C 09C AAO V

112966

C ANDESAR TAN C ILEXETIL FO C US TABLET 16MG

0,50

STUK 1,48840

0C 09C AAO V

112967

C ANDESAR TAN C ILEXETIL FO C US TABLET 32MG

0,25

STUK 2,97680

0C 09C AAO V

EU/1/11/734/002 EDAR BI 20 MG TABLET 28 STUKS

2,00

STUK 0,44652

0C 09C AAO V

EU/1/11/734/006 EDAR BI TABLET 40MG

1,00

STUK 0,74420

0C 09C AAO V

EU/1/11/734/009 EDAR BI TABLET 80MG

0,50

STUK 1,48840

0C 09C AAO V

112898//28782

O LMETEC TABLET FILMO MHULD 10MG

2,00

STUK 0,44652

0C 09C AAO V

113000//28782

O LMETEC TABLET FILMO MHULD 10MG

2,00

STUK 0,44652

0C 09C AAO V

113008//28783

O LMETEC TABLET FILMO MHULD 20MG

1,00

STUK 0,74420

0C 09C AAO V

113001//28784

O LMETEC TABLET FILMO MHULD 40MG

0,50

STUK 1,48840

YC 09DAAO V

113052

C ANDESAR TAN C ILEXETIL/HC TZ FO C US TABLET 16/12,5MG

1,00

STUK 1,54013

0C 10AAAO V

112979//26874

C R ESTO R TABLET FILMO MHULD 40MG

0,25

STUK 5,53612

0C 10AAAO V

107356

SIMVASTATINE TEVA TABLET FILMO MHULD 10MG

3,00

STUK 0,46134

0C 10AAAO V

107357

SIMVASTATINE TEVA TABLET FILMO MHULD 20MG

1,50

STUK 0,92269

0C 10AAAO V

107358

SIMVASTATINE TEVA TABLET FILMO MHULD 40MG

0,75

STUK 1,84537

0C 10AAAO V

107359

SIMVASTATINE TEVA TABLET FILMO MHULD 80MG

0,38

STUK 3,69075

0G03AABO V

112454//12846

C ILEST TABLET

0,75

STUK 0,13253

0G03AABO V

108168

DESO GESTR EL/ETHINYLESTR ADIO L AC T TABL 0,15/0,02MG

0,75

STUK 0,13253

0G03AABO V

108169

DESO GESTR EL/ETHINYLESTR ADIO L AC T TABL 0,15/0,03MG

0,75

STUK 0,13253

0G03AABO V

108161

ETHINYLESTR ADIO L/DESO GESTR TEVA TABLET 0,02/0,15MG

0,75

STUK 0,13253

0G03AABO V

108164

ETHINYLESTR ADIO L/DESO GESTR TEVA TABLET 0,03/0,15MG

0,75

STUK 0,13253

0G03BAAP V

27

SUSTANO N 250 INJVLST 250MG/ML AMPUL 1ML

0,05

ML

6,78400

0G03BAAP V

29437//27

SUSTANO N 250 INJVLST 250MG/ML AMPUL 1ML

0,05

ML

6,78400

0G03BAAP V

105350//27

SUSTANO N 250 INJVLST 250MG/ML AMPUL 1ML

0,05

ML

6,78400

0G03BAAP V

109334//27

SUSTANO N 250 INJVLST 250MG/ML AMPUL 1ML

0,05

ML

6,78400

0G03BAAP V

110344//27

SUSTANO N 250 INJVLST 250MG/ML AMPUL 1ML

0,05

ML

6,78400

0G03GAAP V

110121

FO STIMO N INJP DR FL 150IE + SO LV 1ML W W SP

0,50

STUK 46,00000

0G04AC BO V

112646//13066

MO NUR IL GR ANULAAT 3000MG/8G IN SAC HET

0,25

STUK 2,28706

0G04BDBO V

108820

TO LTER O DINETAR TR AAT SANDO Z R ETAR D C AP SULE MVA 2MG 2,00

STUK 0,41491

0G04BDBO V

108821

TO LTER O DINETAR TR AAT SANDO Z R ETAR D C AP SULE MVA 4MG 1,00

STUK 0,82981

0H03AAAO V

108721

LEVO THYR O XINENATR IUM TEVA DR ANK 5MC G/ML

30,00 ML

0L02AEADI V

113128//18562

ZO LADEX IMP LANTATIESTIFT 10,8MG IN W W SP

0,33

STUK 552,22770

0L04AABO V

113027//30203

MYFO R TIC TABLET MSR 360MG

4,00

STUK 2,95562

1M01AEAO V

101817

IBUP R O FEN AC TAVIS TABLET FILMO MHULD 600MG

2,00

STUK 0,27832

0,00214

0N02AAAO V

111250

O XYC O DO N HC L AC TAVIS C AP SULE 5MG

6,00

STUK 0,41607

0N02AAAO V

111251

O XYC O DO N HC L AC TAVIS C AP SULE 10MG

3,00

STUK 0,69344

0N02AAAO V

111252

O XYC O DO N HC L AC TAVIS C AP SULE 20MG

1,50

STUK 1,38689

0N03AEAO V

6872

R IVO TR IL DR UP PELS 2,5MG/ML

3,20

ML

0N03AEAO V

6870

R IVO TR IL TABLET 0,5MG

16,00 STUK 0,03826

0N03AEAO V

110801//6870

R IVO TR IL TABLET 0,5MG

16,00 STUK 0,03826

0N03AEAO V

6871

R IVO TR IL TABLET 2MG

4,00

STUK 0,09566

0N03AFBO V

104799

O XC AR BAZEPINE JUBILANT TABLET FILMO MHULD 300MG

3,33

STUK 0,29201

0N03AFBO V

104800

O XC AR BAZEPINE JUBILANT TABLET FILMO MHULD 600MG

1,67

STUK 0,58402

0N03AXDO V

EU/1/08/470/020 VIMP AT TABLET O MHULD 50MG

6,00

STUK 0,83414

0N03AXDO V

EU/1/08/470/022 VIMP AT TABLET O MHULD 150MG

2,00

STUK 1,78744

0N06BAAO V

111228

EQ UASYM XL C AP SULE MGA 40MG

0,75

STUK 0,48464

0N06BAAO V

111232

EQ UASYM XL C AP SULE MGA 50MG

0,60

STUK 0,60580

0R 01AC BN V

113043//17886

ALLER GO DIL NEVEL NEUSSP R AY 1MG/ML

0,56

ML

0,67613

0R 01ADAN V

113063//23477

FLIXO NASE NEUSDR UP P ELS 1MG/ML P ATR O O N 0,4ML

0,50

DO

0,67402

0R 01ADAN V

112960//21837

NASAC O R T NEUSSP R AY 55MC G/DO 120DO

4,00

DO

0,08425

0R 03BABID V

113037//31633

ALVESC O 160 AER O SO L 160MC G/DO SPBS 60DO + INH

1,00

DO

0,70100

0R 03BBC ID V

106277//26191

SP IR IVA INHALP DR 18MC G MET HANDIHALER

1,00

STUK 1,49000

0R 03BBC ID V

107100//26191

SP IR IVA INHALP DR 18MC G MET HANDIHALER

1,00

STUK 1,49000

0R 03BBC ID V

111511//26191

SP IR IVA INHALP DR 18MC G MET HANDIHALER

1,00

STUK 1,49000

0R 03BBC ID V

26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

30199//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

31746//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

33047//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

33062//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

33156//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

34168//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

104082//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

104886//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

105556//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

108683//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

109514//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

109956//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

110295//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

110592//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03BBC ID V

111323//26191

SP IR IVA INHALP DR 18MC G

1,00

STUK 1,49000

0R 03DC AO K

104452

MO NTELUKAST ABDI KAUW TABLET 4MG

2,50

STUK 1,10541

0R 03DC AO K

104460

MO NTELUKAST ABDI KAUW TABLET 5MG

2,00

STUK 1,31596

0R 03DC AO K

106626

MO NTELUKAST AC C O R D KAUW TABLET 4MG

2,50

STUK 1,10541

0R 03DC AO K

106634

MO NTELUKAST AC C O R D KAUW TABLET 5MG

2,00

STUK 1,31596

0,11957

0R 03DC AO K

105119

MO NTELUKAST C F KAUW TABLET 4MG

2,50

STUK 1,10541

0R 03DC AO K

105120

MO NTELUKAST C F KAUW TABLET 5MG

2,00

STUK 1,31596

0R 03DC AO K

103804

MO NTELUKAST SANDO Z KAUW TABLET 4MG

2,50

STUK 1,10541

0R 03DC AO K

103805

MO NTELUKAST SANDO Z KAUW TABLET 5MG

2,00

STUK 1,31596

0R 03DC AO V

104471

MO NTELUKAST ABDI TABLET FILMO MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

108516

MO NTELUKAST AC C O R D TABLET FILMO MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

105121

MO NTELUKAST C F TABLET FILMO MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

109803

MO NTELUKAST R P TABLET FILMO MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

102885

MO NTELUKAST SANDO Z TABLET FILMO MHULD 10MG

1,00

STUK 1,31596

YR 03AC C IDC V 112554//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00

DO

0,90703

YR 03AC C IDC V 112553//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00

DO

1,20396

0S01EDC G V

113064//33801

TIMO GEL O O GGEL 1MG/G TUBE 0,4G

1,00

STUK 0,29949

0S01EEAG V

103823

SAFLUTAN O O GDR UP P ELS 15MC G/ML FLAC O N 0,3ML

1,00

STUK 0,85267

0S01EEAG V

108274//103823 SAFLUTAN O O GDR UP P ELS 15MC G/ML FLAC O N 0,3ML

1,00

STUK 0,85267

0S01EEAG V

109326//103823 SAFLUTAN O O GDR UP P ELS 15MC G/ML FLAC O N 0,3ML

1,00

STUK 0,85267

0S01EEAG V

110803//103823 SAFLUTAN O O GDR UP P ELS 15MC G/ML FLAC O N 0,3ML

1,00

STUK 0,85267

0A02BC AO V

107944

R ABEP R AZO LNATR IUM C HEMO IBER IC A TABLET MSR 10MG

2,00

STUK 1,00866

0A02BC AO V

107946

R ABEP R AZO LNATR IUM C HEMO IBER IC A TABLET MSR 20MG

1,00

STUK 1,68111

0A05AAAO V

111016

UDC A TR AMEDIC O 250, FILMO MHULDE TABLETTEN 250 MG

2,40

STUK 0,77044

0A05AAAO V

111017

UDC A TR AMEDIC O TABLET FILMO MHULD 500MG

1,20

STUK 1,54089

0B01ABAP V

113025//13068

C LEXANE INJVLST 100MG/ML W W SP

0,20

ML

8,89410

0B01ABAP V

112461//12788

FR AGMIN 5000 INJVLST 25.000IE/ML W W SP 0,2ML

0,10

ML

17,78820

0B01ABAP V

113041//11876

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,3ML

0,30

ML

5,92940

0B01ABAP V

113049//15963

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,4ML

0,30

ML

5,92940

0B01ABAP V

113040//11877

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,6ML

0,30

ML

5,92940

0C 01BC BO V

110875

FLEC AINIDEAC ETAAT TEVA R ETAR D C AP SULE 50MG

4,00

STUK 0,31111

0C 01BC BO V

110876

FLEC AINIDEAC ETAAT TEVA R ETAR D C AP SULE 100MG

2,00

STUK 0,51852

0C 01BC BO V

110877

FLEC AINIDEAC ETAAT TEVA R ETAR D C AP SULE 150MG

1,33

STUK 0,77778

0C 01BC BO V

110878

FLEC AINIDEAC ETAAT TEVA R ETAR D C AP SULE 200MG

1,00

STUK 1,03704

1C 01DAAO V

113030//17157

P R O MO C AR D DUR ETTE TABLET MGA 30MG

2,00

STUK 0,27227

0C 08C AAO V

112889//15099

LO MIR SR O C AP SULE MGA 5MG

1,00

STUK 0,65450

YC 09BAAO V

113269//11825

C O R ENITEC TABLET 20/12,5MG

1,00

STUK 1,21989

YC 09BAAO V

101970

P ER INDO PR IL TER T-BUTYLAM/INDAP AMI R P 2MG/0,625MG

1,00

STUK 0,31790

0C 10AAAO V

113055//26872

C R ESTO R TABLET FILMO MHULD 10MG

1,00

STUK 1,38403

0C 10AAAO V

113056//26874

C R ESTO R TABLET FILMO MHULD 40MG

0,25

STUK 5,53612

0C 10AC AO V

113301//28626

EZETR O L TABLET 10MG

1,00

STUK 1,72101

0G03AABO V

107290

ETHINYLESTR ADIO L/DR O SPIR ENO N TEVA TAB O MH 0,03/3MG 0,75

STUK 0,13253

0G04C BAO V

102248

FINASTER IDE TEVA TABLET FILMO MHULD 5MG

1,00

STUK 1,12371

0J01MAAO V

108258

C IP R O FLO XAC INE AC C O R D TABLET 250MG

4,00

STUK 0,91700

0J01MAAO V

108260

C IP R O FLO XAC INE AC C O R D TABLET 500MG

2,00

STUK 1,52833

0J01MAAO V

108261

C IP R O FLO XAC INE AC C O R D TABLET 750MG

1,33

STUK 2,29250

0J01XAAP V

113130//15374

TAR GO C ID INJP DR FLAC O N 400MG + SO LVENS 3ML

200,00 MG

YM01AEAO V

113033//106235 VIMO VO TABLET MGA 500/20MG

1,00

STUK 2,23775

0M03AXAP V

110868

DYSPO R T INJEC TIEPO EDER FLAC O N 300E

0,03

STUK 163,36086

0M05BAAO V

113270//20245

BO NEFO S TABLET 800MG

2,00

STUK 4,09794

0M05BABP V

108308

IBANDR O NINEZUUR C F INJVLST 1MG/ML W W SP 3ML

4,00

ML

0N03AXEO V

113045//25836

TO P AMAX SP R INKLE C AP SULE 15MG

20,00

STUK 0,50842

0N03AXEO V

113046//25838

TO P AMAX SP R INKLE C AP SULE 50MG

6,00

STUK 0,79440

2N06ABAO V

111647

ESC ITALO P R AM AC TAVIS 10 MG, FILMO MHULDE TABLETTEN

1,00

STUK 1,06638

2N06ABAO V

111648

ESC ITALO P R AM AC TAVIS 15 MG, FILMO MHULDE TABLETTEN

0,67

STUK 1,59958

2N06ABAO V

111649

ESC ITALO P R AM AC TAVIS 20 MG, FILMO MHULDE TABLETTEN

0,50

STUK 2,13277

0N07AAAO V

EU/1/98/066/028 EXELO N P LEISTER TR ANSDER MAAL 13,3MG/24UUR

0,68

STUK 7,04116

0N07AAAO V

111269

P ER MENTE P LEISTER TR ANSDER MAAL 4,6MG/24UUR

1,96

STUK 2,43529

0N07AAAO V

111274

P ER MENTE P LEISTER TR ANSDER MAAL 9,5MG/24UUR

0,95

STUK 5,02940

ATIMO S AER O SO L 12MC G/DO SIS SP UITBUS 100DO

2,00

DO

0R 03AC C IDAV 113073//31994

0,23895

74,31900

0,46172

0R 03DC AO K

104604

SINGULAIR GR ANULAAT 4MG IN SAC HET

2,50

STUK 1,05277

0R 03DC AO K

30147//23165

SINGULAIR JUNIO R KAUW TABLET 5MG

2,00

STUK 1,31596

0R 03DC AO K

102290//23165

SINGULAIR JUNIO R KAUW TABLET 5MG

2,00

STUK 1,31596

0R 03DC AO K

25800

SINGULAIR KAUW TABLET 4MG

2,50

STUK 1,10541

0R 03DC AO K

103155//25800

SINGULAIR KAUW TABLET 4MG

2,50

STUK 1,10541

0R 03DC AO K

23165

SINGULAIR KAUW TABLET 5MG

2,00

STUK 1,31596

0R 03DC AO V

109575//23164

MO NTELUKAST FISHER TABLET FILMO MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

111057//23164

MO NTELUKAST FISHER TABLET FILMO MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

32353//23164

MO NTELUKAST TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

35104//23164

MO NTELUKAST TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

28462//23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

30282//23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

35111//23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

102289//23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

102626//23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

104887//23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

107104//23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

107483//23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

109513//23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

0R 03DC AO V

111448//23164

SINGULAIR TABLET O MHULD 10MG

1,00

STUK 1,31596

1R 06ABAO V

113035//1848

P O LAR AMINE TABLET 2MG

3,00

STUK 0,13919

0S01AAAG V

113185//11902

FUC ITHALMIC O O GGEL TUBE 5G

0,40

GR AM 0,83224

0S01AXC G V

13510

TR AFLO XAL O O GDR UP P ELS 3MG/ML FLAC O N 5ML

0,40

ML

0,64074

0S01EDAG V

113038//17018

TIMO PTO L XE O O GDR UPP ELS 5MG/ML FLAC O N 2,5ML

0,10

ML

1,87500

0S01XAAG V

113034//107234 LIP O SIC O O GGEL 2MG/G TUBE 10G

0,40

GR AM 0,39706

0A04AAAO V

EU/01/12/766/001 SANC USO P LEISTER TR ANSDER MAAL 3,1MG/24UUR

0,14

STUK 135,78096

0A05AAAO V

112131//8384

UR SO FALK C AP SULE 250MG

2,40

STUK 0,77044

1A06ADAO V

108118

MAC R O GO L EN ELEKTR TR AMEDIC O O R ANGE P DR V DR SAC H

0,76

STUK 0,54285

0A10ABBP D V

EU/1/99/119/010

NO VO R AP ID FLEXP EN INJVLST 100E/ML W W SP 3ML

0,40

ML

2,48974

0A10AEAP I V

EU/1/04/278/003

LEVEMIR P ENFILL INJ 100E/ML PATR O O N 3ML

0,40

ML

3,73467

0B01ABAP V

113410//11876

FR AXIP AR INE INJVLST 9500IE/ML W W SP 0,3ML

0,30

ML

5,92940

0B01AC AP V 0B01AC AP V

111570 111571

VELETR I INFUSIEP O EDER FLAC O N 0,5MG VELETR I INFUSIEP O EDER FLAC O N 1,5MG

8,60 2,87

STUK 145,83590 STUK 437,50770

0B01AXBO V

EU/1/08/442/017

P R ADAXA C APSULE 75MG

4,00

STUK 1,86136

0B01AXBO V 0B01AXBO V

EU/1/08/442/018 EU/1/08/442/019

P R ADAXA C APSULE 110MG P R ADAXA C APSULE 150MG

2,73 2,00

STUK 2,27500 STUK 3,10227

0B01AXBO V

EU/1/11/691/002

ELIQ UIS TABLET FILMO MHULD 2,5MG

4,00

STUK 1,86136

0B01AXBO V

EU/1/11/691/003

ELIQ UIS TABLET FILMO MHULD 2,5MG

4,00

STUK 1,86136

0B01AXBO V 0B01AXBO V

EU/1/11/691/006 EU/1/11/691/008

ELIQ UIS 5 MG FILMO MHULDE TABLET ELIQ UIS TABLET FILMO MHULD 5MG

2,00 2,00

STUK 3,10227 STUK 3,10227

0B01AXBO V

EU/1/11/691/011

ELIQ UIS TABLET FILMO MHULD 5MG

2,00

STUK 3,10227

0C 09C AAO V

103732

VALSAR TAN C F TABLET FILMO MHULD 40MG

2,00

STUK 0,44652

YC 09BAAO V

101517

P ER INDO PR IL TER T-BUTYL/INDAP AMIDE AR R O W T 4/1,25MG 1,00

STUK 0,63581

YC 09BBBO V

113394//100139

P ER INDO PR IL AR G/AMLO DIP INE FISHER TABL FO 5/ 5MG

1,00

STUK 1,38460

0C 10AAAO V

113428//26872

C R ESTO R TABLET FILMO MHULD 10MG

1,00

STUK 1,38403

0C 10AAAO V

113429//26873

C R ESTO R TABLET FILMO MHULD 20MG

0,50

STUK 2,76806

0C 10AAAO V 0C 10AAAO V

113404//26874 113430//26874

C R ESTO R TABLET FILMO MHULD 40MG C R ESTO R TABLET FILMO MHULD 40MG

0,25 0,25

STUK 5,53612 STUK 5,53612

0G03AABO V

113400//12846

C ILEST TABLET

0,75

STUK 0,13253

0G03AABO V

109939

DR O SP IR ENO N/ETHINYLESTR ADIO L SDZ TAB O MH 3/0,02MG

0,86

STUK 0,11597

0G03AC AIM V 113403//6602

DEPO PR O VER A 150 INJSUSP 150MG/ML W W SP 1ML

0,01

ML

0G03AC AO V

106992

SO LGEST TABLET FILMO MHULD 0,075MG

1,00

STUK 0,08071

0G03BABO V

113397//33424

TO STR AN GEL 20MG/G

2,50

GR AM 0,72605

0H01BAAO V

112897//30856

MINR IN MELT LYO P HILISAAT 120MC G

1,50

STUK 2,10597

0H02ABAO V

112888//18765

ENTO C O R T C AP SULE MGA 3MG

3,00

STUK 1,02100

0J01FAAO V

113107//9314

ER YTHR O C INE-ES TABLET 500MG

3,00

STUK 0,81010

0L02AEADI V

113335//18562

ZO LADEX IMP LANTATIESTIFT 10,8MG IN W W SP

0,33

STUK 552,22770

0L03AADP V

EU/1/02/221/017

P EGASYS 90 INJVLST 180MC G/ML W W SP 0,5ML

0,14

ML

0M05BABP V 0M05BABP V

109562 109764

ZO LEDR O NINEZUUR SANDO Z INFVLST 0,04MG/ML FL 100ML ZO LEDR O NINEZUUR SUN INFVLST C O NC 0,8MG/ML FLAC 5ML

1,00 1,00

STUK 297,27600 STUK 297,27600

0N02ABADP K

109404

FENTANYL MATR IX MYLAN P LEISTER 12MC G/UUR

1,33

STUK 5,69800

0N02ABADP V

109416

FENTANYL MATR IX MYLAN P LEISTER 25MC G/UUR

0,67

STUK 5,39635

0N02ABADP V

109417

FENTANYL MATR IX MYLAN P LEISTER 50MC G/UUR

0,33

STUK 10,79271

0N02ABADP V

109418

FENTANYL MATR IX MYLAN P LEISTER 75MC G/UUR

0,22

STUK 16,18906

0N02ABADP V

109419

FENTANYL MATR IX MYLAN P LEISTER 100MC G/UUR

0,17

STUK 21,58541

0N02C C AO V

104485

R IZATR IP TAN DISP 10 MG TEVA O R O DISPER GEER BAR E TABL

1,00

STUK 6,21227

0N02C C AO V

104484

R IZATR IP TAN DISP 5 MG TEVA O R O DISP ER GEER BAR E TABL

2,00

STUK 3,72736

0N03AXDO V

EU/1/11/702/001

LEVETIR AC ETAM R P DR ANK 100MG/ML

15,00

ML

0N03AXEO V

113359//25836

TO P AMAX SP R INKLE C AP SULE 15MG

20,00

STUK 0,50842

0N03AXEO V 0N03AXEO V

113358//25837 113067//25838

TO P AMAX SP R INKLE C AP SULE 25MG TO P AMAX SP R INKLE C AP SULE 50MG

12,00 6,00

STUK 0,39720 STUK 0,79440

0N06DXAO V

EU/1/13/824/003

NEMDATINE TABLET FILMO MHULD 10MG

2,00

STUK 1,86000

0N06DXAO V

EU/1/13/824/014

NEMDATINE TABLET FILMO MHULD 20MG

1,00

STUK 3,10000

2N06ABAO V

113294//30496

LEXAPR O TABLET FILMO MHULD 15MG

0,67

STUK 1,59958

2N06AXBO V

112650//9145

TR AZO LAN TABLET 100MG

3,00

STUK 0,35546

YR 03AC C IDAV 113566//34610

FO STER AER O SO L 100/6MC G/DO SIS SP UITBUS 180DO

1,00

DO

0,40611

YR 03AC C IDAV 113567//34610

FO STER AER O SO L 100/6MC G/DO SIS SP UITBUS 180DO

1,00

DO

0,40611

YR 03AC C IDC V 113289//23529 YR 03AC C IDC V 113290//23530

SER ETIDE DISKUS INHP DR 50/100MC G 60DO SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00 1,00

DO DO

0,72888 0,90703

YR 03AC C IDC V 113291//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00

DO

1,20396

6,96550

192,29151

0,23833

YR 03AKAIDC V 113129//27690

SYMBIC O R T TUR BUHALER INHALP DR 400/12MC G/DO 60DO

1,00

DO

2R 06AEAO V

113283//17708

KESTINE TABLET 10MG

1,00

STUK 0,50499

YS01C AEG V

113062//14223

TO BR ADEX O O GDR UP P ELS FLAC O N 5ML

1,00

ML

1,15170

YS01EDC G V

106539

DO R ZO LAMIDE/TIMO LO L NTC O O GDR 20/5MG/ML FL 5ML

1,00

ML

3,13380

0A02BC AO V

113284//101600

NEXIUM GR ANULAAT MSR V SUSP IN SAC HET 10MG

2,00

STUK 1,00866

0A02BC AO V 0A02BC AO V

113287//25387 113296//25388

NEXIUM TABLET MSR 20MG NEXIUM TABLET MSR 40MG

1,00 0,50

STUK 1,68111 STUK 3,36221

0A03AAAO V

110799//11657

MEBEVER INEHYDR O C HLO R IDE ER C R ETAR D C APS MGA 200MG 2,00

STUK 0,35055

0A05AAAO V

112405

UR SO FALK TABLET FILMO MHULD 500MG

STUK 1,54089

0A07EC C O V

112250//105712

P ENTASA TABLET MVA 1G

1,50

STUK 1,25116

0A07EC C O V 0A07EC C O V

112121//14797 113401//107302

P ENTASA TABLET MVA 500MG SALO FALK GR ANU-STIX GR ANULAAT MGA 3G IN SAC HET

3,00 0,50

STUK 0,62558 STUK 3,75349

0A09AAAO V

112686//16055

C R EO N FO R TE C AP SULE MSR (P ANC R EATINE 300MG)

2,40

STUK 1,00796

0A09AAAO V 0A09AAAO V

112959//16055 113271//16055

C R EO N FO R TE C AP SULE MSR (P ANC R EATINE 300MG) C R EO N FO R TE C AP SULE MSR (P ANC R EATINE 300MG)

2,40 2,40

STUK 1,00796 STUK 1,00796

0A10ABBP I V

EU/1/96/007/023

HUMALO G INJVLST 100E/ML PATR O O N 3ML

0,40

ML

2,26345

0B01ABAP V

113498//12788

FR AGMIN 5000 INJVLST 25.000IE/ML W W SP 0,2ML

0,10

ML

17,78820

0B06AC AO V

EU/1/10/641/001

R UC O NEST INJEC TIEP O EDER FLAC O N 2100E

23,33

ML

67,85714

1C 04ADAO V

113167//11175

TR ENTAL TABLET MGA 400MG

2,50

STUK 0,19835

0C 10AAAO V

113507//30823

C R ESTO R TABLET FILMO MHULD 5MG

2,00

STUK 0,83042

0C 10AC AO V

113575//6761

Q UESTR AN P O EDER 4G IN SAC HET

3,50

STUK 0,49172

0D07ABADL V

113406//16163

LO C O ID C R ELO HUIDEMULSIE 1MG/G

1,00

GR AM 0,14143

0D07ABADL V

113408//16163

LO C O ID C R ELO HUIDEMULSIE 1MG/G

1,00

GR AM 0,14143

0G03AC AIM V 113011//6602

DEPO PR O VER A 150 INJSUSP 150MG/ML W W SP 1ML

0,01

ML

0G04BDBO V 0G04BDBO V

113031//29151 113042//29152

VESIC AR E TABLET FILMO MHULD 5MG VESIC AR E TABLET FILMO MHULD 10MG

1,00 0,50

STUK 0,82981 STUK 1,65963

0G04BDBO V

113520//29152

VESIC AR E TABLET FILMO MHULD 10MG

0,50

STUK 1,65963

YG04C AAO V

113469//104130

C O MBO DAR T C AP SULE 0,5/0,4MG

1,00

STUK 2,08572

YG04C ABO V

111622

VESO MNI TABLET MGA 6/0,4MG

1,00

STUK 1,95779

0J01XAAP V

113444//15374

TAR GO C ID INJP DR FLAC O N 400MG + SO LVENS 3ML

200,00 MG

0L01AXAO V

EU/1/11/697/013

TEMO ZO LO MIDE SUN C AP SULE 5MG

13,40

STUK 8,65384

0L01AXAO V

EU/1/11/697/015

TEMO ZO LO MIDE SUN C AP SULE 20MG

3,35

STUK 21,63461

1,20

0,96642

6,96550

0,23895

0L01AXAO V

EU/1/11/697/019

TEMO ZO LO MIDE SUN C AP SULE 140MG

0,48

STUK 151,44226

0L01AXAO V

EU/1/11/697/021

TEMO ZO LO MIDE SUN C AP SULE 180MG

0,37

STUK 194,71147

0L01AXAO V

EU/1/11/697/023

TEMO ZO LO MIDE SUN C AP SULE 250MG

0,27

STUK 270,43260

0L02AEADI V

113349//30594

LEUP R O R ELINE MEDC O R DEP O T 3 MND IMP L 5MG IN W W SP

0,33

STUK 552,11728

0L02AEAP V

110636

TR IP TO FEM INJVLST 0,1MG/ML W W SP 1ML

1,00

ML

0L03ABAO V

EU/1/11/704/002

VIC TR ELIS C APSULE 200MG

8,00

STUK 8,97500

0L04AAC O V

113363//30043

C ER TIC AN TABLET 0,75MG

2,00

STUK 14,23305

0M01AHBO V

113472//27705

AR C O XIA TABLET FILMO MHULD 60MG

1,00

STUK 1,13188

0M01AHBO V

113471//27706

AR C O XIA TABLET FILMO MHULD 90MG

0,67

STUK 1,69782

0M01AHBO V

113456//27705

ETO R IC O XIB ER C TABLET FILMO MHULD 60MG

1,00

STUK 1,13188

0M01AHBO V

113457//27706

ETO R IC O XIB ER C TABLET FILMO MHULD 90MG

0,67

STUK 1,69782

0N02AAAO V

113314//18758

O R AMO R PH DR ANK 2MG/ML

50,00

ML

0N02C C AO V

113431//26579

R ELP AX TABLET FILMO MHULD 40MG

1,00

STUK 6,21227

0N04BAAO V

113106//12858

SINEMET 62,5 TABLET 50/12,5MG

12,00

STUK 0,11366

0N04BAAO V

113533//6707

SINEMET 275 TABLET 250/25MG

2,40

STUK 0,47358

0N05ANAO V

113005//5821

P R IADEL TABLET MGA 400MG

2,22

STUK 0,04765

0N05AXAP V

113171//27178

R ISP ER DAL C O NSTA INJP DR FLAC O N 25MG + SO LV 2ML

0,11

STUK 117,02000

0N05AXAP V 0N05AXAP V

113170//27179 113169//27180

R ISP ER DAL C O NSTA INJP DR FLAC O N 37,5MG + SO LV 2ML R ISP ER DAL C O NSTA INJP DR FLAC O N 50MG + SO LV 2ML

0,07 0,05

STUK 175,53000 STUK 234,04000

2N06ABAO V

113518//30495

LEXAPR O TABLET FILMO MHULD 10MG

1,00

STUK 1,06638

0R 01ADAN V

113468//21613

NASO NEX NEUSSP R AY 50MC G/DO 140DO

4,00

DO

0,08425

0R 03BAAII V

113356//21835

FLIXO TIDE 2000 INHVLST 1MG/ML NEBULE 2ML

1,50

ML

3,85123

0R 03BBAII V

113522//23418

ATR O VENT UNIT DO SE VER NEVELO P L 250MC G/ML FL 1ML

1,20

ML

0,28668

0R 03BBAII V

113521//12869

ATR O VENT UNIT DO SE VER NEVELO P L 250MC G/ML FL 2ML

1,20

ML

0,28668

FO STER AER O SO L 100/6MC G/DO SIS SP UITBUS 120DO FO STER AER O SO L 100/6MC G/DO SIS SP UITBUS 120DO

1,00 1,00

DO DO

0,40611 0,40611

YR 03AC C IDAV 113068//34610 YR 03AC C IDAV 113310//34610

10,06063

0,05825

2R 06AEAO V

112671

LEVO C ETIR IZINE DIHC L C F TABLET FO 5MG

1,00

STUK 0,50499

2R 06AXAO V

113351//21625

TELFAST TABLET O MHULD 180MG

0,67

STUK 0,75748

0S01XAAG V

113411//14862

VIDISIC C AR BO GEL O O GGEL 2MG/G TUBE 10G

0,40

GR AM 0,39706

1A06ADAO V

108093

MAC R O GO L EN ELEKTR C F C ITR O EN P DR V DR SAC H 6,9G

1,52 STUK

0,32571

1A06ADAO V

108092

MAC R O GO L EN ELEKTR C F C ITR O EN P DR V DR SAC H 13,7G

0,76 STUK

0,54285

0A07EC C O V

112122//31379

P ENTASA C O MPAC T GR ANULAAT MVA 2G IN SAC HET

0,75 STUK

2,50233

0A10BXAP V

EU/1/12/811/005 LYXUMIA 10 EN 20 MC G O P LO SSING VO O R INJ 2 P ENNEN

0,04 VER P

0A10BXAP V

EU/1/12/811/003 LYXUMIA 20 MC G O P LO SSING VO O R INJEC TIE 2 PENNEN

0,20 ML

0A11C C AO V

113332//8318

ETALPHA C AP SULE 0,25MC G

4,00 STUK

0,22078

0A11C C AO V

113333//22263

ETALPHA C AP SULE 0,5MC G

2,00 STUK

0,27597

0B01AC AP V

110442

EPO PR O STENO L FO C US INFP DR FL 0,5MG + SO LV 50ML

8,60 STUK 145,83590

0B01AC AP V

110443

EPO PR O STENO L FO C US INFP DR FL 1,5MG + SO LV 100ML

2,87 STUK 437,50770

0C 01BC BO V

31787

FLEC AINIDEAC ETAAT SANDO Z TABLET 50MG

4,00 STUK

0,31111

0C 01BC BO V

31788

FLEC AINIDEAC ETAAT SANDO Z TABLET 100MG

2,00 STUK

0,51852

0C 01C AAP K

113641//106307 JEXT INJVLST 1MG/ML W W SP 0,15ML

3,33 STUK

44,47050

0C 01C AAP V

113642//106309 JEXT INJVLST 1MG/ML W W SP 0,3ML

3,33 STUK

44,47050

0C 01C AAP V

113643//106309 JEXT INJVLST 1MG/ML W W SP 0,3ML

3,33 STUK

44,47050

1C 01DAAO V

113636//9672

TR ANSIDER M NITR O 5 P LEISTER MGA 25MG

1,00 STUK

0,54454

1C 01DAAO V

113638//9673

TR ANSIDER M NITR O 10 PLEISTER MGA 50MG

0,50 STUK

1,08907

YC 09DAAO V

112791

VALSAR TAN/HC T MYLAN TABL FILMO MHULD 320MG/12,5MG

1,00 STUK

3,02853

YC 09DAAO V

112801

VALSAR TAN/HC T MYLAN TABL FILMO MHULD 320MG/25MG

1,00 STUK

3,08026

0C 10AC AO V

113656//28626

EZETR O L TABLET 10MG

1,00 STUK

1,72101

DER MO VATE HYDR O FIELE C R EME 0,5MG/G

1,00 GR AM

0,16599

3D07ADADC V 113503//6932

108,22500 24,05000

YG04C AAO V

113442//104130 C O MBO DAR T C AP SULE 0,5/0,4MG

1,00 STUK

2,08572

1H03BBAO V

113036//2224

1,00 STUK

0,05645

0J07BC AP V

EU/1/01/183/029 HBVAXP R O 10 INJSUSP 10MC G/ML W W SP 1ML

1,00 ML

0L02AEADI V

110879

LEUP R O R ELINE LUTR ATE DEP O T INJP F 3,75MG+S 2ML W W S

1,00 STUK 184,07590

0M01AHBO V

113531//25053

C ELEC O XIB ER C C AP SULE 100MG

2,00 STUK

0M01AHBO V

113528//25054

C ELEC O XIB ER C C AP SULE 200MG

1,00 STUK

1,13188

0M01AHBO V

113504//27706

ETO R IC O XIB FISHER TABLET FILMO MHULD 90MG

0,67 STUK

1,69782

0M05BABP V

109892

ZO LEDR O NINEZUUR FR ES K INFVLST C O N 0,8MG/ML FL 5ML

1,00 STUK 297,27600

0N02AAAO V

113313//18759

O R AMO R PH DR ANK 20MG/ML

5,00 ML

0N02C C BO V

113357//19853

IMIGR AN ZETP IL 25MG

1,00 STUK

10,43468

0N02C XBO V

113637//6757

DIXAR IT DR AGEE 0,025MG

4,00 STUK

0,08017

1N05ADAPD V

113629//10194

IMPR O MEN DEC ANO AS INJVLST 50MG/ML AMPUL 1ML

0,07 STUK

10,84955

STR UMAZO L TABLET 10MG

29,51840

0,67913

0,41607

2N05AFAO V

112630//5992

FLUANXO L DR AGEE 5MG

1,20 STUK

0,45760

4N05AXAO V

108460

Q UETIAPINE SANDO Z R ETAR D TABLET MVA 200MG

1,50 STUK

2,64201

4N05AXAO V

108466

Q UETIAPINE SANDO Z R ETAR D TABLET MVA 300MG

1,00 STUK

3,96302

4N05AXAO V

108467

Q UETIAPINE SANDO Z R ETAR D TABLET MVA 400MG

0,75 STUK

5,28402

0N06AAAO V

113519//3286

NO R TR ILEN TABLET 25MG

3,00 STUK

0,14743

0N06DXAO V

EU/1/02/219/006 EBIXA DR UP P ELS 10MG/G

2,00 ML

1,55000

0N06DXAO V

EU/1/02/219/005 EBIXA O P LO SSING 5MG/PO MP DO SIS 0,5ML

2,00 ML

1,55000

0N06DXAO V

EU/1/02/219/022 EBIXA STAR TVER P AKKING (7X5MG+7X10MG+7X15MG+7X20MG) 0,05 VER P

0N06DXAO V

EU/1/02/219/001 EBIXA TABLET FILMO MHULD 10MG

2,00 STUK

1,86000

0N06DXAO V

EU/1/02/219/002 EBIXA TABLET FILMO MHULD 10MG

2,00 STUK

1,86000

0N06DXAO V

EU/1/02/219/003 EBIXA TABLET FILMO MHULD 10MG

2,00 STUK

1,86000

0N06DXAO V

EU/1/02/219/007 EBIXA TABLET FILMO MHULD 10MG

2,00 STUK

1,86000

0N06DXAO V

EU/1/02/219/008 EBIXA TABLET FILMO MHULD 10MG

2,00 STUK

1,86000

0N06DXAO V

EU/1/02/219/009 EBIXA TABLET FILMO MHULD 10MG

2,00 STUK

1,86000

0N06DXAO V

EU/1/02/219/017 EBIXA TABLET FILMO MHULD 10MG

2,00 STUK

1,86000

0N06DXAO V

EU/1/02/219/020 EBIXA TABLET FILMO MHULD 10MG

2,00 STUK

1,86000

0N06DXAO V

EU/1/02/219/024 EBIXA TABLET FILMO MHULD 20MG

1,00 STUK

3,10000

0N06DXAO V

EU/1/02/219/027 EBIXA TABLET FILMO MHULD 20MG

1,00 STUK

3,10000

0N06DXAO V

EU/1/02/219/031 EBIXA TABLET FILMO MHULD 20MG

1,00 STUK

3,10000

0N06DXAO V

EU/1/13/836/005 MEMANTINE R P TABLET FILMO MHULD 10MG

2,00 STUK

1,86000

0N06DXAO V

EU/1/13/836/017 MEMANTINE R P TABLET FILMO MHULD 20MG

1,00 STUK

3,10000

0R 01ADAN V

113564//23477

FLIXO NASE NEUSDR UP P ELS 1MG/ML P ATR O O N 0,4ML

0,50 DO

0,67402

0R 01ADAN V

113649//21613

NASO NEX NEUSSP R AY 50MC G/DO 120DO

4,00 DO

0,08425

0R 01ADAN V

113684//21613

NASO NEX NEUSSP R AY 50MC G/DO 140DO

4,00 DO

0,08425

0R 03AC AIDC V 113709//12480

BR IC ANYL TUR BUHALER INHALP DR 0,5MG/DO 100DO

4,00 DO

0,09620

0R 03BABID V

113730//31633

ALVESC O 160 AER O SO L 160MC G/DO SPBS 60DO + INH

1,00 DO

0,70100

0R 03BABID V

113395//16213

FLIXO TIDE AER C FKVR 125MC G/DO SP BS 120 DO + INHAL

4,80 DO

0,14604

0R 03BADID V

113396//18194

FLIXO TIDE DISKUS INHP DR 250MC G 60DO

2,40 DO

0,29692

YR 03AC C IDAV 113645//25865

SER ETIDE AER O SO L 25/ 50MC G/DO C FKVR SP BS 120DO +INH

1,00 DO

0,28928

YR 03AC C IDC V 113353//23529

SER ETIDE DISKUS INHP DR 50/100MC G 60DO

1,00 DO

0,72888

YR 03AC C IDC V 113354//23530

SER ETIDE DISKUS INHP DR 50/250MC G 60DO

1,00 DO

0,90703

YR 03AC C IDC V 113355//23531

SER ETIDE DISKUS INHP DR 50/500MC G 60DO

1,00 DO

1,20396

YR 03AKAII V

113639//20233

C O MBIVENT UNIT DO SE VER NEVELO P LO SSING FLAC O N 2,5ML

1,00 ML

0,28661

YS01C AEG V

113436//14223

TO BR ADEX O O GDR UP P ELS FLAC O N 5ML

1,00 ML

1,15170

B. Lijst van geneesmiddelen waarvoor geen vergoedingslimiet is vastgesteld R e gistra tie num m e r Artik e lnaa m 9974

Ace purin infusie po ede r flacon 1000m g

56,42000

53335

Ace tylsalicylzuur/co ffeine /co d ze tpil 400/50/9,6

12247

Actilyse infusie po e der fla co n 20m g + so lve ns 20m l

12248 12068

Actilyse infusie po e der fla co n 50m g + so lve ns 50m l Adda m e l-n infusie vlst conc

11094

Addiphos infusie vlo e isto f co nce ntra a t flacon 20m l

51919

Adrena line pch injvlst 1m g/m l am pul 1m l

EU/1/00/148/001 EU/1/00/148/002

Agene ra se ca psule 50m g Agene ra se ca psule 150m g

EU/1/00/148/004

Agene ra se drank 15m g/m l

11694

Ak e 1100 m e t gluco se infusie vlo eistof fla c 1000m l

2197 EU/1/98/080/001

Ak ine to n injvlst 5m g/m l a m pul 1m l Alda ra cre m e 50m g/g in sa che t

11013

C YTAR ABINE SANDO Z INFVLST C O NC 50MG/ML

6468

Alex a n injvlst 20m g/m l

6690 4473

Alk e ra n infusie poe de r fla co n 50m g + so lve ns 10m l Alk e ra n table t film o m huld 2m g

16388

Alle rgo vit gras inste lk a +b 2x 3,0m l+10sp

16388

Alle rgo vit gras inste lk a +b 2x 3,0m l+10sp

16388 16388

Alle rgo vit gras ve rvolgk b 1x 3,0m l+10sp Alle rgo vit gras ve rvolgk b 1x 3,0m l+10sp

16445

Aluta rd sq 197 bo m en-3 inste l 4flx 5m l+20sp

16445

Aluta rd sq 197 bo m en-3 inste l 4flx 5m l+20sp

16445 16445

Aluta rd sq 197 bo m en-3 inste l 4flx 5m l+20sp Aluta rd sq 197 bo m en-3 inste l 4flx 5m l+20sp

16445

Aluta rd sq 197 bo m en-3 vervo lg 1flx 5m l+ 5sp

16445

Aluta rd sq 197 bo m en-3 vervo lg 1flx 5m l+ 5sp

16445 16445

Aluta rd sq 197 bo m en-3 vervo lg 1flx 5m l+ 5sp Aluta rd sq 197 bo m en-3 vervo lg 1flx 5m l+ 5sp

31987

Aluta rd sq 225 tim o the e gras inste l 4flx 5m l+20sp

31987

Aluta rd sq 225 tim o the e gras inste l 4flx 5m l+20sp

31987 31987

Aluta rd sq 225 tim o the e gras ve rv 1flx 5m l+ 5sp Aluta rd sq 225 tim o the e gras ve rv 1flx 5m l+ 5sp

16445

Aluta rd sq 293 gra sse n-5 inste l 4flx 5m l+20sp

16445

Aluta rd sq 293 gra sse n-5 inste l 4flx 5m l+20sp

16445 16445

Aluta rd sq 293 gra sse n-5 inste l 4flx 5m l+20sp Aluta rd sq 293 gra sse n-5 inste l 4flx 5m l+20sp

16445

Aluta rd sq 293 gra sse n-5 ve rvo lg 1flx 5m l+ 5sp

16445

Aluta rd sq 293 gra sse n-5 ve rvo lg 1flx 5m l+ 5sp

16445 16445

Aluta rd sq 293 gra sse n-5 ve rvo lg 1flx 5m l+ 5sp Aluta rd sq 293 gra sse n-5 ve rvo lg 1flx 5m l+ 5sp

16469

Aluta rd sq 510 huisstofm ijt-2 instel 4flx 5m l+20sp

16469

Aluta rd sq 510 huisstofm ijt-2 instel 4flx 5m l+20sp

16469 16469

Aluta rd sq 510 huisstofm ijt-2 ve rvo lg 1flx 5m l+5sp Aluta rd sq 510 huisstofm ijt-2 ve rvo lg 1flx 5m l+5sp

16487

Aluta rd sq 555 k a t inste l 4flx 5m l+20sp

16487

Aluta rd sq 555 k a t inste l 4flx 5m l+20sp

16487

Aluta rd sq 555 k a t ve rvolg 1flx 5m l+ 5sp

16487

Aluta rd sq 555 k a t ve rvolg 1flx 5m l+ 5sp

16490

Aluta rd sq 801 bijengif instel 4flx 5m l+20sp

16490

Aluta rd sq 801 bijengif instel 4flx 5m l+20sp

16490

Aluta rd sq 801 bijengif instel 4flx 5m l+20sp

16490

Aluta rd sq 801 bijengif instel 4flx 5m l+20sp

16490

Aluta rd sq 801 bijengif ve rvo lg 1flx 5m l+ 5sp

16490 16490

Aluta rd sq 801 bijengif ve rvo lg 1flx 5m l+ 5sp Aluta rd sq 801 bijengif ve rvo lg 1flx 5m l+ 5sp

16490

Aluta rd sq 802 we spe ngif inste l 4flx 5m l+20sp

16490

Aluta rd sq 802 we spe ngif inste l 4flx 5m l+20sp

16490 16490

Aluta rd sq 802 we spe ngif inste l 4flx 5m l+20sp Aluta rd sq 802 we spe ngif inste l 4flx 5m l+20sp

16490

Aluta rd sq 802 we spe ngif vervo lg 1flx 5m l+ 5sp

16490

Aluta rd sq 802 we spe ngif vervo lg 1flx 5m l+ 5sp

16490 16490

Aluta rd sq 802 we spe ngif vervo lg 1flx 5m l+ 5sp Aluta rd sq 802 we spe ngif vervo lg 1flx 5m l+ 5sp

EU/1/02/224/002

Am birix injsusp wwsp 1m l

6543

Am ine ss n table t

8988 8732

Am ino pla sm a l infvlst 100m g/m l el+k hvr Am ino ste ril n he pa infvlst 80m g/m l fla co n 500m l

9552

Am ino ve no s n pae d infvlst 100m g/m l

9084

Am sidine injvlst 50m g/m l am pul 1,5m l + so lv 13,5m l

8533 7517

Anco til infusievloe isto f 10m g/m l flac 250m l + syst Anco til ta ble t 500m g

7529

Andro cur de po t injvlst 100m g/m l am pul 3m l

9078

Andro cur ta ble t 10m g

12857 35295

Anex a te injvlst 0,1m g/m l Apo-go infvlst 5m g/m l wwsp 10m l

21892

Apo-go injvlst 10m g/m l a m pul 5m l

21893

Apo-go pe n injvlst 10m g/m l wwsp 3m l

EU/1/05/315/001 EU/1/02/206/006

Aptivus ca psule 250m g Arix tra injvlst 5m g/m l wwsp 0,3m l

EU/1/02/206/001

Arix tra injvlst 5m g/m l wwsp 0,5m l

EU/1/02/206/002

Arix tra injvlst 5m g/m l wwsp 0,5m l

EU/1/02/206/003 EU/1/02/206/004

Arix tra injvlst 5m g/m l wwsp 0,5m l Arix tra injvlst 5m g/m l wwsp 0,5m l

16410

AR THR O TEC TABLET MGA 50MG

20871

AR THR O TEC TABLET MGA 75MG

34271//20871 24869//16410

AR THR O TEC TABLET MGA 75MG AR THR O TEC TABLET MGA 50MG

24870//20871

Artro tec table t 75m g

25891//20871

Artro tec table t 75m g

50810 103951//6305

Ascorbinezuur cf injvlst 100m g/m l a m pul 5m l Aspe gic inje ctiepo e de r fla co n 500m g + solvens 5m l

6305

Aspe gic inje ctiepo e de r fla co n 500m g + solvens 5m l

EU/1/07/430/001

Atripla ta ble t film o m huld

50080 50079

Atro pine sulfaa t cf injvlst 0,25m g/m l a m pul 1m l Atro pine sulfaa t cf injvlst 0,50m g/m l a m pul 1m l

50054

Atro pine sulfaa t pch injvlst 0,25m g/m l a m pul 1m l

50055

Atro pine sulfaa t pch injvlst 0,5m g/m l am pul 1m l

50056

Atro pine sulfaa t pch injvlst 1m g/m l a m pul 1m l

26834

Atro ve nt ae ro so l 20m cg/do spbs 200do + inha la tor

14740

Augm e ntin suik e rvrij pdr v susp 100/12,5m g/1m l

103530//20983

Ava x im injvlst 320pm -e /m l wwsp 0,5m l

20983

Ava x im injvlst 320pm -e /m l wwsp 0,5m l

EU/1/97/033/002

Avo ne x 30 inje ctie po e der fl 30m cg + so lv 1m l

EU/1/97/033/003

Avo ne x 30 inje ctie vlo eistof 60m cg/m l wwsp 0,5m l

10466

Aza thioprine pch inje ctie poe de r fla co n 50m g

1761 7231

Ba cico line-b oo rdruppe ls Ba ctrim e l infusie vlo e isto f co nc a m pul 5m l

100916//13761

Ba ctro ba n neusza lf 20m g/g

13761

Ba ctro ba n neusza lf 20m g/g

23892//13761 24855//13761

Ba ctro ba n neusza lf 20m g/g Ba ctro ba n neusza lf 20m g/g

7439

Be lustine ca psule 40m g

15793

Be rodua l inhale tte inha la tie po e der

EU/1/95/003/001 EU/1/95/003/003

Be tafe ro n inje ctiepo e de r fl 9.600.000ie + so lv 2m l Be tafe ro n injpdr fl 9.600.000ie + so lv 1,2m l wwsp

EU/1/95/003/005

Be tafe ro n injpdr fl 9.600.000ie +so lv 1,2m l + to e bh

2697

Be tne sol la ve m ent 0,05m g/m l fla co n 100m l

11307 23015//11307

Be toptic o o gdruppe ls 5m g/m l fla co n 5m l Be toptic o o gdruppe ls 5m g/m l fla co n 5m l

15337

Be toptic s oo gdruppe ls 2,5m g/m l fla co n 5m l

24668//15337

Be toptic s oo gdruppe ls 2,5m g/m l fla co n 5m l

17110 10880

Be toptic s single dose oo gdrup 2,5m g/m l m in 0,25m l Biltricide table t 600m g

8193

Bleu pa tente v injvlst 25m g/m l a m pul 2m l

35123

Bo ostrix po lio injsusp wwsp 0,5m l

544 12412

Brieta l hik m a inje ctiepo e de r Burine x injvlst 0,50m g/m l

101992//3837

Busco pa n injvlst 20m g/m l a m pul 1m l

3837

Busco pa n injvlst 20m g/m l a m pul 1m l

3871 18866

Butazo lidin dra gee 200m g C a d citroe n bruisgra nula a t 500m g/440ie in sache t

18867

C a d citroe n bruisgra nula a t 1000m g/880ie in sa che t

31002

C a d ora nge bruisgra nula at 500m g/440ie in sa che t

31003 25692

C a d ora nge bruisgra nula at 1000m g/880ie in sa chet C a lci chew d3 k a uwtable t 500m g/400ie

27908//25692

C a lci chew d3 k a uwtable t 500m g/400ie

28348//25692

C a lci chew d3 k a uwtable t 500m g/400ie

30973//25692 31814//25692

C a lci chew d3 k a uwtable t 500m g/400ie C a lci chew d3 k a uwtable t 500m g/400ie

32133//25692

C a lci chew d3 k a uwtable t 500m g/400ie

32163//25692

C a lci chew d3 k a uwtable t 500m g/400ie

33066//25692 33661//25692

C a lci chew d3 k a uwtable t 500m g/400ie C a lci chew d3 k a uwtable t 500m g/400ie

101127

C a lci chew d3 k a uwtable t 1000m g/800ie

8201

C a lcitonine sa ndo z injvlst 100ie /m l a m pul 1m l

24713 485

C a lcium d sa ndoz ca -d bruistable t 600m g/400ie C a lcium sando z a m p 1,375g/10m l

6423

C a lm urid cre m e 100m g/g

6996

C a lm urid hc cre m e

18220

C a m pra l ta ble t m sr 333m g

33770//18220

C a m pra l ta ble t m sr 333m g

EU/1/02/246/002

C a rbaglu dispe rge erba a r table t 200m g

EU/1/02/246/003

C a rbaglu dispe rge erba a r table t 200m g

11193

C a rnite ne sigm a ta u dra nk 100m g/m l

11192

C a rnite ne sigm a ta u injvlst 200m g/m l a m pul 5m l

11194

C a rnite ne sigm a ta u table t 330m g

16910 7876

C e a lb infusievloe isto f 200m g/m l C e docard infusievloe isto f co nc 1m g/m l a m pul 10m l

EU/1/07/418/003

C e lse ntri ta blet film om huld 150m g

EU/1/07/418/008

C e lse ntri ta blet film om huld 300m g

EU/1/97/053/001 EU/1/97/053/002

C e re zym e infusiepo e de r fla co n 200e C e re zym e infusiepo e de r fla co n 200e

EU/1/97/053/003

C e re zym e infusiepo e de r fla co n 400e

5633

C e rubidine inje ctie poe de r fla co n 20m g +so lve ns 4m l

19303 52455

C e to r infusie poe de r fla co n 500e +so lv 5m l C hinini sulfas drage e 200m g

30399

C iproflo x acine fdc o ordruppe ls 3m g/m l tube 0,5m l

7820

C ita ne st injvlst 10m g/m l

7821 7824

C ita ne st injvlst 20m g/m l C ita ne st/o cta pre ssine inj 30m g/0,54m cg/m l cil1,8m l

24829

C linda m ycine sa ndo z injvlst 150m g/m l

16863

C lino le ic infvlst 200m g/m l

50914 50916

C o deine hcl pch ta ble t 10m g C o deine hcl pch ta ble t 20m g

20300=53361

C o deine fosfa at a ta ble t 10m g

20301=53362

C o deine fosfa at a ta ble t 20m g

55441 55442

C o deine fosfa at pch ta ble t 10m g C o deine fosfa at pch ta ble t 15m g

55443

C o deine fosfa at pch ta ble t 20m g

53361

C o deine fosfa at rp ta ble t 10m g

53362 17060

C o deine fosfa at rp ta ble t 20m g C o fa ct injpdr fla c ca 250ie +sv 10m l+to e be h

17060

C o fa ct injpdr fla c ca 250ie +sv 10m l+to e be h

17060

C o fa ct injpdr fla c ca 500ie +sv 20m l+to e be h

17060 102274

C o fa ct injpdr fla c ca 500ie +sv 20m l+to e be h C o lchicine a cta vis ta blet 0,5m g

34100

C o lchicine pch table t 0,5m g

21553

C o lchicine rp table t 0,5m g

21347 103956//32744

C o lchicinum table t 0,5m g C o m biga n o o gdruppels fla co n 5m l

32744

C o m biga n o o gdruppels fla co n 5m l

EU/1/98/058/001

C o m bivir ta blet o m huld

EU/1/98/058/002 5445

C o m bivir ta blet o m huld C o m pla m in re ta rd ta blet m ga 500m g

12502

C o ntralum ultra sm e e rse l

30086

C o pax o ne injvlst 20m g/m l wwsp 1m l

32737//30086 10937

C o pax o ne injvlst 20m g/m l wwsp 1m l C o rdaro ne iv injvlst 50m g/m l am pul 3m l

12820

C o ro trope injvlst 1m g/m l a m pul 10m l

25702

C O SMO FER INJVLST 50MG/ML

33660

C o so pt co nse rve e rm idde lvrij o o gdruppels fla c 0,2m l

EU/1/96/024/003

C rix iva n capsule 200m g

EU/1/96/024/005

C rix iva n capsule 400m g

2242

C ura le st injvlst 20m g/m l fla co n 5m l

2243

C ura le st injvlst 50m g/m l

5573

C yk lo k apro n injvlst 100m g/m l a m pul 5m l

5574

C yk lo k apro n table t film o m huld 500m g

13007

C ym e vene infusie po ede r flacon 500m g

EU/1/06/379/001 EU/1/97/039/001

C ysta dane poe de r C ysta gon ca psule 50m g

EU/1/97/039/003

C ysta gon ca psule 150m g

33181//2784

LIO THYR O NINENATR IUM ER C TABLET 25MC G

34991//2784 13724

LIO THYR O NINENATR IUM GLO BAL FAR MA TABLET 25MC G C ytote c ta blet 200m cg

7342

Da k tacort crem e

11506

Da k tacort hydro fo be za lf

6903 6354

Da lacin c injvlst 150m g/m l Da lacin c po e de r voo r suspensie 15m g/m l

6982

Da natro l ca psule 100m g

6983

Da natro l ca psule 200m g

6978 7580

Da ntrium ca psule 25m g Da ntrium ca psule 50m g

8616

Da ntrium inje ctie po e der fla co n 20m g (iv)

24184=52476

Da pso n pch ta blet 100m g

52476 254

DAP SO N MAE TABLET 100MG Da ra prim ta ble t 25m g

126

De ca dura bo lin injvlst 50m g/m l am pul 1m l

7195

De ca dura bo lin injvlst 100m g/m l fla co n 2m l

4749 12594

De hydro be nzpe rido l injvlst 2,5m g/m l De nore x rx sha m po o

9049

De po pro ve ra 500 injsusp 150m g/m l fla co n 3,3m l

16448

DEPO THAL HUISSTO FMIJT D P TER INST 4FL 5ML +15W W SP

16448 16448

DEPO THAL HUISSTO FMIJT D P TER INST 4FL 5ML +15W W SP DEPO THAL HUISSTO FMIJT D P TER INST 4FL 5ML +15W W SP

16448

DEPO THAL HUISSTO FMIJT D P TER INST 4FL 5ML +15W W SP

16448

DEPO THAL HUISSTO FMIJT D P TER VER V 1FL 5ML + 5W W SP

16448 16448

DEPO THAL HUISSTO FMIJT D P TER VER V 1FL 5ML + 5W W SP DEPO THAL HUISSTO FMIJT D P TER VER V 1FL 5ML + 5W W SP

16448

DEPO THAL HUISSTO FMIJT D P TER VER V 1FL 5ML + 5W W SP

16448

DEPO THAL HUISSTO FM M DP TER +DFAR INS 4FL 5ML+15W W SP

16448 16448

DEPO THAL HUISSTO FM M DP TER +DFAR INS 4FL 5ML+15W W SP DEPO THAL HUISSTO FM M DP TER +DFAR INS 4FL 5ML+15W W SP

16448

DEPO THAL HUISSTO FM M DP TER +DFAR INS 4FL 5ML+15W W SP

16448

DEPO THAL HUISSTO FM M DP TER +DFAR VER V 1FL 5ML+5W W SP

16448 16448

DEPO THAL HUISSTO FM M DP TER +DFAR VER V 1FL 5ML+5W W SP DEPO THAL HUISSTO FM M DP TER +DFAR VER V 1FL 5ML+5W W SP

16448

DEPO THAL HUISSTO FM M DP TER +DFAR VER V 1FL 5ML+5W W SP

562

De se ril table t om huld 1m g

29961//3984 32719//3984

De sfe ra l inje ctiepo e de r fla co n 500m g De sfe ra l inje ctiepo e de r fla co n 500m g

3984

De sfe ra l inje ctiepo e de r fla co n 500m g

6334

De suric ta ble t 100m g

9036

De tice ne inje ctie poe de r fla co n 200m g + so lv 20m l

11301

De x am ytrex o o gza lf tube 3g

EU/1/06/367/002

Dia co m it ca psule 250m g

EU/1/06/367/005

Dia co m it ca psule 500m g

EU/1/06/367/008

Dia co m it po ede r vo o r suspe nsie 250m g in sache t

EU/1/06/367/011

Dia co m it po ede r vo o r suspe nsie 500m g in sache t

644

Dia m o x inje ctie po e der fla co n 500m g

101637//16410

Diclo fena cna trium /m iso prosto l de lphi t 50m g/200m cg

13739

Didrok it(14tabl didro nel 400m g +76bruista bl cacit)

20841//13739

Didrok it(14tabl didro nel 400m g +76bruista bl cacit)

21923//13739

Didrok it(14tabl didro nel 400m g +76bruista bl cacit)

22978//13739 30869//13739

Didrok it(14tabl didro nel 400m g +76bruista bl cacit) Didrok it(14tabl didro nel 400m g +76bruista bl cacit)

5394

Dihydra l ta blet 0,2m g

11547

Dipha nto ine injvlst 50m g/m l am pul 5m l

9129 11549

Dipido lor injvlst 10,0m g/m l a m pul 2m l Dipriva n injvlst 10m g/m l

23110//9375

Diprosa lic za lf

29629//9375

Diprosa lic za lf

9375 55540

Diprosa lic za lf Dm a p injvlst 50m g/m l a m pul 5m l

7309

Do pram infusievloe isto f 2m g/m l zak 500m l

10528

Dridase stro o p 1m g/m l

17641 30589

Dtp va ccin Duo do pa inte stina le ge l 20/5m g/m l zak 100m l

8673

Dyna tra dopa m ine infvlst co nc 40m g/m l a m pul 5m l

6292

Efudix cre m e 50m g/g

5327 11801

Elm e x fluid de nta le a pplica tievloe isto f 1% Elo ha es infusie vlo e isto f za k 500m l

EU/1/03/262/002

Em e nd ca psule 80m g

EU/1/03/262/005

Em e nd ca psule 125m g

EU/1/03/262/006 3160

Em e nd ca psule 1x 125m g/2x 80m g Em e safe ne table t

3161

Em e safe ne ze tpil

100630//11015

Em la hydro fie le cre m e 50m g/g

102377//11015 11015

Em la hydro fie le cre m e 50m g/g Em la hydro fie le cre m e 50m g/g

31137//11015

Em la hydro fie le cre m e 50m g/g

32297//11015

Em la hydro fie le cre m e 50m g/g

35253//11015 EU/1/03/261/001

Em la hydro fie le cre m e 50m g/g Em triva capsule 200m g

8058

Endo x an inje ctie poe de r

10573

Epa nutin injvlst 50m g/m l a m pul 5m l

24472 50812

EPAXAL INJEC TIESUSP ENSIE W W SP 0,5ML ADR ENALINE C F INJVLST 1MG/ML AMP UL 1ML

EU/1/96/015/002

Epivir dra nk 10m g/m l

EU/1/96/015/001

Epivir ta blet film om huld 150m g

EU/1/96/015/004 EU/1/96/015/003

Epivir ta blet film om huld 150m g Epivir ta blet film om huld 300m g

15437

Esk a zo le ta blet 400m g

7375

Estra cyt ca psule 140m g

52403

Ethinyle stra diolum table t 0,05m g

535

Euphyllin injvlst 17,57m g/m l am pul 10m l (iv)

EU/1/98/073/001

Evista ta ble t 60m g

EU/1/98/073/002

Evista ta ble t 60m g

EU/1/06/356/001

Ex ja de disp ta ble t 125m g

EU/1/06/356/003

Ex ja de disp ta ble t 250m g

EU/1/06/356/005

Ex ja de disp ta ble t 500m g

EU/1/03/269/001

Faslode x injvlst 50m g/m l wwsp 5m l

51973

Feno barbita l pch injvlst 50m g/m l a m pul 1m l

51974

Feno barbita l pch injvlst 100m g/m l am pul 1m l

19142

Fenta nyl b.bra un injvlst 0,05m g/m l

25458

Fenta nyl bipha rm a injvlst 0,05m g/m l

4748 EU/1/99/108/003

Fenta nyl jansse n injvlst 0,05m g/m l Ferripro x o plossing vo o r ora a l ge bruik 100m g/m l

EU/1/99/108/001

Ferripro x ta blet 500m g

10322

Fla gyl suspensie 40m g/m l

17435 5990

Fle bo ga m m a infvlst 50m g/m l Flo x a pe n inje ctie po e der

25391

Fluclo x acilline a cs do bfa r injpdr fla co n 250m g

25392

Fluclo x acilline a cs do bfa r injpdr fla co n 500m g

25393 57442

Fluclo x acilline a cs do bfa r injpdr fla co n 1000m g Fluclo x acilline cf injectie po ede r

26919

FLUDAR A TABLET O MHULD 10MG

21729=50392

Folium zuur a cta vis ta ble t 5m g

50392 21766=50392

Folium zuur pch ta ble t 5m g Folium zuur rp ta ble t 5m g

13057

Fosca vir infusievloe isto f 24m g/m l

6045

Fucidin inte rtulle leo ga as +za lf 20m g/g

1369 1585

Fucidin table t om huld 250m g Fungizo ne po e de r a d pe rfusio nem fla co n 50m g

55472

Furo sem ide cf injvlst 10m g/m l

25841

Furo sem ide sa ndo z infvlst co nc 10m g/m l

25839 25840

Furo sem ide sa ndo z injvlst 10m g/m l Furo sem ide sa ndo z injvlst 10m g/m l

EU/1/03/252/001

Fuze on injpdr flacon 90m g + solv 1m l + to ebe h

17032

Ga m m a ga rd s/d infpdr flacon 2,5g + so lve ns 50m l

17033 17034

Ga m m a ga rd s/d infpdr flacon 5g + so lve ns 100m l Ga m m a ga rd s/d infpdr flacon 10g + so lve ns 200m l

17031

Ga m m a ga rd s/d injpdr fla co n 0,5g + solvens 10m l

30505

Ga m m a no rm injvlst 165m g/m l

16941 20107

Ga m m a quin injvlst 160m g/m l Ge lopla sm a infusie vlst 30m g/m l fl 500m l k unststo f

11937

Ghrh ferring injpdr fla co n 50m cg + so lve ns 1m l

32728//2011

GLUC AGEN HYP O KIT INJP DR FL1MG SO LV W W SP1ML

33185//2011 2011

GLUC AGEN INJEC TIEP O EDER Gluca ge n injpdr fl 1m g + so lv

52323

Gluco se pch injvlst 400m g/m l a m pul 10m l

52324

Gluco se pch injvlst 500m g/m l fla co n 50m l

10302 16911

Glypre ssin injectie po ede r flacon 1m g Gpo infusie vlo e isto f 40m g/m l

8042

Ha e m a ccel infvlst 35m g/m l fla c 580m l k unst

12192

Ha e s steril infvlst 100m g/m l

17315 30124//17315

Ha vrix injvlst 1440sk b-e /m l Ha vrix injvlst 1440sk b-e /m l wwsp 1m l

31012//17315

Ha vrix injvlst 1440sk b-e /m l wwsp 1m l

31815//17315

Ha vrix injvlst 1440sk b-e /m l wwsp 1m l

31901//17315

Ha vrix injvlst 1440sk b-e /m l wwsp 1m l

34161//17315

Ha vrix injvlst 1440sk b-e /m l wwsp 1m l

19569

Ha vrix junio r injvlst 1440sk b-e /m l wwsp 0,5m l

31816//19569

Ha vrix junio r injvlst 1440sk b-e /m l wwsp 0,5m l

33921//19569

Ha vrix junio r injvlst 1440sk b-e /m l wwsp 0,5m l

16927

He patitis b im m uno glo buline 200ie /m l flacon 1,5m l

16926

He pbquin injvlst 100ie /m l

EU/1/96/027/006 EU/1/96/027/007

Hyca m tin ca psule 0,25m g Hyca m tin ca psule 1m g

51523

Hydro co rtiso n pch za lf 10m g/g

25186

Hydro co rtiso n za lf 10m g/g

7487 15195

Hypno m ida te injvlst 2m g/m l am pul 10m l Im m uk ine injvlst 0,2m g/m l fla co n 0,5m l

103096//21168

IMPLANO N NXT IMP LANTAAT IN APP LIC ATO R 68MG

21168

IMPLANO N NXT IMP LANTAAT IN APP LIC ATO R 68MG

7290 10776

Im ura n injectie po ede r flacon 50m g Indo cid pda inje ctiepo e de r fla co n 1m g

34568

Infa nrix -ipv injsusp wwsp 0,5m l

51722

Infvlst co nc iso prena lini hcl 1m g/m l

56077 51672

Infvlst co nc k cl 74,6m g/m l Infvlst co nc k cl 100,0m g/m l a m pul 10m l k unststo f

56078

Infvlst co nc k cl 149,0m g/m l a m pul 10m l k unststo f

51051

Infvlst gluc/na cl 25/4,5m g/m l

55241 28838

Infvlst gluc/na cl 25/4,5m g/m l Infvlst gluc/na cl 25/4,5m g/m l

51666

Infvlst gluc/na cl 25/4,5m g/m l

51667

Infvlst gluc/na cl 37,5/2,25m g/m l

51047 51661

Infvlst gluco sum 50m g/m l Infvlst gluco sum 50m g/m l

27516

INFVLST GLUC O SUM 50MG/ML

55214

Infvlst gluco sum 100m g/m l

51048 51662

Infvlst gluco sum 100m g/m l Infvlst gluco sum 100m g/m l

55261

INFVLST GLUC O SUM 100MG/ML:

51664

Infvlst gluco sum 200m g/m l fla co n 500m l gla s + a fsk

56047 56049

Infvlst gluco sum 200m g/m l fla co n 500m l k unstst e co Infvlst gluco sum 400m g/m l fla co n 500m l

51665

Infvlst gluco sum 500m g/m l

56050

Infvlst gluco sum 500m g/m l fla co n 100m l gla s

50604 55249

Infvlst hartm a nn Infvlst hartm a nn bra un fla co n 500m l

51675

Infvlst m annitolum 200m g/m l

50586

Infvlst nacl 6,5m g/m l

51679 56178

Infvlst nacl 6,5m g/m l Infvlst nacl 6,5m g/m l

27512

Infvlst nacl 9m g/m l

55259

Infvlst nacl 9m g/m l

51045 51680

Infvlst nacl 9m g/m l Infvlst nacl 9m g/m l

56083

Infvlst nacl 9m g/m l

55220

Infvlst nahco 3 14m g/m l

56354

Infvlst nahco 3 42m g/m l

56355

Infvlst nahco 3 84m g/m l

51676

Infvlst natrium bica rbo na a t 14m g/m l

51677

Infvlst natrium bica rbo na a t 42m g/m l fl100m l gl+afsk

51678

Infvlst natrium bica rbo na a t 84m g/m l fl100m l gl+afsk

28647

Infvlst ringe r

51052

Infvlst ringe r

52600

Infvlst ringe r

28309 51058

Infvlst ringe r/la cta at Infvlst ringe r/la cta at

51694

Infvlst ringe r/la cta at

53418

Injpdr pe nicilline g natr k ngsf fla c 1.000.000ie

51926 51673

Injvlst ca lcii glucona s 0,225m m o l/m l a m p 10m l Injvlst lido ca ini hcl 10m g/m l

51674

Injvlst lido ca ini hcl 20m g/m l

56229

Injvlst nitro glyce rinum 1m g/m l a m pul 5m l

56228 51981

Injvlst nitro glyce rinum 1m g/m l flacon 50m l Injvlst pyrido x ini hcl 50m g/m l am pul 1m l

51923

Injvlst thia m ini hcl 50m g/m l a m pul 1m l

51924

Injvlst thia m ini hcl 100m g/m l a m pul 1m l

104382//29963 104437//29963

Inspra ta ble t 25m g Inspra ta ble t 25m g

29963

Inspra ta ble t 25m g

33488//29963

Inspra ta ble t 25m g

104383//29964 104439//29964

Inspra ta ble t 50m g Inspra ta ble t 50m g

29964

Inspra ta ble t 50m g

33489//29964

Inspra ta ble t 50m g

6689 EU/1/08/468/001

Instilla ge l gel Inte lence ta ble t 100m g

50609

INFVLST MANNITO L 100MG/ML

50600

Intra flex inf ringe r

2609 2608

Intra lipid infusie vlo e isto f 100m g/m l Intra lipid infusie vlo e isto f 200m g/m l

EU/1/96/026/001

Invira se capsule 200m g

EU/1/96/026/002

Invira se ta blet film om huld 500m g

16925 19708

Io pidine oo gdruppe ls 5m g/m l flacon 5m l Io pidine oo gdruppe ls 10m g/m l tube 0,25m l

EU/1/07/436/001

Ise ntre ss ta ble t film o m huld 400m g

52072

Iso nia zide pch ta blet 200m g

52497 30434

Iso nia zide rp ta blet 200m g Iso so rbide dinitra at va se line cre m e 10m g/g fna

EU/1/01/172/001

Ka le tra ca psule za cht 133,3/33,3m g

EU/1/01/172/003

Ka le tra drank

EU/1/01/172/006 EU/1/01/172/004

Ka le tra ta ble t film o m huld 100/25m g Ka le tra ta ble t film o m huld 200/50m g

55206

Ka lium chl cf infvlst co nc 100m g/m l a m p 10m l gla s

55104

Ka lium chl cf infvlst co nc 74,6m g/m l a m p 10m l gla s

11626 11627

Ke tensin injvlst 5m g/m l Ke tensin ta ble t 20m g

EU/1/05/329/001

Kiovig infusie vlo eistof 100m g/m l flacon 10m l

EU/1/05/329/002

Kiovig infusie vlo eistof 100m g/m l flacon 25m l

EU/1/05/329/003

Kiovig infusie vlo eistof 100m g/m l flacon 50m l

EU/1/05/329/004

Kiovig infusie vlo eistof 100m g/m l flacon 100m l

EU/1/05/329/005

Kiovig infusie vlo eistof 100m g/m l flacon 200m l

EU/1/04/298/002

Kive x a ta blet film om huld

3808

Ko na k ion m m injvlst 10m g/m l a m pul 1,0m l

3809

Ko na k ion m m v k inde re n injvlst 10m g/m l a m pul 0,2m l

EU/1/08/481/002

Kuva n oplo sba re ta blet 100m g

5954 1364

Lam pre n capsule 100m g Lano x in injvlst 0,25m g/m l am pul 2m l

1365

Lano x in pg elix er 0,05m g/m l

EU/1/00/134/012

Lantus inj 100e /m l fla co n 10m l

7070 11154

Lanvis ta ble t 40m g Laria m table t 250m g

24672//11154

Laria m table t 250m g

25365//11154

Laria m table t 250m g

7505 4082

Lasix infusie vlo eistof conc 10m g/m l a m pul 25m l Lasix injvlst 10m g/m l

5047

Lede rm ycin ca psule 300m g

2305

Lede rte pa po ede r vo o r bla a sinstillatie flac 15m g

101002//256 256

Leuk e ran ta ble t film o m huld 2m g Leuk e ran ta ble t film o m huld 2m g

31689//256

Leuk e ran ta ble t film o m huld 2m g

100232//11193

Levo ca rnitine dra nk 100m g/m l

102436//11193 9239

Levo ca rnitine e rc dra nk 100m g/m l Lida trim infusie vlo eistof fla co n 250m l

55119

Lido ca ine hcl cf infvlst conc 100m g/m l a m pul 10m l

55126

Lido ca ine hcl cf injvlst 20m g/m l

12789 10905

Ligno spa n 2% spe cia l injvlst pa tro on 1,8m l Lipo fundin m ct/lct infvlst 100m g/m l

10262

Lipo ve no s infusievloe isto f 100m g/m l

11127

Lipo ve no s infusievloe isto f 200m g/m l

10402 104593//11146

Litica n injvlst 25m g/m l am pul 2m l Livial ta ble t 2,5m g

11146

Livial ta ble t 2,5m g

22656//11146

Livial ta ble t 2,5m g

23402//11146 27555//11146

Livial ta ble t 2,5m g Livial ta ble t 2,5m g

29583//11146

Livial ta ble t 2,5m g

34500//11146

Livial ta ble t 2,5m g

5628 5901

Locacorte n-vio fo rm oo rdruppe ls Locasa le n za lf

5901

Locasa le n za lf

8426

Lonno ten ta ble t 10m g

14487 22

Lox a zo l cre m e 50m g/g Lyno ral ta ble t 0,05m g

5075

Lyo va c cosm ege n inje ctiepo e de r fla co n 0,5m g

51948

Ma gnesium sulfa a t pch injvlst 100m g/m l

52332 102480//25386

Ma gnesium sulfa a t pch injvlst 150m g/m l a m pul 5m l Ma la rone ta ble t film o m huld

104692//25386

Ma la rone ta ble t film o m huld

25386

Ma la rone ta ble t film o m huld

8030

Ma rca ine+a dre na line inj 2,5m g/m l/1:200.000 fl 20m l

8031

Ma rca ine+a dre na line inj 5,0m g/m l/1:200.000 fl 20m l

9869

Ma rca ine+gluco se injvlst 5/80m g/m l am pul 4m l

11727

Me da cina se infpdr fla co n 10.000ie (iv)

11728

Me da cina se infpdr fla co n 50.000ie (iv)

11729

Me da cina se infpdr fla co n 100.000ie (iv)

11730

Me da cina se infpdr fla co n 250.000ie (iv)

11731

Me da cina se infpdr fla co n 500.000ie (iv)

17078 34

Me ga lo te ct infusievloe isto f 50e/m l Me no im plant im pla ntatie ta ble t 20m g+im pla nta tie se t

22331

Me piva ca ine de lta sele ct injvlst 10m g/m l flac 20m l

3821

Me stino n dra ge e 60m g

100166//3820 3820

Me stino n table t 10m g Me stino n table t 10m g

100222//3821

Me stino n table t om huld 60m g

101959//3821

Me stino n table t om huld 60m g

29593//3821 3686

Me stino n table t om huld 60m g Me the rgin injvlst 0,2m g/m l am pul 1m l

1615

Me to piro n ca psule 250m g

12087

Me tro nida zo l braun infvlst 5m g/m l

21905=20410 23868=15469

Mico na zo lnitra a t/hydro c a hydrof crem e 20/10m g/g Mico na zo lnitra a t/hydro c a ct hydro f cre m e 20/10m g/g

28067=15469

Mico na zo lnitra a t/hydro c cf hydro f cre m e 20/10m g/g

20600=7342

Mico na zo lnitra a t/hydro c jc hydro f cre m e 20/10m g/g

22844=15469 28998=20410

MIC O NAZO LNITR AAT/HYDR O C AP O HYDR O F C R EME 20/10MG/G MIC O NAZO LNITR AAT/HYDR O C MYL HYDR O F C R EME 20/10MG/G;

15469

Mico na zo lnitra a t/hydro c pch hydrof crem e 20/10m g/g

20410

Mico na zo lnitra a t/hydro c rp hydrof crem e 20/10m g/g

22847=15469 18026

Mico na zo lnitra a t/hydro c sa ndoz cre m e 20/10m g/g Migra fin po ede r sa che t

25223//18026

Migra fin po ede r sa che t

26093//18026

Migra fin po ede r sa che t

26764//18026 29779//18026

Migra fin po ede r sa che t Migra fin po ede r sa che t

EU/1/04/292/002

Mim para ta ble t film o m huld 30m g

EU/1/04/292/006

Mim para ta ble t film o m huld 60m g

EU/1/04/292/010 55470

Mim para ta ble t film o m huld 90m g MINIJET INJ ADR ENALINE 0,1MG/ML W W SP 10ML

55469

MINIJET INJ ATR O P SULF 0,1MG/ML W W SP 10ML(IV)

55465

Minije t inj calc chlo r 100m g/m l wwsp 10m l m 1004

55467 55466

MINIJET INJ LIDO C HC L 10MG/ML W W SP 10ML (IV) MINIJET INJ NAHC O 3 84MG/ML W W SP 50ML (IV)

55213

MINIPLASC C LA INJ GLUC O SE 50MG/ML

56470

MINIPLASC O C LA INF KC L 100MG/ML AMP UL 10ML KUNSTST

55987 55988

MINIPLASC O C LA INF KC L 149MG/ML AMP UL 10ML KUNSTST MINIPLASC O C LA INF NAC L 58,5MG/ML AMP 20ML KUNSTST

55986

MINIPLASC O C LA INF KC L 74,5MG/ML

56835

MINIPLASC O C LAS INJ LIDO C AINE HC L 10MG/ML

56836 55227

MINIPLASC O C LAS INJ LIDO C AINE HC L 20MG/ML MINIPLASC O C LAS INJ NAC L 9MG/ML

19367

MINIPLASC O C LAS MEP IVAC AINE B.BR INJ 10MG/ML

19368

MINIPLASC O C LAS MEP IVAC AINE B.BR INJ 20MG/ML

8868

Minrin injvlst 4m cg/m l am pul 1m l (iv/im )

18923

Minrin ne usspra y 2,5m cg/do fla co n 50do se s

104879//16681

Mire na i.u.d.

16681

Mire na i.u.d.

29568

MITO XANTR O N SANDO Z INFVLST C O NC 2MG/ML

26665

MITO XANTR O N PC H INFVLST C O NC 2MG/ML

9001

Mo no trim suspensie 10m g/m l

1091

Mo rzet ze tpil 10m g

7679 6445

Mo tilium suspe nsie 1m g/m l Mya m buto l ta blet 400m g

16740

Myco butin ca psule 150m g

262

Mylera n ta ble t 2m g

8996 12446

Na la do r 500 inje ctie po e der a m pul 500m cg Na lcrom dra nk 20m g/m l a m pul 5m l

12447

Na lcrom dra nk 20m g/m l a m pul 10m l

10227

Na lcrom gra nula at in sa che t 100m g

10228 31627

Na lcrom gra nula at in sa che t 200m g Na no ga m infusie vlo eistof 50m g/m l

50825

Na trium chloride cf injvlst 9m g/m l

51959

Na trium chloride pch injvlst 9m g/m l

5077 1751

Na tula n ca psule 50m g Ne de ltra n ta blet 5m g

50746

Ne om ycine sulfa a t cf ta ble t 375m g

50842

Ne ostigm inem e thylsulf cf injvlst 0,5m g/m l

13103 24561//13103

Ne otiga so n ca psule 10m g Ne otiga so n ca psule 10m g

13104

Ne otiga so n ca psule 25m g

24562//13104

Ne otiga so n ca psule 25m g

12061 12060

Nim o to p infvlst 0,2m g/m l fla co n 50m l + infslang Nim o to p table t 30m g

16008

Nipe nt inje ctie po e der fla co n 10m g

10393

Nitro po hl infusie vlo eistof 1m g/m l

12790//8938 8938

Nizo ra l ta blet 200m g Nizo ra l ta blet 200m g

9332

No rcuron injpdr a m pul 4m g + so lv 1m l

11243

No rcuron injpdr flacon 10m g

50833 30637//16410

NO R ADR ENALINE C F INFVLST C O NC 1MG/ML No rm ule n ta blet 50m g

EU/1/96/016/003

No rvir ca psule 100m g

EU/1/96/016/004

No rvir ca psule 100m g

EU/1/96/016/001 4069

No rvir drank 80m g/m l No va lgin injvlst 500m g/m l a m pul 2m l

EU/1/00/142/009

No vo m ix 30 fle x pen inj 100e/m l wwsp 3m l

EU/1/00/142/004

No vo m ix 30 pe nfill inj 100e/m l pa troo n 3m l

EU/1/00/142/015 EU/1/00/142/012

No vo m ix 50 fle x pen inj 100e/m l wwsp 3m l No vo m ix 50 pe nfill inj 100e/m l pa troo n 3m l

EU/1/00/142/021

No vo m ix 70 fle x pen inj 100e/m l wwsp 3m l

EU/1/96/006/004

No vo se ven injpdr flacon 1m g + so lv

EU/1/96/006/005 EU/1/96/006/006

No vo se ven injpdr flacon 2m g + so lv No vo se ven injpdr flacon 5m g + so lv

15102

No vux ol hydro fo be zalf

50593

Npbi inf gluc/na cl 37,5/2,25m g/m l

10914

Nutrifle x spe cial 70/240 infvlst

18396

O ctaga m infusie vlo e isto f 50m g/m l

16175

O ctostim ne usspra y 150m cg/do fla co n 25do se s

EU/1/04/303/001

O rfa din capsule 2m g

EU/1/04/303/002

O rfa din capsule 5m g

EU/1/04/303/003

O rfa din capsule 10m g

20403//855

O to spo rin oo rdruppe ls

855

O to spo rin oo rdruppe ls

3170 550

P a lfium table t 5m g P a ludrine ta ble t 100m g

6585

P a no tile o o rdruppe ls

7071

P a rtusiste n infvlst co nc 0,05m g/m l a m pul 10m l

5804 3330

P a vulon injvlst 2m g/m l a m pul 2m l P e nidural injpdr flacon 1.200.000ie + so lve ns 5m l

13417

P e nta ca rinat 300 inje ctiepo e de r fla co n 300m g

15008

P ENTAC AR INAT P O EDER VO O R VER NEVELO PL FLAC O N 300 MG

13343 2415

P e rfan infusievloe isto f co nc 5m g/m l a m p 20m l (iv) P e ria ctin ta ble t 4m g

12620

P e rsa ntin injvlst 5m g/m l a m pul 10m l

3561

P e thidini hcl pch injvlst 50m g/m l

16436 16436

P harm a lge n bije ngif inste l 4flx 1,2m l P harm a lge n bije ngif inste l 4flx 1,2m l

16436

P harm a lge n bije ngif inste l 4flx 1,2m l

16436

P harm a lge n bije ngif inste l 4flx 1,2m l

16436 16436

P harm a lge n bije ngif vervo lg 4flx 1,2m l P harm a lge n bije ngif vervo lg 4flx 1,2m l

16436

P harm a lge n bije ngif vervo lg 4flx 1,2m l

16436

P harm a lge n bije ngif vervo lg 4flx 1,2m l

16436 16436

P harm a lge n wespengif instel 4flx 1,2m l P harm a lge n wespengif instel 4flx 1,2m l

16436

P harm a lge n wespengif instel 4flx 1,2m l

16436

P harm a lge n wespengif instel 4flx 1,2m l

16436 16436

P harm a lge n wespengif ve rvo lg 4flx 1,2m l P harm a lge n wespengif ve rvo lg 4flx 1,2m l

16436

P harm a lge n wespengif ve rvo lg 4flx 1,2m l

16436

P harm a lge n wespengif ve rvo lg 4flx 1,2m l

102380//21551 21551

P hospho ra l dra nk P hospho ra l dra nk

34284//21551

P hospho ra l dra nk

28326//853

P laque nil ta ble t o m huld 200m g

853 17642

P laque nil ta ble t o m huld 200m g P O LIO MYELITISVAC C IN

17642

P O LIO MYELITISVAC C IN

16288

P o llinex injsusp boo m pol 6wwsp

16288 16288

P o llinex injsusp boo m pol 6wwsp P o llinex injsusp graspol 6wwsp

16288

P o llinex injsusp graspol 6wwsp

9044

P o lytrim o o gdruppels fla co n 5m l

12119 EU/1/06/380/001

P re pidil e ndocervica le ge l 0,5m g/3g wwsp + ca th P re zista ta ble t film o m huld 300m g

EU/1/06/380/003

P re zista ta ble t film o m huld 400m g

EU/1/06/380/002

P re zista ta ble t film o m huld 600m g

5251

P rim pe ra n injvlst 5m g/m l a m pul 2m l

6013

P rim pe ra n ze tpil 10m g

13574//6014

P rim pe ra n ze tpil 20m g

26777//6014

P rim pe ra n ze tpil 20m g

31401//6014

P rim pe ra n ze tpil 20m g

6014

P rim pe ra n ze tpil 20m g

EU/1/05/316/003

P ro co rala n table t film o m huld 5m g

EU/1/05/316/010

P ro co rala n table t film o m huld 7,5m g

6865

P ro glice m ca psule 100m g

13354

P ro le uk in iv infusie po e der fla co n 18m ilj ie (1m g)

50249

P ro m e tha zine cf injvlst 25m g/m l

27043

P ro po fo l lipuro injectie e m ulsie 20m g/m l fl 50m l

3775 3776

P ro stigm in injvlst 0,5m g/m l am pul 1m l P ro stigm in injvlst 2,5m g/m l fla co n 5m l

13823

P ro stin e2 vaginale gel 1m g in wwsp 3g

13824

P ro stin e2 vaginale gel 2m g in wwsp 3g

6666 6667

P R O TAMINE MPH INJVLST 1000E/ML P R O TAMINE MPH INJVLST 5000E/ML

EU/1/04/288/003

P ro telo s gra nula a t 2g in sa che t

101993//16734

P ulm o zym e inhala tievloe isto f 1m g/m l a m pul 2,5m l

16734 27368//16734

P ulm o zym e inhala tievloe isto f 1m g/m l a m pul 2,5m l P ulm o zym e inhala tievloe isto f 1m g/m l a m pul 2,5m l

16254

P uretha l po llen gra ssen 1fl 3m l + 8wwsp

859

P uri ne thol ta ble t 50m g

103685//859 103686//859

P urine thol ta ble t 50m g P urine thol ta ble t 50m g

50772

P yra zina m ide cf ta ble t 500m g

15131=50772

P yra zina m ide pch table t 500m g

18718 9860

R a bie sva ccin m erie ux fla co n 2,5ie + so lve ns 1m l R a pife n injvlst 0,5m g/m l

EU/1/98/063/002

R e bif 22 injvlst 44m cg/m l (12m e /m l)wwsp 0,5m l

EU/1/98/063/003

R e bif 22 injvlst 44m cg/m l (12m e /m l)wwsp 0,5m l

EU/1/98/063/006 EU/1/98/063/007

R e bif 44 injvlst 88m cg/m l (24m e /m l)wwsp 0,5m l R e bif sta rtvp injvls(6x 8,8m cg/0,2+6x 22m cg/0,5m l)

4480

R e flux ta ble t m sr 500m g

1635

R e gitine injvlst 10m g/m l a m pul 1m l

EU/1/99/101/001 8175

R e grane x ge l 0,1m g/g R e lefa ct trh injvlst 0,2m g/m l a m pul 1m l

EU/1/08/463/003

R e listo r injvlst 20m g/m l fla co n 0,6m l + toe be h

8071

R e so nium a poe de r

12639 15118

R ETR O VIR C AP SULE 100MG R ETR O VIR DR ANK 10MG/ML

18922

R ETR O VIR TABLET 300MG

EU/1/07/391/004

R e vlim id ca psule 25m g

EU/1/03/267/004 EU/1/03/267/005

R e ya ta z capsule 150m g R e ya ta z capsule 200m g

EU/1/03/267/006

R e ya ta z capsule 200m g

EU/1/03/267/008

R e ya ta z capsule 300m g

EU/1/03/267/007 25773

R e ya ta z po e de r 50m g/1,5g R ia m e t ta ble t 20/120m g

8755

R ifa din infusie po ede r flacon 600m g + so lve ns 10m l

5766

R ifa din suspe nsie 20m g/m l (2%)

15460 6873

R ifina h drage e 300/150m g R ivo tril injvlst 1m g/m l am pul 1m l + so lve ns 1m l

20778//8285

R o ca ltrol ca psule 0,25m cg

8285

R o ca ltrol ca psule 0,25m cg

20779//8286

R o ca ltrol ca psule 0,50m cg

8286

R o ca ltrol ca psule 0,50m cg

15722

Sa bril granulaa t in sa che ts 500m g

13707

Sa bril ta ble t 500m g

18857//13707

Sa bril ta ble t 500m g

9846

Sa ndim m une infusie vlo e isto f co nc 50m g/m l

28218//6258

Sa ndo m igra n table t om huld 0,5m g

29492//6258 6258

Sa ndo m igra n table t om huld 0,5m g Sa ndo m igra n table t om huld 0,5m g

101973//10394

Sa ndo m igra n table t om huld 1,5m g

10394

Sa ndo m igra n table t om huld 1,5m g

28219//10394 29388//10394

Sa ndo m igra n table t om huld 1,5m g Sa ndo m igra n table t om huld 1,5m g

9269

Sca ndo ne st zndr vaso co nst injvl 30m g/m l pa tr 1,8m l

9709

Sco pode rm tts pleister 1,5m g

8700 13674

Se lo k e en injvlst 1m g/m l a m pul 5m l Se pta ne st n injvlst patro o n 1,8m l

13675

Se pta ne st sp injvlst pa tro on 1,8m l

33738

Se reve nt a e ro so l 25m cg/do cfk vr spbs 120do + vo lum

4961 30586//4961

So frade x oo rdruppe ls fla co n 8m l So frade x oo rdruppe ls fla co n 10m l

31703//4961

So frade x oo rdruppe ls fla co n 10m l

33750//4961

So frade x oo rdruppe ls fla co n 10m l

8234 11324

So lda cto ne injectie po ede r SO MATO STATINE EUMEDIC A INFP DR FLAC O N 3MG +SO LV 1ML

11323

SO MATO STATINE EUMEDIC A INJP DR 250MC G + SO LV 1ML

EU/1/02/240/001

So m a vert injpdr fla co n 10m g + so lve ns 8m l

EU/1/02/240/002 EU/1/02/240/003

So m a vert injpdr fla co n 15m g + so lve ns 8m l So m a vert injpdr fla co n 20m g + so lve ns 8m l

10261

So rbisterit po ede r 90% m /m

10876

So tacor injvlst 10m g/m l a m pul 4m l

103156//34382 34382

Spiriva re spim a t opl v inhal 2,5m cg/do pa tr 60do Spiriva re spim a t opl v inhal 2,5m cg/do pa tr 60do

EU/1/03/260/002

Sta le vo ta blet film om huld 50/12,5/200m g

EU/1/03/260/003

Sta le vo ta blet film om huld 50/12,5/200m g

EU/1/03/260/026 EU/1/03/260/006

Sta le vo ta blet film om huld 75/18,75/200m g Sta le vo ta blet film om huld 100/25/200m g

EU/1/03/260/007

Sta le vo ta blet film om huld 100/25/200m g

EU/1/03/260/031

Sta le vo ta blet film om huld 125/31,25/200m g

EU/1/03/260/010 EU/1/03/260/011

Sta le vo ta blet film om huld 150/37,5/200m g Sta le vo ta blet film om huld 150/37,5/200m g

EU/1/03/260/021

Sta le vo ta blet film om huld 200/50/200m g

EU/1/99/111/001

Sto crin capsule 50m g

EU/1/99/111/003 EU/1/99/111/005

Sto crin capsule 200m g Sto crin dra nk 30m g/m l

EU/1/99/111/010

Sto crin ta blet film om huld 50m g

EU/1/99/111/011

Sto crin ta blet film om huld 200m g

EU/1/99/111/008 30924

Sto crin ta blet film om huld 600m g Subcuvia injvlst 160m g/m l

9232

Sufenta fo rte injvlst 0,05m g/m l

9233

Sufenta injvlst 0,005m g/m l

10873

Supre fa ct ne usspra y 0,1m g/do fl 100do + do see rpo m p

26

Susta non 100 injvlst 100m g/m l a m pul 1m l

50863

Sux a m e tho nium chlo ride cf injvlst 50m g/m l a m pul 2m l

12976//5352

Sym m e trel ca psule 100m g

27528//5352

Sym m e trel ca psule 100m g

32927//5352

Sym m e trel ca psule 100m g

5352

Sym m e trel ca psule 100m g

5353

Sym m e trel siro o p 10m g/m l

5082 EU/1/99/117/001

Syna cthe n injvlst 0,25m g/m l a m pul 1m l Syna gis inje ctie po e der fla co n 50m g + so lve ns 1m l

EU/1/99/117/002

Syna gis inje ctie po e der fla co n 100m g + so lve ns 1m l

3714

Synto cinon injvlst 5ie/m l a m pul 1m l

3716 16889

Synto cinon ne usspra y 4ie /do fla co n 50do Ta lo x a suspe nsie 120m g/m l

16890

Ta lo x a table t 400m g

10099

Ta m bo co r injvlst 10m g/m l am pul 15m l

14147 EU/1/97/044/003

Ta rivid infusie vlo eistof 2m g/m l Ta sm a r table t film o m huld 100m g

27387

Ta ure do n injvlst 20m g/m l a m pul 0,5m l

27388

Ta ure do n injvlst 100m g/m l a m pul 0,5m l

11176 11177

Ta uro lin instillatie vlo e isto f 20m g/m l Ta uro lin spoe lvlst ringe r 5m g/m l fla co n 500m l

6089

Ta ve gyl injvlst 1m g/m l

EU/1/04/282/002

Te lzir suspe nsie 50m g/m l

EU/1/04/282/001 8192

Te lzir table t film o m huld 700m g Te m e sta injvlst 4m g/m l a m pul 1m l

3543

Te rra cortril + polym yx ine b oo gza lf tube 3,5g

3542

Te rra cortril + polym yx ine b oo rdruppe ls

14873 18561

Te rra cortril + polym yx ine b oo rzalf Te tanus im m uno glo buline +teta nus vaccin

17639

Te tanus va ccin fla co n 0,5m l

17058

Te taquin injvlst 125ie /m l

53163 50538

Te tracycline hcl cf capsule 250m g Te tracycline hcl pch ca psule 250m g

34094

Te traspan infvlst 60m g/m l zak 500m l

7399

Tft o phtio le o o gdruppe ls 10m g/m l fla co n 5m l

EU/1/99/122/002 18757//7613

Thyro gen inje ctie poe de r fla co n 0,9m g Tiapridal ta ble t 100m g

7613

Tiapridal ta ble t 100m g

12925

Tiena m inje ctiepo e de r fla co n 500m g (im )

17099 17101

Tissucol duo 500 Tissucol k it 1 b19810

17102

Tissucol k it 2 b19820

17103

Tissucol k it 5 b19850

17100 103162//14224

Tissucol k it 0,5 b19805 To bra de x o o gza lf tube 3,5g

14224

To bra de x o o gza lf tube 3,5g

32481//14224

To bra de x o o gza lf tube 3,5g

4562 9981

To x o go nin injvlst 250m g/m l a m pul 1m l Tra crium injvlst 10m g/m l

13511

Tra flo x a l o o gza lf 3m g/g tube 3g

7879

Tra nda te injvlst 5m g/m l am pul 20m l

32372//5574

Tra ne x a m ine zuur table t film o m huld 500m g

6328

Tra nx e ne injectie po ede r flacon 50m g + solv 2,5m l

5312

Tra sylo l infusie vlo e isto f 10.000k ie /m l fla co n 50m l

26830

Trile pta l suspe nsie 60m g/m l

EU/1/00/156/002

Trizivir ta ble t film o m huld

EU/1/00/156/003

Trizivir ta ble t film o m huld

EU/1/04/305/001

Truva da ta blet film om huld

EU/1/96/020/002 EU/1/96/020/007

Twinrix adult injsusp we gwe rpspuit 1m l Twinrix adult injsusp we gwe rpspuit 1m l

EU/1/96/020/004

Twinrix adult injvlst fla co n 1m l

EU/1/96/020/001

Twinrix adult injvlst we gwerpspuit 1m l

7887 25659

Ubre tid ta ble t 5m g Uft ca psule 100/224m g

8183

Ultra ca in d/s forte injvlst a m pul 1,7m l

8182

Ultra ca in d/s injvlst am pul 1,7m l

3964 11510

Ultra co rteno l oo gza lf 5m g/g tube 5g Uro gliss ca the terslijm m et lidocaine

11509

Uro gliss-s ca thete rslijm

12495

Uro k ina se k a bi inje ctie poe de r fla co n 50.000ie

12496 12497

Uro k ina se k a bi inje ctie poe de r fla co n 100.000ie Uro k ina se k a bi inje ctie poe de r fla co n 250.000ie

12498

Uro k ina se k a bi inje ctie poe de r fla co n 500.000ie

8461

Uro m ite x a n injvlst 100m g/m l

10287 10288

Va m in 14 infusie vlo eistof Va m in 14 zo nde r e le ctro lyte n infvlst

10289

Va m in 18 zo nde r e le ctro lyte n infvlst

6825

Va m in gluco se infusie vlo eistof

9570 11984

Va m ino la ct infusie vlo eistof Va ncocin cp ca psule 250m g

21309=20799

Va qta junio r injsusp 50e /m l

16948

Va riquin injvlst 100ie /m l flacon 2m l

EU/1/03/255/004 EU/1/03/255/005

Ve nta vis ve rne ve loplo ssing 10m cg/m l a m pul 1m l Ve nta vis ve rne ve loplo ssing 10m cg/m l a m pul 1m l

21439

Ve nto lin 100 ae r cfk vr 100m cg/do spbs 200do +ba byh

7686

Ve nto lin infusie vlo eistof conc 1m g/m l a m pul 5m l

7687 56335

Ve nto lin injvlst 0,5m g/m l a m pul 1m l Ve rapa m il hcl cf injvlst 2,5m g/m l a m pul 2m l

101711//20455

Ve sa noid ca psule 10m g

20455

Ve sa noid ca psule 10m g

EU/1/02/212/025 6396

Vfe nd infusiepo e de r fla co n 200m g Vibra m ycin sf injvlst 20m g/m l a m pul 5m l (iv)

25450

Vide x e c ca psule m sr 125m g

25451

Vide x e c ca psule m sr 200m g

101436//25452 25452

Vide x e c ca psule m sr 250m g Vide x e c ca psule m sr 250m g

25453

Vide x e c ca psule m sr 400m g

30023

Vide x poe de r vo o r dra nk fla co n 2g

10956 EU/1/97/054/001

VINC R ISTINESULFAAT P C H INJVLST 1MG/ML Viracept po ede r vo o r o raa l gebruik 50m g/g

EU/1/97/054/003

Viracept ta ble t 250m g

EU/1/97/054/004

Viracept ta ble t film o m huld 250m g

EU/1/97/055/002

Viram une suspe nsie 10m g/m l

EU/1/97/055/001

Viram une ta blet 200m g

12588

Virazo le po ede r vo o r inha latie vlo e isto f fla co n 6g

EU/1/01/200/001

Virea d ta ble t film o m huld 245m g

13825

Vitrim ix k v infvlst (va m in gluco se e n intra lipid)

31149

Viva glo bin infvlst 160m g/m l fla co n 10m l

8539

Vum o n infusie vlo e isto f co nc 10m g/m l am pul 5m l

21070

W e llvone suspe nsie 150m g/m l

EU/1/04/286/001 EU/1/04/286/002

W ilzin capsule 25m g W ilzin capsule 50m g

EU/1/04/295/001

Xa grid ca psule 0,5m g

101496

Xa m io l ge l

EU/1/00/163/001 EU/1/00/163/002

Xe lo da table t film o m huld 150m g Xe lo da table t film o m huld 500m g

103089//7207

Xprae p siro o p 2m g/m l

7207

Xprae p siro o p 2m g/m l

7830 7828

Xylo ca ine 2% ge l in tube Xylo ca ine injvlst 10m g/m l

7829

Xylo ca ine injvlst 20m g/m l

7831

Xylo ca ine spra y 100m g/m l in ve rstuive r

7833 EU/1/05/312/001

Xylo ca ine +a drena line inj 2%/1: 80.000 cyl.a m p1,8m l Xyre m drank 500m g/m l

886

Yo m e san ta ble t 500m g

8319

Za dite n table t 1m g

28113 14201

Za ldia r table t film o m huld Za ve dos injpdr fla co n 5m g

EU/1/02/238/001

Za ve sca capsule 100m g

EU/1/99/114/003

Ze ffix dra nk 5m g/m l

EU/1/99/114/001 EU/1/99/114/002

Ze ffix ta ble t film o m huld 100m g Ze ffix ta ble t film o m huld 100m g

EU/1/96/009/002

Ze rit capsule 15m g

EU/1/96/009/004

Ze rit capsule 20m g

EU/1/96/009/006 EU/1/96/009/008

Ze rit capsule 30m g Ze rit capsule 40m g

EU/1/96/009/009

Ze rit po e de r voo r dra nk 1m g/m l

EU/1/99/112/002

Ziage n dra nk 20m g/m l

EU/1/99/112/001 19252

Ziage n table t 300m g Zo fran zetpil 16m g

29721//19252

Zo fran zetpil 16m g

12162

Zo vira x suspe nsie 40m g/m l

EU/1/96/022/016 26569

Zypre x a injectie po ede r flacon 10m g Zyvo x id ta ble t film o m huld 600m g

104696//20871

AR THR O TEC TABLET MGA 75MG

16448

DEPO THAL HUISSTO FMIJT D FAR INST 4FL 5ML +15W W SP

16448 EU/1/07/404/001

DEPO THAL HUISSTO FMIJT D FAR VER V 1FL 5ML +15W W SP FLEBO GAMMADIF 50MG/ML VIAL 10ML

EU/1/07/404/002

FLEBO GAMMA DIF INFVLST 50MG/ML FLAC O N 50ML

EU/1/07/404/003

FLEBO GAMMA DIF INFVLST 50MG/ML FLAC O N 100ML

EU/1/07/404/004 EU/1/07/404/005

FLEBO GAMMA DIF INFVLST 50MG/ML FLAC O N 200ML FLEBO GAMMA DIF INFVLST 50MG/ML FLAC O N 400ML

104881//21168

IMPLANO N NXT IMP LANTAAT IN APP LIC ATO R 68 MG

EU/1/08/497/001

NP LATE INJEC TIEP O EDER FLAC O N 250MC G

EU/1/08/497/002

NP LATE INJEC TIEP O EDER FLAC O N 500MC G

101592

ZALDIAR BR UISTABLET

103595

ALBUMAN INFVLST 200MG/ML

103594

ALBUMAN INFVLST 40MG/ML

103726

C O LC HIC INE MYLAN TABLET 0,5MG

105209//11146

LIVIAL TABLET 2,5MG

EU/1/98/096/025

TEMO DAL HAR DE C AP SULES IN SAC HET 5 MG

EU/1/06/380/005 EU/1/06/380/004

P R EZISTA TABLET FILMO MHULD 75MG P R EZISTA TABLET FILMO MHULD 150MG

EU/1/05/315/002

AP TIVUS DR ANK 100MG/ML

103084

BO NENDR O 70MG/1000MG/880IE(1TB ALENDR O NAX+6SA C AD)

EU/1/01/172/005 EU/1/03/267/003

KALETR A TABLET FILMO MHULD 200/50MG R EYATAZ C AP SULE 150MG

EU/1/04/307/004

ZO NEGR AN C APSULE 100MG

EU/1/04/307/001

ZO NEGR AN 25 MG, HAR DE C APSULES (14 STUKS)

EU/1/04/307/002 EU/1/04/307/003

ZO NEGR AN 25 MG, HAR DE C APSULES (56 STUKS) ZO NEGR AN 50 MG, HAR DE C APSULES (56 STUKS)

105339//16410

AR THR O TEC TABLET MGA 50MG

105340//20871

AR THR O TEC TABLET MGA 75MG

105794//6305

ASPEGIC INJEC TIEP O EDER FLAC O N 500MG + SO LVENS 5ML

106078//1761

BAC IC O LINE-B O O R DR UPP ELS

EU/1/95/003/007 BETAFER O N INJP DR FL 9 600 000IE+SO LV 1,2ML 3MND VP EU/1/95/003/008 BETAFER O N INJP DR FL 9 600 000IE+SO LV 1,2ML STAR TVP 105719//2011

GLUC AGEN INJEC TIEP O EDER

EU/1/06/362/002 BYETTA 5 UG, O P L V INJ VO O R GEV P EN (3 STUKS) EU/1/06/362/004 BYETTA 10 UG, O P L V INJ VO O R GEV P EN (3 STUKS) EU/1/98/063/008 R EBIF 22MC G/0,5ML INJ 44MC G/ML (12ME/ML)P ATR 1,5ML EU/1/98/063/009 R EBIF 44MC G/0,5ML INJ 88MC G/ML (24ME/ML)P ATR 1,5ML EU/1/98/063/010 R EBIF STAR TVP INJ(3X8,8MC G/0,1ML+3X22MC G/0,25ML) EU/1/98/096/014 TEMO DAL 20MG HAR DE C AP SULES EU/1/98/096/016 TEMO DAL 100MG HAR DE C APSULES EU/1/98/096/018 TEMO DAL 140MG HAR DE C APSULES EU/1/98/096/020 TEMO DAL 180MG HAR DE C APSULES EU/1/98/096/022 TEMO DAL 250MG HAR DE C APSULES 106187//6055

C ATAP R ESAN INJVLST 0,150MG/ML AMP UL 1ML

105893//25386

MALAR O NE TABLET FILMO MHULD

105820

C O LC HIC INE SANDO Z TABLET 0,5MG

106097//7375

ESTR AC YT C AP SULE 140MG

105961//17315

HAVR IX INJVLST 1440SKB-E/ML W W SP 1ML

106273//16734

P ULMO ZYME VER NEVELVLO EISTO F 1000E/ML AMP UL 2,5ML

EU/1/07/397/001 SIKLO S TABLET FILMO MHULD 1000MG 104444//28113

TR AMAC ET TABLET FILMO MHULD

EU/1/08/497/006 NP LATE 250 MC G PO EDER EN O P LO SMIDDEL VO O R INJEC TIE EU/1/08/497/008 NP LATE 500 MC G PO EDER EN O P LO SMIDDEL VO O R INJEC TIE EU/1/08/497/005 NP LATE INJP DR FLAC O N 250MC G + SO LV + TO EBEH EU/1/08/497/007 NP LATE INJP DR FLAC O N 500MC G + SO LV + TO EBEH 106687//4473

ALKER AN TABLET FILMO MHULD 2MG

105803//11193

LEVO C AR NITINE FISHER DR ANK 100MG/ML

106593//25386

MALAR O NE TABLET FILMO MHULD

104459

O C TAGAM INFUSIEVLO EISTO F 100MG/ML

106771//859

P UR INETHO L TABLET 50MG

106781//859

P UR INETHO L TABLET 50MG

106698//16410

AR THR O TEC TABLET MGA 50MG

106773//101127 C ALC I C HEW D3 KAUW TABLET 1000MG/800IE 106691//33660

C O SO P T C O NSER VEER MIDDELVR IJ O O GDR UP P ELS FLAC 0,2ML

106822//6292

EFUDIX C R EME 50MG/G

106645//25386

MALAR O NE TABLET FILMO MHULD

106546//16681

MIR ENA I.U.D.

15326

TAZO C IN INJEC TIEP O EDER FLAC O N 2000/250MG

15328

TAZO C IN INJEC TIEP O EDER FLAC O N 4000/500MG

107030//15337

BETO P TIC S O O GDR UP P ELS 2,5MG/ML FLAC O N 5ML

106832//3984

DESFER AL INJEC TIEP O EDER FLAC O N 500MG

EU/1/03/269/002 FASLO DEX INJVLST 50MG/ML W W SP 5ML 106469//16681

MIR ENA I.U.D.

27569

TR IAXIS PO LIO INJSUSP W W SP 0,5ML

106902//7887

UBR ETID TABLET 5MG

EU/1/02/220/006 TR AC LEER DISP ER GEER BAR E TABLET 32MG 22500

C ALISVIT P O EDER VO O R SUSP 1200MG/800IE IN SAC HET

107163//3821

MESTINO N TABLET O MHULD 60MG

106956//101496 XAMIO L GEL 106663//26569

ZYVO XID TABLET FILMO MHULD 600MG

106403//1761

BAC IC O LINE-B O O R DR UPP ELS

106571//1761

BAC IC O LINE-B O O R DR UPP ELS

105832

C ALC I C HEW D3 KAUW TABLET 500MG/800IE

EU/1/96/016/005 NO R VIR TABLET FILMO MHULD 100MG 107252//16410

AR THR O TEC TABLET MGA 50MG

107253//20871

AR THR O TEC TABLET MGA 75MG

107241//33660

C O SO P T C O NSER VEER MIDDELVR IJ O O GDR UP P ELS FLAC 0,2ML

107626//6292

EFUDIX C R EME 50MG/G

107244//101496 XAMIO L GEL EU/1/05/329/006 KIO VIG INFUSIEVLO EISTO F 100MG/ML FLAC O N 300ML 107331//11154

LAR IAM TABLET 250MG

107759//11154

LAR IAM TABLET 250MG

EU/1/10/612/001 R EVO LADE 25 MG FILMO MHULDE TABLETTEN 14 STUKS EU/1/10/612/003 R EVO LADE 25 MG FILMO MHULDE TABLETTEN 84 STUKS EU/1/10/612/004 R EVO LADE 50 MG FILMO MHULDE TABLETTEN 14 STUKS EU/1/10/612/006 R EVO LADE 50 MG FILMO MHULDE TABLETTEN 84 STUKS EU/1/10/612/002 R EVO LADE TABLET O MHULD 25MG EU/1/10/612/005 R EVO LADE TABLET O MHULD 50MG 107257//101496 XAMIO L GEL 19505

C AC IT VITAMINE D3 BR UISGR AN 1000MG/880IE IN SAC HET

19504

C AC IT VITAMINE D3 BR UISGR AN 500MG/440IE IN SAC HET

106949//101127 C ALC I C HEW D3 KAUW TABLET 1000MG/800IE 107625//5573

C YKLO KAP R O N INJVLST 100MG/ML AMP UL 5ML

100401

DO VO BET GEL

EU/1/09/609/001 ELO NVA 100 INJVLST 200MC G/ML W W SP 0,5ML EU/1/09/609/002 ELO NVA 150 INJVLST 300MC G/ML W W SP 0,5ML 107712//17315

HAVR IX INJVLST 1440SKB-E/ML W W SP 1ML

107707//19569

HAVR IX JUNIO R INJVLST 1440SKB-E/ML W W SP 0,5ML

107217//16681

MIR ENA I.U.D.

107216//855

O TO SP O R IN O O R DR UPP ELS

107691//7887

UBR ETID TABLET 5MG

107760//7070

LANVIS TABLET 40MG

107791//16681

MIR ENA I.U.D.

107777//101592 TR AMAC ET BR UISTABLET 108000//101496 XAMIO L GEL 108337//126

DEC ADUR ABO LIN INJVLST 50MG/ML AMP UL 1ML

108629//29963

INSP R A TABLET 25MG

108628//29964

INSP R A TABLET 50MG

EU/1/04/307/005 ZO NEGR AN C APSULE 25MG EU/1/04/307/009 ZO NEGR AN C APSULE 50MG 108609//21253

C ALC IPO TR IO L FISHER LO TIO N 50MC G/ML

107571//6996

C ALMUR ID HC C R EME

102707

KALC IP O S-D KAUW TABLET 500MG/800IE

13354

P R O LEUKIN INJ/INFUSIEP O EDER FLAC O N 22MILJ IE

108374//6258

SANDO MIGR AN TABLET O MHULD 0,5MG

108326//4473

ALKER AN TABLET FILMO MHULD 2MG

108768//26834

ATR O VENT AER O SO L 20MC G/DO SPBS 200DO + INHALATO R

108740//1761

BAC IC O LINE-B O O R DR UPP ELS

107614

C O LC HIC INE C F TABLET 0,5MG

108739//29963

INSP R A TABLET 25MG

108811//25386

MALAR O NE TABLET FILMO MHULD

33614

NO R MO SANG INFVLST C O NC 25MG/ML AMP UL 10ML

108623//8071

R ESO NIUM A PO EDER

108624//8071

R ESO NIUM A PO EDER

108769

C YTO MEL TABLET 25MC G

32712

INTR ATEC T INFUSIEVLO EISTO F 50G/1L FLAC

EU/1/01/172/008 KALETR A TABLET FILMO MHULD 200/50MG EU/1/04/302/001 P R IALT INFVLST 100MC G/ML FLAC O N 1ML EU/1/04/302/002 P R IALT 100 UG/ ML O PLO SSING VO O R INFUSIE 2 ML EU/1/04/302/003 P R IALT 100 UG/ ML O PLO SSING VO O R INFUSIE 5 ML EU/1/97/033/004 AVO NEX 30 INJEC TIEVLO EISTO F 60MC G/ML W W SP 0,5ML 109258//32744

C O MBIGAN O O GDR UPP ELS FLAC O N 5ML

109144//13724

C YTO TEC TABLET 200MC G

29198

INFVLST GLUC /NAC L 33/3,0MG/ML NEW VIAFLO ZK

55262

INFVLST GLUC O SUM 200MG/ML ZAK

31795

INFVLST MANNITO LUM 100MG/ML

31796

INFVLST MANNITO LUM 200MG/ML

17393

INFVLST METR O NIDAZO LUM 5MG/ML

100234

ISO SO R BIDEDINITR AAT VASELINEC R EME 10MG/G FNA

109192//25386

MALAR O NE TABLET FILMO MHULD

EU/1/96/006/007 NO VO SEVEN INJPDR FLAC O N 8MG + SO LV 100081

VINC R ISTINESULFAAT P C H INJVLST 1MG/ML FLAC O N

109329//28113

ZALDIAR TABLET FILMO MHULD

EU/1/09/600/001 ZUTEC TR A INJVLST 500IE/ML W W SP 1ML 109335//9078

ANDR O C UR TABLET 10MG

109256//24713

C ALC IUM D SANDO Z C A-D BR UISTABLET 600MG/400IE

109318//11154

LAR IAM TABLET 250MG

EU/1/08/446/004 P R IVIGEN INFVLST 100MG/ML FLAC O N 25ML EU/1/08/446/001 P R IVIGEN INFVLST 100MG/ML FLAC O N 50ML EU/1/08/446/002 P R IVIGEN INFVLST 100MG/ML FLAC O N 200ML EU/1/08/446/003 P R IVIGEN INFVLST 100MG/ML FLAC O N 100ML EU/1/98/063/013 R EBIF 22 R EBIDO SE INJ 44MC G/ML (12ME/ML)W W SP 0,5ML EU/1/98/063/016 R EBIF 44 R EBIDO SE INJ 88MC G/ML (24ME/ML)W W SP 0,5ML EU/1/98/063/017 R EBIF STV R EBIDO SE INJ(6X8,8MC G/0,2+6X22MC G/0,5ML) 109340//8071

R ESO NIUM A PO EDER

EU/1/07/397/002 SIKLO S TABLET FILMO MHULD 100MG 109323//34382

SP IR IVA R ESP IMAT O P L V INHAL 2,5MC G/DO P ATR 60DO

EU/1/97/033/005 AVO NEX 30 INJEC TIEVLO EISTO F 60MC G/ML P EN 0,5ML EU/1/97/033/006 AVO NEX 30 INJEC TIEVLO EISTO F 60MC G/ML P EN 0,5ML EU/1/10/655/005 BR ILIQ UE 90 MG FILMO MHULDE TABLET 168 STUKS EU/1/10/655/002 BR ILIQ UE 90 MG FILMO MHULDE TABLET 180 STUKS EU/1/10/655/001 BR ILIQ UE 90 MG FILMO MHULDE TABLET 60 STUKS EU/1/10/655/003 BR ILIQ UE TABLET FILMO MHULD 90MG EU/1/10/655/004 BR ILIQ UE TABLET FILMO MHULD 90MG 109452//13724

C YTO TEC TABLET 200MC G

93

DIADR ESO N-F AQ UO SUM INJPDR FLAC O N 25MG

93

DIADR ESO N-F AQ UO SUM INJPDR AMP UL 25MG +SO LVENS 1ML

EU/1/11/687/001 HIZENTR A INJVLST 200MG/ML FLAC O N 5ML EU/1/11/687/004 HIZENTR A INJVLST 200MG/ML FLAC O N 10ML EU/1/11/687/010 HIZENTR A INJVLST 200MG/ML FLAC O N 20ML 109479//855

O TO SP O R IN O O R DR UPP ELS

EU/1/07/397/002 SIKLO S TABLET FILMO MHULD 100MG 109240//34382

SP IR IVA R ESP IMAT O P L V INHAL 2,5MC G/DO P ATR 60DO

109483//34382

SP IR IVA R ESP IMAT O P L V INHAL 2,5MC G/DO P ATR 60DO

109564//101127 C ALC I C HEW D3 KAUW TABLET 1000MG/800IE 109721//6978

DANTR IUM C APSULE 25MG

EU/1/99/108/004 FER R IP R O X 1000MG FILMO MHULDE TABLETTEN EU/1/99/108/005 FER R IP R O X 1000MG FILMO MHULDE TABLETTEN EU/1/99/108/006 FER R IP R O X 1000MG FILMO MHULDE TABLETTEN 109887//29963

INSP R A TABLET 25MG

109367//11154

LAR IAM TABLET 250MG

109728//28113

ZALDIAR TABLET FILMO MHULD

109833//32744

C O MBIGAN O O GDR UPP ELS FLAC O N 5ML

109684//13724

C YTO TEC TABLET 200MC G

109756//8938

NIZO R AL TABLET 200MG

EU/1/08/422/002 P R ADAXA C APSULE 75MG EU/1/00/156/004 TR IZIVIR TABLET FILMO MHULD EU/1/07/440/001 TYVER B 250 MG FILMO MHULDE TABLETTEN 70 STUKS EU/1/07/440/003 TYVER B 250 MG FILMO MHULDE TABLETTEN 84 STUKS 109967//4473

ALKER AN TABLET FILMO MHULD 2MG

EU/1/09/601/001 FIR DAPSE TABLET 10MG

110048//29964

INSP R A TABLET 50MG

EU/1/96/016/008 NO R VIR DR ANK 80MG/ML 110190//21551

P HO SP HO R AL DR ANK

109979//34382

SP IR IVA R ESP IMAT O P L V INHAL 2,5MC G/DO P ATR 60DO

110037//14224

TO BR ADEX O O GZALF TUBE 3,5G

EU/1/11/688/001 C INR YZE INJP DR FLAC O N 500IE + SO LV 5ML 110395//26919

FLUDAR A TABLET O MHULD 10MG

EU/1/06/378/006 INO VELO N TABLET FILMO MHULD 200MG EU/1/06/378/007 INO VELO N TABLET FILMO MHULD 200MG EU/1/06/378/008 INO VELO N TABLET FILMO MHULD 200MG EU/1/06/378/009 INO VELO N TABLET FILMO MHULD 200MG EU/1/06/378/010 INO VELO N TABLET FILMO MHULD 200MG EU/1/06/378/011 INO VELO N TABLET FILMO MHULD 400MG EU/1/06/378/012 INO VELO N TABLET FILMO MHULD 400MG EU/1/06/378/013 INO VELO N TABLET FILMO MHULD 400MG EU/1/06/378/014 INO VELO N TABLET FILMO MHULD 400MG EU/1/06/378/015 INO VELO N TABLET FILMO MHULD 400MG EU/1/06/378/016 INO VELO N TABLET FILMO MHULD 400MG 110445//550

P ALUDR INE TABLET 100MG

110152//8071

R ESO NIUM A PO EDER

108608

C AD O R ANGE BR UISGR ANULAAT 500MG/880IE IN SAC HET

110554//13724

C YTO TEC TABLET 200MC G

EU/1/97/055/007 VIR AMUNE 400 MG TABLETTEN MET VER LENGDE AFGIFTE EU/1/97/055/009 VIR AMUNE 400 MG TABLETTEN MET VER LENGDE AFGIFTE EU/1/97/055/005 VIR AMUNE 50 MG TABLETTEN MET VER LENGDE AFGIFTE EU/1/97/055/006 VIR AMUNE TABLET MVA100MG EU/1/97/055/008 VIR AMUNE TABLET MVA 400MG 110321//101127 C ALC I C HEW D3 KAUW TABLET 1000MG/800IE 110481//18220

C AMP R AL TABLET MSR 333MG

110508//5573

C YKLO KAP R O N INJVLST 100MG/ML AMP UL 5ML

108495//11301

DEXAMYTR EX O O GZALF TUBE 3G

110507//6292

EFUDIX C R EME 50MG/G

109992//17315

HAVR IX INJVLST 1440SKB-E/ML W W SP 1ML

110489//25386

MALAR O NE TABLET FILMO MHULD

110601//16681

MIR ENA I.U.D.

110645//15102

NO VUXO L HYDR O FO BE ZALF

110619//859

P UR INETHO L TABLET 50MG

110666//26830

TR ILEP TAL SUSP ENSIE 60MG/ML

EU/1/07/440/004 TYVER B 250 MG FILMO MHULDE TABLETTEN EU/1/97/055/004 VIR AMUNE TABLET 200MG 110622//19252

ZO FR AN ZETP IL 16MG

100154

R O C UR O NIUMBR O M FR ES KABI INJVLST 10MG/ML

101113

R O C UR O NIUMBR O MIDE SANDO Z INJVLST 10MG/ML

103302

R O C UR O NIUMBR O MIDE R P INJVLST 10MG/ML

16946

ESMER O N INJVLST 10MG/ML

16146

MIVAC R O N INJEC TIEVLO EISTO F 2MG/ML

19471

NIMBEX INJVLST 2MG/ML

19472

NIMBEX INJVLST 5MG/ML

19122

ETO MIDAAT LIP UR O INJVLST 2MG/ML

11772

P ENTO THAL INJEC TIEP O EDER

18473

DIP R IVAN INJVLST 20MG/ML

24720

P R O P O FO L LIP UR O INJEC TIE EMULSIE 10MG/ML

25350

INJVLST P R O P O FO LUM 10MG/ML

25809

P R O P O FO L FR ESENIUS INJ EMULSIE 10MG/ML

26727

P R O P O FO L FR ESEN MC T/LC T INJ EMULS 20MG/ML

31762

P R O P O FO L FR ESEN MC T/LC T INJ EMULS 10MG/ML

31923

P R O P O FO L C LAR IS INJEC TIE EMULSIE 10MG/ML

32676

P R O P O FO L C LAR IS INJEC TIE EMULSIE 20MG/ML

35120

P R O P O FO L DELTASELEC T INJ EMULSIE 20MG/ML

34720

P R O P O FO L DELTASELEC T INJ EMULSIE 10MG/ML

109870

ALENC A D3 70MG/1000MG/800IE(1T ALENDR O NZ+6T C ALC I)

109863

ALENC A D3 70MG/ 500MG/800IE(1T ALENDR O NZ+6T C ALC I)

110647//3820

MESTINO N TABLET 10MG

110652//3821

MESTINO N TABLET O MHULD 60MG

110805//6014

P R IMP ER AN ZETP IL 20MG

110720//859

P UR INETHO L TABLET 50MG

21308=20798

VAQ TA ADULT,SUSP ENSIE VO O R INJEC TIE 50 E/ML

110646//26569

ZYVO XID TABLET FILMO MHULD 600MG

110788//4473

ALKER AN TABLET FILMO MHULD 2MG

EU/1/99/120/001 AMMO NAP S 500 MG TABLETTEN EU/1/99/120/002 AMMO NAP S 500 MG TABLETTEN EU/1/99/120/003 AMMO NAP S 940 MG/G GR ANULAAT EU/1/99/120/004 AMMO NAP S 940 MG/G GR ANULAAT 110058//24713

C ALC IUM D ER C C A-D BR UISTABLET 600MG/400IE

110621//6445

ETHAMBUTO L DIHC L FISHER TABLET FILMO MHULD 400MG

EU/1/11/677/003 GILENYA 0,5 MG HAR DE C AP SULES 110802//2011

GLUC AGEN INJEC TIEP O EDER FLAC O N 1MG + SO LV 1ML

EU/1/06/378/017 INO VELO N SUSPENSIE 40MG/ML EU/1/08/468/002 INTELENC E TABLET 200MG 110822//256

LEUKER AN TABLET FILMO MHULD 2MG

110293//34382

SP IR IVA R ESP IMAT O P L V INHAL 2,5MC G/DO P ATR 60DO

111011//34382

SP IR IVA R ESP IMAT O P L V INHAL 2,5MC G/DO P ATR 60DO

110909

TALO XA TABS TABLET 600MG

110997//7887

UBR ETID TABLET 5MG

21308=20798

VAQ TA ADULT INJSUSP 50E/ML W W SP 1ML

111056//20871

AR THR O TEC TABLET MGA 75MG

108396

C ALC I-BO NED3 O R ANGE KAUW TABLET 1000MG/880IE

104325 DO R ZO LAMIDE/TIMO LO L C O NS VR IJ PC H O O GDR FL 0,2ML 110798//102707 KALC IP O S-D KAUW TABLET 500MG/800IE 110843//25386

MALAR O NE TABLET FILMO MHULD

110824//8071

R ESO NIUM A PO EDER

110912//32633

TR USO P T C O NSER VEER MIDDELVR O O GDR 20MG/ML FL 0,2ML

111361//16410

AR THR O TEC TABLET MGA 50MG

EU/1/11/736/001 EDUR ANT TABLET FILMO MHULD 25MG 110928//19569

HAVR IX JUNIO R INJVLST 1440SKB-E/ML W W SP 0,5ML

111090//21168

IMPLANO N NXT IMP LANTAAT IN APP LIC ATO R 68MG

111334//4961

SO FR ADEX O O R DR UP P ELS

111333//34382

SP IR IVA R ESP IMAT O P L V INHAL 2,5MC G/DO P ATR 60DO

EU/1/11/717/001 VYNDAQ EL C AP SULE 20MG 111367//6305 ASPEGIC INJEC TIEP O EDER FLAC O N 500MG + SO LVENS 5ML EU/1/11/737/001 EVIPLER A 200 MG/25 MG/245 MG FILMO MHULDE TABLETTEN EU/1/11/737/002 EVIPLER A 200 MG/25 MG/245 MG FILMO MHULDE TABLETTEN 111391//25386 35003

MALAR O NE TABLET FILMO MHULD P IP ER AC ILLINE/TAZO BAC T MYLAN INJP DR F 2000MG/250MG

35004

P IP ER AC ILLINE/TAZO BAC T MYLAN INJP DR F 4000MG/500MG

111496//859

P UR INETHO L TABLET 50MG

111354//8286 111591//34382

R O C ALTR O L C AP SULE 0,50MC G SP IR IVA R ESP IMAT O P L V INHAL 2,5MC G/DO P ATR 60DO

111546//16410

AR THR O TEC TABLET MGA 50MG

111548//20871

AR THR O TEC TABLET MGA 75MG

111670//14224 111414//13761

TO BR ADEX O O GZALF TUBE 3,5G BAC TR O BAN NEUSZALF 20MG/G

111675//7070

LANVIS TABLET 40MG

111510//16681

MIR ENA I.U.D.

EU/1/00/142/005 NO VO MIX 30 P ENFILL INJ 100E/ML PATR O O N 3ML 111526//550 P ALUDR INE TABLET 100MG 111635//8285

C ALC ITR IO L FISHER C AP SULE 0,25MC G

109770

DIVISUN TABLET 800IE

112049//29963 INSP R A TABLET 25MG 112035//29964 INSP R A TABLET 50MG 111498//256

LEUKER AN TABLET FILMO MHULD 2MG

112040//11015 EMLA HYDR O FIELE C R EME 50MG/G 111700//3821

MESTINO N TABLET O MHULD 60MG

111936//18026 MIGR AFIN P O EDER SAC HET 112171//853

P LAQ UENIL TABLET O MHULD 200MG

112237//10261 SO R BISTER IT P O EDER 90% M/M 112389//25692

C ALC I C HEW D3 KAUW TABLET 500MG/400IE

112388//105832 C ALC I C HEW D3 KAUW TABLET 500MG/800IE 112242//30086

C O P AXO NE INJVLST 20MG/ML W W SP 1ML

112396//16734

P ULMO ZYME VER NEVELVLO EISTO F 1000E/ML AMP UL 2,5ML

111730//20871

AR THR O TEC TABLET 75MG

111722//16410

AR THR O TEC TABLET MGA 50MG

111377

BO NENDR O 70MG/ 500MG/880IE(1TB ALENDR O NAX+6SA C AD)

112427//12412

BUR INEX INJVLST 0,50MG/ML AMPUL 4ML

112394//101127 C ALC I C HEW D3 KAUW TABLET 1000MG/800IE 112395//101127 C ALC I C HEW D3 KAUW TABLET 1000MG/800IE 112123//8071

R ESO NIUM A PO EDER

112460//8285

R O C ALTR O L C AP SULE 0,25MC G

EU/1/12/753/003 SIGNIFO R INJVLST 0,3MG/ML AMPUL 1ML EU/1/12/753/007 SIGNIFO R INJVLST 0,6MG/ML AMPUL 1ML EU/1/12/753/011 SIGNIFO R INJVLST 0,9MG/ML AMPUL 1ML 112174//20871

AR THR O TEC TABLET MGA 75MG

33687

GAMUNEX INFUSIEVLO EISTO F 100MG/ML

112541//256

LEUKER AN TABLET FILMO MHULD 2MG

EU/1/06/380/006 P R EZISTA SUSP ENSIE 100MG/ML 112691//26830

TR ILEP TAL SUSP ENSIE 60MG/ML

112309//14740 AUGMENTIN SUIKER VR IJ PDR V SUSP 100/12,5MG/1ML 108406

C ALC IUM/VITAMINE D3 SANDO Z KAUW TABLET 1000MG/880IE

107508

KALC IP O S-D TABLET FILMO MHULD 500MG/800IE

107779

LAMIVUDINE/ZIDO VUDINE MYLAN TABL FILMO MH 150/300MG

112842//4069

NO VALGIN INJVLST 500MG/ML

112649//855

O TO SP O R IN O O R DR UPP ELS

112890//859

P UR INETHO L TABLET 50MG

112376//19252 ZO FR AN ZETP IL 16MG 112899//16410

AR THR O TEC TABLET MGA 50MG

112900//20871

AR THR O TEC TABLET MGA 75MG

112875//105832 C ALC I C HEW D3 KAUW TABLET 500MG/800IE 112876//101127 C ALC I C HEW D3 KAUW TABLET 1000MG/800IE 112882//6292

EFUDIX C R EME 50MG/G

EU/1/06/380/007 P R EZISTA TABLET FILMO MHULD 800MG 109086

ATO VAQ UO N/P R O GUANIL MYLAN TABLET FILMO MH 250/100MG

111728//17315

HAVR IX INJVLST 1440SKB-E/ML W W SP 1ML

108926

LAMIVUDINE/ZIDO VUDINE SANDO Z TAB FILMO MH 150/300MG

EU/1/10/663/001 LAMIVUDINE/ZIDO VUDINE TEVA TABL FILMO MH 150/300MG 113003//853

P LAQ UENIL TABLET O MHULD 200MG

113004//853

P LAQ UENIL TABLET O MHULD 200MG

112982//859

P UR I NETHO L TABLET 50MG

111839

TR AMADO L HC L/P AR AC ETAMO L TEVA TABLET 37,5/325MG

113065//28113

ZALDIAR TABLET FILMO MHULD

EU/1/11/733/004 DIFIC LIR TABLET FILMO MHULD 200MG EU/1/09/596/007 LAMIVUDINE TEVA TABLET FILMO MHULD 150MG EU/1/09/596/014 LAMIVUDINE TEVA TABLET FILMO MHULD 300MG 113048//11154

LAR IAM TABLET 250MG

113285//25386

MALAR O NE TABLET FILMO MHULD

EU/1/09/598/001 NEVIR AP INE TEVA TABLET 200MG 113286//34382

SP IR IVA R ESP IMAT O P L V INHAL 2,5MC G/DO P ATR 60DO

EU/1/01/200/003 VIR EAD GR ANULES 33MG/G EU/1/01/200/004 VIR EAD 123 MG, FILMO MHULDE TABLET EU/1/01/200/006 VIR EAD 163 MG, FILMO MHULDE TABLET EU/1/01/200/008 VIR EAD 204 MG, FILMO MHULDE TABLET 113288//28113

ZALDIAR TABLET FILMO MHULD

113131//20871

AR THR O TEC TABLET MGA 75MG

109397

D-C UR A DR ANK 25000IE AMP UL 1ML

109398

D-C UR A DR ANK 100000IE AMPUL 1ML

113302//126

DEC ADUR ABO LIN INJVLST 50MG/ML AMP UL 1ML

113334//16681

MIR ENA I.U.D.

EU/1/00/142/010 NO VO MIX 30 FLEXP EN INJ 100E/ML W W SP 3ML 113399//9709 113006//10261

SC O P O DER M TTS P LEISTER MGA 1,5MG SO R BISTER IT P O EDER 90% M/M

100957

TO C TINO 10 MG C APSULES, ZAC HT

100962

TO C TINO 30 MG C APSULES, ZAC HT

113362//20871 AR THR O TEC TABLET MGA 75MG 113337//101127 C ALC I C HEW D3 KAUW TABLET 1000MG/800IE 113525//26919

FLUDAR A TABLET O MHULD 10MG

113500//29963

INSP R A TABLET 25MG

113502//29964 113021//9709

INSP R A TABLET 50MG SC O P O DER M TTS P LEISTER MGA 1,5MG

113029//10261

SO R BISTER IT P O EDER 90% M/M

113295//3543

TER R A C O R TR IL + P O LYMYXINE B O O GZALF TUBE 3,5G

112458//7887 UBR ETID TABLET 5MG EU/1/01/200/004 VIR EAD TABLET FILMO MHULD 123MG EU/1/01/200/006 VIR EAD TABLET FILMO MHULD 163MG EU/1/01/200/008 VIR EAD TABLET FILMO MHULD 204MG 113467//26569 113523//26834

ZYVO XID TABLET FILMO MHULD 600MG ATR O VENT AER O SO L 20MC G/DO SPBS 200DO + INHALATO R

113336//105832 C ALC I C HEW D3 KAUW TABLET 500MG/800IE 113788//5573

C YKLO KAP R O N INJVLST 100MG/ML AMP UL 5ML

113720//3984

DESFER AL INJEC TIEP O EDER FLAC O N 500MG

107898

NEVIR AP INE MYLAN TABLET 200MG

109115

NEVIR AP INE SANDO Z TABLET 200MG

113708//859

P UR INETHO L TABLET 50MG

Bijlage 2. horende bij artikel 2.5, tweede en derde lid, van de Regeling zorgverzekering 1. Polymere, oligomere, monomere en modulaire dieetpreparaten Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die nie t k an uitk o m e n m e t a ange pa ste no rm ale vo e ding e n a ndere pro ducte n va n bijzonde re vo eding e n die: a.

lijdt a a n e e n sto fwisse lingssto o rnis,

b.

lijdt a a n e e n vo e dse la llergie ,

c.

lijdt a a n e e n reso rptie sto o rnis,

d.

lijdt a a n e e n, via ee n geva lide erd scre eningsinstrum e nt va stge stelde , zie k te ge rela te erde o nde rvo e ding o f ee n risico daa ro p, of

e.

da aro p is a a nge weze n o vere e nk o m stig de richtlijne n die in Ne derla nd do o r de de sbe treffe nde be ro epsgro e pen zijn a anvaa rd.

2 [Ve rva llen.] 3. Difterievaccin, poliomyelitisvaccin, kinkhoestvaccin dan wel combinaties van twee of meer van deze vaccins of met het tetanusvaccin Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde jo nge r da n a chttie n ja a r. 4. Hepatitis vaccins a.

He patitis A-va ccin

uitsluite nd vo o r ee n ve rzek e rde:

b.

1°.

die lijdt a a n ee n chro nische he patitis B-infe ctie,

2°.

m e t ee n chro nische he patitis C -infe ctie , of

3°.

m e t ee n nie t-virale chro nische le ve rzie k te , en die da a rbij e en verho o gde k ans op e e n he patitis A-infe ctie he e ft, tenzij de verho o gde k ans op be sm e tting e en ge vo lg is va n reizen, be roe psuito efe ning o f e en e pide m ie .

He patitis B-va ccin Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde:

c.

1°.

die is aa ngewe ze n o f op a fzie nba re te rm ijn aa ngewe ze n k an zijn o p he t re ge lm atig gebruik e n va n blo e d- o f blo e dpro ducten o f o p dia lyse ,

2°.

m e t he t syndroo m va n Do wn o f m et e e n da a rm ee verge lijk bare e rnstige chro m o so m ale a fwijk ing e n vo or zo ve r dit ge paa rd ga at m e t e en versto orde a fwe e rfunctie ,

3°.

die pa rtner, ge zinslid of huisge no o t is van ie m a nd die HbsAg po sitie f is,

4°.

die a nders dan in be ro e psuito e fe ning in e e n da gve rblijf, in e e n tehuis, o p ee n scho o l vo o r ve rsta ndelijk ge handica pte n dan we l e e n so cia le we rk pla ats, blijk ens ee n risico -a nalyse va n de ge m ee nte lijk ge zondheidsdie nst, e en verho o gde k ans op be sm e tting hee ft, o f

5°.

die lijdt a a n ee n chro nische le ve rzie k te .

He patitis A e n B com bina tie va ccin Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die zo wel voldo et a a n ee n va n de vo orwa a rde n vo o r hepa titis A-va ccin a ls a a n e e n va n de voo rwa arde n vo o r he pa titis B-va ccin.

5. Pneumokokkenvaccin Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde: a.

in de le eftijd va n twe e jaa r o f o ude r m et e e n onvolwa ardige m iltfunctie o fwe l na m iltve rwijde ring,

b.

m e t le k k age va n herse nvo cht,

c.

m e t sik k e lce lzie k te ,

d.

lijde nd a a n de zie k te va n Hodgk in, no n-Hodgk in lym fo o m , m yelo o m o f chro nische lym fatische le uk e m ie,

e.

lijde nd a a n le vercirrho se , chro nische nie rfunctie stoo rnis, chro nisch hartfa le n m e t stuwing, e e n ischem ische ha rtzie k te o f a lcoho lism e m e t pne um o k o k k e ninfe ctie in de ana m ne se,

f.

m e t ee n m arginale longfunctie (dyspnoe na 100 m ete r wa nde len e n ee n FVC <50% va n vo orspeld, FEV1, FEV1/FVC ra tio en Dlco < 40% va n vo orspeld, o f ee n VO 2m a x tussen 10-15 m l/(k g-m in)),

g.

die im m uungecom pro m itte e rd is ten ge vo lge van e e n a uto-im m uunziek te , e en im m uno suppre ssie ve beha nde ling, e e n o rgaa ntra nspla nta tie o f e en be enm e rgtra nspla nta tie , of

h.

die HIV-ge ïnfectee rd is (C DC -classifica tie HIV-infe ctie gro e pen II, III e n IV) m e t ee n goe de im m uunre spo ns.

6 [Ve rva llen.] 7 [Ve rva llen.] 8. Een anti-retroviraal geneesmiddel Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die vo o r be ha nde ling m et zo 'n ge ne e sm idde l e en m e dische indicatie hee ft wa arvo or he t gene e sm idde l k ra chtens de W e t op de Gene e sm idde lenvoo rzie ning is ge re gistree rd.

9. Simvastatine, atorvastatine, fluvastatine, pravastatine, rosuvastatine, ezetimibe Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die ee n ve rho ogde k a ns he e ft op he t ontwik k e len van ca rdiova scula ire a a ndo e ningen e n op be ha ndeling m e t ee n va n deze m iddele n is a ange we zen o ve re e nk o m stig de richtlijne n die in Ne de rla nd do or de desbetre ffe nde be roe psgro e pe n zijn a a nva ard. 10 [Ve rva llen.] 11. Granulocyt koloniestimulerende faktor Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die : a.

wo rdt be hande ld m e t cyto statica voo r e e n k wa ada a rdige aa ndoe ning e n vo o r he t ge ne e sm idde l e en m e dische indicatie hee ft wa arvo or he t gene e sm idde l k ra chte ns de Gene e sm idde lenwe t is gere gistre e rd,

b.

wo rdt be hande ld m e t ga nciclo vir vo o r e en cyto m e ga lo virus retinitis a ls gevo lg van AIDS e n vo or he t gene e sm idde l ee n m edische indica tie he e ft waa rvoo r he t ge ne esm idde l k ra chte ns de Ge ne esm idde le nwet is ge re gistre erd,

c.

wo rdt be hande ld voo r e e n e rnstige co nge nita le , cyclische o f idio pa tische ne utro pe nie, o f

d.

voo r da t ge ne esm idde l e e n nie t-ge registre e rde indicatie hee ft e n lijdt aa n e en zie k te die in Ne derla nd nie t va k er vo ork o m t da n bij 1 o p de 150.000 inwone rs, de werk zaa m heid va n dat ge nee sm iddel bij die indica tie we tenschappe lijk is o nde rbouwd en in Ne de rla nd voo r die a a ndo e ning gee n beha nde ling m o ge lijk is m e t e nig a nde r vo o r die a a ndo e ning ge re gistre erd ge ne e sm idde l.

12 [Ve rva llen.] 13. Imiglucerase Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die lijdt aa n de ziek te va n Ga uche r e n die wordt be ha ndeld o ve re enk o m stig de richtlijnen die vo or Ne de rla nd do or de desbetre ffe nde be roe psbe o efe na ren zijn a anvaa rd. 14. Rabies-vaccin Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die is blo o tgeste ld ge we e st a a n he t ra bie s-virus. 15 [Ve rva llen.] 16. Galantamine Vo orwa a rde : Uitsluitend vo o r e en verze k e rde die lijdt a an: m ilde to t m a tig ernstige dem e ntie bij de zie k te va n Alzhe im e r e n de the rapie wo rdt geë value erd co nfo rm de doo r de be ro e psgroe pe n ge acce pte e rde be hande lrichtlijn voo r m e dica m e nte uze the rapie bij dem e ntie . 17 [Ve rva llen.] 18 [Ve rva llen.] 19. Palivizumab Vo orwa a rde :

a.

ge bo re n is bij e e n zwange rscha psduur va n twe e ënde rtig we k e n o f m inder e n bij he t be gin va n he t re spirato ir syncytie e l virus seizoe n jonge r wa s da n ze s m a a nde n,

b.

jo nge r is da n e e n ja a r e n bro nchopulm o na le dyspla sie he eft,

c.

jo nge r is da n twe e ja a r e n die vo o r de be ha ndeling va n bro nchopulm o na le dyspla sie zuurstofthe ra pie nodig he e ft,

d.

jo nge r is da n twe e ja a r e n die ee n co nge nitale harta a ndo e ning hee ft die he m odyna m isch significant is,

e.

jo nge r is da n e e n ja a r e n e e n ernstige im m uunde ficiëntie he e ft, o f

f.

jo nge r is da n e e n ja a r e n e e n ernstige longpatho logie ten ge vo lge van cystische fibro se hee ft.

20. Montelukast Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die : a.

lijdt a a n m a tig pe rsistere nde a stm a e n bij wie o nvo ldo e nde k linische co ntro le wo rdt be re ik t m e t inha la tie co rticoste roïde n e n k o rtwe rk e nde β-sym pa thico m im e tica, o f

b.

lijdt a a n inspa nningsa stm a , bij wie be hande ling m e t k o rtwe rk e nde β-sym pa thico m im e tica ge e n uitk om st bie dt en die de lee ftijd van vijftie n ja a r no g nie t he eft be re ik t.

21. Clopidogrel en prasugrel Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die : a.

na ee n doo rge m a a k t m yo ca rdinfa rct o f ische m isch ce rebro va scula ir a ccident o f bij e e n va stge ste lde pe rife re a rterië le a a ndo e ning, niet be hande ld k a n wo rden m e t acetylsa licylzuur va nwege o ve rgevo elighe id vo o r acetylsa licylzuur o f ee n a nde re absolute co ntra indica tie vo o r acetylsa licylzuur hee ft, o f

b.

is a a nge we ze n op he t ge ne esm idde l in co m bina tie m e t acetylsa licylzuur bij: 1°.

e e n a cuut co ro na ir syndro o m zo nde r ST-se gm entstijging,

2°.

e e n a cuut co ro na ir syndro o m op ba sis va n e e n acuut m yo ca rdinfa rct m e t ST-se gm e ntstijging, o f

3°.

e e n ste ntpla atsing in he t k a de r van e e n nie t-a cuut coro na ir syndro om .

22. Etanercept [Ve rva llen.] 23. Modafinil Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die lijdt aa n narcole psie en die o nvo ldoe nde re a gee rt o p m e thylfe nida a t of da t m idde l va nwe ge bijwe rk inge n nie t ve rdraa gt. 24 [Ve rva llen.] 25 [Ve rva llen.] 26. Een thiazolidinedion Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde m e t dia be tes m ellitus type 2 die gee n insuline ge bruik t e n dit m idde l ge bruik t: a.

a ls m o no the rapie om da t hij e en co ntra-indica tie o f k linisch re le va nte bijwe rk ing he eft vo or zo we l m etfo rm ine a ls e e n sulfo nylureum derivaa t,

b.

a ls twe evo udige the ra pie in com bina tie m e t m e tform ine 1°.

o m da t de ve rze k e rde e e n sulfo nylure um de riva at nie t k a n gebruik e n doo r co ntra -indica tie o f k linisch re le va nte bijwe rk ing e n

2°. c.

d.

te r ve rvanging van e e n sulfo nylure um de riva at o m dat de blo e dgluco se spie gel o nvo ldo e nde o nde r co ntro le k a n wo rden ge bra cht m e t de co m bina tie va n m e tfo rm ine en e e n sulfo nylure um de riva at,

a ls twe evo udige the ra pie in com bina tie m e t e e n sulfo nylure um de riva at 1°.

o m da t de ve rze k e rde m e tform ine nie t k a n gebruik e n doo r co ntra -indica tie o f k linisch re le va nte bijwe rk ing e n om da t de bloe dgluco sespie ge l o nvo ldoe nde o nder contro le k a n wo rde n ge bracht m e t e en sulfo nylureum derivaa t a lle e n, of

2°.

te r ve rvanging van m e tform ine o m dat de blo e dgluco se spie gel o nvo ldo e nde o nde r co ntro le k a n wo rden ge bra cht m e t de co m bina tie va n m e tfo rm ine en e e n sulfo nylure um de riva at, o f

a ls drievo udige the ra pie in com bina tie m e t m e tform ine e n e en sulfo nylureum derivaa t 1°.

o m da t de blo e dgluco se spie ge l o nvo ldo e nde o nde r co ntrole k an wo rde n gebra cht m et e e n twe e vo udige thera pie é n

2°.

o m da t de toe diening va n insuline o p be zwa re n stuit: –

do or e rnstige aa nhoude nde proble m e n o p de inje ctie pla a tse n ve ro orza ak t do or huida a ndo e ninge n, te we inig o nde rhuids ve twee fsel, infectie s of conta cta lle rgie,

–

do or licha m e lijk e o f ge e ste lijk e bepe rk inge n (ha ndfunctie , zie n, co gnitie) va n de verze k e rde wa a rdoo r hij nie t in staa t is ze lfsta ndig insuline te inje cte re n,

–

do or prik fobie , of

–

o m da t de ve rze k e rde do or insuline ge bruik zijn be ro ep niet m e e r k a n uito e fe ne n.

27. R-DNA -interferon, erytropoëtine en analoga, mycofenolaat-mofetil en mycofenolzuur, glatirameer, anagrelide en levodopa/carbidopa intestinale gel Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die : a.

voo r he t ge ne esm idde l e e n m e dische indica tie he e ft wa a rvo o r het ge nee sm iddel k ra chtens de Ge nee sm iddele nwe t is ge registre e rd, of

b.

voo r da t ge ne esm idde l e e n nie t-ge registre e rde indicatie hee ft e n lijdt aa n e en zie k te die in Ne derla nd nie t va k er vo ork o m t da n bij 1 o p de 150.000 inwone rs, de werk zaa m heid va n dat ge nee sm iddel bij die indica tie we tenschappe lijk is o nde rbouwd en in Ne de rla nd voo r die a a ndo e ning gee n beha nde ling m o ge lijk is m e t e nig a nde r vo o r die a a ndo e ning ge re gistre erd ge ne e sm idde l.

28. A mbrisentan, bosentan, epoprostenol intraveneus, iloprost voor inhalatie, sildenafil, tadalafil en treprostinil subcutaan en intraveneus Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die : a.

lijdt a a n pulm o na le a rte rië le hyperte nsie New Yo rk He a rt Associa tio n k la sse II e n die am brise ntan, bo se ntan, silde na fil of ta da la fil da arvo or k rijgt vo orge schre ven,

b.

lijdt a a n pulm o na le a rte rië le hyperte nsie New Yo rk He a rt Associa tio n k la sse III o f IV e n die k rijgt vo o rge schreve n:

c.

1°.

é é n va n de o rale gene e sm idde len a m brisenta n, bo senta n, silde na fil o f ta da la fil, o f e en co m bina tie va n twe e ora le ge ne e sm idde le n uit ve rschille nde fa rm a co lo gische gro e pe n,

2°.

e e n com bina tie va n ee n o raa l gene e sm idde l m e t ilopro st vo or inhala tie o f m e t epo proste no l intra vene us o f m et tre pro stinil subcuta a n o f intrave ne us,

3°.

ilopro st vo or inhala tie in m ono thera pie uitsluitend te r be ha nde ling va n de prim aire vo rm va n pulm o na le arte rië le hype rte nsie, indie n de o nder 1° ge noe m de be hande ling onvoldo ende resulta a t hee ft e n ee n beha nde ling m e t epo proste no l intrave ne us o f tre prostinil subcuta an o f intra vene us niet no o dza k e lijk is o f niet m o gelijk va nwe ge bijwe rk inge n of contra indica tie s, o f

4°.

uitsluite nd als uite rste the rapie , indien de onde r 1° en 2° ge no e m de be ha ndelinge n o nvo ldo e nde re sultaa t he bbe n, ee n co m bina tie va n twe e ora le ge ne esm idde le n uit ve rschille nde fa rm a co lo gische groe pe n m e t e po pro ste nol intrave ne us o f m e t tre prostinil subcuta an o f intra vene us, o f

lijdt a a n syste m ische scle rose en a a nho ude nde digita le ulce ra e n die 1°.

bo se ntan k rijgt voo rge schre ve n te r vo o rk o m ing van nieuwe digitale ulcera ,

2°.

o nvo ldo e nde re a ge e rt o p de beha nde ling m e t dihydro pyridine ca lcium a ntago niste n e n ilo pro st intrave ne us, da n we l deze ge ne e sm idde le n nie t k a n gebruik e n e n

29 [Ve rva llen.] 30. Tacrolimuszalf Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde va n twe e ja a r o f oude r m e t m a tig to t e rnstig constitutio ne e l ecze e m die onvoldo ende rea ge ert o p be ha ndeling m e t a nde re lo k a le m idde len, wa aro nder in iede r geva l cortico stero ïden. 31. Miglustat Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die lijdt aa n: a.

de zie k te van Ga ucher type 1 e n nie t k an wo rde n beha nde ld m e t im igluce rase , of

b.

de zie k te van Niem a nn-Pick type C .

32. Gonadotrope hormonen, gonadoreline-analoga, gonadoreline-antagonisten, urofollitropine en corifollitropine alfa Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die de ze ge nee sm iddele n k rijgt vo o rge schreve n in ve rba nd m e t: a.

e e n in-vitro fe rtilisatie poging die ten la ste va n de zo rgve rze k ering k o m t, o f

b.

e e n a ndere be ha ndeling da n ee n in-vitro fertilisa tiepo ging.

33. Adalimumab [Ve rva llen.] 34. Pimecrolimus Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde va n twe e ja a r o f oude r m e t m ild to t m atig co nstitutio ne el e czee m die o nvo ldo e nde re a ge e rt o p be ha ndeling m e t a nde re lo k a le m idde len, wa aro nder in iede r geva l cortico stero ïden. 35. Laxantia, kalktabletten, middelen bij allergie, middelen tegen diarree, maagledigingsmiddelen en middelen ter bescherming van de ogen tegen uitdroging die op grond van de Geneesmiddelenwet zonder recept mogen worden afgeleverd en andere geneesmiddelen met eenzelfde werkzaam bestanddeel en in eenzelfde toedieningsvorm Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die blijk e ns he t vo o rschrift la nge r dan zes m aa nden o p he t ge ne e sm idde l is a a nge weze n e n vo o r wie he t ge ne e sm idde l is voo rge schre ve n te r be ha nde ling va n e en chro nische aa ndoe ning, te nzij he t be treft e e n vo o r de verze k e rde nie uwe m e dica tie . 36. Parathyroid hormoon Vo orwa a rde : uitsluite nd vo o r ee n perio de va n m a x im a a l viere ntwintig m a a nde n vo o r e en verze k e rde vro uw m e t e rnstige po stm e no pa uza le o ste o poro se die : a.

o nda nk s be ha ndeling m e t bisfo sfo nate n, ra lo x ifee n, baze do x ifen o f stro ntium ra nela a t na twe e we rve lfra cturen o pnie uw é é n of m e er fra cture n he e ft gek re gen, o f

b.

bisfo sfo na ten, ra lox ife en, ba ze dox ife n e n stro ntium ra nela a t nie t k an ge bruik en.

37 [Ve rva llen.] 38

39. Memantine Vo orwa a rde : Uitsluitend vo o r e en verze k e rde m e t e e n e rnstige vo rm va n de zie k te va n Alzhe im er (AD) en de the ra pie wo rdt ge ë va lue e rd co nfo rm de do or de bero e psgro epe n ge a cce pte erde beha nde lrichtlijn vo o r m e dica m e nte uze the ra pie bij AD. 40. Imiquimod Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde vo or de beha nde ling van k leine superficië le ba sa a lce lcarcino m en, indie n chirurgische e x cisie o p pra k tische be zwa re n stuit. 41 [Ve rva llen.] 42. Rivastigmine Vo orwa a rde : Uitsluitend vo o r e en verze k e rde die lijdt a an: m ilde to t m a tig ernstige dem e ntie bij de zie k te va n Alzhe im e r o f m ilde tot m a tig e rnstige de m e ntie bij pa tië nte n m e t idio pathische zie k te va n Pa rk inso n e n de the ra pie wordt ge ëva lue e rd confo rm de do or de bero e psgro epe n ge a cce pte erde beha nde lrichtlijn vo o r m e dica m e nte uze the rapie bij dem e ntie . 43 [Ve rva llen.] 44 [Ve rva llen.] 45 [Ve rva llen.] 46 [Ve rva llen.] 47 [Ve rva llen.] 48. Infliximab [Ve rva llen.] 50. Ivabradine Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde m e t: a.

stabie le a ngina pe cto ris die ee n co ntra-indica tie o f into le rantie he e ft vo o r e en bè tablo k k e r e n nie t uitk o m t m e t diltia ze m of de co m bina tie va n e e n la ngwe rk e nd nitraa t e n ee n dihydro pyridine ca lcium a nta go nist, e n die iva bradine a ls m o nothe ra pie o f als twe evo udige the ra pie sa m e n m e t e en la ngwe rk e nd nitra a t of e e n dihydro pyridine ca lcium a ntago nist gebruik t, o f

b.

chro nisch hartfa le n NYHA k la sse II-IV m e t systo lische disfunctie e n m e t sinusritm e m e t e e n rustfreque ntie ≥ 75/m in, a ls to e vo e ging bij e en individue el, o ptim a a l e n richtlijnco nfo rm inge ste lde m e dicam e nteuze be hande ling die e en AC E-rem m e r, ee n diure ticum , ee n bèta blok k e r en e e n a ldoste rona ntago nist o f AT1-a ntago nist o m va t tenzij de pa tië nt e e n of m e e r va n de ze m idde len niet ve rdra a gt of e e n co ntra -indicatie hee ft.

51. Sitagliptine, linagliptine en vildagliptine Vo orwa a rde :

uitsluite nd vo o r ee n ve rzek e rde m e t dia be tes m ellitus type 2 die nie t be ha ndeld k an wo rde n m et de co m bina tie van m e tform ine e n e en sulfo nylureum derivaa t, ge en insuline gebruik t e n dit m idde l gebruik t a ls m o nothe ra pie o f als ee n twee voudige o f drie voudige be ha ndeling in co m bina tie m e t m e tfo rm ine e n/of e e n sulfonylure um de riva a t. 52 [Ve rva llen.] 53 [Ve rva llen.] 54 [Ve rva llen.] 55 [Ve rva llen.] 56. Topotecan capsule Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde m e t re cidivere nde k le ince llige longk ank e r die nie t o pnie uw vo or e e n ee rstelijnsbeha nde ling in a a nm e rk ing k om t. 57. Benzodiazepinereceptor-agonist in orale of rectale toedieningsvorm 57a. Benzodiazepinereceptor-agonist, met uitzondering van diazepam Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die dit ge ne e sm idde l gebruik t a ls: a.

o nde rho udsbe ha nde ling bij e pile psie of a ls be hande ling bij e pile ptisch insult,

b.

be ha ndeling va n a ngststoo rnissen, wa arbij m e dica m e nte uze the ra pie m e t ten m inste twe e a ntide pre ssiva o ve re e nk o m stig de ge lde nde richtlijne n, he e ft ge fa a ld,

c.

be ha ndeling bij m ultipe le psychia trische proble m a tie k , wa a rbij beha nde ling m e t ho ge do ses benzodia ze pine n no o dza k elijk is, of

d.

pa llia tie ve se da tie bij te rm ina le zorg.

57b. Diazepam Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die a.

b.

dit ge ne esm idde l ge bruik t a ls: 1°.

o nde rho udsbe ha nde ling bij e pile psie of a ls be hande ling bij e pile ptisch insult,

2°.

be ha ndeling va n a ngststoo rnissen, wa arbij m e dica m e nte uze the ra pie m e t ten m inste twe e a ntide pre ssiva o ve re e nk o m stig de ge ldende richtlijne n, hee ft ge faa ld,

3°.

be ha ndeling bij m ultipe le psychia trische proble m a tie k , wa a rbij beha nde ling m e t ho ge do ses benzodia ze pine n no o dza k elijk is,

4°.

pa llia tie ve se da tie bij te rm ina le zorg, o f

niet a m bula nt is e n dit m idde l ge bruik t a ls spie rrela x ans bij thera piere siste nte spie rspa sm e n ten ge vo lge van e e n ne urolo gische a a ndo e ning.

58. Exenatide en Liraglutide Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde m e t dia be tes m ellitus type 2 en e e n BMI ≥35 k g/m 2, bij wie de blo e dgluco se wa arde n onvoldo ende k unne n wo rde n ge re gule erd m e t de co m bina tie va n m e tfo rm ine en e e n sulfo nylure um de riva at in de m a x im a a l ve rdra a gba re dose ringe n e n die gee n insuline ge bruik t, te nzij de verze k e rde al o p 1 m e i 2011 m e t dit m iddel in co m binatie m et insuline wo rdt be hande ld.

59. Dornase alfa Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die lijdt aa n cystic fibrose . 60. Ustekinumab [Ve rva llen.] 61. Romiplostim en eltrombopag Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde va n a chttie n ja a r en o ude r m e t chronische idio pa thische tro m bocyto penische purpura die : a.

sple nectom ie he e ft o nde rgaa n e n re fra cta ir is o p a ndere be ha ndelinge n, o f

b.

e e n contra -indica tie he e ft vo o r sple ne cto m ie e n nie t m e er vo ldo e nde re age e rt op a nde re beha nde linge n, wa a ro nde r in ie der ge va l co rtico ste ro ïde n.

62. Certolizumab pegol: [Ve rva llen.] 63. Golimumab [Ve rva llen.] 64. A nticonceptiva Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde: a.

jo nge r dan e e ne ntwintig ja a r,

b.

te r beha nde ling van e ndo m e trio se indie n de ve rze k erde hie ro p is a ange we zen o ve re e nk o m stig de richtlijne n die in Ne de rla nd do or de de sbe tre ffe nde bero e psgro epe n zijn a a nva a rd, o f

c.

te r beha nde ling van m e no rra gie wa arbij spra k e is va n blo eda rm oe de , inho ude nde e e n he m oglo bine wa a rde die la ge r is dan de re fe rentie wa a rden zoa ls ge hante e rd in de richtlijne n va n de de sbe treffe nde be ro epsgro e pen.

65. Rivaroxaban, apixaban Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde va n a chttie n ja a r of o uder a.

die o p dit ge nee sm iddel is a a nge we ze n vo o r de pre ve ntie van vene uze tro m bo -e m bo lie na e en e lectie ve k nie- of he upverva nge nde o pera tie , of

b.

m e t no nva lvula ir a trium fibrille re n e n e en o f m ee r risico fa cto re n die dit ge ne e sm idde l te r pre ventie va n ce rebro va scula ir a ccident o f system ische e m bo lie ge bruik t o ve re enk o m stig de intro ductiele idra a d die in Ne derla nd do o r de de sbe treffe nde be ro epsgro e pen is a a nva ard.

66. Dabigatran Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde va n a chttie n ja a r of o uder a.

die o p dit ge nee sm iddel is a a nge we ze n vo o r de prim a ire pre ventie va n ve neuze tro m bo-em bo lische a a ndo e ninge n na e en e lectie ve to ta le k nie- of he upve rva nge nde o pe ratie , o f

b.

m e t no nva lvula ir a trium fibrille re n e n e en o f m ee r risico fa cto re n die dit ge ne e sm idde l te r pre ventie va n ce rebro va scula ir a ccident o f system ische e m bo lie ge bruik t o ve re enk o m stig de intro ductiele idra a d die in Ne derla nd do o r de de sbe treffe nde be ro epsgro e pen is a a nva ard.

67. A ntidepressiva Vo orwa a rde :

de sbe treffe nde be ro epsgro e pen zijn a anvaa rd o f die vo o r dit ge nee sm iddel e e n m e dische indica tie he eft wa a rvo o r he t ge ne e sm idde l k ra chtens de Ge nee sm iddele nwe t is ge re gistree rd, m et die n ve rsta nde da t dit ge ne e sm idde l nie t to t de ve rze k erde presta tie s be ho ort indie n he t wo rdt ge bruik t in he t k ade r va n e en be ha ndeling die ge richt is o p he t stoppe n m e t ro k e n. 68 [Ve rva llen.] 69. A batacept [Ve rva llen.] 70. Ticagrelor Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die is a ange we zen o p he t ge ne e sm idde l in com bina tie m e t a ce tylsalicylzuur bij ee n a cuut coro na ir syndroo m (insta bie le angina pe cto ris, m yo ca rdinfa rct m e t ST-se gm e ntstijging of m yocardinfarct zo nde r ST-se gm entstijging), zo we l bij m e dica m e nte us be hande lde patië nten a ls bij pa tiënte n die e en pe rcutane co ro na ire inte rve ntie o f a rte rië le co rona ire bypa sschirurgie m o ete n o nde rgaa n. 71. Maagzuurremmers in orale toedieningsvorm, inclusief combinatieproducten die een maagzuurremmer bevatten met uitzondering van combinatieproducten met antibiotica bestemd voor bestrijding van Helicobacter Pylori Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde die blijk e ns he t vo o rschrift la nge r dan zes m aa nden o p he t ge ne e sm idde l is a a nge weze n e n vo o r wie he t ge ne e sm idde l is voo rge schre ve n te r be ha nde ling va n e en chro nische aa ndoe ning, te nzij he t be treft e e n vo o r de verze k e rde nie uwe m e dica tie . 72 [Ve rva llen.] 73. Rufinamide Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde va n vier ja a r of o uder die dit m idde l als adjuva ns ge bruik t bij de be hande ling va n he t syndroo m va n Lenno x -Gasta ut na het fa le n va n la m otrigine , to pim a ra at e n benzodia ze pine n en voo r wie fe lbam a a t he t e nige re ste re nde a lte rna tie f is. 74. Everolimus, sirolimus Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde m e t laa g to t m a tig im m uno lo gisch risico die e en a llo ge ne stam ce l o f orga a ntra nspla nta tie he e ft o nde rga an e n die dit m idde l k rijgt vo o rgeschre ve n vo o r de pro fyla x e van a fsto ting (GVHD). 75 [Ve rva llen.] 76. Fingolimod Vo orwa a rde : voo r e e n ve rze k erde va n a chttie n jaa r o f o ude r: a.

m e t ze e r actie ve re la psing-re m itting m ultiple sclero se, die in he t vo o rafga a nde jaa r tijde ns be hande ling m inim a a l éé n schub hee ft do orge m aa k t e n bij wie o p e e n cra nia le MR I m inim aa l é én do or ga dolinium a ange k le urde la esie o f m inim a al ne ge n T2hype rinte nse la esies a anto o nba a r zijn, die : 1°.

niet he e ft ge re a ge e rd op e e n be hande ling m e t interfe ro n bè ta en gla tira m e er, o f

2°.

niet he e ft ge re a ge e rd op e e n a de qua te be ha nde ling m et inte rfero n bèta of glatira m ee r van m inim a al 1 jaa r e n wa a rbij he t starte n m et o f co ntinue re n va n he t a nde re ee rstelijns m idde l nie t m o ge lijk is va nwege de vo lge nde zwa a rwege nde co ntra indica tie s:

voo r interfe ro n bè ta : –

o ve rge vo e ligheid vo o r inte rfe ro n bè ta of hum aa n a lbum ine , o f

–

e rnstige de pressie e n/of ze lfm o o rdne iging, of

voo r glatira m ee r:

b.

–

o ve rge vo e ligheid vo o r gla tira m e e r o f m a nnito l, o f

–

pa tië nte n die na la ngdurig ge bruik va n inte rfe ron bè ta de inje ctie s niet m e e r ve rdrage n va nwe ge lo k a le re a cties o p de inje ctie pla a ts, o f

die is be ha nde ld m e t nata lizum ab vanwe ge zee r a ctie ve re la psing-re m itting m ultiple scle ro se e n bij wie de be hande ling m e t na talizum a b wo rdt ge staa k t va nwege e en po sitieve test o p JC-virus.

77. Saxagliptine: Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde m e t dia be tes m ellitus type 2 die nie t be ha ndeld k an wo rde n m et de co m bina tie van m e tform ine e n e en sulfo nylureum derivaa t, ge en insuline gebruik t e n dit m idde l gebruik t a ls e e n twe e vo udige o f drie vo udige beha nde ling in co m binatie m et m e tform ine e n/o f e en sulfo nylureum derivaa t. 78. Tafamidis Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde va n a chttie n ja a r of o uder m e t a ange too nde tra nsthyretine am ylo ïdose en stadium 1 sym ptom a tische po lyneuro pathie die gee n leve rtranspla ntatie hee ft o nde rga an. 79. Boceprevir, telaprevir Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde va n a chttie n ja a r of o uder m e t chro nische he patitis C virusinfe ctie geno type 1 m e t ge co m pe nse e rde le ve rzie k te die nie t e erde r is be ha ndeld o f bij wie e e rde re beha nde ling m e t pe ginte rfe ro n e n riba virine he e ft gefa a ld e n die dit m iddel ge bruik t in co m bina tie m e t peginterfe ro n alfa e n riba virine . 80 [Ve rva llen.] 81. Pasireotide Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde m e t de ziek te va n C ushing voo r wie e e n ope ra tie niet m o gelijk is of bij wie e en o pera tie nie t is ge sla agd. 82 [Ve rva llen.] 83. Teriparatide Vo orwa a rde : uitsluite nd vo o r de be ha ndeling va n e rnstige oste opo ro se , gedure nde e en pe rio de va n m a x im a a l vie rentwintig m aa nden, voo r a.

b.

e e n ve rze k erde postm eno pauzale vro uw die 1°.

o nda nk s be ha ndeling m e t bisfo sfo nate n, ra lo x ifee n, baze do x ifen o f stro ntium ra nela a t na twe e we rve lfra cturen o pnie uw é é n o f m ee r fra cture n he e ft ge k re ge n, o f

2°.

bisfo sfo na ten, ra lox ife en, ba ze dox ife n e n stro ntium ra nela a t nie t k an ge bruik en, o f

e e n ve rze k erde m an m e t ve rhoo gd risico op bo tbre uk en die: 1°.

o nda nk s be ha ndeling m e t bisfo sfo nate n o f stro ntium ra ne la at na twee we rve lfracture n o pnie uw é é n o f m e er fra cture n he e ft ge k re ge n, o f

2°.

bisfo sfo na ten e n stro ntium ra ne la at nie t k a n gebruik e n.

84. Fidaxomicine Vo orwa a rde :

uitsluite nd vo o r ee n ve rzek e rde va n a chttie n ja a r of o uder m e t C lostridium difficile-ge a sso ciee rde dia rre e bij wie de ziek te na to e passing van m e tronidazo l re cidive e rt en die e rnstig zie k is. 84. Lixisenatide Vo orwa a rde : uitsluite nd vo o r ee n ve rzek e rde m e t dia be tes m ellitus type 2 en e e n BMI ≥35 k g/m 2, bij wie de blo e dgluco se wa arde n onvoldo ende k unne n wo rde n ge re gule erd m e t de co m bina tie va n m e tfo rm ine en e e n sulfo nylure um de riva at in de m a x im a a l ve rdra a gba re dose ringe n e n die gee n insuline ge bruik t. Bijlage 3. van de Regeling zorgverzekering Bijla ge, ho re nde bij a rtik e l 2.23, e e rste lid, o nde rde el a , va n de R e ge ling zo rgve rze k e ring 1 [Ve rva llen.] 2 [Ve rva llen.] 3 [Ve rva llen.] 4 [Ve rva llen.] 5 [Ve rva llen.] 6 [Ve rva llen.] 7. Verbandschoenen Zo rginhoude lijk e crite ria vo o r ve rbandscho e nen zijn: Huidde fe cte n, huidulce ra , se nsibilite its- e n circula tie sto o rnisse n aa n de vo et, a lsm e de in de he rste lperio de na partië le a m puta tie s, tra um a tische be scha diginge n o f ope ra tie ve ingrepe n aa n de vo et. 8 [Ve rva llen.] 9 [Ve rva llen.] 10 [Ve rva llen.] 11 [Ve rva llen.] 12 [Ve rva llen.] Bijlage 4. van de Regeling zorgverzekering Bijla ge be hore nd bij a rtik e l 6.3.1 va n de R e ge ling zo rgve rze k e ring He t in artik e l 6.3.1, ee rste lid, be do elde ve rhoudingsge ta l vo o r he t ja ar 2013, de gem idde lde uitgave n vo or zo rg in het wo o nla nd e n de

be re k e nd, zijn in o nde rsta a nde ta bel o pge no m e n in re spe ctie ve lijk de k o lo m Woonlandfactor, de k o lom Gemiddelde zorgkosten woonland en de k olo m Gemiddelde zorgkosten Nederland e n luide n a ls vo lgt: Land Be lgië

Be rek e ningsja a r Ge m idde lde zo rgk oste n wo o nla nd Ge m idde lde zo rgk oste n Ne derla nd ¹ W o onla ndfa cto r 2009 2.205,28 3.262,21 0,6760

Bo snië-Herze go vina 2010

202,28

3.418,65

0,0592

Bulga rije

2009

136,59

3.262,21

0,0419

C yprus De nem a rk en

2009 2009

554,65 2.322,16

3.262,21 3.262,21

0,1700 0,7118

Duitsla nd

2010

2.419,40

3.418,65

0,7077

Estla nd

2009

506,70

3.262,21

0,1553

Finla nd Frank rijk

2010 2010

1.974,52 2.475,61

3.418,65 3.418,65

0,5776 0,7241

Grie k e nland

2010

1.453,93

3.418,65

0,4253

Ho nga rije

2009

398,91

3.262,21

0,1223

Ie rla nd IJsla nd

2004 2010

2.747,78 2.560,32

2.700,19 3.418,65

1,0176 0,7489

Ita lië

2010

1.841,29

3.418,65

0,5386

Ka apverdië

2009

87,51

3.262,21

0,0268

Kro atië Letla nd

2010 2008

625,87 336,56

3.418,65 3.099,98

0,1831 0,1086

Lie chte nste in

2010

2.493,76

3.418,65

0,7295

Lito uwen

2009

362,87

3.262,21

0,1112

Lux e m burg Ma ce do nië

2010 2010

2.593,12 152,21

3.418,65 3.418,65

0,7585 0,0445

Ma lta

2007

629,21

2.890,21

0,2177

Ma ro k k o

2002

30,56

2.448,29

0,0125

Mo nte ne gro No orwe gen

2008 2010

241,11 4.330,23

3.099,98 3.418,65

0,0778 1,2666

O o stenrijk

2010

2.064,40

3.418,65

0,6039

P o le n

2009

355,39

3.262,21

0,1089

P o rtuga l R o e m e nië

2009 2005

1.037,30 128,34

3.262,21 2.939,58

0,3180 0,0437

Se rvië

2010

243,85

3.418,65

0,0713

Slove nië

2010

986,46

3.418,65

0,2886

Slowa k ije Spanje

2010 2010

654,54 1.382,09

3.418,65 3.418,65

0,1915 0,4043

Tsje chië

2010

817,76

3.418,65

0,2392

Tune sië

2006

62,02

2.874,25

0,0216

Turk ije 2007 Ve renigd Ko nink rijk 2009

246,17 1.961,54

2.890,21 3.262,21

0,0852 0,6013

Zwede n

2009

2.233,13

3.262,21

0,6845

Zwitse rla nd

2010

1.940,80

3.418,65

0,5677

1

De ge m iddelde zo rgk o sten van Ne de rla nd k o m e n te lk e ns o ve re e n m e t het ja a r wa a rvo o r de ge m idde lde zo rgk oste n va n he t woo nland zijn bere k e nd. Bronvermelding gegevens (voor het genoemde berekeningsjaar): Be lgië

No ta re k e ncom m issie EU – A.C .171/11 – 31-03-2011

Bo snië-Herze go vina Info Ha uptverba nd de r Ö sterre ichische n So zia lve rsiche rungsträ ge r – 21-09-2012 Bulga rije

No ta re k e ncom m issie EU – A.C . 196/12 – 12-04-2012

C yprus

No ta re k e ncom m issie EU – A.C .581/11 – 14-10-2011

Duitsla nd

No ta re k e ncom m issie EU – A.C . 592/11 – 24-10-2011

Estla nd

No ta re k e ncom m issie EU – A.C . 389/10 – 29-10-2010

Finla nd

No ta re k e ncom m issie EU – A.C . 221/12 – 20-04-2012

Frank rijk

No ta re k e ncom m issie EU – A.C . 402/12 – 28-09-2012

Grie k e nland

No ta re k e ncom m issie EU – A.C . 403/12 – 02-10-2012

Ho nga rije

No ta re k e ncom m issie EU – A.C . 388/10 – 29-10-2010

Ie rla nd

No ta re k e ncom m issie EU – C A.SS.TM. 397/08 – 01-10-2008

IJsla nd

http://www.sta tice .is/Sta tistics/Hea lth,-so cia l-a ffairs-a nd-justi/So cia l-pro te ctio n-ex pe nditure

Ita lië

No ta re k e ncom m issie EU – A.C . 251/11R EV2 – 10-05-2011

Ka apverdië

Info Instituto Na cio nal de Pre vidê ncia So cia l – 28 se ptem be r 2011

Kro atië

Brief C ro a tian Instute fo r He alth Insura nde in Za gre b – 9 m ei 2011

Letla nd

No ta re k e ncom m issie EU – A.C . 393/10 – 02-11-2010

Lie chte nste in

No ta re k e ncom m issie EU – A.C . 595/11 – 12-10-2011

Lito uwen

No ta re k e ncom m issie EU – A.C . 033/11 – 19-01-2011

Lux e m burg

No ta re k e ncom m issie EU – A.C . 331/12 – 31-07-2012

Ma ce do nië

Brief Fo nd Za Zdra ve stve no O siguruvanje Na Ma k e do nija , Sk opje – 11-05-2011

Ma lta

No ta re k e ncom m issie EU – A.C . 499/11R EV3 – 30-11-2011

Ma ro k k o

R a ppo rt R o ya um e de Ma ro c 'C NSS' – 30 decem be r 2005

Mo nte ne gro

Brief Fo nd Za Zdra ve stve no O siguruvanje , Po dgorica – 03-10-2011

No orwe gen

No ta re k e ncom m issie EU – A.C . 652/11 – 24-11-2011

O o stenrijk

No ta re k e ncom m issie EU – A.C . 556/11 – 03-10-2011

P o le n

No ta re k e ncom m issie EU – A.C . 684/11 – 28-12-2011

P o rtuga l

No ta re k e ncom m issie EU – A.C . 680/11 – 29-12-2011

R o e m e nië

Na tio na l Ho use o f He alth Insura nce – 22-10-2007

Se rvië

Brief R e public Fund Fo r He a lth Insura nce o f Se rbia, Be o gra d – 08-12-2011

Slove nië

No ta re k e ncom m issie EU – A.C . 557/11R EV2 – 06-10-2011

Slowa k ije

No ta re k e ncom m issie EU – A.C . 212/12 – 09-03-2012

Spanje

No ta re k e ncom m issie EU – A.C . 588/11R EV – 08-11-2011

Tsje chië

No ta re k e ncom m issie EU – A.C . 582/11 – 14-10-2011

Tune sië

C a isse Na tiona le de Securite Socia le – 05-04-2011

Turk ije

Brief Dire cto ra te o f So cial Se curity Institution 'SGK' – 29-04-2010

Ve renigd Ko nink rijk

No ta re k e ncom m issie EU – A.C . 591/11 – 19-10-2011

Zwede n

No ta re k e ncom m issie EU – A.C . 209/11 – 18-04-2011

Zwitse rla nd

No ta re k e ncom m issie EU – A.C . 448/11 – 02-09-2011

Bijlage 5. behorende bij artikel 8.3, eerste lid van de Regeling zorgverzekering, geldend voor de terhandstelling van geneesmiddelen in de kalenderjaren 2011 en 2012 voor de uitkering, bedoeld in artikel 118a, eerste lid, van de wet die betrekking heeft op het kalenderjaar 2013 C ER grp

ATC-co de (in 2012)

stofna a m / om schrijving ATC -co de

Eenhe id in 2012, pe r to e die ningswe g / o pm e rk inge n

O

o ra al

O (ae r)

o ra al a e roso l

P

pa rente ra al

P (de pot)

pa rente ra al de po t

R

re cta a l

INH

inha la tie

INH (a e r)

inha la tie a e roso l

INH (pdr)

inha la tie po ede r

INH (o pl)

inha la tie o plo ssing

SL

sublingua al

OCU

o culair VS

re ce ptrege l

mcg

Micro gra m

mg

Milligra m

g

Gra m

ml

Millilite r

IE

interna tiona le e e nhe id

miljE

m iljo e n inte rna tio na le e e nhe den

do

Do sis

tabl caps

Ta ble t ca psule

R

INH (a e r)

INH (pdr) INH (o pl)

0,8 m g 0,8 m g

0,8 m g 0,8 m g

1,5 m g 1,5 m g 80 m g

Tabel 1

A andoeningen van hersenen en ruggemerg

O

P

NMA

M03BX01

BAC LO FEN

50 m g

0,55 mg

NMA NMA

L04AA27 L03AX13

FINGO LIMID GLATIR AMEER

0,5 m g

NMA

L03AB07

INTER FER O N BETA-1A

NMA

L03AB08

INTER FER O N BETA-1B

NMA NMA

N07XX02 N07XX08

R ILUZO L TAFAMIDIS

0,1 g 20 m g

NMA

M03BX02

TIZANIDINE

12 m g

Tabel 2

A stma / COPD

O

CA R CA R

R 03BA01 R 03BA02

BEC LO METASO N BUDESO NIDE

CA R

R 03BA08

C IC LESO NIDE

0,16 m g

CA R

R 03BC 01

C R O MO GLIC INEZUUR

40 m g

80 m g

CA R

R 03AK03

6 do

3 patro o n

CA R

R 03BA05

FENO TER O L m e t ande re ASTMA/C O P Dm idde len FLUTIC ASO N

0,6 m g

0,6 m g

CA R

R 03AC 13

FO R MO TER O L

24 m cg

24 m cg

CA R

R 03AK07

FO R MO TER O L m e t a nde re ASTMA/C O P Dm idde len

4 do

24 m cg

CA R CA R

R 03AC 18 R 03BB01

INDAC ATER O L IP R ATR O P IUM

150 m cg 0,12 m g 0,12 m g

CA R

R 03DC 03

MO NTELUKAST

CA R

R 03BC 03

NEDO C R O MIL

8 mg

CA R CA R

R 03AC 02 R 03C C 02

SALBUTAMO L SALBUTAMO L

0,8 m g

CA R

R 03AK04

SALBUTAMO L m e t a nde re ASTMA/C O P Dm idde len

6 do

CA R

R 03AC 12

SALMETER O L

0,1 m g

0,1 m g

CA R

R 03AK06

SALMETER O L m et a ndere ASTMA/C O P Dm idde len

4 do

2 do

CA R

R 03AC 03

TER BUTALINE

2 mg

2 mg

20 m g

CA R

R 03DA04

THEO FYLLINE

CA R

R 03BB04

TIO TR O P IUM

18 m cg

5 m cg

Tabel 3

Cystic fibrosis / pancreas

CFP

R 05C B13

DO R NASE ALFA

CFP

A09AA02

MULTI-ENZYMEN

20 m g 4,3 m cg 4 m iljE

P

1,5 m g

0,3 m g

10 m g

12 m g

0,4 g O

0,4 g

10 m g 7,5 m l

0,4 g INH (o pl) 2,5 m g

4-6 ta bl/caps

0,8 m g

12 m g

Tabel 4

Diabetes, type I en type II

O

DIA

A10BF01

AC AR BO SE

0,3 g

P

DIA

A10BX04

EXENATIDE

DIA

A10BB01

GLIBENC LAMIDE

10 m g

DIA

A10BB09

GLIC LAZIDE

60 m g

DIA

A10BB12

GLIMEPIR IDE

2 mg

DIA

A10BD04

GLIMEPIR IDE m e t R O SIGLITAZO N

1 ta bl

DIA

A10AB01

INSULINE (hum a a n)

40 IE

DIA

A10AC 01

INSULINE (hum a a n)

40 IE

DIA DIA

A10AD01 A10AB05

INSULINE (hum a a n) INSULINE, ASP AR T

40 IE 40 IE

DIA

A10AD05

INSULINE, ASP AR T

40 IE

DIA

A10AE05

INSULINE, DETEMIR

40 IE

DIA DIA

A10AE04 A10AB06

INSULINE, GLAR GINE INSULINE, GLULISINE

40 IE 40 IE

DIA

A10AB04

INSULINE, LISP R O

40 IE

DIA

A10AD04

INSULINE, LISP R O

DIA DIA

A10BH05 A10BX07

LINAGLIP TINE LIR AGLUTIDE

5 mg

DIA

A10BA02

METFO R MINE

2 g

DIA

A10BD11

METFO R MINE m e t LINAGLIPTINE

2 ta bl

DIA DIA

A10BD05 A10BD03

METFO R MINE m e t PIO GLITAZO N METFO R MINE m e t R O SIGLITAZO N

2 ta bl 2 ta bl

DIA

A10BD07

METFO R MINE m e t SITAGLIP TINE

2 ta bl

DIA

A10BD02

METFO R MINE m e t SULFO NYLUR EUMDER IVATEN

2 ta bl

DIA DIA

A10BD08 A10BG03

METFO R MINE m e t VILDAGLIPTINE P IO GLITAZO N

2 ta bl 30 m g

DIA

A10BX02

R EPAGLINIDE

4 mg

DIA

A10BG02

R O SIGLITAZO N

6 mg

DIA DIA

A10BH03 A10BH01

SAXAGLIP TINE SITAGLIP TINE

5 mg 0,1 g

DIA

A10BB03

TO LBUTAMIDE

1,5 g

DIA

A10BH02

VILDAGLIP TINE

0,1 g

EPI

Tabel 5 N03AF01

Epilepsie C AR BAMAZEPINE

O 1 g

EPI

N03AD01

ETHO SUXIMIDE

1,25 g

EPI

N03AX10

FELBAMAAT

2,4 g

EPI EPI

N03AA02 N03AB02

FENO BAR BITAL FENYTO INE

0,1 g 0,3 g

0,1 g 0,3 g

EPI

N03AX18

LAC O SAMIDE

0,3 g

0,3 g

EPI

N03AX09

LAMO TR IGINE

0,3 g

EPI EPI

N03AX14 N03AF02

LEVETIR AC ETAM O XC AR BAZEPINE

1,5 g 1 g

EPI

N03AA03

P R IMIDO N

1,25 g

EPI

N03AX21

R ETIGABINE

0,9 g

EPI

N03AF03

R UFINAMIDE

1,4 g

EPI

N03AX17

STIR IP ENTO L

1 g

EPI

N03AX03

SULTIAM

0,4 g

EPI

N03AX11

TO P IR AMAAT

0,3 g

EPI

N03AG01

VALP R O INEZUUR

1,5 g

EPI

N03AG04

VIGABATR INE

2 g

EPI

N03AX15

ZO NISAMIDE

0,2 g

15 m cg

40 IE 1,2 m g

P

R 1 g

1,5 g

1,5 g

1,5 g

GLA

S01EC 01

AC ETAZO LAMIDE

GLA

S01EA03

AP R AC LO NIDINE

0,75 g

0,75 g 0,3 m l

GLA

S01ED02

BETAXO LO L

0,2 m l

GLA

S01EE03

BIMATO P R O ST

0,1 m l

GLA

S01EA05

BR IMO NIDINE

0,2 m l

GLA

S01EC 04

BR INZO LAMIDE

0,2 m l

GLA

S01ED05

C AR TEO LO L

0,2 m l

GLA

S01EA02

DIP IVEFR INE

0,2 m l

GLA GLA

S01EC 03 S01EE01

DO R ZO LAMIDE LATANO P R O ST

0,3 m l 0,1 m l

GLA

S01ED03

LEVO BUNO LO L

0,2 m l

GLA

S01ED04

METIP R ANO LO L

GLA GLA

S01ED54 S01EB01

METIP R ANO LO L, C O MBINATIES P ILO C AR PINE

GLA

S01EE05

TAFLUPR O ST

GLA

S01ED01

TIMO LO L

GLA GLA

S01ED51 S01EE04

TIMO LO L, C O MBINATIES TR AVO PR O ST

0,2 m l 0,3 m l 0,4 m l o f 40 m g 0,3 m l 0,2 m l 0,2 m l o f 0,1 m l 0,1 m l

Tabel 7

Groeihormonen

P

GRO

H01AC 03

MEC ASER MINE

2 IE

GRO

H01AC 01 Tabel 8

SO MATR O P INE Hartaandoeningen

O

HA R

C 01BD01

AMIO DAR O N

0,2 g

0,2 g

HA R

C 03C A02

BUMETANIDE

1 mg

1 mg

HA R HA R

C 01AA05 C 01BA03

DIGO XINE DISO P YR AMIDE

0,25 m g 0,4 g

0,25 m g 0,4 g

HA R

C 01C E03

ENO XIMO N

HA R

C 01BC 04

FLEC AINIDE

0,2 g

0,2 g

HA R HA R

C 03C A01 C 01C A16

FUR O SEMIDE IBO P AMINE

40 m g 0,3 g

40 m g

HA R

C 01EB03

INDO METAC INE

HA R

C 01C A02

ISO P R ENALINE

90 m g

90 m g

HA R HA R

C 01DA08 C 01DA14

ISO SO R BIDE DINITR AAT ISO SO R BIDE MO NO NITR AAT

60 m g 40 m g

HA R

C 01EB17

IVABR ADINE

10 m g

HA R

C 01BA01

KINIDINE

1,2 g

HA R HA R

C 01BB01 C 01C E02

LIDO C AINE MILR INO N

HA R

C 01DX16

NIC O R ANDIL

40 m g

HA R

C 01DA02

NITR O GLYC ER INE

5 mg

HA R

C 01BC 03 Tabel 9

P R O P AFENO N HIV / A IDS

0,3 g O

HIV

J05AF06

ABAC AVIR

0,6 g

HIV

J05AE08

ATAZANAVIR

0,3 g

HIV

J05AE10

DAR UNAVIR

1,2 g

HIV

J05AF02

DIDANO SINE

0,4 g

HIV

J05AG03

EFAVIR ENZ

0,6 g

HIV

J05AF09

EMTR IC ITABINE

0,2 g

HIV

J05AR 06

EMTR IC ITABINE m et TENO FO VIR m e t EFAVIR ENZ

1 ta bl

HIV

J05AR 08

EMTR IC ITABINE m et TENO FO VIR m e t R ILP IVIR INE

1 ta bl

2 mg O (ae r) P

SL

TD

20 m g

0,1 g

2,5 m g

5 mg

1 g

1 mg 20 m g

10 m g

3 g 50 m g 2,5 m g 10 m g 0,3 g P

HIV

J05AG04

ETR AVIR INE

0,4 g

HIV

J05AE07

FO SAMPR ENAVIR

1,4 g

HIV

J05AD01

FO SC AR NET

HIV

J05AB06

GANC IC LO VIR

HIV

J05AE02

INDINAVIR

2,4 g

HIV

J05AF05

LAMIVUDINE

0,3 g

HIV

J05AR 02

LAMIVUDINE m e t ABAC AVIR

1 ta bl

HIV

J05AE06

LO P INAVIR

0,8 g

HIV

J05AX09

MAR AVIR O C

0,6 g

HIV HIV

J05AE04 J05AG01

NELFINAVIR NEVIR AP INE

2,25 g 0,4 g

HIV

J05AX08

R ALTEGR AVIR

0,8 g

HIV

J05AG05

R ILP IVIR INE

25 m g

HIV HIV

J05AE03 J05AE01

R ITO NAVIR SAQ UINAVIR

1,2 g 1,8 g

HIV

J05AF04

STAVUDINE

80 m g

HIV

J05AF07

TENO FO VIR DISO P R O XIL

0,245 g

HIV HIV

J05AR 03 J05AE09

TENO FO VIR DISO P R O XIL m et EMTR IC ITABINE TIP R ANAVIR

1 ta bl 1 g

HIV

J05AB14

VALGANC IC LO VIR

0,9 g

HIV

J05AF01

ZIDO VUDINE

0,6 g

HIV HIV

J05AR 01 J05AR 04

ZIDO VUDINE m e t LAMIVUDINE ZIDO VUDINE m e t LAMIVUDINE m e t ABAC AVIR

2 ta bl 2 ta bl O

6,5 g 3 g

0,5 g

0,6 g

Tabel 10

Kanker

KA N

L03AC 01

ALDESLEUKINE

P

KA N KA N

L01XX01 L01XX25

AMSAC R INE BEXAR O TEEN

KA N

L01DC 01

BLEO MYC INE

1 VS

1 VS

KA N

L01AB01

BUSULFAN

1 VS

1 VS

KA N KA N

L01BC 06 L01AA02

C AP EC ITABINE C HLO O R AMBUC IL

1 VS 1 VS

1 VS 1 VS

KA N

L01XA01

C ISP LATINE

1 VS

1 VS

KA N

L01AA01

C YC LO FO SFAMIDE

1 VS

1 VS

KA N KA N

L01BC 01 L01AX04

C YTAR ABINE DAC AR BAZINE

1 VS 1 VS

1 VS 1 VS

KA N

L01DA01

DAC TINO MYC INE

1 VS

1 VS

KA N

L01XE06

DASATINIB

1 VS

1 VS

KA N KA N

L01DB02 L01DB03

DAUNO R UBIC INE EPIR UBIC INE

1 VS 1 VS

1 VS 1 VS

KA N

L01XE03

ER LO TINIB

1 VS

1 VS

KA N

L01XX11

ESTR AMUSTINE

1 VS

1 VS

KA N KA N

L01C B01 L01XE10

ETO PO SIDE EVER O LIMUS

1 VS 1 VS

1 VS 1 VS

KA N

L03AA02

FILGR ASTIM

KA N

L01BB05

FLUDAR ABINE

1 VS

1 VS

KA N

L01BC 02

FLUO R O UR AC IL

1 VS

1 VS

KA N

L01XE02

GEFITINIB

1 VS

1 VS

KA N

L01XX05

HYDR O XYC AR BAMIDE

1 VS

1 VS

KA N

L01DB06

IDAR UBIC INE

1 VS

1 VS

KA N

L01XE01

IMATINIB

1 VS

1 VS

KA N

L01XE07

LAP ATINIB

1 VS

1 VS

0,2 m g 1 VS 1 VS

1 VS 1 VS

0,35 mg

KA N

L04AX04

LENALIDO MIDE

KA N

L03AA10

LENO GR ASTIM

10 m g

KA N

L01AD02

LO MUSTINE

1 VS

KA N

L01AA03

MELFALAN

1 VS

1 VS

KA N

L01BB02

MER C APTO P UR INE

1 VS

1 VS

KA N

L01DC 03

MITO MYC INE

1 VS

1 VS

KA N

L01XX23

MITO TAAN

1 VS

1 VS

KA N

L01DB07

MITO XANTR O N

1 VS

1 VS

KA N

L01XE08

NILO TINIB

1 VS

1 VS

KA N

L01XE11

P AZO PANIB

1 VS

1 VS

KA N KA N

L03AA13 L01XB01

P EGFILGR ASTIM P R O C AR BAZINE

1 VS

0,3 m g 1 VS

KA N

L01XE05

SO R AFENIB

1 VS

1 VS

KA N

L01XE04

SUNITINIB

1 VS

1 VS

KA N KA N

L01BC 53 L01AX03

TEGAFUR , C O MBINATIES TEMO ZO LO MIDE

1 VS 1 VS

1 VS 1 VS

KA N

L01C B02

TENIP O SIDE

1 VS

1 VS

KA N

L01AC 01

THIO TEPA

1 VS

1 VS

KA N KA N

L01BB03 L01XX17

TIO GUANINE TO P O TEC AN

1 VS 1 VS

1 VS 1 VS

KA N

L01XX14

TR ETINO INE

1 VS

1 VS

KA N

L01C A01

VINBLASTINE

1 VS

1 VS

KA N

L01C A02 Tabel 11

VINC R ISTINE Nieraandoeningen

1 VS O

1 VS P

NIE

V03AE04

C ALC IUMAC ETAAT & MAGNESIUMC AR BO NAAT

6 ta bl

NIE

B03XA02

DAR BEP O ETINE ALFA

4,5 m cg

NIE

B03XA01

EPO ETINE

1000 IE

NIE

V03AE03

LANTHAANC AR BO NAAT

NIE

B03XA03

METHO XYP O LYETHYLEENGLYC O L EP O ETINE BETA

NIE

V03AE01

P O LYSTYR EENSULFO NZUUR

45 m g

NIE

V03AE02 Tabel 12

SEVELAMER Ziekte van Parkinson

6,4 g O

PA R

N04BB01

AMANTADINE

0,2 g

PA R

N04BC 07

AP O MO R FINE

PA R PA R

N04BC 01 N04BX02

BR O MO C R IP TINE ENTAC APO N

40 m g 1 g

PA R

N04BA03

LEVO DO P A m et DEC AR BO XYLASE- e n C O MTR EMMER

0,45 g

PA R

N04BA02

LEVO DO P A m et DEC AR BO XYLASER EMMER

0,6 g

PA R PA R

N04BC 02 N04BC 05

P ER GO LIDE P R AMIP EXO L

3 mg 2,5 m g

PA R

N04BD02

R ASAGILINE

1 mg

PA R

N04BC 04

R O P INIR O L

6 mg

PA R

N04BC 09

R O TIGO TINE

PA R

N04BD01

SELEGILINE

5 mg

PA R

N04BX01

TO LC AP O N

0,45 g

Tabel 13

Psychische aandoeningen

O

GGZ

N07BB03

AC AMP R O SAAT

2 g

GGZ

N06AX22

AGO MELATINE

25 m g

0,35 mg 1 VS

2,25 g 4 m cg

P

TD

20 m g

6 mg

P

P (de pot)

R

TD

SL

GGZ

N06AA09

AMITR IP TYLINE

75 m g

75 m g

GGZ

N05AX12

AR IP IP R AZO L

15 m g

15 m g

GGZ

N06BA09

ATO MO XETINE

80 m g

GGZ

N05AD06

BR O O MPER IDO L

10 m g

GGZ

N07BC 01

BUP R ENO R FINE

8 mg

GGZ

N07BC 51

BUP R ENO R FINE, C O MBINATIES

8 mg

GGZ

N06AX12

BUP R O P IO N

0,3 g

GGZ

N05BE01

BUSPIR O N

30 m g

GGZ

N05AA01

C HLO O R P R O MAZINE

0,3 g

0,1 g

GGZ

N05AF03

C HLO O R P R O TIXEEN

0,3 g

50 m g

GGZ GGZ

N05C C 01 N06AB04

C HLO R ALHYDR AAT C ITALO PR AM

1 g 20 m g

20 m g

GGZ

N06AA04

C LO MIP R AMINE

0,1 g

0,1 g

GGZ

N05AH02

C LO ZAP INE

0,3 g

0,3 g

GGZ GGZ

N07BB01 N06AA16

DISULFIR AM DO SULEP INE

0,2 g 0,15 g

GGZ

N06AA12

DO XEPINE

0,1 g

GGZ

N06AX21

DULO XETINE

60 m g

GGZ GGZ

N06AB10 N06AF03

ESC ITALO P R AM FENELZINE

10 m g 60 m g

GGZ

N05AB02

FLUFENAZINE

10 m g

GGZ

N06AB03

FLUO XETINE

20 m g

GGZ GGZ

N05AF01 N05AG01

FLUP ENTIXO L FLUSP IR ILEEN

6 mg

GGZ

N06AB08

FLUVO XAMINE

0,1 g

GGZ

N06DA04

GALANTAMINE

16 m g

GGZ GGZ

N05AD01 N05BB01

HALO PER IDO L HYDR O XYZINE

8 mg 75 m g

8 mg 75 m g

GGZ

N06AA02

IMIP R AMINE

0,1 g

0,1 g

GGZ

N05AN01

LITHIUM

24 m m o l

GGZ GGZ

N06AA21 N06DX01

MAP R O TILINE MEMANTINE

0,1 g 20 m g

0,1 g

GGZ

N07BC 02

METHADO N

25 m g

25 m g

GGZ

N06BA04

METHYLFENIDAAT

30 m g

GGZ GGZ

N06AX03 N06AX11

MIANSER INE MIR TAZAPINE

60 m g 30 m g

GGZ

N06AG02

MO C LO BEMIDE

0,3 g

GGZ

N07BB04

NALTR EXO N

50 m g

GGZ GGZ

N06AA10 N05AH03

NO R TR IP TYLINE O LANZAP INE

75 m g 10 m g

GGZ

N06AX01

O XITR IP TAN

50 m g

GGZ

N05AX13

P ALIP ER IDO N

6 mg

GGZ GGZ

N06AB05 N05AG03

P AR O XETINE P ENFLUR IDO L

20 m g 6 mg

GGZ

N05AB03

P ER FENAZINE

30 m g

10 m g

GGZ

N05AC 01

P ER IC IAZINE

50 m g

20 m g

GGZ

N05AG02

P IMO ZIDE

4 mg

GGZ

N05AD05

P IP AMP ER O N

0,2 g

GGZ

N05AH04

Q UETIAPINE

0,4 g

GGZ

N05AX08

R ISP ER IDO N

5 mg

GGZ

N06DA03

R IVASTIGMINE

9 mg

GGZ

N05AE03

SER TINDO L

16 m g

10 m g

3,3 m g

exclusief (genees)middelen bij stoppen met roken 0,3 g 1 g

0,1 g

1 mg 4 mg 0,7 m g

30 m g 10 m g

3,3 m g

10 m g 2,5 m g

7 mg

16 m g

2,7 m g 9,5 m g

GGZ

N05AL01

SULP IR IDE

0,8 g

GGZ

N06AF04

TR ANYLC YP R O MINE

10 m g

0,8 g

GGZ

N06AX05

TR AZO DO N

0,3 g

GGZ

N06AX16

VENLAFAXINE

0,1 g

GGZ

N05AF05

ZUC LO PENTIXO L

30 m g

30 m g

15 m g

Tabel 14

Reuma

O

P

R

REU

M01C B01

AUR O THIO BAR NSTEENZUUR

REU

P 01BA02

HYDR O XYC HLO R O Q UINE

155 m g

REU

L04AA13

LEFLUNO MIDE

20 m g

REU REU

L01BA01 L04AX03

METHO TR EXAAT METHO TR EXAAT

2,5 m g

REU

M01C C 01

P ENIC ILLAMINE

0,5 g

REU

A07EC 01

SULFASALAZINE

2 g

Schildklieraandoeningen C AR BIMAZO L

O 15 m g

P

THY

Tabel 15 H03BB01

THY

H03AA01

LEVO THYR O XINE

0,15 m g

0,15 mg

THY

H03AA02

LIO THYR O NINE

60 m cg

60 m cg

THY THY

H03BA02 H03BB02

P R O P YLTHIO UR AC IL THIAMAZO L

0,1 g 10 m g

2,4 m g 155 mg (base) komt overeen met 200 mg sulfaat 2,5 m g

2 g

Tabel 16

Transplantaties

O

P

TRA

L04AX01

AZATHIO PR INE

0,15 g

0,15 g

TRA TRA

L04AD01 L04AA18

C IC LO SP O R INE EVER O LIMUS

0,25 g 1,5 m g

0,25 g

TRA

L04AA06

MYC O FENO LZUUR

2 g

2 g

TRA

L04AA10

SIR O LIMUS

3 mg

TRA

L04AD02 Tabel 17

TAC R O LIMUS Ziekte van Crohn / colitis ulcerosa

5 mg O

5 mg R

CRO

A07EA04

BETAMETHASO N

CRO

A07EA06

BUDESO NIDE

9 mg

1 ta bl

CRO CRO

A07EC 02 A07EC 03

MESALAZINE O LSALAZINE

1,5 g 1 g

1,5 g

100 m l

Bijlage 6. behorende bij artikel 8.3, vierde en vijfde lid, van de Regeling zorgverzekering Tabel 1, bedoeld in artikel 8.3, vierde lid, voor de indeling in DKG’s in het jaar 2010 voor de uitkering, bedoeld in artikel 118a, eerste lid, van de wet, die betrekking heeft op 2013 Toelichting op de tabel indeling DKG’s Inde ling in nDx gro e pen 173, 174 en 176 is ge ba se e rd o p de in de ta be l ge noe m de DBC -be hande lcode s. Inde ling in nDx gro e p 175 is ge ba see rd o p in de ta be l ge noe m de DBC -dia gno se co de s van a lle DBC ’s (po lik linisch, da go pna m e e n k linisch). Inde ling in de ove rige nDx gro e pe n is ge ba see rd o p de in de ta be l geno e m de DBC -dia gnose co de s va n DBC ’s m e t e e n k linische pe riode . Bij e e n DBC m e t e en k linische pe rio de is het la a tste cijfer va n de DBC -beha nde lco de e e n 3. DKG Specia lism e

nDx gro e p O m schrijving

DBC dia gnose co de (a lle DBC ’s)

1

Klinische ge ria trie

333025

Dia be te s m e llitus zo nde r/m e t nie t gespecifice e rde 222, 251, 272, 312, co m plica tie s + chro nische obstructie ve lo ngziek te n (C O P D) 321, 323 + rhe um a to ïde a rtritis en a a ndo e ningen van bindwe efse l + e pile psie , co nvulsies + chro nisch ulcus va n de huid + o ste o a rtro se

1

Klinische ge ria trie

331093

C e re bro vasculaire a ando eninge n

263

DBC -be ha ndelco de

1

Klinische ge ria trie

331070

De gene ra tie ve ziek te n va n he t ce ntra le zenuwste lse l

252

1

O o ghee lk unde

243021

Ma ligne neo plasm a o o g + m e ninge o om

509, 659, 854

1

O rtho pedie

111050

O ste o-artro se

1201, 1401, 1501, 1601, 1701, 1801, 2001

1

Uro logie

101150

Inwe ndig le tsel van buik

13

1

He e lk unde

91150

Inwe ndig le tsel van bo rst, buik e n be k k en, bra ndwo nde n

274, 275, 279, 284

1

He e lk unde

91092

Afsluiting e n ste no se va n pre ce re bra le arte rië n

402

1

He e lk unde

91036

Ulcus ve ntriculi, -duo de ni, -pe pticum , -ga stro je juna lis

321

1

Ga stro e ntero lo gie

71036

Ulcus ve ntriculi, -duo de ni, -pe pticum , -ga stro je juna lis

402, 403

1

R e um a to logie

53098

106, 399

1

Longzie k ten

41097

Va ata a ndo e ninge n + a cuut gewrichtsre um a, chro nische re um a tische ha rtaa ndoe ninge n Arte rië le , ove rige ve ne uze em bo lie e n tro m bose

1802

1

C a rdio lo gie

31085

Ge leidingssto o rnisse n en ha rt dysritm ieë n

404, 409

1

Inte rne ge ne e sk unde

21097

Em bo lie e n trom bo se

122, 732, 733

1

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21086

Atrium fibrille ren e n 'flutte r'

106

21081

Dre ige nd, acuut e n po st m yo ca rd infa rct

102, 103

1

Inte rne ge ne e sk unde

21036

Ulcus ve ntriculi, -duo de ni, -pe pticum , -ga stro je juna lis

913, 915, 916, 919

2

Klinische ge ria trie

331089

Ziek te n va n de lo ngcircula tie , ha rtde co m pensatie

262

2 2

Ne uro lo gie Ne uro lo gie

211073 211048

Epile psie, convulsie s R he um a to ïde a rtritis en a a ndo e ningen van bindwe efse l

601 0312, 0313

2

He e lk unde

93050

O ste o-artro se + rhe um a to ïde a rtritis e n a a ndo e ninge n va n bindwe efse l

254, 401

2

He e lk unde

91043

Da rm divertik e ls

327

2

71089

C a rdio lo gische a a ndo e ninge n

907

2

Ga stro e ntero lo gie C a rdio lo gie

31097

Ve ne uze e m bo lie e n tro m bo se (incl. longe m bo lie )

602

2

C a rdio lo gie

31086

Atrium fibrille ren e n 'flutte r'

401, 402

2

C a rdio lo gie

31083

O ve rige (sub)a cute vo rm e n va n ischem ische ha rtzie k te n

203

2

C a rdio lo gie

31081

204, 205, 609, 701

2

Inte rne ge ne e sk unde

21049

P o st e n acuut m yo ca rd infa rct, pe rica rditis e n a rterië le vaa ta fsluiting Infe ctie s van bo t

2

Inte rne ge ne e sk unde

21035

Ziek te n va n de o e so fa gus

901, 902, 903, 906, 907, 909

3

Ne uro lo gie

213027

Dia be te s m e t co m plica ties e n he patisch co m a + nietne uro lo gische a a ndo e ninge n

0311, 9919

3

Ne uro lo gie

211093

C e re bro vasculaire a ando eninge n (incl. he m iple gie )

3

Gyna e co logie

151017

Ma ligne neo plasm a pla ce nta /o varium /uterusadne x a

1101, 1102, 1103, 1111, 1121, 1199 M16, M17

3

Gyna e co logie

151016

Ma ligne neo plasm a ute rus/cervix /vro uwe lijk e ge sla chtso rgane n

M11, M12, M13, M14, M15

3

O rtho pedie

111048

(Infe ctie uze ) a rtritide n en o ste o m ye litis

1394, 1402, 1502, 1602, 1702, 1802, 2002

3

He e lk unde

92153

3

He e lk unde

91070

Inta cra nie e l le tsel zonde r sche delfra ctuur en fra ctuur va n de 204, 273 we rve lk o lo m m e t rugge nm e rgletse l De gene ra tie ve ziek te n va n he t ce ntra le zenuwste lse l 296

3

He e lk unde

91037

1

Ma a gaa ndoe ninge n, ove rige a ando eninge n duo de num e n functiesto ornisse n va n de darm

451, 453

340

3

He e lk unde

91032

Ziek te n va n he t pa ncrea s, absorptie sto o rnisse n va n de da rm

337

3

He e lk unde

91021

Ma ligne neo plasm a schildk lie r, huid e n be we gingsa ppa ra a t

303, 350, 352

3

He e lk unde

91013

Ma ligne neo plasm a tra che a , bro nchus, lo ng, pleura , thym us 313, 314 e n m e diastinum (incl. m e ta sta sen)

3

He e lk unde

91011

Ma ligne neo plasm a va n he t co lon (incl. o ve rgang va n sigm o ïd in rectum )

333, 334

3

Ga stro e ntero lo gie

71041

Ente ritis re gio na lis, idio pa thische proctocolitis

601, 602

3

Ga stro e ntero lo gie Ga stro e ntero lo gie

71035

Ziek te n va n de o e so fa gus (incl. le tse l)

71025

Dia be te s m e llitus

301, 302, 303, 304, 306, 308 902

3

Ga stro e ntero lo gie

71011

Ma ligne neo plasm a va n he t co lon/re ctum (incl. m e ta sta sen) 610

3

R e um a to logie

51050

O ste o-artro se

402, 403, 404, 405

3 3

C a rdio lo gie Inte rne ge ne e sk unde

31084 21088

Angina pe cto ris Longa ando eninge n

202 609

3

Inte rne ge ne e sk unde

21077

O ve rige ca rdia le aa ndoe ninge n

104, 119, 432

3

Inte rne ge ne e sk unde

21043

Dive rticulitis

924

3

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21037

O ve rige m aa g- e n da rm a ando eninge n

21025

Dia be te s m e llitus zo nde r co m plica ties/ m e t ove rige co m plica tie s

911, 917, 931, 937, 939 221, 223

4

O rtho pedie

111049

Ase ptische botne cro se e n (infe ctie uze ) a rtritide n en o ste o m ye litis m e t niet ge spe cifice erde lok a lisa tie

1202, 1302, 1404, 1704

4

Uro logie

101018

Ma ligne neo plasm a pro sta a t/te stis/m anne lijk e ge sla chtso rgane n (incl. m e ta sta se n)

40, 50, 60

4 4

He e lk unde Ga stro e ntero lo gie

91096 71037

Aneurysm a va n de a o rta e n o ve rige a neurysm a O ve rige m aa ga ando eninge n e n functie sto o rnisse n co lo n

403, 405, 406, 416 201, 205, 206, 401, 406, 613

4

Ga stro e ntero lo gie

71032

Ziek te n va n he t pa ncrea s, absorptie sto o rnisse n va n de da rm

202, 409, 751, 753

4

Longzie k ten

41110

Astm a

1201

4 4

C a rdio lo gie C a rdio lo gie

31087 31080

Ve ntricula ire ritm esto ornisse n O ve rige vo rm e n va n chro nische ische m ische ha rtaa ndoe ninge n en a rte rië le va a taa ndoe ninge n

403 601

4

Inte rne ge ne e sk unde

21093

C e re bro vasculaire a ando eninge n

121

4

Inte rne ge ne e sk unde

21089

Ziek te n va n de lo ngcircula tie , ha rtde co m pensatie

107, 125

4

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21041

Ente ritis re gio na lis, idio pa thische proctocolitis

922, 923

21034

Aa ndo e ningen van le ve r e n ga lbla a s

412, 941, 942, 945, 959

174

R a dio the rapie

3

3

4 4

R a dio the rapie 0102, R a dio the rapie 0103, R a dio the rapie 0104, R a dio the rapie 0105, R a dio the rapie 0106, R a dio the rapie

0107, R a dio the rapie 0108, R a dio the rapie 0201, R a dio the rapie 0202, R a dio the rapie 0203, R a dio the rapie 0204, R a dio the rapie 0205 5

Ke el-, ne us-, o o rhe e lk unde

233171

Ernstige co ngenita le a fwijk inge n en m a ligne ne o pla sm a tra che a + be nigne ne o pla sm a he rse nen e n ze nuwstelsel

20, 38, 91

5 5

He e lk unde He e lk unde

92007 91097

O ve rige neo plasm a (incl. m e tasta se n) Aa ndo e ningen gro te va ten

306, 348, 359 409, 417

5

He e lk unde

91014

Bo rstk a nk e r

318

5

Inte rne ge ne e sk unde

21105

C hro nische o bstructie ve lo ngzie k te n (C O P D)/a stm a

601

5

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21032

920, 961, 963, 969

21011

Ziek te n va n he t pa ncrea s, absorptie sto o rnisse n va n de da rm Ma ligne neo plasm a colo n/re ctum (incl. m e tasta se n)

173

C he m o the rapie

5 5

927 Inte rne ge ne e sk unde 4101, Inte rne ge ne e sk unde 4102, Inte rne ge ne e sk unde 4103, Inte rne ge ne e sk unde 4201, Inte rne ge ne e sk unde 4202, Inte rne ge ne e sk unde 4203, Inte rne ge ne e sk unde 4301, Inte rne ge ne e sk unde 4302, Inte rne ge ne e sk unde 4303, Inte rne ge ne e sk unde 4401, Inte rne ge ne e sk unde 4402, Inte rne ge ne e sk unde 4403, Inte rne ge ne e sk unde 4501,

Inte rne ge ne e sk unde 4502, Inte rne ge ne e sk unde 4503, Inte rne ge ne e sk unde 4601, Inte rne ge ne e sk unde 4602, Inte rne ge ne e sk unde 4603, Longgene e sk unde 6041, Longgene e sk unde 6042, Longgene e sk unde 6043, Longgene e sk unde 6071, Longgene e sk unde 6072,

6

176

Thuisbe a dem ing

Longgene e sk unde 6073, Longgene e sk unde 6081, Longgene e sk unde 6082, Longgene e sk unde 6083, Longgene e sk unde 6091, Longgene e sk unde 6092, Longgene e sk unde 6093, Ne uro lo gie 251, Ne uro lo gie 252, Ne uro lo gie 253, R e um a to logie 211, R e um a to logie 212, R e um a to logie 213 Longgene e sk unde 3011, Longgene e sk unde 3012, Longgene e sk unde 3013, Longgene e sk unde 3021, Longgene e sk unde 3022, Longgene e sk unde 3023, Longgene e sk unde 3031, Longgene e sk unde 3032, Longgene e sk unde 3033, Ne uro lo gie 321, Ne uro lo gie 322,

6

Ke el-, ne us-, o o rhe e lk unde

232007

O ve rige m aligne ne opla sm a (incl. m e ta sta se n)

42, 84

6

Gyna e co logie

151007

Me ta sta sen

M99

6

Uro logie

102019

Ma ligne neo plasm a bla as/(bij)nie r/o verige urine-o rga ne n (incl. m eta stase n)

10, 20, 30, 70

6

Uro logie

101171

Ernstige co ngenita le a fwijk inge n

19, 29, 39, 79

6

He e lk unde

91095

P e rife re va a tzie k ten o nde rste e x tre m ite it en o ve rige vaa ta a ndo e ningen

408, 412, 418, 419, 420, 449

6

He e lk unde

91049

Infe ctie s van bo t

293

6 6

He e lk unde He e lk unde

91041 91015

Ente ritis re gio na lis, idio pa thische proctocolitis Ma ligne neo plasm a lym fa tisch e n blo e dvo rm end wee fsel

325, 326 353

6

He e lk unde

91012

Ma ligne neo plasm a va n re ctum

335

6

He e lk unde

91010

Ma ligne neo plasm a m a a g/dunne da rm /o ve rige tra ctus dige stivus

330, 331, 349

6

Anesthesiolo gie

83070

043, 063, 073, 110

6

Ga stro e ntero lo gie

71010

De gene ra tie ve ziek te n va n he t ce ntra le zenuwste lse l + pe rife re va a tzie k ten Ma ligne neo plasm a m a a g (ex cl. ca rdia)/dunne da rm /ove rige tra ctus dige stivus

6

Longzie k ten

41048

R he um a to ïde a rtritis en a a ndo e ningen van bindwe efse l

1602, 1603

6

C a rdio lo gie

31089

Ziek te n va n de lo ngcircula tie , ha rtde co m pensatie , e n o ntste k inge n va n de hartspie r

301, 302, 509, 709

6

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21098

124, 599, 934

21096

Va sculitide n, va scula ire da rm zie k te n e n va scula ire a a ndo e ningen van de ex tre m ite ite n Aneurysm a ta e n o ve rige vasculaire a ando eninge n

6

Inte rne ge ne e sk unde

21048

R he um a to ïde a rtritis en a a ndo e ningen van bindwe efse l

501, 506, 515, 521, 522, 524, 525, 526, 722

6

Inte rne ge ne e sk unde

21027

Dia be te s m e t chro nische com plicatie s

222

6

21022

Be nigne ne o pla sm a herse ne n e n ze nuwste lse l

242, 243

7

Inte rne ge ne e sk unde Ne uro lo gie

211072

O ve rige a ando eninge n va n het centra le ze nuwste lse l

0531, 0599, 1301

7

He e lk unde

91098

O ve rige perife re va a tzie k te n, zie k te va n Buë rge r e n m e se nteria a l tro m bose

336, 431, 439

7

Ga stro e ntero lo gie

71098

Va scula ir be paa lde da rm aa ndoe ninge n

405

7 7

C a rdio lo gie C a rdio lo gie

31171 31077

Ernstige co ngenita le a fwijk inge n Acuut ge wrichtsre um a , chro nische reum a tische ha rtaa ndoe ninge n

502 501, 702

7

Inte rne ge ne e sk unde

21010

Ma ligne neo plasm a m a a g/oe sofa gus/o verige tractus dige stivus

904, 914

7

Inte rne ge ne e sk unde

21003

HIV/AIDS (incl. Kapo si sarcoo m )

461

8 8

He e lk unde R e um a to logie

91027 51049

Dia be te s m e t chro nische com plicatie s Infe ctie s van bo t

432 109, 604, 718

8

Longzie k ten

41105

C hro nische o bstructie ve lo ngzie k te n (C O P D) (e x cl. astm a)

1241

8

Inte rne ge ne e sk unde

21115

Nierziek te n, ne fritis, ne frotisch syndro o m e n nefro se

301, 323, 324

9

Ke el-, ne us-, o o rhe e lk unde

231008

Ma ligne neo plasm a m o ndho lte/farynx /tractus re spira torius/m a ndibula e n wek e dele n

9

De rm ato lo gie

222134

Va scula ir be paa lde a a ndo e ninge n

21, 64, 69, 22,

9

Ne uro lo gie

211070

De gene ra tie ve ziek te n va n he t ce ntra le zenuwste lse l

6

407

129

60, 61, 62, 63, 65, 66, 67, 68, 72 25

0432, 0501, 0521, 0522, 0541, 0542, 0551

9

He e lk unde

91134

C hro nisch ulcus va n de huid

150, 427

9

He e lk unde

91009

Ma ligne neo plasm a o e so fa gus/le ve r/pa ncrea s/galwe ge n e n a m pulla Va te ri

315, 332

9

R e um a to logie

51048

R he um a to ïde a rtritis en a a ndo e ningen van bindwe efse l

101, 301, 306, 310,

112, 303, 307, 311,

114, 201, 304, 305, 308, 309, 312

9

Inte rne ge ne e sk unde

21055

Im m uunde ficië nties, blo e dzie k te n

313, 704, 712, 729,

493, 705, 719, 741,

527, 703, 706, 711, 721, 723, 742

9

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21021

214, 264, 843

21016

Ma ligne neo plasm a be wegingsa ppa ra at e n e ndo crie ne k lie re n Ma ligne neo plasm a ute rus/cervix

822, 823

10

Ga stro e ntero lo gie

71034

Leve raa ndoe ninge n, oe sofa gusvarice s en HIV/AIDS

701, 708, 709, 714

10

Ga stro e ntero lo gie

71009

Ma ligne neo plasm a o e so fa gus/ca rdia/pa ncre a s

307, 735, 755

10

21017 211144

Ma ligne neo plasm a o varium /uterusadne x a (incl. m e tasta se n) Fractuur van de we rvelk o lo m m et ruggem e rgle tsel

821

11

Inte rne ge ne e sk unde Ne uro lo gie

11

Ne uro lo gie

211007

Ne opla sm a ta (incl. m e tasta se n)

0201, 0211, 0221, 0231, 0241, 0299

11

O rtho pedie

113171

C o nge nitale a ando eninge n + fra ctuur va n de werve lk o lom m e t rugge nm e rgle tsel

1010, 1020, 3005, 1397

11 11

Uro logie Longzie k ten

101072 41013

Aa ndo e ningen van he t ce ntra le ze nuwstelsel Ma ligne neo plasm a tra ctus respira to rius e n o verige ne opla sm a

37 1303, 1304, 1305, 1306, 1307

11

Longzie k ten

41007

Me ta sta sen (intra tho ra ca a l)

1308

11

Inte rne ge ne e sk unde

23171

Ernstige co ngenita le a fwijk inge n + oste o-artro se

304, 514, 921

11

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21084

Angina pe cto ris

101

21018

Ma ligne neo plasm a pro sta a t/te stis/m anne lijk e ge sla chtso rgane n

831, 832

11

Inte rne ge ne e sk unde

21014

Bo rstk a nk e r (incl. m e ta sta sen)

811

11

Inte rne ge ne e sk unde

21009

Ma ligne neo plasm a pa ncre as

964

11

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21008

Ma ligne neo plasm a m o ndho lte/farynx /tractus re spirato rius

623, 801

21007

O ve rige m aligne ne opla sm a (incl. m e ta sta se n)

624, 802, 839, 841, 842, 899, 955, 979

12

Ne uro lo gie

211171

Ernstige co ngenita le a fwijk inge n

0302, 1399

12

Ga stro e ntero lo gie

72007

O ve rige m aligne ne opla sm a (incl. m e ta sta se n)

408, 712, 906

12 12

Longzie k ten Longzie k ten

42089 41111

Ziek te n va n ha rt e n lo ngcircula tie Bro nchië cta sie ë n, pne um o co nio sen e n ove rige longzie k ten

1801, 1803, 2101 1403, 1404, 1601

12

Inte rne ge ne e sk unde

21019

Ma ligne neo plasm a bla as/nier/ove rige urine -o rgane n

833, 834

12

Inte rne ge ne e sk unde

21015

Ma ligne neo plasm a lym fa tisch e n blo e dvo rm end wee fsel

714, 751, 752, 753, 754, 756, 757, 759, 761, 762, 763, 771

12

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21013

Ma ligne neo plasm a tra che a , bro nchus, lo ng, tho rax e n m e dia stinum (incl. m e tasta se n) (Thuis) dialyse

621, 622, 629

9

11

11

13

175

1411

322, 325, 326, 328, 331, 332, 333, 334,

335, 336, 337, 338 Tabel 2, bedoeld in artikel 8.3, vijfde lid, voor de indeling in DKG’s in het jaar 2011 voor de uitkering, bedoeld in artikel 118a, eerste lid, van de wet, die betrekking heeft op heeft op het jaar 2013 Toelichting op de tabel indeling DKG’s Inde ling in nDx gro e pen 173, 174 en 176 is ge ba se e rd o p de in de ta be l ge noe m de DBC -be hande lcode s. Inde ling in nDx gro e p 175 is ge ba see rd o p in de ta be l ge noe m de DBC -dia gno se co de s van a lle DBC ’s (po lik linisch, da go pna m e e n k linisch). Inde ling in de ove rige nDx gro e pe n is ge ba see rd o p de in de ta be l geno e m de DBC -dia gnose co de s va n DBC ’s m e t e e n k linische pe riode . Bij e e n DBC m e t e en k linische pe rio de is het la a tste cijfer va n de DBC -beha nde lco de e e n 3. DKG Specia lism e

nDx gro e p O m schrijving

1

Klinische ge ria trie

333025

Dia be te s m e llitus zo nde r/m e t nie t gespecifice e rde co m plica tie s + chro nische obstructie ve lo ngziek te n (C O P D) + rhe um a to ïde a rtritis en a a ndo e ningen van bindwe efse l + e pile psie , co nvulsies + chro nisch ulcus va n de huid + o ste o a rtro se

1

Klinische ge ria trie

331093

C e re bro vasculaire a ando eninge n

263

1

Klinische ge ria trie

331070

De gene ra tie ve ziek te n va n he t ce ntra le zenuwste lse l

252

1 1

O o ghee lk unde O rtho pedie

243021 111050

Ma ligne neo plasm a o o g + m e ninge o om O ste o-artro se

509, 659, 854 1201, 1401, 1501, 1601, 1701, 1801, 2001

1

Uro logie

101150

Inwe ndig le tsel van buik

13

1

He e lk unde

91150

Inwe ndig le tsel van bo rst, buik e n be k k en, bra ndwo nde n

274, 275, 279, 284

1 1

He e lk unde He e lk unde

91092 91036

Afsluiting e n ste no se va n pre ce re bra le arte rië n Ulcus ve ntriculi, -duo de ni, -pe pticum , -ga stro je juna lis

402 321

1

Ga stro e ntero lo gie

71036

Ulcus ve ntriculi, -duo de ni, -pe pticum , -ga stro je juna lis

402, 403

1

R e um a to logie

53098

Va ata a ndo e ninge n + a cuut gewrichtsre um a, chro nische re um a tische ha rtaa ndoe ninge n

106, 399

1 1

Longzie k ten C a rdio lo gie

41097 31085

Arte rië le , ove rige ve ne uze em bo lie e n tro m bose Ge leidingssto o rnisse n en ha rt dysritm ieë n

1802 404, 409

1

Inte rne ge ne e sk unde

21097

Em bo lie e n trom bo se

122, 732, 733

1

Inte rne ge ne e sk unde

21086

Atrium fibrille ren e n 'flutte r'

106

1

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21081

Dre ige nd, acuut e n po st m yo ca rd infa rct

102, 103

21036

Ulcus ve ntriculi, -duo de ni, -pe pticum , -ga stro je juna lis

913, 915, 916, 919

2

Klinische ge ria trie

331089

Ziek te n va n de lo ngcircula tie , ha rtde co m pensatie

262

2

Ne uro lo gie

211073

Epile psie, convulsie s

601

2 2

Ne uro lo gie He e lk unde

211048 93050

R he um a to ïde a rtritis en a a ndo e ningen van bindwe efse l O ste o-artro se + rhe um a to ïde a rtritis e n a a ndo e ninge n va n bindwe efse l

0312, 0313 254, 401

2

He e lk unde

91043

Da rm divertik e ls

327

2

Ga stro e ntero lo gie

71089

C a rdio lo gische a a ndo e ninge n

907

2 2

C a rdio lo gie C a rdio lo gie

31097 31086

Ve ne uze e m bo lie e n tro m bo se (incl. longe m bo lie ) Atrium fibrille ren e n 'flutte r'

602 401, 402

1

DBC dia gnose co de (a lle DBC ’s) 222, 251, 272, 312, 321, 323

DBC -be ha ndelco de

2

C a rdio lo gie

31083

O ve rige (sub)a cute vo rm e n va n ischem ische ha rtzie k te n

203

2

C a rdio lo gie

31081

P o st e n acuut m yo ca rd infa rct, pe rica rditis e n a rterië le vaa ta fsluiting

204, 205, 609, 701

2

Inte rne ge ne e sk unde

21049

Infe ctie s van bo t

451, 453

2

Inte rne ge ne e sk unde

21035

Ziek te n va n de o e so fa gus

901, 902, 903, 906, 907, 909

3

Ne uro lo gie

213027

Dia be te s m e t co m plica ties e n he patisch co m a + nietne uro lo gische a a ndo e ninge n

0311, 9919

3

Ne uro lo gie

211093

C e re bro vasculaire a ando eninge n (incl. he m iple gie )

1101, 1102, 1103, 1111, 1121, 1199

3 3

Gyna e co logie Gyna e co logie

151017 151016

Ma ligne neo plasm a pla ce nta /o varium /uterusadne x a Ma ligne neo plasm a ute rus/cervix /vro uwe lijk e ge sla chtso rgane n

M16, M17 M11, M12, M13, M14, M15

3

O rtho pedie

111048

(Infe ctie uze ) a rtritide n en o ste o m ye litis

1394, 1402, 1502, 1602, 1702, 1802, 2002

3

He e lk unde

92153

Inta cra nie e l le tsel zonde r sche delfra ctuur en fra ctuur va n de 204, 273 we rve lk o lo m m e t rugge nm e rgletse l

3 3

He e lk unde He e lk unde

91070 91037

De gene ra tie ve ziek te n va n he t ce ntra le zenuwste lse l Ma a gaa ndoe ninge n, ove rige a ando eninge n duo de num e n functiesto ornisse n va n de darm

296 340

3

He e lk unde

91032

Ziek te n va n he t pa ncrea s, absorptie sto o rnisse n va n de da rm

337

3

He e lk unde

91021

Ma ligne neo plasm a schildk lie r, huid e n be we gingsa ppa ra a t

303, 350, 352

3

He e lk unde

91013

3

He e lk unde

91011

Ma ligne neo plasm a tra che a , bro nchus, lo ng, pleura , thym us 313, 314 e n m e diastinum (incl. m e ta sta sen) Ma ligne neo plasm a va n he t co lon (incl. o ve rgang va n 333, 334 sigm o ïd in rectum )

3

Ga stro e ntero lo gie

71041

Ente ritis re gio na lis, idio pa thische proctocolitis

601, 602

3

Ga stro e ntero lo gie

71035

Ziek te n va n de o e so fa gus (incl. le tse l)

301, 302, 303, 304, 306, 308

3

Ga stro e ntero lo gie Ga stro e ntero lo gie

71025

Dia be te s m e llitus

902

71011

Ma ligne neo plasm a va n he t co lon/re ctum (incl. m e ta sta sen) 610

3

R e um a to logie

51050

O ste o-artro se

402, 403, 404, 405

3

C a rdio lo gie

31084

Angina pe cto ris

202

3

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21088

Longa ando eninge n

609

21077

O ve rige ca rdia le aa ndoe ninge n

104, 119, 432

3

Inte rne ge ne e sk unde

21043

Dive rticulitis

924

3

Inte rne ge ne e sk unde

21037

O ve rige m aa g- e n da rm a ando eninge n

911, 917, 931, 937, 939

3

21025 111049

Dia be te s m e llitus zo nde r co m plica ties/ m e t ove rige co m plica tie s Ase ptische botne cro se e n (infe ctie uze ) a rtritide n en o ste o m ye litis m e t niet ge spe cifice erde lok a lisa tie

221, 223

4

Inte rne ge ne e sk unde O rtho pedie

4

Uro logie

101018

Ma ligne neo plasm a pro sta a t/te stis/m anne lijk e ge sla chtso rgane n (incl. m e ta sta se n)

40, 50, 60

4

He e lk unde

91096

Aneurysm a va n de a o rta e n o ve rige a neurysm a

403, 405, 406, 416

4

Ga stro e ntero lo gie Ga stro e ntero lo gie

71037

O ve rige m aa ga ando eninge n e n functie sto o rnisse n co lo n

71032

Ziek te n va n he t pa ncrea s, absorptie sto o rnisse n va n de da rm

201, 205, 206, 401, 406, 613 202, 409, 751, 753

3

3

4

1202, 1302, 1404, 1704

4

Longzie k ten

41110

Astm a

1201

4

C a rdio lo gie

31087

Ve ntricula ire ritm esto ornisse n

403

4

C a rdio lo gie

31080

O ve rige vo rm e n va n chro nische ische m ische ha rtaa ndoe ninge n en a rte rië le va a taa ndoe ninge n

601

4

Inte rne ge ne e sk unde

21093

C e re bro vasculaire a ando eninge n

121

4

Inte rne ge ne e sk unde

21089

Ziek te n va n de lo ngcircula tie , ha rtde co m pensatie

107, 125

4

Inte rne ge ne e sk unde

21041

Ente ritis re gio na lis, idio pa thische proctocolitis

922, 923

4

Inte rne ge ne e sk unde

21034

Aa ndo e ningen van le ve r e n ga lbla a s

412, 941, 942, 945, 959

174

R a dio the rapie

4

R a dio the rapie 0102, R a dio the rapie 0103, R a dio the rapie 0104, R a dio the rapie 0105, R a dio the rapie 0106, R a dio the rapie 0107, R a dio the rapie 0108, R a dio the rapie 0201, R a dio the rapie 0202, R a dio the rapie 0203, R a dio the rapie 0204, R a dio the rapie 0205

5

Ke el-, ne us-, o o rhe e lk unde

233171

Ernstige co ngenita le a fwijk inge n en m a ligne ne o pla sm a tra che a + be nigne ne o pla sm a he rse nen e n ze nuwstelsel

20, 38, 91

5

He e lk unde

92007

O ve rige neo plasm a (incl. m e tasta se n)

306, 348, 359

5 5

He e lk unde He e lk unde

91097 91014

Aa ndo e ningen gro te va ten Bo rstk a nk e r

409, 417 318

5

Inte rne ge ne e sk unde

21105

C hro nische o bstructie ve lo ngzie k te n (C O P D)/a stm a

601

5

Inte rne ge ne e sk unde

21032

Ziek te n va n he t pa ncrea s, absorptie sto o rnisse n va n de da rm

920, 961, 963, 969

5

Inte rne ge ne e sk unde

21011

Ma ligne neo plasm a colo n/re ctum (incl. m e tasta se n)

927

173

C he m o the rapie

5

Inte rne ge ne e sk unde 4101, Inte rne ge ne e sk unde 4102, Inte rne ge ne e sk unde 4103, Inte rne ge ne e sk unde 4201, Inte rne ge ne e sk unde 4202,

Inte rne ge ne e sk unde 4203, Inte rne ge ne e sk unde 4301, Inte rne ge ne e sk unde 4302, Inte rne ge ne e sk unde 4303, Inte rne ge ne e sk unde 4401, Inte rne ge ne e sk unde 4402, Inte rne ge ne e sk unde 4403, Inte rne ge ne e sk unde 4501, Inte rne ge ne e sk unde 4502, Inte rne ge ne e sk unde 4503, Inte rne ge ne e sk unde 4601, Inte rne ge ne e sk unde 4602, Inte rne ge ne e sk unde 4603, Longgene e sk unde 6041, Longgene e sk unde 6042, Longgene e sk unde 6043, Longgene e sk unde 6071, Longgene e sk unde 6072, Longgene e sk unde 6073, Longgene e sk unde 6081, Longgene e sk unde 6082, Longgene e sk unde 6083, Longgene e sk unde 6091, Longgene e sk unde 6092, Longgene e sk unde 6093, Ne uro lo gie 251, Ne uro lo gie 252,

Ne uro lo gie 253, R e um a to logie 211, R e um a to logie 212, R e um a to logie 213 6

176

Thuisbe a dem ing

Longgene e sk unde 3011, Longgene e sk unde 3012, Longgene e sk unde 3013, Longgene e sk unde 3021, Longgene e sk unde 3022, Longgene e sk unde 3023, Longgene e sk unde 3031, Longgene e sk unde 3032, Longgene e sk unde 3033, Ne uro lo gie 321, Ne uro lo gie 322, Ne uro lo gie 323

6

Ke el-, ne us-, o o rhe e lk unde

232007

O ve rige m aligne ne opla sm a (incl. m e ta sta se n)

42, 84

6

Gyna e co logie

151007

Me ta sta sen

M99

6

Uro logie

102019

Ma ligne neo plasm a bla as/(bij)nie r/o verige urine-o rga ne n (incl. m eta stase n)

10, 20, 30, 70

6 6

Uro logie He e lk unde

101171 91095

Ernstige co ngenita le a fwijk inge n P e rife re va a tzie k ten o nde rste e x tre m ite it en o ve rige vaa ta a ndo e ningen

19, 29, 39, 79 408, 412, 418, 419, 420, 449

6

He e lk unde

91049

Infe ctie s van bo t

293

6

He e lk unde

91041

Ente ritis re gio na lis, idio pa thische proctocolitis

325, 326

6 6

He e lk unde He e lk unde

91015 91012

Ma ligne neo plasm a lym fa tisch e n blo e dvo rm end wee fsel Ma ligne neo plasm a va n re ctum

353 335

6

He e lk unde

91010

Ma ligne neo plasm a m a a g/dunne da rm /o ve rige tra ctus dige stivus

330, 331, 349

6

Anesthesiolo gie

83070

De gene ra tie ve ziek te n va n he t ce ntra le zenuwste lse l + pe rife re va a tzie k ten

043, 063, 073, 110

6

71010 41048

Ma ligne neo plasm a m a a g (ex cl. ca rdia)/dunne da rm /ove rige tra ctus dige stivus R he um a to ïde a rtritis en a a ndo e ningen van bindwe efse l

407

6

Ga stro e ntero lo gie Longzie k ten

6

C a rdio lo gie

31089

Ziek te n va n de lo ngcircula tie , ha rtde co m pensatie , e n o ntste k inge n va n de hartspie r

301, 302, 509, 709

6

Inte rne ge ne e sk unde

21098

Va sculitide n, va scula ire da rm zie k te n e n va scula ire a a ndo e ningen van de ex tre m ite ite n

124, 599, 934

6

Inte rne ge ne e sk unde Inte rne ge ne e sk unde

21096

Aneurysm a ta e n o ve rige vasculaire a ando eninge n

129

21048

R he um a to ïde a rtritis en a a ndo e ningen van bindwe efse l

501, 506, 515, 521, 522, 524, 525, 526, 722

6

Inte rne ge ne e sk unde

21027

Dia be te s m e t chro nische com plicatie s

222

6

Inte rne ge ne e sk unde

21022

Be nigne ne o pla sm a herse ne n e n ze nuwste lse l

242, 243

7 7

Ne uro lo gie He e lk unde

211072 91098

O ve rige a ando eninge n va n het centra le ze nuwste lse l O ve rige perife re va a tzie k te n, zie k te va n Buë rge r e n m e se nteria a l tro m bose

0531, 0599, 1301 336, 431, 439

6

1602, 1603

e ntero lo gie 10

Ga stro e ntero lo gie

71009

Ma ligne neo plasm a o e so fa gus/ca rdia/pa ncre a s

307, 735, 755

10

Inte rne ge ne e sk unde

21017

Ma ligne neo plasm a o varium /uterusadne x a (incl. m e tasta se n)

821

11 11

Ne uro lo gie Ne uro lo gie

211144 211007

Fractuur van de we rvelk o lo m m et ruggem e rgle tsel Ne opla sm a ta (incl. m e tasta se n)

1411 0201, 0211, 0221, 0231, 0241, 0299

11

O rtho pedie

113171

C o nge nitale a ando eninge n + fra ctuur va n de werve lk o lom m e t rugge nm e rgle tsel

1010, 1020, 3005, 1397

11

Uro logie

101072

Aa ndo e ningen van he t ce ntra le ze nuwstelsel

37

11

Longzie k ten

41013

Ma ligne neo plasm a tra ctus respira to rius e n o verige ne opla sm a

1303, 1304, 1305, 1306, 1307

11

Longzie k ten

41007

Me ta sta sen (intra tho ra ca a l)

1308

11

Inte rne ge ne e sk unde

23171

Ernstige co ngenita le a fwijk inge n + oste o-artro se

304, 514, 921

11

Inte rne ge ne e sk unde

21084

Angina pe cto ris

101

11

Inte rne ge ne e sk unde

21018

Ma ligne neo plasm a pro sta a t/te stis/m anne lijk e ge sla chtso rgane n

831, 832

11

Inte rne ge ne e sk unde

21014

Bo rstk a nk e r (incl. m e ta sta sen)

811

11

Inte rne ge ne e sk unde

21009

Ma ligne neo plasm a pa ncre as

964

11

Inte rne ge ne e sk unde

21008

Ma ligne neo plasm a m o ndho lte/farynx /tractus re spirato rius

623, 801

11

Inte rne ge ne e sk unde Ne uro lo gie

21007

O ve rige m aligne ne opla sm a (incl. m e ta sta se n)

211171

Ernstige co ngenita le a fwijk inge n

624, 802, 839, 841, 842, 899, 955, 979 0302, 1399

12

Ga stro e ntero lo gie

72007

O ve rige m aligne ne opla sm a (incl. m e ta sta se n)

408, 712, 906

12

Longzie k ten

42089

Ziek te n va n ha rt e n lo ngcircula tie

1801, 1803, 2101

12 12

Longzie k ten Inte rne ge ne e sk unde

41111 21019

Bro nchië cta sie ë n, pne um o co nio sen e n ove rige longzie k ten Ma ligne neo plasm a bla as/nier/ove rige urine -o rgane n

1403, 1404, 1601 833, 834

12

Inte rne ge ne e sk unde

21015

Ma ligne neo plasm a lym fa tisch e n blo e dvo rm end wee fsel

714, 751, 752, 753, 754, 756, 757, 759, 761, 762, 763, 771

12

Inte rne ge ne e sk unde

21013

Ma ligne neo plasm a tra che a , bro nchus, lo ng, tho rax e n m e dia stinum (incl. m e tasta se n)

621, 622, 629

13

Inte rne ge ne e sk unde

175

(Thuis) dialyse

322, 325, 326, 328, 331, 332, 333, 334, 335, 336, 337, 338

12

Bijlage 6a [Vervallen per 01-01-2012] Bijlage 6b [Vervallen per 01-01-2012] Bijlage 7 [Vervallen per 01-01-2012]